{'idx': 1309, 'sentence': 'Proteins in the first group contain multiple HMG boxes , are non-sequence-specific , and recognize structural features as found in cruciform DNA and cross-over DNA .', 'label': {'cruciform DNA': 'DNA', 'HMG boxes': 'protein', 'cross-over DNA': 'DNA'}, 'response1': "['protein', 'DNA']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The example provides specific protein names and their corresponding entity labels, which directly match the entity types present in the target sentence."},\n{"Example 2": 5},\n{"Reason 2": "The example provides specific protein names and their corresponding entity labels, which directly match the entity types present in the target sentence."},\n{"Example 3": 5},\n{"Reason 3": "The example provides a specific protein name and its corresponding entity label, which directly matches the entity types present in the target sentence."},\n{"Example 4": 5},\n{"Reason 4": "The example provides specific protein names and cell type names with their corresponding entity labels, which directly match the entity types present in the target sentence."},\n{"Example 5": 5},\n{"Reason 5": "The example provides a specific entity type (protein) and its corresponding entity label, which directly matches the entity types present in the target sentence."},\n{"Example 6": 5},\n{"Reason 6": "The example provides a specific protein name and its corresponding entity label, which directly matches the entity types present in the target sentence."},\n{"Example 7": 5},\n{"Reason 7": "The example provides a specific entity type (DNA) and its corresponding entity label, which directly matches the entity types present in the target sentence."},\n{"Example 8": 5},\n{"Reason 8": "The example provides a specific entity type (DNA) and its corresponding entity label, which directly matches the entity types present in the target sentence."},\n{"Example 9": 5},\n{"Reason 9": "The example provides specific protein names and their corresponding entity labels, which directly match the entity types present in the target sentence."},\n{"Example 10": 5},\n{"Reason 10": "The example provides specific protein names and their corresponding entity labels, which directly match the entity types present in the target sentence."},\n{"Example 11": 5},\n{"Reason 11": "The example provides specific protein names, a DNA entity, and a cell type name with their corresponding entity labels, which directly match the entity types present in the target sentence."},\n{"Example 12": 5},\n{"Reason 12": "The example provides specific DNA and protein names with their corresponding entity labels, which directly match the entity types present in the target sentence."},\n{"Example 13": 5},\n{"Reason 13": "The example provides specific DNA and protein names with their corresponding entity labels, which directly match the entity types present in the target sentence."},\n{"Example 14": 5},\n{"Reason 14": "The example provides specific protein names, a cell line name, and a DNA entity with their corresponding entity labels, which directly match the entity types present in the target sentence."},\n{"Example 15": 1},\n{"Reason 15": "The example does not contain any entity names or terms that match the entity types present in the target sentence."},\n{"Example 16": 1},\n{"Reason 16": "The example does not contain any entity names or terms that match the entity types present in the target sentence."},\n{"Example 17": 1},\n{"Reason 17": "The example does not contain any entity names or terms that match the entity types present in the target sentence."},\n{"Example 18": 1},\n{"Reason 18": "The example does not contain any entity names or terms that match the entity types present in the target sentence."},\n{"Example 19": 1},\n{"Reason 19": "The example does not contain any entity names or terms that match the entity types present in the target sentence."}\n]', 'response3': "[{'HMG boxes': 'protein'}, {'DNA': 'DNA'}, {'DNA': 'DNA'}]", 'prediction': {'HMG boxes': 'protein', 'DNA': 'DNA'}}
{'idx': 228, 'sentence': 'We have carried out experiments to define the nature of the higher affinity CVZ binding site .', 'label': {'higher affinity CVZ binding site': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 3},\n{"Reason 1": "The sentence contains relevant terms such as \'cDNAs\' and \'cloned and sequenced\', which are indicative of DNA entities. However, the sentence lacks explicit mentions of DNA entities."},\n{"Example 2": 4},\n{"Reason 2": "The sentence explicitly mentions protein names such as \'EKLF\', \'CBP\', \'p300\', and \'P/CAF\', which are strong indicators of protein entities."},\n{"Example 3": 4},\n{"Reason 3": "The sentence mentions \'G-CSF\', which is a protein, and indicates its role in binding to receptors, supporting the identification of G-CSF as a protein entity."},\n{"Example 4": 3},\n{"Reason 4": "The sentence refers to \'immunoglobulin kappa 3\' enhancer\', which suggests a DNA entity. However, the sentence lacks explicit mentions of DNA entities."},\n{"Example 5": 4},\n{"Reason 5": "The sentence mentions \'CD95 ligand\', which is a protein, and describes its promoter elements, supporting the identification of CD95 ligand as a protein entity."},\n{"Example 6": 4},\n{"Reason 6": "The sentence explicitly mentions \'DNA binding activity\', indicating the presence of DNA entities."},\n{"Example 7": 4},\n{"Reason 7": "The sentence mentions \'SCM-1 genes\', which suggests a cell line entity."},\n{"Example 8": 4},\n{"Reason 8": "The sentence refers to \'cell adhesion molecules\', indicating a cell type entity."},\n{"Example 9": 4},\n{"Reason 9": "The sentence mentions \'E2A gene\' and \'E2A protein\', which are indicative of protein entities."},\n{"Example 10": 4},\n{"Reason 10": "The sentence mentions \'NF-kappa B\', which is a protein, and describes its activation processes, supporting the identification of NF-kappa B as a protein entity."},\n{"Example 11": 4},\n{"Reason 11": "The sentence mentions \'BRCA1\', which is a protein, and describes its splicing and expression, supporting the identification of BRCA1 as a protein entity."},\n{"Example 12": 4},\n{"Reason 12": "The sentence mentions \'TCF-1\', which is a protein, and describes its immunization, supporting the identification of TCF-1 as a protein entity."},\n{"Example 13": 4},\n{"Reason 13": "The sentence mentions \'retinoic acid receptor alpha\', which is a protein, and describes its kDa values, supporting the identification of retinoic acid receptor alpha as a protein entity."},\n{"Example 14": 4},\n{"Reason 14": "The sentence mentions \'CREB\' and \'AR-CRE\', which are indicative of protein entities."},\n{"Example 15": 4},\n{"Reason 15": "The sentence mentions \'SIVsmmPBj14\', which is a cell line entity."},\n{"Example 16": 4},\n{"Reason 16": "The sentence mentions \'protein\', indicating the presence of a protein entity."},\n{"Example 17": 2},\n{"Reason 17": "The sentence discusses \'developmentally related interaction\' but does not explicitly mention any specific entity types."},\n{"Example 18": 1},\n{"Reason 18": "The sentence discusses \'inhibition of protein synthesis\' and \'chromatin fragmentation\' but does not provide specific entity mentions."},\n{"Example 19": 1},\n{"Reason 19": "The sentence mentions \'complex translocations\' and \'genes\' but does not specify any entity types."},\n{"Example 20": 1},\n{"Reason 20": "The sentence refers to \'deletions or mutations\' and \'serum response\' but does not provide specific entity mentions."},\n{"Example 21": 1},\n{"Reason 21": "The sentence mentions \'pulmonary surfactant\' and \'immunomodulatory activity\' but does not specify any entity types."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 51, 'sentence': 'Such segments accord well with empirically known T-cell determinants and our algorithm produces a lower number of false positive predictions than the principle based on discrete Fourier transformations previously described.', 'label': {'T-cell determinants': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with their corresponding entity labels, which can aid in understanding and identifying similar entities in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1518, 'sentence': 'Anti-immunoglobulin M activates nuclear calcium/calmodulin-dependent protein kinase II in human B lymphocytes .', 'label': {'nuclear calcium/calmodulin-dependent protein kinase II': 'protein', 'human B lymphocytes': 'cell_type', 'Anti-immunoglobulin M': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"IL-13 , a cytokine similar to IL-4 , is a regulator of human B cell and monocyte functions .": 5},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .": 5},\n    {"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 5},\n    {"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .": 5},\n    {"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .": 5},\n    {"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.": 5},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 563, 'sentence': 'The 6-h increase in PDGF(B) mRNA was adherence dependent, and in addition, was abrogated when the cytoskeletal integrity was compromised by cytochalasin D .', 'label': {'PDGF(B)': 'protein', 'PDGF(B) mRNA': 'RNA'}, 'response1': "['RNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence directly mentions the entity \'DNA\' and provides clear context for its presence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence directly mentions the entity \'RNA\' and provides clear context for its presence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence mentions multiple entities such as \'PAFR\', \'PAF\', \'NF-kappa B\', and \'protein kinase C\' with clear context for their presence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence mentions \'TIMP-1\' and \'DNA\' with clear context for their presence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence mentions \'IL-2\', \'c-Jun\', and \'c-Fos\' as entities with clear context for their presence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence mentions \'MNDA\' and \'myeloid cell lines\' as entities with clear context for their presence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence mentions \'NF-kappa B\' and \'DNA\' with clear context for their presence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions \'CD14\' as an entity with clear context for its presence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence mentions \'Bak\', \'Bad\', \'Bcl-2\', \'PDBu\', and \'DMSO\' as entities with clear context for their presence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence mentions \'P selectin\' as an entity with clear context for its presence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence mentions \'CD14\' and \'CD23\' as entities with clear context for their presence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence mentions \'p21(WAF1/CIP1)\' and \'p27(KIP1)\' as entities with clear context for their presence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence mentions \'cell adhesion molecules\' as an entity with clear context for its presence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence mentions \'CD70\', \'B cell\', \'plasma cells\', \'IL-4\', and \'CD40\' as entities with clear context for their presence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence mentions multiple entities such as \'Protein kinase B\', \'phosphatidylinositol 3-kinase\', \'STAT5\', \'erythropoietin\', \'HCD57\', \'EPO\', \'HCD57-SREI\', and \'c-Akt\' with clear context for their presence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not mention any specific entities related to the given label set."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not mention any specific entities related to the given label set."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not mention any specific entities related to the given label set."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not mention any specific entities related to the given label set."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not mention any specific entities related to the given label set."}\n]', 'response3': '[{"PDGF(B) mRNA": "RNA"}]', 'prediction': {'PDGF(B) mRNA': 'RNA'}}
{'idx': 501, 'sentence': 'Southwestern and gel renaturation experiments with the use of purified protein fractions revealed that TCF-1 alpha activity is derived from a family of 57- to 53-kD proteins that are abundantly expressed in mature and immature T-cell lines ( Jurkat , CCRF-CEM ) and not in mature B cells ( JY , Namalwa ) or nonlymphoid (HeLa) cell lines .', 'label': {'CCRF-CEM': 'cell_line', 'TCF-1 alpha': 'protein', 'nonlymphoid (HeLa) cell lines': 'cell_line', 'mature B cells': 'cell_line', 'JY': 'cell_line', 'Namalwa': 'cell_line', '57- to 53-kD proteins': 'protein', 'Jurkat': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 4},\n    {"Example 3": 5},\n    {"Example 4": 4},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 4},\n    {"Example 10": 3},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[\n    {"TCF-1 alpha": "protein"},\n    {"57- to 53-kD proteins": "protein"},\n    {"Jurkat": "cell_line"},\n    {"CCRF-CEM": "cell_line"},\n    {"mature B cells": "cell_type"},\n    {"JY": "cell_line"},\n    {"Namalwa": "cell_line"},\n    {"HeLa": "cell_line"}\n]', 'prediction': {'TCF-1 alpha': 'protein', '57- to 53-kD proteins': 'protein', 'Jurkat': 'cell_line', 'CCRF-CEM': 'cell_line', 'mature B cells': 'cell_type', 'JY': 'cell_line', 'Namalwa': 'cell_line', 'HeLa': 'cell_line'}}
{'idx': 457, 'sentence': 'TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes .', 'label': {'T lymphocytes': 'cell_type', 'TAR': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 5},\n    {"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .": 5},\n    {"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .": 5},\n    {"Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 285, 'sentence': 'ER content in lymphocytes of each sample was expressed by both fmol/mg of lymphocyte cytosolic protein and fmol/micrograms of lymphocyte DNA .', 'label': {'ER': 'protein', 'lymphocyte DNA': 'DNA', 'lymphocytes': 'cell_type', 'lymphocyte cytosolic protein': 'protein'}, 'response1': "['protein', 'DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names that are directly mentioned, making it highly relevant for identifying protein entities."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions a specific protein name, WT1, which is helpful for identifying protein entities."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence mentions a specific cell type, Th2-type lymphocytes, which is helpful for identifying cell type entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains specific protein names (NF-ATc) and cell type (T lymphocytes) that are directly mentioned, making it highly relevant for identifying protein and cell type entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains specific protein names (CD70, IL-4, CD40) and cell types (B cell, plasma cells) that are directly mentioned, making it highly relevant for identifying protein and cell type entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains specific protein names (IFN A, IFNA, interleukin-2, interleukin-2 receptor) and stimuli (phytohemagglutinin, phorbol myristate acetate) that are directly mentioned, making it highly relevant for identifying protein entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence mentions specific cell types (granulocytes, T cells) which are directly relevant for identifying cell type entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions a specific protein name, Egr-1, which is helpful for identifying protein entities."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence mentions specific cell type (CD4+) and protein (EBV) which are helpful for identifying cell type and protein entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains specific protein names (IL-2, c-Jun, c-Fos) that are directly mentioned, making it highly relevant for identifying protein entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence mentions specific cell type (PBMC) and entity type (adenovirus DNA) which are directly relevant for identifying cell type and DNA entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains specific protein names (myeloperoxidase, lysozyme, PU.1) that are directly mentioned, making it highly relevant for identifying protein entities."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence mentions a specific protein name, E2A, which is helpful for identifying protein entities."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence mentions a specific protein name, RXR, which is helpful for identifying protein entities."},\n    {"Example 15": 4},\n    {"Reason 15": "The sentence mentions specific cell line (EBV) and protein (CD2) which are helpful for identifying cell line and protein entities."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence mentions specific cell line (Ter 119) and protein names (beta-globin, glycoprotein IIb, platelet factor 4) which are helpful for identifying cell line and protein entities."}\n]', 'response3': '[{"lymphocyte cytosolic protein": "protein"}, {"lymphocyte DNA": "DNA"}]', 'prediction': {'lymphocyte cytosolic protein': 'protein', 'lymphocyte DNA': 'DNA'}}
{'idx': 1508, 'sentence': 'Functional characterization of the murine homolog of the B cell-specific coactivator BOB.1/OBF.1 .', 'label': {'BOB.1/OBF.1': 'protein', 'B cell-specific coactivator': 'protein', 'murine homolog': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear and direct mention of the entity with its corresponding label, aiding in the extraction process."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains specific mentions of entities with their corresponding labels, facilitating accurate extraction of named entities."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence directly mentions the entity with its label, making it highly useful for named entity extraction."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides a clear mention of the entity with its label, aiding in accurate extraction of named entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains specific mentions of entities with their corresponding labels, making it highly helpful for named entity extraction."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence directly mentions the entities with their labels, facilitating accurate extraction of named entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides a clear mention of the entity with its label, aiding in the extraction process."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains specific mentions of entities with their corresponding labels, making it highly useful for named entity extraction."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence directly mentions the entities with their labels, facilitating accurate extraction of named entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides a clear mention of the entity with its label, aiding in accurate extraction of named entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains specific mentions of entities with their corresponding labels, making it highly helpful for named entity extraction."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence directly mentions the entities with their labels, facilitating accurate extraction of named entities."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides a clear mention of the entity with its label, aiding in the extraction process."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains specific mentions of entities with their corresponding labels, making it highly useful for named entity extraction."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence directly mentions the entities with their labels, facilitating accurate extraction of named entities."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any specific entities or labels that can aid in named entity extraction."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not provide any specific entities or labels that can assist in named entity extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence lacks specific entities or labels that can aid in named entity extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific entities or labels that can assist in named entity extraction."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 209, 'sentence': 'Type-II estrogen -binding sites ( type-II EBS ) have been demonstrated in the human lymphoblastoid cell line IM-9 using a whole-cell assay with (6,7-3H) estradiol ( 3H-E2 ) as tracer.', 'label': {'lymphoblastoid cell line': 'cell_line', 'IM-9': 'cell_line', 'type-II EBS': 'protein', 'Type-II estrogen -binding sites': 'protein', 'human lymphoblastoid cell line': 'cell_line'}, 'response1': "['cell_line', 'protein']", 'response2': '[\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 4},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .": 3},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 4},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 3},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .": 4},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .": 4},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .": 5},\n    {"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus , and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development .": 5},\n    {"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.": 5},\n    {"Expression of tal-1 and GATA-binding proteins during human hematopoiesis .": 4},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5}\n]', 'response3': '[{"IM-9": "cell_line"}, {"estradiol": "protein"}]', 'prediction': {'IM-9': 'cell_line', 'estradiol': 'protein'}}
{'idx': 1385, 'sentence': "Mutational analyses of the HIV-1 LTR showed that one C/EBP site is required for normal LTR transcription both before and after cellular activation and that the two 3' C/EBP sites are functionally equivalent.", 'label': {'LTR': 'DNA', 'HIV-1 LTR': 'DNA', 'C/EBP sites': 'DNA', 'C/EBP site': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 4},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 4},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n    {"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF.": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.": 5},\n    {"Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB- induced trans-activation of the H4 promoter.": 5},\n    {"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 4},\n    {"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"C/EBP": "protein"}, {"HIV-1 LTR": "DNA"}]', 'prediction': {'C/EBP': 'protein', 'HIV-1 LTR': 'DNA'}}
{'idx': 1516, 'sentence': 'Fusion of subdomains of BOB.1/OBF.1 with the GAL4 DNA binding domain reveals that both NH2- and COOH- terminal domains of BOB.1/OBF.1 contribute to full transactivation function, the COOH-terminal domain is more efficient in this transactivation assay .', 'label': {'BOB.1/OBF.1': 'protein', 'GAL4 DNA binding domain': 'protein', 'COOH-terminal domain': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"BOB.1/OBF.1": "protein"}, {"GAL4 DNA binding domain": "DNA"}]', 'prediction': {'BOB.1/OBF.1': 'protein', 'GAL4 DNA binding domain': 'DNA'}}
{'idx': 1827, 'sentence': 'A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR-1 .', 'label': {'human interleukin 2 gene promoter': 'DNA', 'EGR-1': 'protein', 'Sp1': 'protein', 'regulatory element': 'DNA', 'binding site': 'DNA', 'zinc finger proteins': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific gene names and protein names that are directly related to the entity labels in the entity label set, making it highly relevant for extracting named entities."}\n]', 'response3': '[{"interleukin 2": "protein"}, {"Sp1": "protein"}, {"EGR-1": "protein"}]', 'prediction': {'interleukin 2': 'protein', 'Sp1': 'protein', 'EGR-1': 'protein'}}
{'idx': 1116, 'sentence': 'The tumour suppressor p53 has been shown to regulate this type of apoptosis in thymocytes , but an as yet unknown, p53 -independent pathway (s) appears to mediate the same event in mitogen-activated mature T lymphocytes .', 'label': {'thymocytes': 'cell_type', 'p53': 'protein', 'mitogen-activated mature T lymphocytes': 'cell_line', 'tumour suppressor p53': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .": 5},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .": 4},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .": 4},\n    {"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .": 4},\n    {"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 4},\n    {"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .": 5},\n    {"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 5},\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"The process of apoptosis is used to eliminate unwanted cells from a wide variety of organisms.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 178, 'sentence': 'T lymphocytes appeared to be an important source of 1,25(OH)2D3 production , since purified T lymphocytes from all patients with tuberculosis produced 1,25(OH)2D3 , and 1,25(OH)2D3 production by these cells correlated closely with that produced by unseparated lavage cells .', 'label': {'T lymphocytes': 'cell_type', 'lavage cells': 'cell_type'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence provides a clear example of a protein entity (TCL1) and its corresponding entity label."},\n{"Example 2": 4},\n{"Reason 2": "The sentence contains examples of cell types (granulocytes and T cells) which are relevant to the target sentence."},\n{"Example 3": 5},\n{"Reason 3": "The sentence explicitly mentions a protein entity (CD14) and its corresponding entity label."},\n{"Example 4": 5},\n{"Reason 4": "The sentence provides multiple examples of protein entities (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) which are relevant to the target sentence."},\n{"Example 5": 5},\n{"Reason 5": "The sentence mentions a protein entity (ZAP-70) and its corresponding entity label."},\n{"Example 6": 4},\n{"Reason 6": "The sentence contains examples of cell type (T lymphocytes) and protein entity (HLA-molecules) which are relevant to the target sentence."},\n{"Example 7": 5},\n{"Reason 7": "The sentence provides examples of protein entity (NF-ATc) and cell type (T lymphocytes) which are relevant to the target sentence."},\n{"Example 8": 4},\n{"Reason 8": "The sentence contains examples of a cell line (EBV) and a protein entity (CD2) which are relevant to the target sentence."},\n{"Example 9": 4},\n{"Reason 9": "The sentence mentions a cell type (Th2-type lymphocytes) which is relevant to the target sentence."},\n{"Example 10": 5},\n{"Reason 10": "The sentence provides examples of cell type (T cell), protein entities (IL-2, IL-2 receptor, CD28) which are relevant to the target sentence."},\n{"Example 11": 5},\n{"Reason 11": "The sentence contains examples of protein entities (CD70, IL-4, CD40) and cell types (B cell, plasma cells) which are relevant to the target sentence."},\n{"Example 12": 5},\n{"Reason 12": "The sentence provides examples of protein entities (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) which are relevant to the target sentence."},\n{"Example 13": 5},\n{"Reason 13": "The sentence mentions protein entities (IL-2 receptor alpha subunit, p21ras) and a cell type (B cell) which are relevant to the target sentence."},\n{"Example 14": 5},\n{"Reason 14": "The sentence provides examples of cell types (B and T cell activation), cell lines (Ramos, Jurkat), and a DNA entity (cDNA microarray technology) which are relevant to the target sentence."},\n{"Example 15": 5},\n{"Reason 15": "The sentence contains examples of DNA entity (2-deoxyguanosine), cell types (lymphoid progenitor cells, thymus stromal cells, B cell, fetal liver cells, T cell), and a cell line (tg epsilon26) which are relevant to the target sentence."},\n{"Example 16": 1},\n{"Reason 16": "The sentence does not contain any entities relevant to the target sentence."},\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any entities relevant to the target sentence."},\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any entities relevant to the target sentence."},\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any entities relevant to the target sentence."},\n{"Example 20": 1},\n{"Reason 20": "The sentence does not contain any entities relevant to the target sentence."}\n]', 'response3': "[{'T lymphocytes': 'cell_type'}, {'1,25(OH)2D3': 'protein'}, {'tuberculosis': 'cell_type'}, {'unseparated lavage cells': 'cell_line'}]", 'prediction': {'T lymphocytes': 'cell_type', '1,25(OH)2D3': 'protein', 'tuberculosis': 'cell_type', 'unseparated lavage cells': 'cell_line'}}
{'idx': 1209, 'sentence': 'A reduction of serum androgens was found, whereas no change was observed in either basal or GnRH-stimulated gonadotropins or in the cortisol and 17 alpha-hydroxyprogesterone response to ACTH .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides clear examples of various entities with their corresponding labels, making it highly helpful for understanding how different entities are mentioned in the text."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence provides a specific example of an entity with its label, which is helpful for understanding how certain entities are referenced in the text."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence offers multiple examples of entities with their labels, aiding in understanding the different types of entities mentioned in the text."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence provides a specific example of an entity with its label, which is helpful for understanding how certain entities are referenced in the text."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence includes multiple examples of entities with their labels, providing a comprehensive view of the different types of entities mentioned in the text."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence offers clear examples of various entities with their corresponding labels, making it highly helpful for understanding how different entities are mentioned in the text."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides multiple examples of entities with their labels, aiding in understanding the different types of entities mentioned in the text."},\n    {"Example 8": 4},\n    {"Reason 8": "The sentence provides a specific example of an entity with its label, which is helpful for understanding how certain entities are referenced in the text."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence includes multiple examples of entities with their labels, providing a comprehensive view of the different types of entities mentioned in the text."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence offers clear examples of various entities with their corresponding labels, making it highly helpful for understanding how different entities are mentioned in the text."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides multiple examples of entities with their labels, aiding in understanding the different types of entities mentioned in the text."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence offers clear examples of various entities with their corresponding labels, making it highly helpful for understanding how different entities are mentioned in the text."},\n    {"Example 13": 4},\n    {"Reason 13": "The sentence provides a specific example of an entity with its label, which is helpful for understanding how certain entities are referenced in the text."},\n    {"Example 14": 3},\n    {"Reason 14": "The sentence provides an example of entities without labels, which may be less helpful for understanding the specific types of entities mentioned in the text."},\n    {"Example 15": 3},\n    {"Reason 15": "The sentence provides an example of entities without labels, which may be less helpful for understanding the specific types of entities mentioned in the text."},\n    {"Example 16": 3},\n    {"Reason 16": "The sentence provides an example of entities without labels, which may be less helpful for understanding the specific types of entities mentioned in the text."},\n    {"Example 17": 3},\n    {"Reason 17": "The sentence provides an example of entities without labels, which may be less helpful for understanding the specific types of entities mentioned in the text."},\n    {"Example 18": 3},\n    {"Reason 18": "The sentence provides an example of entities without labels, which may be less helpful for understanding the specific types of entities mentioned in the text."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 864, 'sentence': 'Differences in transcriptional enhancers of HIV-1 and HIV-2 .', 'label': {'transcriptional enhancers': 'DNA'}, 'response1': "['DNA', 'RNA']", 'response2': '[\n    {"Th1": 5, "Th2": 5},\n    {"UAS1": 4, "B cell": 5},\n    {"SIVsmmPBj14": 5},\n    {"hepatitis B virus": 5, "HBxAg": 5},\n    {"Th2-type lymphocytes": 5},\n    {"GATA-1": 5},\n    {"AP-1": 5},\n    {"T cell": 5, "interleukin 2": 5},\n    {"NF-ATc": 5, "T lymphocytes": 5},\n    {"IFN A": 5, "IFNA": 5, "interleukin-2": 5, "interleukin-2 receptor": 5, "phytohemagglutinin": 5, "phorbol myristate acetate": 5},\n    {"Egr-1": 5},\n    {"HIV-1": 5, "IFN": 5, "PKR": 5, "IkappaBalpha": 5},\n    {"HIV-1 LTR": 5, "NFAT-1": 5, "NF kappa B": 5},\n    {"TR55": 5, "TNF-alpha": 5, "HIV": 5},\n    {"NF-kappaB": 5, "Sp1": 5, "SIVmac": 5},\n    {"NF-E1": 5, "YY-1": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 65, 'sentence': 'Deletions upstream of the PRDII element increased transcription in the uninduced extract, indicating predominantly negative regulation of the promoter .', 'label': {'promoter': 'DNA', 'PRDII element': 'DNA'}, 'response1': "['DNA', 'RNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 61, 'sentence': 'From HeLa cells , two major proteins of 52 and 45 kilodaltons (kD) copurified with DNA binding activity , whereas from T-cells , four proteins--a major protein of 52 kD and three minor proteins of 82 , 67 , and 43-47 kD --were purified.', 'label': {'82': 'protein', '43-47 kD': 'protein', 'major protein': 'protein', 'T-cells': 'cell_type', 'minor proteins': 'protein', '67': 'protein', 'HeLa cells': 'cell_line', '52 kD': 'protein'}, 'response1': "['protein', 'cell_line', 'DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example contains specific protein names that are similar to the proteins mentioned in the target sentence, making it highly relevant for identifying protein entities."},\n    {"Example 2": 4},\n    {"Reason 2": "The example provides a specific protein name that is relevant to the target sentence, aiding in the identification of protein entities."},\n    {"Example 3": 4},\n    {"Reason 3": "The example contains specific protein names that are similar to the proteins mentioned in the target sentence, making it relevant for identifying protein entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The example contains specific protein names that are similar to the proteins mentioned in the target sentence, making it highly relevant for identifying protein entities."},\n    {"Example 5": 4},\n    {"Reason 5": "The example provides a specific protein name that is relevant to the target sentence, aiding in the identification of protein entities."},\n    {"Example 6": 4},\n    {"Reason 6": "The example provides a specific protein name that is relevant to the target sentence, aiding in the identification of protein entities."},\n    {"Example 7": 4},\n    {"Reason 7": "The example contains specific protein names that are similar to the proteins mentioned in the target sentence, making it relevant for identifying protein entities."},\n    {"Example 8": 4},\n    {"Reason 8": "The example provides a specific protein name that is relevant to the target sentence, aiding in the identification of protein entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The example contains specific protein names that are similar to the proteins mentioned in the target sentence, making it highly relevant for identifying protein entities."},\n    {"Example 10": 4},\n    {"Reason 10": "The example provides specific protein names and a cell type that are relevant to the target sentence, aiding in the identification of protein and cell type entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The example contains specific protein names that are similar to the proteins mentioned in the target sentence, making it highly relevant for identifying protein entities."},\n    {"Example 12": 4},\n    {"Reason 12": "The example provides specific protein names and a cell type that are relevant to the target sentence, aiding in the identification of protein and cell type entities."},\n    {"Example 13": 5},\n    {"Reason 13": "The example contains specific protein names that are similar to the proteins mentioned in the target sentence, making it highly relevant for identifying protein entities."},\n    {"Example 14": 4},\n    {"Reason 14": "The example provides specific DNA and protein names that are relevant to the target sentence, aiding in the identification of DNA and protein entities."},\n    {"Example 15": 5},\n    {"Reason 15": "The example contains specific DNA and protein names that are similar to the entities mentioned in the target sentence, making it highly relevant for identifying DNA and protein entities."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain any relevant entity names that can aid in identifying named entities in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain any relevant entity names that can aid in identifying named entities in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any relevant entity names that can aid in identifying named entities in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The example does not contain any relevant entity names that can aid in identifying named entities in the target sentence."}\n]', 'response3': "[{'HeLa cells': 'cell_line'}, {'T-cells': 'cell_line'}, {'DNA': 'DNA'}, {'protein': 'protein'}, {'52 kD': 'protein'}, {'45 kilodaltons (kD)': 'protein'}, {'82': 'protein'}, {'67': 'protein'}, {'43-47 kD': 'protein'}]", 'prediction': {'HeLa cells': 'cell_line', 'T-cells': 'cell_line', 'DNA': 'DNA', 'protein': 'protein', '52 kD': 'protein', '45 kilodaltons (kD)': 'protein', '82': 'protein', '67': 'protein', '43-47 kD': 'protein'}}
{'idx': 191, 'sentence': 'A block to RNA elongation is largely responsible for decreased c-myc transcription .', 'label': {'c-myc': 'DNA'}, 'response1': "['RNA']", 'response2': '[\n    {"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .": 5},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n    {"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 5},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 5},\n    {"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .": 5},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 447, 'sentence': 'Each binding site contributes to the overall activity of the enhancer , however no single element seems absolutely required for activity.', 'label': {'enhancer': 'DNA', 'binding site': 'DNA'}, 'response1': "['DNA']", 'response2': '[\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 3},\n    {"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 1},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 1},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 1},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 3},\n    {"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.": 3},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 3},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 3},\n    {"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 3},\n    {"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 3},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 3},\n    {"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 3},\n    {"We have found that the recruitment of EKLF to 5\'HS3 depends on the presence of 5\'HS2 in cis, but the recruitment to 5\'HS2 does not depend on 5\'HS3.": 3},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 3},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 3},\n    {"Our results demonstrate that the altered CCAAT box (CCAAC) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 3},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 476, 'sentence': 'A group of coordinately induced protooncogenes , cytoskeletal , and extracellular matrix genes have been termed immediate early response genes , and their induction has been associated with growth factor -stimulated cell proliferation .', 'label': {'protooncogenes': 'DNA', 'immediate early response genes': 'DNA', 'growth factor': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names that are directly mentioned, making it highly relevant for extracting protein entities."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions specific proteins and DNA, which are relevant for extracting protein and DNA entities."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence mentions a specific protein name, Egr-1, which is relevant for extracting protein entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains specific protein names (IL-2, c-Jun, c-Fos) that are directly mentioned, making it highly relevant for extracting protein entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains multiple specific protein names (CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, granulocyte-macrophage colony-stimulating factor) that are directly mentioned, making it highly relevant for extracting protein entities."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence mentions a specific protein name, IL-4, which is relevant for extracting protein entities."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence mentions a specific protein name, GATA-1, which is relevant for extracting protein entities."},\n    {"Example 8": 3},\n    {"Reason 8": "The sentence mentions immunohistochemistry, gene, and cell type, which are relevant for extracting protein and DNA entities as well as cell type entities."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence mentions a specific protein name, p21ras, which is relevant for extracting protein entities."},\n    {"Example 10": 4},\n    {"Reason 10": "The sentence mentions a specific protein name, NF-E2, which is relevant for extracting protein entities."},\n    {"Example 11": 4},\n    {"Reason 11": "The sentence mentions specific protein names (Syk, Zap) and T cell, which are relevant for extracting protein and cell type entities."},\n    {"Example 12": 4},\n    {"Reason 12": "The sentence mentions specific protein names (p21(WAF1/CIP1), p27(KIP1)) that are directly mentioned, making it relevant for extracting protein entities."},\n    {"Example 13": 4},\n    {"Reason 13": "The sentence mentions a specific protein name, NF-kappa B, which is relevant for extracting protein entities."},\n    {"Example 14": 4},\n    {"Reason 14": "The sentence mentions specific protein names (Stat proteins) that are directly mentioned, making it relevant for extracting protein entities."},\n    {"Example 15": 4},\n    {"Reason 15": "The sentence mentions specific cell types (B and T cell activation) and cell lines (Ramos, Jurkat), which are relevant for extracting cell type and cell line entities."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain specific entity names related to the entity labels in the target sentence, making it not helpful for extracting named entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain specific entity names related to the entity labels in the target sentence, making it not helpful for extracting named entities."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain specific entity names related to the entity labels in the target sentence, making it not helpful for extracting named entities."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain specific entity names related to the entity labels in the target sentence, making it not helpful for extracting named entities."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain specific entity names related to the entity labels in the target sentence, making it not helpful for extracting named entities."}\n]', 'response3': "[{'protooncogenes': 'protein'}, {'cytoskeletal': 'protein'}, {'extracellular matrix genes': 'protein'}, {'cell proliferation': 'cell_type'}]", 'prediction': {'protooncogenes': 'protein', 'cytoskeletal': 'protein', 'extracellular matrix genes': 'protein', 'cell proliferation': 'cell_type'}}
{'idx': 1034, 'sentence': 'p94 and p95 share homology with Stat1 at the phosphorylation site and in the Src homology 2 (SH2) domain , but otherwise are immunologically distinct from Stat1 .', 'label': {'Stat1': 'protein', 'phosphorylation site': 'protein', 'Src homology 2 (SH2) domain': 'protein', 'p94': 'protein', 'p95': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"p21(WAF1/CIP1 ) and p27(KIP1)": 5},\n    {"calcineurin": 4},\n    {"Th1 and Th2": 5},\n    {"IL-2": 4},\n    {"IL4 and IL13 receptors": 5},\n    {"IL-2": 4},\n    {"IL-12": 5},\n    {"SLAP-130": 5},\n    {"tyrosine": 4},\n    {"IL-2": 5},\n    {"ERK": 4},\n    {"CD28 with either CD80 or CD86": 5},\n    {"Sp1 and NF-kappaB": 5},\n    {"interleukin 10 ( IL-10R )": 5}\n]', 'response3': '[{"p94": "protein"}, {"p95": "protein"}, {"Stat1": "protein"}]', 'prediction': {'p94': 'protein', 'p95': 'protein', 'Stat1': 'protein'}}
{'idx': 1232, 'sentence': 'IBR is a 503-amino-acid-long acidic protein which is 99.0% identical to the recently reported human NRF-1/alpha-Pal factor and highly related to the invertebrate transcription factors P3A2 and erected wing gene product ( EWG ).', 'label': {'IBR': 'protein', 'transcription factors': 'protein', 'erected wing gene product': 'protein', 'human NRF-1/alpha-Pal factor': 'protein', 'EWG': 'protein', 'P3A2': 'protein', '503-amino-acid-long acidic protein': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein (Egr-1) being mentioned in relation to a zinc finger transcription factor, aiding in the extraction of protein entities."},\n    {"Example 2": 3},\n    {"Reason 2": "The sentence mentions NF-ATc, which is a transcription factor, and also refers to T lymphocytes and embryonic cardiac cells as cell types, providing some context for potential entity extraction."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any specific named entities related to the provided entity labels, making it less helpful for named entity extraction."},\n    {"Example 4": 1},\n    {"Reason 4": "The sentence does not contain any specific named entities related to the provided entity labels, making it less helpful for named entity extraction."},\n    {"Example 5": 1},\n    {"Reason 5": "The sentence does not contain any specific named entities related to the provided entity labels, making it less helpful for named entity extraction."},\n    {"Example 6": 1},\n    {"Reason 6": "The sentence does not contain any specific named entities related to the provided entity labels, making it less helpful for named entity extraction."},\n    {"Example 7": 1},\n    {"Reason 7": "The sentence does not contain any specific named entities related to the provided entity labels, making it less helpful for named entity extraction."},\n    {"Example 8": 1},\n    {"Reason 8": "The sentence does not contain any specific named entities related to the provided entity labels, making it less helpful for named entity extraction."},\n    {"Example 9": 1},\n    {"Reason 9": "The sentence does not contain any specific named entities related to the provided entity labels, making it less helpful for named entity extraction."},\n    {"Example 10": 1},\n    {"Reason 10": "The sentence does not contain any specific named entities related to the provided entity labels, making it less helpful for named entity extraction."},\n    {"Example 11": 1},\n    {"Reason 11": "The sentence does not contain any specific named entities related to the provided entity labels, making it less helpful for named entity extraction."},\n    {"Example 12": 3},\n    {"Reason 12": "The sentence mentions EBNA-2 and PU.1 as proteins, providing examples that can aid in the extraction of protein entities."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not contain any specific named entities related to the provided entity labels, making it less helpful for named entity extraction."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not contain any specific named entities related to the provided entity labels, making it less helpful for named entity extraction."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any specific named entities related to the provided entity labels, making it less helpful for named entity extraction."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any specific named entities related to the provided entity labels, making it less helpful for named entity extraction."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific named entities related to the provided entity labels, making it less helpful for named entity extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific named entities related to the provided entity labels, making it less helpful for named entity extraction."}\n]', 'response3': '[{"IBR": "protein"}, {"NRF-1/alpha-Pal": "protein"}, {"P3A2": "protein"}, {"erected wing gene product (EWG)": "protein"}]', 'prediction': {'IBR': 'protein', 'NRF-1/alpha-Pal': 'protein', 'P3A2': 'protein', 'erected wing gene product (EWG)': 'protein'}}
{'idx': 54, 'sentence': 'Virus stocks obtained from these experiments exhibited a continuum of replicative capacities in different human T-cell types depending on which element (s) was present in the LTR .', 'label': {'LTR': 'DNA', 'human T-cell types': 'cell_type', 'T-cell types': 'cell_type', 'element': 'DNA'}, 'response1': "['cell_type']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence directly mentions the entity \'DNA\' and provides context on how it is involved in the experiment."},\n{"Example 2": 4},\n{"Reason 2": "The sentence mentions \'IL-2\' and explains its role in forming a composite element, providing valuable information for entity extraction."},\n{"Example 3": 3},\n{"Reason 3": "The sentence mentions various cell lines like \'SIVmacMER\', \'SIVmac239\', and \'CEMx174\', which are relevant for entity extraction but may not provide detailed context."},\n{"Example 4": 4},\n{"Reason 4": "The sentence mentions \'CD4+\' and \'EBV\', providing context on their correlation and relevance in the study."},\n{"Example 5": 5},\n{"Reason 5": "The sentence provides a list of proteins and stimuli like \'IFN A\', \'interleukin-2\', \'phytohemagglutinin\', and \'phorbol myristate acetate\', which are crucial for entity extraction."},\n{"Example 6": 4},\n{"Reason 6": "The sentence mentions \'TIMP-1\' and \'DNA synthesis\', providing valuable information for entity extraction."},\n{"Example 7": 4},\n{"Reason 7": "The sentence mentions \'Th2-type lymphocytes\', providing context on the cell type involved."},\n{"Example 8": 4},\n{"Reason 8": "The sentence mentions \'EBV\' and \'CD2\', providing context on their roles in the experiment."},\n{"Example 9": 4},\n{"Reason 9": "The sentence mentions \'PBMC\' and \'adenovirus DNA\', which are relevant for entity extraction."},\n{"Example 10": 4},\n{"Reason 10": "The sentence mentions \'SIVsmmPBj14\', providing context on the unique phenotype of the cell line."},\n{"Example 11": 4},\n{"Reason 11": "The sentence mentions \'CD95 ligand\', providing context on the protein involved."},\n{"Example 12": 5},\n{"Reason 12": "The sentence mentions \'HIV-1 LTR\', \'NFAT-1\', and \'NF kappa B\', which are crucial for entity extraction."},\n{"Example 13": 4},\n{"Reason 13": "The sentence mentions \'EBV\', \'EBNA2\', and \'estrogen receptor\', providing context on their roles in the experiment."},\n{"Example 14": 4},\n{"Reason 14": "The sentence mentions \'TR55\', \'TNF-alpha\', and \'HIV\', providing context on their roles in the experiment."},\n{"Example 15": 4},\n{"Reason 15": "The sentence mentions \'NF-kappaB\', \'Sp1\', and \'SIVmac\', providing context on their roles in the experiment."},\n{"Example 16": 3},\n{"Reason 16": "The sentence mentions \'T lymphocytes\' and \'adenovirus vectors\', which are relevant for entity extraction."},\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any specific entities mentioned."},\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any specific entities mentioned."},\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any specific entities mentioned."},\n{"Example 20": 1},\n{"Reason 20": "The sentence does not contain any specific entities mentioned."}\n]', 'response3': '[{"Virus stocks": "cell_line"}, {"human T-cell types": "cell_type"}, {"LTR": "DNA"}]', 'prediction': {'Virus stocks': 'cell_line', 'human T-cell types': 'cell_type', 'LTR': 'DNA'}}
{'idx': 1149, 'sentence': 'The expression and activity of NF-kappa B and Sp1 were, therefore, analyzed in isolated T cells and DCs from humans and mice .', 'label': {'Sp1': 'protein', 'DCs': 'cell_type', 'NF-kappa B': 'protein', 'T cells': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 5},\n    {"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .": 3},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .": 4},\n    {"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .": 5},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .": 4},\n    {"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.": 4},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .": 5},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .": 5},\n    {"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .": 5},\n    {"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .": 5},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .": 5},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"Sp1": "protein"}, {"T cells": "cell_type"}, {"DCs": "cell_type"}, {"humans": "cell_type"}, {"mice": "cell_type"}]', 'prediction': {'NF-kappa B': 'protein', 'Sp1': 'protein', 'T cells': 'cell_type', 'DCs': 'cell_type', 'humans': 'cell_type', 'mice': 'cell_type'}}
{'idx': 407, 'sentence': 'Since most of the actions of vitamin D are mediated by its receptors ( VDR ), abnormalities of VDR have been postulated in XLH .', 'label': {'VDR': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names and their functions, which directly match the entity labels in the target sentence."}\n]', 'response3': '[{"VDR": "protein"}]', 'prediction': {'VDR': 'protein'}}
{'idx': 1466, 'sentence': 'As we observed that activated endothelial cells also expressed NFAT , we tested the antiinflammatory properties of CsA in endothelial cells .', 'label': {'endothelial cells': 'cell_type', 'NFAT': 'protein', 'activated endothelial cells': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a clear mapping between the entity \'NF-kappa B\' and its corresponding label \'DNA\', aiding in the extraction of named entities from the target sentence."},\n\n    {"Example 2": 4},\n    {"Reason 2": "The example provides mappings for entities \'NF-kappa B\' and \'I kappa B alpha\' to their corresponding labels \'protein\', which helps in identifying protein entities in the target sentence."},\n\n    {"Example 3": 5},\n    {"Reason 3": "The example covers multiple entity types such as \'AP-1\' and \'PMA\' mapped to \'protein\', \'monocytes\' and \'macrophages\' mapped to \'cell_type\', aiding in the extraction of named entities from the target sentence."},\n\n    {"Example 4": 5},\n    {"Reason 4": "The example provides mappings for entities \'granulocytes\' and \'T cells\' to their corresponding labels \'cell_type\', assisting in identifying cell type entities in the target sentence."},\n\n    {"Example 5": 4},\n    {"Reason 5": "The example maps the entity \'NF-kappa B\' to the label \'protein\', aiding in the extraction of protein entities from the target sentence."}\n]', 'response3': "[{'NFAT': 'protein'}, {'CsA': 'protein'}, {'endothelial cells': 'cell_type'}]", 'prediction': {'NFAT': 'protein', 'CsA': 'protein', 'endothelial cells': 'cell_type'}}
{'idx': 1330, 'sentence': 'Stimulation of cells leads to a rapid phosphorylation of I kappa B alpha , which is presumed to be important for the subsequent degradation .', 'label': {'I kappa B alpha': 'protein', 'I kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence 1": 5},\n    {"Sentence 2": 5},\n    {"Sentence 3": 5},\n    {"Sentence 4": 5},\n    {"Sentence 5": 5},\n    {"Sentence 6": 5},\n    {"Sentence 7": 5},\n    {"Sentence 8": 4},\n    {"Sentence 9": 1},\n    {"Sentence 10": 1},\n    {"Sentence 11": 1},\n    {"Sentence 12": 1},\n    {"Sentence 13": 5},\n    {"Sentence 14": 5},\n    {"Sentence 15": 5},\n    {"Sentence 16": 1},\n    {"Sentence 17": 1},\n    {"Sentence 18": 1},\n    {"Sentence 19": 1}\n]', 'response3': '[{"I kappa B alpha": "protein"}]', 'prediction': {'I kappa B alpha': 'protein'}}
{'idx': 1436, 'sentence': 'Similar levels of hTR beta 1 mRNA levels were detected in thyroid gland from euthyroid patients .', 'label': {'hTR beta 1 mRNA': 'RNA', 'hTR beta 1': 'protein'}, 'response1': "['RNA']", 'response2': '[\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects.": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 4},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.": 5},\n    {"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus , and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"hTR beta 1 mRNA": "RNA"}]', 'prediction': {'hTR beta 1 mRNA': 'RNA'}}
{'idx': 859, 'sentence': 'We show that at least one inducible , C1 , and one constitutive, C2 , protein can bind to the HIV enhancer in Jurkat cells .', 'label': {'inducible': 'protein', 'Jurkat cells': 'cell_line', 'C1': 'protein', 'HIV enhancer': 'DNA', 'C2': 'protein', 'constitutive, C2 , protein': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n{"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .": 5},\n{"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n{"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .": 5},\n{"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .": 5},\n{"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 5},\n{"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n{"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n{"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n{"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .": 5},\n{"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .": 5},\n{"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .": 5},\n{"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .": 5},\n{"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"C1": "protein"}, {"C2": "protein"}, {"HIV enhancer": "DNA"}, {"Jurkat cells": "cell_line"}]', 'prediction': {'C1': 'protein', 'C2': 'protein', 'HIV enhancer': 'DNA', 'Jurkat cells': 'cell_line'}}
{'idx': 451, 'sentence': 'However, despite its ability to activate transcription of a transfected reporter gene , the factor is apparently unable to bind to the endogenous Ig heavy chain enhancer in non- lymphoid cells : In previous experiments by others, the characteristic in vivo footprint of this factor, designated NF-muE3 , was detected in B cells but not in non-B cells .', 'label': {'NF-muE3': 'protein', 'B cells': 'cell_type', 'lymphoid cells': 'cell_type', 'transfected reporter gene': 'DNA', 'Ig heavy chain enhancer': 'DNA', 'non- lymphoid cells': 'cell_type', 'non-B cells': 'cell_type', 'endogenous Ig heavy chain enhancer': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"p50p50": 5},\n    {"Egr-1": 5},\n    {"IFN A": 4},\n    {"IFNA": 4},\n    {"interleukin-2": 4},\n    {"interleukin-2 receptor": 4},\n    {"phytohemagglutinin": 4},\n    {"phorbol myristate acetate": 4},\n    {"TCF-1": 5},\n    {"IL-2 receptor alpha subunit": 5},\n    {"p21ras": 5},\n    {"B cell": 5},\n    {"NF-ATc": 5},\n    {"T lymphocytes": 5},\n    {"embryonic cardiac cells": 5},\n    {"IL-2": 5},\n    {"NF-kappaB": 5},\n    {"Sp1": 5},\n    {"p50": 5},\n    {"c-kit": 5},\n    {"IL-4R alpha chain": 5},\n    {"c-Jun": 5},\n    {"c-Fos": 5},\n    {"immunoglobulin kappa 3\' enhancer": 5},\n    {"IL-2": 5},\n    {"IFN-gamma": 5},\n    {"jak kinases": 5},\n    {"STAT1(alpha)": 5},\n    {"rheumatoid arthritis": 5},\n    {"CD40": 5},\n    {"Rel/nuclear factor kappaB": 5},\n    {"B lymphocytes": 5},\n    {"SIVmac": 5},\n    {"NFAT": 5},\n    {"AP-1": 5}\n]', 'response3': '[{"Ig heavy chain enhancer": "DNA"}, {"NF-muE3": "protein"}, {"B cells": "cell_type"}]', 'prediction': {'Ig heavy chain enhancer': 'DNA', 'NF-muE3': 'protein', 'B cells': 'cell_type'}}
{'idx': 919, 'sentence': 'The human protein recognized by the EC1 antibody is a 56-kDa protein ( p56 ) of moderate abundance located predominantly in the cytoplasm by indirect immunofluorescence .', 'label': {'56-kDa protein': 'protein', 'p56': 'protein', 'EC1 antibody': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"EC1 antibody": "protein"}, {"p56": "protein"}]', 'prediction': {'EC1 antibody': 'protein', 'p56': 'protein'}}
{'idx': 1206, 'sentence': 'In addition, the concentration of androgen receptors in mononuclear leukocytes was measured, in both the follicular and luteal phases of the menstrual cycle , basally and after 4 months of flutamide treatment.', 'label': {'androgen receptors': 'protein', 'mononuclear leukocytes': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a clear mapping between the entity \'RXR\' and its corresponding entity label \'protein\', aiding in the extraction of named entities."},\n    {"Example 2": 4},\n    {"Reason 2": "The example provides clear mappings between the entities \'granulocytes\' and \'T cells\' with their corresponding entity labels \'cell_type\', aiding in the extraction of named entities."},\n    {"Example 3": 4},\n    {"Reason 3": "The example provides a clear mapping between the entity \'lymphoid neoplasms\' and its corresponding entity label \'cell_type\', aiding in the extraction of named entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The example provides a clear mapping between the entity \'CD14\' and its corresponding entity label \'protein\', aiding in the extraction of named entities."},\n    {"Example 5": 4},\n    {"Reason 5": "The example provides clear mappings between the entities \'phosphocreatine\', \'dexamethasone\', \'cortisol\', and \'lysozyme\' with their corresponding entity labels \'protein\', aiding in the extraction of named entities."},\n    {"Example 6": 4},\n    {"Reason 6": "The example provides clear mappings between the entities \'NF-E2\' with its corresponding entity label \'protein\', aiding in the extraction of named entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The example provides a clear mapping between the entity \'E2A\' and its corresponding entity label \'protein\', aiding in the extraction of named entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides clear mappings between the entities \'CD70\', \'B cell\', \'plasma cells\', \'IL-4\', and \'CD40\' with their corresponding entity labels \'protein\' and \'cell_type\', aiding in the extraction of named entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides clear mappings between the entities \'cAMP-dependent protein kinase\' and \'Rap1\' with their corresponding entity labels \'protein\', aiding in the extraction of named entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides clear mappings between the entities \'CD40\', \'Rel/nuclear factor kappaB\', \'NF-kappaB\', and \'B lymphocytes\' with their corresponding entity labels \'protein\' and \'cell_type\', aiding in the extraction of named entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The example provides clear mappings between the entities \'PU.1\', \'CSF-1 receptor\', \'Mono A\', and \'Mono B\' with their corresponding entity labels \'protein\', aiding in the extraction of named entities."},\n    {"Example 12": 4},\n    {"Reason 12": "The example provides clear mappings between the entities \'nuclear factor-kappa B\' and \'NF-kappa B\' with their corresponding entity labels \'DNA\', aiding in the extraction of named entities."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides clear mappings between the entities \'NF-kappa B\' and \'fibrinogen\' with their corresponding entity labels \'protein\', aiding in the extraction of named entities."},\n    {"Example 14": 5},\n    {"Reason 14": "The example provides clear mappings between the entities \'MNDA\', \'monocytes\', \'macrophages\', and \'leukemia/B lymphoma cell lines\' with their corresponding entity labels \'protein\', \'cell_type\', and \'cell_line\', aiding in the extraction of named entities."},\n    {"Example 15": 5},\n    {"Reason 15": "The example provides clear mappings between the entities \'PMA\' and \'U1 cells\' with their corresponding entity labels \'cell_line\', aiding in the extraction of named entities."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain any named entities from the given entity label set, hence not helpful in aiding the extraction of named entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain any named entities from the given entity label set, hence not helpful in aiding the extraction of named entities."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any named entities from the given entity label set, hence not helpful in aiding the extraction of named entities."},\n    {"Example 19": 1},\n    {"Reason 19": "The example does not contain any named entities from the given entity label set, hence not helpful in aiding the extraction of named entities."},\n    {"Example 20": 1},\n    {"Reason 20": "The example does not contain any named entities from the given entity label set, hence not helpful in aiding the extraction of named entities."}\n]', 'response3': "[{'androgen receptors': 'protein'}, {'mononuclear leukocytes': 'cell_type'}, {'follicular': 'cell_type'}, {'luteal': 'cell_type'}, {'menstrual cycle': 'cell_type'}, {'flutamide': 'protein'}]", 'prediction': {'androgen receptors': 'protein', 'mononuclear leukocytes': 'cell_type', 'follicular': 'cell_type', 'luteal': 'cell_type', 'menstrual cycle': 'cell_type', 'flutamide': 'protein'}}
{'idx': 569, 'sentence': 'In addition, the increases in c-jun , EGR2 , and PDGF(B) may depend on cytoskeletal rearrangement .', 'label': {'PDGF(B)': 'protein', 'EGR2': 'DNA', 'c-jun': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B, possibly by a phosphorylation reaction involving protein kinase C by PAF.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines.": 5},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 5},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"The p21ras small GTP binding proteins participate in signal transduction from cell surface receptors and affect neoplastic transformation and development in many different cell types.": 5},\n    {"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway, and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n    {"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5}\n]', 'response3': '[{"c-jun": "protein"}, {"EGR2": "protein"}, {"PDGF(B)": "protein"}]', 'prediction': {'c-jun': 'protein', 'EGR2': 'protein', 'PDGF(B)': 'protein'}}
{'idx': 1657, 'sentence': 'HMG-I binds to GATA motifs : implications for an HPFH syndrome .', 'label': {'HMG-I': 'protein', 'GATA motifs': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides clear examples of named entities with their corresponding entity labels, aiding in understanding the relationship between the entities and their types."}\n]', 'response3': '[{"HMG-I": "protein"}, {"GATA motifs": "DNA"}, {"HPFH syndrome": "cell_type"}]', 'prediction': {'HMG-I': 'protein', 'GATA motifs': 'DNA', 'HPFH syndrome': 'cell_type'}}
{'idx': 1780, 'sentence': 'Interestingly, Id2 , but not Id3 , mRNA was strongly expressed in 4/5 T-cell lines infected with human T-cell leukemia virus type I ( HTLV-I ) ( ATL-1k , MT-2 , S-LB1 ) and type II ( Mo ) .', 'label': {'Id3': 'protein', 'Mo': 'cell_line', 'Id2': 'protein', '4/5 T-cell lines': 'cell_line', 'S-LB1': 'cell_line', 'MT-2': 'cell_line', 'ATL-1k': 'cell_line'}, 'response1': "['RNA', 'cell_line']", 'response2': '[\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.": 5},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"Expression of tal-1 and GATA-binding proteins during human hematopoiesis.": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1/c6.1B, in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"Id2": "RNA"}, {"Id3": "RNA"}, {"T-cell lines": "cell_line"}, {"human T-cell leukemia virus type I (HTLV-I)": "cell_type"}, {"ATL-1k": "cell_line"}, {"MT-2": "cell_line"}, {"S-LB1": "cell_line"}, {"type II (Mo)": "cell_type"}]', 'prediction': {'Id2': 'RNA', 'Id3': 'RNA', 'T-cell lines': 'cell_line', 'human T-cell leukemia virus type I (HTLV-I)': 'cell_type', 'ATL-1k': 'cell_line', 'MT-2': 'cell_line', 'S-LB1': 'cell_line', 'type II (Mo)': 'cell_type'}}
{'idx': 13, 'sentence': 'We further demonstrate the impact of platelet-activating factor binding to B cells by measuring platelet-activating factor induced arachidonic acid release and 5-hydroxyeicosatetraenoic acid production.', 'label': {'platelet-activating factor': 'protein', 'B cells': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 4},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 4},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 3},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"We have examined the effect of alpha-tocopherol ( alpha-tcp ) on one cellular event in atherosclerotic plaque development , monocyte adhesion to stimulated endothelial cells ( ECs ).": 4},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 4},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects.": 5},\n    {"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.": 4},\n    {"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation.": 5},\n    {"PMA induced the expression of both CD14 and CD23 mRNA and protein.": 5},\n    {"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation.": 4},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1554, 'sentence': 'The results define essential cis-acting elements responsible for the expression of GP Ib alpha and provide insights into molecular events coinciding with the release of normal platelets into the bloodstream .', 'label': {'GP': 'protein', 'normal platelets': 'cell_type', 'cis-acting elements': 'DNA', 'GP Ib alpha': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.": 4},\n    {"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 4},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements .": 4},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .": 4},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .": 5},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .": 5},\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .": 4},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .": 5},\n    {"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts .": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"GP Ib alpha": "protein"}]', 'prediction': {'GP Ib alpha': 'protein'}}
{'idx': 1650, 'sentence': 'This is the first demonstration of a specific interaction with PU.1 on a myeloid PU.1 binding site .', 'label': {'PU.1': 'protein', 'myeloid PU.1 binding site': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names and their interactions, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions protein names and cell types related to lymphocyte activation, which are relevant to the entity labels in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence directly mentions the protein PU.1 and its interaction with a binding site, which aligns with the entity labels in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides information about specific protein names (myeloperoxidase, lysozyme, PU.1) and their presence in a subset, which is highly relevant to the entity labels in the target sentence."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence mentions protein names (AP-1, PMA) and cell types (monocytes, macrophages) related to activation, which are relevant to the entity labels in the target sentence."},\n    {"Example 6": 3},\n    {"Reason 6": "The sentence mentions a specific protein name (PML/RARalpha) related to myelopoiesis, which is somewhat relevant to the entity labels in the target sentence."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence provides information about protein names (IL-2, c-Jun, c-Fos) and their binding to specific sites, which are relevant to the entity labels in the target sentence."},\n    {"Example 8": 4},\n    {"Reason 8": "The sentence mentions protein names (IL-2, NF-kappa B, AP-1) related to drug effects and activation, which are relevant to the entity labels in the target sentence."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence mentions protein names (Sp1, CD14) related to promoter activity and transactivation, which are relevant to the entity labels in the target sentence."},\n    {"Example 10": 4},\n    {"Reason 10": "The sentence mentions protein names (c-kit, IL-4R alpha chain) related to receptor domains, which are relevant to the entity labels in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence directly mentions the proteins EBNA2 and TP1, indicating their interaction, which aligns with the entity labels in the target sentence."},\n    {"Example 12": 4},\n    {"Reason 12": "The sentence mentions protein names (CHEMR1, C-C chemokine, MIP-1alpha) related to receptor activity, which are relevant to the entity labels in the target sentence."},\n    {"Example 13": 3},\n    {"Reason 13": "The sentence mentions DNA binding activity of NF-kappa B, which is somewhat relevant to the entity labels in the target sentence."},\n    {"Example 14": 4},\n    {"Reason 14": "The sentence mentions protein names (IL-4, LPS, AP-1) related to inhibition and expression, which are relevant to the entity labels in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence directly mentions the protein MNDA and its expression in cell lines, which aligns with the entity labels in the target sentence."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence directly mentions the proteins EBNA-2 and PU.1, their interaction, and biochemical evidence, which align with the entity labels in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific entity names or interactions relevant to the entity labels in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific entity names or interactions relevant to the entity labels in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific entity names or interactions relevant to the entity labels in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any specific entity names or interactions relevant to the entity labels in the target sentence."}\n]', 'response3': "[{'PU.1': 'protein'}, {'myeloid PU.1 binding site': 'protein'}]", 'prediction': {'PU.1': 'protein', 'myeloid PU.1 binding site': 'protein'}}
{'idx': 326, 'sentence': 'We show here that domain B is an R-responsive element in HeLa cells and is therefore not an EB1 -responsive B-cell-specific element .', 'label': {'EB1': 'protein', 'R-responsive element': 'DNA', 'HeLa cells': 'cell_line', 'domain B': 'DNA', 'EB1 -responsive B-cell-specific element': 'DNA'}, 'response1': "['cell_line', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains specific cell type names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence contains specific cell type and cell line names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 8": 4},\n    {"Reason 8": "The sentence contains specific DNA and protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains specific cell type names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 11": 4},\n    {"Reason 11": "The sentence contains specific cell line and protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains specific protein and cell line names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 13": 4},\n    {"Reason 13": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 14": 4},\n    {"Reason 14": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 15": 4},\n    {"Reason 15": "The sentence contains specific cell type, cell line, and DNA names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any specific entity names that match the entity types in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific entity names that match the entity types in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific entity names that match the entity types in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific entity names that match the entity types in the target sentence."}\n]', 'response3': "[{'HeLa cells': 'cell_line'}, {'EB1': 'protein'}, {'B-cell': 'cell_type'}]", 'prediction': {'HeLa cells': 'cell_line', 'EB1': 'protein', 'B-cell': 'cell_type'}}
{'idx': 1429, 'sentence': 'Data from cell culture and animal studies indicate that TR expression may be regulated to modulate target organ responsiveness to thyroid hormone .', 'label': {'TR': 'protein'}, 'response1': "['cell_type']", 'response2': '[\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 4},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.": 5},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 5},\n    {"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 4},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 4},\n    {"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL-mediated NF-kappaB activation, but failed to affect constitutive signaling induced by receptor overexpression, revealing a selective role for TRAF6 in ligand-induced activation events.": 5},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb/Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"TR": "protein"}]', 'prediction': {'TR': 'protein'}}
{'idx': 865, 'sentence': 'Response to T cell activation signals .', 'label': {'T cell': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n{"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n{"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n{"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.": 4},\n{"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n{"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 4},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n{"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n{"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.": 5},\n{"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.": 5},\n{"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n{"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n{"Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency.": 5},\n{"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n{"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.": 4},\n{"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n{"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 696, 'sentence': 'First, from different cell lines three or all four of the nuclear proteins were specifically cross-linked by UV irradiation to the radioactively labeled TRE -DNA fragment .', 'label': {'TRE -DNA fragment': 'DNA', 'nuclear proteins': 'protein', 'TRE': 'DNA'}, 'response1': "['protein', 'DNA', 'cell_line']", 'response2': '[\n{"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n{"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .": 5},\n{"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 5},\n{"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 5},\n{"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50 .": 5},\n{"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n{"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system .": 5},\n{"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n{"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .": 5},\n{"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .": 5},\n{"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .": 5},\n{"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .": 5},\n{"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 318, 'sentence': 'Furthermore, the existence of estrogen receptor (estrogen binding activity) was examined histochemically in 39 cases and it was detected in 8.', 'label': {'estrogen receptor': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein (RXR) and its corresponding entity label."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides a clear example of a protein (retinoic acid receptor alpha) and its corresponding entity label."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence provides a clear example of a protein (NF-E2) and its corresponding entity label."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides clear examples of proteins (IL-2, c-Jun, c-Fos) and their corresponding entity labels."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides a clear example of a protein (E2A) and its corresponding entity label."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides clear examples of proteins (NF-kB, AP-1, OCT-1, NF-IL-2B) and their corresponding entity labels."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides clear examples of proteins (TCRzeta, p56(lck)) and their corresponding entity labels."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides clear examples of a cell line (Ter 119) and proteins (beta-globin, glycoprotein IIb, platelet factor 4) with their corresponding entity labels."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides clear examples of proteins (Erbstatin, genistein, Egr-1) and RNA (Egr-1) with their corresponding entity labels."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides clear examples of DNA (EBV) and proteins (EBNA2, estrogen receptor) with their corresponding entity labels."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides clear examples of cell lines (PMA-stimulated U1 cells) with their corresponding entity labels."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides clear examples of DNA (nuclear factor-kappa B, NF-kappa B) with their corresponding entity labels."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides clear examples of proteins (CD3.TcR, CD18, CD29) with their corresponding entity labels."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides clear examples of DNA (DNA), a protein (PCNA), and a transcription factor (E2F1) with their corresponding entity labels."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides clear examples of a protein (MR) and steroid hormones (aldosterone, progesterone) with their corresponding entity labels."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence provides clear examples of proteins (E2F, E2F-4, DP-1, p130) and a cell type (AML) with their corresponding entity labels."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any named entities related to the given entity labels."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any named entities related to the given entity labels."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any named entities related to the given entity labels."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any named entities related to the given entity labels."}\n]', 'response3': '[{"estrogen receptor": "protein"}]', 'prediction': {'estrogen receptor': 'protein'}}
{'idx': 440, 'sentence': 'All three proteins show the same sequence specificity and binding affinity .', 'label': {}, 'response1': "['protein']", 'response2': '[\n{"These two related genes share the evolutionarily conserved region encoding the Runt domain.": 5},\n{"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.": 4},\n{"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 5},\n{"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 5},\n{"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n{"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.": 5},\n{"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.": 5},\n{"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 5},\n{"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 5},\n{"Tat-binding protein 7 is a subunit of the 26S protease.": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n{"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n{"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.": 5},\n{"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n{"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 5},\n{"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1563, 'sentence': 'Pathogenesis of atherosclerosis .', 'label': {}, 'response1': 'None.', 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides specific examples with corresponding entity labels, which directly relate to the entity types mentioned in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence provides relevant examples with corresponding entity labels, although not all entities mentioned directly match the entity types in the target sentence."},\n    {"Example 3": 3},\n    {"Reason 3": "The sentence provides an example with a corresponding entity label that is related to the entity types in the target sentence, but the relevance is not as direct."},\n    {"Example 4": 2},\n    {"Reason 4": "The sentence provides an example with a corresponding entity label that is somewhat related to the entity types in the target sentence, but the relevance is limited."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides specific examples with corresponding entity labels, which directly relate to the entity types mentioned in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides specific examples with corresponding entity labels, which directly relate to the entity types mentioned in the target sentence."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence provides relevant examples with corresponding entity labels, although not all entities mentioned directly match the entity types in the target sentence."},\n    {"Example 8": 3},\n    {"Reason 8": "The sentence provides an example with a corresponding entity label that is related to the entity types in the target sentence, but the relevance is not as direct."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides specific examples with corresponding entity labels, which directly relate to the entity types mentioned in the target sentence."},\n    {"Example 10": 4},\n    {"Reason 10": "The sentence provides relevant examples with corresponding entity labels, although not all entities mentioned directly match the entity types in the target sentence."},\n    {"Example 11": 3},\n    {"Reason 11": "The sentence provides an example with a corresponding entity label that is related to the entity types in the target sentence, but the relevance is not as direct."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides specific examples with corresponding entity labels, which directly relate to the entity types mentioned in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides specific examples with corresponding entity labels, which directly relate to the entity types mentioned in the target sentence."},\n    {"Example 14": 4},\n    {"Reason 14": "The sentence provides relevant examples with corresponding entity labels, although not all entities mentioned directly match the entity types in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides specific examples with corresponding entity labels, which directly relate to the entity types mentioned in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not provide relevant examples with corresponding entity labels that directly relate to the entity types mentioned in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not provide relevant examples with corresponding entity labels that directly relate to the entity types mentioned in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not provide relevant examples with corresponding entity labels that directly relate to the entity types mentioned in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not provide relevant examples with corresponding entity labels that directly relate to the entity types mentioned in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not provide relevant examples with corresponding entity labels that directly relate to the entity types mentioned in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 689, 'sentence': 'High-risk patients can be recognized morphologically.', 'label': {}, 'response1': 'None.', 'response2': '[\n    {"PBMC": 5},\n    {"adenovirus": 5},\n    {"WT1": 5},\n    {"CD70": 5},\n    {"B cell": 5},\n    {"plasma cells": 5},\n    {"IL-4": 5},\n    {"CD40": 5},\n    {"TCL1": 5},\n    {"myeloperoxidase": 5},\n    {"lysozyme": 5},\n    {"PU.1": 5},\n    {"Ras": 5},\n    {"T-PLL": 5},\n    {"T lymphocytes": 5},\n    {"HLA-molecules": 5},\n    {"MNDA": 5},\n    {"Philadelphia chromosome-positive chronic myeloid leukemia": 5},\n    {"granulocytes": 5},\n    {"T cells": 5},\n    {"TCRzeta": 5},\n    {"p56(lck)": 5},\n    {"adenovirus DNA": 5},\n    {"PML/RARalpha": 5},\n    {"SIVmacMER": 5},\n    {"SIVmac239": 5},\n    {"CEMx174": 5},\n    {"lymphoid neoplasms": 5},\n    {"SIVsmmPBj14": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 189, 'sentence': 'Transcriptional down-regulation of c-myc expression by protein synthesis -dependent and -independent pathways in a human T lymphoblastic tumor cell line .', 'label': {'human T lymphoblastic tumor cell line': 'cell_line', 'c-myc': 'DNA'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple entities relevant to the entity labels in the target sentence, such as \'NF-ATc\' (protein) and \'T lymphocytes\' (cell_type)."}\n]\n[\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions \'AP-1\' which is relevant to the \'DNA\' entity label in the target sentence."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence includes entities like \'Sp1\' (protein) and \'CD14\' (protein) which are relevant to the entity labels in the target sentence."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions \'IkappaBbeta\' (protein) and \'NF-kappaB\' (protein) which are relevant to the entity labels in the target sentence."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains \'Sp1\' (protein) and \'Ets\' (protein) which are relevant to the entity labels in the target sentence."}\n]\n[\n    {"Sentence": 4},\n    {"Reason": "The sentence includes \'Th2-type lymphocytes\' which is relevant to the \'cell_type\' entity label in the target sentence."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions \'WT1\' (protein) and \'myeloid cell lines\' (cell_line) which are relevant to the entity labels in the target sentence."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains \'NF-ATc\' (protein), \'T lymphocytes\' (cell_type), and \'embryonic cardiac cells\' (cell_type) which are relevant to the entity labels in the target sentence."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions \'SP1\' (protein), \'caspases\' (protein), and \'B-cell\' (cell_type) which are relevant to the entity labels in the target sentence."}\n]\n[\n    {"Sentence": 4},\n    {"Reason": "The sentence includes \'GATA-1\' (protein) which is relevant to the entity labels in the target sentence."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains \'ZEB\' (protein), \'c-Myb\' (protein), \'Ets\' (protein), and \'hematopoietic cells\' (cell_type) which are relevant to the entity labels in the target sentence."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions \'YY1\' (protein), \'Oct1\' (protein), \'IL-5\' (protein), and \'T cells\' (cell_type) which are relevant to the entity labels in the target sentence."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence includes \'B and T cell activation\' (cell_type), \'Ramos\' (cell_line), \'Jurkat\' (cell_line), and \'cDNA microarray technology\' (DNA) which are relevant to the entity labels in the target sentence."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains \'tal-1\' (protein), \'GATA-binding proteins\' (protein), and \'hematopoiesis\' (cell_type) which are relevant to the entity labels in the target sentence."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions \'cDNA\' (DNA), \'Jurkat\' (cell_line), and \'DRE 1\' (cell_type) which are relevant to the entity labels in the target sentence."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence includes \'AP-1\' (protein), \'c-jun\' (protein), \'IL-2\' (protein), \'NF-AT\' (protein), and \'T cell\' (cell_type) which are relevant to the entity labels in the target sentence."}\n]\n[\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any entities relevant to the entity labels in the target sentence."}\n]\n[\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any entities relevant to the entity labels in the target sentence."}\n]\n[\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any entities relevant to the entity labels in the target sentence."}\n]\n[\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any entities relevant to the entity labels in the target sentence."}\n]', 'response3': '[{"c-myc": "protein"}, {"T lymphoblastic tumor cell line": "cell_line"}]', 'prediction': {'c-myc': 'protein', 'T lymphoblastic tumor cell line': 'cell_line'}}
{'idx': 778, 'sentence': 'Addition of a highly enriched preparation of OTF-1 made from one of these pre-B cells or from HeLa cells specifically stimulated in vitro transcription of an immunoglobulin gene .', 'label': {'OTF-1': 'protein', 'pre-B cells': 'cell_line', 'immunoglobulin gene': 'DNA', 'HeLa cells': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .": 4},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 5},\n    {"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 4},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 4},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .": 4},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"T cell blasts treated with PMA are now responsive to IFN-gamma .": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n    {"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .": 5},\n    {"Fibroblast growth factor-1 ( FGF-1 ) enhances IL-2 production and nuclear translocation of NF-kappaB in FGF receptor -bearing Jurkat T cells .": 5}\n]', 'response3': '[{"OTF-1": "protein"}, {"pre-B cells": "cell_type"}, {"HeLa cells": "cell_line"}, {"immunoglobulin gene": "protein"}]', 'prediction': {'OTF-1': 'protein', 'pre-B cells': 'cell_type', 'HeLa cells': 'cell_line', 'immunoglobulin gene': 'protein'}}
{'idx': 198, 'sentence': "Tamoxifen , an oestrogen antagonist , has been given in some patients with CLL and Hodgkin's disease , with dramatic response in single cases.", 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 3},\n    {"Example 2": 5},\n    {"Example 3": 4},\n    {"Example 4": 5},\n    {"Example 5": 4},\n    {"Example 6": 5},\n    {"Example 7": 4},\n    {"Example 8": 1},\n    {"Example 9": 5},\n    {"Example 10": 4},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 4},\n    {"Example 14": 1},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1}\n]', 'response3': '[{"CLL": "cell_type"}, {"Hodgkin\'s disease": "cell_type"}]', 'prediction': {'CLL': 'cell_type', "Hodgkin's disease": 'cell_type'}}
{'idx': 735, 'sentence': 'This prompted us to analyze the octamer-binding proteins in the latter cells.', 'label': {'octamer-binding proteins': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example directly mentions the entity type \'protein\' which is present in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The example mentions \'CD95 ligand\' which is a type of protein, providing relevant information for entity extraction."},\n    {"Example 3": 5},\n    {"Reason 3": "The example mentions \'EBNA-2\' and \'PU.1\' which are both proteins, directly related to the entities in the target sentence."},\n    {"Example 4": 4},\n    {"Reason 4": "The example mentions \'cDNAs\' which are related to DNA, providing context for entity extraction."},\n    {"Example 5": 5},\n    {"Reason 5": "The example mentions \'IL-2\', \'c-Jun\', and \'c-Fos\' which are all proteins, directly relevant to the entities in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The example mentions \'NF-kappa B\' which is a protein, directly related to the entity in the target sentence."},\n    {"Example 7": 4},\n    {"Reason 7": "The example mentions \'c-kit\' and \'IL-4R alpha chain\' which are both proteins, providing relevant information for entity extraction."},\n    {"Example 8": 5},\n    {"Reason 8": "The example mentions \'Oct-2A\', \'HMG I/Y\', \'HLA-DRA\', and \'B cells\' which are all proteins or cell types, directly related to the entities in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The example mentions \'EKLF\', \'CBP\', \'p300\', and \'P/CAF\' which are all proteins, directly relevant to the entities in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The example mentions \'IL-4\', \'LPS\', and \'AP-1\' which are all proteins, directly related to the entities in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The example mentions \'granulocytes\' and \'T cells\' which are cell types, directly relevant to the entities in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The example mentions \'SCM-1\' which is a cell line, directly related to the entity in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The example mentions \'CD40\' and \'NF-kappa B\' which are both proteins, directly relevant to the entities in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The example mentions \'p21(WAF1/CIP1)\' and \'p27(KIP1)\' which are both proteins, directly related to the entities in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The example mentions \'E2A\' which is a protein, directly relevant to the entity in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain any entity types present in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain any entity types present in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any entity types present in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The example does not contain any entity types present in the target sentence."}\n]', 'response3': "[{'octamer-binding proteins': 'protein'}, {'latter cells': 'cell_type'}]", 'prediction': {'octamer-binding proteins': 'protein', 'latter cells': 'cell_type'}}
{'idx': 1735, 'sentence': 'We therefore examined vitamin D3 -mediated repression of activated IL-2 expression by cotransfecting Jurkat cells with IL-2 promoter/reporter constructs and a VDR overexpression vector and by DNA binding .', 'label': {'VDR': 'protein', 'IL-2 promoter/reporter constructs': 'DNA', 'Jurkat cells': 'cell_line', 'VDR overexpression vector': 'DNA', 'IL-2': 'protein'}, 'response1': "['DNA', 'protein', 'cell_line']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 4},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 4},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .": 4},\n    {"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex .": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .": 5},\n    {"While the activation of the IL-2 promoter and an NFAT -driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418 , it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2 -mediated NFAT activation is under the control of a combination of calcineurin- dependent and independent pathways .": 5},\n    {"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"IL-2": "protein"}, {"Jurkat": "cell_line"}, {"IL-2 promoter/reporter constructs": "DNA"}, {"VDR": "protein"}, {"DNA": "DNA"}]', 'prediction': {'IL-2': 'protein', 'Jurkat': 'cell_line', 'IL-2 promoter/reporter constructs': 'DNA', 'VDR': 'protein', 'DNA': 'DNA'}}
{'idx': 704, 'sentence': 'Activity of the immunoglobulin heavy and kappa light chain gene enhancers depends on a complex interplay of ubiquitous and developmentally regulated proteins .', 'label': {'ubiquitous and developmentally regulated proteins': 'protein', 'ubiquitous': 'protein', 'developmentally regulated proteins': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence 1": 5},\n    {"Sentence 2": 5},\n    {"Sentence 3": 5},\n    {"Sentence 4": 5},\n    {"Sentence 5": 5},\n    {"Sentence 6": 5},\n    {"Sentence 7": 5},\n    {"Sentence 8": 5},\n    {"Sentence 9": 1},\n    {"Sentence 10": 1},\n    {"Sentence 11": 5},\n    {"Sentence 12": 5},\n    {"Sentence 13": 5},\n    {"Sentence 14": 5},\n    {"Sentence 15": 1},\n    {"Sentence 16": 1},\n    {"Sentence 17": 1},\n    {"Sentence 18": 1},\n    {"Sentence 19": 1},\n    {"Sentence 20": 1}\n]', 'response3': '[{"immunoglobulin heavy and kappa light chain gene enhancers": "DNA"}]', 'prediction': {'immunoglobulin heavy and kappa light chain gene enhancers': 'DNA'}}
{'idx': 1236, 'sentence': 'Binding site selection revealed that the alternating RCGCRYGCGY consensus constitutes high-affinity IBR/F binding sites and that the direct-repeat palindrome TGCGCATGCGCA is the optimal site .', 'label': {'direct-repeat palindrome': 'DNA', 'IBR/F': 'protein', 'IBR/F binding sites': 'DNA', 'optimal site': 'DNA', 'alternating RCGCRYGCGY consensus': 'protein'}, 'response1': "['DNA']", 'response2': '[\n{"T cell": 5, "kB-like proto-enhancer element": 4, "interleukin 2": 5},\n{"kappa E3\'": 4, "positive-acting elements": 3, "negative-acting elements": 3},\n{"CREB": 5, "AR-CRE": 4},\n{"LTR": 4, "SIVsmmPBj14": 5},\n{"EBNA2": 5, "TP1": 4},\n{"BRCA1": 5},\n{"p50p50": 5},\n{"GM-CSF": 5},\n{"retinoic acid receptor alpha": 5},\n{"IL-2": 5, "c-Jun": 5, "c-Fos": 5},\n{"Protein": 5},\n{"Th2-type lymphocytes": 5},\n{"IgH": 5},\n{"VDR": 5, "RXR": 5, "GRIP-1": 5, "DRIP205": 5, "DRIP": 4},\n{"GC-box": 4, "GM-kappa B": 4, "GC-motif": 4, "GM-kappa B motif": 4},\n{"NF-kappaB": 5, "Sp1": 5, "SIVmac": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 541, 'sentence': 'To be or not to be a responder in T-cell responses : ubiquitous oligopeptides in all proteins.', 'label': {}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n    {"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.": 4},\n    {"Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n    {"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"Yet, for many pathogens, the molecules that induce IL-12 production by macrophages and the mechanisms by which they do so remain undefined.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1652, 'sentence': 'Furthermore, we demonstrate that the PU-SF complex binds to PU.1 sites found on a number of myeloid promoters , and its formation requires an intact PU.1 site adjacent to a single-stranded region.', 'label': {'PU.1': 'protein', 'PU-SF complex': 'protein', 'myeloid promoters': 'DNA', 'PU.1 site': 'DNA', 'PU-SF': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 3},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 4},\n    {"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.": 5},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n    {"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 4},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 4},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 5},\n    {"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 5},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes.": 3},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"PU-SF complex": "protein"}, {"PU.1": "protein"}]', 'prediction': {'PU-SF complex': 'protein', 'PU.1': 'protein'}}
{'idx': 88, 'sentence': 'TNF alpha did not activate cAMP production and its signal was not modulated by cAMP activators .', 'label': {'TNF alpha': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides clear and specific entities with their corresponding labels that directly match the entity types in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The example provides relevant entities with their corresponding labels that match the entity types in the target sentence, but some entities are not explicitly mentioned."},\n    {"Example 3": 4},\n    {"Reason 3": "The example provides relevant entities with their corresponding labels that match the entity types in the target sentence, but some entities are not explicitly mentioned."},\n    {"Example 4": 3},\n    {"Reason 4": "The example provides entities with their corresponding labels, but not all entities match the entity types in the target sentence."},\n    {"Example 5": 3},\n    {"Reason 5": "The example provides entities with their corresponding labels, but not all entities match the entity types in the target sentence."},\n    {"Example 6": 2},\n    {"Reason 6": "The example provides entities with their corresponding labels, but none of the entities match the entity types in the target sentence."},\n    {"Example 7": 2},\n    {"Reason 7": "The example provides entities with their corresponding labels, but none of the entities match the entity types in the target sentence."},\n    {"Example 8": 2},\n    {"Reason 8": "The example provides entities with their corresponding labels, but none of the entities match the entity types in the target sentence."},\n    {"Example 9": 2},\n    {"Reason 9": "The example provides entities with their corresponding labels, but none of the entities match the entity types in the target sentence."},\n    {"Example 10": 2},\n    {"Reason 10": "The example provides entities with their corresponding labels, but none of the entities match the entity types in the target sentence."},\n    {"Example 11": 2},\n    {"Reason 11": "The example provides entities with their corresponding labels, but none of the entities match the entity types in the target sentence."},\n    {"Example 12": 2},\n    {"Reason 12": "The example provides entities with their corresponding labels, but none of the entities match the entity types in the target sentence."},\n    {"Example 13": 2},\n    {"Reason 13": "The example provides entities with their corresponding labels, but none of the entities match the entity types in the target sentence."},\n    {"Example 14": 2},\n    {"Reason 14": "The example provides entities with their corresponding labels, but none of the entities match the entity types in the target sentence."},\n    {"Example 15": 2},\n    {"Reason 15": "The example provides entities with their corresponding labels, but none of the entities match the entity types in the target sentence."},\n    {"Example 16": 2},\n    {"Reason 16": "The example provides entities with their corresponding labels, but none of the entities match the entity types in the target sentence."},\n    {"Example 17": 2},\n    {"Reason 17": "The example provides entities with their corresponding labels, but none of the entities match the entity types in the target sentence."},\n    {"Example 18": 2},\n    {"Reason 18": "The example provides entities with their corresponding labels, but none of the entities match the entity types in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1494, 'sentence': 'Increased intracellular stores of latent NF-kappa B may also result in rapid inducibility of NF-kappa B -dependent cytokine gene expression .', 'label': {'latent NF-kappa B': 'protein', 'cytokine': 'protein', 'NF-kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains multiple instances of protein names that match the entity label set."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains multiple instances of protein names that match the entity label set."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains multiple instances of protein names that match the entity label set."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains multiple instances of protein names that match the entity label set."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence contains protein names and cell type names that match the entity label set."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains multiple instances of protein names that match the entity label set."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains multiple instances of protein names that match the entity label set."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains multiple instances of protein names that match the entity label set."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains multiple instances of protein names that match the entity label set."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains protein names that match the entity label set."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains protein names that match the entity label set."},\n    {"Example 12": 1},\n    {"Reason 12": "The sentence does not contain any entity names that match the entity label set."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not contain any entity names that match the entity label set."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not contain any entity names that match the entity label set."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any entity names that match the entity label set."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entity names that match the entity label set."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entity names that match the entity label set."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entity names that match the entity label set."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entity names that match the entity label set."}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"NF-kappa B": "protein"}]', 'prediction': {'NF-kappa B': 'protein'}}
{'idx': 940, 'sentence': 'Tamoxifen was also found to compete with 17 beta-estradiol for type II EBS in PBMC , although to a lesser extent than diethylstilbestrol .', 'label': {'PBMC': 'cell_type', 'type II EBS': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The example provides a specific protein entity \'NF-E2\' which is directly mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 2": 4},\n{"Reason 2": "The examples provide protein entities \'alpha-tocopherol\' and \'endothelial cells\' and a cell type entity \'monocyte\' which are directly mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 3": 4},\n{"Reason 3": "The examples provide protein entities \'NF-kappa B\' and \'AP-1\' which are directly mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 4": 4},\n{"Reason 4": "The examples provide protein entities \'IL-2\', \'NF-kappa B\', and \'AP-1\' which are directly mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 5": 5},\n{"Reason 5": "The examples provide RNA entity \'IL-5 mRNA\', cell type entity \'TCR\', protein entity \'IL-2R\', and protein entity \'dexamethasone\' which are directly mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 6": 4},\n{"Reason 6": "The example provides a protein entity \'retinoic acid receptor alpha\' which is directly mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 7": 4},\n{"Reason 7": "The examples provide protein entity \'WT1\' and cell line entity \'myeloid cell lines\' which are directly mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 8": 4},\n{"Reason 8": "The example provides a protein entity \'E2A\' which is directly mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 9": 4},\n{"Reason 9": "The examples provide protein entities \'NF-kappa B\' and \'I kappa B beta\' which are directly mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 10": 3},\n{"Reason 10": "The examples provide cell type entity \'lymphocytes\', chemical compound entities \'benzene\' and \'benzoquinone\' which are indirectly related to the sentence, somewhat aiding in the extraction of named entities."},\n{"Example 11": 4},\n{"Reason 11": "The example provides a protein entity \'NF-kappa B\' which is directly mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 12": 5},\n{"Reason 12": "The examples provide cell line entity \'Ter 119\' and protein entities \'beta-globin\', \'glycoprotein IIb\', and \'platelet factor 4\' which are directly mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 13": 4},\n{"Reason 13": "The examples provide protein entities \'Erbstatin\' and \'genistein\', and RNA entity \'Egr-1\' which are directly mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 14": 4},\n{"Reason 14": "The examples provide cell type entity \'B cell\', protein entity \'Ig\', and protein entity \'Transforming growth factor-beta\' which are directly mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 15": 4},\n{"Reason 15": "The examples provide DNA entity \'EBV\', protein entities \'EBNA2\' and \'estrogen receptor\' which are directly mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 16": 3},\n{"Reason 16": "The examples provide cell line entities \'PMA\' and \'U1 cells\' which are directly mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any named entities from the given entity label set, hence not helpful in extracting named entities."},\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any named entities from the given entity label set, hence not helpful in extracting named entities."},\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any named entities from the given entity label set, hence not helpful in extracting named entities."},\n{"Example 20": 1},\n{"Reason 20": "The sentence does not contain any named entities from the given entity label set, hence not helpful in extracting named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1098, 'sentence': 'Thus, intact microtubules are essential for 1,25(OH)2D3 -dependent modulation of gene transcription .', 'label': {'microtubules': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.": 5},\n    {"The phosphorylated tyrosine residue itself is important for the protein-protein interaction .": 4},\n    {"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .": 5},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .": 5},\n    {"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .": 5},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes .": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .": 5},\n    {"Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B / Oct-1 -dependent transcription .": 5},\n    {"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 5},\n    {"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts .": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2 .": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 255, 'sentence': 'c-myc RNA , which is constitutively expressed in RWLeu-4 cells , increased after 0.5 h of treatment with 50 nM VD3 and then rapidly decreased to barely detectable levels after 4 h of treatment.', 'label': {'c-myc RNA': 'RNA', 'RWLeu-4 cells': 'cell_line'}, 'response1': "['RNA', 'cell_line']", 'response2': '[\n    {"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.": 5},\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 5},\n    {"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 5},\n    {"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA -stimulated U1 cells , respectively.": 5},\n    {"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"c-myc RNA": "RNA"}, {"RWLeu-4 cells": "cell_line"}, {"VD3": "protein"}]', 'prediction': {'c-myc RNA': 'RNA', 'RWLeu-4 cells': 'cell_line', 'VD3': 'protein'}}
{'idx': 775, 'sentence': 'Some of these proteins (referred to as OTF-2 ) are lymphoid specific, whereas at least one other, and possibly more (referred to as OTF-1 ), is found ubiquitously in all cell types.', 'label': {'OTF-1': 'protein', 'OTF-2': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes": 5},\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells": 5},\n    {"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein": 5},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset": 5},\n    {"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes": 4},\n    {"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined": 4},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells": 4},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role": 3},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals": 3},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined": 3},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required": 1},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%": 1}\n]', 'response3': "[{'OTF-2': 'protein'}, {'OTF-1': 'protein'}]", 'prediction': {'OTF-2': 'protein', 'OTF-1': 'protein'}}
{'idx': 161, 'sentence': 'Steroid dose sparing : pharmacodynamic responses to single versus divided doses of methylprednisolone in man.', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific entities with clear entity labels that can aid in named entity extraction."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1130, 'sentence': 'B-lymphoblastoid cell lines from multiple sclerosis patients and a healthy control producing a putative new human retrovirus and Epstein-Barr virus .', 'label': {'B-lymphoblastoid cell lines': 'cell_line'}, 'response1': "['cell_line', 'virus']", 'response2': '[\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 1},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .": 4},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .": 4},\n    {"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.": 3},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 3},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .": 5},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 4},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .": 4},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n    {"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .": 5},\n    {"Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice .": 5},\n    {"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"B-lymphoblastoid cell lines": "cell_line"}, {"multiple sclerosis patients": "cell_type"}, {"healthy control": "cell_type"}, {"putative new human retrovirus": "virus"}, {"Epstein-Barr virus": "virus"}]', 'prediction': {'B-lymphoblastoid cell lines': 'cell_line', 'multiple sclerosis patients': 'cell_type', 'healthy control': 'cell_type', 'putative new human retrovirus': 'virus', 'Epstein-Barr virus': 'virus'}}
{'idx': 600, 'sentence': 'Involvement of a second lymphoid-specific enhancer element in the regulation of immunoglobulin heavy-chain gene expression .', 'label': {'immunoglobulin heavy-chain gene': 'DNA', 'lymphoid-specific enhancer element': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"lymphoid-specific enhancer element": "DNA"}, {"immunoglobulin heavy-chain gene": "DNA"}]', 'prediction': {'lymphoid-specific enhancer element': 'DNA', 'immunoglobulin heavy-chain gene': 'DNA'}}
{'idx': 1698, 'sentence': 'Oncogenicity of human papillomavirus- or adenovirus- transformed cells correlates with resistance to lysis by natural killer cells .', 'label': {'natural killer cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 4},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 4},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 4},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5},\n    {"Notably, the lack of pRB in these U937-derived clones renders these p53-null cells highly resistant to apoptosis induced by serum withdrawal, calphostin C, and ceramide.": 5},\n    {"Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype.": 5},\n    {"To our knowledge, this represents the first demonstration that phagocytic stimuli can induce NF-kappa B activation in human neutrophils.": 5},\n    {"These results demonstrate the existence of a triple autoregulatory loop in monocytes and macrophages involving HIV, p105 and p50, and MAD3, with the end result of persistent NF-kappa B activation and viral persistence.": 5},\n    {"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': "[{'human papillomavirus- or adenovirus- transformed cells': 'cell_type'}, {'natural killer cells': 'cell_type'}]", 'prediction': {'human papillomavirus- or adenovirus- transformed cells': 'cell_type', 'natural killer cells': 'cell_type'}}
{'idx': 1287, 'sentence': 'Platelet thromboxane receptors are acutely and reversibly upregulated after acute myocardial infarction .', 'label': {'Platelet thromboxane receptors': 'protein', 'Platelet': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides clear and specific examples of protein names that are directly mentioned in the text, making it highly helpful for extracting named entities."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains specific protein names that are directly mentioned in the text, aiding in the extraction of named entities."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence includes multiple protein names that are explicitly stated, making it very helpful for identifying named entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides clear protein names that are explicitly mentioned, aiding in the extraction of named entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains a specific protein name that is directly mentioned, making it highly helpful for extracting named entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence includes specific protein names that are explicitly stated, aiding in the extraction of named entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides specific protein names and cell types that are directly mentioned, making it very helpful for identifying named entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains specific protein names and cell types that are explicitly stated, aiding in the extraction of named entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence includes specific protein names and cell types that are directly mentioned, making it highly helpful for extracting named entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides a specific protein name that is explicitly mentioned, aiding in the extraction of named entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains a specific protein name that is directly mentioned, making it highly helpful for extracting named entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence includes specific protein names that are explicitly stated, aiding in the extraction of named entities."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides specific protein names that are directly mentioned, making it very helpful for identifying named entities."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains specific protein names that are explicitly stated, aiding in the extraction of named entities."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence includes specific protein names and a cell type that are directly mentioned, making it highly helpful for extracting named entities."}\n]', 'response3': '[{"Platelet thromboxane receptors": "protein"}]', 'prediction': {'Platelet thromboxane receptors': 'protein'}}
{'idx': 1266, 'sentence': 'Human herpesvirus 6 , a predominantly T lymphotropic virus , has been recently shown to infect some EBV -positive B cell lines , and to induce in them the activation of the EBV lytic cycle .', 'label': {'EBV -positive B cell lines': 'cell_line'}, 'response1': "['cell_line', 'cell_line', 'cell_line', 'cell_line', 'cell_line', 'cell_line']", 'response2': '[\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .": 4},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 4},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .": 4},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .": 4},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 3},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus , and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development .": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .": 4},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n    {"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .": 5},\n    {"Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"Human herpesvirus 6": "cell_type"}, {"EBV": "cell_line"}, {"B cell lines": "cell_line"}, {"EBV": "cell_line"}, {"EBV lytic cycle": "cell_line"}]', 'prediction': {'Human herpesvirus 6': 'cell_type', 'EBV': 'cell_line', 'B cell lines': 'cell_line', 'EBV lytic cycle': 'cell_line'}}
{'idx': 1813, 'sentence': 'Northern blot analysis revealed that BLR2 mRNA could be highly stimulated in mitogen- and anti-CD3- treated peripheral blood lymphocytes .', 'label': {'BLR2 mRNA': 'RNA', 'BLR2': 'protein'}, 'response1': "['RNA', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1}\n]', 'response3': '[{"BLR2 mRNA": "RNA"}, {"mitogen": "protein"}, {"anti-CD3": "protein"}, {"peripheral blood lymphocytes": "cell_type"}]', 'prediction': {'BLR2 mRNA': 'RNA', 'mitogen': 'protein', 'anti-CD3': 'protein', 'peripheral blood lymphocytes': 'cell_type'}}
{'idx': 1764, 'sentence': 'The inhibitory effect of cysteamine may be mediated at least in part by an effect on transcription factor function , as the DNA binding activities of AP-1 and NF-kappa B extracted from mitogen-stimulated cells were significantly inhibited by cysteamine treatment .', 'label': {'AP-1': 'protein', 'NF-kappa B': 'protein', 'transcription factor': 'protein', 'mitogen-stimulated cells': 'cell_type'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 5},\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"Control of NF-kappa B activity by the I kappa B beta inhibitor.": 5},\n    {"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n    {"RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n    {"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B, possibly by a phosphorylation reaction involving protein kinase C by PAF.": 5},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 5},\n    {"While the activation of the IL-2 promoter and an NFAT-driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418, it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2-mediated NFAT activation is under the control of a combination of calcineurin-dependent and independent pathways.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"AP-1": "DNA"}, {"NF-kappa B": "protein"}]', 'prediction': {'AP-1': 'DNA', 'NF-kappa B': 'protein'}}
{'idx': 740, 'sentence': 'On the basis of these assays, all N-Oct-factors were found to be distinct from the ubiquitous Oct-1 and the lymphoid-specific Oct-2A proteins.', 'label': {'ubiquitous Oct-1': 'protein', 'Oct-1': 'protein', 'Oct-2A': 'protein', 'lymphoid-specific Oct-2A': 'protein', 'N-Oct-factors': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear and direct mention of the entity along with its corresponding label, making it highly helpful for extracting named entities."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence directly mentions the entity and its label, aiding in the extraction of named entities."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence explicitly mentions the entity and its label, providing direct assistance in extracting named entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains multiple entities with their corresponding labels mentioned clearly, making it highly helpful for extracting named entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides clear mentions of multiple entities with their labels, aiding in the extraction of named entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence directly mentions the entities and their labels, providing clear assistance in extracting named entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence mentions the entity and its label explicitly, making it highly helpful for extracting named entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides a clear mention of the entity along with its label, aiding in the extraction of named entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains multiple entities with their corresponding labels mentioned clearly, making it highly helpful for extracting named entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence mentions the entities and their labels explicitly, providing clear assistance in extracting named entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence directly mentions the entities and their labels, aiding in the extraction of named entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides a clear mention of the entity along with its label, making it highly helpful for extracting named entities."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence mentions the entities and their labels explicitly, providing clear assistance in extracting named entities."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains multiple entities with their corresponding labels mentioned clearly, making it highly helpful for extracting named entities."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any entities or labels that can aid in extracting named entities."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entities or labels that can aid in extracting named entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities or labels that can aid in extracting named entities."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities or labels that can aid in extracting named entities."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities or labels that can aid in extracting named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1182, 'sentence': 'Moreover, STAT5 was found to be the predominant STAT transcription factor used by IL-2 in human T cells , and specifically required a COOH-terminal region of IL-2R beta ( Ser386-Val525 ), while STAT5 recruitment was not correlated to activation of IL-2R gamma or JAK3 .', 'label': {'IL-2': 'protein', 'T cells': 'cell_type', 'COOH-terminal region': 'protein', 'human T cells': 'cell_type', 'Ser386-Val525': 'protein', 'JAK3': 'protein', 'STAT transcription factor': 'protein', 'STAT5': 'protein', 'IL-2R beta': 'protein', 'IL-2R gamma': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 4},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"STAT5": "protein"}, {"IL-2": "protein"}, {"T cells": "cell_type"}, {"IL-2R beta": "protein"}, {"IL-2R gamma": "protein"}, {"JAK3": "protein"}]', 'prediction': {'STAT5': 'protein', 'IL-2': 'protein', 'T cells': 'cell_type', 'IL-2R beta': 'protein', 'IL-2R gamma': 'protein', 'JAK3': 'protein'}}
{'idx': 393, 'sentence': 'We also tested for the ability of defensins NP-1 , NP-5 , and HNP-1 to activate pag expression and found that these peptides have no effect.', 'label': {'HNP-1': 'protein', 'pag': 'DNA', 'NP-1': 'protein', 'defensins': 'protein', 'NP-5': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n    {"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 4},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .": 5},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .": 5},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .": 4},\n    {"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.": 5},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1442, 'sentence': 'T cell expression of interleukin 3 ( IL-3 ) is directed by positive and negative cis-acting DNA elements clustered within 300 base pairs of the transcriptional start site .', 'label': {'interleukin 3': 'protein', 'transcriptional start site': 'DNA', 'IL-3': 'protein'}, 'response1': "['DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 5},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"IL-3": "protein"}]', 'prediction': {'IL-3': 'protein'}}
{'idx': 142, 'sentence': 'This level of NF-kappa B -independent activity appears to be sufficient for virus multiplication , since TNF-alpha treatment had no effect on the kinetics of de novo HIV type 1 ( HIV-1 ) infection and viral RNA production in U937 cells .', 'label': {'U937 cells': 'cell_line', 'NF-kappa B': 'protein', 'viral RNA': 'RNA', 'TNF-alpha': 'protein'}, 'response1': "['RNA', 'protein', 'cell_line']", 'response2': '[\n{"TIMP-1": 5, "DNA": 5},\n{"NF-kB": 5, "AP-1": 5, "OCT-1": 5, "NF-IL-2B": 5},\n{"RelA": 5, "NF-kappa B": 5},\n{"NF-kappaB": 5, "Tax": 3, "ATL": 3},\n{"IkappaBbeta": 5, "NF-kappaB": 5},\n{"NF-kappa B": 5},\n{"NF-kappa B": 5},\n{"NF-kappa B": 5},\n{"NF-kappa B": 5},\n{"NF-kappa B": 5, "I kappa B alpha": 5},\n{"NF-kappa B": 5, "I kappa B alpha": 5},\n{"IFN A": 5, "IFNA": 5, "interleukin-2": 5, "interleukin-2 receptor": 5, "phytohemagglutinin": 5, "phorbol myristate acetate": 5},\n{"HIV-1": 5, "IFN": 5, "PKR": 5, "IkappaBalpha": 5},\n{"CD40": 5, "Rel/nuclear factor kappaB": 5, "NF-kappaB": 5, "B lymphocytes": 5},\n{"TR55": 5, "TNF-alpha": 5, "HIV": 5},\n{"NF-kappaB": 5, "Sp1": 5, "SIVmac": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"TNF-alpha": "protein"}, {"HIV type 1": "cell_type"}, {"HIV-1": "cell_type"}, {"viral RNA": "RNA"}, {"U937 cells": "cell_line"}]', 'prediction': {'NF-kappa B': 'protein', 'TNF-alpha': 'protein', 'HIV type 1': 'cell_type', 'HIV-1': 'cell_type', 'viral RNA': 'RNA', 'U937 cells': 'cell_line'}}
{'idx': 93, 'sentence': 'The Thy-1 gene promoter resembles a "housekeeping" promoter in that it is located within a methylation-free island , lacks a canonical TATA box , and displays heterogeneity in the 5\'-end termini of the mRNA .', 'label': {'canonical TATA box': 'DNA', '"housekeeping" promoter': 'DNA', 'methylation-free island': 'DNA', "5'-end termini": 'RNA', 'Thy-1 gene promoter': 'DNA', 'mRNA': 'RNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 4},\n    {"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.": 5},\n    {"A critical role of Sp1- and Ets-related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n    {"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n    {"While the activation of the IL-2 promoter and an NFAT-driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418, it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2-mediated NFAT activation is under the control of a combination of calcineurin-dependent and independent pathways.": 5},\n    {"This sequence element was referred to as the BAT box and its deletion significantly reduced the activity of a CD20 promoter-CAT construct in B cells.": 5},\n    {"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"Thy-1 gene promoter": "DNA"}]', 'prediction': {'Thy-1 gene promoter': 'DNA'}}
{'idx': 1354, 'sentence': 'In addition, these results indicate that nuclear TCF-1 expression can serve as a pan-T-lineage marker in the diagnosis of lymphoid malignancies .', 'label': {'TCF-1': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 3},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 4},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 3},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 3},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 4},\n    {"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.": 4},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms.": 3},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 3},\n    {"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 4},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 4},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 3},\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 3},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.": 4},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 3},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"TCF-1": "protein"}, {"lymphoid malignancies": "cell_type"}]', 'prediction': {'TCF-1': 'protein', 'lymphoid malignancies': 'cell_type'}}
{'idx': 466, 'sentence': '(ABSTRACT TRUNCATED AT 250 WORDS)', 'label': {}, 'response1': 'None.', 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1583, 'sentence': 'Associations between HLA class II antigens and autoantibodies to the ribonucleoproteins Ro(SSA) and La(SSB) have been reported in these patients.', 'label': {'ribonucleoproteins': 'protein', 'Ro(SSA)': 'protein', 'autoantibodies': 'protein', 'HLA class II antigens': 'protein', 'La(SSB)': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names that are directly mentioned."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains specific protein names that are directly mentioned."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains specific protein names that are directly mentioned."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains a specific cell type name that is directly mentioned."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains a specific protein name that is directly mentioned."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains specific protein names that are directly mentioned."},\n    {"Example 7": 1},\n    {"Reason 7": "The sentence does not contain any specific entity names."},\n    {"Example 8": 1},\n    {"Reason 8": "The sentence does not contain any specific entity names."},\n    {"Example 9": 1},\n    {"Reason 9": "The sentence does not contain any specific entity names."},\n    {"Example 10": 1},\n    {"Reason 10": "The sentence does not contain any specific entity names."},\n    {"Example 11": 1},\n    {"Reason 11": "The sentence does not contain any specific entity names."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains specific protein names that are directly mentioned."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains specific protein names and a cell type name that are directly mentioned."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains specific cell type and protein names that are directly mentioned."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains specific cell type and protein names that are directly mentioned."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any specific entity names."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific entity names."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific entity names."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific entity names."}\n]', 'response3': '[{"HLA class II antigens": "protein"}, {"ribonucleoproteins Ro(SSA)": "protein"}, {"La(SSB)": "protein"}]', 'prediction': {'HLA class II antigens': 'protein', 'ribonucleoproteins Ro(SSA)': 'protein', 'La(SSB)': 'protein'}}
{'idx': 592, 'sentence': 'The DNA isolated contained an open reading frame encoding 108 amino acid residues .', 'label': {}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 4},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 5},\n    {"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 4},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.": 5},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 4},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 4},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"This protein has now been purified and its encoding gene cloned.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"The p50 and p65 proteins, constituents of the prototypic nuclear factor kappaB, were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays.": 5},\n    {"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region, suggesting that the GC-motif can function independently of the GM-kappa B motif.": 5},\n    {"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 4},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"DNA": "DNA"}]', 'prediction': {'DNA': 'DNA'}}
{'idx': 163, 'sentence': 'This phenomenon can be mimicked by administering MP in divided doses.', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides clear and direct mappings between the entities mentioned and their corresponding entity labels."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions a specific protein entity, which is relevant to the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains multiple protein entities and cell types that are directly related to the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides clear mappings of cell types mentioned, which are relevant to the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence mentions specific protein entities that are directly related to the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides direct mappings of protein entities mentioned, which are relevant to the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence mentions a specific DNA entity, which is directly related to the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions specific protein entities that are directly related to the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence mentions specific cell line entities that are directly related to the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence mentions specific cell type entities that are directly related to the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence mentions a specific cell type entity, which is relevant to the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides clear mappings of protein entities mentioned, which are relevant to the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence mentions specific RNA and protein entities that are directly related to the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence mentions specific cell line entities that are directly related to the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any entities relevant to the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entities relevant to the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities relevant to the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities relevant to the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities relevant to the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1751, 'sentence': 'This effect is thought to be largely mediated through inactivation of the phosphatase calcineurin , which in turn inhibits translocation of an NFAT component to the nucleus.', 'label': {'NFAT': 'protein', 'calcineurin': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence 1": 5},\n    {"Sentence 2": 5},\n    {"Sentence 3": 5},\n    {"Sentence 4": 5},\n    {"Sentence 5": 5},\n    {"Sentence 6": 5},\n    {"Sentence 7": 5},\n    {"Sentence 8": 5},\n    {"Sentence 9": 5},\n    {"Sentence 10": 5},\n    {"Sentence 11": 5},\n    {"Sentence 12": 5},\n    {"Sentence 13": 5},\n    {"Sentence 14": 5},\n    {"Sentence 15": 5},\n    {"Sentence 16": 1},\n    {"Sentence 17": 1},\n    {"Sentence 18": 1},\n    {"Sentence 19": 1},\n    {"Sentence 20": 1}\n]', 'response3': '[{"calcineurin": "protein"}, {"NFAT": "protein"}]', 'prediction': {'calcineurin': 'protein', 'NFAT': 'protein'}}
{'idx': 1774, 'sentence': 'Further studies are needed to elucidate if this sex difference in PBMC receptors for 1.25 Dihydroxyvitamin D3 is of any pathophysiological relevance .', 'label': {'PBMC': 'cell_type', 'PBMC receptors': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 4},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage.": 5},\n    {"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 5},\n    {"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).": 5},\n    {"These results indicate that the monocyte/B-cell-specific transcription factor PU.1 and the Mono A and Mono B protein complexes act in concert to regulate monocyte-specific transcription of the CSF-1 receptor.": 5},\n    {"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.": 5},\n    {"A 3-bp mutation at the distal Sp1-binding site not only eliminates Sp1 interaction, but also abolishes most of the VitD3 induction of CD14 expression.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 206, 'sentence': 'It is concluded that (i) patients with CLL rarely express ER and (ii) immunocytochemical staining of cytospin preparations is a valid technique for the measurement of ER .', 'label': {'ER': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor )": 5},\n    {"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 4},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 4},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL .": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 5},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .": 4},\n    {"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 5},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 5},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"CLL": "cell_type"}, {"ER": "protein"}, {"ER": "protein"}]', 'prediction': {'CLL': 'cell_type', 'ER': 'protein'}}
{'idx': 928, 'sentence': 'A mouse ets-1 cDNA clone was obtained by screening a mouse thymus cDNA expression library with a double-stranded oligonucleotide probe representing 20 bp of the Moloney murine sarcoma virus ( MSV ) long terminal repeat ( LTR ).', 'label': {'ets-1': 'protein', 'long terminal repeat': 'DNA', 'double-stranded oligonucleotide probe': 'DNA', 'mouse thymus cDNA expression library': 'DNA', 'mouse ets-1 cDNA clone': 'DNA', 'LTR': 'DNA'}, 'response1': "['DNA', 'RNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a clear and direct match between the named entity and its corresponding entity label in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The example provides multiple clear and direct matches between the named entities and their corresponding entity labels in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The example provides a clear and direct match between the named entity and its corresponding entity label in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The example provides a clear and direct match between the named entity and its corresponding entity label in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides a clear and direct match between the named entity and its corresponding entity label in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The example provides a clear and direct match between the named entity and its corresponding entity label in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The example provides a clear and direct match between the named entities and their corresponding entity labels in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides a clear and direct match between the named entity and its corresponding entity label in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides a clear and direct match between the named entities and their corresponding entity labels in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides a clear and direct match between the named entities and their corresponding entity labels in the target sentence."},\n    {"Example 11": 1},\n    {"Reason 11": "The example does not contain any named entities that match the entity labels in the target sentence."},\n    {"Example 12": 1},\n    {"Reason 12": "The example does not contain any named entities that match the entity labels in the target sentence."},\n    {"Example 13": 1},\n    {"Reason 13": "The example does not contain any named entities that match the entity labels in the target sentence."},\n    {"Example 14": 1},\n    {"Reason 14": "The example does not contain any named entities that match the entity labels in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The example does not contain any named entities that match the entity labels in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1301, 'sentence': 'It was found that the most significant variable predicting NK activity at follow-up was tumor ER concentration , with higher NK activity associated with ER -status .', 'label': {'ER': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines.": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n    {"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"The expression of NDP kinase was intense in KA and SCC compared with BCC.": 5},\n    {"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 4},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 5},\n    {"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"ER": "protein"}, {"NK activity": "cell_type"}, {"tumor ER concentration": "cell_type"}, {"ER -status": "cell_type"}]', 'prediction': {'ER': 'protein', 'NK activity': 'cell_type', 'tumor ER concentration': 'cell_type', 'ER -status': 'cell_type'}}
{'idx': 1708, 'sentence': 'The Ca(2+) -dependent phosphatase calcineurin , a target of FK506 and CsA , synergizes with PKC -induced activation of nuclear factor (NF)-kappa B in T cell lines .', 'label': {'nuclear factor (NF)-kappa B': 'protein', 'T cell lines': 'cell_line', 'Ca(2+) -dependent phosphatase': 'protein', 'PKC': 'protein', 'calcineurin': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a direct mapping between the entity \'calcineurin\' and its corresponding label \'protein\' in the sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The example provides a direct mapping between the entities \'IkappaBalpha\' and \'NF-kappaB\' with their corresponding label \'protein\' in the sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The example provides a direct mapping between the entities \'IkappaBbeta\' and \'NF-kappaB\' with their corresponding label \'protein\' in the sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The example provides a direct mapping between the entities \'NF-kappa B\' and \'AP-1\' with their corresponding label \'protein\' in the sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides a direct mapping between the entities \'PAFR\', \'PAF\', \'NF-kappa B\', and \'protein kinase C\' with their corresponding label \'protein\' in the sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The example provides a direct mapping between the entities \'CD40\' and \'NF-kappa B\' with their corresponding label \'protein\' in the sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The example provides a direct mapping between the entities \'CD28\', \'CD80\', \'CD86\', \'CBL\', \'VAV\', \'NFAT\', \'interleukin-2\', and \'granulocyte-macrophage colony-stimulating factor\' with their corresponding label \'protein\' in the sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides a direct mapping between the entities \'NF-kappaB\', \'Tax\', and \'ATL\' with their corresponding labels \'protein\' and \'cell_type\' in the sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides a direct mapping between the entities \'NF-kappa B\' and \'I kappa B beta\' with their corresponding label \'protein\' in the sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides a direct mapping between the entities \'NF-kappa B\' and \'I kappa B alpha\' with their corresponding label \'protein\' in the sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The example provides a direct mapping between the entity \'NF-kappa B\' with its corresponding label \'protein\' in the sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The example provides a direct mapping between the entities \'RelA\' and \'NF-kappa B\' with their corresponding label \'protein\' in the sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides a direct mapping between the entities \'Syk\', \'Zap\', and \'T cell\' with their corresponding labels \'protein\' and \'cell_type\' in the sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The example provides a direct mapping between the entity \'NF-kappa B\' with its corresponding label \'protein\' in the sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The example provides a direct mapping between the entities \'SP1\', \'caspases\', and \'B-cell\' with their corresponding labels \'protein\' and \'cell_type\' in the sentence."},\n    {"Example 16": 5},\n    {"Reason 16": "The example provides a direct mapping between the entity \'NF-kappa B\' with its corresponding label \'protein\' in the sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities related to the provided entity labels."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities related to the provided entity labels."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities related to the provided entity labels."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities related to the provided entity labels."}\n]', 'response3': '[{"calcineurin": "protein"}, {"FK506": "protein"}, {"CsA": "protein"}, {"PKC": "protein"}, {"NF-kappa B": "protein"}, {"T cell lines": "cell_line"}]', 'prediction': {'calcineurin': 'protein', 'FK506': 'protein', 'CsA': 'protein', 'PKC': 'protein', 'NF-kappa B': 'protein', 'T cell lines': 'cell_line'}}
{'idx': 747, 'sentence': 'Protein kinase inhibitor H-7 blocks accumulation of unspliced mRNA of human T-cell leukemia virus type I ( HTLV-I ).', 'label': {'unspliced mRNA': 'RNA'}, 'response1': "['protein', 'RNA']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .": 5},\n    {"Control of NF-kappa B activity by the I kappa B beta inhibitor .": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 4},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 4},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Tat-binding protein 7 is a subunit of the 26S protease .": 5},\n    {"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 4},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n    {"Binding of YY1 and Oct1 to a novel element that downregulates expression of IL-5 in human T cells .": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 333, 'sentence': 'These protoenhancers alone are weakly or not responsive to R .', 'label': {'protoenhancers': 'DNA', 'R': 'protein'}, 'response1': "['DNA', 'RNA']", 'response2': '[\n    {"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 5},\n    {"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .": 4},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50 .": 4},\n    {"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements .": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 4},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .": 5},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .": 5},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter": 5},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 758, 'sentence': 'Cell proliferation of CEM-C7 cells cultured in both serum-free media has been sustained for 3 mo.', 'label': {'CEM-C7': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.": 5},\n    {"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 4},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 4},\n    {"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 4},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 3},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 5},\n    {"Thus, we were able to derive a hematopoietic cell line, called 47.10, that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.": 5},\n    {"Notably, the lack of pRB in these U937-derived clones renders these p53-null cells highly resistant to apoptosis induced by serum withdrawal, calphostin C, and ceramide.": 5},\n    {"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.": 5},\n    {"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.": 5},\n    {"We isolated a novel subline, UT-7/GMT, from the human leukemia cell line UT-7/GM (N. Komatsu, et al., Blood, 89: 4021-4033, 1997).": 5},\n    {"The modified vectors were used to transduce human hematopoietic cell lines, cord blood-derived CD34(+) stem/progenitor cells, and murine bone marrow repopulating stem cells.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 727, 'sentence': 'The importance of the internal ATGs to Rex function is not known.', 'label': {'Rex': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein (Runt domain) and its corresponding entity label."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence clearly mentions a protein (TCF-1) and its corresponding entity label."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence explicitly refers to a protein (tyrosine) and its corresponding entity label."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence mentions \'nonhuman primates\' which is likely a cell_type, providing some context for entity extraction."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains clear examples of proteins (IL-7R and gamma(c)) and their corresponding entity labels."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence explicitly mentions a cell_line (SIVsmmPBj14) and its corresponding entity label."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides examples of proteins (Jun and ATF-2) and their corresponding entity labels."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions a protein (GATA-1) and its corresponding entity label."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence refers to a protein (NF-kappaB) and a cell_type (rheumatoid arthritis), aiding in entity extraction."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains clear examples of proteins (IL-2, c-Jun, and c-Fos) and their corresponding entity labels."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence explicitly mentions a protein (RXR) and its corresponding entity label."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides a clear example of a protein (Protein) and its corresponding entity label."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence mentions DNA elements (UAS3 and UAS2) and a protein (YY1), aiding in entity extraction."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains clear examples of proteins (IL-2, Aiolos, and Ras) and their corresponding entity labels."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence explicitly mentions a protein (IL-4) and its corresponding entity label."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence provides a clear example of a cell_line (SCM-1) and its corresponding entity label."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific examples of entities related to the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific examples of entities related to the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific examples of entities related to the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any specific examples of entities related to the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 429, 'sentence': 'As shown by mobility-shift , methylation interference , and mutational analyses , the mammalian protein BSAP recognizes all four sea urchin binding sites in a manner indistinguishable from TSAP ; however, the two proteins differ in molecular weight.', 'label': {'TSAP': 'protein', 'mammalian protein': 'protein', 'sea urchin binding sites': 'DNA', 'BSAP': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.": 5},\n    {"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n    {"Tat-binding protein 7 is a subunit of the 26S protease.": 5},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 5},\n    {"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 5},\n    {"A gst-EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2-PU.1 interaction.": 5},\n    {"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.": 5},\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 5},\n    {"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1372, 'sentence': 'The TCL1 oncogene on human chromosome 14q32.1 is involved in chromosome translocations [ t(14;14)(q11;q32.1) and t(7;14)(q35;q32.1) ] and inversions [ inv14(q11;q32.1) ] with TCR alpha/beta loci in T-cell leukemias , such as T-prolymphocytic ( T-PLL ).', 'label': {'14q32.1': 'DNA', 'TCR alpha/beta loci': 'DNA', 't(14;14)(q11;q32.1)': 'DNA', 'TCL1 oncogene': 'DNA', 'human chromosome': 'DNA', 't(7;14)(q35;q32.1)': 'DNA', 'inv14(q11;q32.1)': 'DNA'}, 'response1': "['DNA', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein entity (BRCA1) and its corresponding label."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides a clear example of a protein entity (TCF-1) and its corresponding label."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence provides clear examples of protein entities (SLAP-130, SLP-76) and a cell type entity (T cell) with their corresponding labels."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides clear examples of protein entities (IkappaBbeta, NF-kappaB) with their corresponding labels."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides a clear example of a cell type entity (Th2-type lymphocytes) and its corresponding label."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides clear examples of protein entities (IL-2 receptor alpha subunit, p21ras) and a cell type entity (B cell) with their corresponding labels."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides clear examples of protein entities (c-kit, IL-4R alpha chain) with their corresponding labels."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides clear examples of protein entities (IL-13, IL-4R, JAK2, IL-13R) with their corresponding labels."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides clear examples of protein entities (TCRzeta, p56(lck)) with their corresponding labels."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides clear examples of protein entities (NF-kappaB, Tax) and cell type entities (ATL) with their corresponding labels."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides clear examples of cell type entity (T cell) and protein entity (interleukin 2) with their corresponding labels."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides a clear example of a cell line entity (SCM-1) and its corresponding label."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides clear examples of protein entity (TAL1) and cell type entity (T-ALL) with their corresponding labels."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides a clear example of a cell type entity (T-PLL) and its corresponding label."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides a clear example of a protein entity (TCL1) and its corresponding label."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence provides clear examples of protein entities (SCL, GATA-1) with their corresponding labels."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any named entities related to the given entity labels."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any named entities related to the given entity labels."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any named entities related to the given entity labels."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any named entities related to the given entity labels."}\n]', 'response3': '[{"TCL1": "protein"}, {"TCR alpha/beta": "protein"}, {"T-cell": "cell_type"}, {"T-prolymphocytic (T-PLL)": "cell_type"}]', 'prediction': {'TCL1': 'protein', 'TCR alpha/beta': 'protein', 'T-cell': 'cell_type', 'T-prolymphocytic (T-PLL)': 'cell_type'}}
{'idx': 546, 'sentence': 'Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin .', 'label': {'T lymphocytes': 'cell_type', 'immunophilin': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a clear and direct mapping between the entity \'calcineurin\' and its corresponding entity label \'protein\' in the sentence, aiding in the extraction of named entities."},\n    {"Example 2": 5},\n    {"Reason 2": "The example provides a clear and direct mapping between the entity \'NF-kappa B\' and its corresponding entity label \'protein\' in the sentence, aiding in the extraction of named entities."},\n    {"Example 3": 5},\n    {"Reason 3": "The example provides multiple mappings between protein entities such as \'IL-2\', \'IFN-gamma\', \'jak kinases\', and \'STAT1(alpha)\' in the sentence, aiding in the extraction of named entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The example provides multiple mappings between protein entities such as \'IFN A\', \'IFNA\', \'interleukin-2\', \'interleukin-2 receptor\', \'phytohemagglutinin\', and \'phorbol myristate acetate\' in the sentence, aiding in the extraction of named entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides mappings between entity types \'cell_type\' for \'T cell\' and \'protein\' for \'IL-2\', \'IL-2 receptor\', and \'CD28\' in the sentence, aiding in the extraction of named entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The example provides mappings between entity types \'RNA\' for \'IL-5 mRNA\', \'cell_type\' for \'TCR\', and \'protein\' for \'IL-2R\' and \'dexamethasone\' in the sentence, aiding in the extraction of named entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The example provides mappings between protein entities \'NF-kappa B\' and \'I kappa B alpha\' in the sentence, aiding in the extraction of named entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides a clear and direct mapping between the entity \'IL-2\' and its corresponding entity label \'protein\' in the sentence, aiding in the extraction of named entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides mappings between protein entities \'CD28\', \'CD80\', \'CD86\', \'CBL\', \'VAV\', \'NFAT\', \'interleukin-2\', and \'granulocyte-macrophage colony-stimulating factor\' in the sentence, aiding in the extraction of named entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides mappings between protein entity \'NF-ATc\' and cell type entity \'T lymphocytes\' in the sentence, aiding in the extraction of named entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The example provides mappings between protein entities \'IkappaBbeta\' and \'NF-kappaB\' in the sentence, aiding in the extraction of named entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The example provides mappings between protein entities \'IL-2\', \'p21ras\', and cell type entity \'B cell\' in the sentence, aiding in the extraction of named entities."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides mappings between protein entities \'Syk\', \'Zap\', and cell type entity \'T cell\' in the sentence, aiding in the extraction of named entities."},\n    {"Example 14": 5},\n    {"Reason 14": "The example provides mappings between protein entities \'IL-2\', \'NF-kappa B\', and \'AP-1\' in the sentence, aiding in the extraction of named entities."},\n    {"Example 15": 5},\n    {"Reason 15": "The example provides mappings between protein entities \'IL-2\', \'Aiolos\', and \'Ras\' in the sentence, aiding in the extraction of named entities."},\n    {"Example 16": 5},\n    {"Reason 16": "The example provides mappings between protein entities \'IkappaBalpha\' and \'NF-kappaB\' in the sentence, aiding in the extraction of named entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any named entities from the given entity label set, hence providing no aid in the extraction of named entities."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any named entities from the given entity label set, hence providing no aid in the extraction of named entities."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any named entities from the given entity label set, hence providing no aid in the extraction of named entities."}\n]', 'response3': '[{"T lymphocytes": "cell_type"}, {"immunophilin": "protein"}, {"FK506": "protein"}, {"rapamycin": "protein"}]', 'prediction': {'T lymphocytes': 'cell_type', 'immunophilin': 'protein', 'FK506': 'protein', 'rapamycin': 'protein'}}
{'idx': 1437, 'sentence': 'In summary, we developed an assay for the quantitative determination of hTR beta 1 mRNA levels in small human tissue samples , containing as little as 50 ng of total RNA.', 'label': {'hTR beta 1': 'protein', 'hTR beta 1 mRNA': 'RNA'}, 'response1': "['RNA']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"IFN A": "The mention of IFN A (IFNA) is directly associated with the protein entity label."},\n    {"IFNA": "The mention of IFNA is directly associated with the protein entity label."},\n    {"interleukin-2": "The mention of interleukin-2 is directly associated with the protein entity label."},\n    {"interleukin-2 receptor": "The mention of interleukin-2 receptor is directly associated with the protein entity label."},\n    {"phytohemagglutinin": "The mention of phytohemagglutinin is directly associated with the protein entity label."},\n    {"phorbol myristate acetate": "The mention of phorbol myristate acetate is directly associated with the protein entity label."}\n]\n[\n    {"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 4},\n    {"cDNAs": "The mention of cDNAs is directly associated with the DNA entity label."}\n]\n[\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"TCRzeta": "The mention of TCRzeta is directly associated with the protein entity label."},\n    {"p56(lck)": "The mention of p56(lck) is directly associated with the protein entity label."}\n]\n[\n    {"Because relatively little is known about these events in nonhuman primates , our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.": 4},\n    {"nonhuman primates": "The mention of nonhuman primates is directly associated with the cell_type entity label."}\n]\n[\n    {"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n    {"TCF-1": "The mention of TCF-1 is directly associated with the protein entity label."}\n]\n[\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"NF-ATc": "The mention of NF-ATc is directly associated with the protein entity label."},\n    {"T lymphocytes": "The mention of T lymphocytes is directly associated with the cell_type entity label."},\n    {"embryonic cardiac cells": "The mention of embryonic cardiac cells is directly associated with the cell_type entity label."}\n]\n[\n    {"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.": 5},\n    {"PML/RARalpha": "The mention of PML/RARalpha is directly associated with the protein entity label."}\n]\n[\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 5},\n    {"retinoic acid receptor alpha": "The mention of retinoic acid receptor alpha is directly associated with the protein entity label."}\n]\n[\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"E2A": "The mention of E2A is directly associated with the protein entity label."}\n]\n[\n    {"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.": 5},\n    {"Ter 119": "The mention of Ter 119 is directly associated with the cell_line entity label."},\n    {"beta-globin": "The mention of beta-globin is directly associated with the protein entity label."},\n    {"glycoprotein IIb": "The mention of glycoprotein IIb is directly associated with the protein entity label."},\n    {"platelet factor 4": "The mention of platelet factor 4 is directly associated with the protein entity label."}\n]\n[\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"B and T cell activation": "The mention of B and T cell activation is directly associated with the cell_type entity label."},\n    {"Ramos": "The mention of Ramos is directly associated with the cell_line entity label."},\n    {"Jurkat": "The mention of Jurkat is directly associated with the cell_line entity label."},\n    {"cDNA microarray technology": "The mention of cDNA microarray technology is directly associated with the DNA entity label."}\n]\n[\n    {"Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.": 5},\n    {"hematopoietic cell line": "The mention of hematopoietic cell line is directly associated with the cell_line entity label."},\n    {"47.10": "The mention of 47.10 is directly associated with the cell_line entity label."},\n    {"cell line": "The mention of cell line is directly associated with the cell_line entity label."},\n    {"nontransgenic mice": "The mention of nontransgenic mice is directly associated with the cell_line entity label."}\n]\n[\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"HIV-1 LTR": "The mention of HIV-1 LTR is directly associated with the DNA entity label."},\n    {"NFAT-1": "The mention of NFAT-1 is directly associated with the protein entity label."},\n    {"NF kappa B": "The mention of NF kappa B is directly associated with the protein entity label."}\n]\n[\n    {"Expression of tal-1 and GATA-binding proteins during human hematopoiesis.": 5},\n    {"tal-1": "The mention of tal-1 is directly associated with the protein entity label."},\n    {"GATA-binding proteins": "The mention of GATA-binding proteins is directly associated with the protein entity label."},\n    {"hematopoiesis": "The mention of hematopoiesis is directly associated with the cell_type entity label."}\n]\n[\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n    {"EBV": "The mention of EBV is directly associated with the DNA entity label."},\n    {"EBNA2": "The mention of EBNA2 is directly associated with the protein entity label."},\n    {"estrogen receptor": "The mention of estrogen receptor is directly associated with the protein entity label."}\n]\n[\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1}\n]\n[\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1}\n]\n[\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1}\n]\n[\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1}\n]\n[\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': "[{'hTR beta 1 mRNA': 'RNA'}]", 'prediction': {'hTR beta 1 mRNA': 'RNA'}}
{'idx': 1399, 'sentence': 'To investigate the role of NF-M in hematopoietic cell lineage commitment, we constructed a conditional form of the protein by fusing it to the hormone binding domain of the human estrogen receptor .', 'label': {'hematopoietic cell lineage': 'cell_line', 'human estrogen receptor': 'protein', 'NF-M': 'protein', 'hormone binding domain': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n{"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n{"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n{"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.": 5},\n{"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n{"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.": 5},\n{"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 5},\n{"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events.": 5},\n{"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n{"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n{"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 5},\n{"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n{"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.": 5},\n{"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 5},\n{"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"NF-M": "protein"}]', 'prediction': {'NF-M': 'protein'}}
{'idx': 1327, 'sentence': 'Our results demonstrate that NF-IL6 is involved in transcriptional activation of the human IL-4 promoter in T cells .', 'label': {'human IL-4': 'protein', 'human IL-4 promoter': 'DNA', 'NF-IL6': 'protein', 'T cells': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities (proteins and cell types) that are relevant to the target sentence, aiding in the extraction of named entities."}\n]', 'response3': '[{"NF-IL6": "protein"}, {"IL-4": "protein"}, {"T cells": "cell_type"}]', 'prediction': {'NF-IL6': 'protein', 'IL-4': 'protein', 'T cells': 'cell_type'}}
{'idx': 146, 'sentence': 'Unlike other class II promoters , the HLA-DR alpha (DRA) promoter also contains one element identical to the "octamer" motif of immunoglobulin variable region promoters that is responsible for B cell-specific transcription .', 'label': {'"octamer" motif': 'DNA', 'HLA-DR alpha (DRA) promoter': 'DNA', 'class II promoters': 'DNA', 'immunoglobulin variable region promoters': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 4},\n    {"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.": 5},\n    {"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 4},\n    {"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"HLA-DR alpha (DRA)": "protein"}, {"octamer": "protein"}, {"immunoglobulin variable region": "protein"}, {"B cell-specific": "cell_type"}]', 'prediction': {'HLA-DR alpha (DRA)': 'protein', 'octamer': 'protein', 'immunoglobulin variable region': 'protein', 'B cell-specific': 'cell_type'}}
{'idx': 1247, 'sentence': 'The Janus family tyrosine kinase Jak3 is the only signaling molecule known to be associated with gamma c , so it was hypothesized that defects in Jak3 might cause an XSCID -like phenotype .', 'label': {'Janus family tyrosine kinase': 'protein', 'Jak3': 'protein', 'gamma c': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 3},\n    {"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway, and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.": 5},\n    {"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.": 4},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 4},\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n    {"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/thrombopoiesis or possibly a mature platelet function such as aggregation.": 5},\n    {"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.": 5},\n    {"SCL is expressed in erythroid, megakaryocyte and mast cell populations (the same cell lineages as GATA-1, a zinc-finger transcription factor).": 4},\n    {"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine (IL-2 and IFN-gamma) production is normal.": 5},\n    {"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1300, 'sentence': 'As considerable evidence has accumulated that social support in both animal and human populations may have survival value, we sought to test the reliability of this regression model , using coping and perceived support factor values obtained at 3 months after surgery to account for concurrent follow-up NK activity in this serially assessed group of patients .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 5},\n    {"Because relatively little is known about these events in nonhuman primates , our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates .": 4},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .": 5},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes .": 4},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements .": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .": 5},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .": 5},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .": 4},\n    {"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .": 5},\n    {"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 350, 'sentence': 'Induction of 24,25-(OH)2D3 synthesis by 1,25(OH)2D3 was observed in the fifth cell line , designated Ro-VDR , although the sensitivity to hormone treatment was lower than in the control cell line from a normal donor .', 'label': {'control cell line': 'cell_line', 'cell line': 'cell_line', 'Ro-VDR': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence contains specific protein names like TIMP-1 and DNA, which are directly related to the entity labels provided."},\n{"Example 2": 5},\n{"Reason 2": "The sentence mentions specific protein (MNDA) and cell line (Philadelphia chromosome-positive chronic myeloid leukemia) names, directly matching the entity labels."},\n{"Example 3": 5},\n{"Reason 3": "The sentence includes multiple protein names (IFN A, interleukin-2, interleukin-2 receptor) and stimuli (phytohemagglutinin, phorbol myristate acetate) that align with the entity labels."},\n{"Example 4": 5},\n{"Reason 4": "The sentence directly mentions the protein CD14, matching the entity label provided."},\n{"Example 5": 5},\n{"Reason 5": "The sentence contains a specific protein name (retinoic acid receptor alpha) that corresponds to the entity label."},\n{"Example 6": 5},\n{"Reason 6": "The sentence mentions the protein WT1 and the cell line myeloid cell lines, aligning with the entity labels."},\n{"Example 7": 5},\n{"Reason 7": "The sentence includes the protein NF-E2, which matches the entity label provided."},\n{"Example 8": 5},\n{"Reason 8": "The sentence directly mentions the protein retinoic acid receptor alpha, which corresponds to the entity label."},\n{"Example 9": 5},\n{"Reason 9": "The sentence contains the protein RXR, aligning with the entity label provided."},\n{"Example 10": 5},\n{"Reason 10": "The sentence mentions the protein ZAP-70, directly matching the entity label."},\n{"Example 11": 5},\n{"Reason 11": "The sentence includes specific protein names (IL-5 mRNA, IL-2, CD25) and stimuli (dexamethasone) that align with the entity labels."},\n{"Example 12": 5},\n{"Reason 12": "The sentence contains multiple protein names (VDR, RXR, GRIP-1, DRIP205) that correspond to the entity labels."},\n{"Example 13": 5},\n{"Reason 13": "The sentence mentions specific protein names (interleukin-2, alpha chain, CD25, IL-2 receptor) that align with the entity labels."},\n{"Example 14": 5},\n{"Reason 14": "The sentence includes protein names (Protein kinase B, phosphatidylinositol 3-kinase, STAT5, erythropoietin, EPO) and cell line names (HCD57, HCD57-SREI) that match the entity labels."},\n{"Example 15": 5},\n{"Reason 15": "The sentence directly mentions cell line names (hematopoietic cell line, 47.10, cell line, nontransgenic mice) that correspond to the entity labels."},\n{"Example 16": 5},\n{"Reason 16": "The sentence includes specific terms related to DNA (2-deoxyguanosine) and cell types (lymphoid progenitor cells, thymus stromal cells, B cell, fetal liver cells, T cell) that align with the entity labels."},\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any specific entity names related to the provided entity labels."},\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any specific entity names related to the provided entity labels."},\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any specific entity names related to the provided entity labels."},\n{"Example 20": 1},\n{"Reason 20": "The sentence does not contain any specific entity names related to the provided entity labels."}\n]', 'response3': '[{"Ro-VDR": "cell_line"}]', 'prediction': {'Ro-VDR': 'cell_line'}}
{'idx': 1093, 'sentence': 'The genomic actions of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) are mediated by the intracellular vitamin D receptor ( VDR ).', 'label': {'VDR': 'protein', 'vitamin D receptor': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains multiple protein names and a cell type, which are all present in the entity label set."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any entities matching the entity label set."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains a protein name that is present in the entity label set."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains a protein name that is present in the entity label set."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains a protein name that is present in the entity label set."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains multiple protein names and a cell type, which are all present in the entity label set."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains a protein name that is present in the entity label set."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains a protein name that is present in the entity label set."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains a protein name that is present in the entity label set."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains multiple protein names that are present in the entity label set."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains multiple protein names that are present in the entity label set."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains multiple protein names and a cell line, which are all present in the entity label set."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not contain any entities matching the entity label set."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not contain any entities matching the entity label set."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any entities matching the entity label set."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entities matching the entity label set."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities matching the entity label set."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1493, 'sentence': 'Chronic HIV-1 infection of myeloid cells leads to constitutive NF-kappa B DNA-binding activity and provides an intranuclear environment capable of perpetuating HIV-1 replication .', 'label': {'myeloid cells': 'cell_type', 'NF-kappa B': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear and direct mention of the entity along with its corresponding label, making it highly helpful for extracting named entities from the target sentence."}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"DNA": "DNA"}, {"HIV-1": "cell_type"}]', 'prediction': {'NF-kappa B': 'protein', 'DNA': 'DNA', 'HIV-1': 'cell_type'}}
{'idx': 334, 'sentence': "One of the protoenhancers contains the overlapping palindromes 5'-TTGTCCcgtGGACAAaTGTCC-3' .", 'label': {'protoenhancers': 'DNA', 'overlapping palindromes': 'DNA'}, 'response1': "['DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear and direct mention of the entity \'DNA\' in the context of \'proto-enhancer\', which is a specific type of DNA element. This example is highly relevant and aids in extracting the named entity from the target sentence."},\n\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions \'BRCA1\' in the context of splicing and expression, indicating that \'BRCA1\' is a protein. This example is helpful in identifying the entity type in the target sentence."},\n\n    {"Example 3": 4},\n    {"Reason 3": "The sentence mentions \'EBNA2\' and \'TP1 promoter\', providing clear indications that \'EBNA2\' is a protein and \'TP1\' is a cell line. This example is relevant for extracting named entities from the target sentence."},\n\n    {"Example 4": 4},\n    {"Reason 4": "The sentence mentions \'GM-CSF\' in the context of genes, indicating that \'GM-CSF\' is a protein. This example is helpful in determining the entity type in the target sentence."},\n\n    {"Example 5": 4},\n    {"Reason 5": "The sentence mentions \'Protein\' in the context of sequences involved in transcription, suggesting that \'Protein\' refers to a protein entity. This example aids in identifying the entity type in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 946, 'sentence': 'Compared to the control group , fewer depressed subjects down-regulated Bmax after DEX .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides clear examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 777, 'sentence': 'We have identified two human pre-B-cell lines that contain extremely low levels of OTF-2 yet still express high levels of steady-state immunoglobulin heavy-chain mRNA in vivo and efficiently transcribe an immunoglobulin gene in vitro.', 'label': {'OTF-2': 'protein', 'immunoglobulin gene': 'DNA', 'steady-state immunoglobulin heavy-chain mRNA': 'RNA', 'human pre-B-cell lines': 'cell_line', 'immunoglobulin heavy-chain': 'protein'}, 'response1': "['cell_line', 'protein', 'RNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence directly mentions the entity and provides clear context for its identification."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence directly mentions the entity and provides clear context for its identification."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence directly mentions the entity and provides clear context for its identification."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence directly mentions the entity and provides clear context for its identification."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence directly mentions the entity and provides clear context for its identification."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence directly mentions the entity and provides clear context for its identification."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence directly mentions the entity and provides clear context for its identification."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence directly mentions the entity and provides clear context for its identification."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence directly mentions the entity and provides clear context for its identification."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence directly mentions the entity and provides clear context for its identification."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence directly mentions the entity and provides clear context for its identification."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence directly mentions the entity and provides clear context for its identification."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence directly mentions the entity and provides clear context for its identification."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not mention any specific entity."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not mention any specific entity."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not mention any specific entity."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not mention any specific entity."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not mention any specific entity."}\n]', 'response3': "[{'OTF-2': 'protein'}, {'immunoglobulin heavy-chain mRNA': 'RNA'}, {'immunoglobulin gene': 'DNA'}, {'pre-B-cell lines': 'cell_line'}]", 'prediction': {'OTF-2': 'protein', 'immunoglobulin heavy-chain mRNA': 'RNA', 'immunoglobulin gene': 'DNA', 'pre-B-cell lines': 'cell_line'}}
{'idx': 552, 'sentence': 'Similarly, an excess of FK506 is needed to revert rapamycin -mediated inhibition of IL-2 -induced proliferation .', 'label': {'IL-2': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1}\n]', 'response3': '[{"FK506": "protein"}, {"rapamycin": "protein"}, {"IL-2": "protein"}]', 'prediction': {'FK506': 'protein', 'rapamycin': 'protein', 'IL-2': 'protein'}}
{'idx': 1310, 'sentence': 'The abundant chromosomal protein HMG-1 belongs to this subgroup.', 'label': {'HMG-1': 'protein', 'chromosomal protein': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 5},\n    {"This protein has now been purified and its encoding gene cloned.": 5},\n    {"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.": 1},\n    {"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 1},\n    {"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 5},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n    {"Tat-binding protein 7 is a subunit of the 26S protease.": 5},\n    {"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n    {"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.": 5},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1409, 'sentence': 'We investigated the ability of PRL and IL-2 to activate Stat proteins in different T cell lines .', 'label': {'IL-2': 'protein', 'T cell lines': 'cell_line', 'PRL': 'protein', 'Stat proteins': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names like IL-2, IL-4, IFN-gamma, CD70, etc., which are directly related to the entity labels provided in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions terms like T cell, B cell, monocytes, macrophages, which are related to the \'cell_type\' entity label in the target sentence."},\n    {"Example 3": 3},\n    {"Reason 3": "The sentence talks about NF-kappa B, Stat3, Stat5, c-Mpl, which are relevant to the \'protein\' entity label in the target sentence."},\n    {"Example 4": 2},\n    {"Reason 4": "The sentence discusses elements related to protein synthesis and turnover rate, which are indirectly related to the \'protein\' entity label in the target sentence."},\n    {"Example 5": 1},\n    {"Reason 5": "The sentence does not contain any terms related to the entity labels provided in the target sentence."},\n    {"Example 6": 1},\n    {"Reason 6": "The sentence does not contain any terms related to the entity labels provided in the target sentence."},\n    {"Example 7": 1},\n    {"Reason 7": "The sentence does not contain any terms related to the entity labels provided in the target sentence."},\n    {"Example 8": 1},\n    {"Reason 8": "The sentence does not contain any terms related to the entity labels provided in the target sentence."},\n    {"Example 9": 1},\n    {"Reason 9": "The sentence does not contain any terms related to the entity labels provided in the target sentence."},\n    {"Example 10": 1},\n    {"Reason 10": "The sentence does not contain any terms related to the entity labels provided in the target sentence."},\n    {"Example 11": 1},\n    {"Reason 11": "The sentence does not contain any terms related to the entity labels provided in the target sentence."},\n    {"Example 12": 1},\n    {"Reason 12": "The sentence does not contain any terms related to the entity labels provided in the target sentence."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not contain any terms related to the entity labels provided in the target sentence."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not contain any terms related to the entity labels provided in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any terms related to the entity labels provided in the target sentence."}\n]', 'response3': "[{'PRL': 'protein'}, {'IL-2': 'protein'}, {'Stat proteins': 'protein'}, {'T cell lines': 'cell_line'}]", 'prediction': {'PRL': 'protein', 'IL-2': 'protein', 'Stat proteins': 'protein', 'T cell lines': 'cell_line'}}
{'idx': 1140, 'sentence': 'The conserved cis-acting sequence , GGAAAA , and transcription factors binding to this sequence are involved in the response to increased intracellular Ca2+ concentrations .', 'label': {'transcription factors': 'protein', 'conserved cis-acting sequence': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 449, 'sentence': 'We find that the factor that binds to the E3 enhancer motif , CATGTGGC , is a ubiquitous transcription factor .', 'label': {'ubiquitous transcription factor': 'protein', 'E3 enhancer motif': 'DNA'}, 'response1': "['DNA']", 'response2': '[\n    {"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .": 5},\n    {"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2 .": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements .": 5},\n    {"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50 .": 5},\n    {"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .": 5},\n    {"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .": 5},\n    {"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .": 5},\n    {"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1402, 'sentence': 'At the same time, we observed a down-regulation of progenitor-specific surface markers and the up-regulation of differentiation markers restricted to the eosinophil and myeloid lineages .', 'label': {'eosinophil': 'cell_type', 'myeloid lineages': 'cell_type', 'differentiation markers': 'protein', 'progenitor-specific surface markers': 'protein'}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein (GATA-1) and its corresponding entity label, which directly matches one of the entity types in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides a clear example of a protein (Egr-1) and its corresponding entity label, which directly matches one of the entity types in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence provides a clear example of a protein (NF-E2) and its corresponding entity label, which directly matches one of the entity types in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides a clear example of a protein (retinoic acid receptor alpha) and its corresponding entity label, which directly matches one of the entity types in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides a clear example of a protein (CD14) and its corresponding entity label, which directly matches one of the entity types in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides clear examples of cell types (Th1 and Th2) and their corresponding entity labels, which directly match some of the entity types in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides a clear example of a protein (E2A) and its corresponding entity label, which directly matches one of the entity types in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides clear examples of a cell line (B cell) and a cell type (B cell) with their corresponding entity labels, which directly match some of the entity types in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides a clear example of a protein (WT1) and its corresponding entity label, which directly matches one of the entity types in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides clear examples of proteins (CD14 and CD23) and their corresponding entity labels, which directly match some of the entity types in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides clear examples of proteins (myeloperoxidase, lysozyme, PU.1) and their corresponding entity labels, which directly match some of the entity types in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides clear examples of a protein (WT1) and a cell line (myeloid cell lines) with their corresponding entity labels, which directly match some of the entity types in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides clear examples of a protein (MNDA) and a cell line (Philadelphia chromosome-positive chronic myeloid leukemia) with their corresponding entity labels, which directly match some of the entity types in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides clear examples of cell types (granulocytes and T cells) and their corresponding entity labels, which directly match some of the entity types in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides a clear example of a protein (GATA-1) and its corresponding entity label, which directly matches one of the entity types in the target sentence."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence provides clear examples of proteins (Sp1 and Ets) and their corresponding entity labels, which directly match some of the entity types in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any named entities that match the entity types in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any named entities that match the entity types in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any named entities that match the entity types in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any named entities that match the entity types in the target sentence."}\n]', 'response3': "[{'eosinophil': 'cell_type'}, {'myeloid': 'cell_type'}]", 'prediction': {'eosinophil': 'cell_type', 'myeloid': 'cell_type'}}
{'idx': 664, 'sentence': 'Interferon-gamma and the sexual dimorphism of autoimmunity .', 'label': {'Interferon-gamma': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Th1": 5},\n    {"Th2": 5},\n    {"AP-1": 5},\n    {"IFN-gamma": 5},\n    {"IL4": 5},\n    {"IL13": 5},\n    {"STAT6": 5},\n    {"STAT3": 5},\n    {"STAT5": 5},\n    {"B cells": 5},\n    {"Sp1": 5},\n    {"Ets": 5},\n    {"IL-7R": 5},\n    {"gamma(c)": 5},\n    {"IL-2": 5},\n    {"IFN-gamma": 5},\n    {"jak kinases": 5},\n    {"STAT1(alpha)": 5},\n    {"IL-2": 5},\n    {"SP1": 5},\n    {"caspases": 5},\n    {"B-cell": 5},\n    {"IFN A": 5},\n    {"IFNA": 5},\n    {"interleukin-2": 5},\n    {"interleukin-2 receptor": 5},\n    {"phytohemagglutinin": 5},\n    {"phorbol myristate acetate": 5},\n    {"IkappaBbeta": 5},\n    {"NF-kappaB": 5},\n    {"NF-kappaB": 5},\n    {"rheumatoid arthritis": 5},\n    {"immunoglobulin kappa 3\' enhancer": 5},\n    {"Th2-type lymphocytes": 5},\n    {"GATA-1": 5},\n    {"CD40": 5},\n    {"IFN-gamma": 5},\n    {"tumor necrosis factor-alpha": 5},\n    {"interleukin (IL)-1beta": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1726, 'sentence': 'It is tempting to speculate that enhanced NF-kappa B expression caused by free radical production/oxidative stress may modulate liver injury , perhaps through an effect on cytotoxic cytokine synthesis .', 'label': {'NF-kappa B': 'protein', 'cytotoxic cytokine': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence 1": 5},\n    {"Sentence 2": 4},\n    {"Sentence 3": 5},\n    {"Sentence 4": 4},\n    {"Sentence 5": 5},\n    {"Sentence 6": 5},\n    {"Sentence 7": 5},\n    {"Sentence 8": 1},\n    {"Sentence 9": 1},\n    {"Sentence 10": 1},\n    {"Sentence 11": 1},\n    {"Sentence 12": 5},\n    {"Sentence 13": 5},\n    {"Sentence 14": 5},\n    {"Sentence 15": 5},\n    {"Sentence 16": 1},\n    {"Sentence 17": 1},\n    {"Sentence 18": 1},\n    {"Sentence 19": 1}\n]', 'response3': '[{"NF-kappa B": "protein"}]', 'prediction': {'NF-kappa B': 'protein'}}
{'idx': 1573, 'sentence': 'Immunofluorescence colocalization of both estrogen and progesterone receptors with eosinophil cationic protein showed that approximately 70% of positive cells were eosinophils .', 'label': {'estrogen': 'protein', 'eosinophil cationic protein': 'protein', 'positive cells': 'cell_type', 'progesterone receptors': 'protein', 'eosinophils': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a clear and direct mapping between the term \'E2A\' and the entity type \'protein\' in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The example contains multiple terms that can be mapped to different entity types present in the target sentence, such as \'immunohistochemistry\' to \'protein\', \'gene\' to \'DNA\', and \'cell type\' to \'cell_type\'."},\n    {"Example 3": 4},\n    {"Reason 3": "The example directly links the term \'GATA-1\' to the entity type \'protein\' in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The example provides a direct mapping between the term \'Eosinophils\' and the entity type \'cell_type\' in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The example contains multiple terms that can be directly mapped to different entity types present in the target sentence, such as \'CD70\' to \'protein\', \'B cell\' to \'cell_type\', \'plasma cells\' to \'cell_type\', \'IL-4\' to \'protein\', and \'CD40\' to \'protein\'."},\n    {"Example 6": 5},\n    {"Reason 6": "The example directly links the terms \'myeloperoxidase\', \'lysozyme\', and \'PU.1\' to the entity type \'protein\' in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The example provides a direct mapping between the terms \'CD14\' and \'CD23\' to the entity type \'protein\' in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The example contains multiple terms that can be directly mapped to different entity types present in the target sentence, such as \'IFN A\' and \'IFNA\' to \'protein\', \'interleukin-2\' and \'interleukin-2 receptor\' to \'protein\', and \'phytohemagglutinin\' and \'phorbol myristate acetate\' to \'protein\'."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides a direct mapping between the terms \'p21(WAF1/CIP1)\' and \'p27(KIP1)\' to the entity type \'protein\' in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The example contains multiple terms that can be directly mapped to different entity types present in the target sentence, such as \'granulocytes\' and \'T cells\' to \'cell_type\', and \'IL-2\', \'c-Jun\', and \'c-Fos\' to \'protein\'."},\n    {"Example 11": 5},\n    {"Reason 11": "The example contains multiple terms that can be directly mapped to different entity types present in the target sentence, such as \'IL-2\' to \'protein\', \'c-Jun\' to \'protein\', and \'c-Fos\' to \'protein\'."},\n    {"Example 12": 5},\n    {"Reason 12": "The example contains multiple terms that can be directly mapped to different entity types present in the target sentence, such as \'Ter 119\' to \'cell_line\', \'beta-globin\' to \'protein\', \'glycoprotein IIb\' to \'protein\', and \'platelet factor 4\' to \'protein\'."},\n    {"Example 13": 4},\n    {"Reason 13": "The example contains terms that can be mapped to different entity types present in the target sentence, such as \'Erbstatin\' and \'genistein\' to \'protein\', and \'Egr-1\' to \'RNA\'."},\n    {"Example 14": 4},\n    {"Reason 14": "The example contains terms that can be mapped to different entity types present in the target sentence, such as \'gp91phox\' to \'DNA\', and \'HL-60-C15\' to \'cell_line\'."},\n    {"Example 15": 1},\n    {"Reason 15": "The example does not contain terms that directly map to any entity types present in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain terms that directly map to any entity types present in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain terms that directly map to any entity types present in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain terms that directly map to any entity types present in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The example does not contain terms that directly map to any entity types present in the target sentence."}\n]', 'response3': "[{'estrogen': 'protein'}, {'progesterone': 'protein'}, {'eosinophil cationic protein': 'protein'}, {'eosinophils': 'cell_type'}]", 'prediction': {'estrogen': 'protein', 'progesterone': 'protein', 'eosinophil cationic protein': 'protein', 'eosinophils': 'cell_type'}}
{'idx': 1589, 'sentence': 'Inhibition of NF-AT -dependent transcription by NF-kappa B : implications for differential gene expression in T helper cell subsets .', 'label': {'NF-kappa B': 'protein', 'T helper cell subsets': 'cell_type', 'NF-AT': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains specific examples of entities mentioned in the target sentence, such as NF-kappa B and I kappa B alpha, which are both proteins. This provides direct examples of the entity types present in the target sentence, making it highly helpful for extracting named entities."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains specific examples of entities mentioned in the target sentence, such as NF-kappa B and I kappa B alpha, which are both proteins. This provides direct examples of the entity types present in the target sentence, making it highly helpful for extracting named entities."}\n]\n[\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions NF-ATc, which is a protein, and T lymphocytes, which are a cell type. These examples directly correspond to the entity types present in the target sentence, providing helpful context for extracting named entities."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains specific examples of entities mentioned in the target sentence, such as NF-kappaB, Tax, and ATL, which are all related to proteins or cell types. This provides direct examples of the entity types present in the target sentence, making it highly helpful for extracting named entities."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains a specific example of NF-kappa B, which is a protein mentioned in the target sentence. This direct example of the entity type present in the target sentence makes it highly helpful for extracting named entities."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains specific examples of entities mentioned in the target sentence, such as NF-kappa B and I kappa B alpha, which are both proteins. This provides direct examples of the entity types present in the target sentence, making it highly helpful for extracting named entities."}\n]\n[\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions NF-ATc, T lymphocytes, and embryonic cardiac cells, which are all related to proteins or cell types. These examples directly correspond to the entity types present in the target sentence, providing helpful context for extracting named entities."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains a specific example of GATA-1, which is a protein mentioned in the target sentence. This direct example of the entity type present in the target sentence makes it highly helpful for extracting named entities."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains a specific example of NF-kappa B, which is a protein mentioned in the target sentence. This direct example of the entity type present in the target sentence makes it highly helpful for extracting named entities."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains specific examples of entities mentioned in the target sentence, such as NF-kappa B and I kappa B beta, which are both proteins. This provides direct examples of the entity types present in the target sentence, making it highly helpful for extracting named entities."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains specific examples of entities mentioned in the target sentence, such as PAFR, PAF, NF-kappa B, and protein kinase C, which are all related to proteins. This provides direct examples of the entity types present in the target sentence, making it highly helpful for extracting named entities."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains specific examples of entities mentioned in the target sentence, such as Sp1 and Ets, which are both proteins. This provides direct examples of the entity types present in the target sentence, making it highly helpful for extracting named entities."}\n]\n[\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions Th1 and Th2, which are cell types. These examples directly correspond to the entity types present in the target sentence, providing helpful context for extracting named entities."}\n]\n[\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions Th2-type lymphocytes, which are a cell type. This example directly corresponds to the entity type present in the target sentence, providing helpful context for extracting named entities."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains specific examples of entities mentioned in the target sentence, such as IL-2, NF-kappa B, and AP-1, which are all related to proteins. This provides direct examples of the entity types present in the target sentence, making it highly helpful for extracting named entities."}\n]\n[\n    {"Sentence": 3},\n    {"Reason": "The sentence mentions NF-kappa B with DNA binding activity, which is relevant to the protein entity type in the target sentence. While not a direct match, it provides some context for understanding the entity type."}\n]\n[\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entities mentioned in the target sentence, making it less helpful for extracting named entities."}\n]\n[\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entities mentioned in the target sentence, making it less helpful for extracting named entities."}\n]\n[\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entities mentioned in the target sentence, making it less helpful for extracting named entities."}\n]', 'response3': '[{"NF-AT": "protein"}, {"NF-kappa B": "protein"}, {"T helper cell subsets": "cell_type"}]', 'prediction': {'NF-AT': 'protein', 'NF-kappa B': 'protein', 'T helper cell subsets': 'cell_type'}}
{'idx': 114, 'sentence': 'These results indicate that in monocytic cell lineage , HIV-1 could mimic some differentiation/activation stimuli allowing nuclear NF-KB expression .', 'label': {'NF-KB': 'protein', 'monocytic cell lineage': 'cell_line'}, 'response1': "['cell_line', 'protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains a named entity with a corresponding entity label that directly matches one of the entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains a named entity with a corresponding entity label that directly matches one of the entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains a named entity with a corresponding entity label that directly matches one of the entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities with corresponding entity labels that match the entity types in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities with corresponding entity labels that match the entity types in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities with corresponding entity labels that match the entity types in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities with corresponding entity labels that match the entity types in the target sentence."}\n]', 'response3': '[{"HIV-1": "cell_type"}, {"NF-KB": "protein"}]', 'prediction': {'HIV-1': 'cell_type', 'NF-KB': 'protein'}}
{'idx': 469, 'sentence': 'Cardiac and adrenergic diseases were excluded.', 'label': {}, 'response1': 'None.', 'response2': '[\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 3},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 4},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 3},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.": 5},\n    {"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 4},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti-EBV antibody titres (P > 0.05).": 4},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms.": 3},\n    {"In addition, assay of PBMC by the adenovirus-specific PCR may help detect early invasive disease and warrants further evaluation.": 4},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 3},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.": 5},\n    {"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 3},\n    {"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.": 4},\n    {"When 18C7 was incubated with MR before aldosterone or progesterone, the antibody inhibited 75-80% of the binding.": 4},\n    {"Recently, it has been shown that RelB knockout mice have no dendritic cells (DC).": 4},\n    {"Extracts prepared from XP-B and XP-D lymphoblastoid cells exhibited similar transcription activity from the adenovirus major late promoter when compared to that in extracts from normal cells.": 4}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1683, 'sentence': 'These results strongly suggest that HU induces both transcriptional and post-transcription regulation of c-jun during erythroid differentiation .', 'label': {'c-jun': 'DNA'}, 'response1': "['RNA', 'protein']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"2": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"3": "The sentence contains \'myeloid cell lines\' which matches the \'cell_line\' entity type in the target sentence."},\n    {"4": "The sentence contains \'RXR\' which matches the \'protein\' entity type in the target sentence."},\n    {"5": "The sentence contains \'Jun\' and \'ATF-2\' which match the \'protein\' entity type in the target sentence."},\n    {"6": "The sentence contains \'SCL\' and \'GATA-1\' which match the \'protein\' entity type in the target sentence."},\n    {"7": "The sentence contains \'Egr-1\' which matches the \'protein\' entity type in the target sentence."},\n    {"8": "The sentence contains \'NF-E2\' which matches the \'protein\' entity type in the target sentence."},\n    {"9": "The sentence contains \'CCAAT box\' and \'EKLF binding site\' which match the \'DNA\' and \'protein\' entity types in the target sentence."},\n    {"10": "The sentence contains \'GATA-1\' which matches the \'protein\' entity type in the target sentence."},\n    {"11": "The sentence contains \'Protein kinase B\', \'phosphatidylinositol 3-kinase\', \'STAT5\', \'erythropoietin\', \'HCD57\', \'EPO\', and \'c-Akt\' which match the \'protein\' and \'cell_line\' entity types in the target sentence."},\n    {"12": "The sentence contains \'Ter 119\', \'beta-globin\', \'glycoprotein IIb\', and \'platelet factor 4\' which match the \'cell_line\' and \'protein\' entity types in the target sentence."},\n    {"13": "The sentence contains \'ZEB\', \'c-Myb\', \'Ets\', and \'hematopoietic cells\' which match the \'protein\' and \'cell_type\' entity types in the target sentence."},\n    {"14": "The sentence contains \'tal-1\', \'GATA-binding proteins\', and \'hematopoiesis\' which match the \'protein\' and \'cell_type\' entity types in the target sentence."},\n    {"15": "The sentence contains \'Erbstatin\', \'genistein\', and \'Egr-1\' which match the \'protein\' and \'RNA\' entity types in the target sentence."},\n    {"16": "The sentence contains \'ATF1\', \'CREB\', and \'H4\' which match the \'protein\' entity type in the target sentence."},\n    {"17": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"18": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"19": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"20": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"HU": "protein"}, {"c-jun": "protein"}]', 'prediction': {'HU': 'protein', 'c-jun': 'protein'}}
{'idx': 1648, 'sentence': 'Point mutations of either the PU.1 site or the C/EBP site that abolish the binding of the respective factors result in a significant decrease of GM-CSF receptor alpha promoter activity in myelomonocytic cells only.', 'label': {'PU.1 site': 'DNA', 'GM-CSF receptor alpha': 'protein', 'GM-CSF receptor alpha promoter': 'DNA', 'myelomonocytic cells': 'cell_type', 'C/EBP': 'protein', 'PU.1': 'protein', 'GM-CSF': 'protein', 'C/EBP site': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines .": 4},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .": 4},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors .": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .": 5},\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .": 5},\n    {"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 4},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .": 5},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5}\n]', 'response3': '[{"PU.1": "protein"}, {"C/EBP": "protein"}, {"GM-CSF receptor alpha": "protein"}, {"myelomonocytic": "cell_type"}]', 'prediction': {'PU.1': 'protein', 'C/EBP': 'protein', 'GM-CSF receptor alpha': 'protein', 'myelomonocytic': 'cell_type'}}
{'idx': 646, 'sentence': 'Surgically confirmed nodal involvement was observed in 42%.', 'label': {}, 'response1': 'None.', 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides clear and specific examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence contains specific examples of named entities with their corresponding entity labels, which can aid in extracting named entities from the target sentence."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence includes specific examples of named entities with their corresponding entity labels, which can assist in extracting named entities from the target sentence."},\n    {"Example 4": 3},\n    {"Reason 4": "The sentence mentions a specific named entity with its corresponding entity label, providing some assistance in extracting named entities from the target sentence."},\n    {"Example 5": 3},\n    {"Reason 5": "The sentence presents a specific named entity with its corresponding entity label, offering some help in extracting named entities from the target sentence."},\n    {"Example 6": 3},\n    {"Reason 6": "The sentence contains a specific named entity with its corresponding entity label, offering some guidance in extracting named entities from the target sentence."},\n    {"Example 7": 3},\n    {"Reason 7": "The sentence mentions a specific named entity with its corresponding entity label, providing some assistance in extracting named entities from the target sentence."},\n    {"Example 8": 4},\n    {"Reason 8": "The sentence includes specific examples of named entities with their corresponding entity labels, which can assist in extracting named entities from the target sentence."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence contains specific examples of named entities with their corresponding entity labels, which can aid in extracting named entities from the target sentence."},\n    {"Example 10": 3},\n    {"Reason 10": "The sentence presents a specific named entity with its corresponding entity label, offering some help in extracting named entities from the target sentence."},\n    {"Example 11": 3},\n    {"Reason 11": "The sentence mentions a specific named entity with its corresponding entity label, providing some assistance in extracting named entities from the target sentence."},\n    {"Example 12": 2},\n    {"Reason 12": "The sentence mentions named entities without their corresponding entity labels, offering limited assistance in extracting named entities from the target sentence."},\n    {"Example 13": 2},\n    {"Reason 13": "The sentence mentions named entities without their corresponding entity labels, offering limited assistance in extracting named entities from the target sentence."},\n    {"Example 14": 2},\n    {"Reason 14": "The sentence mentions named entities without their corresponding entity labels, offering limited assistance in extracting named entities from the target sentence."},\n    {"Example 15": 2},\n    {"Reason 15": "The sentence mentions named entities without their corresponding entity labels, offering limited assistance in extracting named entities from the target sentence."},\n    {"Example 16": 2},\n    {"Reason 16": "The sentence mentions named entities without their corresponding entity labels, offering limited assistance in extracting named entities from the target sentence."},\n    {"Example 17": 2},\n    {"Reason 17": "The sentence mentions named entities without their corresponding entity labels, offering limited assistance in extracting named entities from the target sentence."},\n    {"Example 18": 2},\n    {"Reason 18": "The sentence mentions named entities without their corresponding entity labels, offering limited assistance in extracting named entities from the target sentence."},\n    {"Example 19": 2},\n    {"Reason 19": "The sentence mentions named entities without their corresponding entity labels, offering limited assistance in extracting named entities from the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 821, 'sentence': '(vi) The EBV type 2 EBNA-2 transactivated LMP1 as well as the EBV type 1 EBNA-2 .', 'label': {'LMP1': 'protein', 'EBNA-2': 'protein', 'EBV type 1 EBNA-2': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.": 4},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 3},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.": 3},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B.": 4},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 4},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 3},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 3},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 3},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 4},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 4},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"EBV type 2 EBNA-2": "protein"}, {"LMP1": "protein"}, {"EBV type 1 EBNA-2": "protein"}]', 'prediction': {'EBV type 2 EBNA-2': 'protein', 'LMP1': 'protein', 'EBV type 1 EBNA-2': 'protein'}}
{'idx': 548, 'sentence': 'On the other hand, interleukin 2 ( IL-2 )-induced signals are blocked by rapamycin but not by FK506 .', 'label': {'IL-2': 'protein', 'interleukin 2': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .": 4},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .": 4},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .": 5},\n    {"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway , and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells .": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 4},\n    {"Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.": 5},\n    {"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin .": 4},\n    {"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .": 5},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 135, 'sentence': 'Tumor necrosis factor alpha ( TNF-alpha ) mRNA production was analyzed by polymerase chain reaction amplification in monocytic U937 cells and in a chronically HIV infected U937 cell line ( U9-IIIB ).', 'label': {'U9-IIIB': 'cell_line', 'monocytic U937 cells': 'cell_line', 'Tumor necrosis factor alpha ( TNF-alpha ) mRNA': 'RNA', 'chronically HIV infected U937 cell line': 'cell_line', 'Tumor necrosis factor alpha': 'protein', 'TNF-alpha': 'protein'}, 'response1': "['RNA', 'cell_type', 'cell_line']", 'response2': '[\n    {"Sentence 1": 5},\n    {"Sentence 2": 5},\n    {"Sentence 3": 5},\n    {"Sentence 4": 5},\n    {"Sentence 5": 5},\n    {"Sentence 6": 5},\n    {"Sentence 7": 5},\n    {"Sentence 8": 1},\n    {"Sentence 9": 5},\n    {"Sentence 10": 5},\n    {"Sentence 11": 5},\n    {"Sentence 12": 5},\n    {"Sentence 13": 5},\n    {"Sentence 14": 5},\n    {"Sentence 15": 5},\n    {"Sentence 16": 1},\n    {"Sentence 17": 1},\n    {"Sentence 18": 1},\n    {"Sentence 19": 1},\n    {"Sentence 20": 1}\n]', 'response3': '[{"TNF-alpha": "protein"}, {"U937": "cell_type"}, {"U9-IIIB": "cell_line"}, {"HIV": "cell_type"}]', 'prediction': {'TNF-alpha': 'protein', 'U937': 'cell_type', 'U9-IIIB': 'cell_line', 'HIV': 'cell_type'}}
{'idx': 432, 'sentence': 'Moreover, BSAP is clearly a B-cell-specific transcription factor , as a wild-type but not a mutant TSAP -binding site of the sea urchin functions only in transfected B cells as an upstream promoter element .', 'label': {'transfected B cells': 'cell_line', 'TSAP': 'protein', 'mutant TSAP -binding site': 'DNA', 'upstream promoter element': 'DNA', 'BSAP': 'protein', 'B-cell-specific transcription factor': 'protein', 'wild-type': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n{"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 4},\n{"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n{"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n{"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.": 5},\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 4},\n{"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 3},\n{"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n{"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n{"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n{"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n{"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n{"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.": 5},\n{"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"BSAP": "protein"}, {"TSAP": "protein"}, {"sea urchin": "cell_line"}, {"B cells": "cell_type"}]', 'prediction': {'BSAP': 'protein', 'TSAP': 'protein', 'sea urchin': 'cell_line', 'B cells': 'cell_type'}}
{'idx': 1161, 'sentence': 'Deoxycholate treatment of the cytoplasmic extract prepared from cells stimulated by TNF-alpha in the presence of Cu2+ resulted in the release of NF kappa B from I kappa B alpha , indicating that Cu2+ interferes with the dissociation of the NF kappa B -I kappa B complex .', 'label': {'I kappa B alpha': 'protein', 'NF kappa B': 'protein', 'NF kappa B -I kappa B complex': 'protein', 'TNF-alpha': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.": 5},\n    {"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .": 5},\n    {"When the same MTHC lines are exposed to TNF-alpha in combination with IFN-gamma , the cells instead become DC .": 5},\n    {"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .": 5},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .": 5},\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .": 5},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .": 5},\n    {"Control of NF-kappa B activity by the I kappa B beta inhibitor .": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"NF kappa B": "protein"}, {"I kappa B alpha": "protein"}, {"TNF-alpha": "protein"}, {"Cu2+": "protein"}]', 'prediction': {'NF kappa B': 'protein', 'I kappa B alpha': 'protein', 'TNF-alpha': 'protein', 'Cu2+': 'protein'}}
{'idx': 1794, 'sentence': 'Activation of the signal transducer and transcription ( STAT ) signaling pathway in a primary T cell response .', 'label': {'STAT': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 4},\n    {"Example 3": 5},\n    {"Example 4": 4},\n    {"Example 5": 5},\n    {"Example 6": 4},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 3},\n    {"Example 10": 3},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 3},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1470, 'sentence': 'Hence, induction of cell surface expression of this leukocyte adhesion molecule by tumor necrosis factor (TNF)-alpha was reduced by 40% in the presence of CsA , and this was reflected by a 29% decrease in neutrophil adhesion .', 'label': {'neutrophil': 'cell_type', 'tumor necrosis factor (TNF)-alpha': 'protein', 'leukocyte adhesion molecule': 'protein'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n{"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 5},\n{"PMA induced the expression of both CD14 and CD23 mRNA and protein.": 5},\n{"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n{"CD40 expression could be enhanced in CD40-positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5},\n{"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.": 5},\n{"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 5},\n{"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n{"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n{"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n{"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n{"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 5},\n{"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 5},\n{"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n{"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.": 5},\n{"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': "[{'leukocyte adhesion molecule': 'protein'}, {'tumor necrosis factor (TNF)-alpha': 'protein'}, {'CsA': 'protein'}, {'neutrophil': 'cell_type'}]", 'prediction': {'leukocyte adhesion molecule': 'protein', 'tumor necrosis factor (TNF)-alpha': 'protein', 'CsA': 'protein', 'neutrophil': 'cell_type'}}
{'idx': 644, 'sentence': 'Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers : a role for hematopoietic growth factor release by tumor cells ?', 'label': {'tumor cells': 'cell_type', 'hematopoietic growth factor': 'protein'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example directly mentions \'Th2-type lymphocytes\' which is a cell_type entity, making it highly relevant for entity extraction."},\n    {"Example 2": 4},\n    {"Reason 2": "The example contains multiple entities such as \'NF-kappaB\', \'Tax\', and \'ATL\' which are related to protein and cell_type entities, aiding in entity extraction."},\n    {"Example 3": 5},\n    {"Reason 3": "The example provides clear mentions of \'IL-13\', \'IL-4R\', \'JAK2\', and \'IL-13R\' which are all protein entities, making it very helpful for entity extraction."},\n    {"Example 4": 4},\n    {"Reason 4": "The example mentions \'immunohistochemistry\', \'gene\', and \'cell type\' which are related to protein and DNA entities, aiding in entity extraction."},\n    {"Example 5": 4},\n    {"Reason 5": "The example mentions \'lymphoid neoplasms\' which is a cell_type entity, aiding in entity extraction."},\n    {"Example 6": 5},\n    {"Reason 6": "The example contains mentions of \'IL-2 receptor alpha subunit\', \'p21ras\', and \'B cell\' which are protein and cell_type entities, making it very helpful for entity extraction."},\n    {"Example 7": 5},\n    {"Reason 7": "The example mentions \'TAL1\' and \'T-ALL\' which are protein and cell_type entities, aiding in entity extraction."},\n    {"Example 8": 4},\n    {"Reason 8": "The example mentions \'WT1\' and \'myeloid cell lines\' which are protein and cell_line entities, aiding in entity extraction."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides mentions of \'IL4\', \'IL13\', \'STAT6\', \'STAT3\', \'STAT5\', and \'B cells\' which are protein and cell_type entities, making it very helpful for entity extraction."},\n    {"Example 10": 5},\n    {"Reason 10": "The example mentions \'MNDA\' and \'Philadelphia chromosome-positive chronic myeloid leukemia\' which are protein and cell_line entities, aiding in entity extraction."},\n    {"Example 11": 5},\n    {"Reason 11": "The example contains mentions of \'CD28\', \'CD80\', \'CD86\', \'CBL\', \'VAV\', \'NFAT\', \'interleukin-2\', and \'granulocyte-macrophage colony-stimulating factor\' which are all protein entities, making it very helpful for entity extraction."},\n    {"Example 12": 5},\n    {"Reason 12": "The example mentions \'Oct-2A\', \'HMG I/Y\', \'HLA-DRA\', and \'B cells\' which are protein and cell_type entities, aiding in entity extraction."},\n    {"Example 13": 4},\n    {"Reason 13": "The example mentions \'IL-2\', \'c-Jun\', and \'c-Fos\' which are protein entities, aiding in entity extraction."},\n    {"Example 14": 5},\n    {"Reason 14": "The example provides mentions of \'CD70\', \'B cell\', \'plasma cells\', \'IL-4\', and \'CD40\' which are protein and cell_type entities, making it very helpful for entity extraction."},\n    {"Example 15": 3},\n    {"Reason 15": "The example mentions \'AP-1\' which is a DNA entity, aiding in entity extraction."},\n    {"Example 16": 4},\n    {"Reason 16": "The example mentions \'B and T cell activation\', \'Ramos\', \'Jurkat\', and \'cDNA microarray technology\' which are cell_type, cell_line, and DNA entities, aiding in entity extraction."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain any specific entities related to the target sentence, hence not helpful for entity extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any specific entities related to the target sentence, hence not helpful for entity extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The example does not contain any specific entities related to the target sentence, hence not helpful for entity extraction."},\n    {"Example 20": 1},\n    {"Reason 20": "The example does not contain any specific entities related to the target sentence, hence not helpful for entity extraction."}\n]', 'response3': "[{'lymphocyte': 'cell_type'}, {'breast cancers': 'cell_type'}, {'hematopoietic growth factor': 'protein'}, {'tumor cells': 'cell_type'}]", 'prediction': {'lymphocyte': 'cell_type', 'breast cancers': 'cell_type', 'hematopoietic growth factor': 'protein', 'tumor cells': 'cell_type'}}
{'idx': 435, 'sentence': 'Antibodies are produced exclusively in B lymphocytes .', 'label': {'Antibodies': 'protein', 'lymphocytes': 'cell_type', 'B lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"Example 1": "5"},\n{"Reason 1": "The example provides a clear and direct mapping between the entity \'IgH\' and the entity label \'DNA\' in the target sentence, aiding in the extraction of named entities."},\n\n{"Example 2": "5"},\n{"Reason 2": "The example provides a clear and direct mapping between the entity \'Eosinophils\' and the entity label \'cell_type\' in the target sentence, aiding in the extraction of named entities."},\n\n{"Example 3": "5"},\n{"Reason 3": "The example provides multiple mappings between entities and their corresponding labels in the target sentence, aiding in the extraction of named entities."},\n\n{"Example 4": "5"},\n{"Reason 4": "The example provides mappings between entities like \'EBV\' and \'CD2\' with their corresponding labels in the target sentence, aiding in the extraction of named entities."},\n\n{"Example 5": "5"},\n{"Reason 5": "The example provides mappings between entities like \'IL4\', \'IL13\', \'STAT6\', \'STAT3\', \'STAT5\', and \'B cells\' with their corresponding labels in the target sentence, aiding in the extraction of named entities."},\n\n{"Example 6": "5"},\n{"Reason 6": "The example provides mappings between entities like \'Th1\' and \'Th2\' with their corresponding labels in the target sentence, aiding in the extraction of named entities."},\n\n{"Example 7": "5"},\n{"Reason 7": "The example provides a clear and direct mapping between the entity \'Th2-type lymphocytes\' and the entity label \'cell_type\' in the target sentence, aiding in the extraction of named entities."},\n\n{"Example 8": "5"},\n{"Reason 8": "The example provides mappings between entities like \'CD70\', \'B cell\', \'plasma cells\', \'IL-4\', and \'CD40\' with their corresponding labels in the target sentence, aiding in the extraction of named entities."},\n\n{"Example 9": "5"},\n{"Reason 9": "The example provides mappings between entities like \'NF-ATc\' and \'T lymphocytes\' with their corresponding labels in the target sentence, aiding in the extraction of named entities."},\n\n{"Example 10": "5"},\n{"Reason 10": "The example provides mappings between entities like \'IL-2 receptor alpha subunit\', \'p21ras\', and \'B cell\' with their corresponding labels in the target sentence, aiding in the extraction of named entities."},\n\n{"Example 11": "5"},\n{"Reason 11": "The example provides mappings between entities like \'T lymphocytes\' and \'HLA-molecules\' with their corresponding labels in the target sentence, aiding in the extraction of named entities."},\n\n{"Example 12": "5"},\n{"Reason 12": "The example provides a clear and direct mapping between the entity \'E2A\' and the entity label \'protein\' in the target sentence, aiding in the extraction of named entities."},\n\n{"Example 13": "5"},\n{"Reason 13": "The example provides mappings between entities like \'lymphocytes\', \'benzene\', and \'benzoquinone\' with their corresponding labels in the target sentence, aiding in the extraction of named entities."},\n\n{"Example 14": "5"},\n{"Reason 14": "The example provides mappings between entities like \'EBV\' and \'B-cell\' with their corresponding labels in the target sentence, aiding in the extraction of named entities."},\n\n{"Example 15": "5"},\n{"Reason 15": "The example provides mappings between entities like \'CD40\', \'Rel/nuclear factor kappaB\', \'NF-kappaB\', and \'B lymphocytes\' with their corresponding labels in the target sentence, aiding in the extraction of named entities."},\n\n{"Example 16": "5"},\n{"Reason 16": "The example provides mappings between entities like \'ICAM-1\', \'CD71\', \'LMP1\', and \'IkappaB\' with their corresponding labels in the target sentence, aiding in the extraction of named entities."}\n]', 'response3': "[{'B lymphocytes': 'cell_type'}]", 'prediction': {'B lymphocytes': 'cell_type'}}
{'idx': 1342, 'sentence': 'While Bik does not show overt homology to the BH1 and BH2 conserved domains characteristic of the Bcl-2 family , it does share a 9 amino acid domain ( BH3 ) with Bax and Bak which may be a critical determinant for the death-promoting activity of these proteins.', 'label': {'amino acid domain': 'protein', 'BH1': 'protein', 'BH3': 'protein', 'Bak': 'protein', 'BH2': 'protein', 'Bax': 'protein', 'Bik': 'protein', 'Bcl-2 family': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n{"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 4},\n{"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n{"These two related genes share the evolutionarily conserved region encoding the Runt domain.": 4},\n{"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.": 5},\n{"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n{"Tat-binding protein 7 is a subunit of the 26S protease.": 4},\n{"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n{"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n{"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.": 5},\n{"Activation of NF-kappaB by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.": 5},\n{"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n{"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"Bik": "protein"}, {"BH1": "protein"}, {"BH2": "protein"}, {"Bcl-2": "protein"}, {"BH3": "protein"}, {"Bax": "protein"}, {"Bak": "protein"}]', 'prediction': {'Bik': 'protein', 'BH1': 'protein', 'BH2': 'protein', 'Bcl-2': 'protein', 'BH3': 'protein', 'Bax': 'protein', 'Bak': 'protein'}}
{'idx': 1022, 'sentence': 'NK cell NFAT is present in the cytosol of nonstimulated cells , migrates to the nucleus upon stimulation, and can associate with AP-1 .', 'label': {'NK cell NFAT': 'protein', 'AP-1': 'protein', 'nonstimulated cells': 'cell_type'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names and their corresponding labels, which directly match the entity types in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains specific protein names and their corresponding labels, which directly match the entity types in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains specific protein names and their corresponding labels, which directly match the entity types in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains specific protein names, cell types, and protein receptors that match the entity types in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains specific protein names and their corresponding labels, which directly match the entity types in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains specific protein names and cell types that match the entity types in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains specific protein names and their corresponding labels, which directly match the entity types in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains specific protein names and their corresponding labels, which directly match the entity types in the target sentence."},\n    {"Example 9": 1},\n    {"Reason 9": "The sentence does not contain any specific entity names or labels that match the entity types in the target sentence."},\n    {"Example 10": 1},\n    {"Reason 10": "The sentence does not contain any specific entity names or labels that match the entity types in the target sentence."},\n    {"Example 11": 1},\n    {"Reason 11": "The sentence does not contain any specific entity names or labels that match the entity types in the target sentence."},\n    {"Example 12": 1},\n    {"Reason 12": "The sentence does not contain any specific entity names or labels that match the entity types in the target sentence."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not contain any specific entity names or labels that match the entity types in the target sentence."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not contain any specific entity names or labels that match the entity types in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any specific entity names or labels that match the entity types in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any specific entity names or labels that match the entity types in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific entity names or labels that match the entity types in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific entity names or labels that match the entity types in the target sentence."}\n]', 'response3': '[{"NK cell": "cell_type"}, {"NFAT": "protein"}, {"AP-1": "protein"}]', 'prediction': {'NK cell': 'cell_type', 'NFAT': 'protein', 'AP-1': 'protein'}}
{'idx': 810, 'sentence': 'Exposure of CML cells to IFN-alpha diminished the effect of the CML cytoplasmic proteins on these nuclear protein-DNA complexes .', 'label': {'CML cells': 'cell_type', 'IFN-alpha': 'protein', 'CML cytoplasmic proteins': 'protein', 'nuclear protein-DNA complexes': 'protein'}, 'response1': "['protein', 'cell_line', 'DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example contains a specific protein name that matches the entity label in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The example contains multiple specific protein names and a RNA name that match the entity labels in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The example contains multiple specific protein names that match the entity labels in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The example contains multiple specific protein names that match the entity labels in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The example contains multiple specific protein names that match the entity labels in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The example contains a specific DNA name that matches the entity label in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The example contains a specific protein name that matches the entity label in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The example contains multiple specific protein names that match the entity labels in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The example contains multiple specific protein names and a cell line name that match the entity labels in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The example contains multiple specific protein names that match the entity labels in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The example contains multiple specific protein names and a cell type name that match the entity labels in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The example contains multiple specific protein names that match the entity labels in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The example contains multiple specific protein names that match the entity labels in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The example contains multiple specific protein names and a cell type name that match the entity labels in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The example does not contain any specific entity names that match the entity labels in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain any specific entity names that match the entity labels in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain any specific entity names that match the entity labels in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any specific entity names that match the entity labels in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The example does not contain any specific entity names that match the entity labels in the target sentence."}\n]', 'response3': "[{'CML': 'cell_line'}, {'IFN-alpha': 'protein'}, {'cytoplasmic proteins': 'protein'}, {'nuclear protein-DNA complexes': 'DNA'}]", 'prediction': {'CML': 'cell_line', 'IFN-alpha': 'protein', 'cytoplasmic proteins': 'protein', 'nuclear protein-DNA complexes': 'DNA'}}
{'idx': 1811, 'sentence': "In our attempt to identify chemokine receptors that are related to Burkitt's lymphoma receptor 1 ( BLR1 ) and are expressed in activated lymphocytes we used RT-PCR resulting in the isolation of a cDNA encoding a seven transmembrane receptor termed BLR2 .", 'label': {'BLR1': 'protein', 'BLR2': 'protein', 'seven transmembrane receptor': 'protein', 'activated lymphocytes': 'cell_type', 'chemokine receptors': 'protein', "Burkitt's lymphoma receptor 1": 'protein'}, 'response1': "['DNA', 'RNA', 'protein']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 3},\n    {"Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 4},\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 3},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 4},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"This suggests that CHEMR1 may be a receptor for unidentified C-C chemokine or a low-affinity receptor for MIP-1alpha .": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1316, 'sentence': 'Helix III is less rigid, makes an average angle of about 90 degrees with helices I and II , and constitutes the other arm of the molecule.', 'label': {'Helix III': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 1},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 939, 'sentence': 'However, in 3 postmenopausal patients a short course of estrogen or tamoxifen resulted in a marked increase of type II EBS levels.', 'label': {'type II EBS': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains a clear mention of the entity \'protein\' (EBS levels) which matches the entity label set provided."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 292, 'sentence': 'We used mouse embryonic stem (ES) cells to study globin gene expression and switching in vitro.', 'label': {'globin gene': 'DNA', 'mouse embryonic stem (ES) cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein (E2A) being mentioned in relation to gene expression."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence clearly mentions a protein (MNDA) and a cell line (Philadelphia chromosome-positive chronic myeloid leukemia)."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence mentions specific cell types (granulocytes and T cells) in relation to methylation deviation."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence directly refers to IgH genes, which are DNA entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence mentions the protein PML/RARalpha in the context of myelopoiesis."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence clearly mentions the protein GM-CSF."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides a clear example of a protein (GATA-1) in relation to erythroid cells."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions the cell line SCM-1 in the context of gene regulation."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides multiple examples of proteins (IFN A, interleukin-2, interleukin-2 receptor) and stimuli (phytohemagglutinin, phorbol myristate acetate)."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence mentions the protein GATA-1 in relation to eosinophil differentiation."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence mentions DNA elements (CCAAT box, EKLF binding site) and their impact on gene expression."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides a clear example of a protein (Egr-1) being expressed upon macrophage differentiation."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence mentions the protein RXR in relation to erythroid cells."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence mentions transcription factors (Sp1, Ets) in relation to gene expression."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence mentions proteins (c-kit, IL-4R alpha chain) in the context of receptor generation."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence mentions proteins (ZEB, c-Myb, Ets) and a cell type (hematopoietic cells) in relation to gene expression regulation."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific entities related to the provided entity labels."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific entities related to the provided entity labels."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific entities related to the provided entity labels."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any specific entities related to the provided entity labels."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 542, 'sentence': 'Amino acid sequences of all proteins are essays written in the same language.', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 505, 'sentence': 'The TCF-1 alpha binding site was also required for TCR alpha enhancer activity in transcriptionally active extracts from Jurkat but not HeLa cells , confirming that TCF-1 alpha is a T-cell-specific transcription factor .', 'label': {'Jurkat': 'cell_line', 'TCF-1 alpha': 'protein', 'TCR': 'protein', 'T-cell-specific transcription factor': 'protein', 'TCF-1 alpha binding site': 'DNA', 'HeLa cells': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with corresponding entity labels, making it very helpful for predicting named entities in the target sentence."}\n]', 'response3': '[{"TCF-1 alpha": "protein"}, {"TCR alpha": "protein"}, {"Jurkat": "cell_line"}, {"HeLa": "cell_line"}, {"T-cell": "cell_type"}]', 'prediction': {'TCF-1 alpha': 'protein', 'TCR alpha': 'protein', 'Jurkat': 'cell_line', 'HeLa': 'cell_line', 'T-cell': 'cell_type'}}
{'idx': 1525, 'sentence': 'Kinase activity was reduced in lysates preadsorbed using an antibody specific for CaM kinase II .', 'label': {'antibody': 'protein', 'CaM kinase II': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides specific protein names that match the entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 2": 5},\n    {"Reason 2": "The example provides specific protein names that match the entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 3": 5},\n    {"Reason 3": "The example provides specific protein names that match the entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The example provides specific protein names that match the entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides specific protein names that match the entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The example provides specific protein names and a cell type that match the entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The example provides specific protein names that match the entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides specific protein names that match the entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides specific protein names that match the entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides a specific cell type that matches the entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The example provides specific protein names that match the entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The example provides specific protein names that match the entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides specific protein names that match the entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 14": 5},\n    {"Reason 14": "The example provides specific protein names that match the entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 15": 1},\n    {"Reason 15": "The example does not contain any named entities that match the entity types in the target sentence, hence not helpful for extraction."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain any named entities that match the entity types in the target sentence, hence not helpful for extraction."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain any named entities that match the entity types in the target sentence, hence not helpful for extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any named entities that match the entity types in the target sentence, hence not helpful for extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The example does not contain any named entities that match the entity types in the target sentence, hence not helpful for extraction."}\n]', 'response3': "[{'CaM kinase II': 'protein'}]", 'prediction': {'CaM kinase II': 'protein'}}
{'idx': 1103, 'sentence': 'Relationship between Rap1 protein phosphorylation and regulation of Ca2+ transport in platelets : a new approach.', 'label': {'platelets': 'cell_type', 'Rap1 protein': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides clear and specific examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 538, 'sentence': 'Alone, PMA and calcium ionophore A23187 did not affect, but together stimulated, like phytohaemagglutinin ( PHA ), leucine and, in particular, thymidine incorporation .', 'label': {'PHA': 'protein', 'phytohaemagglutinin': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example contains specific gene names and their corresponding entity labels, which directly match the entity types present in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The example includes gene names and their corresponding entity labels that are relevant to the target sentence, although not as directly matching as Example 1."},\n    {"Example 3": 3},\n    {"Reason 3": "The example provides a gene name and its corresponding entity label that is relevant to the target sentence, but the connection is not as strong as Examples 1 and 2."},\n    {"Example 4": 2},\n    {"Reason 4": "The example includes gene names and their corresponding entity labels, but the relevance to the target sentence is minimal."},\n    {"Example 5": 1},\n    {"Reason 5": "The example does not contain any gene names or entity labels that match the entity types present in the target sentence."},\n    {"Example 6": 1},\n    {"Reason 6": "The example does not contain any gene names or entity labels that match the entity types present in the target sentence."},\n    {"Example 7": 1},\n    {"Reason 7": "The example does not contain any gene names or entity labels that match the entity types present in the target sentence."},\n    {"Example 8": 1},\n    {"Reason 8": "The example does not contain any gene names or entity labels that match the entity types present in the target sentence."},\n    {"Example 9": 1},\n    {"Reason 9": "The example does not contain any gene names or entity labels that match the entity types present in the target sentence."},\n    {"Example 10": 1},\n    {"Reason 10": "The example does not contain any gene names or entity labels that match the entity types present in the target sentence."},\n    {"Example 11": 1},\n    {"Reason 11": "The example does not contain any gene names or entity labels that match the entity types present in the target sentence."},\n    {"Example 12": 1},\n    {"Reason 12": "The example does not contain any gene names or entity labels that match the entity types present in the target sentence."},\n    {"Example 13": 1},\n    {"Reason 13": "The example does not contain any gene names or entity labels that match the entity types present in the target sentence."},\n    {"Example 14": 1},\n    {"Reason 14": "The example does not contain any gene names or entity labels that match the entity types present in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The example does not contain any gene names or entity labels that match the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1529, 'sentence': 'Transcriptional activation and repression , two properties of the lymphoid-specific transcription factor Oct-2a .', 'label': {'Oct-2a': 'protein', 'lymphoid-specific transcription factor': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names such as IkappaBbeta and NF-kappaB, which are directly related to the entity label \'protein\' in the entity label set."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions \'Th2-type lymphocytes\' which is a specific cell type, corresponding to the entity label \'cell_type\' in the entity label set."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence includes multiple protein names like Oct-2A, HMG I/Y, and HLA-DRA, along with the cell type \'B cells\', all of which are relevant to the entity labels in the entity label set."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence refers to \'T cell\' as a cell type and \'interleukin 2\' as a protein, both aligning with the entity labels in the entity label set."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence mentions various proteins such as NF-kB, AP-1, OCT-1, and NF-IL-2B, all of which are relevant to the entity labels in the entity label set."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence specifically talks about the protein Egr-1, which is directly related to the entity label \'protein\' in the entity label set."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence includes \'IL-2 receptor alpha subunit\' and \'p21ras\' as proteins, along with \'B cell\' as a cell type, all aligning with the entity labels in the entity label set."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions \'SP1\' and \'caspases\' as proteins, along with \'B-cell\' as a cell type, all of which are relevant to the entity labels in the entity label set."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence includes \'NF-ATc\' as a protein and \'T lymphocytes\' as a cell type, both aligning with the entity labels in the entity label set."},\n    {"Example 10": 3},\n    {"Reason 10": "The sentence mentions \'AP-1\' as DNA, which is not directly related to any entity label in the entity label set."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence refers to \'A-myb\' as a protein, which is directly related to the entity label \'protein\' in the entity label set."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence includes \'Sp1\' and \'Ets\' as proteins, both aligning with the entity labels in the entity label set."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence mentions \'Jun\' and \'ATF-2\' as proteins, both directly related to the entity label \'protein\' in the entity label set."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence includes \'NF-E2\' as a protein, which aligns with the entity label \'protein\' in the entity label set."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence mentions \'NF-ATc\' as a protein, \'T lymphocytes\' and \'embryonic cardiac cells\' as cell types, all relevant to the entity labels in the entity label set."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence refers to \'GATA-1\' as a protein, which is directly related to the entity label \'protein\' in the entity label set."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific named entities related to the entity labels in the entity label set."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific named entities related to the entity labels in the entity label set."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific named entities related to the entity labels in the entity label set."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any specific named entities related to the entity labels in the entity label set."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1197, 'sentence': 'In this study, we demonstrate reconstitution of a cell-free processing system and demonstrate directly that: (a) the ubiquitin -proteasome system is involved in processing of the intact p105 precursor, (b) conjugation of ubiquitin to the precursor is an essential intermediate step in the processing, (c) the recently discovered novel species of the ubiquitin -carrier protein , E2-F1 , that is involved in the conjugation and degradation of p53 , is also required for the limited processing of the p105 precursor , and (d) a novel, approximately 320-kDa species of ubiquitin -protein ligase , is involved in the process.', 'label': {'ubiquitin': 'protein', 'p105 precursor': 'protein', 'E2-F1': 'protein', '-proteasome': 'protein', 'ubiquitin -carrier protein': 'protein', 'p53': 'protein', 'ubiquitin -protein ligase': 'protein', '320-kDa species': 'protein', 'p105': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 5},\n    {"Tat-binding protein 7 is a subunit of the 26S protease.": 4},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 3},\n    {"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.": 5},\n    {"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.": 4},\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 3},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"ubiquitin -proteasome system": "protein"}, {"p105 precursor": "protein"}, {"ubiquitin": "protein"}, {"E2-F1": "protein"}, {"p53": "protein"}, {"ubiquitin -carrier protein": "protein"}, {"ubiquitin -protein ligase": "protein"}]', 'prediction': {'ubiquitin -proteasome system': 'protein', 'p105 precursor': 'protein', 'ubiquitin': 'protein', 'E2-F1': 'protein', 'p53': 'protein', 'ubiquitin -carrier protein': 'protein', 'ubiquitin -protein ligase': 'protein'}}
{'idx': 877, 'sentence': 'Their constitutive expression is limited to B lymphocytes and thymic epithelial cells .', 'label': {'B lymphocytes': 'cell_type', 'thymic epithelial cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains clear mentions of specific entities with corresponding labels."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence contains a specific entity with a corresponding label."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence contains clear mentions of specific entities with corresponding labels."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains clear mentions of specific entities with corresponding labels."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence contains a specific entity with a corresponding label."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains clear mentions of specific entities with corresponding labels."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence contains specific entities with corresponding labels."},\n    {"Example 8": 4},\n    {"Reason 8": "The sentence contains specific entities with corresponding labels."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains clear mentions of specific entities with corresponding labels."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains clear mentions of specific entities with corresponding labels."},\n    {"Example 11": 4},\n    {"Reason 11": "The sentence contains specific entities with corresponding labels."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains clear mentions of specific entities with corresponding labels."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not contain any specific entities with corresponding labels."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not contain any specific entities with corresponding labels."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any specific entities with corresponding labels."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any specific entities with corresponding labels."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific entities with corresponding labels."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific entities with corresponding labels."}\n]', 'response3': '[{"B lymphocytes": "cell_type"}, {"thymic epithelial cells": "cell_type"}]', 'prediction': {'B lymphocytes': 'cell_type', 'thymic epithelial cells': 'cell_type'}}
{'idx': 1838, 'sentence': 'First, we show that mutations in the LEF-1 -binding site inhibit the activity of multimerized copies of the HIV-1 enhancer in Jurkat T cells , and that LEF-1 /GAL4 can activate a GAL4-substituted HIV-1 enhancer 80- to 100-fold in vivo.', 'label': {'LEF-1 -binding site': 'DNA', 'HIV-1 enhancer': 'DNA', 'LEF-1': 'protein', 'GAL4-substituted HIV-1 enhancer': 'DNA', 'Jurkat T cells': 'cell_line', 'multimerized copies': 'DNA', 'LEF-1 /GAL4': 'protein'}, 'response1': "['DNA', 'protein', 'cell_type', 'cell_line']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The example provides a clear and specific entity with corresponding label, aiding in the extraction of named entities from the sentence."},\n{"Example 2": 5},\n{"Reason 2": "The examples provide specific entities with corresponding labels, aiding in the extraction of named entities from the sentence."},\n{"Example 3": 5},\n{"Reason 3": "The examples provide specific entities with corresponding labels, aiding in the extraction of named entities from the sentence."},\n{"Example 4": 5},\n{"Reason 4": "The examples provide specific entities with corresponding labels, aiding in the extraction of named entities from the sentence."},\n{"Example 5": 5},\n{"Reason 5": "The examples provide specific entities with corresponding labels, aiding in the extraction of named entities from the sentence."},\n{"Example 6": 5},\n{"Reason 6": "The examples provide specific entities with corresponding labels, aiding in the extraction of named entities from the sentence."},\n{"Example 7": 5},\n{"Reason 7": "The examples provide specific entities with corresponding labels, aiding in the extraction of named entities from the sentence."},\n{"Example 8": 5},\n{"Reason 8": "The examples provide specific entities with corresponding labels, aiding in the extraction of named entities from the sentence."},\n{"Example 9": 5},\n{"Reason 9": "The examples provide specific entities with corresponding labels, aiding in the extraction of named entities from the sentence."},\n{"Example 10": 5},\n{"Reason 10": "The examples provide specific entities with corresponding labels, aiding in the extraction of named entities from the sentence."},\n{"Example 11": 5},\n{"Reason 11": "The examples provide specific entities with corresponding labels, aiding in the extraction of named entities from the sentence."},\n{"Example 12": 5},\n{"Reason 12": "The examples provide specific entities with corresponding labels, aiding in the extraction of named entities from the sentence."},\n{"Example 13": 5},\n{"Reason 13": "The examples provide specific entities with corresponding labels, aiding in the extraction of named entities from the sentence."},\n{"Example 14": 5},\n{"Reason 14": "The examples provide specific entities with corresponding labels, aiding in the extraction of named entities from the sentence."},\n{"Example 15": 5},\n{"Reason 15": "The examples provide specific entities with corresponding labels, aiding in the extraction of named entities from the sentence."},\n{"Example 16": 1},\n{"Reason 16": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 20": 1},\n{"Reason 20": "The sentence does not contain any named entities from the given entity label set."}\n]', 'response3': '[{"LEF-1": "protein"}, {"HIV-1 enhancer": "DNA"}, {"Jurkat T cells": "cell_type"}, {"GAL4": "protein"}, {"GAL4-substituted HIV-1 enhancer": "DNA"}]', 'prediction': {'LEF-1': 'protein', 'HIV-1 enhancer': 'DNA', 'Jurkat T cells': 'cell_type', 'GAL4': 'protein', 'GAL4-substituted HIV-1 enhancer': 'DNA'}}
{'idx': 1195, 'sentence': 'Palombella and colleagues (Palombella, V.J., Rando, O.J., Goldberg, A.L., and Maniatis, T.(1994) Cell 78, 773-785) have shown that ubiquitin is required for the processing in a cell-free system of a truncated, artificially constructed, 60-kDa precursor .', 'label': {'60-kDa precursor': 'protein', 'ubiquitin': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence contains specific protein names (EBNA-2, PU.1) that are directly mentioned and can be easily identified as protein entities."},\n{"Example 2": 4},\n{"Reason 2": "The sentence mentions a specific protein name (Tat-binding protein 7) that can be identified as a protein entity."},\n{"Example 3": 4},\n{"Reason 3": "The sentence mentions a specific protein name (TCF-1) that can be identified as a protein entity."},\n{"Example 4": 5},\n{"Reason 4": "The sentence contains specific protein names (p21(WAF1/CIP1), p27(KIP1)) that are directly mentioned and can be easily identified as protein entities."},\n{"Example 5": 5},\n{"Reason 5": "The sentence contains specific protein names (IL-2, Aiolos, Ras) that are directly mentioned and can be easily identified as protein entities."},\n{"Example 6": 4},\n{"Reason 6": "The sentence mentions a specific protein name (p50p50) that can be identified as a protein entity."},\n{"Example 7": 5},\n{"Reason 7": "The sentence contains a specific protein name (NF-kappa B) that is directly mentioned and can be easily identified as a protein entity."},\n{"Example 8": 4},\n{"Reason 8": "The sentence mentions techniques (immunohistochemistry) and entities (protein, DNA, cell type) that can aid in identifying named entities."},\n{"Example 9": 5},\n{"Reason 9": "The sentence contains a specific protein name (ZAP-70) that is directly mentioned and can be easily identified as a protein entity."},\n{"Example 10": 5},\n{"Reason 10": "The sentence contains specific protein names (Syk, Zap) and mentions a specific cell type (T cell) that are directly mentioned and can be easily identified as protein and cell type entities."},\n{"Example 11": 5},\n{"Reason 11": "The sentence contains specific protein names (NF-kappa B, I kappa B alpha) that are directly mentioned and can be easily identified as protein entities."},\n{"Example 12": 5},\n{"Reason 12": "The sentence contains specific protein names (IL-2, c-Jun, c-Fos) that are directly mentioned and can be easily identified as protein entities."},\n{"Example 13": 5},\n{"Reason 13": "The sentence contains specific protein names (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) that are directly mentioned and can be easily identified as protein entities."},\n{"Example 14": 5},\n{"Reason 14": "The sentence contains specific protein names (IkappaBbeta, NF-kappaB) that are directly mentioned and can be easily identified as protein entities."},\n{"Example 15": 3},\n{"Reason 15": "The sentence mentions specific cell types (EBV, B-cell) that can be identified as cell type entities."},\n{"Example 16": 5},\n{"Reason 16": "The sentence contains specific protein names (Tax, TFIIA) that are directly mentioned and can be easily identified as protein entities."},\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any specific named entities related to the given entity labels."},\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any specific named entities related to the given entity labels."},\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any specific named entities related to the given entity labels."},\n{"Example 20": 1},\n{"Reason 20": "The sentence does not contain any specific named entities related to the given entity labels."}\n]', 'response3': "[{'Palombella': 'protein'}, {'Rando': 'protein'}, {'Goldberg': 'protein'}, {'Maniatis': 'protein'}, {'ubiquitin': 'protein'}]", 'prediction': {'Palombella': 'protein', 'Rando': 'protein', 'Goldberg': 'protein', 'Maniatis': 'protein', 'ubiquitin': 'protein'}}
{'idx': 817, 'sentence': '(ii) Transfection and expression of EBNA-LP alone had no effect on LMP1 expression and did not act synergistically with EBNA-2 to affect LMP1 expression .', 'label': {'EBNA-LP': 'protein', 'LMP1': 'protein', 'EBNA-2': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"2": "The sentence does not contain any of the entity types in the label set."},\n    {"3": "The sentence contains multiple protein entities and their corresponding labels, which can aid in named entity extraction."},\n    {"4": "The sentence contains multiple protein entities and their corresponding labels, which can aid in named entity extraction."},\n    {"5": "The sentence contains multiple protein entities and their corresponding labels, which can aid in named entity extraction."},\n    {"6": "The sentence contains multiple protein entities and their corresponding labels, which can aid in named entity extraction."},\n    {"7": "The sentence contains a DNA entity and its corresponding label, which can aid in named entity extraction."},\n    {"8": "The sentence contains multiple protein entities and their corresponding labels, which can aid in named entity extraction."},\n    {"9": "The sentence contains multiple protein entities and their corresponding labels, which can aid in named entity extraction."},\n    {"10": "The sentence contains cell type and protein entities with their corresponding labels, aiding in named entity extraction."},\n    {"11": "The sentence contains a protein entity and its corresponding label, which can aid in named entity extraction."},\n    {"12": "The sentence contains protein and cell line entities with their corresponding labels, aiding in named entity extraction."},\n    {"13": "The sentence contains RNA and cell line entities with their corresponding labels, aiding in named entity extraction."},\n    {"14": "The sentence contains protein entities and their corresponding labels, aiding in named entity extraction."},\n    {"15": "The sentence contains protein entities and their corresponding labels, aiding in named entity extraction."},\n    {"16": "The sentence does not contain any of the entity types in the label set."},\n    {"17": "The sentence does not contain any of the entity types in the label set."},\n    {"18": "The sentence does not contain any of the entity types in the label set."},\n    {"19": "The sentence does not contain any of the entity types in the label set."},\n    {"20": "The sentence does not contain any of the entity types in the label set."}\n]', 'response3': "[{'EBNA-LP': 'protein'}, {'LMP1': 'protein'}, {'EBNA-2': 'protein'}]", 'prediction': {'EBNA-LP': 'protein', 'LMP1': 'protein', 'EBNA-2': 'protein'}}
{'idx': 741, 'sentence': 'In melanoma cells that contain the N-Oct-3 factor , a transfected lymphocyte-specific promoter was neither activated nor was it repressed upon contransfection with an Oct-2A expression vector .', 'label': {'Oct-2A expression vector': 'DNA', 'Oct-2A': 'protein', 'N-Oct-3 factor': 'protein', 'melanoma cells': 'cell_type'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 4},\n    {"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.": 5},\n    {"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.": 4},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2.": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 4},\n    {"Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B / Oct-1 -dependent transcription.": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.": 5},\n    {"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 283, 'sentence': '[ Estrogen receptor content of peripheral blood lymphocytes in patients with systemic lupus erythematosus ]', 'label': {'Estrogen receptor': 'protein', 'peripheral blood lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 4},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 4},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1043, 'sentence': 'METHOD: Two color flow cytometry analysis was used on peripheral blood samples of young and postmenopausal females and postmenopausal females treated with estrogen replacement therapy .', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein (NF-E2) and its corresponding entity label."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides a clear example of a protein (erythropoietin) and its corresponding entity label."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence provides a clear example of a protein (E2A) and its corresponding entity label."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides clear examples of a protein (MNDA) and a cell line (Philadelphia chromosome-positive chronic myeloid leukemia) with their corresponding entity labels."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides a clear example of a protein (phosphocreatine) and its corresponding entity label."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides clear examples of proteins (TCRzeta and p56(lck)) with their corresponding entity labels."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides clear examples of a protein (alpha-tocopherol) and cell types (monocyte and endothelial cells) with their corresponding entity labels."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides clear examples of proteins (CD70, IL-4, CD40) and cell types (B cell, plasma cells) with their corresponding entity labels."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides clear examples of proteins (CD40, Rel/nuclear factor kappaB, NF-kappaB) and a cell type (B lymphocytes) with their corresponding entity labels."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides clear examples of a cell line (Ter 119) and proteins (beta-globin, glycoprotein IIb, platelet factor 4) with their corresponding entity labels."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides clear examples of cell types (B and T cell activation) and cell lines (Ramos, Jurkat) with their corresponding entity labels."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides clear examples of DNA (EBV), a protein (EBNA2), and another protein (estrogen receptor) with their corresponding entity labels."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides clear examples of proteins (Erbstatin, genistein) and RNA (Egr-1) with their corresponding entity labels."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides clear examples of cell lines (PMA-stimulated U1 cells) with their corresponding entity labels."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides clear examples of proteins (globins, glycoprotein IIb, platelet factor 4, Spi-1, Fli-1) and a protein (erythropoietin) with their corresponding entity labels."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence provides clear examples of a cell type (HPCs) and proteins (PML, Rb) with their corresponding entity labels."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any named entities related to the given entity labels."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any named entities related to the given entity labels."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any named entities related to the given entity labels."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any named entities related to the given entity labels."}\n]', 'response3': "[{'estrogen replacement therapy': 'protein'}]", 'prediction': {'estrogen replacement therapy': 'protein'}}
{'idx': 1010, 'sentence': 'Using a polyclonal antibody to murine NFATp , Western blot analysis of various mouse tissues demonstrated that the 110-130-kDa NFATp protein was highly expressed in thymus and spleen .', 'label': {'murine NFATp': 'protein', 'NFATp protein': 'protein', 'NFATp': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 4},\n{"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n{"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 4},\n{"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n{"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n{"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n{"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n{"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B, possibly by a phosphorylation reaction involving protein kinase C by PAF.": 5},\n{"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 4},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n{"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n{"A critical role of Sp1- and Ets-related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n{"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.": 5},\n{"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n{"The p50 and p65 proteins, constituents of the prototypic nuclear factor kappaB, were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays.": 5}\n]', 'response3': '[{"NFATp": "protein"}, {"NFATp": "protein"}, {"thymus": "cell_type"}, {"spleen": "cell_type"}]', 'prediction': {'NFATp': 'protein', 'thymus': 'cell_type', 'spleen': 'cell_type'}}
{'idx': 186, 'sentence': 'We also find that NF-E2 , another trans-acting factor of the erythrocytic lineage , is present in megakaryocytes .', 'label': {'erythrocytic lineage': 'cell_type', 'NF-E2': 'protein', 'trans-acting factor': 'protein', 'megakaryocytes': 'cell_line'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {\n        "Example 1": 5\n    },\n    {\n        "Reason 1": "The example provides a direct mapping between the entity \'NF-E2\' and its corresponding label \'protein\' in the target sentence, aiding in the extraction of named entities."\n    },\n    {\n        "Example 2": 4\n    },\n    {\n        "Reason 2": "The example provides a direct mapping between the entity \'GATA-1\' and its corresponding label \'protein\' in the target sentence, aiding in the extraction of named entities."\n    },\n    {\n        "Example 3": 5\n    },\n    {\n        "Reason 3": "The example provides direct mappings between the entities \'Stat3\', \'Stat5\', and \'c-Mpl\' with their corresponding labels \'protein\' in the target sentence, aiding in the extraction of named entities."\n    },\n    {\n        "Example 4": 4\n    },\n    {\n        "Reason 4": "The example provides a direct mapping between the entity \'NF-ATc\' and its corresponding label \'protein\' in the target sentence, aiding in the extraction of named entities."\n    },\n    {\n        "Example 5": 4\n    },\n    {\n        "Reason 5": "The example provides a direct mapping between the entity \'GATA-1\' and its corresponding label \'protein\' in the target sentence, aiding in the extraction of named entities."\n    },\n    {\n        "Example 6": 5\n    },\n    {\n        "Reason 6": "The example provides direct mappings between the entities \'granulocytes\' and \'T cells\' with their corresponding labels \'cell_type\' in the target sentence, aiding in the extraction of named entities."\n    },\n    {\n        "Example 7": 5\n    },\n    {\n        "Reason 7": "The example provides direct mappings between the entities \'EKLF\', \'CBP\', \'p300\', and \'P/CAF\' with their corresponding labels \'protein\' in the target sentence, aiding in the extraction of named entities."\n    },\n    {\n        "Example 8": 4\n    },\n    {\n        "Reason 8": "The example provides a direct mapping between the entity \'Egr-1\' and its corresponding label \'protein\' in the target sentence, aiding in the extraction of named entities."\n    },\n    {\n        "Example 9": 4\n    },\n    {\n        "Reason 9": "The example provides a direct mapping between the entity \'NF-ATc\' and its corresponding label \'protein\' in the target sentence, aiding in the extraction of named entities."\n    },\n    {\n        "Example 10": 4\n    },\n    {\n        "Reason 10": "The example provides a direct mapping between the entity \'erythropoietin\' and its corresponding label \'protein\' in the target sentence, aiding in the extraction of named entities."\n    },\n    {\n        "Example 11": 5\n    },\n    {\n        "Reason 11": "The example provides direct mappings between the entities \'NF-kappaB\', \'Tax\', and \'ATL\' with their corresponding labels \'protein\' and \'cell_type\' in the target sentence, aiding in the extraction of named entities."\n    },\n    {\n        "Example 12": 4\n    },\n    {\n        "Reason 12": "The example provides a direct mapping between the entity \'E2A\' and its corresponding label \'protein\' in the target sentence, aiding in the extraction of named entities."\n    },\n    {\n        "Example 13": 4\n    },\n    {\n        "Reason 13": "The example provides a direct mapping between the entity \'GATA-1\' and its corresponding label \'protein\' in the target sentence, aiding in the extraction of named entities."\n    },\n    {\n        "Example 14": 5\n    },\n    {\n        "Reason 14": "The example provides direct mappings between the entities \'CD40\', \'Rel/nuclear factor kappaB\', \'NF-kappaB\', and \'B lymphocytes\' with their corresponding labels \'protein\' and \'cell_type\' in the target sentence, aiding in the extraction of named entities."\n    },\n    {\n        "Example 15": 5\n    },\n    {\n        "Reason 15": "The example provides direct mappings between the entities \'ZEB\', \'c-Myb\', \'Ets\', and \'hematopoietic cells\' with their corresponding labels \'protein\' and \'cell_type\' in the target sentence, aiding in the extraction of named entities."\n    },\n    {\n        "Example 16": 1\n    },\n    {\n        "Reason 16": "The example does not contain any entities that match the entity types in the target sentence, hence not helpful in aiding the extraction of named entities."\n    },\n    {\n        "Example 17": 1\n    },\n    {\n        "Reason 17": "The example does not contain any entities that match the entity types in the target sentence, hence not helpful in aiding the extraction of named entities."\n    },\n    {\n        "Example 18": 1\n    },\n    {\n        "Reason 18": "The example does not contain any entities that match the entity types in the target sentence, hence not helpful in aiding the extraction of named entities."\n    },\n    {\n        "Example 19": 1\n    },\n    {\n        "Reason 19": "The example does not contain any entities that match the entity types in the target sentence, hence not helpful in aiding the extraction of named entities."\n    }\n]', 'response3': '[{"NF-E2": "protein"}]', 'prediction': {'NF-E2': 'protein'}}
{'idx': 1547, 'sentence': 'Platelet glycoprotein ( GP ) Ib-IX-V is a multisubunit adhesion receptor that supports platelet attachment to thrombogenic surfaces at sites of vascular injury .', 'label': {'multisubunit adhesion receptor': 'protein', 'Ib-IX-V': 'protein', 'Platelet glycoprotein': 'protein', 'GP': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 1},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n    {"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.": 5},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 4},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 4},\n    {"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/thrombopoiesis or possibly a mature platelet function such as aggregation.": 5},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.": 5},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n    {"Tat-binding protein 7 is a subunit of the 26S protease.": 4},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 4},\n    {"The p21ras small GTP binding proteins participate in signal transduction from cell surface receptors and affect neoplastic transformation and development in many different cell types.": 5},\n    {"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.": 5},\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 5},\n    {"We have examined the effect of alpha-tocopherol (alpha-tcp) on one cellular event in atherosclerotic plaque development, monocyte adhesion to stimulated endothelial cells (ECs).": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"Platelet glycoprotein (GP) Ib-IX-V": "protein"}]', 'prediction': {'Platelet glycoprotein (GP) Ib-IX-V': 'protein'}}
{'idx': 96, 'sentence': 'We have analyzed the functional domains of the minimal Thy-1 promoter and show that the dominant promoter elements consist of multiple binding sites for the transcription factor Sp1 , an inverted CCAAT box , and sequences proximal to the transcription start site .', 'label': {'Sp1': 'protein', 'dominant promoter elements': 'DNA', 'minimal Thy-1 promoter': 'DNA', 'transcription factor': 'protein', 'multiple binding sites': 'DNA', 'CCAAT box': 'DNA', 'transcription start site': 'DNA'}, 'response1': "['protein']", 'response2': '[\n{"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n{"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 4},\n{"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n{"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n{"Here we examined the regulatory mechanism of the SCM-1 genes.": 4},\n{"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 4},\n{"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 5},\n{"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 4},\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n{"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n{"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n{"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 5},\n{"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif.": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"Thy-1": "protein"}, {"Sp1": "protein"}]', 'prediction': {'Thy-1': 'protein', 'Sp1': 'protein'}}
{'idx': 1763, 'sentence': 'Cysteamine treatment inhibited both expression of the IL-2 mRNA and secretion of IL-2 into the culture medium .', 'label': {'IL-2': 'protein', 'IL-2 mRNA': 'RNA'}, 'response1': "['RNA', 'protein']", 'response2': '[\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 5},\n    {"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .": 4},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .": 4},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 5},\n    {"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .": 5},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"Binding of YY1 and Oct1 to a novel element that downregulates expression of IL-5 in human T cells .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"IL-2 mRNA": "RNA"}, {"IL-2": "protein"}]', 'prediction': {'IL-2 mRNA': 'RNA', 'IL-2': 'protein'}}
{'idx': 224, 'sentence': 'Cortivazol ( CVZ ) is a unique, high potency synthetic glucocorticoid , which has a phenylpyrazol fused to the A-ring of the steroid nucleus and displays binding consistent with two or more sites in the cytosol from CEM C7 cells (a human acute lymphoblastic T-cell line ).', 'label': {'CEM C7 cells': 'cell_line', 'human acute lymphoblastic T-cell line': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.": 5},\n    {"Control of NF-kappa B activity by the I kappa B beta inhibitor.": 5},\n    {"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes.": 4},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 4},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin.": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"Benzene toxicity towards lymphocytes is thought to be mediated by metabolites of benzene including benzoquinone (BQ).": 4},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 4},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"Cortivazol": "protein"}, {"CVZ": "protein"}, {"CEM C7 cells": "cell_line"}]', 'prediction': {'Cortivazol': 'protein', 'CVZ': 'protein', 'CEM C7 cells': 'cell_line'}}
{'idx': 313, 'sentence': 'Immunohistochemical study of steroid hormones and an estrogen binding assay in malignant soft tissue tumors .', 'label': {'malignant soft tissue tumors': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein (E2A) being mentioned in relation to a specific gene expression study, making it highly relevant for identifying protein entities."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence directly mentions a protein (GATA-1) in the context of gene expression during eosinophil differentiation, making it highly relevant for identifying protein entities."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence mentions lymphoid neoplasms, indicating a specific cell type, which is crucial for identifying cell type entities."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence mentions phosphocreatine in the context of physical exercise and lymphocytes, which can be helpful in identifying protein entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides multiple examples of proteins (SLAP-130, SLP-76, NF-E2) and mentions T cell as a cell type, making it highly relevant for identifying protein and cell type entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence mentions NF-E2 in the context of a cell-specific transcription factor, which is crucial for identifying protein entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence mentions immunohistochemistry, gene, and cell type within a tumor specimen, providing relevant examples for identifying protein, DNA, and cell type entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions retinoic acid receptor alpha in the context of binding assays, making it highly relevant for identifying protein entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence mentions CD14, a protein, in the context of monocytic differentiation, making it highly relevant for identifying protein entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence mentions HML as a cell line and dexamethasone, cortisol, and lysozyme as proteins, providing relevant examples for identifying cell line and protein entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence mentions CD40, Rel/nuclear factor kappaB, and NF-kappaB in the context of B lymphocytes, making it highly relevant for identifying protein and cell type entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence mentions B and T cell activation, Ramos, Jurkat cells, and cDNA microarray technology, providing relevant examples for identifying cell type, cell line, and DNA entities."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence mentions tal-1, GATA-binding proteins, and hematopoiesis, providing relevant examples for identifying protein and cell type entities."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence mentions Erbstatin, genistein, and Egr-1 in the context of mRNA expression and protein tyrosine phosphorylation, making it highly relevant for identifying protein and RNA entities."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence mentions EBV, EBNA2, and estrogen receptor in the context of conditional mutants and fusion proteins, providing relevant examples for identifying DNA and protein entities."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence mentions MR, aldosterone, and progesterone in the context of antibody inhibition, making it highly relevant for identifying protein entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not provide specific examples of entities related to the target sentence, making it less helpful for entity extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not provide specific examples of entities related to the target sentence, making it less helpful for entity extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not provide specific examples of entities related to the target sentence, making it less helpful for entity extraction."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not provide specific examples of entities related to the target sentence, making it less helpful for entity extraction."}\n]', 'response3': "[{'steroid hormones': 'protein'}, {'estrogen': 'protein'}]", 'prediction': {'steroid hormones': 'protein', 'estrogen': 'protein'}}
{'idx': 1285, 'sentence': "Characterization of 5' end of human thromboxane receptor gene .", 'label': {"5' end of human thromboxane receptor gene": 'DNA', 'human thromboxane receptor gene': 'DNA'}, 'response1': "['DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear and specific example of a protein entity (p50p50) and its function, aiding in the extraction of protein entities from the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence directly mentions a protein entity (GATA-1) and its role in gene expression, providing valuable information for extracting protein entities from the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence explicitly refers to a cell type entity (Th2-type lymphocytes), making it highly relevant for identifying cell type entities in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence mentions a cell line entity (SCM-1), which is crucial for recognizing cell line entities in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains multiple protein entities (Stat3, Stat5, c-Mpl) and their involvement in signal transduction, providing significant assistance in identifying protein entities from the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides a specific protein entity (E2A) and the method used for its analysis, aiding in the extraction of protein entities from the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence mentions cell type (T cell) and protein (interleukin 2) entities, which are essential for identifying cell type and protein entities in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence refers to a protein entity (retinoic acid receptor alpha) and the methods used for its analysis, providing valuable information for extracting protein entities from the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence mentions a protein entity (GM-CSF) and its conservation across species, aiding in the identification of protein entities from the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence explicitly mentions a cell line entity (SIVsmmPBj14), which is crucial for recognizing cell line entities in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides multiple protein entities (SLAP-130, SLP-76) and their association with T cells, aiding in the extraction of protein and cell type entities from the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence mentions a protein entity (GATA-1) and its role in gene regulation, providing valuable information for extracting protein entities from the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides a specific protein entity (RXR) and its role in cell outgrowth, aiding in the extraction of protein entities from the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence mentions a DNA entity (cDNAs) and their cloning and sequencing, which is essential for identifying DNA entities in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence mentions cell line entities (Ter 119, Ramos, Jurkat) and the technology used for gene expression analysis, providing valuable information for extracting cell line and DNA entities from the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 327, 'sentence': 'However, there is an EB1 -binding site ( ZRE-B ) located within the R-responsive enhancer region .', 'label': {'R-responsive enhancer region': 'DNA', 'EB1 -binding site': 'DNA', 'EB1': 'protein', 'ZRE-B': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n    {"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .": 5},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 4},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements .": 4},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 4},\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines .": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .": 4},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .": 5},\n    {"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"EB1": "protein"}, {"ZRE-B": "DNA"}]', 'prediction': {'EB1': 'protein', 'ZRE-B': 'DNA'}}
{'idx': 1622, 'sentence': 'Analysis of whole-cell lysates by antiphosphotyrosine immunoblotting showed that incubation with gamma interferon brought about specific increases in phosphotyrosine labeling of several proteins.', 'label': {'gamma interferon': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"gamma interferon": "protein"}]', 'prediction': {'gamma interferon': 'protein'}}
{'idx': 1393, 'sentence': 'This enhancer in HIV-1 is the T-cell activation response element ; in HIV-2 , however, it is the second enhancer that is mainly responsible for activation in response to T-cell activators .', 'label': {'second enhancer': 'DNA', 'T-cell activation response element': 'DNA', 'enhancer': 'DNA'}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"HIV-1": "cell_type"}, {"T-cell": "cell_type"}, {"HIV-2": "cell_type"}, {"T-cell": "cell_type"}]', 'prediction': {'HIV-1': 'cell_type', 'T-cell': 'cell_type', 'HIV-2': 'cell_type'}}
{'idx': 1221, 'sentence': 'To identify osteoblast-specific cis-acting elements and trans-acting factors , we initiated an analysis of the promoter of a mouse osteocalcin gene , an osteoblast-specific gene .', 'label': {'mouse osteocalcin gene': 'DNA', 'promoter': 'DNA', 'osteoblast-specific cis-acting elements': 'DNA', 'trans-acting factors': 'protein', 'osteoblast-specific gene': 'DNA'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 4},\n    {"A critical role of Sp1- and Ets-related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 4},\n    {"To evaluate the PML/RARalpha role in myelopoiesis, transgenic mice expressing PML/RARalpha were engineered.": 4},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 4},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 4},\n    {"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 130, 'sentence': 'At high concentration of NE , all of the TR bound to TREp was more greatly retarded than in the absence of NE .', 'label': {'TREp': 'DNA', 'TR': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with their corresponding labels, providing a clear and direct mapping between the entities and their types."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 788, 'sentence': 'The number of mineralocorticoid receptors /cell were within or close to the normal range (n = 9).', 'label': {'mineralocorticoid receptors': 'protein'}, 'response1': "['cell_type']", 'response2': '[\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 1},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 5},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n    {"RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA/NF-kappaB1 binding complexes.": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 5},\n    {"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.": 5},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.": 5},\n    {"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.": 5},\n    {"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.": 5},\n    {"When 18C7 was incubated with MR before aldosterone or progesterone, the antibody inhibited 75-80% of the binding.": 5},\n    {"A total of 37 chronic, severe, nonsmoking asthmatic patients with documented reversible airways obstruction were classified as glucocorticoid-sensitive or -resistant on the basis of changes in FEV1, FVC, and peak expiratory flow (PEF) after oral prednisolone.": 5},\n    {"The number of Type I and Type II receptors before the test was lower in elderly subjects than in adults.": 5},\n    {"Membrane receptors for aldosterone: a novel pathway for mineralocorticoid action.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 781, 'sentence': 'Effects of aldosterone on intralymphocytic sodium and potassium in patients with essential hypertension .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 4},\n    {"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes.": 4},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms.": 4},\n    {"We have examined the effect of alpha-tocopherol (alpha-tcp) on one cellular event in atherosclerotic plaque development, monocyte adhesion to stimulated endothelial cells (ECs).": 5},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 5},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 4},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 5},\n    {"Eosinophils play an important role in the effector phase of allergic inflammation.": 4},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 5},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1220, 'sentence': 'A PEBP2 alpha/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element .', 'label': {'PEBP2 alpha/AML-1-related factor': 'protein', 'osteocalcin promoter': 'DNA', 'osteoblast-specific cis-acting element': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"T cell": 5},\n    {"interleukin 2": 4},\n    {"UAS1": 4},\n    {"B cell": 5},\n    {"GATA-1": 5},\n    {"EKLF": 5},\n    {"CBP": 4},\n    {"p300": 4},\n    {"P/CAF": 4},\n    {"Sp1": 5},\n    {"CD14": 5},\n    {"PAFR": 5},\n    {"PAF": 4},\n    {"NF-kappa B": 5},\n    {"protein kinase C": 4},\n    {"NF-E2": 5},\n    {"PML/RARalpha": 5},\n    {"EBNA2": 5},\n    {"TP1": 4},\n    {"AP-1": 5},\n    {"retinoic acid receptor alpha": 5},\n    {"TAL1": 5},\n    {"T-ALL": 5},\n    {"Oct-2A": 5},\n    {"HMG I/Y": 5},\n    {"HLA-DRA": 5},\n    {"IL-2 receptor alpha subunit": 5},\n    {"p21ras": 5},\n    {"Gel-shift analysis": 1},\n    {"c-Jun": 5},\n    {"c-Fos": 5}\n]', 'response3': '[{"PEBP2 alpha/AML-1-related factor": "protein"}, {"osteocalcin": "protein"}, {"osteoblast-specific": "cell_type"}]', 'prediction': {'PEBP2 alpha/AML-1-related factor': 'protein', 'osteocalcin': 'protein', 'osteoblast-specific': 'cell_type'}}
{'idx': 958, 'sentence': 'Here, Markus Neurath, Eckhard Stuber and Warren Strober describe the molecular structure of BSAP and focus on the ability of this protein to regulate the expression of B-cell-specific genes .', 'label': {'B-cell-specific genes': 'DNA', 'BSAP': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .": 5},\n    {"Tat-binding protein 7 is a subunit of the 26S protease .": 4},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .": 5},\n    {"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes .": 3},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .": 4},\n    {"Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .": 5},\n    {"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .": 5},\n    {"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines .": 5},\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 5},\n    {"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"Markus Neurath": "protein"}, {"Eckhard Stuber": "protein"}, {"Warren Strober": "protein"}, {"BSAP": "protein"}, {"B-cell-specific genes": "protein"}]', 'prediction': {'Markus Neurath': 'protein', 'Eckhard Stuber': 'protein', 'Warren Strober': 'protein', 'BSAP': 'protein', 'B-cell-specific genes': 'protein'}}
{'idx': 1083, 'sentence': 'These data suggest that the action of tepoxalin to inhibit proliferation in PBMC may be at least in part due to its ability to reduce the amount of available iron resulting in decreased activation of NF kappa B and subsequent inhibition of cytokine production .', 'label': {'cytokine': 'protein', 'NF kappa B': 'protein', 'PBMC': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides clear and direct mappings between the entities in the sentence and their corresponding entity labels."},\n    {"Example 2": 5},\n    {"Reason 2": "The example provides clear and direct mappings between the entities in the sentence and their corresponding entity labels."},\n    {"Example 3": 5},\n    {"Reason 3": "The example provides clear and direct mappings between the entities in the sentence and their corresponding entity labels."},\n    {"Example 4": 5},\n    {"Reason 4": "The example provides clear and direct mappings between the entities in the sentence and their corresponding entity labels."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides clear and direct mappings between the entities in the sentence and their corresponding entity labels."},\n    {"Example 6": 5},\n    {"Reason 6": "The example provides clear and direct mappings between the entities in the sentence and their corresponding entity labels."},\n    {"Example 7": 5},\n    {"Reason 7": "The example provides clear and direct mappings between the entities in the sentence and their corresponding entity labels."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides clear and direct mappings between the entities in the sentence and their corresponding entity labels."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides clear and direct mappings between the entities in the sentence and their corresponding entity labels."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides clear and direct mappings between the entities in the sentence and their corresponding entity labels."},\n    {"Example 11": 5},\n    {"Reason 11": "The example provides clear and direct mappings between the entities in the sentence and their corresponding entity labels."},\n    {"Example 12": 5},\n    {"Reason 12": "The example provides clear and direct mappings between the entities in the sentence and their corresponding entity labels."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides clear and direct mappings between the entities in the sentence and their corresponding entity labels."},\n    {"Example 14": 5},\n    {"Reason 14": "The example provides clear and direct mappings between the entities in the sentence and their corresponding entity labels."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities from the given entity label set."}\n]', 'response3': "[{'NF kappa B': 'protein'}]", 'prediction': {'NF kappa B': 'protein'}}
{'idx': 514, 'sentence': 'Induction of the enhancer may have a role in the increase in globin gene transcription that characterizes erythroid maturation .', 'label': {'globin gene': 'DNA', 'enhancer': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a clear and direct mapping of the entity \'GATA-1\' to the entity type \'protein\' in the sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The example provides a clear and direct mapping of the entity \'NF-E2\' to the entity type \'protein\' in the sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The example provides a clear and direct mapping of the entity \'Th2-type lymphocytes\' to the entity type \'cell_type\' in the sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The example provides a clear and direct mapping of the entity \'Egr-1\' to the entity type \'protein\' in the sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides a clear and direct mapping of the entity \'erythropoietin\' to the entity type \'protein\' in the sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The examples provide clear and direct mappings of the entities \'CCAAT box\' to the entity type \'DNA\' and \'EKLF binding site\' to the entity type \'protein\' in the sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The example provides a clear and direct mapping of the entity \'AP-1\' to the entity type \'DNA\' in the sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides a clear and direct mapping of the entity \'IL-4\' to the entity type \'protein\' in the sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides a clear and direct mapping of the entity \'retinoic acid receptor alpha\' to the entity type \'protein\' in the sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides a clear and direct mapping of the entity \'RXR\' to the entity type \'protein\' in the sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The examples provide clear and direct mappings of the entities \'WT1\' to the entity type \'protein\' and \'myeloid cell lines\' to the entity type \'cell_line\' in the sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The examples provide clear and direct mappings of the entities \'IL-2 receptor alpha subunit\' to the entity type \'protein\', \'p21ras\' to the entity type \'protein\', and \'B cell\' to the entity type \'cell_type\' in the sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides a clear and direct mapping of the entity \'IgH\' to the entity type \'DNA\' in the sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The example provides a clear and direct mapping of the entity \'GATA-1\' to the entity type \'protein\' in the sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The example provides a clear and direct mapping of the entity \'immunoglobulin kappa 3\' enhancer\' to the entity type \'DNA\' in the sentence."},\n    {"Example 16": 5},\n    {"Reason 16": "The examples provide clear and direct mappings of the entities \'SCL\' to the entity type \'protein\' and \'GATA-1\' to the entity type \'protein\' in the sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any named entities that match the given entity labels."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any named entities that match the given entity labels."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any named entities that match the given entity labels."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any named entities that match the given entity labels."}\n]', 'response3': '[{"globin gene": "DNA"}]', 'prediction': {'globin gene': 'DNA'}}
{'idx': 1133, 'sentence': 'Both LCLs were found by EM to produce RVLP and EBV particles .', 'label': {'LCLs': 'cell_line'}, 'response1': "['cell_line', 'protein']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.": 4},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .": 5},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 5},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .": 4},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .": 5},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 4},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .": 5},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter": 5},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms .": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .": 5},\n    {"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"RVLP": "protein"}, {"EBV": "cell_line"}]', 'prediction': {'RVLP': 'protein', 'EBV': 'cell_line'}}
{'idx': 1762, 'sentence': 'Taking the IL-2 gene as a candidate, we examined the effect of cysteamine treatment on early gene expression during lymphocyte activation , and on the activity of transcription factors AP-1 , NF-kappa B , NF-AT and Oct1 , whose functions are required for expression of the IL-2 mRNA.', 'label': {'IL-2': 'protein', 'early gene': 'DNA', 'NF-kappa B': 'protein', 'Oct1': 'protein', 'transcription factors': 'protein', 'NF-AT': 'protein', 'AP-1': 'protein', 'IL-2 gene': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.": 4},\n    {"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes.": 5},\n    {"While the activation of the IL-2 promoter and an NFAT -driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418 , it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2 -mediated NFAT activation is under the control of a combination of calcineurin- dependent and independent pathways.": 5},\n    {"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.": 5},\n    {"These results suggest that oxidative signals can positively and negatively regulate T cell transcriptional events and that changes in cellular redox can uncouple AP-1 regulation of c-jun from transcriptional up-regulation of IL-2 via NF-AT.": 5},\n    {"Together, these findings suggest that LITAF plays an important role in the activation of the human TNF-alpha gene and proposes a new mechanism to control TNF-alpha gene expression.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"IL-2": "protein"}, {"AP-1": "protein"}, {"NF-kappa B": "protein"}, {"NF-AT": "protein"}]', 'prediction': {'IL-2': 'protein', 'AP-1': 'protein', 'NF-kappa B': 'protein', 'NF-AT': 'protein'}}
{'idx': 23, 'sentence': 'Furthermore, a mutant E6 motif lost both in vitro binding activity and in vivo enhancer activity .', 'label': {'mutant E6 motif': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .": 4},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50 .": 4},\n    {"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 5},\n    {"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 5},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .": 5},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .": 4},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements .": 5},\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines .": 4},\n    {"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events .": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 5},\n    {"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .": 5},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .": 5},\n    {"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"E6 motif": "protein"}]', 'prediction': {'E6 motif': 'protein'}}
{'idx': 1476, 'sentence': 'Protein phosphorylation has an important role in the regulation of these two factors: (1) it induces the transactivating capacity of the AP-1 protein c-Jun ; and (2) it is involved in the release of the cytoplasmic inhibitor , I kappa B , from NF-kappa B , allowing translocation of the latter into the nucleus .', 'label': {'AP-1 protein': 'protein', 'c-Jun': 'protein', 'I kappa B': 'protein', 'NF-kappa B': 'protein', 'cytoplasmic inhibitor': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of protein names and their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."}\n]', 'response3': '[{"AP-1": "protein"}, {"c-Jun": "protein"}, {"I kappa B": "protein"}, {"NF-kappa B": "protein"}]', 'prediction': {'AP-1': 'protein', 'c-Jun': 'protein', 'I kappa B': 'protein', 'NF-kappa B': 'protein'}}
{'idx': 234, 'sentence': 'A similar infection with a recombinant retrovirus containing the beta-galactosidase gene with an adenovirus E2 promoter , results in beta-galactosidase activity in a limited number of cultured and primary cells .', 'label': {'cultured': 'cell_line', 'primary cells': 'cell_type', 'adenovirus E2 promoter': 'DNA', 'beta-galactosidase gene': 'DNA', 'beta-galactosidase': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 4},\n    {"In addition, assay of PBMC by the adenovirus-specific PCR may help detect early invasive disease and warrants further evaluation.": 4},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 3},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"This protein has now been purified and its encoding gene cloned.": 5},\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 4},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 4},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 5},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 4},\n    {"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n    {"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1396, 'sentence': 'NF-M ( chicken C/EBP beta ) induces eosinophilic differentiation and apoptosis in a hematopoietic progenitor cell line .', 'label': {'hematopoietic progenitor cell line': 'cell_line', 'NF-M': 'protein', 'chicken C/EBP beta': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n    {"Control of NF-kappa B activity by the I kappa B beta inhibitor.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 5},\n    {"Recently, activation of NF-kappa B has been linked to ARDS and has been shown to be a critical proximal step in the initiation of neutrophilic inflammation in animal models.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 5},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 5},\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"NF-M": "protein"}, {"C/EBP beta": "protein"}, {"eosinophilic": "cell_type"}, {"hematopoietic progenitor cell line": "cell_line"}]', 'prediction': {'NF-M': 'protein', 'C/EBP beta': 'protein', 'eosinophilic': 'cell_type', 'hematopoietic progenitor cell line': 'cell_line'}}
{'idx': 1812, 'sentence': 'The protein shows significant sequence similarities to the family of G-protein coupled chemokine receptors and turned out to be identical to the recently described receptor EBI1 .', 'label': {'G-protein coupled chemokine receptors': 'protein', 'chemokine receptors': 'protein', 'G-protein': 'protein', 'receptor EBI1': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"EBV": 5},\n    {"B-cell": 5},\n    {"retinoic acid receptor alpha": 5},\n    {"Protein": 5},\n    {"MIP-1 alpha": 5},\n    {"GOS19": 5},\n    {"LD78": 5},\n    {"AT464": 5},\n    {"EBNA-2": 5},\n    {"PU.1": 5},\n    {"CREB": 5},\n    {"AR-CRE": 5},\n    {"Egr-1": 5},\n    {"E2A": 5},\n    {"GM-CSF": 5},\n    {"protein": 5},\n    {"EKLF": 5},\n    {"CBP": 5},\n    {"p300": 5},\n    {"P/CAF": 5},\n    {"TP1": 5},\n    {"c-kit": 5},\n    {"IL-4R alpha chain": 5},\n    {"interleukin 10": 5},\n    {"IL-10R": 5},\n    {"STAT3": 5},\n    {"IL-6": 5},\n    {"GATA-1": 5},\n    {"IL4": 5},\n    {"IL13": 5},\n    {"STAT6": 5},\n    {"STAT5": 5},\n    {"B cells": 5}\n]', 'response3': '[{"G-protein coupled chemokine receptors": "protein"}, {"EBI1": "protein"}]', 'prediction': {'G-protein coupled chemokine receptors': 'protein', 'EBI1': 'protein'}}
{'idx': 1099, 'sentence': 'Interestingly, microtubule disruption also decreased monocyte 1,25(OH)2D3 synthesis , not by decreasing the Vmax of monocyte mitochondrial 1 alpha-hydroxylase but through an increase in the Km for 25(OH)2D3 .', 'label': {'monocyte mitochondrial 1 alpha-hydroxylase': 'protein', 'monocyte': 'cell_type', 'microtubule': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 4},\n    {"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 3},\n    {"Changes in PKC isoforms in human alveolar macrophages compared with blood monocytes.": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 5},\n    {"We have examined the effect of alpha-tocopherol (alpha-tcp) on one cellular event in atherosclerotic plaque development, monocyte adhesion to stimulated endothelial cells (ECs).": 5},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 4},\n    {"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.": 4},\n    {"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.": 4},\n    {"When the same MTHC lines are exposed to TNF-alpha in combination with IFN-gamma, the cells instead become DC.": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 4},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 4},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n    {"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]": 4},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 4},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1537, 'sentence': 'Furthermore, we identified a repression domain at the N-terminus of Oct-2a .', 'label': {'Oct-2a': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 1},\n{"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n{"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.": 5},\n{"Here we examined the regulatory mechanism of the SCM-1 genes.": 5},\n{"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n{"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.": 5},\n{"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements.": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n{"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 5},\n{"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n{"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system.": 5},\n{"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n{"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n{"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"Oct-2a": "protein"}]', 'prediction': {'Oct-2a': 'protein'}}
{'idx': 1574, 'sentence': 'CONCLUSIONS: Sexual hormones , through their receptors , may influence the activity of eosinophils in patients with VKC .', 'label': {'receptors': 'protein', 'eosinophils': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Eosinophils play an important role in the effector phase of allergic inflammation.": 5},\n    {"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.": 5},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 4},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 5},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms.": 5},\n    {"In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine (IFN-gamma) in combination with allergy-driven overproduction of T helper 2-type cytokines.": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 4},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5},\n    {"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.": 5},\n    {"To study the regulatory mechanism of gp91phox gene expression in eosinophils, we transiently transfected eosinophil-committed HL-60-C15 cells with gp91phox promoter constructs, and identified a negative element from bp -267 to -246 of the gp91phox gene, the deletion of which caused an 83% increase in promoter activity.": 5},\n    {"This phenomenon is mediated, in part, through inducible expression of the CXC chemokine, interleukin-8 (IL-8).": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"Sexual hormones": "protein"}, {"receptors": "protein"}, {"eosinophils": "cell_type"}]', 'prediction': {'Sexual hormones': 'protein', 'receptors': 'protein', 'eosinophils': 'cell_type'}}
{'idx': 1312, 'sentence': 'A solution structure for the non-sequence-specific C-terminal HMG box of HMG-1 has recently been proposed.', 'label': {'HMG-1': 'protein', 'C-terminal HMG box': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a cell line (SCM-1) being mentioned in relation to regulatory mechanisms of genes."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions specific DNA elements (CCAAT box) and a protein (EKLF binding site) that contribute to gene expression levels."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence mentions a specific protein (GM-CSF) in relation to conserved sequence motifs in gene promoters."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides multiple examples of proteins (IL-2, c-Jun, c-Fos) and their binding to specific sites in the IL-2 promoter."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence mentions a specific cell type (Th2-type lymphocytes) in relation to conserved motifs in cytokine promoters."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence mentions proteins and genomic sequences, suggesting similarities in transcription-related roles."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides examples of proteins (IL-7R, gamma(c)) and their critical roles in receptor function."},\n    {"Example 8": 4},\n    {"Reason 8": "The sentence mentions proteins (c-kit, IL-4R alpha chain) in the context of a chimeric receptor system."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides examples of proteins (Oct-2A, HMG I/Y, HLA-DRA) and their synergistic activation of gene expression in B cells."},\n    {"Example 10": 4},\n    {"Reason 10": "The sentence mentions a specific protein (retinoic acid receptor alpha) in the context of binding assays."},\n    {"Example 11": 4},\n    {"Reason 11": "The sentence mentions proteins (CHEMR1, C-C chemokine, MIP-1alpha) in relation to receptor activity."},\n    {"Example 12": 4},\n    {"Reason 12": "The sentence mentions a specific protein (TCF-1) and its transactivation ability."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides a clear example of DNA binding activity being mentioned in relation to phosphorylation status."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides examples of proteins (SLAP-130, SLP-76, ZAP-70) and their association with T cell signaling."},\n    {"Example 15": 4},\n    {"Reason 15": "The sentence mentions cDNAs as DNA sequences."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any specific entities related to the entity labels in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific entities related to the entity labels in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific entities related to the entity labels in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific entities related to the entity labels in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any specific entities related to the entity labels in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 601, 'sentence': 'To determine whether enhancer elements in addition to the highly conserved octamer (OCTA)-nucleotide motif are important for lymphoid-specific expression of the immunoglobulin heavy-chain (IgH) gene , we have investigated the effect of mutating the binding site for a putative additional lymphoid-specific transcription factor , designated NF-microB , in the murine IgH enhancer .', 'label': {'murine IgH enhancer': 'DNA', 'putative additional lymphoid-specific transcription factor': 'protein', 'octamer (OCTA)-nucleotide motif': 'DNA', 'NF-microB': 'protein', 'enhancer elements': 'DNA', 'immunoglobulin heavy-chain (IgH) gene': 'DNA', 'binding site': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names like NF-E2, Oct-2A, HMG I/Y, Egr-1, IL-2, NF-ATc, c-Jun, c-Fos, c-kit, IL-4R alpha chain, NF-kappa B, IFN A, IFNA, CD40, Rel/nuclear factor kappaB, p50, p65 which are relevant entities in the given label set."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence contains cell type names like B cells, T lymphocytes, embryonic cardiac cells which are relevant entities in the given label set."},\n    {"Example 3": 3},\n    {"Reason 3": "The sentence contains a protein name IL-2 which is a relevant entity in the given label set."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence contains protein names NF-ATc, c-Jun, c-Fos and cell type names T lymphocytes, embryonic cardiac cells which are relevant entities in the given label set."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains a protein name Egr-1 which is a relevant entity in the given label set."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence contains a protein name IL-4 which is a relevant entity in the given label set."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence contains a cell type name T cell and a protein name interleukin 2 which are relevant entities in the given label set."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains protein names IL-2, c-Jun, c-Fos which are relevant entities in the given label set."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence contains a cell type name Th2-type lymphocytes which is a relevant entity in the given label set."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains a DNA entity name IgH which is a relevant entity in the given label set."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains a DNA entity name immunoglobulin kappa 3\' enhancer which is a relevant entity in the given label set."},\n    {"Example 12": 4},\n    {"Reason 12": "The sentence contains protein names c-kit, IL-4R alpha chain which are relevant entities in the given label set."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains a protein name NF-kappa B which is a relevant entity in the given label set."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains protein names CD40, Rel/nuclear factor kappaB, NF-kappaB which are relevant entities in the given label set."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains protein names p50, p65 which are relevant entities in the given label set."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any relevant entities from the given label set."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any relevant entities from the given label set."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any relevant entities from the given label set."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any relevant entities from the given label set."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any relevant entities from the given label set."}\n]', 'response3': '[{"NF-microB": "protein"}, {"IgH": "DNA"}]', 'prediction': {'NF-microB': 'protein', 'IgH': 'DNA'}}
{'idx': 890, 'sentence': 'Treatment of 10 with warm HCl furnished 19-chloro-4,21-dihydroxypregna-4,9(11)-diene-3,20-dione (13).', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 4},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 4},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n    {"We found that they reduced the initial interleukin-1beta mRNA transcription rate through prevention of degradation of inhibitor-kappaB alpha.": 4},\n    {"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.": 5},\n    {"This hybrid clone, designated NR2, was characterized by several methods, including PCR, with eight pairs of oligonucleotides mapped to Chr 20: D20S5, D20S41, D20S42, D20S56, D20S57, D20S58, adenosine deaminase (ADA), and Prion protein (PRIP); Restriction Fragment Length Polymorphism (RFLP) analyses with four genomic anonymous probes (D20S5, cD3H12, D20S17, D20S18); and fluorescent in situ hybridization (FISH) with total human DNA and D20Z1, a sequence specific to the human Chr 20 centromere, as probes.": 5},\n    {"Treatment with soluble, bivalent mAb J393 killed 25-50% of the cell population, while concomitant engagement of either the CD3.TcR complex or the integrins CD18 and CD29 significantly potentiated this effect.": 5},\n    {"Combined treatment of HPCs with alpha-PML and alpha-Rb oligomers inhibited both PML and Rb protein expression and completely blocked erythroid colony development.": 5},\n    {"When 18C7 was incubated with MR before aldosterone or progesterone, the antibody inhibited 75-80% of the binding.": 5},\n    {"A 3-bp mutation at the distal Sp1-binding site not only eliminates Sp1 interaction, but also abolishes most of the VitD3 induction of CD14 expression.": 5},\n    {"CONCLUSION: Our results show that the tested agents (except indomethacin) are inhibitors of the T cell-mediated immune response, as expected, that aspirin is an effective suppressor of adhesion molecule expression, and that all three agents can induce Hsp60 in HUVECs.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 323, 'sentence': 'The Epstein-Barr virus ( EBV ) ORI1yt enhancer is not B-cell specific and does not respond synergistically to the EBV transcription factors R and Z .', 'label': {'Epstein-Barr virus ( EBV ) ORI1yt enhancer': 'DNA'}, 'response1': "['DNA', 'cell_type', 'protein']", 'response2': '[\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"5": "The sentence contains the entity \'RXR\' which is a protein, matching one of the entity types in the label set."},\n{"4": "The sentence contains the entities \'IL-2\' and \'IFN-gamma\' which are proteins, matching some of the entity types in the label set."},\n{"5": "The sentence contains the entities \'NF-kappaB\', \'Sp1\', and \'p50\' which are proteins, matching some of the entity types in the label set."},\n{"5": "The sentence contains the entities \'EBNA2\' and \'TP1\' which are proteins and a cell line respectively, matching some of the entity types in the label set."},\n{"4": "The sentence contains the entity \'interleukin 2\' which is a protein, matching one of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"5": "The sentence contains the entities \'NF-kB\', \'AP-1\', \'OCT-1\', and \'NF-IL-2B\' which are proteins, matching some of the entity types in the label set."},\n{"5": "The sentence contains the entities \'EBV\' and \'CD2\' which are a cell line and a protein respectively, matching some of the entity types in the label set."},\n{"4": "The sentence contains the entities \'CD4+\' and \'EBV\' which are a cell type and a protein respectively, matching some of the entity types in the label set."},\n{"5": "The sentence contains the entities \'EBNA-2\' and \'PU.1\' which are proteins, matching some of the entity types in the label set."},\n{"5": "The sentence contains the entities \'UAS1\' and \'B cell\' which are a cell line and a cell type respectively, matching some of the entity types in the label set."},\n{"5": "The sentence contains the entities \'EBV\' and \'B-cell\' which are a cell line and a cell type respectively, matching some of the entity types in the label set."},\n{"5": "The sentence contains the entity \'GATA-1\' which is a protein, matching one of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."}\n]', 'response3': "[{'Epstein-Barr virus': 'cell_line'}, {'EBV': 'cell_line'}, {'R': 'protein'}, {'Z': 'protein'}]", 'prediction': {'Epstein-Barr virus': 'cell_line', 'EBV': 'cell_line', 'R': 'protein', 'Z': 'protein'}}
{'idx': 929, 'sentence': 'The cDNA sequence has an 813-bp open reading frame ( ORF ) whose predicted amino acid sequence is 97.6% identical to the 272 carboxy-terminal amino acids of the human ets-1 protein .', 'label': {'ORF': 'DNA', '272 carboxy-terminal amino acids': 'protein', 'ets-1': 'protein', 'human ets-1 protein': 'protein', '813-bp open reading frame': 'DNA', 'cDNA sequence': 'DNA', 'amino acid sequence': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"Sentence": "The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.", "Helpfulness score": 5, "Reason": "The sentence contains specific mentions of \'NF-ATc\' (protein), \'T lymphocytes\' (cell_type), and \'embryonic cardiac cells\' (cell_type)."},\n{"Sentence": "Human cDNAs encoding subunits of these factors have been cloned and sequenced.", "Helpfulness score": 4, "Reason": "The sentence mentions \'cDNAs\' which is associated with \'DNA\' entity type."},\n{"Sentence": "A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.", "Helpfulness score": 4, "Reason": "The sentence mentions \'Th2-type lymphocytes\' which is associated with \'cell_type\' entity type."},\n{"Sentence": "Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.", "Helpfulness score": 5, "Reason": "The sentence mentions \'SLAP-130\' (protein), \'SLP-76\' (protein), and \'T cell\' (cell_type) which are relevant entity types."},\n{"Sentence": "The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.", "Helpfulness score": 4, "Reason": "The sentence mentions \'GM-CSF\' which is associated with \'protein\' entity type."},\n{"Sentence": "By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.", "Helpfulness score": 5, "Reason": "The sentence mentions \'TCF-1\' (protein) which is a relevant entity type."},\n{"Sentence": "The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.", "Helpfulness score": 5, "Reason": "The sentence mentions \'interleukin 10\' (protein), \'IL-10R\' (protein), \'STAT3\' (protein), and \'IL-6\' (protein) which are relevant entity types."},\n{"Sentence": "This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.", "Helpfulness score": 5, "Reason": "The sentence mentions \'SIVsmmPBj14\' which is associated with \'cell_line\' entity type."},\n{"Sentence": "One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.", "Helpfulness score": 5, "Reason": "The sentence mentions \'Egr-1\' (protein) which is a relevant entity type."},\n{"Sentence": "We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.", "Helpfulness score": 5, "Reason": "The sentence mentions \'E2A\' (protein) which is a relevant entity type."},\n{"Sentence": "This protein has now been purified and its encoding gene cloned.", "Helpfulness score": 5, "Reason": "The sentence mentions \'protein\' which is associated with \'protein\' entity type."},\n{"Sentence": "Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.", "Helpfulness score": 5, "Reason": "The sentence mentions \'Protein\' which is associated with \'protein\' entity type."},\n{"Sentence": "Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.", "Helpfulness score": 4, "Reason": "The sentence mentions \'cDNA\' (DNA), \'Jurkat\' (cell_line), and \'DRE 1\' (cell_type) which are relevant entity types."},\n{"Sentence": "Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB-induced trans-activation of the H4 promoter.", "Helpfulness score": 5, "Reason": "The sentence mentions \'ATF1\' (protein), \'CREB\' (protein), and \'H4\' (protein) which are relevant entity types."},\n{"Sentence": "Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.", "Helpfulness score": 5, "Reason": "The sentence mentions \'NF-kappaB\' (protein), \'Sp1\' (protein), and \'SIVmac\' (cell_line) which are relevant entity types."},\n{"Sentence": "Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.", "Helpfulness score": 5, "Reason": "The sentence mentions \'HIV-1 LTR\' (DNA), \'NFAT-1\' (protein), and \'NF kappa B\' (protein) which are relevant entity types."},\n{"Sentence": "We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.", "Helpfulness score": 1, "Reason": "The sentence does not contain any specific entity mentions relevant to the entity labels."},\n{"Sentence": "However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.", "Helpfulness score": 1, "Reason": "The sentence does not contain any specific entity mentions relevant to the entity labels."},\n{"Sentence": "In 2 complex translocations, none of the three genes was rearranged.", "Helpfulness score": 1, "Reason": "The sentence does not contain any specific entity mentions relevant to the entity labels."},\n{"Sentence": "Deletions or mutations in this element also reduced the serum response by 80-90%.", "Helpfulness score": 1, "Reason": "The sentence does not contain any specific entity mentions relevant to the entity labels."},\n{"Sentence": "In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.", "Helpfulness score": 1, "Reason": "The sentence does not contain any specific entity mentions relevant to the entity labels."}\n]', 'response3': '[{"cDNA": "DNA"}, {"ets-1 protein": "protein"}]', 'prediction': {'cDNA': 'DNA', 'ets-1 protein': 'protein'}}
{'idx': 6, 'sentence': 'Platelet-activating factor induces phospholipid turnover , calcium flux , arachidonic acid liberation , eicosanoid generation , and oncogene expression in a human B cell line .', 'label': {'Platelet-activating factor': 'protein', 'oncogene': 'DNA', 'human B cell line': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 4},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 4},\n    {"Example 7": 4},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 4},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 3},\n    {"Example 14": 4},\n    {"Example 15": 4},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"Platelet-activating factor": "protein"}, {"phospholipid": "protein"}, {"calcium": "protein"}, {"arachidonic acid": "protein"}, {"eicosanoid": "protein"}, {"oncogene": "protein"}, {"human B cell line": "cell_line"}]', 'prediction': {'Platelet-activating factor': 'protein', 'phospholipid': 'protein', 'calcium': 'protein', 'arachidonic acid': 'protein', 'eicosanoid': 'protein', 'oncogene': 'protein', 'human B cell line': 'cell_line'}}
{'idx': 1478, 'sentence': 'Furthermore, in activated T cells , the kinetics of the two phosphorylation events are essentially similar.', 'label': {'activated T cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n    {"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 4},\n    {"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n    {"The phosphorylated tyrosine residue itself is important for the protein-protein interaction .": 4},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .": 4},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .": 5},\n    {"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 1},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .": 5},\n    {"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .": 5},\n    {"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1793, 'sentence': 'The clinical benefits of salicylates in the treatment of several diseases, including atherosclerosis and rheumatoid arthritis , may be related to their ability to reduce monocyte gene expression .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example contains specific terms that directly correspond to entity labels in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The example contains a specific term that corresponds to an entity label in the target sentence."},\n    {"Example 3": 4},\n    {"Reason 3": "The example contains a specific term that corresponds to an entity label in the target sentence."},\n    {"Example 4": 4},\n    {"Reason 4": "The example contains a specific term that corresponds to an entity label in the target sentence."},\n    {"Example 5": 4},\n    {"Reason 5": "The example contains a specific term that corresponds to an entity label in the target sentence."},\n    {"Example 6": 4},\n    {"Reason 6": "The example contains a specific term that corresponds to an entity label in the target sentence."},\n    {"Example 7": 4},\n    {"Reason 7": "The example contains specific terms that directly correspond to entity labels in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The example contains a specific term that directly corresponds to an entity label in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The example contains specific terms that directly correspond to entity labels in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The example contains specific terms that directly correspond to entity labels in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The example contains specific terms that directly correspond to entity labels in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The example contains specific terms that directly correspond to entity labels in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The example contains specific terms that directly correspond to entity labels in the target sentence."},\n    {"Example 14": 1},\n    {"Reason 14": "The example does not contain any terms that correspond to entity labels in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The example does not contain any terms that correspond to entity labels in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain any terms that correspond to entity labels in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain any terms that correspond to entity labels in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any terms that correspond to entity labels in the target sentence."}\n]', 'response3': "[{'salicylates': 'protein'}, {'atherosclerosis': 'cell_type'}, {'rheumatoid arthritis': 'cell_type'}, {'monocyte': 'cell_type'}]", 'prediction': {'salicylates': 'protein', 'atherosclerosis': 'cell_type', 'rheumatoid arthritis': 'cell_type', 'monocyte': 'cell_type'}}
{'idx': 1473, 'sentence': 'Costimulation requirement for AP-1 and NF-kappa B transcription factor activation in T cells .', 'label': {'NF-kappa B': 'protein', 'T cells': 'cell_type', 'AP-1': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example contains specific protein names that match the entity types in the target sentence, providing direct assistance in identifying named entities."},\n    {"Example 2": 4},\n    {"Reason 2": "The example contains specific protein names that match the entity types in the target sentence, providing direct assistance in identifying named entities."},\n    {"Example 3": 5},\n    {"Reason 3": "The example contains specific protein names that match the entity types in the target sentence, providing direct assistance in identifying named entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The example contains specific protein names that match the entity types in the target sentence, providing direct assistance in identifying named entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The example contains specific protein names that match the entity types in the target sentence, providing direct assistance in identifying named entities."},\n    {"Example 6": 4},\n    {"Reason 6": "The example contains specific protein names that match the entity types in the target sentence, providing direct assistance in identifying named entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The example contains specific protein names that match the entity types in the target sentence, providing direct assistance in identifying named entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The example contains specific protein names that match the entity types in the target sentence, providing direct assistance in identifying named entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The example contains specific protein names that match the entity types in the target sentence, providing direct assistance in identifying named entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The example contains specific protein names that match the entity types in the target sentence, providing direct assistance in identifying named entities."},\n    {"Example 11": 4},\n    {"Reason 11": "The example contains specific protein names that match the entity types in the target sentence, providing direct assistance in identifying named entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The example contains specific protein names that match the entity types in the target sentence, providing direct assistance in identifying named entities."},\n    {"Example 13": 5},\n    {"Reason 13": "The example contains specific protein names that match the entity types in the target sentence, providing direct assistance in identifying named entities."},\n    {"Example 14": 5},\n    {"Reason 14": "The example contains specific protein names that match the entity types in the target sentence, providing direct assistance in identifying named entities."},\n    {"Example 15": 5},\n    {"Reason 15": "The example contains specific protein names that match the entity types in the target sentence, providing direct assistance in identifying named entities."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain any named entities matching the entity types in the target sentence, providing no assistance in identifying named entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain any named entities matching the entity types in the target sentence, providing no assistance in identifying named entities."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any named entities matching the entity types in the target sentence, providing no assistance in identifying named entities."},\n    {"Example 19": 1},\n    {"Reason 19": "The example does not contain any named entities matching the entity types in the target sentence, providing no assistance in identifying named entities."}\n]', 'response3': '[{"AP-1": "protein"}, {"NF-kappa B": "protein"}, {"T cells": "cell_type"}]', 'prediction': {'AP-1': 'protein', 'NF-kappa B': 'protein', 'T cells': 'cell_type'}}
{'idx': 539, 'sentence': 'PMA enhanced slightly the stimulatory effect of PHA .', 'label': {'PHA': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names (NF-kappa B, AP-1) that match the entity labels in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains a specific protein name (NF-E2) that matches the entity label in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains specific protein names (AP-1, PMA) and cell types (monocytes, macrophages) that match the entity labels in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains specific protein names (PAFR, PAF, NF-kappa B, protein kinase C) that match the entity labels in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains specific protein names (IL-2, NF-kappa B, AP-1) that match the entity labels in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains a specific protein name (MNDA) and a specific cell line (Philadelphia chromosome-positive chronic myeloid leukemia) that match the entity labels in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains specific protein names (Oct-2A, HMG I/Y, HLA-DRA) and a cell type (B cells) that match the entity labels in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains a specific protein name (NF-kappa B) that matches the entity label in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains a specific protein name (P selectin) that matches the entity label in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains a specific protein name (phosphocreatine) that matches the entity label in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains specific protein names (NDP kinase, KA, SCC, BCC) that match the entity labels in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains specific protein names (CD14, CD23) that match the entity labels in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains specific protein names (IL-4, LPS, AP-1) that match the entity labels in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains specific protein names (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) that match the entity labels in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains specific protein names (Epo, alpha-globin, beta-globin, haemoglobin, haemin, delta-ALA) that match the entity labels in the target sentence."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence contains specific protein names (PMA, IFN-gamma) and a cell type (T cell blasts) that match the entity labels in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entity names that match the entity labels in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entity names that match the entity labels in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entity names that match the entity labels in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entity names that match the entity labels in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1025, 'sentence': 'NK cells do not express NFATc constitutively, but NFATc mRNA accumulation is induced in these cells within 2 h of stimulation with CD16 ligands .', 'label': {'NFATc': 'protein', 'NK cells': 'cell_type', 'NFATc mRNA': 'RNA'}, 'response1': "['RNA', 'cell_type', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein entity (NF-kappa B) and its corresponding label."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides multiple examples of protein entities (NF-ATc, RelA) and cell type entities (T lymphocytes, embryonic cardiac cells) with their corresponding labels."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence provides multiple examples of protein entities (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) with their corresponding labels."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides multiple examples of protein entities (CD40, IFN-gamma, tumor necrosis factor-alpha, interleukin (IL)-1beta) with their corresponding labels."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides a clear example of a DNA entity (NF-kappa B) and its corresponding label."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides multiple examples of protein entities (NF-kappa B, I kappa B alpha) with their corresponding labels."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides multiple examples of protein entities (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) with their corresponding labels."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides multiple examples of protein entities (RelA, NF-kappa B) with their corresponding labels."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides multiple examples of protein entities (FasL, IL-2, IFN-gamma) with their corresponding labels."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides multiple examples of protein entities (NF-ATc) and cell type entities (T lymphocytes) with their corresponding labels."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides multiple examples of protein entities (NF-kappa B, I kappa B alpha) with their corresponding labels."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides multiple examples of protein entities (NF-kappa B, Tax, NF-kappaB) and cell type entities (ATL) with their corresponding labels."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides multiple examples of protein entities (STAT, STAT3) and cell type entities (T cells) with their corresponding labels."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides multiple examples of protein entities (IkappaBbeta, NF-kappaB) with their corresponding labels."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides multiple examples of protein entities (CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, granulocyte-macrophage colony-stimulating factor) with their corresponding labels."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any named entities related to the given entity labels."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any named entities related to the given entity labels."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any named entities related to the given entity labels."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any named entities related to the given entity labels."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any named entities related to the given entity labels."}\n]', 'response3': '[{"NFATc": "protein"}, {"NFATc mRNA": "RNA"}, {"NK cells": "cell_type"}, {"CD16 ligands": "protein"}]', 'prediction': {'NFATc': 'protein', 'NFATc mRNA': 'RNA', 'NK cells': 'cell_type', 'CD16 ligands': 'protein'}}
{'idx': 1560, 'sentence': 'Moreover, in human T helper (Th) clones functionally characterized as being of the type 0, type 1 and type 2 (28%, < 1% und 93% CD30+, respectively), the extent of CD30 -mediated NF-kappa B activation correlated with the proportion of CD30+ cells .', 'label': {'human T helper (Th) clones': 'cell_line', 'CD30+ cells': 'cell_line', 'CD30': 'protein', 'NF-kappa B': 'protein'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 4},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.": 4},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation.": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 4},\n    {"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.": 5},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 4},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"Th": "cell_type"}, {"CD30": "protein"}, {"NF-kappa B": "protein"}]', 'prediction': {'Th': 'cell_type', 'CD30': 'protein', 'NF-kappa B': 'protein'}}
{'idx': 365, 'sentence': 'Run-on analysis demonstrated detectable levels of c-jun gene transcription in untreated HL-60 cells , and that exposure to TPA increases this rate 3.3-fold.', 'label': {'c-jun': 'DNA', 'HL-60 cells': 'cell_line', 'untreated HL-60 cells': 'cell_line'}, 'response1': "['DNA', 'cell_type', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific gene names and proteins that are directly related to the entity labels in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions a specific protein (TCL1) that is relevant to the entity labels in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence provides information about specific proteins (p21(WAF1/CIP1) and p27(KIP1)) that are directly related to the entity labels in the target sentence."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence mentions a specific protein (ZAP-70) that is relevant to the entity labels in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains specific gene names and proteins (IL-2, c-Jun, c-Fos) that are directly related to the entity labels in the target sentence."},\n    {"Example 6": 3},\n    {"Reason 6": "The sentence mentions a specific DNA binding activity (AP-1) that is somewhat related to the entity labels in the target sentence."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence provides information about specific proteins (NF-kappaB, Tax) and a cell type (ATL) that are relevant to the entity labels in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains specific gene names, proteins, and stimuli (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) that are directly related to the entity labels in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence mentions a specific protein (TAL1) and a cell type (T-ALL) that are directly related to the entity labels in the target sentence."},\n    {"Example 10": 4},\n    {"Reason 10": "The sentence mentions a specific protein (PML/RARalpha) that is relevant to the entity labels in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains specific cell types, cell lines, gene expression, and technology (B and T cell activation, Ramos, Jurkat, cDNA microarray technology) that are directly related to the entity labels in the target sentence."},\n    {"Example 12": 4},\n    {"Reason 12": "The sentence mentions specific proteins (Tip, Tap) and a cell line (Jurkat-T cells) that are relevant to the entity labels in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains specific gene names, proteins, and a cell type (tal-1, GATA-binding proteins, hematopoiesis) that are directly related to the entity labels in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains specific proteins, transcriptional events, and regulatory factors (AP-1, c-jun, IL-2, NF-AT, T cell) that are directly related to the entity labels in the target sentence."},\n    {"Example 15": 3},\n    {"Reason 15": "The sentence mentions specific DNA binding activity (nuclear factor-kappa B, NF-kappa B) that is somewhat related to the entity labels in the target sentence."},\n    {"Example 16": 4},\n    {"Reason 16": "The sentence mentions specific proteins (TCL1, MTCP1/c6.1B) that are relevant to the entity labels in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific entities related to the entity labels in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific entities related to the entity labels in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific entities related to the entity labels in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any specific entities related to the entity labels in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1039, 'sentence': 'Peripheral blood mononuclear cells ( pbmc ) and bone marrow cells of 26 patients were examined for c-fos , c-myc , p53 and the hybrid bcr/abl mRNA levels .', 'label': {'Peripheral blood mononuclear cells': 'cell_type', 'pbmc': 'cell_type', 'bone marrow cells': 'cell_type'}, 'response1': "['RNA', 'protein']", 'response2': '[\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.": 5},\n    {"PMA induced the expression of both CD14 and CD23 mRNA and protein.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"To evaluate the PML/RARalpha role in myelopoiesis, transgenic mice expressing PML/RARalpha were engineered.": 5},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells (Daudi) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner.": 5},\n    {"These results indicate that the monocyte/B-cell-specific transcription factor PU.1 and the Mono A and Mono B protein complexes act in concert to regulate monocyte-specific transcription of the CSF-1 receptor.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"Peripheral blood mononuclear cells": "cell_type"}, {"bone marrow cells": "cell_type"}, {"c-fos": "protein"}, {"c-myc": "protein"}, {"p53": "protein"}, {"hybrid bcr/abl mRNA": "RNA"}]', 'prediction': {'Peripheral blood mononuclear cells': 'cell_type', 'bone marrow cells': 'cell_type', 'c-fos': 'protein', 'c-myc': 'protein', 'p53': 'protein', 'hybrid bcr/abl mRNA': 'RNA'}}
{'idx': 217, 'sentence': 'Quantitation of glucocorticoid receptors ( GCR ) and the study of their affinity for glucocorticosteroids ( GCS ) were made in peripheral blood lymphocytes of bronchial asthma ( BA ) patients in consideration of GCR treatment and serum levels of endogenous cortisol .', 'label': {'GCR': 'protein', 'glucocorticoid receptors': 'protein', 'peripheral blood lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 3},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 4},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.": 5},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.": 5},\n    {"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n    {"In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine (IFN-gamma) in combination with allergy-driven overproduction of T helper 2-type cytokines.": 4},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 4},\n    {"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1782, 'sentence': 'In addition, resting PBL constitutively expressed prominent levels of Id2 mRNA , but not Id3 mRNA .', 'label': {'Id3': 'protein', 'resting PBL': 'cell_type', 'Id3 mRNA': 'RNA', 'PBL': 'cell_type', 'Id2': 'protein', 'Id2 mRNA': 'RNA'}, 'response1': "['RNA']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 5},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n    {"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.": 5},\n    {"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA/NF-kappaB1 binding complexes.": 5},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti-EBV antibody titres (P > 0.05).": 5},\n    {"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells, but not in primary T cells, consistent with the lack of the IL-12 receptor in resting T cells.": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"PMA induced the expression of both CD14 and CD23 mRNA and protein.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"Id2 mRNA": "RNA"}, {"Id3 mRNA": "RNA"}]', 'prediction': {'Id2 mRNA': 'RNA', 'Id3 mRNA': 'RNA'}}
{'idx': 1280, 'sentence': "Sequence analysis of the 5'-flanking region of the CD69 gene revealed the presence of a potential TATA element 30 base pairs upstream of the major transcription initiation site and several putative binding sequences for inducible transcription factors ( NF-kappa B , Egr-1 , AP-1 ), which might mediate the inducible expression of this gene.", 'label': {'NF-kappa B': 'protein', 'TATA element': 'DNA', 'transcription factors': 'protein', 'CD69': 'protein', 'AP-1': 'protein', '30 base pairs upstream': 'DNA', 'CD69 gene': 'DNA', "5'-flanking region": 'DNA', 'transcription initiation site': 'DNA', 'Egr-1': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes": 4},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein": 5},\n{"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms": 4},\n{"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells": 5},\n{"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation": 5},\n{"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor": 5},\n{"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter": 4},\n{"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements": 5},\n{"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements": 5},\n{"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif": 4},\n{"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF": 5},\n{"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region": 5},\n{"These properties suggest that TAFII105 is a cell type-specific subunit of TFIID that may be responsible for mediating transcription by a subset of activators in B cells": 5},\n{"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B": 5},\n{"This sequence element was referred to as the BAT box and its deletion significantly reduced the activity of a CD20 promoter-CAT construct in B cells": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required": 1},\n{"In 2 complex translocations, none of the three genes was rearranged": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity": 1}\n]', 'response3': '[{"CD69 gene": "protein"}, {"TATA element": "DNA"}, {"NF-kappa B": "protein"}, {"Egr-1": "protein"}, {"AP-1": "protein"}]', 'prediction': {'CD69 gene': 'protein', 'TATA element': 'DNA', 'NF-kappa B': 'protein', 'Egr-1': 'protein', 'AP-1': 'protein'}}
{'idx': 611, 'sentence': 'Transactivation by some DNA viruses has been implicated in inducing HIV-1 replication and pathogenesis.', 'label': {}, 'response1': "['DNA', 'RNA']", 'response2': '[\n    {"TCL1": 5},\n    {"NF-kappa B": 5},\n    {"TIMP-1": 5, "DNA": 5},\n    {"AP-1": 5},\n    {"IkappaBbeta": 5, "NF-kappaB": 5},\n    {"ZAP-70": 5},\n    {"SIVsmmPBj14": 5},\n    {"hepatitis B virus": 5, "HBxAg": 5},\n    {"IFN A": 5, "IFNA": 5, "interleukin-2": 5, "interleukin-2 receptor": 5, "phytohemagglutinin": 5, "phorbol myristate acetate": 5},\n    {"TCF-1": 5},\n    {"HIV-1": 5, "IFN": 5, "PKR": 5, "IkappaBalpha": 5},\n    {"EBV": 5, "EBNA2": 5, "estrogen receptor": 5},\n    {"NF-kappaB": 5, "Sp1": 5, "SIVmac": 5},\n    {"TR55": 5, "TNF-alpha": 5, "HIV": 5},\n    {"HIV-1 LTR": 5, "NFAT-1": 5, "NF kappa B": 5},\n    {"T lymphocytes": 5, "adenovirus vectors": 5}\n]', 'response3': "[{'DNA viruses': 'DNA'}, {'HIV-1': 'cell_type'}]", 'prediction': {'DNA viruses': 'DNA', 'HIV-1': 'cell_type'}}
{'idx': 1723, 'sentence': 'In vitro treatment of a monocyte/macrophage cell line with CCl4 led to enhanced NF-kappa B binding and an increase in tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA levels .', 'label': {'tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA': 'RNA', 'NF-kappa B': 'protein', 'tumor necrosis factor-alpha': 'protein', 'TNF-alpha': 'protein'}, 'response1': "['cell_line', 'protein', 'RNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains multiple examples of proteins and cell types that are relevant to the entity labels in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence contains examples of proteins and cytokines that are relevant to the entity labels in the target sentence."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence contains examples of proteins that are relevant to the entity labels in the target sentence."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence contains examples of proteins and cell types that are relevant to the entity labels in the target sentence."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence contains examples of proteins that are relevant to the entity labels in the target sentence."},\n    {"Example 6": 3},\n    {"Reason 6": "The sentence contains an example of a protein that is relevant to the entity labels in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains multiple examples of proteins, cytokines, and cell types that are relevant to the entity labels in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains examples of proteins that are relevant to the entity labels in the target sentence."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence contains examples of proteins and cell types that are relevant to the entity labels in the target sentence."},\n    {"Example 10": 4},\n    {"Reason 10": "The sentence contains examples of proteins and cell types that are relevant to the entity labels in the target sentence."},\n    {"Example 11": 3},\n    {"Reason 11": "The sentence contains an example of DNA binding activity that is relevant to the entity labels in the target sentence."},\n    {"Example 12": 4},\n    {"Reason 12": "The sentence contains an example of protein inhibition that is relevant to the entity labels in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains examples of proteins, transcription factors, and cell types that are relevant to the entity labels in the target sentence."},\n    {"Example 14": 4},\n    {"Reason 14": "The sentence contains examples of proteins and cell types that are relevant to the entity labels in the target sentence."},\n    {"Example 15": 4},\n    {"Reason 15": "The sentence contains examples of proteins and cell types that are relevant to the entity labels in the target sentence."},\n    {"Example 16": 3},\n    {"Reason 16": "The sentence contains an example of immunomodulatory activity that is relevant to the entity labels in the target sentence."}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"TNF-alpha": "protein"}, {"RNA": "RNA"}, {"cell_line": "cell_line"}]', 'prediction': {'NF-kappa B': 'protein', 'TNF-alpha': 'protein', 'RNA': 'RNA', 'cell_line': 'cell_line'}}
{'idx': 1308, 'sentence': 'Two groups of HMG box proteins are distinguished.', 'label': {'HMG box proteins': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of HMG box proteins, which are directly relevant to the target sentence and can help in identifying proteins."},\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions cDNAs, which are relevant to DNA entities, providing a clear example for DNA extraction."},\n    {"Sentence": 4},\n    {"Reason": "The sentence refers to IgH genes, which are related to DNA entities, aiding in DNA extraction."},\n    {"Sentence": 4},\n    {"Reason": "The sentence includes specific DNA elements like CCAAT box and EKLF binding site, which are crucial for DNA entity extraction."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of specific proteins like p21(WAF1/CIP1) and p27(KIP1), directly relevant to the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains key proteins like NF-kappaB, Sp1, and p50, which are essential for protein extraction."},\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions the transcription factor NF-ATc and specific cell types like T lymphocytes and embryonic cardiac cells, aiding in protein and cell type extraction."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides a specific example of a protein, GATA-1, which is crucial for protein extraction."},\n    {"Sentence": 5},\n    {"Reason": "The sentence includes the protein EKLF, directly relevant to the target sentence and helpful for protein extraction."},\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions proteins involved in transcription, which are essential for protein extraction."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains proteins like IL-2, c-Jun, and c-Fos, which are directly relevant to the target sentence and helpful for protein extraction."},\n    {"Sentence": 5},\n    {"Reason": "The sentence refers to the protein calcineurin, which is crucial for protein extraction."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides an example of a cell line, SCM-1, which is directly relevant to the target sentence and helpful for cell line extraction."},\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions the protein A-myb, which is essential for protein extraction."},\n    {"Sentence": 5},\n    {"Reason": "The sentence includes the protein IL-4, directly relevant to the target sentence and helpful for protein extraction."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides an example of a protein, E2A, which is crucial for protein extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant entities for extraction based on the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant entities for extraction based on the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant entities for extraction based on the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant entities for extraction based on the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant entities for extraction based on the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant entities for extraction based on the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant entities for extraction based on the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant entities for extraction based on the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 765, 'sentence': 'Our results suggest that substances in serum influence steroid effects on these cells and that the molecular details of glucocorticoid hormone action may be pursued more precisely in a clearly defined culture medium.', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a cell type (B cell) and the specific context in which it is mentioned, aiding in the extraction of named entities."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence clearly mentions specific proteins (IL-5 mRNA, TCR, IL-2R, dexamethasone) and their roles in the context, making it highly helpful for extracting named entities."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence mentions a specific protein (E2A) and provides context for its study at the protein level, aiding in the extraction of named entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides multiple examples of cell types (granulocytes, T cells) and their correlation, making it very helpful for extracting named entities."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence mentions a specific protein (IL-4) and its regulation, providing helpful context for extracting named entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence mentions multiple proteins (IL-2, c-Jun, c-Fos) and their presence in a specific context, making it highly helpful for extracting named entities."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence mentions a specific protein (phosphocreatine) and its role in a study context, aiding in the extraction of named entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides clear examples of a cell line (HML) and specific proteins (dexamethasone, cortisol, lysozyme) in a study context, making it highly helpful for extracting named entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence mentions a specific protein (IFN-gamma) and its role in asthma pathogenesis, providing helpful context for extracting named entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence mentions a specific protein (NF-kappa B) and its role in a study context, making it highly helpful for extracting named entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides examples of multiple proteins (VDR, RXR, GRIP-1, DRIP205, DRIP) and their interactions, aiding in the extraction of named entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence mentions specific proteins (CD40, Rel/nuclear factor kappaB, NF-kappaB) and a cell type (B lymphocytes) in a study context, making it highly helpful for extracting named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1561, 'sentence': 'In all cell lines investigated, the NF-kappa B complexes induced following CD30 engagement were shown to contain p50 NF-kappa B1 , p65 RelA , and possibly other transcription factors .', 'label': {'CD30': 'protein', 'NF-kappa B complexes': 'protein', 'p65 RelA': 'protein', 'p50 NF-kappa B1': 'protein', 'NF-kappa B': 'protein', 'transcription factors': 'protein'}, 'response1': "['cell_line', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 4},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 4},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 3},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 5},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"p50 NF-kappa B1": "protein"}, {"p65 RelA": "protein"}]', 'prediction': {'NF-kappa B': 'protein', 'p50 NF-kappa B1': 'protein', 'p65 RelA': 'protein'}}
{'idx': 330, 'sentence': 'ZRE-B is therefore not part of the R- inducible enhancer .', 'label': {'ZRE-B': 'DNA', 'R- inducible enhancer': 'DNA'}, 'response1': 'None.', 'response2': '[\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 3},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 4},\n    {"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 2},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 3},\n    {"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 4},\n    {"Our results demonstrate that the altered CCAAT box (CCAAC) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 3},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n    {"RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA/NF-kappaB1 binding complexes.": 4},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 5},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 4},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.": 4},\n    {"Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B/Oct-1-dependent transcription.": 4},\n    {"We have found that the recruitment of EKLF to 5\'HS3 depends on the presence of 5\'HS2 in cis, but the recruitment to 5\'HS2 does not depend on 5\'HS3.": 4},\n    {"The protein from E. coli specifically converted dUTP to dUMP and did not react with other dNTPs or NTPs.": 3},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"ZRE-B": "None"}, {"R-": "None"}]', 'prediction': {'ZRE-B': 'None', 'R-': 'None'}}
{'idx': 1104, 'sentence': 'Although the interrelationship between the two messengers Ca2+ and cyclic AMP in platelet function is well documented, its mechanism of action still remains to be established.', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 4},\n    {"Example 7": 4},\n    {"Example 8": 4},\n    {"Example 9": 4},\n    {"Example 10": 4},\n    {"Example 11": 3},\n    {"Example 12": 3},\n    {"Example 13": 3},\n    {"Example 14": 3},\n    {"Example 15": 2},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1594, 'sentence': 'Human IL4 promoter -mediated transcription is downregulated in Jurkat cells stimulated with the NF-kappa B -activating cytokine tumor necrosis factor alpha and suppressed in RelA -overexpressing cells .', 'label': {'Jurkat cells': 'cell_line', 'NF-kappa B -activating cytokine': 'protein', 'Human IL4 promoter': 'DNA', 'tumor necrosis factor alpha': 'protein', 'RelA -overexpressing cells': 'cell_line', 'NF-kappa B': 'protein', 'RelA': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"1": "The sentence does not contain any named entities."},\n    {"1": "The sentence does not contain any named entities."},\n    {"5": "The sentence contains \'RelA\' and \'NF-kappa B\' which are both proteins mentioned in the target sentence."},\n    {"5": "The sentence contains \'NF-kappa B\' and \'I kappa B alpha\' which are both proteins mentioned in the target sentence."},\n    {"5": "The sentence contains \'IL4\', \'IL13\', \'STAT6\', \'STAT3\', \'STAT5\', and \'B cells\' which are all proteins or cell types mentioned in the target sentence."},\n    {"5": "The sentence contains \'IFN A\', \'IFNA\', \'interleukin-2\', \'interleukin-2 receptor\', \'phytohemagglutinin\', and \'phorbol myristate acetate\' which are all proteins mentioned in the target sentence."},\n    {"5": "The sentence contains \'IkappaBalpha\' and \'NF-kappaB\' which are both proteins mentioned in the target sentence."},\n    {"5": "The sentence contains \'NF-kappa B\' and \'I kappa B alpha\' which are both proteins mentioned in the target sentence."},\n    {"5": "The sentence contains \'IL-2\', \'IFN-gamma\', \'jak kinases\', and \'STAT1(alpha)\' which are all proteins mentioned in the target sentence."},\n    {"5": "The sentence contains \'IkappaBbeta\' and \'NF-kappaB\' which are both proteins mentioned in the target sentence."},\n    {"5": "The sentence contains \'NF-kappaB\', \'Tax\', and \'ATL\' which are all proteins or cell types mentioned in the target sentence."},\n    {"5": "The sentence contains \'HIV-1\', \'IFN\', \'PKR\', and \'IkappaBalpha\' which are all proteins or cell types mentioned in the target sentence."},\n    {"5": "The sentence contains \'CD40\', \'Rel/nuclear factor kappaB\', \'NF-kappaB\', and \'B lymphocytes\' which are all proteins or cell types mentioned in the target sentence."},\n    {"5": "The sentence contains \'YY1\', \'Oct1\', \'IL-5\', and \'T cells\' which are all proteins or cell types mentioned in the target sentence."},\n    {"5": "The sentence contains \'interleukin-2\', \'alpha chain\', \'CD25\', and \'IL-2 receptor\' which are all proteins mentioned in the target sentence."},\n    {"5": "The sentence contains \'CTLA4Ig\', \'NFAT\', and \'AP-1\' which are all proteins or cell types mentioned in the target sentence."},\n    {"1": "The sentence does not contain any named entities."},\n    {"1": "The sentence does not contain any named entities."},\n    {"1": "The sentence does not contain any named entities."},\n    {"1": "The sentence does not contain any named entities."}\n]', 'response3': '[{"Jurkat cells": "cell_line"}, {"NF-kappa B": "protein"}, {"tumor necrosis factor alpha": "protein"}, {"RelA": "protein"}]', 'prediction': {'Jurkat cells': 'cell_line', 'NF-kappa B': 'protein', 'tumor necrosis factor alpha': 'protein', 'RelA': 'protein'}}
{'idx': 1086, 'sentence': 'Analysis of the expression of human I kappa B alpha protein in stable transfectants of mouse 70Z/3 cells shows that, as for the endogenous murine protein, exogenous I kappa B alpha is degraded in response to inducers of NF-kappa B activity , such as phorbol myristate acetate or lipopolysaccharide .', 'label': {'NF-kappa B': 'protein', 'I kappa B alpha': 'protein', 'human I kappa B alpha protein': 'protein', 'mouse 70Z/3 cells': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 4},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 4},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[\n    {"I kappa B alpha": "protein"},\n    {"mouse 70Z/3 cells": "cell_line"},\n    {"NF-kappa B": "protein"},\n    {"phorbol myristate acetate": "protein"},\n    {"lipopolysaccharide": "protein"}\n]', 'prediction': {'I kappa B alpha': 'protein', 'mouse 70Z/3 cells': 'cell_line', 'NF-kappa B': 'protein', 'phorbol myristate acetate': 'protein', 'lipopolysaccharide': 'protein'}}
{'idx': 1, 'sentence': 'When the homeodomain from HB24 was compared to known mammalian and Drosophila homeodomains it was found to be only moderately conserved, but when it was compared to a highly diverged Drosophila homeodomain , H2.0, it was found to be 80% identical.', 'label': {'homeodomain': 'DNA', 'HB24': 'DNA', 'Drosophila homeodomain': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n    {"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 5},\n    {"Like Drosophila Toll, human Toll is a type I transmembrane protein with an extracellular domain consisting of a leucine-rich repeat (LRR) domain, and a cytoplasmic domain homologous to the cytoplasmic domain of the human interleukin (IL)-1 receptor.": 5},\n    {"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Our results demonstrate that the altered CCAAT box (CCAAC) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 5},\n    {"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 5},\n    {"These two related genes share the evolutionarily conserved region encoding the Runt domain.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 5},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes.": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 5},\n    {"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.": 5},\n    {"Thus, we were able to derive a hematopoietic cell line, called 47.10, that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1226, 'sentence': 'Lastly, the different mobilities of osteoblast nuclear extract-DNA complexes compared with T-cell nuclear extract-DNA complexes , along with the inability of OSF2 to be upregulated by retinoic acid , unlike the other PEBP2 alpha factors , suggest that OSF2 is a new member of this family of transcription factors .', 'label': {'transcription factors': 'protein', 'T-cell nuclear extract-DNA complexes': 'protein', 'OSF2': 'protein', 'osteoblast nuclear extract-DNA complexes': 'protein', 'PEBP2 alpha factors': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 5},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n    {"An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage.": 5},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.": 5},\n    {"The p50 and p65 proteins, constituents of the prototypic nuclear factor kappaB, were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"OSF2": "protein"}, {"PEBP2 alpha factors": "protein"}]', 'prediction': {'OSF2': 'protein', 'PEBP2 alpha factors': 'protein'}}
{'idx': 663, 'sentence': 'The cells lines described here should be useful for the delineation of signaling pathways utilized in the selective regulation of gene expression .', 'label': {}, 'response1': "['cell_line', 'gene']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of different entity types mentioned in the target sentence, such as \'protein\', \'cell_type\', and \'cell_line\', making it highly relevant for predicting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides clear examples of \'protein\', \'cell_type\', and \'cell_line\' entities, directly related to the target sentence, thus aiding in the extraction of named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence directly mentions the \'protein\' entity type, which is relevant to the target sentence, making it highly helpful for predicting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence explicitly mentions the \'cell_line\' entity type, which is relevant to the target sentence, thus aiding in the extraction of named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides a clear example of the \'cell_type\' entity type mentioned in the target sentence, making it highly relevant for predicting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence directly mentions the \'protein\' entity type, which is relevant to the target sentence, making it highly helpful for predicting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of \'protein\', \'DNA\', and \'cell_type\' entities, directly related to the target sentence, thus aiding in the extraction of named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of \'protein\' entities directly related to the target sentence, making it highly relevant for predicting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions both \'protein\' and \'cell_line\' entities, which are relevant to the target sentence, thus aiding in the extraction of named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of \'protein\' entities directly related to the target sentence, making it highly relevant for predicting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions the \'cell_type\' entity type, which is relevant to the target sentence, making it highly helpful for predicting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of \'protein\' entities directly related to the target sentence, making it highly relevant for predicting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of \'protein\' entities directly related to the target sentence, making it highly relevant for predicting named entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entity types mentioned in the target sentence, thus not helpful for predicting named entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entity types mentioned in the target sentence, thus not helpful for predicting named entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entity types mentioned in the target sentence, thus not helpful for predicting named entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entity types mentioned in the target sentence, thus not helpful for predicting named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1000, 'sentence': 'Analysis of the biochemical and cell biological properties of these HSFs reveals that HSF3 has properties in common with both HSF1 and HSF2 and yet has features which are distinct from both.', 'label': {'HSF2': 'protein', 'HSF3': 'protein', 'HSFs': 'protein', 'HSF1': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear and direct mention of the entity \'protein\' with the term \'GM-CSF\', making it highly helpful for extracting named entities."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence directly mentions specific DNA sequences \'UAS3\' and \'UAS2\' along with the protein \'YY1\', providing clear context for entity extraction."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence explicitly mentions \'Protein\' in the context of genomic sequences, aiding in the extraction of the entity."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence mentions specific proteins \'IL-2\', \'c-Jun\', and \'c-Fos\' in the context of nuclear factors, facilitating entity extraction."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence mentions the protein \'NF-ATc\' along with cell types \'T lymphocytes\' and \'embryonic cardiac cells\', providing valuable information for entity extraction."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence directly mentions the protein \'EKLF\', aiding in the extraction of this named entity."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence mentions the protein \'A-myb\' in a specific context, making it highly helpful for entity extraction."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides a direct interaction between proteins \'Tax\' and \'TFIIA\', aiding in the extraction of these entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence mentions \'cDNAs\' in the context of cloning and sequencing, making it highly relevant for entity extraction."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence mentions the protein \'GATA-1\' in the context of positive regulators, aiding in entity extraction."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides direct interactions of the protein \'EKLF\' with other proteins, making it highly helpful for entity extraction."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence mentions \'SCM-1\' in the context of genes, aiding in the extraction of the cell line entity."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence mentions the protein \'NF-E2\' in the context of a cellular differentiation program, facilitating entity extraction."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence mentions specific proteins \'p21(WAF1/CIP1)\' and \'p27(KIP1)\' in the context of mRNA and protein levels, aiding in entity extraction."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence mentions multiple isoforms of the protein \'NF-ATc\' in the context of T lymphocytes, providing valuable information for entity extraction."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence mentions the protein \'E2A\' in the context of examining gene expression at the protein level, aiding in entity extraction."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific entities related to the given entity labels, making it not helpful for entity extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not mention any specific entities related to the given entity labels, making it not helpful for entity extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific entities related to the given entity labels, making it not helpful for entity extraction."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not mention any specific entities related to the given entity labels, making it not helpful for entity extraction."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 39, 'sentence': 'Most hybrids express both KBF1 and NF-kappa B in their nuclei , but one hybrid expresses only KBF1 .', 'label': {'KBF1': 'protein', 'NF-kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with their corresponding entity labels, providing a clear and direct mapping between the entities and their types."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains a clear example of a named entity with its corresponding entity label, aiding in understanding the relationship between the entity and its type."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides multiple examples of named entities with their corresponding entity labels, helping to identify the entities and their types."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains a clear example of a named entity with its corresponding entity label, aiding in understanding the relationship between the entity and its type."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides multiple examples of named entities with their corresponding entity labels, helping to identify the entities and their types."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with their corresponding entity labels, providing a clear and direct mapping between the entities and their types."},\n    {"Sentence": 3},\n    {"Reason": "The sentence contains an example of a named entity with its corresponding entity label, but the context is less specific and may not directly aid in understanding the entity type."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels provided."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels provided."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels provided."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels provided."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels provided."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels provided."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels provided."}\n]', 'response3': "[{'KBF1': 'protein'}, {'NF-kappa B': 'protein'}]", 'prediction': {'KBF1': 'protein', 'NF-kappa B': 'protein'}}
{'idx': 229, 'sentence': "We now show that: 1) CVZ has more than one binding site in a second, independent, B-cell line , IM-9 ; 2) the antiglucocorticoid RU 38486 is able to block both CVZ 's higher and lower affinity sites; 3) all of CVZ 's binding sites are on a protein immunologically indistinguishable from the human GR ; and 4) freshly isolated clones of CVZ -resistant cells have lost all binding sites for CVZ .", 'label': {'B-cell line': 'cell_line', 'IM-9': 'cell_line', 'GR': 'protein', "CVZ 's binding sites": 'protein'}, 'response1': "['cell_line', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example contains specific terms that directly match the entity labels in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The example contains specific terms that directly match the entity labels in the target sentence, but not as directly as Example 1."},\n    {"Example 3": 4},\n    {"Reason 3": "The example contains specific terms that directly match the entity labels in the target sentence, but not as directly as Example 1."},\n    {"Example 4": 5},\n    {"Reason 4": "The example contains specific terms that directly match the entity labels in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The example contains a specific term that directly matches the entity label in the target sentence."},\n    {"Example 6": 4},\n    {"Reason 6": "The example contains specific terms that directly match the entity labels in the target sentence, but not as directly as Example 1."},\n    {"Example 7": 4},\n    {"Reason 7": "The example contains specific terms that directly match the entity labels in the target sentence, but not as directly as Example 1."},\n    {"Example 8": 5},\n    {"Reason 8": "The example contains a specific term that directly matches the entity label in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The example contains specific terms that directly match the entity labels in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The example contains specific terms that directly match the entity labels in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The example contains specific terms that directly match the entity labels in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The example contains a specific term that directly matches the entity label in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The example contains a specific term that directly matches the entity label in the target sentence."},\n    {"Example 14": 1},\n    {"Reason 14": "The example does not contain any terms that match the entity labels in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The example does not contain any terms that match the entity labels in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain any terms that match the entity labels in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain any terms that match the entity labels in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any terms that match the entity labels in the target sentence."}\n]', 'response3': "[{'CVZ': 'protein'}, {'IM-9': 'cell_line'}, {'RU 38486': 'protein'}, {'GR': 'protein'}]", 'prediction': {'CVZ': 'protein', 'IM-9': 'cell_line', 'RU 38486': 'protein', 'GR': 'protein'}}
{'idx': 743, 'sentence': 'Detection in non-erythroid cells of a factor with the binding characteristics of the erythroid cell transcription factor EF1 .', 'label': {'erythroid cell transcription factor': 'protein', 'non-erythroid cells': 'cell_type', 'EF1': 'protein'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Sentence": "SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor ).", "helpfulness score": 5, "reasons": "The sentence provides examples of proteins (SCL, GATA-1) expressed in specific cell lineages (erythroid, megakaryocyte, mast cell populations). This directly relates to the entity types mentioned in the target sentence."},\n    {"Sentence": "Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.", "helpfulness score": 4, "reasons": "The sentence mentions a protein (WT1) and its association with myeloid cell lines, which is relevant to the cell line entity type in the target sentence."},\n    {"Sentence": "Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.", "helpfulness score": 3, "reasons": "The sentence provides an example of a protein (NF-E2) involved in binding to an enhancer element, which is relevant to the protein entity type in the target sentence."},\n    {"Sentence": "It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.", "helpfulness score": 4, "reasons": "The sentence mentions a protein (RXR) and its role in supporting the outgrowth of erythroid cells, which is relevant to the protein entity type in the target sentence."},\n    {"Sentence": "The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts.", "helpfulness score": 5, "reasons": "The sentence directly mentions a protein (GATA-1) involved in erythroid development and gene regulation, which aligns with the protein entity type in the target sentence."},\n    {"Sentence": "One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.", "helpfulness score": 4, "reasons": "The sentence provides an example of a protein (Egr-1) and its association with macrophage differentiation, which is relevant to the protein entity type in the target sentence."},\n    {"Sentence": "The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.", "helpfulness score": 3, "reasons": "The sentence mentions a DNA-binding protein (AP-1) and its activity in lymphocytes, which is relevant to the DNA entity type in the target sentence."},\n    {"Sentence": "Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.", "helpfulness score": 4, "reasons": "The sentence provides an example of a protein (TCF-1) and its transactivation ability in non-T cells, which is relevant to the protein entity type in the target sentence."},\n    {"Sentence": "Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.", "helpfulness score": 5, "reasons": "The sentence directly mentions proteins (IL-2, c-Jun, c-Fos) and their binding activity in nuclear factors, aligning with the protein entity type in the target sentence."},\n    {"Sentence": "In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.", "helpfulness score": 4, "reasons": "The sentence provides an example of a protein (GATA-1) and its association with eosinophil differentiation, which is relevant to the protein entity type in the target sentence."},\n    {"Sentence": "We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF.", "helpfulness score": 5, "reasons": "The sentence directly mentions proteins (EKLF, CBP, p300, P/CAF) and their interactions, aligning with the protein entity type in the target sentence."},\n    {"Sentence": "Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.", "helpfulness score": 4, "reasons": "The sentence provides an example of a protein (SP1) and its cleavage by caspases during B-cell apoptosis, which is relevant to the protein and cell_type entity types in the target sentence."},\n    {"Sentence": "Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.", "helpfulness score": 5, "reasons": "The sentence directly mentions a protein (GATA-1) and its role as a regulator in differentiating erythroid cells, aligning with the protein entity type in the target sentence."},\n    {"Sentence": "The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.", "helpfulness score": 5, "reasons": "The sentence directly mentions a protein (NF-ATc) and its role in gene expression in T lymphocytes and embryonic cardiac cells, aligning with the protein and cell_type entity types in the target sentence."},\n    {"Sentence": "The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays.", "helpfulness score": 5, "reasons": "The sentence directly mentions proteins (p50, p65) and their involvement in DNA-protein complexes, aligning with the protein and DNA entity types in the target sentence."},\n    {"Sentence": "However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.", "helpfulness score": 5, "reasons": "The sentence directly mentions proteins (beta-globin, glycoprotein IIb, platelet factor 4) and their expression in Ter 119 erythroid cells and megakaryocytic transcripts, aligning with the protein and cell_line entity types in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1799, 'sentence': 'These STAT proteins were detected by using the IFN-gamma-activated sequence ( GAS ) and related oligonucleotides as probes in electrophoretic mobility shift assay .', 'label': {'GAS': 'DNA', 'IFN-gamma-activated sequence': 'DNA', 'STAT proteins': 'protein'}, 'response1': "['protein', 'DNA']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines.": 5},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Moreover, monocytes express a novel IL-10 -stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti- STAT3 Ab but is not observed in T cells.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"Activated Stat proteins form homo- or heterodimers, translocate to the nucleus, and induce transcription from responsive genes.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1703, 'sentence': "E1A blocked IFN 's induction of cytolytic resistance , resulting in the selective lysis of adenovirus-transformed cells by IFN -activated NK cells .", 'label': {'E1A': 'protein', 'IFN': 'protein', 'adenovirus-transformed cells': 'cell_line', 'IFN -activated NK cells': 'cell_line'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.": 4},\n    {"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells.": 5},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 4},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 4},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 3},\n    {"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.": 5},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 4},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis.": 4},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 4},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"E1A": "protein"}, {"IFN": "protein"}, {"adenovirus-transformed cells": "cell_line"}, {"NK cells": "cell_type"}]', 'prediction': {'E1A': 'protein', 'IFN': 'protein', 'adenovirus-transformed cells': 'cell_line', 'NK cells': 'cell_type'}}
{'idx': 629, 'sentence': 'Depletion of CD8+ cells was accompanied by 62 +/- 18% loss of progesterone receptor -bearing cells , while depletion of CD4+ cells resulted in a twofold increase in the number of positively staining lymphocytes .', 'label': {'progesterone receptor': 'protein', 'CD8+ cells': 'cell_line', 'lymphocytes': 'cell_line', 'progesterone receptor -bearing cells': 'cell_line', 'CD4+ cells': 'cell_line'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains multiple named entities with clear entity labels, making it highly helpful for extracting named entities."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains named entities with clear entity labels, making it highly helpful for extracting named entities."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains named entities with clear entity labels, making it highly helpful for extracting named entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains named entities with clear entity labels, making it highly helpful for extracting named entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains named entities with clear entity labels, making it highly helpful for extracting named entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains named entities with clear entity labels, making it highly helpful for extracting named entities."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence contains a named entity with a clear entity label, but the sentence is not as rich in named entities as others."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains named entities with clear entity labels, making it highly helpful for extracting named entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains named entities with clear entity labels, making it highly helpful for extracting named entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains named entities with clear entity labels, making it highly helpful for extracting named entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains named entities with clear entity labels, making it highly helpful for extracting named entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains named entities with clear entity labels, making it highly helpful for extracting named entities."},\n    {"Example 13": 4},\n    {"Reason 13": "The sentence contains a named entity with a clear entity label, but the sentence is not as rich in named entities as others."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains named entities with clear entity labels, making it highly helpful for extracting named entities."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains named entities with clear entity labels, making it highly helpful for extracting named entities."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any named entities with clear entity labels, making it not helpful for extracting named entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any named entities with clear entity labels, making it not helpful for extracting named entities."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any named entities with clear entity labels, making it not helpful for extracting named entities."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any named entities with clear entity labels, making it not helpful for extracting named entities."}\n]', 'response3': '[{"CD8+": "cell_type"}, {"progesterone receptor": "protein"}, {"CD4+": "cell_type"}, {"lymphocytes": "cell_type"}]', 'prediction': {'CD8+': 'cell_type', 'progesterone receptor': 'protein', 'CD4+': 'cell_type', 'lymphocytes': 'cell_type'}}
{'idx': 490, 'sentence': 'Cyclosporin A ( CsA ) is thought to exert its immunosuppressive effects by inhibiting the expression of a distinct set of lymphokine genes which are induced upon T-cell activation , among them the gene coding for interleukin-2 .', 'label': {'lymphokine genes': 'DNA', 'interleukin-2': 'protein'}, 'response1': "['protein', 'RNA']", 'response2': '[\n    {"Sentence": 5},\n    {"Example": 5},\n    {"Sentence": 5},\n    {"Example": 5},\n    {"Sentence": 5},\n    {"Example": 5},\n    {"Sentence": 5},\n    {"Example": 5},\n    {"Sentence": 5},\n    {"Example": 5},\n    {"Sentence": 5},\n    {"Example": 5},\n    {"Sentence": 5},\n    {"Example": 5},\n    {"Sentence": 5},\n    {"Example": 5},\n    {"Sentence": 1},\n    {"Example": 1},\n    {"Sentence": 1},\n    {"Example": 1},\n    {"Sentence": 1},\n    {"Example": 1},\n    {"Sentence": 1},\n    {"Example": 1},\n    {"Sentence": 1},\n    {"Example": 1},\n    {"Sentence": 1},\n    {"Example": 1},\n    {"Sentence": 1},\n    {"Example": 1},\n    {"Sentence": 1},\n    {"Example": 1},\n    {"Sentence": 1},\n    {"Example": 1},\n    {"Sentence": 1},\n    {"Example": 1}\n]', 'response3': '[{"CsA": "protein"}, {"lymphokine genes": "protein"}, {"T-cell": "cell_type"}, {"interleukin-2": "protein"}]', 'prediction': {'CsA': 'protein', 'lymphokine genes': 'protein', 'T-cell': 'cell_type', 'interleukin-2': 'protein'}}
{'idx': 118, 'sentence': "Similar to 1;14 translocations , this deletion disrupts the SCL 5' regulatory region .", 'label': {'SCL': 'protein', "SCL 5' regulatory region": 'DNA'}, 'response1': "['DNA']", 'response2': '[\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 3},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 4},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"We have found that the recruitment of EKLF to 5\'HS3 depends on the presence of 5\'HS2 in cis, but the recruitment to 5\'HS2 does not depend on 5\'HS3.": 4},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.": 5},\n    {"Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.": 5},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n    {"SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor).": 4},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.": 4},\n    {"By the time of diagnosis of T-PLL , the clone contains many more genetic changes in the form of additional translocations.": 4},\n    {"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 4},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"SCL": "RNA"}]', 'prediction': {'SCL': 'RNA'}}
{'idx': 493, 'sentence': 'Here we report that the formation of two distinct mitogen-inducible DNA-binding complexes , the kappa B complex within the HIV enhancer and the NFAT-1 complex within the interleukin-2 enhancer , is inhibited in the presence of CsA .', 'label': {'NFAT-1 complex': 'protein', 'mitogen-inducible DNA-binding complexes': 'protein', 'kappa B complex': 'protein', 'interleukin-2': 'protein', 'interleukin-2 enhancer': 'DNA', 'HIV enhancer': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 5},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 5},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.": 5},\n    {"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.": 5},\n    {"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.": 5},\n    {"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin.": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"kappa B complex": "protein"}, {"NFAT-1 complex": "protein"}, {"interleukin-2 enhancer": "protein"}]', 'prediction': {'kappa B complex': 'protein', 'NFAT-1 complex': 'protein', 'interleukin-2 enhancer': 'protein'}}
{'idx': 1798, 'sentence': 'In purified human peripheral blood T cells , nuclear STAT proteins were activated approximately 3 h after activation by cross-linked anti-CD3 Abs .', 'label': {'purified human peripheral blood T cells': 'cell_type', 'anti-CD3 Abs': 'protein', 'nuclear STAT proteins': 'protein', 'T cells': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains multiple protein names and a cell type, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains multiple protein names and a cell type, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains multiple protein names and a cell type, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains a protein name and a cell type, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains multiple protein names, a cell type, and a protein receptor, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains multiple protein names, a cell type, and signaling molecules, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains a cell type, proteins, and signaling molecules, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains a protein name and a cell type, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 9": 1},\n    {"Reason 9": "The sentence does not contain any named entities relevant to the entity labels in the target sentence."},\n    {"Example 10": 1},\n    {"Reason 10": "The sentence does not contain any named entities relevant to the entity labels in the target sentence."},\n    {"Example 11": 1},\n    {"Reason 11": "The sentence does not contain any named entities relevant to the entity labels in the target sentence."},\n    {"Example 12": 1},\n    {"Reason 12": "The sentence does not contain any named entities relevant to the entity labels in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains multiple protein names, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains multiple protein names and a cell type, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains multiple protein names and a cell type, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any named entities relevant to the entity labels in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any named entities relevant to the entity labels in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any named entities relevant to the entity labels in the target sentence."}\n]', 'response3': '[{"STAT proteins": "protein"}, {"T cells": "cell_type"}, {"anti-CD3 Abs": "protein"}]', 'prediction': {'STAT proteins': 'protein', 'T cells': 'cell_type', 'anti-CD3 Abs': 'protein'}}
{'idx': 175, 'sentence': 'To compare extra-renal 1,25(OH)2D3 production in different types of granulomatous disease , and to identify the cell types responsible, we have evaluated the conversion of 25(OH)D3 in 1,25(OH)2D3 by uncultured cells recovered by bronchoalveolar lavage and blood mononuclear cells from normocalcemic patients with sarcoidosis and tuberculosis.', 'label': {'blood mononuclear cells': 'cell_type', 'uncultured cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release .": 4},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .": 4},\n    {"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]": 4},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine ( IFN-gamma ) in combination with allergy-driven overproduction of T helper 2-type cytokines .": 4},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .": 4},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .": 4},\n    {"Changes in PKC isoforms in human alveolar macrophages compared with blood monocytes .": 5},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .": 4},\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .": 4},\n    {"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"bronchoalveolar lavage": "cell_type"}, {"blood mononuclear cells": "cell_type"}, {"sarcoidosis": "cell_type"}, {"tuberculosis": "cell_type"}]', 'prediction': {'bronchoalveolar lavage': 'cell_type', 'blood mononuclear cells': 'cell_type', 'sarcoidosis': 'cell_type', 'tuberculosis': 'cell_type'}}
{'idx': 1498, 'sentence': 'Steroid mediated lysis of lymphoblasts requires the DNA binding region of the steroid hormone receptor.', 'label': {'lymphoblasts': 'cell_type'}, 'response1': "['DNA', 'cell_type']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of different entity types that are explicitly mentioned and can be easily identified."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains a specific example of a protein entity that is explicitly mentioned and can be easily identified."},\n    {"Sentence": 3},\n    {"Reason": "The sentence contains a specific example of a DNA entity that is explicitly mentioned and can be easily identified."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of different entity types that are explicitly mentioned and can be easily identified."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of different entity types that are explicitly mentioned and can be easily identified."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of different entity types that are explicitly mentioned and can be easily identified."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of different entity types that are explicitly mentioned and can be easily identified."},\n    {"Sentence": 3},\n    {"Reason": "The sentence contains a specific example of a protein entity that is explicitly mentioned and can be easily identified."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of different entity types that are explicitly mentioned and can be easily identified."},\n    {"Sentence": 3},\n    {"Reason": "The sentence contains a specific example of a DNA entity that is explicitly mentioned and can be easily identified."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of the entity types present in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of the entity types present in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of the entity types present in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of the entity types present in the target sentence."}\n]', 'response3': '[{"DNA": "DNA"}, {"lymphoblasts": "cell_type"}]', 'prediction': {'DNA': 'DNA', 'lymphoblasts': 'cell_type'}}
{'idx': 995, 'sentence': 'The hierarchy of transcriptional control in B-cell development has recently been analyzed by targeted gene inactivation in the mouse .', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific gene names and their corresponding entity labels, making it highly relevant for extracting named entities."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence includes gene names and their corresponding entity labels, which are helpful for extracting named entities, but not as specific as Example 1."},\n    {"Example 3": 3},\n    {"Reason 3": "The sentence mentions a gene name and its corresponding entity label, providing some relevance for extracting named entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains a specific gene name and its corresponding entity label, making it highly relevant for extracting named entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence includes a specific gene name and its corresponding entity label, making it highly relevant for extracting named entities."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence mentions a gene name and its corresponding entity label, providing some relevance for extracting named entities, but not as specific as Example 5."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains specific gene names and their corresponding entity labels, making it highly relevant for extracting named entities."},\n    {"Example 8": 4},\n    {"Reason 8": "The sentence includes gene names and their corresponding entity labels, which are helpful for extracting named entities, but not as specific as Example 7."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains a specific gene name and its corresponding entity label, making it highly relevant for extracting named entities."},\n    {"Example 10": 4},\n    {"Reason 10": "The sentence mentions a gene name and its corresponding entity label, providing some relevance for extracting named entities, but not as specific as Example 9."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains specific gene names and their corresponding entity labels, making it highly relevant for extracting named entities."},\n    {"Example 12": 4},\n    {"Reason 12": "The sentence includes gene names and their corresponding entity labels, which are helpful for extracting named entities, but not as specific as Example 11."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains a specific gene name and its corresponding entity label, making it highly relevant for extracting named entities."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence includes a specific gene name and its corresponding entity label, making it highly relevant for extracting named entities."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains specific gene names and their corresponding entity labels, making it highly relevant for extracting named entities."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any specific gene names or entity labels, making it not helpful for extracting named entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific gene names or entity labels, making it not helpful for extracting named entities."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific gene names or entity labels, making it not helpful for extracting named entities."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific gene names or entity labels, making it not helpful for extracting named entities."}\n]', 'response3': '[{"B-cell": "cell_type"}, {"mouse": "cell_type"}]', 'prediction': {'B-cell': 'cell_type', 'mouse': 'cell_type'}}
{'idx': 1671, 'sentence': 'Both phosphorylation and proliferation were inhibited by IL-6 neutralizing antibodies .', 'label': {'IL-6 neutralizing antibodies': 'protein', 'IL-6': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities that match the entity labels in the target sentence, such as \'p21(WAF1/CIP1)\' and \'p27(KIP1)\' being labeled as \'protein\' entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains named entities like \'T cell\' and \'interleukin 2\' that match the entity labels in the target sentence, such as \'cell_type\' and \'protein\' entities."},\n    {"Sentence": 3},\n    {"Reason": "The sentence contains a named entity \'P selectin\' that matches the entity label \'protein\' in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities that match the entity labels in the target sentence, such as \'IL-4\', \'LPS\', and \'AP-1\' being labeled as \'protein\' entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities that match the entity labels in the target sentence, such as \'IL-5 mRNA\' being labeled as \'RNA\', \'TCR\' as \'cell_type\', \'IL-2R\' as \'protein\', and \'dexamethasone\' as \'protein\' entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities that match the entity labels in the target sentence, such as \'T cell\' being labeled as \'cell_type\', \'IL-2\' and \'IL-2 receptor\' as \'protein\', and \'CD28\' as \'protein\' entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains a named entity \'NF-kappa B\' that matches the entity label \'protein\' in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities that match the entity labels in the target sentence, such as \'IFN A\' and \'IFNA\' being labeled as \'protein\', \'interleukin-2\' and \'interleukin-2 receptor\' as \'protein\', and \'phytohemagglutinin\' and \'phorbol myristate acetate\' as \'protein\' entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities that match the entity labels in the target sentence, such as \'IL-2\' being labeled as \'protein\', \'Aiolos\' as \'protein\', and \'Ras\' as \'protein\' entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities that match the entity labels in the target sentence, such as \'IL4\' and \'IL13\' being labeled as \'protein\', \'gamma c chain\' as \'protein\', and \'STAT6\', \'STAT3\', and \'STAT5\' as \'protein\' entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains a named entity \'NF-E2\' that matches the entity label \'protein\' in the target sentence."},\n    {"Sentence": 3},\n    {"Reason": "The sentence contains a named entity \'DNA\' that matches the entity label \'DNA\' in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities that match the entity labels in the target sentence, such as \'IL-2\' being labeled as \'protein\', \'NF-kappa B\' as \'protein\', and \'AP-1\' as \'protein\' entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities that match the entity labels in the target sentence, such as \'NF-kappa B\' as \'protein\' and \'AP-1\' as \'protein\' entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities that match the entity labels in the target sentence, such as \'interleukin-2\' being labeled as \'protein\', \'alpha chain\' as \'protein\', \'CD25\' as \'protein\', and \'IL-2 receptor\' as \'protein\' entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains named entities like \'CTLA4Ig\', \'NFAT\', and \'AP-1\' that match the entity labels in the target sentence, such as \'protein\', \'cell_type\', and \'cell_type\' entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities that match the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities that match the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities that match the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities that match the entity labels in the target sentence."}\n]', 'response3': '[{"IL-6": "protein"}]', 'prediction': {'IL-6': 'protein'}}
{'idx': 141, 'sentence': 'TNF-alpha was able to increase expression of the HIV LTR in T cells , but in monocytic cells , TNF-alpha did not induce the HIV LTR above a constitutive level of activity .', 'label': {'monocytic cells': 'cell_type', 'TNF-alpha': 'protein', 'HIV LTR': 'DNA', 'T cells': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5},\n    {"When the same MTHC lines are exposed to TNF-alpha in combination with IFN-gamma , the cells instead become DC.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Moreover, monocytes express a novel IL-10 -stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti- STAT3 Ab but is not observed in T cells.": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process.": 5},\n    {"Interestingly, CTLA4Ig did not significantly inhibit the activation of either NF of activated T cells ( NFAT ) or AP-1 reporters.": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"Together, these findings suggest that LITAF plays an important role in the activation of the human TNF-alpha gene and proposes a new mechanism to control TNF-alpha gene expression.": 5},\n    {"Remixing of purified T cells showed that naive T cells do not suppress LAI replication in memory T cells and that memory T cells do not restore LAI expression in naive T cells.": 5},\n    {"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.": 5},\n    {"These results demonstrate the existence of a triple autoregulatory loop in monocytes and macrophages involving HIV , p105 and p50 , and MAD3 , with the end result of persistent NF-kappa B activation and viral persistence.": 5},\n    {"We conclude, rather, that alpha 4 beta 1 in freshly isolated T cells delivers a distinct signal that synergizes early with signals initiated by TCR/CD3 ligation to induce DNA binding of multiple transcription factors required for cytokine gene induction.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"TNF-alpha": "protein"}, {"HIV LTR": "DNA"}, {"T cells": "cell_type"}, {"monocytic cells": "cell_type"}]', 'prediction': {'TNF-alpha': 'protein', 'HIV LTR': 'DNA', 'T cells': 'cell_type', 'monocytic cells': 'cell_type'}}
{'idx': 1557, 'sentence': "In this report, we show that following incubation of L540 cells ( Hodgkin's disease -derived, T cell-like, CD30 + cells ) with the agonistic anti- CD30 monoclonal antibodies ( mAb ) M44 and M67 , two nuclear factor (NF)-kappa B DNA binding activities were induced in nuclear extracts , as determined in gel retardation assays .", 'label': {"Hodgkin's disease -derived, T cell-like, CD30 + cells": 'cell_line', 'nuclear factor (NF)-kappa B': 'protein', 'M44': 'protein', 'L540 cells': 'cell_line', 'M67': 'protein', 'mAb': 'protein', 'agonistic anti- CD30 monoclonal antibodies': 'protein', 'CD30': 'protein'}, 'response1': "['cell_line', 'protein', 'DNA']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"2": "The sentence does not contain any of the entity types in the label set."},\n    {"3": "The sentence contains multiple examples of protein entities and their corresponding labels, which can aid in extracting named entities from the target sentence. The examples cover a variety of proteins involved in signal transduction events and transcriptional activation."},\n    {"4": "The sentence contains an example of a protein entity and its corresponding label, which can aid in extracting named entities from the target sentence."},\n    {"5": "The sentence contains multiple examples of protein entities and their corresponding labels, which can aid in extracting named entities from the target sentence. The examples cover proteins involved in B cell activation and signal transduction."},\n    {"4": "The sentence contains multiple examples of protein entities and their corresponding labels, which can aid in extracting named entities from the target sentence. The examples cover proteins involved in immunosuppression and transcriptional activation."},\n    {"4": "The sentence contains an example of a protein entity and its corresponding label, which can aid in extracting named entities from the target sentence."},\n    {"4": "The sentence contains an example of a protein entity and its corresponding label, which can aid in extracting named entities from the target sentence."},\n    {"5": "The sentence contains multiple examples of protein entities and their corresponding labels, which can aid in extracting named entities from the target sentence. The examples cover proteins involved in B cell differentiation and signaling."},\n    {"4": "The sentence contains multiple examples of protein entities and their corresponding labels, which can aid in extracting named entities from the target sentence. The examples cover proteins involved in viral infection and signaling."},\n    {"4": "The sentence contains multiple examples of protein entities and their corresponding labels, which can aid in extracting named entities from the target sentence. The examples cover proteins involved in viral infection and signaling."},\n    {"5": "The sentence contains multiple examples of protein entities and their corresponding labels, which can aid in extracting named entities from the target sentence. The examples cover proteins involved in signal transduction events and transcriptional activation."},\n    {"5": "The sentence contains multiple examples of protein entities and their corresponding labels, which can aid in extracting named entities from the target sentence. The examples cover proteins involved in signal transduction events and transcriptional activation."},\n    {"5": "The sentence contains multiple examples of protein entities and their corresponding labels, which can aid in extracting named entities from the target sentence. The examples cover proteins involved in signal transduction events and transcriptional activation."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."}\n]', 'response3': '[{"L540 cells": "cell_line"}, {"Hodgkin\'s disease": "cell_type"}, {"T cell-like": "cell_type"}, {"CD30": "protein"}, {"NF-kappa B": "DNA"}, {"M44": "protein"}, {"M67": "protein"}]', 'prediction': {'L540 cells': 'cell_line', "Hodgkin's disease": 'cell_type', 'T cell-like': 'cell_type', 'CD30': 'protein', 'NF-kappa B': 'DNA', 'M44': 'protein', 'M67': 'protein'}}
{'idx': 1090, 'sentence': 'Further analysis reveals that the inducible phosphorylation of I kappa B alpha maps to two serines in the N terminus of the protein (residues 32 and 36) and that the mutation of either residue is sufficient to abolish ligand-induced degradation, whereas both residues must be mutated to abolish inducible phosphorylation of the protein.', 'label': {'N terminus': 'protein', 'I kappa B alpha': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 1, "Helpfulness score": 5, "Reason": "The sentence contains multiple protein names that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 2, "Helpfulness score": 4, "Reason": "The sentence mentions NF-kappa B, which is relevant to the entity label \'protein\' in the target sentence."},\n    {"Sentence": 3, "Helpfulness score": 5, "Reason": "The sentence contains protein names like IL-2, c-Jun, and c-Fos which are relevant to the entity labels in the target sentence."},\n    {"Sentence": 4, "Helpfulness score": 4, "Reason": "The sentence mentions RelA and NF-kappa B, which are relevant to the entity label \'protein\' in the target sentence."},\n    {"Sentence": 5, "Helpfulness score": 5, "Reason": "The sentence contains protein names like IL-2, Aiolos, and Ras which are relevant to the entity labels in the target sentence."},\n    {"Sentence": 6, "Helpfulness score": 4, "Reason": "The sentence mentions Syk, Zap, and T cell, which are relevant to the entity labels in the target sentence."},\n    {"Sentence": 7, "Helpfulness score": 5, "Reason": "The sentence contains protein names like p21(WAF1/CIP1) and p27(KIP1) which are relevant to the entity labels in the target sentence."},\n    {"Sentence": 8, "Helpfulness score": 4, "Reason": "The sentence mentions T cell and interleukin 2, which are relevant to the entity labels in the target sentence."},\n    {"Sentence": 9, "Helpfulness score": 5, "Reason": "The sentence contains protein names like PAFR, PAF, NF-kappa B, and protein kinase C which are relevant to the entity labels in the target sentence."},\n    {"Sentence": 10, "Helpfulness score": 5, "Reason": "The sentence contains protein names like TRAF6 and RANKL which are relevant to the entity labels in the target sentence."},\n    {"Sentence": 11, "Helpfulness score": 1, "Reason": "The sentence mentions DNA, which is not relevant to the entity labels in the target sentence."},\n    {"Sentence": 12, "Helpfulness score": 4, "Reason": "The sentence mentions NF-kappaB, Tax, and ATL, which are relevant to the entity labels in the target sentence."},\n    {"Sentence": 13, "Helpfulness score": 5, "Reason": "The sentence contains protein names like NF-kappa B and I kappa B beta which are relevant to the entity labels in the target sentence."},\n    {"Sentence": 14, "Helpfulness score": 5, "Reason": "The sentence contains protein names like CD40 and NF-kappa B which are relevant to the entity labels in the target sentence."},\n    {"Sentence": 15, "Helpfulness score": 3, "Reason": "The sentence mentions tyrosine, which is relevant to the entity label \'protein\' in the target sentence."},\n    {"Sentence": 16, "Helpfulness score": 1, "Reason": "The sentence does not contain any relevant entity labels to the target sentence."},\n    {"Sentence": 17, "Helpfulness score": 1, "Reason": "The sentence does not contain any relevant entity labels to the target sentence."},\n    {"Sentence": 18, "Helpfulness score": 1, "Reason": "The sentence does not contain any relevant entity labels to the target sentence."},\n    {"Sentence": 19, "Helpfulness score": 1, "Reason": "The sentence does not contain any relevant entity labels to the target sentence."},\n    {"Sentence": 20, "Helpfulness score": 1, "Reason": "The sentence does not contain any relevant entity labels to the target sentence."}\n]', 'response3': '[{"I kappa B alpha": "protein"}]', 'prediction': {'I kappa B alpha': 'protein'}}
{'idx': 1568, 'sentence': 'The inverse relation between high density lipoprotein ( HDL ) and atherosclerotic events may in part be due to enzymes associated with HDL that destroy the biologically active lipids generated in LDL .', 'label': {'enzymes': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example contains a specific protein entity that is directly mentioned in the sentence, making it highly relevant for extracting named entities."},\n    {"Example 2": 4},\n    {"Reason 2": "The example contains a specific protein entity that is directly mentioned in the sentence, which is helpful for extracting named entities."},\n    {"Example 3": 5},\n    {"Reason 3": "The examples contain multiple specific protein entities that are directly mentioned in the sentence, making them highly relevant for extracting named entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The example contains multiple specific protein entities and a cell line entity that are directly mentioned in the sentence, making it highly relevant for extracting named entities."},\n    {"Example 5": 4},\n    {"Reason 5": "The example contains a specific protein entity that is directly mentioned in the sentence, which is helpful for extracting named entities."},\n    {"Example 6": 4},\n    {"Reason 6": "The example contains a specific protein entity that is directly mentioned in the sentence, which is helpful for extracting named entities."},\n    {"Example 7": 3},\n    {"Reason 7": "The example contains a specific DNA entity that is directly mentioned in the sentence, providing some relevance for extracting named entities."},\n    {"Example 8": 4},\n    {"Reason 8": "The example contains a specific protein entity that is directly mentioned in the sentence, which is helpful for extracting named entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The example contains multiple specific protein entities, a cell line entity, and a DNA entity that are directly mentioned in the sentence, making them highly relevant for extracting named entities."},\n    {"Example 10": 4},\n    {"Reason 10": "The example contains a specific protein entity that is directly mentioned in the sentence, which is helpful for extracting named entities."},\n    {"Example 11": 3},\n    {"Reason 11": "The example contains a specific cell type entity that is directly mentioned in the sentence, providing some relevance for extracting named entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The example contains multiple specific protein entities that are directly mentioned in the sentence, making them highly relevant for extracting named entities."},\n    {"Example 13": 3},\n    {"Reason 13": "The example contains a specific DNA entity that is directly mentioned in the sentence, providing some relevance for extracting named entities."},\n    {"Example 14": 3},\n    {"Reason 14": "The example contains specific cell type entities that are directly mentioned in the sentence, providing some relevance for extracting named entities."},\n    {"Example 15": 1},\n    {"Reason 15": "The example does not contain any specific entities mentioned in the sentence, hence not very helpful for extracting named entities."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain any specific entities mentioned in the sentence, hence not very helpful for extracting named entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain any specific entities mentioned in the sentence, hence not very helpful for extracting named entities."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any specific entities mentioned in the sentence, hence not very helpful for extracting named entities."}\n]', 'response3': "[{'HDL': 'protein'}, {'LDL': 'protein'}]", 'prediction': {'HDL': 'protein', 'LDL': 'protein'}}
{'idx': 257, 'sentence': 'Because of the presence of a functional receptor-effector system for VD3 and multiple biological responses to the hormone, these cells provide a unique model system with which to probe the specific effects of VD3 on cell growth and differentiation in chronic myelogenous leukemia .', 'label': {}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells": 5},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures": 5},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors": 4},\n    {"An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage": 4},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained": 5},\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia": 5},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction": 5},\n    {"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function": 5},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells": 5},\n    {"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R )": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 262, 'sentence': 'This complementary DNA encoded a protein with structural similarities to the c-jun proto-oncogene product , and its target sequence was closely related to the palindromic target sequence of c-jun .', 'label': {'complementary DNA': 'DNA', 'c-jun proto-oncogene product': 'protein', 'palindromic target sequence': 'DNA', 'c-jun': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 5},\n{"Here we examined the regulatory mechanism of the SCM-1 genes.": 1},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"These two related genes share the evolutionarily conserved region encoding the Runt domain.": 5},\n{"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n{"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.": 5},\n{"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n{"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 5},\n{"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n{"This protein has now been purified and its encoding gene cloned.": 5},\n{"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 5},\n{"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 5},\n{"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 5},\n{"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n{"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"complementary DNA": "DNA"}, {"protein": "protein"}, {"c-jun": "protein"}]', 'prediction': {'complementary DNA': 'DNA', 'protein': 'protein', 'c-jun': 'protein'}}
{'idx': 1351, 'sentence': 'Western blotting yielded a set of bands ranging from 25 kD to 55 kD, resulting from extensive alternative splicing .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"25 kD": "protein"}, {"55 kD": "protein"}]', 'prediction': {'25 kD': 'protein', '55 kD': 'protein'}}
{'idx': 973, 'sentence': 'To assess the transcription regulatory function of MZF-1 , the full-length MZF-1 coding region was fused to the DNA binding domain of the yeast transactivator GAL4 .', 'label': {'MZF-1': 'DNA', 'DNA binding domain': 'protein', 'yeast transactivator GAL4': 'protein', 'GAL4': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a cell line (SCM-1) in the context of examining regulatory mechanisms of genes."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions a specific protein (p50p50) in the context of binding efficiency and mutation effects."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence discusses transgenic mice expressing a specific protein (PML/RARalpha) in the context of evaluating its role in myelopoiesis."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides multiple examples of proteins (EKLF, CBP, p300, P/CAF) involved in transcription factor interactions."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence mentions a specific protein (GATA-1) as a positive regulator of lineage-specific transcription factor in erythroid cells."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence discusses the transactivation ability of a specific protein (TCF-1) in non-T cells."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence mentions a specific protein (ZEBRA) in the context of transactivation."},\n    {"Example 8": 4},\n    {"Reason 8": "The sentence discusses a specific protein (A-myb) with a restricted pattern of expression and a specific role in transcription."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence mentions proteins involved in transcription based on similarities in sequences."},\n    {"Example 10": 4},\n    {"Reason 10": "The sentence mentions a specific protein (CD95 ligand) in the context of a luciferase reporter construct."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides examples of proteins (Tax, TFIIA) interacting in a yeast two-hybrid system."},\n    {"Example 12": 4},\n    {"Reason 12": "The sentence mentions a specific protein (Egr-1) as a zinc finger transcription factor expressed upon macrophage differentiation."},\n    {"Example 13": 4},\n    {"Reason 13": "The sentence discusses proteins (IL-2, c-Jun, c-Fos) involved in binding to the IL-2 promoter."},\n    {"Example 14": 4},\n    {"Reason 14": "The sentence mentions a specific protein (GATA-1) required for erythroid development and gene regulation."},\n    {"Example 15": 4},\n    {"Reason 15": "The sentence discusses the expression of a specific protein (E2A) at the protein level."},\n    {"Example 16": 4},\n    {"Reason 16": "The sentence mentions transcription factors (Sp1, Ets) in maintaining gene expression."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not provide any specific examples of named entities related to the entity labels in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not provide any specific examples of named entities related to the entity labels in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not provide any specific examples of named entities related to the entity labels in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not provide any specific examples of named entities related to the entity labels in the target sentence."}\n]', 'response3': '[{"MZF-1": "protein"}, {"DNA": "DNA"}, {"GAL4": "protein"}]', 'prediction': {'MZF-1': 'protein', 'DNA': 'DNA', 'GAL4': 'protein'}}
{'idx': 1125, 'sentence': 'This indicates that the CR of GR may be of functional significance.', 'label': {'GR': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The example provides a clear entity-label mapping for \'immunoglobulin kappa 3\' enhancer\' as \'DNA\', which directly aids in extracting named entities from the target sentence."},\n\n{"Example 2": 4},\n{"Reason 2": "The example provides entity-label mappings for \'MNDA\' as \'protein\' and \'Philadelphia chromosome-positive chronic myeloid leukemia\' as \'cell_line\', which are relevant to the target sentence and help in identifying named entities."},\n\n{"Example 3": 4},\n{"Reason 3": "The example provides entity-label mappings for \'IL-7R\' and \'gamma(c)\' as \'protein\', which are directly related to the target sentence and assist in recognizing named entities."},\n\n{"Example 4": 5},\n{"Reason 4": "The example provides entity-label mappings for \'granulocytes\' and \'T cells\' as \'cell_type\', which are explicitly mentioned in the target sentence, aiding in extracting named entities."},\n\n{"Example 5": 5},\n{"Reason 5": "The example provides a clear entity-label mapping for \'Protein\' as \'protein\', which directly assists in identifying named entities from the target sentence."},\n\n{"Example 6": 4},\n{"Reason 6": "The example provides an entity-label mapping for \'GM-CSF\' as \'protein\', which is relevant to the target sentence and helps in recognizing named entities."},\n\n{"Example 7": 4},\n{"Reason 7": "The example provides an entity-label mapping for \'G-CSF\' as \'protein\', which is directly related to the target sentence and aids in identifying named entities."},\n\n{"Example 8": 5},\n{"Reason 8": "The example provides an entity-label mapping for \'SIVsmmPBj14\' as \'cell_line\', which is explicitly mentioned in the target sentence, aiding in extracting named entities."},\n\n{"Example 9": 4},\n{"Reason 9": "The example provides entity-label mappings for \'IL-2\', \'c-Jun\', and \'c-Fos\' as \'protein\', which are directly related to the target sentence and help in recognizing named entities."},\n\n{"Example 10": 5},\n{"Reason 10": "The example provides entity-label mappings for \'CREB\' and \'AR-CRE\' as \'protein\', which are explicitly mentioned in the target sentence, aiding in extracting named entities."},\n\n{"Example 11": 5},\n{"Reason 11": "The example provides entity-label mappings for \'CHEMR1\', \'C-C chemokine\', and \'MIP-1alpha\' as \'protein\', which are directly related to the target sentence and assist in recognizing named entities."},\n\n{"Example 12": 5},\n{"Reason 12": "The example provides an entity-label mapping for \'lymphoid neoplasms\' as \'cell_type\', which is explicitly mentioned in the target sentence, aiding in extracting named entities."},\n\n{"Example 13": 5},\n{"Reason 13": "The example provides an entity-label mapping for \'SCM-1\' as \'cell_line\', which is directly related to the target sentence and helps in identifying named entities."},\n\n{"Example 14": 5},\n{"Reason 14": "The example provides an entity-label mapping for \'SCL\' as \'RNA\', which is explicitly mentioned in the target sentence, aiding in extracting named entities."},\n\n{"Example 15": 5},\n{"Reason 15": "The example provides an entity-label mapping for \'RXR\' as \'protein\', which is directly related to the target sentence and assists in recognizing named entities."},\n\n{"Example 16": 5},\n{"Reason 16": "The example provides entity-label mappings for \'VDR\', \'RXR\', \'GRIP-1\', and \'DRIP205\' as \'protein\', which are explicitly mentioned in the target sentence, aiding in extracting named entities."},\n\n{"Example 17": 1},\n{"Reason 17": "The example does not contain any named entities relevant to the target sentence, hence not helpful in extracting named entities."},\n\n{"Example 18": 1},\n{"Reason 18": "The example does not contain any named entities relevant to the target sentence, hence not helpful in extracting named entities."},\n\n{"Example 19": 1},\n{"Reason 19": "The example does not contain any named entities relevant to the target sentence, hence not helpful in extracting named entities."},\n\n{"Example 20": 1},\n{"Reason 20": "The example does not contain any named entities relevant to the target sentence, hence not helpful in extracting named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 338, 'sentence': 'Nuclear T3R in lymphocytes was determined by radio-ligand binding analysis .', 'label': {'T3R': 'protein', 'lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 1},\n    {"Example 9": 1},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1080, 'sentence': 'However, the concurrent addition of iron (in the form of ferrous or ferric chloride and other iron salts ) reversed the inhibition of proliferation caused by tepoxalin .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not contain any entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not contain any entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities with clear entity labels that match the entity types in the target sentence."}\n]', 'response3': '[{"iron": "protein"}, {"ferrous": "protein"}, {"ferric chloride": "protein"}, {"iron salts": "protein"}, {"tepoxalin": "protein"}]', 'prediction': {'iron': 'protein', 'ferrous': 'protein', 'ferric chloride': 'protein', 'iron salts': 'protein', 'tepoxalin': 'protein'}}
{'idx': 1786, 'sentence': 'Binding of plasma Factor VII/VIIa to the tissue factor (TF) receptor initiates the coagulation protease cascades .', 'label': {'coagulation protease': 'protein', 'tissue factor (TF) receptor': 'protein', 'plasma Factor VII/VIIa': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 1},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"Factor VII/VIIa": "protein"}, {"tissue factor (TF) receptor": "protein"}]', 'prediction': {'Factor VII/VIIa': 'protein', 'tissue factor (TF) receptor': 'protein'}}
{'idx': 1242, 'sentence': 'LPS signaling was found to involve NF kappa B activation by the p50/p65 heterodimers .', 'label': {'NF kappa B': 'protein', 'p50/p65 heterodimers': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence 1": 5},\n    {"Sentence 2": 5},\n    {"Sentence 3": 5},\n    {"Sentence 4": 5},\n    {"Sentence 5": 5},\n    {"Sentence 6": 5},\n    {"Sentence 7": 5},\n    {"Sentence 8": 5},\n    {"Sentence 9": 5},\n    {"Sentence 10": 5},\n    {"Sentence 11": 5},\n    {"Sentence 12": 5},\n    {"Sentence 13": 5},\n    {"Sentence 14": 5},\n    {"Sentence 15": 5},\n    {"Sentence 16": 1},\n    {"Sentence 17": 1},\n    {"Sentence 18": 1},\n    {"Sentence 19": 1},\n    {"Sentence 20": 1}\n]', 'response3': '[{"NF kappa B": "protein"}, {"p50": "protein"}, {"p65": "protein"}]', 'prediction': {'NF kappa B': 'protein', 'p50': 'protein', 'p65': 'protein'}}
{'idx': 866, 'sentence': 'T cell activation results in high levels of HIV replication and is thought to be one mechanism leading to the conversion from latent to active viral infection .', 'label': {'T cell': 'cell_type'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with their corresponding labels, making it highly helpful for extracting named entities from the target sentence."}\n]', 'response3': '[{"T cell": "cell_type"}, {"HIV": "cell_type"}]', 'prediction': {'T cell': 'cell_type', 'HIV': 'cell_type'}}
{'idx': 433, 'sentence': 'Competition experiments did not reveal any high-affinity binding site for BSAP in known regulatory regions of immunoglobulin and class II major histocompatibility (MHC) genes , suggesting that BSAP is a regulator of a different set of B-lymphoid-specific genes .', 'label': {'regulatory regions': 'DNA', 'BSAP': 'protein', 'high-affinity binding site': 'DNA', 'B-lymphoid-specific genes': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 5},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"BSAP": "protein"}, {"immunoglobulin": "protein"}, {"class II major histocompatibility (MHC) genes": "DNA"}, {"B-lymphoid-specific genes": "cell_type"}]', 'prediction': {'BSAP': 'protein', 'immunoglobulin': 'protein', 'class II major histocompatibility (MHC) genes': 'DNA', 'B-lymphoid-specific genes': 'cell_type'}}
{'idx': 1546, 'sentence': 'Identification of essential GATA and Ets binding motifs within the promoter of the platelet glycoprotein Ib alpha gene .', 'label': {'platelet glycoprotein Ib alpha gene': 'DNA', 'GATA': 'DNA', 'Ets binding motifs': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides specific entities mentioned in the sentence with their corresponding labels, which directly aids in identifying named entities in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The example includes entities mentioned in the sentence with their corresponding labels, which are relevant for extracting named entities in the target sentence."},\n    {"Example 3": 3},\n    {"Reason 3": "The example includes an entity mentioned in the sentence with its corresponding label, which is somewhat relevant for extracting named entities in the target sentence."},\n    {"Example 4": 2},\n    {"Reason 4": "The example includes an entity mentioned in the sentence with its corresponding label, which is minimally relevant for extracting named entities in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides specific entities mentioned in the sentence with their corresponding labels, which directly aids in identifying named entities in the target sentence."},\n    {"Example 6": 4},\n    {"Reason 6": "The example includes entities mentioned in the sentence with their corresponding labels, which are relevant for extracting named entities in the target sentence."},\n    {"Example 7": 4},\n    {"Reason 7": "The example includes an entity mentioned in the sentence with its corresponding label, which is relevant for extracting named entities in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides specific entities mentioned in the sentence with their corresponding labels, which directly aids in identifying named entities in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides specific entities mentioned in the sentence with their corresponding labels, which directly aids in identifying named entities in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides specific entities mentioned in the sentence with their corresponding labels, which directly aids in identifying named entities in the target sentence."},\n    {"Example 11": 4},\n    {"Reason 11": "The example includes entities mentioned in the sentence with their corresponding labels, which are relevant for extracting named entities in the target sentence."},\n    {"Example 12": 4},\n    {"Reason 12": "The example includes an entity mentioned in the sentence with its corresponding label, which is relevant for extracting named entities in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides specific entities mentioned in the sentence with their corresponding labels, which directly aids in identifying named entities in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The example provides specific entities mentioned in the sentence with their corresponding labels, which directly aids in identifying named entities in the target sentence."},\n    {"Example 15": 3},\n    {"Reason 15": "The example includes an entity mentioned in the sentence with its corresponding label, which is somewhat relevant for extracting named entities in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not include any entities mentioned in the sentence with their corresponding labels, hence not helpful in extracting named entities in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not include any entities mentioned in the sentence with their corresponding labels, hence not helpful in extracting named entities in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not include any entities mentioned in the sentence with their corresponding labels, hence not helpful in extracting named entities in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The example does not include any entities mentioned in the sentence with their corresponding labels, hence not helpful in extracting named entities in the target sentence."}\n]', 'response3': '[{"GATA": "protein"}, {"Ets": "protein"}]', 'prediction': {'GATA': 'protein', 'Ets': 'protein'}}
{'idx': 1412, 'sentence': 'We found that these parameters were indistinguishable for one of the PRL- and IL-2- induced factors .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example with a specific gene name and its corresponding entity label, which is helpful for understanding the relationship between the gene and the entity type."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains multiple gene names and their corresponding entity labels, providing valuable information for identifying protein entities."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence includes gene names and their corresponding entity labels, aiding in the recognition of protein entities involved in the analysis."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence presents cell type names and their corresponding entity labels, assisting in the identification of cell type entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides gene names and their corresponding entity labels, helping in recognizing protein entities and cell type entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains gene names and their corresponding entity labels, aiding in the identification of protein entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence includes gene names and their corresponding entity labels, assisting in the recognition of protein entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence presents cell type names and their corresponding entity labels, aiding in the identification of cell type entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides gene names and their corresponding entity labels, helping in recognizing protein entities and cell type entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains gene names and their corresponding entity labels, aiding in the identification of protein entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence includes gene names and their corresponding entity labels, assisting in the recognition of protein entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides gene names and their corresponding entity labels, helping in recognizing protein entities."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains gene names and their corresponding entity labels, aiding in the identification of protein entities."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence presents cell type names and their corresponding entity labels, aiding in the identification of cell type entities."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides gene names and their corresponding entity labels, helping in recognizing protein entities and cell type entities."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any specific gene names or entity labels, making it less helpful for entity extraction."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not include any gene names or entity labels, providing no information for entity extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific gene names or entity labels, making it less helpful for entity extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not include any gene names or entity labels, providing no information for entity extraction."}\n]', 'response3': "[{'PRL-': 'protein'}, {'IL-2-': 'protein'}]", 'prediction': {'PRL-': 'protein', 'IL-2-': 'protein'}}
{'idx': 411, 'sentence': 'There was a significant positive correlation between VDR concentration and serum phosphate (P less than 0.05).', 'label': {'VDR': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 4},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 4},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 4},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.": 5},\n    {"Both haemin and delta-ALA caused a de novo increase in alpha-globin expression as well as enhancing Epo-induced beta-globin expression, leading to a marked increase in haemoglobin production.": 5},\n    {"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 4},\n    {"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.": 5},\n    {"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.": 4},\n    {"The affinity of the BAT box binding proteins for the BAT box was approximately 25-fold less than for the octamer sequence and the BAT box binding proteins dissociated from the BAT box 10-fold more rapidly than from the octamer sequence.": 5}\n]', 'response3': '[{"VDR": "protein"}, {"serum phosphate": "protein"}]', 'prediction': {'VDR': 'protein', 'serum phosphate': 'protein'}}
{'idx': 1460, 'sentence': 'In contrast, in a number of multiple myeloma cell lines , representing differentiated, plasma cell-like B cells , PU.1 DNA binding activity , mRNA expression , and Pu box -dependent transactivation were absent or detectable at a very low level.', 'label': {'multiple myeloma cell lines': 'cell_line', 'PU.1': 'protein', 'Pu box': 'DNA', 'differentiated, plasma cell-like B cells': 'cell_type'}, 'response1': "['cell_line', 'DNA', 'RNA', 'protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities relevant to the entity labels in the target sentence, such as IL-2 receptor alpha subunit, p21ras, and B cell, providing a diverse set of entities for extraction."},\n    {"Sentence": 4},\n    {"Reason": "The sentence includes examples of named entities like myeloperoxidase, lysozyme, and PU.1, which are relevant to the entity labels in the target sentence, aiding in the extraction of protein entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions RelA and NF-kappa B, which are relevant protein entities in the context of the target sentence, contributing to the extraction of protein entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of DNA entities like UAS3 and UAS2, as well as a protein entity YY1, which are relevant to the entity labels in the target sentence, assisting in the extraction of DNA and protein entities."},\n    {"Sentence": 3},\n    {"Reason": "The sentence contains an example of the protein entity PML/RARalpha, which is relevant to the entity labels in the target sentence, aiding in the extraction of protein entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence includes examples of named entities like WT1 and myeloid cell lines, which are relevant to the entity labels in the target sentence, assisting in the extraction of protein and cell_line entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of named entities such as CD70, B cell, plasma cells, IL-4, and CD40, which are relevant to the entity labels in the target sentence, offering a diverse set of entities for extraction."},\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions IL-2, c-Jun, and c-Fos, which are relevant protein entities in the context of the target sentence, contributing to the extraction of protein entities."},\n    {"Sentence": 3},\n    {"Reason": "The sentence contains an example of the DNA entity AP-1, which is relevant to the entity labels in the target sentence, aiding in the extraction of DNA entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence includes examples of named entities like IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, and phorbol myristate acetate, which are relevant to the entity labels in the target sentence, assisting in the extraction of protein entities."},\n    {"Sentence": 3},\n    {"Reason": "The sentence provides an example of the protein entity GATA-1, which is relevant to the entity labels in the target sentence, aiding in the extraction of protein entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions AP-1, PMA, monocytes, and macrophages, which are relevant entities in the context of the target sentence, contributing to the extraction of protein and cell_type entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of named entities like EBNA-2 and PU.1, which are relevant to the entity labels in the target sentence, providing a diverse set of entities for extraction."},\n    {"Sentence": 4},\n    {"Reason": "The sentence includes examples of named entities like Sp1 and CD14, which are relevant to the entity labels in the target sentence, assisting in the extraction of protein entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of named entities such as MNDA and Philadelphia chromosome-positive chronic myeloid leukemia, which are relevant to the entity labels in the target sentence, aiding in the extraction of protein and cell_line entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions UAS1 and B cell, which are relevant entities in the context of the target sentence, contributing to the extraction of cell_line and cell_type entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, making it less helpful for entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, making it less helpful for entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, making it less helpful for entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, making it less helpful for entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, making it less helpful for entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, making it less helpful for entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, making it less helpful for entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, making it less helpful for entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, making it less helpful for entity extraction."}\n]', 'response3': '[{"PU.1": "protein"}, {"mRNA": "RNA"}]', 'prediction': {'PU.1': 'protein', 'mRNA': 'RNA'}}
{'idx': 638, 'sentence': 'Thus the VLA-5 fibronectin receptor on CD4 cells can play a complementary role in CD3 - TCR -mediated signal transduction through its interaction with fibronectin .', 'label': {'CD3': 'protein', 'TCR': 'protein', 'VLA-5 fibronectin receptor': 'protein', 'fibronectin': 'protein', 'CD4 cells': 'cell_line'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence provides examples of proteins that are relevant to the entity types in the target sentence, although not as directly matching as Example 1."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence directly mentions specific proteins and a cell type that match the entity types in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains specific protein names and a cell type that align with the entity types in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides examples of proteins and a cell type that are directly relevant to the entity types in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence directly mentions specific proteins and a cell type that match the entity types in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains specific protein names and a cell type that align with the entity types in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence directly mentions specific proteins that match the entity types in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides examples of proteins that are directly relevant to the entity types in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains specific protein names that directly match the entity types in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence directly mentions specific proteins that align with the entity types in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides examples of proteins that are directly relevant to the entity types in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence directly mentions specific proteins and a cell type that match the entity types in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains specific protein names that align with the entity types in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any entity names or labels that match the entity types in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entity names or labels that match the entity types in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entity names or labels that match the entity types in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entity names or labels that match the entity types in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entity names or labels that match the entity types in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1375, 'sentence': 'We have analyzed the expression of TCL1 mRNA and protein in peripheral blood lymphocytes ( PBLs ) from four AT cases and from healthy controls .', 'label': {'PBLs': 'cell_type', 'peripheral blood lymphocytes': 'cell_type', 'TCL1 mRNA': 'RNA', 'protein': 'protein'}, 'response1': "['RNA', 'protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein (TCL1) being expressed."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides multiple examples of proteins (IL-2, c-Jun, c-Fos) being mentioned."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence directly mentions a cell line (SCM-1)."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence directly mentions a DNA entity (AP-1)."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides examples of proteins (NF-kappaB, Tax) and a cell type (ATL) being mentioned."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides examples of a protein (TAL1) and a cell type (T-ALL) being mentioned."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides examples of proteins (SCL, GATA-1) being expressed."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides examples of proteins (SLAP-130, SLP-76) and a cell type (T cell) being mentioned."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence directly mentions a protein entity (E2A)."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides examples of a protein (MNDA) and a cell line (Philadelphia chromosome-positive chronic myeloid leukemia) being expressed."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides examples of proteins (TCRzeta, p56(lck)) being detected."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides examples of cell types (granulocytes, T cells) being mentioned."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence directly mentions a protein entity (WT1)."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides examples of proteins (CD70, IL-4, CD40) and cell types (B cell, plasma cells) being mentioned."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides examples of cell types (B and T cell activation, B lymphocytes) and proteins (CD40, Rel/nuclear factor kappaB, NF-kappaB) being mentioned."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any named entities relevant to the entity labels."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any named entities relevant to the entity labels."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any named entities relevant to the entity labels."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any named entities relevant to the entity labels."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any named entities relevant to the entity labels."}\n]', 'response3': '[{"TCL1": "protein"}, {"PBLs": "cell_type"}, {"AT": "cell_type"}]', 'prediction': {'TCL1': 'protein', 'PBLs': 'cell_type', 'AT': 'cell_type'}}
{'idx': 764, 'sentence': 'The increased sensitivity of CEM-C7 cells and its subclones to dexamethasone in serum-free medium returned to previous levels when these cells were recultured in serum-containing medium .', 'label': {'CEM-C7': 'cell_line', 'CEM-C7 cells': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .": 4},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 4},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .": 4},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release .": 4},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 4},\n    {"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .": 4},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .": 4},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice .": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 897, 'sentence': 'The system is based on the use of an oligomerized NFAT-1 binding motif that directs transcription of SV40 T-antigen in transgenic mice .', 'label': {'transcription of SV40 T-antigen': 'protein', 'NFAT-1': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with their corresponding entity labels, providing a clear and direct mapping."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides a clear example of a named entity with its corresponding entity label, aiding in understanding the relationship between the entity and its label."},\n    {"Sentence": 4},\n    {"Reason": "The sentence directly mentions a named entity with its corresponding entity label, facilitating the extraction process."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of named entities with their corresponding entity labels, aiding in understanding the relationship between the entities and their labels."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides clear examples of named entities with their corresponding entity labels, aiding in understanding the relationship between the entities and their labels."},\n    {"Sentence": 4},\n    {"Reason": "The sentence directly mentions a named entity with its corresponding entity label, facilitating the extraction process."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides a clear example of a named entity with its corresponding entity label, aiding in understanding the relationship between the entity and its label."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with their corresponding entity labels, providing a clear and direct mapping."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides a clear example of a named entity with its corresponding entity label, aiding in understanding the relationship between the entity and its label."},\n    {"Sentence": 4},\n    {"Reason": "The sentence directly mentions a named entity with its corresponding entity label, facilitating the extraction process."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides a clear example of a named entity with its corresponding entity label, aiding in understanding the relationship between the entity and its label."},\n    {"Sentence": 4},\n    {"Reason": "The sentence directly mentions a named entity with its corresponding entity label, facilitating the extraction process."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides a clear example of a named entity with its corresponding entity label, aiding in understanding the relationship between the entity and its label."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels in the target sentence."}\n]', 'response3': '[{"NFAT-1": "protein"}, {"SV40 T-antigen": "protein"}]', 'prediction': {'NFAT-1': 'protein', 'SV40 T-antigen': 'protein'}}
{'idx': 1842, 'sentence': 'Individually or collectively, none of the three enhancer-binding proteins ( LEF-1 , Ets-1 , and TFE-3 ) could activate transcription in the absence of Sp1 .', 'label': {'Ets-1': 'protein', 'TFE-3': 'protein', 'LEF-1': 'protein', 'enhancer-binding proteins': 'protein', 'Sp1': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of proteins (NF-kB, AP-1, OCT-1, NF-IL-2B) which are relevant to the entity labels in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions a specific protein (GATA-1) which is relevant to the entity labels in the target sentence."},\n    {"Sentence": 3},\n    {"Reason": "The sentence includes a cell type (T cell) and a protein (interleukin 2) which are relevant to the entity labels in the target sentence."},\n    {"Sentence": 2},\n    {"Reason": "The sentence mentions a protein (PU.1), a protein (M-CSF receptor), and a cell type (macrophage) which are relevant to the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence contains examples of proteins (NF-kappaB, Sp1, p50) which are relevant to the entity labels in the target sentence."}\n]', 'response3': '[{"LEF-1": "protein"}, {"Ets-1": "protein"}, {"TFE-3": "protein"}, {"Sp1": "protein"}]', 'prediction': {'LEF-1': 'protein', 'Ets-1': 'protein', 'TFE-3': 'protein', 'Sp1': 'protein'}}
{'idx': 1059, 'sentence': 'Transcription factors belonging to the NF-kappa B family are controlled by inhibitory I kappa B proteins , mainly I kappa B alpha and I kappa B beta .', 'label': {'NF-kappa B family': 'protein', 'Transcription factors': 'protein', 'I kappa B beta': 'protein', 'inhibitory I kappa B proteins': 'protein', 'I kappa B alpha': 'protein', 'NF-kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific entities (NF-kappaB, Tax, ATL) that are directly related to the entity labels in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence contains specific entities (NF-ATc, T lymphocytes) that are directly related to the entity labels in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains specific entities (NF-kappa B, I kappa B alpha) that are directly related to the entity labels in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains specific entities (NF-kappa B, I kappa B beta) that are directly related to the entity labels in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains specific entities (IkappaBalpha, NF-kappaB) that are directly related to the entity labels in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains specific entities (IkappaBbeta, NF-kappaB) that are directly related to the entity labels in the target sentence."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence contains specific entities (NF-ATc, T lymphocytes, embryonic cardiac cells) that are directly related to the entity labels in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains specific entities (NF-kappa B, AP-1) that are directly related to the entity labels in the target sentence."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence contains specific entities (NF-kappaB, rheumatoid arthritis) that are directly related to the entity labels in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains specific entities (NF-kappaB, Sp1, p50) that are directly related to the entity labels in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains specific entities (NF-kB, AP-1, OCT-1, NF-IL-2B) that are directly related to the entity labels in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains specific entities (RelA, NF-kappa B) that are directly related to the entity labels in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains specific entities (PAFR, PAF, NF-kappa B, protein kinase C) that are directly related to the entity labels in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains specific entities (NF-kappa B, I kappa B alpha) that are directly related to the entity labels in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains specific entities (NF-kappa B) that are directly related to the entity labels in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entities related to the entity labels in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities related to the entity labels in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities related to the entity labels in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities related to the entity labels in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities related to the entity labels in the target sentence."}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"I kappa B": "protein"}, {"I kappa B alpha": "protein"}, {"I kappa B beta": "protein"}]', 'prediction': {'NF-kappa B': 'protein', 'I kappa B': 'protein', 'I kappa B alpha': 'protein', 'I kappa B beta': 'protein'}}
{'idx': 924, 'sentence': 'We conclude that p56 exists in cytosol in a higher order complex containing hsp70 and hsp90 , both of which in turn have been found to be associated with untransformed steroid receptors .', 'label': {'hsp70': 'protein', 'untransformed steroid receptors': 'protein', 'hsp90': 'protein', 'p56': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Sentence": 4},\n    {"Sentence": 4},\n    {"Sentence": 4},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 4},\n    {"Sentence": 5},\n    {"Sentence": 4},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 1},\n    {"Sentence": 1},\n    {"Sentence": 1},\n    {"Sentence": 1}\n]', 'response3': '[{"p56": "protein"}, {"hsp70": "protein"}, {"hsp90": "protein"}, {"steroid receptors": "protein"}]', 'prediction': {'p56': 'protein', 'hsp70': 'protein', 'hsp90': 'protein', 'steroid receptors': 'protein'}}
{'idx': 247, 'sentence': 'Antigen B27 seems to be a cause of lower levels of glucocorticoid receptors in blood lymphocytes .', 'label': {'Antigen B27': 'protein', 'glucocorticoid receptors': 'protein', 'blood lymphocytes': 'cell_type', 'lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.": 4},\n    {"Benzene toxicity towards lymphocytes is thought to be mediated by metabolites of benzene including benzoquinone ( BQ ).": 4},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.": 5},\n    {"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes.": 4},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 4},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 4},\n    {"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.": 4},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.": 5},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms.": 4},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 4},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"Antigen B27": "protein"}, {"glucocorticoid receptors": "protein"}, {"blood lymphocytes": "cell_type"}]', 'prediction': {'Antigen B27': 'protein', 'glucocorticoid receptors': 'protein', 'blood lymphocytes': 'cell_type'}}
{'idx': 507, 'sentence': 'Thus, the transcriptional activity of TCF-1 alpha appears to depend on the TCF-2 alpha and T alpha 1 ( CREB ) transcription factors and the context of its binding site within the TCR alpha enhancer .', 'label': {'TCF-2 alpha': 'protein', 'TCR alpha enhancer': 'DNA', 'CREB': 'protein', 'transcription factors': 'protein', 'T alpha 1': 'protein', 'TCR': 'protein', 'TCF-1 alpha': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 5},\n    {"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 5},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 4},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n    {"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n    {"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.": 5},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system.": 5},\n    {"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 5},\n    {"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes.": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.": 5},\n    {"While the activation of the IL-2 promoter and an NFAT -driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418, it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2 -mediated NFAT activation is under the control of a combination of calcineurin- dependent and independent pathways.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"TCF-1 alpha": "protein"}, {"TCF-2 alpha": "protein"}, {"T alpha 1": "protein"}, {"CREB": "protein"}, {"TCR alpha enhancer": "DNA"}]', 'prediction': {'TCF-1 alpha': 'protein', 'TCF-2 alpha': 'protein', 'T alpha 1': 'protein', 'CREB': 'protein', 'TCR alpha enhancer': 'DNA'}}
{'idx': 460, 'sentence': "To characterize these regulatory elements further, mutations in these regions were inserted into both the 5' and 3' HIV LTRs and infectious proviral constructs were assembled.", 'label': {'HIV LTRs': 'DNA', 'regulatory elements': 'DNA'}, 'response1': "['DNA', 'RNA']", 'response2': '[\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 5},\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 5},\n    {"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 5},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes.": 5},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 5},\n    {"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements.": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 131, 'sentence': 'Truncation of TR alpha 1 at amino acid 210 prevented additional complex formation in the presence of NE without affecting DNA binding , suggesting that the carboxyl-terminus of the TRs is essential for interaction with nuclear proteins .', 'label': {'TRs': 'protein', 'carboxyl-terminus': 'protein', 'TR alpha 1': 'protein', 'nuclear proteins': 'protein', 'amino acid 210': 'protein'}, 'response1': "['protein', 'DNA']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains specific protein names that are mentioned in the entity label set, making it highly relevant for named entity extraction."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains specific protein names that are mentioned in the entity label set, making it highly relevant for named entity extraction."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains specific protein names that are mentioned in the entity label set, making it highly relevant for named entity extraction."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains a specific protein name that is mentioned in the entity label set, making it highly relevant for named entity extraction."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains a specific protein name that is mentioned in the entity label set, making it highly relevant for named entity extraction."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains specific protein names that are mentioned in the entity label set, making it highly relevant for named entity extraction."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains specific protein names that are mentioned in the entity label set, making it highly relevant for named entity extraction."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains specific protein names that are mentioned in the entity label set, making it highly relevant for named entity extraction."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains specific protein names that are mentioned in the entity label set, making it highly relevant for named entity extraction."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains specific protein names that are mentioned in the entity label set, making it highly relevant for named entity extraction."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains a specific protein name that is mentioned in the entity label set, making it highly relevant for named entity extraction."}\n]\n[\n    {"Sentence": 1},\n    {"Reason": "The sentence mentions a DNA-binding activity but does not provide specific DNA entity names, making it less helpful for named entity extraction."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains specific protein names that are mentioned in the entity label set, making it highly relevant for named entity extraction."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains specific protein names and a DNA entity name that are mentioned in the entity label set, making it highly relevant for named entity extraction."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains specific protein names and DNA entity names that are mentioned in the entity label set, making it highly relevant for named entity extraction."}\n]\n[\n    {"Sentence": 1},\n    {"Reason": "The sentence does not mention any specific entity names from the entity label set, making it less helpful for named entity extraction."}\n]\n[\n    {"Sentence": 1},\n    {"Reason": "The sentence does not mention any specific entity names from the entity label set, making it less helpful for named entity extraction."}\n]\n[\n    {"Sentence": 1},\n    {"Reason": "The sentence does not mention any specific entity names from the entity label set, making it less helpful for named entity extraction."}\n]\n[\n    {"Sentence": 1},\n    {"Reason": "The sentence does not mention any specific entity names from the entity label set, making it less helpful for named entity extraction."}\n]', 'response3': "[{'TR alpha 1': 'protein'}, {'NE': 'cell_line'}, {'DNA': 'DNA'}]", 'prediction': {'TR alpha 1': 'protein', 'NE': 'cell_line', 'DNA': 'DNA'}}
{'idx': 692, 'sentence': 'The human T-cell leukemia virus type I ( HTLV-I ) promoter contains three copies of imperfect repeats of a 21-base pair sequence designated here as TRE ( Tax -response element ) that is responsive to the virally encoded transactivator protein Tax .', 'label': {'virally encoded transactivator protein': 'protein', 'Tax -response element': 'DNA', 'TRE': 'DNA', 'human T-cell leukemia virus type I ( HTLV-I ) promoter': 'DNA', 'Tax': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 5},\n{"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.": 5},\n{"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .": 4},\n{"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .": 5},\n{"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .": 5},\n{"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n{"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .": 5},\n{"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n{"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 5},\n{"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .": 4},\n{"Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB- induced trans-activation of the H4 promoter .": 5},\n{"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .": 5},\n{"Expression of tal-1 and GATA-binding proteins during human hematopoiesis .": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"HTLV-I": "cell_type"}, {"TRE": "DNA"}, {"Tax": "protein"}]', 'prediction': {'HTLV-I': 'cell_type', 'TRE': 'DNA', 'Tax': 'protein'}}
{'idx': 43, 'sentence': 'T-helper-cell determinants in protein antigens are preferentially located in cysteine-rich antigen segments resistant to proteolytic cleavage by cathepsin B , L , and D .', 'label': {'cysteine-rich antigen segments': 'protein', 'T-helper-cell determinants': 'protein', 'protein antigens': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities (proteins and cell types) that are directly mentioned and can be easily identified."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of a specific protein and a cell line, aiding in the extraction of these entities from the text."},\n    {"Sentence": 3},\n    {"Reason": "The sentence mentions a specific cell type, which is helpful for identifying cell type entities in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions a specific protein, aiding in the extraction of protein entities from the text."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities (proteins) that are directly mentioned and can be easily identified."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of specific proteins and a cell type, aiding in the extraction of these entities from the text."},\n    {"Sentence": 3},\n    {"Reason": "The sentence mentions a specific protein, which is helpful for identifying protein entities in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of specific proteins, aiding in the extraction of protein entities from the text."},\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions a specific protein and cell types, aiding in the extraction of these entities from the text."},\n    {"Sentence": 3},\n    {"Reason": "The sentence mentions specific cell types, which is helpful for identifying cell type entities in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of specific cell types and proteins, aiding in the extraction of these entities from the text."},\n    {"Sentence": 3},\n    {"Reason": "The sentence mentions specific cell types, which is helpful for identifying cell type entities in the target sentence."},\n    {"Sentence": 3},\n    {"Reason": "The sentence mentions a specific protein, which is helpful for identifying protein entities in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities that are relevant to the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities that are relevant to the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities that are relevant to the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities that are relevant to the target sentence."}\n]', 'response3': '[{"T-helper-cell": "cell_type"}, {"protein": "protein"}, {"cathepsin B": "protein"}, {"cathepsin L": "protein"}, {"cathepsin D": "protein"}]', 'prediction': {'T-helper-cell': 'cell_type', 'protein': 'protein', 'cathepsin B': 'protein', 'cathepsin L': 'protein', 'cathepsin D': 'protein'}}
{'idx': 1204, 'sentence': 'Hirsutism , graded by the modified Ferriman-Gallwey score , and hormonal parameters were evaluated basally and at 4-month intervals during treatment.', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a clear and specific entity label that directly corresponds to the named entity in the sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The example provides a specific entity label that corresponds to the named entity in the sentence, but it requires some context to determine the exact entity type."},\n    {"Example 3": 5},\n    {"Reason 3": "The example provides multiple specific entity labels that directly correspond to the named entities in the sentence."},\n    {"Example 4": 4},\n    {"Reason 4": "The example provides a specific entity label that corresponds to the named entity in the sentence, but it requires some context to determine the exact entity type."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides a clear and specific entity label that directly corresponds to the named entity in the sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The example provides a clear and specific entity label that directly corresponds to the named entity in the sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The example provides multiple clear and specific entity labels that directly correspond to the named entities in the sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides a clear and specific entity label that directly corresponds to the named entity in the sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides multiple clear and specific entity labels that directly correspond to the named entities in the sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides multiple clear and specific entity labels that directly correspond to the named entities in the sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The example provides multiple clear and specific entity labels that directly correspond to the named entities in the sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The example provides multiple clear and specific entity labels that directly correspond to the named entities in the sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides multiple clear and specific entity labels that directly correspond to the named entities in the sentence."},\n    {"Example 14": 3},\n    {"Reason 14": "The example provides specific entity labels that correspond to the named entities in the sentence, but the context is needed to determine the exact entity type."},\n    {"Example 15": 1},\n    {"Reason 15": "The example provides a specific entity label that corresponds to the named entity in the sentence, but it requires additional context to determine the exact entity type."},\n    {"Example 16": 1},\n    {"Reason 16": "The example provides a specific entity label that corresponds to the named entity in the sentence, but it requires additional context to determine the exact entity type."},\n    {"Example 17": 1},\n    {"Reason 17": "The example provides a specific entity label that corresponds to the named entity in the sentence, but it requires additional context to determine the exact entity type."},\n    {"Example 18": 1},\n    {"Reason 18": "The example provides a specific entity label that corresponds to the named entity in the sentence, but it requires additional context to determine the exact entity type."},\n    {"Example 19": 1},\n    {"Reason 19": "The example provides a specific entity label that corresponds to the named entity in the sentence, but it requires additional context to determine the exact entity type."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1134, 'sentence': 'Reverse transcriptase (RT) assays were positive in purified viral material from both LCLs .', 'label': {'LCLs': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 4},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 5},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 5},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis.": 4},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 4},\n    {"In addition, assay of PBMC by the adenovirus -specific PCR may help detect early invasive disease and warrants further evaluation.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 4},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process.": 4},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"LCLs": "cell_line"}]', 'prediction': {'LCLs': 'cell_line'}}
{'idx': 471, 'sentence': 'The lymphocyte nuclear T3 receptor was found with an affinity close to that of normal volunteers (Ka: 1.42 x 10(10) M-1 vs 1.95 +/- 0.35 x 10(10) M-1) and a binding capacity markedly increased (9.9 vs 3.7 +/- 0.4 fmol T3 /100 micrograms DNA).', 'label': {'lymphocyte nuclear T3 receptor': 'protein'}, 'response1': "['protein', 'DNA']", 'response2': '[\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 3},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 3},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.": 4},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 4},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"T3 receptor": "protein"}, {"DNA": "DNA"}]', 'prediction': {'T3 receptor': 'protein', 'DNA': 'DNA'}}
{'idx': 1205, 'sentence': 'Gonadotropin-releasing hormone and ACTH stimulation tests were performed before and after 3 to 4 months of therapy .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides multiple examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence provides an example of a named entity with its corresponding entity label, which is helpful for extracting named entities from the target sentence."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence provides multiple examples of named entities with their corresponding entity labels, which is helpful for extracting named entities from the target sentence."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence provides an example of a named entity with its corresponding entity label, which is helpful for extracting named entities from the target sentence."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence provides an example of a named entity with its corresponding entity label, which is helpful for extracting named entities from the target sentence."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence provides multiple examples of named entities with their corresponding entity labels, which is helpful for extracting named entities from the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides multiple examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."},\n    {"Example 8": 3},\n    {"Reason 8": "The sentence provides an example of a named entity with its corresponding entity label, but the relevance to the target sentence is not as direct as other examples."},\n    {"Example 9": 3},\n    {"Reason 9": "The sentence provides an example of a named entity with its corresponding entity label, but the relevance to the target sentence is not as direct as other examples."},\n    {"Example 10": 4},\n    {"Reason 10": "The sentence provides multiple examples of named entities with their corresponding entity labels, which is helpful for extracting named entities from the target sentence."},\n    {"Example 11": 4},\n    {"Reason 11": "The sentence provides multiple examples of named entities with their corresponding entity labels, which is helpful for extracting named entities from the target sentence."},\n    {"Example 12": 4},\n    {"Reason 12": "The sentence provides multiple examples of named entities with their corresponding entity labels, which is helpful for extracting named entities from the target sentence."},\n    {"Example 13": 4},\n    {"Reason 13": "The sentence provides multiple examples of named entities with their corresponding entity labels, which is helpful for extracting named entities from the target sentence."},\n    {"Example 14": 4},\n    {"Reason 14": "The sentence provides multiple examples of named entities with their corresponding entity labels, which is helpful for extracting named entities from the target sentence."},\n    {"Example 15": 3},\n    {"Reason 15": "The sentence provides an example of a named entity with its corresponding entity label, but the relevance to the target sentence is not as direct as other examples."},\n    {"Example 16": 3},\n    {"Reason 16": "The sentence provides an example of a named entity with its corresponding entity label, but the relevance to the target sentence is not as direct as other examples."},\n    {"Example 17": 3},\n    {"Reason 17": "The sentence provides an example of a named entity with its corresponding entity label, but the relevance to the target sentence is not as direct as other examples."},\n    {"Example 18": 3},\n    {"Reason 18": "The sentence provides an example of a named entity with its corresponding entity label, but the relevance to the target sentence is not as direct as other examples."},\n    {"Example 19": 3},\n    {"Reason 19": "The sentence provides an example of a named entity with its corresponding entity label, but the relevance to the target sentence is not as direct as other examples."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 14, 'sentence': 'Moreover, platelet-activating factor was capable of inducing transcription of the nuclear proto-oncogenes c-fos and c-jun .', 'label': {'c-fos': 'DNA', 'nuclear proto-oncogenes': 'DNA', 'c-jun': 'DNA', 'platelet-activating factor': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a clear mapping between the entities in the sentence and their corresponding entity labels, making it highly helpful for extracting named entities."},\n    {"Example 2": 5},\n    {"Reason 2": "The example accurately identifies the entities in the sentence and their corresponding entity labels, aiding in the extraction of named entities."},\n    {"Example 3": 5},\n    {"Reason 3": "The example correctly maps the entities in the sentence to their respective entity labels, facilitating the extraction of named entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The example provides a precise mapping between the entities in the sentence and their corresponding entity labels, aiding in the extraction of named entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The example accurately identifies the entities in the sentence and their corresponding entity labels, making it highly helpful for extracting named entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The example correctly maps the entities in the sentence to their respective entity labels, facilitating the extraction of named entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The example provides a clear mapping between the entities in the sentence and their corresponding entity labels, aiding in the extraction of named entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The example accurately identifies the entities in the sentence and their corresponding entity labels, making it highly helpful for extracting named entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The example correctly maps the entities in the sentence to their respective entity labels, facilitating the extraction of named entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides a precise mapping between the entities in the sentence and their corresponding entity labels, aiding in the extraction of named entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The example accurately identifies the entities in the sentence and their corresponding entity labels, making it highly helpful for extracting named entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The example correctly maps the entities in the sentence to their respective entity labels, facilitating the extraction of named entities."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides a clear mapping between the entities in the sentence and their corresponding entity labels, aiding in the extraction of named entities."},\n    {"Example 14": 1},\n    {"Reason 14": "The example does not contain any entities that match the entity labels provided, hence it is not helpful for extracting named entities."},\n    {"Example 15": 1},\n    {"Reason 15": "The example does not contain any entities that match the entity labels provided, hence it is not helpful for extracting named entities."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain any entities that match the entity labels provided, hence it is not helpful for extracting named entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain any entities that match the entity labels provided, hence it is not helpful for extracting named entities."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any entities that match the entity labels provided, hence it is not helpful for extracting named entities."}\n]', 'response3': '[{"c-fos": "protein"}, {"c-jun": "protein"}]', 'prediction': {'c-fos': 'protein', 'c-jun': 'protein'}}
{'idx': 145, 'sentence': 'Two consensus sequences, called X and Y boxes , capable of binding nuclear proteins and regulating expression in B cells have been defined within the immediate upstream region of major histocompatibility complex (MHC) class II promoters .', 'label': {'nuclear proteins': 'protein', 'major histocompatibility complex (MHC) class II promoters': 'DNA', 'B cells': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 4},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 4},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n    {"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements.": 4},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.": 5},\n    {"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"X boxes": "protein"}, {"Y boxes": "protein"}, {"B cells": "cell_type"}, {"major histocompatibility complex (MHC) class II promoters": "DNA"}]', 'prediction': {'X boxes': 'protein', 'Y boxes': 'protein', 'B cells': 'cell_type', 'major histocompatibility complex (MHC) class II promoters': 'DNA'}}
{'idx': 1449, 'sentence': 'DNA binding specificity of complex 3 overlaps with that of upstream stimulatory factor but is clearly distinct.', 'label': {'upstream stimulatory factor': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"A-myb": 5},\n    {"Protein": 5},\n    {"NF-kappa B": 5, "AP-1": 5},\n    {"UAS3": 4, "UAS2": 4, "YY1": 5},\n    {"UAS1": 4, "B cell": 4},\n    {"DNA": 5},\n    {"NF-ATc": 5, "T lymphocytes": 4, "embryonic cardiac cells": 4},\n    {"PU.1": 5, "M-CSF receptor": 5, "macrophage": 4},\n    {"T cell": 4, "interleukin 2": 5},\n    {"EKLF": 5, "CBP": 5, "p300": 5, "P/CAF": 5},\n    {"RelA": 5, "NF-kappaB1": 5},\n    {"immunoglobulin kappa 3\' enhancer": 5},\n    {"NF-kappa B": 5},\n    {"NF-kappaB": 5, "Sp1": 5, "p50": 5},\n    {"Jun": 5, "ATF-2": 5},\n    {"p50p50": 5}\n]', 'response3': '[{"DNA": "DNA"}]', 'prediction': {'DNA': 'DNA'}}
{'idx': 1292, 'sentence': "Promoter function of the 5' flanking region of the thromboxane receptor gene was evaluated by transfection of thromboxane receptor gene promoter/ chloramphenicol acetyltransferase ( CAT ) chimera plasmids into platelet-like K562 cells .", 'label': {'thromboxane receptor': 'protein', 'thromboxane receptor gene': 'DNA', 'CAT': 'protein', 'chloramphenicol acetyltransferase': 'protein', "5' flanking region": 'DNA', 'thromboxane receptor gene promoter/ chloramphenicol acetyltransferase ( CAT ) chimera plasmids': 'DNA', 'K562 cells': 'cell_line'}, 'response1': "['DNA', 'protein', 'cell_line']", 'response2': '[\n    {"1": "The sentence does not contain any named entities."},\n    {"2": "The sentence does not contain any named entities."},\n    {"3": "The sentence does not contain any named entities."},\n    {"4": "The sentence contains multiple protein entities (Stat3, Stat5, c-Mpl) which are relevant to the entity labels provided."},\n    {"5": "The sentence contains the protein entity \'TCF-1\' which is relevant to the entity labels provided."},\n    {"6": "The sentence contains multiple protein entities (PAFR, PAF, NF-kappa B, protein kinase C) which are relevant to the entity labels provided."},\n    {"7": "The sentence contains multiple protein entities (Sp1, CD14) which are relevant to the entity labels provided."},\n    {"8": "The sentence contains the protein entity \'E2A\' which is relevant to the entity labels provided."},\n    {"9": "The sentence contains multiple protein entities (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) which are relevant to the entity labels provided."},\n    {"10": "The sentence contains the protein entity \'CD95 ligand\' which is relevant to the entity labels provided."},\n    {"11": "The sentence contains the cell line entity \'SCM-1\' which is relevant to the entity labels provided."},\n    {"12": "The sentence contains multiple cell line entities (Ramos, Jurkat) and the DNA entity \'cDNA microarray technology\' which are relevant to the entity labels provided."},\n    {"13": "The sentence contains multiple protein entities (Ter 119, beta-globin, glycoprotein IIb, platelet factor 4) and the cell line entity \'Ter 119\' which are relevant to the entity labels provided."},\n    {"14": "The sentence contains multiple protein entities (ATF1, CREB, H4) which are relevant to the entity labels provided."},\n    {"15": "The sentence contains the DNA entity \'BAT box\', the protein entity \'CD20\', and the cell type entity \'B cells\' which are relevant to the entity labels provided."},\n    {"16": "The sentence contains multiple DNA entities (IL-2, NFAT), protein entities (NFAT delta418, calcineurin, Tpl-2, cyclosporin A) which are relevant to the entity labels provided."},\n    {"17": "The sentence does not contain any named entities."},\n    {"18": "The sentence does not contain any named entities."},\n    {"19": "The sentence does not contain any named entities."},\n    {"20": "The sentence does not contain any named entities."}\n]', 'response3': '[{"thromboxane receptor gene": "protein"}, {"thromboxane receptor gene promoter": "protein"}, {"chloramphenicol acetyltransferase (CAT)": "protein"}, {"K562 cells": "cell_line"}]', 'prediction': {'thromboxane receptor gene': 'protein', 'thromboxane receptor gene promoter': 'protein', 'chloramphenicol acetyltransferase (CAT)': 'protein', 'K562 cells': 'cell_line'}}
{'idx': 120, 'sentence': 'Two other T cell lines , CEM and RPMI 8402 , have essentially identical deletions.', 'label': {'RPMI 8402': 'cell_line', 'T cell lines': 'cell_line', 'CEM': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 3},\n    {"These two related genes share the evolutionarily conserved region encoding the Runt domain.": 4},\n    {"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 5},\n    {"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.": 5},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 4},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 4},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"CEM": "cell_line"}, {"RPMI 8402": "cell_line"}]', 'prediction': {'CEM': 'cell_line', 'RPMI 8402': 'cell_line'}}
{'idx': 468, 'sentence': 'A 52-year-old male presented himself with tachycardia crises which appeared first during childhood, increased in frequency without goiter or exophthalmos .', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 5},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 5},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms.": 4},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 4},\n    {"By the time of diagnosis of T-PLL, the clone contains many more genetic changes in the form of additional translocations.": 4},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 4},\n    {"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 4},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"Expression of tal-1 and GATA-binding proteins during human hematopoiesis.": 5},\n    {"Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1/c6.1B, in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients.": 5},\n    {"Initiation of proliferation but not of differentiation was followed by a 20- to 25-fold increase in the nuclear level of the DNA polymerase-associated processivity factor PCNA and of the proliferation-specific transcription factor E2F1.": 5},\n    {"A total of 37 chronic, severe, nonsmoking asthmatic patients with documented reversible airways obstruction were classified as glucocorticoid-sensitive or -resistant on the basis of changes in FEV1, FVC, and peak expiratory flow (PEF) after oral prednisolone.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 138, 'sentence': 'The effects of TNF-alpha on gene expression were examined by transient expression assays using reporter chloramphenicol acetyltransferase plasmids linked to regulatory elements from the HIV long terminal repeat ( LTR ) and the beta interferon promoter .', 'label': {'beta interferon promoter': 'DNA', 'regulatory elements': 'DNA', 'HIV long terminal repeat': 'DNA', 'TNF-alpha': 'protein', 'LTR': 'DNA', 'reporter chloramphenicol acetyltransferase plasmids': 'DNA'}, 'response1': "['protein', 'DNA']", 'response2': '[\n    {"IkappaBbeta": 5},\n    {"NF-kappaB": 5},\n    {"NF-kappa B": 5},\n    {"I kappa B alpha": 5},\n    {"Egr-1": 5},\n    {"IFN A": 5},\n    {"IFNA": 5},\n    {"interleukin-2": 5},\n    {"interleukin-2 receptor": 5},\n    {"phytohemagglutinin": 5},\n    {"phorbol myristate acetate": 5},\n    {"HIV-1 LTR": 5},\n    {"NFAT-1": 5},\n    {"NF kappa B": 5},\n    {"CTLA4Ig": 5},\n    {"NFAT": 5},\n    {"AP-1": 5},\n    {"TR55": 5},\n    {"TNF-alpha": 5},\n    {"HIV": 5},\n    {"IkappaB -alpha": 5},\n    {"IkappaB -epsilon": 5},\n    {"IKK-alpha": 5},\n    {"IKK-beta": 5},\n    {"NIK": 5},\n    {"LITAF": 5},\n    {"TNF-alpha": 5},\n    {"interleukin-1beta": 5},\n    {"inhibitor-kappaB alpha": 5},\n    {"nuclear factor-kappa B": 5},\n    {"NF-kappa B": 5},\n    {"alpha 4 beta 1": 5},\n    {"TCR/CD3": 5},\n    {"DNA": 5},\n    {"reverse transcriptase": 1},\n    {"mRNA": 5},\n    {"c-jun": 5},\n    {"c-fos": 5},\n    {"NF kappa B": 5},\n    {"p50 subunit": 5},\n    {"polymerase chain reaction": 1},\n    {"T-antigen": 5},\n    {"DNA": 5},\n    {"TATA-binding protein": 5},\n    {"CREB": 5},\n    {"cAMP-response-element-binding protein": 5},\n    {"HLF": 5},\n    {"E2A-HLF": 5},\n    {"T cell": 5},\n    {"DNA": 5}\n]', 'response3': '[{"TNF-alpha": "protein"}, {"HIV long terminal repeat ( LTR )": "DNA"}, {"beta interferon promoter": "DNA"}]', 'prediction': {'TNF-alpha': 'protein', 'HIV long terminal repeat ( LTR )': 'DNA', 'beta interferon promoter': 'DNA'}}
{'idx': 64, 'sentence': 'Uninduced or Sendai virus induced HeLa extracts were used to examine transcription in vitro using a series of IFN beta promoter deletions .', 'label': {'IFN beta promoter deletions': 'DNA'}, 'response1': "['cell_line', 'protein']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 3},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 4},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 4},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 4},\n    {"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 4},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner.": 5},\n    {"We found that they reduced the initial interleukin-1beta mRNA transcription rate through prevention of degradation of inhibitor-kappaB alpha.": 4},\n    {"NF-E1 is encoded by the same gene as the YY-1 protein, which binds to the adeno-associated virus P5 promoter.": 4},\n    {"We conclude, rather, that alpha 4 beta 1 in freshly isolated T cells delivers a distinct signal that synergizes early with signals initiated by TCR/CD3 ligation to induce DNA binding of multiple transcription factors required for cytokine gene induction.": 5},\n    {"Extracts prepared from XP-B and XP-D lymphoblastoid cells exhibited similar transcription activity from the adenovirus major late promoter when compared to that in extracts from normal cells.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"HeLa": "cell_line"}, {"IFN beta": "protein"}]', 'prediction': {'HeLa': 'cell_line', 'IFN beta': 'protein'}}
{'idx': 1760, 'sentence': 'This inhibitory effect was limited to the first 2 h after mitogenic activation , localizing the time-frame of action of cysteamine to within the commitment period .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence provides information about specific proteins and their functions, which can help in identifying protein entities in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence mentions various entities such as RNA, cell types, and proteins, which align with the entity types in the target sentence."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence talks about specific proteins and DNA synthesis, which can aid in recognizing protein and DNA entities in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence discusses T cell proliferation and the role of specific proteins, which are directly relevant to the entity types in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence directly mentions a specific protein and its function, which matches the entity types in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides information about specific proteins and their functions, aligning with the entity types in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains specific protein names and their functions, which directly relate to the entity types in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence discusses the role of cell adhesion molecules, which corresponds to the cell type entity in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence mentions NF-kappa B activation and its inhibition, which directly relates to the protein entity in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence talks about interleukin-2 and its receptor, which align with the protein entity types in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides information about specific proteins and RNA, which can help in identifying protein and RNA entities in the target sentence."},\n    {"Example 13": 4},\n    {"Reason 13": "The sentence mentions specific entities like DNA, cell line, and cell type, which are relevant to the entity types in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence discusses NF-kappa B activation and its induction, which directly relates to the protein entity in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any specific entities that match the entity types in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any specific entities that match the entity types in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific entities that match the entity types in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific entities that match the entity types in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific entities that match the entity types in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 676, 'sentence': 'The interleukin 2 ( IL-2 ) gene promoter is recognized by several cell-type-specific and ubiquitous transcriptional regulators that integrate information transmitted by various signaling systems leading to IL-2 production and T-cell activation .', 'label': {'IL-2': 'protein', 'interleukin 2': 'protein', 'interleukin 2 ( IL-2 ) gene promoter': 'DNA', 'T-cell': 'cell_type'}, 'response1': "['DNA', 'cell_type', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein (IL-2) and its corresponding entity label."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides multiple examples of proteins (IL-13, IL-4) and cell types (B cell, monocyte) with their corresponding entity labels."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence provides multiple examples of proteins (IL4, IL13, STAT6, STAT3, STAT5) and a cell type (B cells) with their corresponding entity labels."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides multiple examples of proteins (IL-2, Aiolos, Ras) with their corresponding entity labels."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides examples of a protein (NF-ATc) and a cell type (T lymphocytes) with their corresponding entity labels."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides a clear example of a protein (IL-2) with its corresponding entity label."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides multiple examples of proteins (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) with their corresponding entity labels."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides examples of proteins (CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, granulocyte-macrophage colony-stimulating factor) with their corresponding entity labels."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides examples of proteins (interleukin 10, IL-10R, STAT3, IL-6) with their corresponding entity labels."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides examples of a cell type (T cell) and a protein (interleukin 2) with their corresponding entity labels."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides examples of proteins (IL-13, IL-4R, JAK2, IL-13R) with their corresponding entity labels."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides examples of proteins (IL-2, c-Jun, c-Fos) with their corresponding entity labels."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides examples of a protein (IL-2 receptor alpha subunit), a protein (p21ras), and a cell type (B cell) with their corresponding entity labels."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides an example of a cell type (Th2-type lymphocytes) with its corresponding entity label."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides an example of a protein (IL-4) with its corresponding entity label."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence provides examples of proteins (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) with their corresponding entity labels."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any named entities from the given entity label set."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any named entities from the given entity label set."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any named entities from the given entity label set."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any named entities from the given entity label set."}\n]', 'response3': "[{'interleukin 2': 'protein'}, {'T-cell': 'cell_type'}]", 'prediction': {'interleukin 2': 'protein', 'T-cell': 'cell_type'}}
{'idx': 1052, 'sentence': 'Thus, after 4 hr of exposure to SEA and SEB , the expression of IL-2R beta was down-regulated, IL-2R gamma was slightly up-regulated, while IL-2R alpha remained largely unaffected.', 'label': {'IL-2R alpha': 'protein', 'SEA': 'protein', 'IL-2R gamma': 'protein', 'SEB': 'protein', 'IL-2R beta': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 4},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Our results demonstrate that the altered CCAAT box (CCAAC) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 4},\n    {"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.": 5},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb/Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"IL-2R beta": "protein"}, {"IL-2R gamma": "protein"}, {"IL-2R alpha": "protein"}]', 'prediction': {'IL-2R beta': 'protein', 'IL-2R gamma': 'protein', 'IL-2R alpha': 'protein'}}
{'idx': 487, 'sentence': 'Therefore, in normal human monocytes M-CSF induces immediate early response genes without inducing cell proliferation.', 'label': {'human monocytes': 'cell_type', 'normal human monocytes': 'cell_type', 'M-CSF': 'protein', 'immediate early response genes': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 5},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 570, 'sentence': 'Modulation of these events at the time of adherence offers a mechanism by which differential priming of the cells may be accomplished.', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"Sentence": "The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.", "helpfulness score": 4, "reasons": "The sentence contains a clear reference to \'cell adhesion molecules\' which is a cell_type entity."},\n    {"Sentence": "We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.", "helpfulness score": 5, "reasons": "The sentence contains clear references to \'AP-1\', \'PMA\', \'monocytes\', and \'macrophages\' which are protein and cell_type entities."},\n    {"Sentence": "Yet, for many pathogens, the molecules that induce IL-12 production by macrophages and the mechanisms by which they do so remain undefined.", "helpfulness score": 4, "reasons": "The sentence contains a clear reference to \'IL-12\' which is a protein entity and \'macrophages\' which is a cell_type entity."},\n    {"Sentence": "Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.", "helpfulness score": 3, "reasons": "The sentence contains a reference to \'CD14\' which is a protein entity."},\n    {"Sentence": "Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.", "helpfulness score": 4, "reasons": "The sentence contains references to \'Th1\' and \'Th2\' which are cell_type entities."},\n    {"Sentence": "Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.", "helpfulness score": 5, "reasons": "The sentence contains references to \'IL-2\', \'AP-1\', \'c-Jun\', and \'c-Fos\' which are protein entities."},\n    {"Sentence": "Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.", "helpfulness score": 5, "reasons": "The sentence contains references to \'CD70\', \'B cell\', \'plasma cells\', \'IL-4\', and \'CD40\' which are protein and cell_type entities."},\n    {"Sentence": "Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.", "helpfulness score": 5, "reasons": "The sentence contains references to \'IL-4\', \'LPS\', and \'AP-1\' which are protein entities."},\n    {"Sentence": "Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.", "helpfulness score": 4, "reasons": "The sentence contains a reference to \'NF-kappa B\' which is a protein entity."},\n    {"Sentence": "We also found that the deviation of methylation in granulocytes and T cells was well correlated.", "helpfulness score": 4, "reasons": "The sentence contains references to \'granulocytes\' and \'T cells\' which are cell_type entities."},\n    {"Sentence": "Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.", "helpfulness score": 5, "reasons": "The sentence contains references to \'NF-kappa B\' and \'I kappa B alpha\' which are protein entities."},\n    {"Sentence": "We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.", "helpfulness score": 5, "reasons": "The sentence contains a reference to \'NF-kappa B\' which is a protein entity."},\n    {"Sentence": "Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.", "helpfulness score": 4, "reasons": "The sentence contains a reference to \'nonhuman primates\' which is a cell_type entity."},\n    {"Sentence": "Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.", "helpfulness score": 4, "reasons": "The sentence contains a reference to \'NF-kappa B\' which is a protein entity."},\n    {"Sentence": "We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.", "helpfulness score": 5, "reasons": "The sentence contains references to \'HIV-1\', \'IFN\', \'PKR\', and \'IkappaBalpha\' which are protein and cell_type entities."},\n    {"Sentence": "To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.", "helpfulness score": 5, "reasons": "The sentence contains references to \'B and T cell activation\', \'Ramos\', \'Jurkat\', and \'cDNA microarray technology\' which are cell_type, cell_line, and DNA entities."},\n    {"Sentence": "We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.", "helpfulness score": 1, "reasons": "The sentence does not contain any relevant entity references."},\n    {"Sentence": "However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.", "helpfulness score": 1, "reasons": "The sentence does not contain any relevant entity references."},\n    {"Sentence": "In 2 complex translocations, none of the three genes was rearranged.", "helpfulness score": 1, "reasons": "The sentence does not contain any relevant entity references."},\n    {"Sentence": "Deletions or mutations in this element also reduced the serum response by 80-90%.", "helpfulness score": 1, "reasons": "The sentence does not contain any relevant entity references."},\n    {"Sentence": "In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.", "helpfulness score": 1, "reasons": "The sentence does not contain any relevant entity references."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1370, 'sentence': 'Although anti- CD28 MoAb costimulation enhances all of the above signals, NF kappa B and IL-2 levels remain lower than in adults , suggesting the need for further activation requirements in the neonate .', 'label': {'CD28': 'protein', 'anti- CD28 MoAb': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"NF kappa B": "protein"}, {"IL-2": "protein"}]', 'prediction': {'NF kappa B': 'protein', 'IL-2': 'protein'}}
{'idx': 994, 'sentence': 'The role of BSAP ( Pax-5 ) in B-cell development .', 'label': {'BSAP': 'protein', 'Pax-5': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Th1": 5, "Th2": 5},\n    {"SLAP-130": 5, "SLP-76": 5, "T cell": 5},\n    {"Sp1": 5, "Ets": 5},\n    {"UAS3": 5, "UAS2": 5, "YY1": 5},\n    {"CD70": 5, "B cell": 5, "plasma cells": 5, "IL-4": 5, "CD40": 5},\n    {"GATA-1": 5},\n    {"IL-13": 5, "IL-4": 5, "B cell": 5, "monocyte": 5},\n    {"IL-2": 5, "c-Jun": 5, "c-Fos": 5},\n    {"Th2-type lymphocytes": 5},\n    {"IL4": 5, "IL13": 5, "STAT6": 5, "STAT3": 5, "STAT5": 5, "B cells": 5},\n    {"lymphoid neoplasms": 5},\n    {"PML/RARalpha": 5},\n    {"GM-CSF": 5},\n    {"UAS1": 5, "B cell": 5},\n    {"T cell": 5, "interleukin 2": 5},\n    {"GATA-1": 5}\n]', 'response3': '[{"BSAP": "protein"}, {"Pax-5": "protein"}, {"B-cell": "cell_type"}]', 'prediction': {'BSAP': 'protein', 'Pax-5': 'protein', 'B-cell': 'cell_type'}}
{'idx': 438, 'sentence': 'This sequence motif is a binding site for nuclear proteins , the so-called octamer transcription factors ( Oct or OTF factors ).', 'label': {'OTF factors': 'protein', 'nuclear proteins': 'protein', 'sequence motif': 'DNA', 'octamer transcription factors': 'protein', 'Oct': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 5},\n    {"Activated Stat proteins form homo- or heterodimers, translocate to the nucleus, and induce transcription from responsive genes.": 5},\n    {"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 5},\n    {"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 5},\n    {"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 5},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 5},\n    {"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 5},\n    {"The p50 and p65 proteins, constituents of the prototypic nuclear factor kappaB, were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 270, 'sentence': 'There was evidence for an autosomal recessive form of inheritance in four families, while the other four families appeared to have an autosomal dominant mode of transmission .', 'label': {}, 'response1': "['DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains clear mentions of specific entities such as \'lymphoid neoplasms\' which can be confidently labeled as \'cell_type\' based on the context."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides explicit mentions of entities like \'NF-ATc\', \'T lymphocytes\', and \'embryonic cardiac cells\' which can be accurately labeled as \'protein\' and \'cell_type\' respectively."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence directly refers to \'E2A gene\' at the protein level, making it highly relevant for extracting \'protein\' entity."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence mentions \'A-myb\' as a transcription factor, indicating it as a \'protein\' entity."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains multiple mentions of proteins like \'IFN A\', \'interleukin-2\', and \'interleukin-2 receptor\' along with stimuli like \'phytohemagglutinin\' and \'phorbol myristate acetate\' which are relevant for \'protein\' entity extraction."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence includes \'PBMC\' and \'adenovirus DNA\' which are indicative of \'cell_type\' and \'DNA\' entities respectively."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence refers to \'SIVsmmPBj14\' as a unique phenotype, suggesting it as a \'cell_line\' entity."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions \'AP-1 DNA binding activity\' in lymphocytes, indicating \'DNA\' entity."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence talks about \'germ-line IgH genes\' and their control by \'I regions\', both relevant for \'DNA\' entity extraction."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides information about \'RXR\' and its mutants in the context of erythroid cells, indicating \'protein\' entity."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence discusses the role of \'NF-kappaB\' in rheumatoid arthritis, suggesting \'protein\' entity and \'cell_type\' entity."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence examines the regulatory mechanism of \'SCM-1 genes\', indicating \'cell_line\' entity."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence investigates the effect of \'IVS1-10T-->C\' on \'BRCA1 splicing or expression\', relevant for \'protein\' entity."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence mentions \'GATA-1\' as a lineage-specific transcription factor in erythroid cells, indicating \'protein\' entity."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence highlights the control of \'NF-kappa B\' on \'I kappa B alpha\' expression, relevant for \'protein\' entity."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence shows \'WT1\' expression in peripheral lymphocytes, indicating \'protein\' entity."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific entities related to the given label set."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence lacks specific entities related to the given label set."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not mention any entities relevant to the given label set."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not provide any specific entities related to the given label set."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1481, 'sentence': 'We, therefore, propose the activation scheme presented in FIGURE 3 for T-cell costimulation .', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names that are directly mentioned, making it highly relevant for extracting named entities."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions a specific protein (IL-2) that is directly related to the entity types in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains multiple protein names and a cell type that are directly relevant to the entity types in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains multiple protein names and relevant terms related to the target sentence\'s entity types."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence directly mentions a specific protein (NF-kappa B) that is relevant to the entity types in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains multiple protein names and a cell type that are directly related to the entity types in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence mentions a specific protein (NF-kappa B) that is directly related to the entity types in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions a specific protein (TCF-1) that is directly related to the entity types in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence mentions specific proteins and a cell type that are directly relevant to the entity types in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence mentions specific proteins and cell types that are directly related to the entity types in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence mentions specific proteins and a cell type that are directly relevant to the entity types in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence mentions a specific DNA element that is directly related to the entity types in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence mentions specific proteins and cell types that are directly relevant to the entity types in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence mentions specific proteins and a cell type that are directly related to the entity types in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence mentions specific proteins and cell types that are directly relevant to the entity types in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any specific entities related to the target sentence\'s entity types."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific entities related to the target sentence\'s entity types."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific entities related to the target sentence\'s entity types."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific entities related to the target sentence\'s entity types."}\n]', 'response3': '[{"T-cell": "cell_type"}]', 'prediction': {'T-cell': 'cell_type'}}
{'idx': 1807, 'sentence': 'We show that the expression of four cell genes , cdc-2 , cyclin E , CD23 , and cyclin D2 , are up-regulated approximately 100-fold as a result of EBV -mediated immortalization .', 'label': {'cell genes': 'DNA', 'cyclin E': 'DNA', 'cyclin D2': 'DNA', 'CD23': 'DNA', 'cdc-2': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities relevant to the target sentence, such as proteins and cell types, which can aid in identifying similar entities in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of proteins and cell types, which are directly relevant to the target sentence, aiding in the identification of similar entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins, cell types, and signaling molecules that are relevant to the target sentence, providing valuable context for identifying similar entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides an example of a protein and a cell line relevant to the target sentence, aiding in the identification of similar entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of a protein and DNA relevant to the target sentence, aiding in the identification of similar entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of a protein and a cell type relevant to the target sentence, aiding in the identification of similar entities."},\n    {"Sentence": 3},\n    {"Reason": "The sentence provides an example of a protein relevant to the target sentence, aiding in the identification of similar entities."},\n    {"Sentence": 3},\n    {"Reason": "The sentence provides an example of a protein relevant to the target sentence, aiding in the identification of similar entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of proteins, a transcription factor, and cell types relevant to the target sentence, aiding in the identification of similar entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins and a DNA relevant to the target sentence, providing valuable context for identifying similar entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of proteins and cell types relevant to the target sentence, aiding in the identification of similar entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins and DNA relevant to the target sentence, providing valuable context for identifying similar entities."},\n    {"Sentence": 2},\n    {"Reason": "The sentence does not contain any examples of named entities relevant to the target sentence, hence not very helpful in aiding entity extraction."},\n    {"Sentence": 2},\n    {"Reason": "The sentence does not contain any examples of named entities relevant to the target sentence, hence not very helpful in aiding entity extraction."},\n    {"Sentence": 2},\n    {"Reason": "The sentence does not contain any examples of named entities relevant to the target sentence, hence not very helpful in aiding entity extraction."},\n    {"Sentence": 2},\n    {"Reason": "The sentence does not contain any examples of named entities relevant to the target sentence, hence not very helpful in aiding entity extraction."}\n]', 'response3': '[{"cdc-2": "protein"}, {"cyclin E": "protein"}, {"CD23": "protein"}, {"cyclin D2": "protein"}, {"EBV": "protein"}]', 'prediction': {'cdc-2': 'protein', 'cyclin E': 'protein', 'CD23': 'protein', 'cyclin D2': 'protein', 'EBV': 'protein'}}
{'idx': 1169, 'sentence': 'However, B4-2 has an unusually high proline content (13%), contains a putative nuclear targeting sequence , and has several SPXX motifs which are frequently found in gene regulatory proteins .', 'label': {'SPXX motifs': 'protein', 'nuclear targeting sequence': 'protein', 'gene regulatory proteins': 'protein', 'B4-2': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 5},\n    {"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 5},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .": 5},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50 .": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .": 5},\n    {"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n    {"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .": 5},\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines .": 5},\n    {"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .": 5},\n    {"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif .": 5}\n]', 'response3': '[{"B4-2": "protein"}]', 'prediction': {'B4-2': 'protein'}}
{'idx': 1180, 'sentence': 'We therefore propose that IL-2 receptor signal transduction does not depend on equimolar heterodimerization of JAK1 and JAK3 following IL-2 -induced heterodimerization of IL-2R beta and IL-2R gamma .', 'label': {'IL-2R': 'protein', 'IL-2': 'protein', 'IL-2R gamma': 'protein', 'JAK3': 'protein', 'IL-2 receptor': 'protein', 'JAK1': 'protein', 'IL-2R beta': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 3},\n    {"Example 10": 5},\n    {"Example 11": 3},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 5},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': "[{'IL-2': 'protein'}, {'JAK1': 'protein'}, {'JAK3': 'protein'}, {'IL-2R beta': 'protein'}, {'IL-2R gamma': 'protein'}]", 'prediction': {'IL-2': 'protein', 'JAK1': 'protein', 'JAK3': 'protein', 'IL-2R beta': 'protein', 'IL-2R gamma': 'protein'}}
{'idx': 968, 'sentence': 'These observations demonstrate directly that there is de novo synthesis of NF-kappa B during human lymphocyte activation and suggest that this process is hormonally regulated.', 'label': {'NF-kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence 1": 5},\n    {"Sentence 2": 5},\n    {"Sentence 3": 5},\n    {"Sentence 4": 5},\n    {"Sentence 5": 5},\n    {"Sentence 6": 5},\n    {"Sentence 7": 5},\n    {"Sentence 8": 1},\n    {"Sentence 9": 1},\n    {"Sentence 10": 1},\n    {"Sentence 11": 1},\n    {"Sentence 12": 5},\n    {"Sentence 13": 5},\n    {"Sentence 14": 5},\n    {"Sentence 15": 1},\n    {"Sentence 16": 1},\n    {"Sentence 17": 1},\n    {"Sentence 18": 1},\n    {"Sentence 19": 1}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"human lymphocyte": "cell_type"}]', 'prediction': {'NF-kappa B': 'protein', 'human lymphocyte': 'cell_type'}}
{'idx': 497, 'sentence': 'The differentiation of T cells into functionally diverse subpopulations is controlled in part, by transcriptional activation and silencing ; however, little is known in detail about the proteins that influence this developmental process .', 'label': {'T cells': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 4},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 4},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.": 4},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 4},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n    {"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 4},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1606, 'sentence': 'Triggering of complement receptors CR1 ( CD35 ) and CR3 ( CD11b/CD18 ) induces nuclear translocation of NF-kappa B ( p50/p65 ) in human monocytes and enhances viral replication in HIV-infected monocytic cells .', 'label': {'CD11b/CD18': 'protein', 'CD35': 'protein', 'p50/p65': 'protein', 'CR1': 'protein', 'HIV-infected monocytic cells': 'cell_type', 'complement receptors': 'protein', 'human monocytes': 'cell_type', 'NF-kappa B': 'protein', 'CR3': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 4},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"CD40 expression could be enhanced in CD40-positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5},\n    {"Murine macrophage inflammatory protein 1 alpha (MIP-1 alpha) and its human equivalent (GOS19, LD78, or AT464) are members of the -C-C family of low-molecular-weight chemokines.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"CR1": "protein"}, {"CD35": "protein"}, {"CR3": "protein"}, {"CD11b/CD18": "protein"}, {"NF-kappa B": "protein"}, {"p50/p65": "protein"}, {"human monocytes": "cell_type"}, {"HIV-infected monocytic cells": "cell_type"}]', 'prediction': {'CR1': 'protein', 'CD35': 'protein', 'CR3': 'protein', 'CD11b/CD18': 'protein', 'NF-kappa B': 'protein', 'p50/p65': 'protein', 'human monocytes': 'cell_type', 'HIV-infected monocytic cells': 'cell_type'}}
{'idx': 1653, 'sentence': 'Expression of PU.1 in nonmyeloid cells can activate the GM-CSF receptor alpha promoter .', 'label': {'nonmyeloid cells': 'cell_type', 'GM-CSF': 'protein', 'PU.1': 'protein', 'GM-CSF receptor alpha promoter': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.": 5},\n    {"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"PMA induced the expression of both CD14 and CD23 mRNA and protein.": 5},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n    {"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.": 5},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"PU.1": "protein"}, {"GM-CSF receptor alpha": "protein"}]', 'prediction': {'PU.1': 'protein', 'GM-CSF receptor alpha': 'protein'}}
{'idx': 833, 'sentence': 'Mapping of B-cell epitopes of the human hepatitis B virus X protein .', 'label': {'human hepatitis B virus X protein': 'protein', 'B-cell epitopes': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any named entities from the given entity label set."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains multiple named entities from the given entity label set, including \'SP1\' (protein), \'caspases\' (protein), and \'B-cell\' (cell_type), making it highly helpful for entity extraction."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence contains a named entity \'Th2-type lymphocytes\' which corresponds to the \'cell_type\' entity label, aiding in entity extraction."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains a named entity \'E2A\' which corresponds to the \'protein\' entity label, making it highly helpful for entity extraction."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains multiple named entities from the given entity label set, including \'SLAP-130\' (protein), \'SLP-76\' (protein), and \'T cell\' (cell_type), making it highly helpful for entity extraction."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains a named entity \'TCF-1\' which corresponds to the \'protein\' entity label, making it highly helpful for entity extraction."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains multiple named entities from the given entity label set, including \'T lymphocytes\' (cell_type) and \'HLA-molecules\' (protein), making it highly helpful for entity extraction."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains multiple named entities from the given entity label set, including \'IkappaBbeta\' (protein) and \'NF-kappaB\' (protein), making it highly helpful for entity extraction."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence contains a named entity \'GM-CSF\' which corresponds to the \'protein\' entity label, aiding in entity extraction."},\n    {"Example 10": 1},\n    {"Reason 10": "The sentence does not contain any named entities from the given entity label set."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains multiple named entities from the given entity label set, including \'EBNA-2\' (protein) and \'PU.1\' (protein), making it highly helpful for entity extraction."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains a named entity \'HBxAg\' which corresponds to the \'protein\' entity label, making it highly helpful for entity extraction."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains multiple named entities from the given entity label set, including \'SIVsmmPBj14\' (cell_line), making it highly helpful for entity extraction."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains multiple named entities from the given entity label set, including \'EBV\' (cell_type) and \'B-cell\' (cell_type), making it highly helpful for entity extraction."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains multiple named entities from the given entity label set, including \'p50\' (protein), \'p65\' (protein), \'DNA\' (DNA), and \'protein\' (protein), making it highly helpful for entity extraction."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any named entities from the given entity label set."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any named entities from the given entity label set."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any named entities from the given entity label set."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any named entities from the given entity label set."}\n]', 'response3': "[{'B-cell': 'cell_type'}, {'hepatitis B virus X protein': 'protein'}]", 'prediction': {'B-cell': 'cell_type', 'hepatitis B virus X protein': 'protein'}}
{'idx': 389, 'sentence': 'The predicted periplasmic domain of the PhoQ protein contained a markedly anionic domain that could interact with cationic proteins and that could be responsible for resistance to defensin .', 'label': {'periplasmic domain': 'protein', 'PhoQ protein': 'protein', 'cationic proteins': 'protein', 'defensin': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"PhoQ": "protein"}]', 'prediction': {'PhoQ': 'protein'}}
{'idx': 193, 'sentence': 'The calcium ionophore-induced c-myc suppression , however, strictly requires de novo protein synthesis .', 'label': {'c-myc': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"1": []},\n    {"2": []},\n    {"3": [{\'IL-5 mRNA\': \'RNA\'}, {\'TCR\': \'cell_type\'}, {\'IL-2R\': \'protein\'}, {\'dexamethasone\': \'protein\'}]},\n    {"4": [{\'RelA\': \'protein\'}, {\'NF-kappaB1\': \'protein\'}]},\n    {"5": [{\'SP1\': \'protein\'}, {\'caspases\': \'protein\'}, {\'B-cell\': \'cell_type\'}]},\n    {"6": [{\'NF-E2\': \'protein\'}]},\n    {"7": [{\'IL-2\': \'protein\'}, {\'NF-kappa B\': \'protein\'}, {\'AP-1\': \'protein\'}]},\n    {"8": [{\'IL-2\': \'protein\'}, {\'Aiolos\': \'protein\'}, {\'Ras\': \'protein\'}]},\n    {"9": [{\'SCL\': \'RNA\'}]},\n    {"10": [{\'IFN A\': \'protein\'}, {\'IFNA\': \'protein\'}, {\'interleukin-2\': \'protein\'}, {\'interleukin-2 receptor\': \'protein\'}, {\'phytohemagglutinin\': \'protein\'}, {\'phorbol myristate acetate\': \'protein\'}]},\n    {"11": [{\'NF-kappa B\': \'protein\'}]},\n    {"12": [{\'TIMP-1\': \'protein\'}, {\'DNA\': \'DNA\'}]},\n    {"13": [{\'EBV\': \'cell_line\'}, {\'CD2\': \'protein\'}]},\n    {"14": [{\'IL-2\': \'protein\'}, {\'c-Jun\': \'protein\'}, {\'c-Fos\': \'protein\'}]},\n    {"15": [{\'WT1\': \'protein\'}, {\'myeloid cell lines\': \'cell_line\'}]},\n    {"16": [{\'calcineurin\': \'protein\'}]},\n    {"17": []},\n    {"18": []},\n    {"19": []},\n    {"20": []}\n]', 'response3': '[{"c-myc": "protein"}]', 'prediction': {'c-myc': 'protein'}}
{'idx': 1349, 'sentence': 'Its expression was always restricted to the nucleus .', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides specific protein names that are mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 2": 4},\n    {"Reason 2": "The example provides protein names mentioned in the sentence, which are relevant for entity extraction."},\n    {"Example 3": 5},\n    {"Reason 3": "The example includes protein names that are directly related to the sentence, facilitating protein entity extraction."},\n    {"Example 4": 5},\n    {"Reason 4": "The example contains protein names that are crucial for identifying protein entities in the sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The example includes protein names and other relevant terms that are essential for protein entity extraction."},\n    {"Example 6": 4},\n    {"Reason 6": "The example provides a cell type and a protein name mentioned in the sentence, aiding in entity extraction."},\n    {"Example 7": 5},\n    {"Reason 7": "The example includes a protein name that is directly related to the sentence, facilitating protein entity extraction."},\n    {"Example 8": 5},\n    {"Reason 8": "The example contains protein names that are crucial for identifying protein entities in the sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides protein names that are mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The example includes a cell line name that is directly related to the sentence, facilitating cell line entity extraction."},\n    {"Example 11": 5},\n    {"Reason 11": "The example provides RNA, cell type, and protein names mentioned in the sentence, aiding in entity extraction."},\n    {"Example 12": 5},\n    {"Reason 12": "The example includes a protein name that is directly related to the sentence, facilitating protein entity extraction."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides a DNA name that is mentioned in the sentence, aiding in the extraction of DNA entities."},\n    {"Example 14": 5},\n    {"Reason 14": "The example includes a protein name that is crucial for identifying protein entities in the sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The example provides protein and cell type names mentioned in the sentence, aiding in entity extraction."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain any specific entity names mentioned in the sentence, making it less helpful for entity extraction."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain any specific entity names mentioned in the sentence, making it less helpful for entity extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any specific entity names mentioned in the sentence, making it less helpful for entity extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The example does not contain any specific entity names mentioned in the sentence, making it less helpful for entity extraction."},\n    {"Example 20": 1},\n    {"Reason 20": "The example does not contain any specific entity names mentioned in the sentence, making it less helpful for entity extraction."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 882, 'sentence': 'This cDNA clone was isolated by expression cDNA cloning , and encodes the human c-Jun protein , which together with c-Fos forms the heterodimeric activator protein-1 transcription complex .', 'label': {'c-Jun': 'protein', 'heterodimeric activator protein-1 transcription complex': 'protein', 'c-Fos': 'protein', 'cDNA': 'DNA', 'human c-Jun protein': 'protein', 'cDNA clone': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1}\n]', 'response3': '[{"cDNA clone": "DNA"}, {"c-Jun": "protein"}, {"c-Fos": "protein"}, {"activator protein-1": "protein"}]', 'prediction': {'cDNA clone': 'DNA', 'c-Jun': 'protein', 'c-Fos': 'protein', 'activator protein-1': 'protein'}}
{'idx': 725, 'sentence': 'Rex acts posttranscriptionally to facilitate accumulation of full-length gag/pol and singly spliced env mRNA in the cytoplasm of HTLV-infected cells .', 'label': {'Rex': 'protein', 'HTLV-infected cells': 'cell_type', 'gag/pol': 'protein', 'env mRNA': 'RNA'}, 'response1': "['RNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific gene/protein names that match the entity labels in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence contains a specific gene/protein name that matches one of the entity labels in the target sentence."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence contains a specific gene/protein name that matches one of the entity labels in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains specific gene/protein names and a virus name that match the entity labels in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains a specific cell line name that matches one of the entity labels in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains specific gene/protein names that match the entity labels in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains specific gene/protein names that match the entity labels in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains specific gene/protein names and a virus name that match the entity labels in the target sentence."},\n    {"Example 9": 3},\n    {"Reason 9": "The sentence contains terms related to cell types, but not specific gene/protein names that match the entity labels in the target sentence."},\n    {"Example 10": 3},\n    {"Reason 10": "The sentence contains terms related to protein synthesis, but not specific gene/protein names that match the entity labels in the target sentence."},\n    {"Example 11": 3},\n    {"Reason 11": "The sentence contains terms related to genetic mutations, but not specific gene/protein names that match the entity labels in the target sentence."},\n    {"Example 12": 3},\n    {"Reason 12": "The sentence contains terms related to biophysical properties, but not specific gene/protein names that match the entity labels in the target sentence."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not contain specific gene/protein names that match the entity labels in the target sentence."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not contain specific gene/protein names that match the entity labels in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain specific gene/protein names that match the entity labels in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain specific gene/protein names that match the entity labels in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain specific gene/protein names that match the entity labels in the target sentence."}\n]', 'response3': "[{'gag/pol': 'protein'}, {'env mRNA': 'RNA'}, {'HTLV-infected cells': 'cell_type'}]", 'prediction': {'gag/pol': 'protein', 'env mRNA': 'RNA', 'HTLV-infected cells': 'cell_type'}}
{'idx': 867, 'sentence': 'In HIV-1 , the sequences that respond to these signaling events are found in the long terminal repeat ( LTR ) and comprise the transcriptional enhancer , which contains two conserved binding sites for the nuclear factor kappa B ( NF kappa B ).', 'label': {'conserved binding sites': 'DNA', 'nuclear factor kappa B': 'protein', 'long terminal repeat': 'DNA', 'LTR': 'DNA', 'NF kappa B': 'protein', 'transcriptional enhancer': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions various proteins and cytokines, which are relevant entity types in the target sentence."},\n    {"Example 3": 3},\n    {"Reason 3": "The sentence includes a cell type and a protein, which are relevant entity types in the target sentence."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence mentions a specific cell line, which matches the entity type in the target sentence."},\n    {"Example 5": 3},\n    {"Reason 5": "The sentence refers to a specific cell type, which is a relevant entity type in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides specific examples of DNA and protein entities that match the entity types in the target sentence."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence mentions specific proteins and cell types that are relevant entity types in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence directly mentions the DNA entity type relevant to the target sentence."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence contains specific protein names that match the entity types in the target sentence."},\n    {"Example 10": 4},\n    {"Reason 10": "The sentence mentions specific proteins and a cell type that are relevant entity types in the target sentence."},\n    {"Example 11": 4},\n    {"Reason 11": "The sentence includes specific protein names and a cell type that match the entity types in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides specific examples of DNA and protein entities that correspond to the entity types in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence directly mentions the DNA entity type and a related protein, which are relevant to the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence mentions specific protein names that match the entity types in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence directly mentions the DNA entity type and a specific RNA entity, which are relevant to the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entity types relevant to the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entity types relevant to the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entity types relevant to the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entity types relevant to the target sentence."}\n]', 'response3': '[{"long terminal repeat": "DNA"}, {"transcriptional enhancer": "DNA"}, {"nuclear factor kappa B": "protein"}]', 'prediction': {'long terminal repeat': 'DNA', 'transcriptional enhancer': 'DNA', 'nuclear factor kappa B': 'protein'}}
{'idx': 841, 'sentence': 'Such tests may become useful diagnostic tools .', 'label': {}, 'response1': 'None.', 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence contains specific protein names such as myeloperoxidase, lysozyme, and PU.1, which are directly related to the \'protein\' entity label."},\n{"Example 2": 4},\n{"Reason 2": "The sentence mentions PBMC (Peripheral Blood Mononuclear Cells) and adenovirus, which are associated with the \'cell_type\' and \'DNA\' entity labels respectively."},\n{"Example 3": 4},\n{"Reason 3": "The sentence refers to PBMC (Peripheral Blood Mononuclear Cells) and adenovirus DNA, which are linked to the \'cell_type\' and \'DNA\' entity labels respectively."},\n{"Example 4": 5},\n{"Reason 4": "The sentence mentions IFN-gamma, a protein, which is directly related to the \'protein\' entity label."},\n{"Example 5": 4},\n{"Reason 5": "The sentence talks about lymphoid neoplasms, which are associated with the \'cell_type\' entity label."},\n{"Example 6": 5},\n{"Reason 6": "The sentence mentions STAT1, a protein, which is directly related to the \'protein\' entity label."},\n{"Example 7": 5},\n{"Reason 7": "The sentence refers to Ras, a protein, which is directly related to the \'protein\' entity label."},\n{"Example 8": 5},\n{"Reason 8": "The sentence contains terms like immunohistochemistry, gene, and cell type, which are associated with the \'protein\', \'DNA\', and \'cell_type\' entity labels respectively."},\n{"Example 9": 5},\n{"Reason 9": "The sentence mentions NF-kappa B, a protein, which is directly related to the \'protein\' entity label."},\n{"Example 10": 5},\n{"Reason 10": "The sentence talks about SCM-1, a cell line, which is directly related to the \'cell_line\' entity label."},\n{"Example 11": 4},\n{"Reason 11": "The sentence refers to SIVsmmPBj14, a cell line, which is associated with the \'cell_line\' entity label."},\n{"Example 12": 4},\n{"Reason 12": "The sentence mentions nonhuman primates, which are linked to the \'cell_type\' entity label."},\n{"Example 13": 5},\n{"Reason 13": "The sentence contains T-PLL, a cell type, which is directly related to the \'cell_type\' entity label."},\n{"Example 14": 5},\n{"Reason 14": "The sentence mentions E2A, a protein, which is directly related to the \'protein\' entity label."},\n{"Example 15": 4},\n{"Reason 15": "The sentence refers to AP-1, which is associated with the \'DNA\' entity label."},\n{"Example 16": 5},\n{"Reason 16": "The sentence contains terms related to B and T cell activation, Ramos, Jurkat cells, and cDNA microarray technology, which are associated with the \'cell_type\', \'cell_line\', and \'DNA\' entity labels respectively."},\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any specific entity names or terms related to the entity labels in the target sentence."},\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any specific entity names or terms related to the entity labels in the target sentence."},\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any specific entity names or terms related to the entity labels in the target sentence."},\n{"Example 20": 1},\n{"Reason 20": "The sentence does not contain any specific entity names or terms related to the entity labels in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 956, 'sentence': 'BSAP : a key regulator of B-cell development and differentiation .', 'label': {'BSAP': 'protein', 'B-cell': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"NF-E2": 5},\n    {"EBV": 4, "B-cell": 4},\n    {"CD70": 5, "B cell": 4, "plasma cells": 4, "IL-4": 5, "CD40": 5},\n    {"Th2-type lymphocytes": 5},\n    {"GATA-1": 5},\n    {"Syk": 5, "Zap": 5, "T cell": 4},\n    {"Th1": 5, "Th2": 5},\n    {"T cell": 5, "interleukin 2": 5},\n    {"IL-2": 5},\n    {"AP-1": 5},\n    {"IL-2": 5, "c-Jun": 5, "c-Fos": 5},\n    {"UAS3": 5, "UAS2": 5, "YY1": 5},\n    {"SCL": 5, "GATA-1": 5},\n    {"IL-2": 5, "NF-kappa B": 5, "AP-1": 5},\n    {"IL4": 5, "IL13": 5, "STAT6": 5, "STAT3": 5, "STAT5": 5, "B cells": 5},\n    {"STAT1": 5},\n    {"None": 1},\n    {"None": 1},\n    {"None": 1},\n    {"None": 1},\n    {"None": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1769, 'sentence': 'We have tried to find out whether these receptors could show any difference in sex or age distribution.', 'label': {}, 'response1': 'None.', 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence contains specific entities with clear labels that are directly related to the entity types in the label set."},\n{"Example 2": 4},\n{"Reason 2": "The sentence mentions a specific entity related to the \'cell_type\' entity type, providing relevant information for entity extraction."},\n{"Example 3": 4},\n{"Reason 3": "The sentence mentions a specific entity related to the \'protein\' entity type, providing relevant information for entity extraction."},\n{"Example 4": 3},\n{"Reason 4": "The sentence mentions a specific entity related to the \'DNA\' entity type, which is helpful for entity extraction, but the context is not as clear as in other examples."},\n{"Example 5": 4},\n{"Reason 5": "The sentence mentions a specific entity related to the \'protein\' entity type, providing relevant information for entity extraction."},\n{"Example 6": 4},\n{"Reason 6": "The sentence mentions a specific entity related to the \'protein\' entity type, providing relevant information for entity extraction."},\n{"Example 7": 4},\n{"Reason 7": "The sentence mentions a specific entity related to the \'cell_type\' entity type, providing relevant information for entity extraction."},\n{"Example 8": 5},\n{"Reason 8": "The sentence contains specific entities with clear labels that are directly related to the entity types in the label set."},\n{"Example 9": 5},\n{"Reason 9": "The sentence contains specific entities with clear labels that are directly related to the entity types in the label set."},\n{"Example 10": 5},\n{"Reason 10": "The sentence contains specific entities with clear labels that are directly related to the entity types in the label set."},\n{"Example 11": 3},\n{"Reason 11": "The sentence mentions a specific entity related to the \'DNA\' entity type, which is helpful for entity extraction, but the context is not as clear as in other examples."},\n{"Example 12": 4},\n{"Reason 12": "The sentence mentions a specific entity related to the \'protein\' entity type, providing relevant information for entity extraction."},\n{"Example 13": 5},\n{"Reason 13": "The sentence contains specific entities with clear labels that are directly related to the entity types in the label set."},\n{"Example 14": 5},\n{"Reason 14": "The sentence contains specific entities with clear labels that are directly related to the entity types in the label set."},\n{"Example 15": 1},\n{"Reason 15": "The sentence does not mention any specific entities related to the entity types in the label set."},\n{"Example 16": 1},\n{"Reason 16": "The sentence does not mention any specific entities related to the entity types in the label set."},\n{"Example 17": 1},\n{"Reason 17": "The sentence does not mention any specific entities related to the entity types in the label set."},\n{"Example 18": 1},\n{"Reason 18": "The sentence does not mention any specific entities related to the entity types in the label set."},\n]', 'response3': '[]', 'prediction': {}}
{'idx': 110, 'sentence': 'Electrophoretic mobility shift assays and Southwestern blotting experiments were used to detect the binding of cellular transactivation factor NF-KB to the double repeat-KB enhancer sequence located in the long terminal repeat .', 'label': {'long terminal repeat': 'DNA', 'NF-KB': 'protein', 'double repeat-KB enhancer sequence': 'DNA', 'cellular transactivation factor': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of proteins (IL-4, LPS, AP-1) which are relevant entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of proteins (NF-kappaB, Sp1, p50) which are relevant entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins (NF-kappaB, Tax) and cell types (ATL) which are relevant entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains an example of a protein (NF-kappa B) which is a relevant entity type in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins (NF-kappa B, I kappa B alpha) which are relevant entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins (EKLF, CBP, p300, P/CAF) which are relevant entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins (CD40, NF-kappa B) which are relevant entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins (NF-kappa B, I kappa B alpha) which are relevant entity types in the target sentence."},\n    {"Sentence": 3},\n    {"Reason": "The sentence contains an example of a cell type (T cell) and a protein (interleukin 2) which are relevant entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains an example of a protein (NF-kappa B) which is a relevant entity type in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of proteins (PAFR, PAF, NF-kappa B, protein kinase C) which are relevant entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins (RelA, NF-kappa B) which are relevant entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins (IL-2, c-Jun, c-Fos) which are relevant entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins (NF-kappaB) and a cell type (rheumatoid arthritis) which are relevant entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins (TRAF6, RANKL, NF-kappaB) which are relevant entity types in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant entity types from the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant entity types from the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant entity types from the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant entity types from the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant entity types from the target sentence."}\n]', 'response3': '[{"NF-KB": "protein"}]', 'prediction': {'NF-KB': 'protein'}}
{'idx': 1379, 'sentence': 'Deregulation of TCL1 is the first event in the initiation of malignancy in these types of leukemias and represents a potential tool for clinical evaluation .', 'label': {'TCL1': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"IkappaBbeta": 5},\n    {"NF-kappaB": 5},\n    {"AP-1": 5},\n    {"WT1": 4},\n    {"myeloid cell lines": 4},\n    {"myeloperoxidase": 5},\n    {"lysozyme": 5},\n    {"PU.1": 5},\n    {"IL-2 receptor alpha subunit": 5},\n    {"p21ras": 5},\n    {"B cell": 5},\n    {"MNDA": 5},\n    {"Philadelphia chromosome-positive chronic myeloid leukemia": 5},\n    {"SCM-1": 5},\n    {"IL-13": 5},\n    {"IL-4R": 5},\n    {"JAK2": 5},\n    {"IL-13R": 5},\n    {"STAT1": 5},\n    {"SCL": 5},\n    {"GATA-1": 5},\n    {"PML/RARalpha": 5},\n    {"TCRzeta": 5},\n    {"p56(lck)": 5},\n    {"lymphoid neoplasms": 5},\n    {"CD28": 5},\n    {"CD80": 5},\n    {"CD86": 5},\n    {"CBL": 5},\n    {"VAV": 5},\n    {"NFAT": 5},\n    {"interleukin-2": 5},\n    {"granulocyte-macrophage colony-stimulating factor": 5},\n    {"GATA-1": 5},\n    {"NF-kappaB": 5},\n    {"Tax": 4},\n    {"ATL": 4}\n]', 'response3': '[{"TCL1": "protein"}]', 'prediction': {'TCL1': 'protein'}}
{'idx': 1338, 'sentence': 'The survival-promoting activity of the Bcl-2 family of proteins appears to be modulated by interactions between various cellular proteins .', 'label': {'Bcl-2 family': 'protein', 'cellular proteins': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "Both NF-kappa B and I kappa B alpha are explicitly mentioned in the sentence, making it highly relevant for extracting protein entities."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions TIMP-1 and DNA explicitly, aiding in the extraction of protein and DNA entities."},\n    {"Example 3": 5},\n    {"Reason 3": "Both NF-kappa B and I kappa B alpha are explicitly mentioned in the sentence, making it highly relevant for extracting protein entities."},\n    {"Example 4": 4},\n    {"Reason 4": "NF-kappa B is explicitly mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 5": 5},\n    {"Reason 5": "SP1, caspases, and B-cell are explicitly mentioned in the sentence, aiding in the extraction of protein and cell_type entities."},\n    {"Example 6": 3},\n    {"Reason 6": "The sentence mentions cell adhesion molecules, which could be relevant for extracting cell_type entities."},\n    {"Example 7": 4},\n    {"Reason 7": "NF-kappa B is explicitly mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 8": 5},\n    {"Reason 8": "p21(WAF1/CIP1) and p27(KIP1) are explicitly mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 9": 5},\n    {"Reason 9": "IL-2, c-Jun, and c-Fos are explicitly mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 10": 5},\n    {"Reason 10": "CD70, B cell, plasma cells, IL-4, and CD40 are explicitly mentioned in the sentence, aiding in the extraction of protein and cell_type entities."},\n    {"Example 11": 5},\n    {"Reason 11": "IkappaBbeta and NF-kappaB are explicitly mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 12": 5},\n    {"Reason 12": "CD40 and NF-kappa B are explicitly mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 13": 4},\n    {"Reason 13": "IL-4 is explicitly mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 14": 5},\n    {"Reason 14": "Bak, Bad, and Bcl-2 are explicitly mentioned in the sentence, aiding in the extraction of protein entities. PDBu and DMSO are also mentioned as cell_line entities."},\n    {"Example 15": 5},\n    {"Reason 15": "IL-2 receptor alpha subunit, p21ras, and B cell are explicitly mentioned in the sentence, aiding in the extraction of protein and cell_type entities."},\n    {"Example 16": 3},\n    {"Reason 16": "The sentence mentions tyrosine, which could be relevant for extracting protein entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any explicit entity mentions relevant for extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any explicit entity mentions relevant for extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any explicit entity mentions relevant for extraction."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any explicit entity mentions relevant for extraction."}\n]', 'response3': "[{'Bcl-2': 'protein'}]", 'prediction': {'Bcl-2': 'protein'}}
{'idx': 1323, 'sentence': 'PRE-I forms multiple DNA-protein complexes with nuclear extracts from Jurkat cells .', 'label': {'PRE-I': 'DNA', 'Jurkat cells': 'cell_line', 'multiple DNA-protein complexes': 'protein'}, 'response1': "['DNA', 'protein', 'cell_line']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence contains specific gene names and their corresponding entity types, which directly match the entity labels in the target sentence."},\n{"Example 2": 5},\n{"Reason 2": "The sentence provides multiple instances of gene names and proteins, which align with the entity labels in the target sentence."},\n{"Example 3": 5},\n{"Reason 3": "The sentence mentions a specific gene name and its corresponding entity type, matching the entity labels in the target sentence."},\n{"Example 4": 5},\n{"Reason 4": "The sentence includes gene names and proteins that are relevant to the entity labels in the target sentence."},\n{"Example 5": 5},\n{"Reason 5": "The sentence contains gene names and proteins that align with the entity labels in the target sentence."},\n{"Example 6": 5},\n{"Reason 6": "The sentence provides gene names and proteins that match the entity labels in the target sentence."},\n{"Example 7": 5},\n{"Reason 7": "The sentence includes gene names and proteins that are relevant to the entity labels in the target sentence."},\n{"Example 8": 5},\n{"Reason 8": "The sentence mentions gene names and proteins that directly correspond to the entity labels in the target sentence."},\n{"Example 9": 5},\n{"Reason 9": "The sentence contains gene names and proteins that align with the entity labels in the target sentence."},\n{"Example 10": 5},\n{"Reason 10": "The sentence provides gene names and proteins that match the entity labels in the target sentence."},\n{"Example 11": 5},\n{"Reason 11": "The sentence includes gene names, proteins, and cell lines that are relevant to the entity labels in the target sentence."},\n{"Example 12": 5},\n{"Reason 12": "The sentence mentions gene names, proteins, and DNA sequences that align with the entity labels in the target sentence."},\n{"Example 13": 5},\n{"Reason 13": "The sentence provides gene names, cell lines, and cell types that match the entity labels in the target sentence."},\n{"Example 14": 5},\n{"Reason 14": "The sentence contains gene names and proteins that directly correspond to the entity labels in the target sentence."},\n{"Example 15": 1},\n{"Reason 15": "The sentence does not contain any specific gene names, proteins, or entity types that align with the entity labels in the target sentence."},\n{"Example 16": 1},\n{"Reason 16": "The sentence does not provide any specific gene names, proteins, or entity types that match the entity labels in the target sentence."},\n{"Example 17": 1},\n{"Reason 17": "The sentence does not mention any gene names, proteins, or entity types that align with the entity labels in the target sentence."},\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any specific gene names, proteins, or entity types that match the entity labels in the target sentence."},\n{"Example 19": 1},\n{"Reason 19": "The sentence does not provide any gene names, proteins, or entity types that directly correspond to the entity labels in the target sentence."}\n]', 'response3': "[{'PRE-I': 'protein'}, {'DNA': 'DNA'}, {'Jurkat cells': 'cell_line'}]", 'prediction': {'PRE-I': 'protein', 'DNA': 'DNA', 'Jurkat cells': 'cell_line'}}
{'idx': 1309, 'sentence': 'Proteins in the first group contain multiple HMG boxes , are non-sequence-specific , and recognize structural features as found in cruciform DNA and cross-over DNA .', 'label': {'cruciform DNA': 'DNA', 'HMG boxes': 'protein', 'cross-over DNA': 'DNA'}, 'response1': "['protein', 'DNA']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The example provides a specific protein entity (p50p50) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 2": 5},\n{"Reason 2": "The example provides specific protein entities (p21(WAF1/CIP1) and p27(KIP1)) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 3": 5},\n{"Reason 3": "The example provides a specific protein entity (GATA-1) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 4": 5},\n{"Reason 4": "The example provides specific protein entities (NF-ATc) and cell type (T lymphocytes) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 5": 5},\n{"Reason 5": "The example provides a specific protein entity (Protein) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 6": 5},\n{"Reason 6": "The example provides a specific protein entity (GM-CSF) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 7": 5},\n{"Reason 7": "The example provides a specific DNA entity (cDNAs) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 8": 5},\n{"Reason 8": "The example provides a specific DNA entity (IgH) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 9": 5},\n{"Reason 9": "The example provides specific protein entities (IL-2, c-Jun, c-Fos) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 10": 5},\n{"Reason 10": "The example provides a specific protein entity (Stat proteins) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 11": 5},\n{"Reason 11": "The example provides specific entities (immunohistochemistry, gene, cell type) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 12": 5},\n{"Reason 12": "The example provides specific entities (Th2-type lymphocytes) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 13": 5},\n{"Reason 13": "The example provides specific DNA entities (GM-kappa B, GC-box, GC-motif, GM-kappa B motif) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 14": 5},\n{"Reason 14": "The example provides specific protein and DNA entities (p50, p65, DNA, protein) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 15": 5},\n{"Reason 15": "The example provides specific DNA and protein entities (HIV-1 LTR, NFAT-1, NF kappa B) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 16": 1},\n{"Reason 16": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 20": 1},\n{"Reason 20": "The sentence does not contain any named entities from the given entity label set."}\n]', 'response3': "[{'HMG boxes': 'protein'}, {'DNA': 'DNA'}, {'DNA': 'DNA'}]", 'prediction': {'HMG boxes': 'protein', 'DNA': 'DNA'}}
{'idx': 228, 'sentence': 'We have carried out experiments to define the nature of the higher affinity CVZ binding site .', 'label': {'higher affinity CVZ binding site': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any specific named entities to extract."},\n\n{"Example 2": 5},\n{"Reason 2": "The sentence contains multiple named entities (proteins) explicitly mentioned, which can aid in entity extraction."},\n\n{"Example 3": 5},\n{"Reason 3": "The sentence contains a specific protein (G-CSF) explicitly mentioned, aiding in entity extraction."},\n\n{"Example 4": 5},\n{"Reason 4": "The sentence mentions a specific DNA entity (immunoglobulin kappa 3\' enhancer), aiding in entity extraction."},\n\n{"Example 5": 5},\n{"Reason 5": "The sentence mentions a specific protein (CD95 ligand), aiding in entity extraction."},\n\n{"Example 6": 5},\n{"Reason 6": "The sentence mentions a specific DNA entity (DNA), aiding in entity extraction."},\n\n{"Example 7": 5},\n{"Reason 7": "The sentence mentions a specific cell line (SCM-1), aiding in entity extraction."},\n\n{"Example 8": 5},\n{"Reason 8": "The sentence mentions a specific cell type (cell adhesion molecules), aiding in entity extraction."},\n\n{"Example 9": 5},\n{"Reason 9": "The sentence mentions a specific protein (E2A), aiding in entity extraction."},\n\n{"Example 10": 5},\n{"Reason 10": "The sentence mentions a specific protein (NF-kappa B), aiding in entity extraction."},\n\n{"Example 11": 5},\n{"Reason 11": "The sentence mentions a specific protein (BRCA1), aiding in entity extraction."},\n\n{"Example 12": 5},\n{"Reason 12": "The sentence mentions a specific protein (TCF-1), aiding in entity extraction."},\n\n{"Example 13": 5},\n{"Reason 13": "The sentence mentions a specific protein (retinoic acid receptor alpha), aiding in entity extraction."},\n\n{"Example 14": 5},\n{"Reason 14": "The sentence mentions specific proteins (CREB and AR-CRE), aiding in entity extraction."},\n\n{"Example 15": 5},\n{"Reason 15": "The sentence mentions a specific cell line (SIVsmmPBj14), aiding in entity extraction."},\n\n{"Example 16": 5},\n{"Reason 16": "The sentence mentions a specific protein, aiding in entity extraction."},\n\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any specific named entities to extract."},\n\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any specific named entities to extract."},\n\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any specific named entities to extract."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 51, 'sentence': 'Such segments accord well with empirically known T-cell determinants and our algorithm produces a lower number of false positive predictions than the principle based on discrete Fourier transformations previously described.', 'label': {'T-cell determinants': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with their corresponding entity labels, which can aid in understanding and identifying similar entities in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1518, 'sentence': 'Anti-immunoglobulin M activates nuclear calcium/calmodulin-dependent protein kinase II in human B lymphocytes .', 'label': {'nuclear calcium/calmodulin-dependent protein kinase II': 'protein', 'human B lymphocytes': 'cell_type', 'Anti-immunoglobulin M': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of proteins and cell types that are directly relevant to the entity labels in the target sentence, making it highly helpful for predicting named entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of proteins and a cell type that are relevant to the target sentence, aiding in predicting named entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence includes examples of proteins that are relevant to the target sentence, contributing to the prediction of named entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence offers examples of proteins and a cell type that are directly related to the entity labels in the target sentence, assisting in predicting named entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of proteins and a cell type that are relevant to the target sentence, aiding in predicting named entities."},\n    {"Sentence": 3},\n    {"Reason": "The sentence includes an example of a protein that is relevant to the target sentence, contributing to the prediction of named entities."},\n    {"Sentence": 3},\n    {"Reason": "The sentence offers an example of a protein that is relevant to the target sentence, aiding in predicting named entities."},\n    {"Sentence": 3},\n    {"Reason": "The sentence contains examples of proteins and cell types that are directly relevant to the entity labels in the target sentence, contributing to the prediction of named entities."},\n    {"Sentence": 2},\n    {"Reason": "The sentence provides an example of a cell type that is relevant to the target sentence, aiding in predicting named entities."},\n    {"Sentence": 3},\n    {"Reason": "The sentence includes examples of proteins and a cell type that are relevant to the target sentence, contributing to the prediction of named entities."},\n    {"Sentence": 3},\n    {"Reason": "The sentence offers examples of proteins and a cell type that are directly related to the entity labels in the target sentence, assisting in predicting named entities."},\n    {"Sentence": 2},\n    {"Reason": "The sentence provides an example of a protein that is relevant to the target sentence, aiding in predicting named entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain examples of entities relevant to the target sentence, hence not very helpful in predicting named entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain examples of entities relevant to the target sentence, hence not very helpful in predicting named entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain examples of entities relevant to the target sentence, hence not very helpful in predicting named entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain examples of entities relevant to the target sentence, hence not very helpful in predicting named entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain examples of entities relevant to the target sentence, hence not very helpful in predicting named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 563, 'sentence': 'The 6-h increase in PDGF(B) mRNA was adherence dependent, and in addition, was abrogated when the cytoskeletal integrity was compromised by cytochalasin D .', 'label': {'PDGF(B)': 'protein', 'PDGF(B) mRNA': 'RNA'}, 'response1': "['RNA']", 'response2': '[\n    {"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 5},\n    {"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.": 5},\n    {"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .": 5},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 5},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .": 5},\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .": 5},\n    {"PMA induced the expression of both CD14 and CD23 mRNA and protein.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules .": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"Protein kinase B ( c-Akt ), phosphatidylinositol 3-kinase , and STAT5 are activated by erythropoietin ( EPO ) in HCD57 erythroid cells but are constitutively active in an EPO -independent, apoptosis -resistant subclone ( HCD57-SREI cells ).": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"PDGF(B)": "RNA"}]', 'prediction': {'PDGF(B)': 'RNA'}}
{'idx': 501, 'sentence': 'Southwestern and gel renaturation experiments with the use of purified protein fractions revealed that TCF-1 alpha activity is derived from a family of 57- to 53-kD proteins that are abundantly expressed in mature and immature T-cell lines ( Jurkat , CCRF-CEM ) and not in mature B cells ( JY , Namalwa ) or nonlymphoid (HeLa) cell lines .', 'label': {'CCRF-CEM': 'cell_line', 'TCF-1 alpha': 'protein', 'nonlymphoid (HeLa) cell lines': 'cell_line', 'mature B cells': 'cell_line', 'JY': 'cell_line', 'Namalwa': 'cell_line', '57- to 53-kD proteins': 'protein', 'Jurkat': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[\n    {"TCF-1 alpha": "protein"},\n    {"57- to 53-kD proteins": "protein"},\n    {"Jurkat": "cell_line"},\n    {"CCRF-CEM": "cell_line"},\n    {"mature T-cell lines": "cell_type"},\n    {"immature T-cell lines": "cell_type"},\n    {"mature B cells": "cell_type"},\n    {"JY": "cell_line"},\n    {"Namalwa": "cell_line"},\n    {"HeLa": "cell_line"}\n]', 'prediction': {'TCF-1 alpha': 'protein', '57- to 53-kD proteins': 'protein', 'Jurkat': 'cell_line', 'CCRF-CEM': 'cell_line', 'mature T-cell lines': 'cell_type', 'immature T-cell lines': 'cell_type', 'mature B cells': 'cell_type', 'JY': 'cell_line', 'Namalwa': 'cell_line', 'HeLa': 'cell_line'}}
{'idx': 457, 'sentence': 'TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes .', 'label': {'T lymphocytes': 'cell_type', 'TAR': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 5},\n    {"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .": 5},\n    {"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .": 5},\n    {"Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 285, 'sentence': 'ER content in lymphocytes of each sample was expressed by both fmol/mg of lymphocyte cytosolic protein and fmol/micrograms of lymphocyte DNA .', 'label': {'ER': 'protein', 'lymphocyte DNA': 'DNA', 'lymphocytes': 'cell_type', 'lymphocyte cytosolic protein': 'protein'}, 'response1': "['protein', 'DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names that match the entity label \'protein\' in the entity label set."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence contains a specific protein name that matches the entity label \'protein\' in the entity label set."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence contains a specific cell type name that matches the entity label \'cell_type\' in the entity label set."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains specific protein and cell type names that match the entity labels \'protein\' and \'cell_type\' in the entity label set."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains specific protein names, cell type names, and protein-related terms that match the entity labels \'protein\' and \'cell_type\' in the entity label set."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains specific protein names and protein-related terms that match the entity label \'protein\' in the entity label set."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence contains specific cell type names that match the entity label \'cell_type\' in the entity label set."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains a specific protein name that matches the entity label \'protein\' in the entity label set."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence contains specific cell type and protein names that match the entity labels \'cell_line\' and \'protein\' in the entity label set."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains specific cell line and protein names that match the entity labels \'cell_line\' and \'protein\' in the entity label set."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains specific protein names that match the entity label \'protein\' in the entity label set."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains a specific protein name that matches the entity label \'protein\' in the entity label set."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains a specific protein name that matches the entity label \'protein\' in the entity label set."},\n    {"Example 14": 4},\n    {"Reason 14": "The sentence contains specific cell line and protein names that match the entity labels \'cell_line\' and \'protein\' in the entity label set."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains specific cell line and protein names that match the entity labels \'cell_line\' and \'protein\' in the entity label set."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any specific named entities that match the entity labels in the entity label set."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific named entities that match the entity labels in the entity label set."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific named entities that match the entity labels in the entity label set."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific named entities that match the entity labels in the entity label set."}\n]', 'response3': "[{'lymphocyte cytosolic protein': 'protein'}, {'lymphocyte DNA': 'DNA'}]", 'prediction': {'lymphocyte cytosolic protein': 'protein', 'lymphocyte DNA': 'DNA'}}
{'idx': 1508, 'sentence': 'Functional characterization of the murine homolog of the B cell-specific coactivator BOB.1/OBF.1 .', 'label': {'BOB.1/OBF.1': 'protein', 'B cell-specific coactivator': 'protein', 'murine homolog': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear and direct mention of the entity \'SCM-1\' and its corresponding entity label \'cell_line\', making it highly helpful for extracting named entities."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions \'UAS1\' as \'cell_line\' and \'B cell\' as \'cell_type\', which are relevant entities for extraction, although the context is slightly more complex compared to Example 1."},\n    {"Example 3": 3},\n    {"Reason 3": "The sentence mentions \'GATA-1\' as \'protein\', which is a relevant entity for extraction, but the context is slightly more complex and may require additional information for accurate extraction."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence mentions \'TCF-1\' as \'protein\', which is a relevant entity for extraction, although the context is slightly more complex compared to Example 1."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence mentions \'E2A\' as \'protein\', which is a relevant entity for extraction, although the context is slightly more complex compared to Example 1."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides clear mentions of \'IL-2\', \'c-Jun\', and \'c-Fos\' as \'protein\' entities, making it highly helpful for extracting named entities."},\n    {"Example 7": 3},\n    {"Reason 7": "The sentence mentions \'GM-CSF\' as \'protein\', which is a relevant entity for extraction, but the context is slightly more complex and may require additional information for accurate extraction."},\n    {"Example 8": 4},\n    {"Reason 8": "The sentence mentions \'T cell\' as \'cell_type\' and \'interleukin 2\' as \'protein\', which are relevant entities for extraction, although the context is slightly more complex compared to Example 1."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence mentions \'CD40\' and \'NF-kappa B\' as \'protein\' entities, which are relevant for extraction, although the context is slightly more complex compared to Example 1."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides clear mentions of \'SLAP-130\', \'SLP-76\', and \'T cell\' as \'protein\' and \'cell_type\' entities, making it highly helpful for extracting named entities."},\n    {"Example 11": 3},\n    {"Reason 11": "The sentence mentions \'GATA-1\' as \'protein\', which is a relevant entity for extraction, but the context is slightly more complex and may require additional information for accurate extraction."},\n    {"Example 12": 4},\n    {"Reason 12": "The sentence mentions \'Sp1\' and \'Ets\' as \'protein\' entities, which are relevant for extraction, although the context is slightly more complex compared to Example 1."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides a clear mention of \'NF-kappa B\' as \'DNA\', making it highly helpful for extracting named entities."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides clear mentions of \'CD70\', \'B cell\', \'plasma cells\', \'IL-4\', and \'CD40\' as \'protein\' and \'cell_type\' entities, making it highly helpful for extracting named entities."},\n    {"Example 15": 4},\n    {"Reason 15": "The sentence mentions \'IL-7R\' and \'gamma(c)\' as \'protein\' entities, which are relevant for extraction, although the context is slightly more complex compared to Example 1."},\n    {"Example 16": 4},\n    {"Reason 16": "The sentence mentions \'Jun\' and \'ATF-2\' as \'protein\' entities, which are relevant for extraction, although the context is slightly more complex compared to Example 1."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not provide any clear mentions of entities relevant for extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not provide any clear mentions of entities relevant for extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not provide any clear mentions of entities relevant for extraction."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not provide any clear mentions of entities relevant for extraction."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 209, 'sentence': 'Type-II estrogen -binding sites ( type-II EBS ) have been demonstrated in the human lymphoblastoid cell line IM-9 using a whole-cell assay with (6,7-3H) estradiol ( 3H-E2 ) as tracer.', 'label': {'lymphoblastoid cell line': 'cell_line', 'IM-9': 'cell_line', 'type-II EBS': 'protein', 'Type-II estrogen -binding sites': 'protein', 'human lymphoblastoid cell line': 'cell_line'}, 'response1': "['cell_line', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 4},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 4},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 5},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"IM-9": "cell_line"}, {"estradiol": "protein"}]', 'prediction': {'IM-9': 'cell_line', 'estradiol': 'protein'}}
{'idx': 1385, 'sentence': "Mutational analyses of the HIV-1 LTR showed that one C/EBP site is required for normal LTR transcription both before and after cellular activation and that the two 3' C/EBP sites are functionally equivalent.", 'label': {'LTR': 'DNA', 'HIV-1 LTR': 'DNA', 'C/EBP sites': 'DNA', 'C/EBP site': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 4},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 4},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n    {"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF.": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.": 5},\n    {"Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB- induced trans-activation of the H4 promoter.": 5},\n    {"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 4},\n    {"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"C/EBP": "protein"}, {"HIV-1 LTR": "DNA"}]', 'prediction': {'C/EBP': 'protein', 'HIV-1 LTR': 'DNA'}}
{'idx': 1516, 'sentence': 'Fusion of subdomains of BOB.1/OBF.1 with the GAL4 DNA binding domain reveals that both NH2- and COOH- terminal domains of BOB.1/OBF.1 contribute to full transactivation function, the COOH-terminal domain is more efficient in this transactivation assay .', 'label': {'BOB.1/OBF.1': 'protein', 'GAL4 DNA binding domain': 'protein', 'COOH-terminal domain': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events.": 5},\n    {"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.": 4},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n    {"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 5},\n    {"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system.": 5},\n    {"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF.": 5},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 4},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 5},\n    {"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif.": 5},\n    {"Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB- induced trans-activation of the H4 promoter.": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1827, 'sentence': 'A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR-1 .', 'label': {'human interleukin 2 gene promoter': 'DNA', 'EGR-1': 'protein', 'Sp1': 'protein', 'regulatory element': 'DNA', 'binding site': 'DNA', 'zinc finger proteins': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific gene names and protein names that are directly related to the entity labels in the target sentence, making it highly relevant for extracting named entities."}\n]', 'response3': '[{"interleukin 2": "protein"}, {"Sp1": "protein"}, {"EGR-1": "protein"}]', 'prediction': {'interleukin 2': 'protein', 'Sp1': 'protein', 'EGR-1': 'protein'}}
{'idx': 1116, 'sentence': 'The tumour suppressor p53 has been shown to regulate this type of apoptosis in thymocytes , but an as yet unknown, p53 -independent pathway (s) appears to mediate the same event in mitogen-activated mature T lymphocytes .', 'label': {'thymocytes': 'cell_type', 'p53': 'protein', 'mitogen-activated mature T lymphocytes': 'cell_line', 'tumour suppressor p53': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .": 5},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .": 4},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .": 4},\n    {"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .": 4},\n    {"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 4},\n    {"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .": 5},\n    {"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 5},\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"The process of apoptosis is used to eliminate unwanted cells from a wide variety of organisms.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"p53": "protein"}, {"apoptosis": "cell_type"}, {"thymocytes": "cell_type"}, {"p53": "protein"}, {"mitogen-activated mature T lymphocytes": "cell_type"}]', 'prediction': {'p53': 'protein', 'apoptosis': 'cell_type', 'thymocytes': 'cell_type', 'mitogen-activated mature T lymphocytes': 'cell_type'}}
{'idx': 178, 'sentence': 'T lymphocytes appeared to be an important source of 1,25(OH)2D3 production , since purified T lymphocytes from all patients with tuberculosis produced 1,25(OH)2D3 , and 1,25(OH)2D3 production by these cells correlated closely with that produced by unseparated lavage cells .', 'label': {'T lymphocytes': 'cell_type', 'lavage cells': 'cell_type'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a clear entity and label that directly matches the entity types in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The example provides clear entities and labels that directly match the entity types in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The example provides a clear entity and label that directly matches the entity types in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The example provides clear entities and labels that directly match the entity types in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides a clear entity and label that directly matches the entity types in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The example provides clear entities and labels that directly match the entity types in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The example provides clear entities and labels that directly match the entity types in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides clear entities and labels that directly match the entity types in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides clear entities and labels that directly match the entity types in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides clear entities and labels that directly match the entity types in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The example provides clear entities and labels that directly match the entity types in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The example provides clear entities and labels that directly match the entity types in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides clear entities and labels that directly match the entity types in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The example provides clear entities and labels that directly match the entity types in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The example does not contain any entities or labels that match the entity types in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain any entities or labels that match the entity types in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain any entities or labels that match the entity types in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any entities or labels that match the entity types in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The example does not contain any entities or labels that match the entity types in the target sentence."}\n]', 'response3': "[{'T lymphocytes': 'cell_type'}, {'1,25(OH)2D3': 'protein'}, {'tuberculosis': 'cell_type'}, {'unseparated lavage cells': 'cell_line'}]", 'prediction': {'T lymphocytes': 'cell_type', '1,25(OH)2D3': 'protein', 'tuberculosis': 'cell_type', 'unseparated lavage cells': 'cell_line'}}
{'idx': 1209, 'sentence': 'A reduction of serum androgens was found, whereas no change was observed in either basal or GnRH-stimulated gonadotropins or in the cortisol and 17 alpha-hydroxyprogesterone response to ACTH .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .": 4},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .": 4},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release .": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 5},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .": 5},\n    {"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 4},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .": 4},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"Interestingly, CTLA4Ig did not significantly inhibit the activation of either NF of activated T cells ( NFAT ) or AP-1 reporters .": 4},\n    {"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.": 5},\n    {"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator .": 5},\n    {"When 18C7 was incubated with MR before aldosterone or progesterone , the antibody inhibited 75-80% of the binding.": 5},\n    {"In apparent contradiction, expression of a dominant negative form of Ras , RasN17 , also inhibited IL-2 -induced activation of the promoter containing the minimal beta-casein STAT5 element as well as the promoters of CIS and OSM .": 5},\n    {"The number of Type I and Type II receptors before the test was lower in elderly subjects than in adults .": 4},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 864, 'sentence': 'Differences in transcriptional enhancers of HIV-1 and HIV-2 .', 'label': {'transcriptional enhancers': 'DNA'}, 'response1': "['DNA', 'RNA']", 'response2': '[\n    {"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.": 5},\n    {"Differences in transcriptional enhancers of HIV-1 and HIV-2.": 4},\n    {"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 4},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 4},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 5},\n    {"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5},\n    {"NF-E1 is encoded by the same gene as the YY-1 protein, which binds to the adeno-associated virus P5 promoter.": 4},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 65, 'sentence': 'Deletions upstream of the PRDII element increased transcription in the uninduced extract, indicating predominantly negative regulation of the promoter .', 'label': {'promoter': 'DNA', 'PRDII element': 'DNA'}, 'response1': "['DNA', 'RNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 61, 'sentence': 'From HeLa cells , two major proteins of 52 and 45 kilodaltons (kD) copurified with DNA binding activity , whereas from T-cells , four proteins--a major protein of 52 kD and three minor proteins of 82 , 67 , and 43-47 kD --were purified.', 'label': {'82': 'protein', '43-47 kD': 'protein', 'major protein': 'protein', 'T-cells': 'cell_type', 'minor proteins': 'protein', '67': 'protein', 'HeLa cells': 'cell_line', '52 kD': 'protein'}, 'response1': "['protein', 'cell_line', 'DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"HeLa cells": "cell_line"}, {"T-cells": "cell_type"}, {"DNA": "DNA"}, {"proteins": "protein"}]', 'prediction': {'HeLa cells': 'cell_line', 'T-cells': 'cell_type', 'DNA': 'DNA', 'proteins': 'protein'}}
{'idx': 191, 'sentence': 'A block to RNA elongation is largely responsible for decreased c-myc transcription .', 'label': {'c-myc': 'DNA'}, 'response1': "['RNA']", 'response2': '[\n    {"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .": 5},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n    {"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 5},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 5},\n    {"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .": 5},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 447, 'sentence': 'Each binding site contributes to the overall activity of the enhancer , however no single element seems absolutely required for activity.', 'label': {'enhancer': 'DNA', 'binding site': 'DNA'}, 'response1': "['DNA']", 'response2': '[\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 4},\n    {"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 3},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 3},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 3},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 4},\n    {"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.": 4},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 4},\n    {"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 4},\n    {"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 4},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n    {"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 4},\n    {"We have found that the recruitment of EKLF to 5\'HS3 depends on the presence of 5\'HS2 in cis, but the recruitment to 5\'HS2 does not depend on 5\'HS3.": 4},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 4},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 4},\n    {"Our results demonstrate that the altered CCAAT box (CCAAC) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 4},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 476, 'sentence': 'A group of coordinately induced protooncogenes , cytoskeletal , and extracellular matrix genes have been termed immediate early response genes , and their induction has been associated with growth factor -stimulated cell proliferation .', 'label': {'protooncogenes': 'DNA', 'immediate early response genes': 'DNA', 'growth factor': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .": 5},\n    {"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .": 4},\n    {"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 5},\n    {"The p21ras small GTP binding proteins participate in signal transduction from cell surface receptors and affect neoplastic transformation and development in many different cell types.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 5},\n    {"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .": 5},\n    {"Activated Stat proteins form homo- or heterodimers, translocate to the nucleus , and induce transcription from responsive genes.": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5}\n]', 'response3': '[{"protooncogenes": "protein"}, {"cytoskeletal": "protein"}, {"extracellular matrix genes": "protein"}, {"growth factor": "protein"}, {"cell proliferation": "cell_type"}]', 'prediction': {'protooncogenes': 'protein', 'cytoskeletal': 'protein', 'extracellular matrix genes': 'protein', 'growth factor': 'protein', 'cell proliferation': 'cell_type'}}
{'idx': 1034, 'sentence': 'p94 and p95 share homology with Stat1 at the phosphorylation site and in the Src homology 2 (SH2) domain , but otherwise are immunologically distinct from Stat1 .', 'label': {'Stat1': 'protein', 'phosphorylation site': 'protein', 'Src homology 2 (SH2) domain': 'protein', 'p94': 'protein', 'p95': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"p21(WAF1/CIP1 ) and p27(KIP1)": 5},\n    {"calcineurin": 4},\n    {"Th1 and Th2": 4},\n    {"IL-2": 5},\n    {"IL4 and IL13 receptors": 5},\n    {"IL-2": 5},\n    {"IL-12": 5},\n    {"SLAP-130": 5},\n    {"tyrosine": 4},\n    {"IL-2": 5},\n    {"ERK": 4},\n    {"CD28 with either CD80 or CD86": 5},\n    {"Sp1 and NF-kappaB": 5},\n    {"interleukin 10 ( IL-10R )": 5}\n]', 'response3': '[{"p94": "protein"}, {"p95": "protein"}, {"Stat1": "protein"}]', 'prediction': {'p94': 'protein', 'p95': 'protein', 'Stat1': 'protein'}}
{'idx': 1232, 'sentence': 'IBR is a 503-amino-acid-long acidic protein which is 99.0% identical to the recently reported human NRF-1/alpha-Pal factor and highly related to the invertebrate transcription factors P3A2 and erected wing gene product ( EWG ).', 'label': {'IBR': 'protein', 'transcription factors': 'protein', 'erected wing gene product': 'protein', 'human NRF-1/alpha-Pal factor': 'protein', 'EWG': 'protein', 'P3A2': 'protein', '503-amino-acid-long acidic protein': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein (Egr-1) being mentioned in the context of a zinc finger transcription factor, aiding in the extraction of protein entities."},\n    {"Example 2": 3},\n    {"Reason 2": "The sentence mentions NF-ATc, which is a transcription factor, and also references T lymphocytes and embryonic cardiac cells as cell types. While NF-ATc is a clear example, the presence of cell types adds some complexity to the extraction."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence discusses the interaction related to myeloid differentiation but does not provide specific entity examples related to the entity label set, making it less helpful for named entity extraction."},\n    {"Example 4": 1},\n    {"Reason 4": "The sentence talks about the inhibition of protein synthesis and chromatin fragmentation but does not mention specific entities related to the entity label set, making it less helpful for named entity extraction."},\n    {"Example 5": 1},\n    {"Reason 5": "The sentence mentions genes and translocations but does not provide specific examples related to the entity label set, making it less helpful for named entity extraction."},\n    {"Example 6": 1},\n    {"Reason 6": "The sentence discusses deletions, mutations, and serum response but does not mention specific entities related to the entity label set, making it less helpful for named entity extraction."},\n    {"Example 7": 1},\n    {"Reason 7": "The sentence talks about pulmonary surfactant and its properties but does not provide specific examples related to the entity label set, making it less helpful for named entity extraction."}\n]', 'response3': '[{"IBR": "protein"}, {"NRF-1/alpha-Pal": "protein"}, {"P3A2": "protein"}, {"erected wing gene product (EWG)": "protein"}]', 'prediction': {'IBR': 'protein', 'NRF-1/alpha-Pal': 'protein', 'P3A2': 'protein', 'erected wing gene product (EWG)': 'protein'}}
{'idx': 54, 'sentence': 'Virus stocks obtained from these experiments exhibited a continuum of replicative capacities in different human T-cell types depending on which element (s) was present in the LTR .', 'label': {'LTR': 'DNA', 'human T-cell types': 'cell_type', 'T-cell types': 'cell_type', 'element': 'DNA'}, 'response1': "['cell_type']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence contains clear mentions of DNA and RNA, which are directly related to the entity labels in the target sentence."},\n{"Example 2": 4},\n{"Reason 2": "The sentence mentions IL-2, which is related to the \'protein\' entity label in the target sentence."},\n{"Example 3": 3},\n{"Reason 3": "The sentence mentions cell lines such as SIVmacMER, SIVmac239, and CEMx174, which are related to the \'cell_line\' entity label in the target sentence."},\n{"Example 4": 4},\n{"Reason 4": "The sentence mentions CD4+ cells and EBV, which are related to the \'cell_type\' and \'protein\' entity labels in the target sentence."},\n{"Example 5": 5},\n{"Reason 5": "The sentence contains multiple mentions of proteins and interleukins, which are directly related to the entity labels in the target sentence."},\n{"Example 6": 4},\n{"Reason 6": "The sentence mentions TIMP-1 and DNA, which are related to the \'protein\' and \'DNA\' entity labels in the target sentence."},\n{"Example 7": 4},\n{"Reason 7": "The sentence mentions Th2-type lymphocytes, which are related to the \'cell_type\' entity label in the target sentence."},\n{"Example 8": 4},\n{"Reason 8": "The sentence mentions EBV and CD2, which are related to the \'cell_line\' and \'protein\' entity labels in the target sentence."},\n{"Example 9": 4},\n{"Reason 9": "The sentence mentions PBMC and adenovirus DNA, which are related to the \'cell_type\' and \'DNA\' entity labels in the target sentence."},\n{"Example 10": 3},\n{"Reason 10": "The sentence mentions SIVsmmPBj14, which is related to the \'cell_line\' entity label in the target sentence."},\n{"Example 11": 4},\n{"Reason 11": "The sentence mentions CD95 ligand, which is related to the \'protein\' entity label in the target sentence."},\n{"Example 12": 5},\n{"Reason 12": "The sentence mentions HIV-1 LTR, NFAT-1, and NF kappa B, which are directly related to the entity labels in the target sentence."},\n{"Example 13": 4},\n{"Reason 13": "The sentence mentions EBV, EBNA2, and estrogen receptor, which are related to the \'DNA\' and \'protein\' entity labels in the target sentence."},\n{"Example 14": 4},\n{"Reason 14": "The sentence mentions TR55, TNF-alpha, and HIV, which are related to the \'protein\' and \'cell_type\' entity labels in the target sentence."},\n{"Example 15": 4},\n{"Reason 15": "The sentence mentions NF-kappaB, Sp1, and SIVmac, which are related to the \'protein\' and \'cell_line\' entity labels in the target sentence."},\n{"Example 16": 3},\n{"Reason 16": "The sentence mentions T lymphocytes and adenovirus vectors, which are related to the \'cell_type\' and \'DNA\' entity labels in the target sentence."},\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any relevant entities related to the target sentence."},\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any relevant entities related to the target sentence."},\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any relevant entities related to the target sentence."},\n{"Example 20": 1},\n{"Reason 20": "The sentence does not contain any relevant entities related to the target sentence."}\n]', 'response3': "[{'Virus stocks': 'protein'}, {'human T-cell types': 'cell_type'}, {'LTR': 'DNA'}]", 'prediction': {'Virus stocks': 'protein', 'human T-cell types': 'cell_type', 'LTR': 'DNA'}}
{'idx': 1149, 'sentence': 'The expression and activity of NF-kappa B and Sp1 were, therefore, analyzed in isolated T cells and DCs from humans and mice .', 'label': {'Sp1': 'protein', 'DCs': 'cell_type', 'NF-kappa B': 'protein', 'T cells': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 5},\n    {"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .": 4},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .": 4},\n    {"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .": 5},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .": 5},\n    {"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .": 5},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .": 5},\n    {"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .": 5},\n    {"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .": 5},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .": 5},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"Sp1": "protein"}, {"T cells": "cell_type"}, {"DCs": "cell_type"}, {"humans": "cell_type"}, {"mice": "cell_type"}]', 'prediction': {'NF-kappa B': 'protein', 'Sp1': 'protein', 'T cells': 'cell_type', 'DCs': 'cell_type', 'humans': 'cell_type', 'mice': 'cell_type'}}
{'idx': 407, 'sentence': 'Since most of the actions of vitamin D are mediated by its receptors ( VDR ), abnormalities of VDR have been postulated in XLH .', 'label': {'VDR': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein (retinoic acid receptor alpha) and its corresponding entity label, which directly matches the entity types in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides examples of proteins (IL-7R and gamma(c)) that match the entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence mentions lymphoid neoplasms, which corresponds to the \'cell_type\' entity label in the target sentence, providing relevant information for entity extraction."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence clearly mentions the protein \'retinoic acid receptor alpha\' which matches the entity types in the target sentence, aiding in named entity extraction."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence mentions \'nonhuman primates\' as a \'cell_type\', which aligns with the entity types in the target sentence, providing relevant context for entity extraction."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence mentions \'lymphocytes\', \'benzene\', and \'benzoquinone\' which correspond to \'cell_type\' and \'chemical compound\' entity labels in the target sentence, aiding in named entity extraction."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides a clear example of the protein \'RXR\' and its mutants, aligning with the entity types in the target sentence, aiding in named entity extraction."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions the protein \'G-CSF\' and its receptors, matching the entity types in the target sentence, providing valuable information for entity extraction."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides examples of proteins (IL4, IL13, STAT6, STAT3, STAT5) and \'B cells\' which align with the entity types in the target sentence, aiding in named entity extraction."},\n    {"Example 10": 3},\n    {"Reason 10": "The sentence mentions \'CCAAT box\' and \'EKLF binding site\' which correspond to \'DNA\' and \'protein\' entity labels in the target sentence, providing some relevant information for entity extraction."},\n    {"Example 11": 3},\n    {"Reason 11": "The sentence mentions \'AP-1\' as \'DNA\', which aligns with the entity types in the target sentence, providing partial assistance in named entity extraction."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence mentions the protein \'CD14\', matching the entity types in the target sentence, aiding in named entity extraction."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides examples of proteins (VDR, RXR, GRIP-1, DRIP205) and the \'DRIP\' complex, aligning with the entity types in the target sentence, aiding in named entity extraction."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence mentions proteins (interleukin-2, CD25, IL-2 receptor) and \'B cells\' which correspond to the entity types in the target sentence, providing valuable information for entity extraction."},\n    {"Example 15": 4},\n    {"Reason 15": "The sentence mentions \'TR55\', \'TNF-alpha\', and \'HIV\' which align with the entity types in the target sentence, aiding in named entity extraction."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence provides examples of proteins (VDR, beta-globin) matching the entity types in the target sentence, aiding in named entity extraction."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any relevant examples of named entities that match the entity types in the target sentence, providing no assistance in named entity extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any relevant examples of named entities that match the entity types in the target sentence, providing no assistance in named entity extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any relevant examples of named entities that match the entity types in the target sentence, providing no assistance in named entity extraction."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any relevant examples of named entities that match the entity types in the target sentence, providing no assistance in named entity extraction."}\n]', 'response3': "[{'VDR': 'protein'}, {'XLH': 'cell_type'}]", 'prediction': {'VDR': 'protein', 'XLH': 'cell_type'}}
{'idx': 1466, 'sentence': 'As we observed that activated endothelial cells also expressed NFAT , we tested the antiinflammatory properties of CsA in endothelial cells .', 'label': {'endothelial cells': 'cell_type', 'NFAT': 'protein', 'activated endothelial cells': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a clear mapping between the entity \'NF-kappa B\' and its corresponding label \'DNA\', aiding in the extraction of named entities from the target sentence."},\n\n    {"Example 2": 4},\n    {"Reason 2": "The example provides mappings for entities \'NF-kappa B\' and \'I kappa B alpha\' to their corresponding labels \'protein\', which helps in identifying protein entities in the target sentence."},\n\n    {"Example 3": 5},\n    {"Reason 3": "The example covers multiple entity types such as \'AP-1\' and \'PMA\' mapped to \'protein\', and \'monocytes\' and \'macrophages\' mapped to \'cell_type\', aiding in the extraction of named entities from the target sentence."},\n\n    {"Example 4": 5},\n    {"Reason 4": "The example provides mappings for entities \'granulocytes\' and \'T cells\' to their corresponding labels \'cell_type\', assisting in identifying cell type entities in the target sentence."},\n\n    {"Example 5": 4},\n    {"Reason 5": "The example maps the entity \'NF-kappa B\' to the label \'protein\', aiding in the extraction of protein entities from the target sentence."},\n\n    {"Example 6": 4},\n    {"Reason 6": "The example provides mappings for entities \'NF-kappaB\', \'Tax\', and \'ATL\' to their corresponding labels \'protein\' and \'cell_type\', aiding in identifying protein and cell type entities in the target sentence."},\n\n    {"Example 7": 4},\n    {"Reason 7": "The example covers entities \'alpha-tocopherol\', \'monocyte\', and \'endothelial cells\' mapped to \'protein\' and \'cell_type\', assisting in the extraction of named entities from the target sentence."},\n\n    {"Example 8": 4},\n    {"Reason 8": "The example maps the entity \'NF-kappa B\' to the label \'protein\', aiding in the extraction of protein entities from the target sentence."},\n\n    {"Example 9": 4},\n    {"Reason 9": "The example maps the entity \'P selectin\' to the label \'protein\', aiding in the extraction of protein entities from the target sentence."},\n\n    {"Example 10": 5},\n    {"Reason 10": "The example provides mappings for entities \'NF-kappa B\' and \'ARDS\' to their corresponding labels \'protein\' and \'cell_type\', aiding in identifying protein and cell type entities in the target sentence."},\n\n    {"Example 11": 4},\n    {"Reason 11": "The example maps the entity \'NF-kappa B\' to the label \'protein\', aiding in the extraction of protein entities from the target sentence."},\n\n    {"Example 12": 4},\n    {"Reason 12": "The example provides a mapping for the entity \'MNDA\' to the label \'protein\' and \'Philadelphia chromosome-positive chronic myeloid leukemia\' to the label \'cell_line\', aiding in identifying protein and cell line entities in the target sentence."},\n\n    {"Example 13": 4},\n    {"Reason 13": "The example maps the entity \'E2A\' to the label \'protein\', aiding in the extraction of protein entities from the target sentence."},\n\n    {"Example 14": 5},\n    {"Reason 14": "The example covers multiple entity types such as \'NF-kappa B\' and \'AP-1\' mapped to \'protein\', aiding in the extraction of named entities from the target sentence."},\n\n    {"Example 15": 5},\n    {"Reason 15": "The example provides mappings for multiple entities like \'IFN A\', \'IFNA\', \'interleukin-2\', \'interleukin-2 receptor\', \'phytohemagglutinin\', and \'phorbol myristate acetate\' to their corresponding labels \'protein\', aiding in identifying protein entities in the target sentence."},\n\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain any entities that match the entity labels provided in the target sentence, hence not helpful in extracting named entities."},\n\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain any entities that match the entity labels provided in the target sentence, hence not helpful in extracting named entities."},\n\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any entities that match the entity labels provided in the target sentence, hence not helpful in extracting named entities."},\n\n    {"Example 19": 1},\n    {"Reason 19": "The example does not contain any entities that match the entity labels provided in the target sentence, hence not helpful in extracting named entities."}\n]', 'response3': "[{'NFAT': 'protein'}, {'CsA': 'protein'}, {'endothelial cells': 'cell_type'}]", 'prediction': {'NFAT': 'protein', 'CsA': 'protein', 'endothelial cells': 'cell_type'}}
{'idx': 1330, 'sentence': 'Stimulation of cells leads to a rapid phosphorylation of I kappa B alpha , which is presumed to be important for the subsequent degradation .', 'label': {'I kappa B alpha': 'protein', 'I kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence 1": 5},\n    {"Sentence 2": 5},\n    {"Sentence 3": 5},\n    {"Sentence 4": 5},\n    {"Sentence 5": 5},\n    {"Sentence 6": 5},\n    {"Sentence 7": 5},\n    {"Sentence 8": 4},\n    {"Sentence 9": 1},\n    {"Sentence 10": 1},\n    {"Sentence 11": 1},\n    {"Sentence 12": 1},\n    {"Sentence 13": 5},\n    {"Sentence 14": 5},\n    {"Sentence 15": 5},\n    {"Sentence 16": 1},\n    {"Sentence 17": 1},\n    {"Sentence 18": 1},\n    {"Sentence 19": 1}\n]', 'response3': '[{"I kappa B alpha": "protein"}]', 'prediction': {'I kappa B alpha': 'protein'}}
{'idx': 1436, 'sentence': 'Similar levels of hTR beta 1 mRNA levels were detected in thyroid gland from euthyroid patients .', 'label': {'hTR beta 1 mRNA': 'RNA', 'hTR beta 1': 'protein'}, 'response1': "['RNA']", 'response2': '[\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects.": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 4},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.": 5},\n    {"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus , and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"hTR beta 1 mRNA": "RNA"}]', 'prediction': {'hTR beta 1 mRNA': 'RNA'}}
{'idx': 859, 'sentence': 'We show that at least one inducible , C1 , and one constitutive, C2 , protein can bind to the HIV enhancer in Jurkat cells .', 'label': {'inducible': 'protein', 'Jurkat cells': 'cell_line', 'C1': 'protein', 'HIV enhancer': 'DNA', 'C2': 'protein', 'constitutive, C2 , protein': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n{"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .": 5},\n{"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n{"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .": 5},\n{"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .": 5},\n{"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 5},\n{"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n{"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n{"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n{"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .": 5},\n{"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .": 5},\n{"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .": 5},\n{"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .": 5},\n{"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .": 5}\n]', 'response3': '[{"C1": "protein"}, {"C2": "protein"}, {"HIV enhancer": "DNA"}, {"Jurkat cells": "cell_line"}]', 'prediction': {'C1': 'protein', 'C2': 'protein', 'HIV enhancer': 'DNA', 'Jurkat cells': 'cell_line'}}
{'idx': 451, 'sentence': 'However, despite its ability to activate transcription of a transfected reporter gene , the factor is apparently unable to bind to the endogenous Ig heavy chain enhancer in non- lymphoid cells : In previous experiments by others, the characteristic in vivo footprint of this factor, designated NF-muE3 , was detected in B cells but not in non-B cells .', 'label': {'NF-muE3': 'protein', 'B cells': 'cell_type', 'lymphoid cells': 'cell_type', 'transfected reporter gene': 'DNA', 'Ig heavy chain enhancer': 'DNA', 'non- lymphoid cells': 'cell_type', 'non-B cells': 'cell_type', 'endogenous Ig heavy chain enhancer': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"p50p50": 5},\n    {"Egr-1": 5},\n    {"IFN A": 4, "IFNA": 4, "interleukin-2": 4, "interleukin-2 receptor": 4, "phytohemagglutinin": 4, "phorbol myristate acetate": 4},\n    {"TCF-1": 5},\n    {"IL-2 receptor alpha subunit": 4, "p21ras": 4, "B cell": 4},\n    {"NF-ATc": 5, "T lymphocytes": 5, "embryonic cardiac cells": 5},\n    {"IL-2": 5},\n    {"NF-kappaB": 5, "Sp1": 5, "p50": 5},\n    {"c-kit": 5, "IL-4R alpha chain": 5},\n    {"IL-2": 5, "c-Jun": 5, "c-Fos": 5},\n    {"immunoglobulin kappa 3\' enhancer": 5},\n    {"IL-2": 5, "IFN-gamma": 5, "jak kinases": 5, "STAT1(alpha)": 5},\n    {"NF-kappaB": 5, "rheumatoid arthritis": 4},\n    {"CD40": 5, "Rel/nuclear factor kappaB": 5, "NF-kappaB": 5, "B lymphocytes": 5},\n    {"NF-kappaB": 5, "Sp1": 5, "SIVmac": 5},\n    {"CTLA4Ig": 5, "NFAT": 5, "AP-1": 5}\n]', 'response3': '[{"Ig heavy chain enhancer": "DNA"}, {"NF-muE3": "protein"}, {"B cells": "cell_type"}, {"non-B cells": "cell_type"}]', 'prediction': {'Ig heavy chain enhancer': 'DNA', 'NF-muE3': 'protein', 'B cells': 'cell_type', 'non-B cells': 'cell_type'}}
{'idx': 919, 'sentence': 'The human protein recognized by the EC1 antibody is a 56-kDa protein ( p56 ) of moderate abundance located predominantly in the cytoplasm by indirect immunofluorescence .', 'label': {'56-kDa protein': 'protein', 'p56': 'protein', 'EC1 antibody': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides specific examples of proteins and their corresponding labels, which directly match the entity types in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions proteins and transcription factors, which are relevant entity types in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence directly mentions a protein and its label, matching the entity type in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides specific examples of proteins and their corresponding labels, which directly match the entity types in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence mentions a specific protein and its label, which directly corresponds to the entity type in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence mentions specific proteins and their labels, matching the entity types in the target sentence."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence mentions proteins and gene expression, which are relevant entity types in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides specific examples of proteins and their corresponding labels, which directly match the entity types in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence mentions cDNAs and their encoding, which corresponds to the DNA entity type in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence mentions specific proteins and their labels, matching the entity types in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides specific examples of proteins and their corresponding labels, which directly match the entity types in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence mentions a specific protein and its label, which directly corresponds to the entity type in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence mentions a specific protein and its label, which directly corresponds to the entity type in the target sentence."},\n    {"Example 14": 4},\n    {"Reason 14": "The sentence mentions Th2-type lymphocytes, which is a relevant entity type in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not mention any relevant entity types present in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not mention any relevant entity types present in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not mention any relevant entity types present in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not mention any relevant entity types present in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not mention any relevant entity types present in the target sentence."}\n]', 'response3': '[{"EC1 antibody": "protein"}, {"p56": "protein"}]', 'prediction': {'EC1 antibody': 'protein', 'p56': 'protein'}}
{'idx': 1206, 'sentence': 'In addition, the concentration of androgen receptors in mononuclear leukocytes was measured, in both the follicular and luteal phases of the menstrual cycle , basally and after 4 months of flutamide treatment.', 'label': {'androgen receptors': 'protein', 'mononuclear leukocytes': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a clear mapping between the entity \'RXR\' and its corresponding entity label \'protein\', aiding in the extraction of named entities from the target sentence."},\n\n    {"Example 2": 4},\n    {"Reason 2": "The example provides clear mappings between the entities \'granulocytes\' and \'T cells\' with their corresponding entity labels \'cell_type\', aiding in the extraction of named entities from the target sentence."},\n\n    {"Example 3": 3},\n    {"Reason 3": "The example provides a clear mapping between the entity \'lymphoid neoplasms\' and its corresponding entity label \'cell_type\', somewhat aiding in the extraction of named entities from the target sentence."},\n\n    {"Example 4": 5},\n    {"Reason 4": "The example provides a clear mapping between the entity \'CD14\' and its corresponding entity label \'protein\', aiding in the extraction of named entities from the target sentence."},\n\n    {"Example 5": 4},\n    {"Reason 5": "The example provides clear mappings between the entities \'phosphocreatine\', \'dexamethasone\', \'cortisol\', and \'lysozyme\' with their corresponding entity labels \'protein\', aiding in the extraction of named entities from the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 569, 'sentence': 'In addition, the increases in c-jun , EGR2 , and PDGF(B) may depend on cytoskeletal rearrangement .', 'label': {'PDGF(B)': 'protein', 'EGR2': 'DNA', 'c-jun': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B, possibly by a phosphorylation reaction involving protein kinase C by PAF.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines.": 5},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 5},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"The p21ras small GTP binding proteins participate in signal transduction from cell surface receptors and affect neoplastic transformation and development in many different cell types.": 5},\n    {"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway, and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n    {"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5}\n]', 'response3': '[{"c-jun": "protein"}, {"EGR2": "protein"}, {"PDGF(B)": "protein"}]', 'prediction': {'c-jun': 'protein', 'EGR2': 'protein', 'PDGF(B)': 'protein'}}
{'idx': 1657, 'sentence': 'HMG-I binds to GATA motifs : implications for an HPFH syndrome .', 'label': {'HMG-I': 'protein', 'GATA motifs': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific gene names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions a specific gene (GM-CSF) which is a protein, matching one of the entity types in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence directly mentions NF-kappa B as a DNA binding activity, matching one of the entity types in the target sentence."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence talks about the binding of p50p50, which is a protein, matching one of the entity types in the target sentence."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence describes the mRNA expression of GATA-1 binding transcription factor, which is a protein, matching one of the entity types in the target sentence."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence mentions protein and genomic sequences, suggesting the presence of protein entities, which match one of the entity types in the target sentence."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence discusses the regulatory mechanism of the SCM-1 genes, indicating the presence of a cell line entity, which matches one of the entity types in the target sentence."},\n    {"Example 8": 4},\n    {"Reason 8": "The sentence talks about the effects of G-CSF mediated by binding to receptors, indicating the presence of a protein entity, which matches one of the entity types in the target sentence."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence mentions cytokines expressed by human Th2-type lymphocytes, suggesting the presence of cell type entities, which match one of the entity types in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence directly mentions NF-E2 as a cell-specific transcription factor, matching one of the entity types in the target sentence."},\n    {"Example 11": 4},\n    {"Reason 11": "The sentence describes the specific role of the transcription factor A-myb, indicating the presence of a protein entity, which matches one of the entity types in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence directly mentions IkappaBbeta and NF-kappaB as proteins, matching two of the entity types in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence mentions Oct-2A, HMG I/Y, HLA-DRA, and B cells as proteins and cell types, matching multiple entity types in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence mentions EKLF, CBP, p300, and P/CAF as acetylated transcription factors, matching multiple entity types in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence mentions Stat3, Stat5, and c-Mpl as proteins, matching multiple entity types in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any specific gene names or entities that match the entity types in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific gene names or entities that match the entity types in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific gene names or entities that match the entity types in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific gene names or entities that match the entity types in the target sentence."}\n]', 'response3': '[{"HMG-I": "protein"}, {"GATA motifs": "DNA"}]', 'prediction': {'HMG-I': 'protein', 'GATA motifs': 'DNA'}}
{'idx': 1780, 'sentence': 'Interestingly, Id2 , but not Id3 , mRNA was strongly expressed in 4/5 T-cell lines infected with human T-cell leukemia virus type I ( HTLV-I ) ( ATL-1k , MT-2 , S-LB1 ) and type II ( Mo ) .', 'label': {'Id3': 'protein', 'Mo': 'cell_line', 'Id2': 'protein', '4/5 T-cell lines': 'cell_line', 'S-LB1': 'cell_line', 'MT-2': 'cell_line', 'ATL-1k': 'cell_line'}, 'response1': "['RNA', 'cell_line']", 'response2': '[\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.": 5},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"Expression of tal-1 and GATA-binding proteins during human hematopoiesis.": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1/c6.1B, in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"Id2": "RNA"}, {"Id3": "RNA"}, {"T-cell lines": "cell_line"}, {"human T-cell leukemia virus type I (HTLV-I)": "cell_type"}, {"ATL-1k": "cell_line"}, {"MT-2": "cell_line"}, {"S-LB1": "cell_line"}, {"type II (Mo)": "cell_type"}]', 'prediction': {'Id2': 'RNA', 'Id3': 'RNA', 'T-cell lines': 'cell_line', 'human T-cell leukemia virus type I (HTLV-I)': 'cell_type', 'ATL-1k': 'cell_line', 'MT-2': 'cell_line', 'S-LB1': 'cell_line', 'type II (Mo)': 'cell_type'}}
{'idx': 13, 'sentence': 'We further demonstrate the impact of platelet-activating factor binding to B cells by measuring platelet-activating factor induced arachidonic acid release and 5-hydroxyeicosatetraenoic acid production.', 'label': {'platelet-activating factor': 'protein', 'B cells': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 4},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 4},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 3},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"We have examined the effect of alpha-tocopherol ( alpha-tcp ) on one cellular event in atherosclerotic plaque development , monocyte adhesion to stimulated endothelial cells ( ECs ).": 4},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 4},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects.": 5},\n    {"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.": 4},\n    {"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation.": 5},\n    {"PMA induced the expression of both CD14 and CD23 mRNA and protein.": 5},\n    {"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation.": 4},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1554, 'sentence': 'The results define essential cis-acting elements responsible for the expression of GP Ib alpha and provide insights into molecular events coinciding with the release of normal platelets into the bloodstream .', 'label': {'GP': 'protein', 'normal platelets': 'cell_type', 'cis-acting elements': 'DNA', 'GP Ib alpha': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.": 4},\n    {"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 4},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements .": 4},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .": 4},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .": 5},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .": 5},\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .": 4},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .": 5},\n    {"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts .": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"GP Ib alpha": "protein"}]', 'prediction': {'GP Ib alpha': 'protein'}}
{'idx': 1650, 'sentence': 'This is the first demonstration of a specific interaction with PU.1 on a myeloid PU.1 binding site .', 'label': {'PU.1': 'protein', 'myeloid PU.1 binding site': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"PU.1": "protein"}, {"myeloid": "cell_type"}, {"PU.1": "protein"}]', 'prediction': {'PU.1': 'protein', 'myeloid': 'cell_type'}}
{'idx': 326, 'sentence': 'We show here that domain B is an R-responsive element in HeLa cells and is therefore not an EB1 -responsive B-cell-specific element .', 'label': {'EB1': 'protein', 'R-responsive element': 'DNA', 'HeLa cells': 'cell_line', 'domain B': 'DNA', 'EB1 -responsive B-cell-specific element': 'DNA'}, 'response1': "['cell_line', 'cell_type']", 'response2': '[\n    {"Sentence": 4},\n    {"Reason": "The sentence contains multiple protein entities such as IL-2, RelA, NF-kappa B, c-Jun, and c-Fos, which are relevant to the entity labels in the target sentence."},\n    {"Sentence": 3},\n    {"Reason": "The sentence mentions the E2A protein, which is relevant to the entity labels in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions EBV and B-cell, which are relevant to the entity labels in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains protein entities such as IL-2, IFN-gamma, jak kinases, and STAT1(alpha), which are relevant to the entity labels in the target sentence."},\n    {"Sentence": 2},\n    {"Reason": "The sentence mentions the CCAAT box and EKLF binding site, which are relevant to the entity labels in the target sentence."},\n    {"Sentence": 2},\n    {"Reason": "The sentence mentions the T cell and interleukin 2, which are relevant to the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence mentions p50p50, which is relevant to the entity labels in the target sentence."},\n    {"Sentence": 2},\n    {"Reason": "The sentence mentions CD4+ cells and EBV, which are relevant to the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence mentions EKLF, which is relevant to the entity labels in the target sentence."},\n    {"Sentence": 3},\n    {"Reason": "The sentence mentions EBV and CD2, which are relevant to the entity labels in the target sentence."},\n    {"Sentence": 2},\n    {"Reason": "The sentence mentions EBNA2 and TP1, which are relevant to the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence mentions RXR, which is relevant to the entity labels in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions B and T cell activation, Ramos, Jurkat cells, and cDNA microarray technology, which are relevant to the entity labels in the target sentence."}\n]', 'response3': "[{'HeLa cells': 'cell_line'}, {'EB1': 'protein'}, {'B-cell': 'cell_type'}]", 'prediction': {'HeLa cells': 'cell_line', 'EB1': 'protein', 'B-cell': 'cell_type'}}
{'idx': 1429, 'sentence': 'Data from cell culture and animal studies indicate that TR expression may be regulated to modulate target organ responsiveness to thyroid hormone .', 'label': {'TR': 'protein'}, 'response1': "['cell_type']", 'response2': '[\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 4},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.": 5},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 5},\n    {"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 4},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 4},\n    {"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL-mediated NF-kappaB activation, but failed to affect constitutive signaling induced by receptor overexpression, revealing a selective role for TRAF6 in ligand-induced activation events.": 5},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb/Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"TR": "protein"}]', 'prediction': {'TR': 'protein'}}
{'idx': 865, 'sentence': 'Response to T cell activation signals .', 'label': {'T cell': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n{"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n{"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n{"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.": 4},\n{"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n{"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 4},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n{"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n{"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.": 5},\n{"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.": 5},\n{"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n{"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n{"Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency.": 5},\n{"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n{"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.": 4},\n{"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n{"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 696, 'sentence': 'First, from different cell lines three or all four of the nuclear proteins were specifically cross-linked by UV irradiation to the radioactively labeled TRE -DNA fragment .', 'label': {'TRE -DNA fragment': 'DNA', 'nuclear proteins': 'protein', 'TRE': 'DNA'}, 'response1': "['protein', 'cell_line', 'DNA']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 5},\n    {"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50 .": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system .": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .": 5},\n    {"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .": 5},\n    {"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .": 5}\n]', 'response3': '[{"DNA": "DNA"}]', 'prediction': {'DNA': 'DNA'}}
{'idx': 318, 'sentence': 'Furthermore, the existence of estrogen receptor (estrogen binding activity) was examined histochemically in 39 cases and it was detected in 8.', 'label': {'estrogen receptor': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein (RXR) and its corresponding entity label."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides a clear example of a protein (retinoic acid receptor alpha) and its corresponding entity label."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence provides a clear example of a protein (NF-E2) and its corresponding entity label."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides clear examples of proteins (IL-2, c-Jun, c-Fos) and their corresponding entity labels."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides a clear example of a protein (E2A) and its corresponding entity label."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides clear examples of proteins (NF-kB, AP-1, OCT-1, NF-IL-2B) and their corresponding entity labels."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides clear examples of proteins (TCRzeta, p56(lck)) and their corresponding entity labels."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides clear examples of a cell line (Ter 119) and proteins (beta-globin, glycoprotein IIb, platelet factor 4) with their corresponding entity labels."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides clear examples of proteins (Erbstatin, genistein, Egr-1) and RNA (Egr-1) with their corresponding entity labels."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides clear examples of DNA (EBV) and proteins (EBNA2, estrogen receptor) with their corresponding entity labels."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides clear examples of cell lines (PMA-stimulated U1 cells) with their corresponding entity labels."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides clear examples of DNA (nuclear factor-kappa B, NF-kappa B) with their corresponding entity labels."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides clear examples of proteins (CD3.TcR, CD18, CD29) with their corresponding entity labels."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides clear examples of DNA (DNA), a protein (PCNA), and a transcription factor (E2F1) with their corresponding entity labels."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides clear examples of a protein (MR) and hormones (aldosterone, progesterone) with their corresponding entity labels."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence provides clear examples of proteins (E2F, E2F-4, DP-1, p130) and a cell type (AML) with their corresponding entity labels."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any named entities relevant to the entity label set."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any named entities relevant to the entity label set."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any named entities relevant to the entity label set."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any named entities relevant to the entity label set."}\n]', 'response3': '[{"estrogen receptor": "protein"}]', 'prediction': {'estrogen receptor': 'protein'}}
{'idx': 440, 'sentence': 'All three proteins show the same sequence specificity and binding affinity .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"These two related genes share the evolutionarily conserved region encoding the Runt domain.": 5},\n    {"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.": 4},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.": 5},\n    {"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.": 5},\n    {"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 5},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n    {"Tat-binding protein 7 is a subunit of the 26S protease.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n    {"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 5},\n    {"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1563, 'sentence': 'Pathogenesis of atherosclerosis .', 'label': {}, 'response1': 'None.', 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides clear examples of entities and their corresponding labels, making it very helpful for understanding how to extract named entities from the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 689, 'sentence': 'High-risk patients can be recognized morphologically.', 'label': {}, 'response1': 'None.', 'response2': '[\n    {"PBMC": 5},\n    {"adenovirus": 5},\n    {"WT1": 5},\n    {"CD70": 5},\n    {"B cell": 5},\n    {"plasma cells": 5},\n    {"IL-4": 5},\n    {"CD40": 5},\n    {"TCL1": 5},\n    {"myeloperoxidase": 5},\n    {"lysozyme": 5},\n    {"PU.1": 5},\n    {"Ras": 5},\n    {"T-PLL": 5},\n    {"T lymphocytes": 5},\n    {"HLA-molecules": 5},\n    {"MNDA": 5},\n    {"Philadelphia chromosome-positive chronic myeloid leukemia": 5},\n    {"granulocytes": 5},\n    {"T cells": 5},\n    {"TCRzeta": 5},\n    {"p56(lck)": 5},\n    {"adenovirus DNA": 5},\n    {"PML/RARalpha": 5},\n    {"SIVmacMER": 5},\n    {"SIVmac239": 5},\n    {"CEMx174": 5},\n    {"lymphoid neoplasms": 5},\n    {"SIVsmmPBj14": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 189, 'sentence': 'Transcriptional down-regulation of c-myc expression by protein synthesis -dependent and -independent pathways in a human T lymphoblastic tumor cell line .', 'label': {'human T lymphoblastic tumor cell line': 'cell_line', 'c-myc': 'DNA'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple entities relevant to the entity labels in the target sentence, such as \'NF-ATc\' (protein) and \'T lymphocytes\' (cell_type)."}\n]\n[\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions \'AP-1\' which is relevant to the \'DNA\' entity label in the target sentence."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains entities like \'Sp1\' (protein) and \'CD14\' (protein) which are relevant to the entity labels in the target sentence."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions \'IkappaBbeta\' (protein) and \'NF-kappaB\' (protein) which are relevant to the entity labels in the target sentence."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains entities like \'Sp1\' (protein) and \'Ets\' (protein) which are relevant to the entity labels in the target sentence."}\n]\n[\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions \'Th2-type lymphocytes\' which is relevant to the \'cell_type\' entity label in the target sentence."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions \'WT1\' (protein) and \'myeloid cell lines\' (cell_line) which are relevant to the entity labels in the target sentence."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains entities like \'NF-ATc\' (protein), \'T lymphocytes\' (cell_type), and \'embryonic cardiac cells\' (cell_type) which are relevant to the entity labels in the target sentence."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions \'SP1\' (protein), \'caspases\' (protein), and \'B-cell\' (cell_type) which are relevant to the entity labels in the target sentence."}\n]\n[\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions \'GATA-1\' which is relevant to the \'protein\' entity label in the target sentence."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains entities like \'ZEB\' (protein), \'c-Myb\' (protein), \'Ets\' (protein), and \'hematopoietic cells\' (cell_type) which are relevant to the entity labels in the target sentence."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions \'YY1\' (protein), \'Oct1\' (protein), \'IL-5\' (protein), and \'T cells\' (cell_type) which are relevant to the entity labels in the target sentence."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains entities like \'B and T cell activation\' (cell_type), \'Ramos\' (cell_line), \'Jurkat\' (cell_line), and \'cDNA microarray technology\' (DNA) which are relevant to the entity labels in the target sentence."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions \'tal-1\' (protein), \'GATA-binding proteins\' (protein), and \'hematopoiesis\' (cell_type) which are relevant to the entity labels in the target sentence."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains entities like \'cDNA\' (DNA), \'Jurkat\' (cell_line), and \'DRE 1\' (cell_type) which are relevant to the entity labels in the target sentence."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions \'AP-1\' (protein), \'c-jun\' (protein), \'IL-2\' (protein), \'NF-AT\' (protein), and \'T cell\' (cell_type) which are relevant to the entity labels in the target sentence."}\n]\n[\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any entities relevant to the entity labels in the target sentence."}\n]\n[\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any entities relevant to the entity labels in the target sentence."}\n]\n[\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any entities relevant to the entity labels in the target sentence."}\n]\n[\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any entities relevant to the entity labels in the target sentence."}\n]', 'response3': '[{"c-myc": "protein"}, {"T lymphoblastic tumor cell line": "cell_line"}]', 'prediction': {'c-myc': 'protein', 'T lymphoblastic tumor cell line': 'cell_line'}}
{'idx': 778, 'sentence': 'Addition of a highly enriched preparation of OTF-1 made from one of these pre-B cells or from HeLa cells specifically stimulated in vitro transcription of an immunoglobulin gene .', 'label': {'OTF-1': 'protein', 'pre-B cells': 'cell_line', 'immunoglobulin gene': 'DNA', 'HeLa cells': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .": 4},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 4},\n    {"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 4},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 4},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .": 4},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"T cell blasts treated with PMA are now responsive to IFN-gamma .": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n    {"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .": 5},\n    {"Fibroblast growth factor-1 ( FGF-1 ) enhances IL-2 production and nuclear translocation of NF-kappaB in FGF receptor -bearing Jurkat T cells .": 5}\n]', 'response3': '[{"OTF-1": "protein"}, {"pre-B cells": "cell_type"}, {"HeLa cells": "cell_line"}, {"immunoglobulin gene": "protein"}]', 'prediction': {'OTF-1': 'protein', 'pre-B cells': 'cell_type', 'HeLa cells': 'cell_line', 'immunoglobulin gene': 'protein'}}
{'idx': 198, 'sentence': "Tamoxifen , an oestrogen antagonist , has been given in some patients with CLL and Hodgkin's disease , with dramatic response in single cases.", 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 3},\n    {"Example 2": 5},\n    {"Example 3": 4},\n    {"Example 4": 5},\n    {"Example 5": 4},\n    {"Example 6": 5},\n    {"Example 7": 4},\n    {"Example 8": 3},\n    {"Example 9": 3},\n    {"Example 10": 5},\n    {"Example 11": 4},\n    {"Example 12": 3},\n    {"Example 13": 4},\n    {"Example 14": 5},\n    {"Example 15": 3},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"CLL": "cell_type"}, {"Hodgkin\'s disease": "cell_type"}]', 'prediction': {'CLL': 'cell_type', "Hodgkin's disease": 'cell_type'}}
{'idx': 735, 'sentence': 'This prompted us to analyze the octamer-binding proteins in the latter cells.', 'label': {'octamer-binding proteins': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence directly mentions the entity \'DNA\' and provides clear context for its presence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions \'CD95 ligand promoter\' which is associated with the entity type \'protein\', providing relevant information for entity extraction."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence mentions \'EBNA-2\' and \'PU.1\' as proteins, providing direct information for entity extraction."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence mentions \'cDNAs\' which are associated with the entity type \'DNA\', aiding in entity extraction."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides information about \'IL-2\', \'c-Jun\', and \'c-Fos\' as proteins, aiding in entity extraction."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence directly mentions \'NF-kappa B\' as a protein, aiding in entity extraction."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides information about \'c-kit\' and \'IL-4R alpha chain\' as proteins, aiding in entity extraction."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions \'AP-1\', \'PMA\', \'monocytes\', and \'macrophages\' which are associated with protein and cell type entities, aiding in entity extraction."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence mentions \'Oct-2A\', \'HMG I/Y\', \'HLA-DRA\', and \'B cells\' as proteins and cell type, aiding in entity extraction."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides information about \'EKLF\', \'CBP\', \'p300\', and \'P/CAF\' as proteins, aiding in entity extraction."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence mentions \'IL-4\', \'LPS\', and \'AP-1\' as proteins, aiding in entity extraction."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence mentions \'granulocytes\' and \'T cells\' as cell types, aiding in entity extraction."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence mentions \'SCM-1\' as a cell line, aiding in entity extraction."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence mentions \'CD40\' and \'NF-kappa B\' as proteins, aiding in entity extraction."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence mentions \'p21(WAF1/CIP1)\' and \'p27(KIP1)\' as proteins, aiding in entity extraction."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence mentions \'E2A\' as a protein, aiding in entity extraction."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entity types mentioned in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1735, 'sentence': 'We therefore examined vitamin D3 -mediated repression of activated IL-2 expression by cotransfecting Jurkat cells with IL-2 promoter/reporter constructs and a VDR overexpression vector and by DNA binding .', 'label': {'VDR': 'protein', 'IL-2 promoter/reporter constructs': 'DNA', 'Jurkat cells': 'cell_line', 'VDR overexpression vector': 'DNA', 'IL-2': 'protein'}, 'response1': "['DNA', 'protein', 'cell_line']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 4},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 4},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .": 4},\n    {"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex .": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .": 5},\n    {"While the activation of the IL-2 promoter and an NFAT -driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418 , it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2 -mediated NFAT activation is under the control of a combination of calcineurin- dependent and independent pathways .": 5},\n    {"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"IL-2": "protein"}, {"Jurkat": "cell_line"}, {"IL-2 promoter/reporter constructs": "DNA"}, {"VDR": "protein"}, {"DNA": "DNA"}]', 'prediction': {'IL-2': 'protein', 'Jurkat': 'cell_line', 'IL-2 promoter/reporter constructs': 'DNA', 'VDR': 'protein', 'DNA': 'DNA'}}
{'idx': 704, 'sentence': 'Activity of the immunoglobulin heavy and kappa light chain gene enhancers depends on a complex interplay of ubiquitous and developmentally regulated proteins .', 'label': {'ubiquitous and developmentally regulated proteins': 'protein', 'ubiquitous': 'protein', 'developmentally regulated proteins': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"immunoglobulin heavy and kappa light chain gene enhancers": "DNA"}]', 'prediction': {'immunoglobulin heavy and kappa light chain gene enhancers': 'DNA'}}
{'idx': 1236, 'sentence': 'Binding site selection revealed that the alternating RCGCRYGCGY consensus constitutes high-affinity IBR/F binding sites and that the direct-repeat palindrome TGCGCATGCGCA is the optimal site .', 'label': {'direct-repeat palindrome': 'DNA', 'IBR/F': 'protein', 'IBR/F binding sites': 'DNA', 'optimal site': 'DNA', 'alternating RCGCRYGCGY consensus': 'protein'}, 'response1': "['DNA']", 'response2': '[\n{"T cell": 5, "kB-like proto-enhancer element": 4, "interleukin 2": 4},\n{"immunoglobulin kappa 3\' enhancer": 5},\n{"CREB": 4, "AR-CRE": 4},\n{"SIVsmmPBj14": 5},\n{"EBNA2": 4, "TP1": 4},\n{"BRCA1": 5},\n{"p50p50": 5},\n{"GM-CSF": 4},\n{"retinoic acid receptor alpha": 4},\n{"IL-2": 4, "c-Jun": 4, "c-Fos": 4},\n{"Protein": 4},\n{"Th2-type lymphocytes": 5},\n{"IgH": 5},\n{"VDR": 4, "RXR": 4, "GRIP-1": 4, "DRIP205": 4, "DRIP": 4},\n{"GM-kappa B": 4, "GC-box": 4, "GC-motif": 4, "GM-kappa B motif": 4},\n{"NF-kappaB": 4, "Sp1": 4, "SIVmac": 4}\n]', 'response3': '[{"RCGCRYGCGY": "DNA"}, {"IBR/F": "protein"}, {"TGCGCATGCGCA": "DNA"}]', 'prediction': {'RCGCRYGCGY': 'DNA', 'IBR/F': 'protein', 'TGCGCATGCGCA': 'DNA'}}
{'idx': 541, 'sentence': 'To be or not to be a responder in T-cell responses : ubiquitous oligopeptides in all proteins.', 'label': {}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1652, 'sentence': 'Furthermore, we demonstrate that the PU-SF complex binds to PU.1 sites found on a number of myeloid promoters , and its formation requires an intact PU.1 site adjacent to a single-stranded region.', 'label': {'PU.1': 'protein', 'PU-SF complex': 'protein', 'myeloid promoters': 'DNA', 'PU.1 site': 'DNA', 'PU-SF': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 3},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 4},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 3},\n    {"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.": 4},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 4},\n    {"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 3},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 4},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 4},\n    {"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 4},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes.": 3},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"PU-SF complex": "protein"}, {"PU.1": "protein"}]', 'prediction': {'PU-SF complex': 'protein', 'PU.1': 'protein'}}
{'idx': 88, 'sentence': 'TNF alpha did not activate cAMP production and its signal was not modulated by cAMP activators .', 'label': {'TNF alpha': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides clear and specific entities with their corresponding labels that directly match the entity types in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The example provides relevant entities with their corresponding labels that match the entity types in the target sentence, but some entities are not explicitly mentioned."},\n    {"Example 3": 4},\n    {"Reason 3": "The example provides relevant entities with their corresponding labels that match the entity types in the target sentence, but some entities are not explicitly mentioned."},\n    {"Example 4": 3},\n    {"Reason 4": "The example provides entities with their corresponding labels, but not all entities match the entity types in the target sentence."},\n    {"Example 5": 3},\n    {"Reason 5": "The example provides entities with their corresponding labels, but not all entities match the entity types in the target sentence."},\n    {"Example 6": 2},\n    {"Reason 6": "The example provides entities with their corresponding labels, but none of the entities match the entity types in the target sentence."},\n    {"Example 7": 2},\n    {"Reason 7": "The example provides entities with their corresponding labels, but none of the entities match the entity types in the target sentence."},\n    {"Example 8": 2},\n    {"Reason 8": "The example provides entities with their corresponding labels, but none of the entities match the entity types in the target sentence."},\n    {"Example 9": 2},\n    {"Reason 9": "The example provides entities with their corresponding labels, but none of the entities match the entity types in the target sentence."},\n    {"Example 10": 2},\n    {"Reason 10": "The example provides entities with their corresponding labels, but none of the entities match the entity types in the target sentence."},\n    {"Example 11": 2},\n    {"Reason 11": "The example provides entities with their corresponding labels, but none of the entities match the entity types in the target sentence."},\n    {"Example 12": 2},\n    {"Reason 12": "The example provides entities with their corresponding labels, but none of the entities match the entity types in the target sentence."},\n    {"Example 13": 2},\n    {"Reason 13": "The example provides entities with their corresponding labels, but none of the entities match the entity types in the target sentence."},\n    {"Example 14": 2},\n    {"Reason 14": "The example provides entities with their corresponding labels, but none of the entities match the entity types in the target sentence."},\n    {"Example 15": 2},\n    {"Reason 15": "The example provides entities with their corresponding labels, but none of the entities match the entity types in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1494, 'sentence': 'Increased intracellular stores of latent NF-kappa B may also result in rapid inducibility of NF-kappa B -dependent cytokine gene expression .', 'label': {'latent NF-kappa B': 'protein', 'cytokine': 'protein', 'NF-kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 4},\n    {"Example 6": 4},\n    {"Example 7": 4},\n    {"Example 8": 4},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 1},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 3},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"NF-kappa B": "protein"}]', 'prediction': {'NF-kappa B': 'protein'}}
{'idx': 940, 'sentence': 'Tamoxifen was also found to compete with 17 beta-estradiol for type II EBS in PBMC , although to a lesser extent than diethylstilbestrol .', 'label': {'PBMC': 'cell_type', 'type II EBS': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The example provides a specific protein entity (NF-E2) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 2": 4},\n{"Reason 2": "The examples provide protein entities (alpha-tocopherol), cell type entities (monocyte, endothelial cells) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 3": 4},\n{"Reason 3": "The examples provide protein entities (NF-kappa B, AP-1) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 4": 4},\n{"Reason 4": "The examples provide protein entities (IL-2, NF-kappa B, AP-1) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 5": 5},\n{"Reason 5": "The examples provide RNA entity (IL-5 mRNA), cell type entities (TCR), protein entity (IL-2R, dexamethasone) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 6": 4},\n{"Reason 6": "The example provides a specific protein entity (retinoic acid receptor alpha) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 7": 4},\n{"Reason 7": "The examples provide protein entity (WT1), cell line entity (myeloid cell lines) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 8": 4},\n{"Reason 8": "The example provides a specific protein entity (E2A) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 9": 4},\n{"Reason 9": "The examples provide protein entities (NF-kappa B, I kappa B beta) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 10": 3},\n{"Reason 10": "The examples provide cell type entity (lymphocytes), chemical compound entities (benzene, benzoquinone) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 11": 4},\n{"Reason 11": "The example provides a specific protein entity (NF-kappa B) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 12": 5},\n{"Reason 12": "The examples provide cell line entity (Ter 119), protein entities (beta-globin, glycoprotein IIb, platelet factor 4) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 13": 4},\n{"Reason 13": "The examples provide protein entities (Erbstatin, genistein), RNA entity (Egr-1) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 14": 4},\n{"Reason 14": "The examples provide cell type entity (B cell), protein entity (Ig, Transforming growth factor-beta) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 15": 4},\n{"Reason 15": "The examples provide DNA entity (EBV), protein entities (EBNA2, estrogen receptor) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 16": 4},\n{"Reason 16": "The examples provide cell line entities (PMA, U1 cells) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 20": 1},\n{"Reason 20": "The sentence does not contain any named entities from the given entity label set."}\n]', 'response3': "[{'17 beta-estradiol': 'protein'}, {'diethylstilbestrol': 'protein'}]", 'prediction': {'17 beta-estradiol': 'protein', 'diethylstilbestrol': 'protein'}}
{'idx': 1098, 'sentence': 'Thus, intact microtubules are essential for 1,25(OH)2D3 -dependent modulation of gene transcription .', 'label': {'microtubules': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.": 5},\n{"The phosphorylated tyrosine residue itself is important for the protein-protein interaction .": 5},\n{"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 5},\n{"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .": 5},\n{"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .": 5},\n{"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .": 5},\n{"Here we examined the regulatory mechanism of the SCM-1 genes .": 5},\n{"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .": 5},\n{"Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B / Oct-1 -dependent transcription .": 5},\n{"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .": 5},\n{"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 5},\n{"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts .": 5},\n{"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .": 5},\n{"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n{"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2 .": 5},\n{"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 255, 'sentence': 'c-myc RNA , which is constitutively expressed in RWLeu-4 cells , increased after 0.5 h of treatment with 50 nM VD3 and then rapidly decreased to barely detectable levels after 4 h of treatment.', 'label': {'c-myc RNA': 'RNA', 'RWLeu-4 cells': 'cell_line'}, 'response1': "['RNA', 'cell_line']", 'response2': '[\n    {"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.": 5},\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 5},\n    {"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 5},\n    {"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA -stimulated U1 cells , respectively.": 5},\n    {"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 775, 'sentence': 'Some of these proteins (referred to as OTF-2 ) are lymphoid specific, whereas at least one other, and possibly more (referred to as OTF-1 ), is found ubiquitously in all cell types.', 'label': {'OTF-1': 'protein', 'OTF-2': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"NF-ATc": 5},\n    {"T lymphocytes": 5},\n    {"IL-4": 4},\n    {"Protein": 4},\n    {"WT1": 4},\n    {"IFN A": 5},\n    {"IFNA": 5},\n    {"interleukin-2": 5},\n    {"interleukin-2 receptor": 5},\n    {"phytohemagglutinin": 5},\n    {"phorbol myristate acetate": 5},\n    {"GATA-1": 5},\n    {"Syk": 5},\n    {"Zap": 5},\n    {"T cell": 5},\n    {"RXR": 5},\n    {"E2A": 5},\n    {"Th2-type lymphocytes": 5},\n    {"TCF-1": 5},\n    {"immunohistochemistry": 4},\n    {"gene": 3},\n    {"DNA": 3},\n    {"cell type": 5},\n    {"myeloperoxidase": 5},\n    {"lysozyme": 5},\n    {"PU.1": 5},\n    {"Th1": 5},\n    {"Th2": 5},\n    {"Egr-1": 5},\n    {"CD70": 5},\n    {"B cell": 5},\n    {"plasma cells": 5},\n    {"IL-4": 5},\n    {"CD40": 5}\n]', 'response3': "[{'OTF-2': 'protein'}, {'OTF-1': 'protein'}]", 'prediction': {'OTF-2': 'protein', 'OTF-1': 'protein'}}
{'idx': 161, 'sentence': 'Steroid dose sparing : pharmacodynamic responses to single versus divided doses of methylprednisolone in man.', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific entities with clear entity labels that can aid in named entity extraction."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1130, 'sentence': 'B-lymphoblastoid cell lines from multiple sclerosis patients and a healthy control producing a putative new human retrovirus and Epstein-Barr virus .', 'label': {'B-lymphoblastoid cell lines': 'cell_line'}, 'response1': "['cell_line', 'virus']", 'response2': '[\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 1},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .": 4},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .": 4},\n    {"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.": 3},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 3},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .": 5},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 4},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .": 4},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n    {"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .": 5},\n    {"Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice .": 5},\n    {"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"B-lymphoblastoid cell lines": "cell_line"}, {"multiple sclerosis patients": "cell_type"}, {"healthy control": "cell_type"}, {"putative new human retrovirus": "virus"}, {"Epstein-Barr virus": "virus"}]', 'prediction': {'B-lymphoblastoid cell lines': 'cell_line', 'multiple sclerosis patients': 'cell_type', 'healthy control': 'cell_type', 'putative new human retrovirus': 'virus', 'Epstein-Barr virus': 'virus'}}
{'idx': 600, 'sentence': 'Involvement of a second lymphoid-specific enhancer element in the regulation of immunoglobulin heavy-chain gene expression .', 'label': {'immunoglobulin heavy-chain gene': 'DNA', 'lymphoid-specific enhancer element': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"lymphoid-specific enhancer element": "DNA"}, {"immunoglobulin heavy-chain gene": "DNA"}]', 'prediction': {'lymphoid-specific enhancer element': 'DNA', 'immunoglobulin heavy-chain gene': 'DNA'}}
{'idx': 1698, 'sentence': 'Oncogenicity of human papillomavirus- or adenovirus- transformed cells correlates with resistance to lysis by natural killer cells .', 'label': {'natural killer cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 4},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 4},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 4},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5},\n    {"Notably, the lack of pRB in these U937-derived clones renders these p53-null cells highly resistant to apoptosis induced by serum withdrawal, calphostin C, and ceramide.": 5},\n    {"Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype.": 5},\n    {"To our knowledge, this represents the first demonstration that phagocytic stimuli can induce NF-kappa B activation in human neutrophils.": 5},\n    {"These results demonstrate the existence of a triple autoregulatory loop in monocytes and macrophages involving HIV, p105 and p50, and MAD3, with the end result of persistent NF-kappa B activation and viral persistence.": 5},\n    {"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': "[{'human papillomavirus-': 'DNA'}, {'adenovirus-': 'DNA'}, {'natural killer cells': 'cell_type'}]", 'prediction': {'human papillomavirus-': 'DNA', 'adenovirus-': 'DNA', 'natural killer cells': 'cell_type'}}
{'idx': 1287, 'sentence': 'Platelet thromboxane receptors are acutely and reversibly upregulated after acute myocardial infarction .', 'label': {'Platelet thromboxane receptors': 'protein', 'Platelet': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides clear and specific examples of protein names that are directly mentioned in the text, making it highly helpful for extracting named entities."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions protein names that are relevant to the context and can aid in identifying protein entities, although the specificity is slightly lower compared to Example 1."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains multiple protein names that are explicitly stated, directly relevant to the context, and crucial for named entity extraction."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence mentions protein names that are relevant to the context and can aid in identifying protein entities, although the specificity is slightly lower compared to Example 3."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence mentions a protein name that is relevant to the context and can aid in identifying protein entities, although the specificity is slightly lower compared to Example 3."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides clear and specific examples of protein names that are directly mentioned in the text, making it highly helpful for extracting named entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains protein names and cell types that are explicitly stated, directly relevant to the context, and crucial for named entity extraction."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides clear and specific examples of protein names and cell types that are directly mentioned in the text, making it highly helpful for extracting named entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains protein names and cell types that are explicitly stated, directly relevant to the context, and crucial for named entity extraction."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides clear and specific examples of protein names that are directly mentioned in the text, making it highly helpful for extracting named entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides clear and specific examples of protein names that are directly mentioned in the text, making it highly helpful for extracting named entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains protein names that are explicitly stated, directly relevant to the context, and crucial for named entity extraction."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains protein names that are explicitly stated, directly relevant to the context, and crucial for named entity extraction."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains protein names and cell types that are explicitly stated, directly relevant to the context, and crucial for named entity extraction."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains protein names, cell types, and protein activation information that are explicitly stated, directly relevant to the context, and crucial for named entity extraction."}\n]', 'response3': "[{'Platelet thromboxane receptors': 'protein'}]", 'prediction': {'Platelet thromboxane receptors': 'protein'}}
{'idx': 1266, 'sentence': 'Human herpesvirus 6 , a predominantly T lymphotropic virus , has been recently shown to infect some EBV -positive B cell lines , and to induce in them the activation of the EBV lytic cycle .', 'label': {'EBV -positive B cell lines': 'cell_line'}, 'response1': "['cell_line', 'cell_line', 'cell_line', 'cell_line', 'cell_line', 'cell_line', 'cell_line']", 'response2': '[\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .": 4},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 3},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .": 4},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .": 4},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 3},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus , and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development .": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .": 4},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n    {"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .": 5},\n    {"Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype .": 4},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"Human herpesvirus 6": "cell_type"}, {"EBV": "cell_line"}, {"B cell lines": "cell_line"}, {"EBV": "cell_line"}, {"EBV": "cell_line"}]', 'prediction': {'Human herpesvirus 6': 'cell_type', 'EBV': 'cell_line', 'B cell lines': 'cell_line'}}
{'idx': 1813, 'sentence': 'Northern blot analysis revealed that BLR2 mRNA could be highly stimulated in mitogen- and anti-CD3- treated peripheral blood lymphocytes .', 'label': {'BLR2 mRNA': 'RNA', 'BLR2': 'protein'}, 'response1': "['RNA', 'cell_type']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities (proteins, cytokines, receptors) that are relevant to the entity labels in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities (proteins, cytokines, receptors) that are relevant to the entity labels in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities (proteins, cytokines, receptors, cell types) that are relevant to the entity labels in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities (proteins) that are relevant to the entity labels in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities (proteins, cytokines, receptors) that are relevant to the entity labels in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities (proteins, cell types) that are relevant to the entity labels in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities (proteins, cytokines, transcription factors) that are relevant to the entity labels in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains an example of a named entity (cell type) that is relevant to the entity labels in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of named entities (virus, protein) that are relevant to the entity labels in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains an example of a named entity (protein) that is relevant to the entity labels in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities (proteins, cytokines, kinases, transcription factors) that are relevant to the entity labels in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of named entities (cell types, cell lines, technology) that are relevant to the entity labels in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of named entities (proteins, receptors) that are relevant to the entity labels in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of named entities (proteins, transcription factors, cell types) that are relevant to the entity labels in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, hence it is not helpful for extracting named entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, hence it is not helpful for extracting named entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, hence it is not helpful for extracting named entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, hence it is not helpful for extracting named entities."}\n]', 'response3': "[{'BLR2 mRNA': 'RNA'}, {'mitogen': 'protein'}, {'anti-CD3': 'protein'}, {'peripheral blood lymphocytes': 'cell_type'}]", 'prediction': {'BLR2 mRNA': 'RNA', 'mitogen': 'protein', 'anti-CD3': 'protein', 'peripheral blood lymphocytes': 'cell_type'}}
{'idx': 1764, 'sentence': 'The inhibitory effect of cysteamine may be mediated at least in part by an effect on transcription factor function , as the DNA binding activities of AP-1 and NF-kappa B extracted from mitogen-stimulated cells were significantly inhibited by cysteamine treatment .', 'label': {'AP-1': 'protein', 'NF-kappa B': 'protein', 'transcription factor': 'protein', 'mitogen-stimulated cells': 'cell_type'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides clear examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 740, 'sentence': 'On the basis of these assays, all N-Oct-factors were found to be distinct from the ubiquitous Oct-1 and the lymphoid-specific Oct-2A proteins.', 'label': {'ubiquitous Oct-1': 'protein', 'Oct-1': 'protein', 'Oct-2A': 'protein', 'lymphoid-specific Oct-2A': 'protein', 'N-Oct-factors': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 5},\n    {"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n    {"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 5},\n    {"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.": 5},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"N-Oct-factors": "protein"}, {"Oct-1": "protein"}, {"Oct-2A": "protein"}]', 'prediction': {'N-Oct-factors': 'protein', 'Oct-1': 'protein', 'Oct-2A': 'protein'}}
{'idx': 1182, 'sentence': 'Moreover, STAT5 was found to be the predominant STAT transcription factor used by IL-2 in human T cells , and specifically required a COOH-terminal region of IL-2R beta ( Ser386-Val525 ), while STAT5 recruitment was not correlated to activation of IL-2R gamma or JAK3 .', 'label': {'IL-2': 'protein', 'T cells': 'cell_type', 'COOH-terminal region': 'protein', 'human T cells': 'cell_type', 'Ser386-Val525': 'protein', 'JAK3': 'protein', 'STAT transcription factor': 'protein', 'STAT5': 'protein', 'IL-2R beta': 'protein', 'IL-2R gamma': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras.": 5},\n    {"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.": 4},\n    {"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation.": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway , and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.": 5},\n    {"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.": 5},\n    {"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines.": 5},\n    {"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"STAT5": "protein"}, {"IL-2": "protein"}, {"IL-2R beta": "protein"}, {"IL-2R gamma": "protein"}, {"JAK3": "protein"}, {"T cells": "cell_type"}]', 'prediction': {'STAT5': 'protein', 'IL-2': 'protein', 'IL-2R beta': 'protein', 'IL-2R gamma': 'protein', 'JAK3': 'protein', 'T cells': 'cell_type'}}
{'idx': 393, 'sentence': 'We also tested for the ability of defensins NP-1 , NP-5 , and HNP-1 to activate pag expression and found that these peptides have no effect.', 'label': {'HNP-1': 'protein', 'pag': 'DNA', 'NP-1': 'protein', 'defensins': 'protein', 'NP-5': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n    {"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 3},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 3},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .": 5},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .": 5},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .": 5},\n    {"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.": 5},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1442, 'sentence': 'T cell expression of interleukin 3 ( IL-3 ) is directed by positive and negative cis-acting DNA elements clustered within 300 base pairs of the transcriptional start site .', 'label': {'interleukin 3': 'protein', 'transcriptional start site': 'DNA', 'IL-3': 'protein'}, 'response1': "['DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names and cell types that match the entity labels in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence contains a specific protein name and cell type that match the entity labels in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains a specific DNA element name that matches the entity label in the target sentence."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence contains specific protein and cell type names that match the entity labels in the target sentence."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence contains a specific cell type name that matches the entity label in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains specific protein names that match the entity labels in the target sentence."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence contains a specific protein name that matches the entity label in the target sentence."},\n    {"Example 8": 4},\n    {"Reason 8": "The sentence contains specific protein and cell type names that match the entity labels in the target sentence."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence contains specific protein names that match the entity labels in the target sentence."},\n    {"Example 10": 4},\n    {"Reason 10": "The sentence contains specific protein names that match the entity labels in the target sentence."},\n    {"Example 11": 4},\n    {"Reason 11": "The sentence contains a specific protein name that matches the entity label in the target sentence."},\n    {"Example 12": 4},\n    {"Reason 12": "The sentence contains a specific protein name that matches the entity label in the target sentence."},\n    {"Example 13": 4},\n    {"Reason 13": "The sentence contains a specific protein name that matches the entity label in the target sentence."},\n    {"Example 14": 4},\n    {"Reason 14": "The sentence contains specific protein names that match the entity labels in the target sentence."},\n    {"Example 15": 4},\n    {"Reason 15": "The sentence contains specific protein names that match the entity labels in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any relevant entity types mentioned in the target sentence."}\n]', 'response3': '[{"interleukin 3": "protein"}, {"IL-3": "protein"}, {"DNA": "DNA"}]', 'prediction': {'interleukin 3': 'protein', 'IL-3': 'protein', 'DNA': 'DNA'}}
{'idx': 142, 'sentence': 'This level of NF-kappa B -independent activity appears to be sufficient for virus multiplication , since TNF-alpha treatment had no effect on the kinetics of de novo HIV type 1 ( HIV-1 ) infection and viral RNA production in U937 cells .', 'label': {'U937 cells': 'cell_line', 'NF-kappa B': 'protein', 'viral RNA': 'RNA', 'TNF-alpha': 'protein'}, 'response1': "['RNA', 'protein', 'cell_line']", 'response2': '[\n    {"TIMP-1": 5},\n    {"DNA": 4},\n    {"NF-kB": 4},\n    {"AP-1": 4},\n    {"OCT-1": 4},\n    {"NF-IL-2B": 4},\n    {"RelA": 4},\n    {"NF-kappa B": 5},\n    {"Tax": 4},\n    {"ATL": 4},\n    {"IkappaBbeta": 4},\n    {"IL-2": 4},\n    {"I kappa B alpha": 4},\n    {"IFN A": 4},\n    {"IFNA": 4},\n    {"interleukin-2": 4},\n    {"interleukin-2 receptor": 4},\n    {"phytohemagglutinin": 4},\n    {"phorbol myristate acetate": 4},\n    {"HIV-1": 4},\n    {"PKR": 4},\n    {"TR55": 4},\n    {"SIVmac": 4},\n    {"Sp1": 4}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"TNF-alpha": "protein"}, {"HIV type 1": "cell_type"}, {"HIV-1": "cell_type"}, {"RNA": "RNA"}, {"U937 cells": "cell_line"}]', 'prediction': {'NF-kappa B': 'protein', 'TNF-alpha': 'protein', 'HIV type 1': 'cell_type', 'HIV-1': 'cell_type', 'RNA': 'RNA', 'U937 cells': 'cell_line'}}
{'idx': 93, 'sentence': 'The Thy-1 gene promoter resembles a "housekeeping" promoter in that it is located within a methylation-free island , lacks a canonical TATA box , and displays heterogeneity in the 5\'-end termini of the mRNA .', 'label': {'canonical TATA box': 'DNA', '"housekeeping" promoter': 'DNA', 'methylation-free island': 'DNA', "5'-end termini": 'RNA', 'Thy-1 gene promoter': 'DNA', 'mRNA': 'RNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 4},\n    {"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 4},\n    {"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.": 4},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n    {"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"While the activation of the IL-2 promoter and an NFAT-driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418, it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2-mediated NFAT activation is under the control of a combination of calcineurin-dependent and independent pathways.": 5},\n    {"This sequence element was referred to as the BAT box and its deletion significantly reduced the activity of a CD20 promoter-CAT construct in B cells.": 5},\n    {"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"Thy-1 gene": "protein"}]', 'prediction': {'Thy-1 gene': 'protein'}}
{'idx': 1354, 'sentence': 'In addition, these results indicate that nuclear TCF-1 expression can serve as a pan-T-lineage marker in the diagnosis of lymphoid malignancies .', 'label': {'TCF-1': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 3},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 4},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 3},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 3},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 4},\n    {"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.": 4},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms.": 3},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 3},\n    {"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 4},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 4},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 3},\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 3},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.": 4},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 3},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"TCF-1": "protein"}, {"lymphoid malignancies": "cell_type"}]', 'prediction': {'TCF-1': 'protein', 'lymphoid malignancies': 'cell_type'}}
{'idx': 466, 'sentence': '(ABSTRACT TRUNCATED AT 250 WORDS)', 'label': {}, 'response1': 'None.', 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a clear and specific entity with its corresponding label, aiding in understanding how named entities are identified in the sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The example includes multiple entities with their respective labels, demonstrating the variety of named entities present in the sentence and how they are categorized."},\n    {"Example 3": 5},\n    {"Reason 3": "The example highlights a specific entity and its label, contributing to the understanding of named entity extraction in the sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The example presents a clear entity with its label, showcasing how named entities related to proteins are identified in the sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides a specific entity and its label, aiding in understanding how cell types are identified in the sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The example includes a specific entity with its label, demonstrating the identification of DNA entities in the sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The example showcases multiple entities with their corresponding labels, illustrating the variety of named entities present in the sentence and how they are categorized."},\n    {"Example 8": 5},\n    {"Reason 8": "The example presents a specific entity with its label, aiding in understanding how proteins are identified in the sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides a specific entity with its label, demonstrating the identification of cell lines in the sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The example includes a specific entity with its label, aiding in understanding how cell lines are identified in the sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The example showcases multiple entities with their corresponding labels, illustrating the variety of named entities present in the sentence and how they are categorized."},\n    {"Example 12": 5},\n    {"Reason 12": "The example presents specific entities with their labels, aiding in understanding how proteins are identified in the sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides a clear entity with its label, demonstrating the identification of proteins in the sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The example includes a specific entity with its label, aiding in understanding how proteins are identified in the sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The example showcases multiple entities with their corresponding labels, illustrating the variety of named entities present in the sentence and how they are categorized."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not provide any specific entity or label relevant to the named entity types in the sentence, hence not aiding in understanding named entity extraction."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not offer any specific entity or label relevant to the named entity types in the sentence, hence not aiding in understanding named entity extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not present any specific entity or label relevant to the named entity types in the sentence, hence not aiding in understanding named entity extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The example does not include any specific entity or label relevant to the named entity types in the sentence, hence not aiding in understanding named entity extraction."},\n    {"Example 20": 1},\n    {"Reason 20": "The example does not provide any specific entity or label relevant to the named entity types in the sentence, hence not aiding in understanding named entity extraction."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1583, 'sentence': 'Associations between HLA class II antigens and autoantibodies to the ribonucleoproteins Ro(SSA) and La(SSB) have been reported in these patients.', 'label': {'ribonucleoproteins': 'protein', 'Ro(SSA)': 'protein', 'autoantibodies': 'protein', 'HLA class II antigens': 'protein', 'La(SSB)': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names that are directly mentioned."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains specific protein names that are directly mentioned."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains specific protein names that are directly mentioned."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains a specific cell type name that is directly mentioned."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains a specific protein name that is directly mentioned."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains specific protein names that are directly mentioned."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains a specific DNA name that is directly mentioned."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains specific protein names that are directly mentioned."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains specific protein and cell type names that are directly mentioned."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains specific protein and cell type names that are directly mentioned."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains specific protein and cell type names that are directly mentioned."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains a specific protein name that is directly mentioned."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains specific protein and cell type names that are directly mentioned."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains specific protein and cell type names that are directly mentioned."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains specific cell type and protein names that are directly mentioned."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any specific named entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific named entities."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific named entities."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific named entities."}\n]', 'response3': '[{"HLA class II antigens": "protein"}, {"ribonucleoproteins Ro(SSA)": "protein"}, {"La(SSB)": "protein"}]', 'prediction': {'HLA class II antigens': 'protein', 'ribonucleoproteins Ro(SSA)': 'protein', 'La(SSB)': 'protein'}}
{'idx': 592, 'sentence': 'The DNA isolated contained an open reading frame encoding 108 amino acid residues .', 'label': {}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains a specific protein name \'CD95 ligand\' which is directly associated with the entity label \'protein\' in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence mentions a specific cell line \'SIVsmmPBj14\' which directly corresponds to the entity label \'cell_line\' in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence refers to \'cDNAs\' which is a type of DNA, matching the entity label \'DNA\' in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence explicitly mentions \'Protein\' which aligns with the entity label \'protein\' in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence talks about \'E2A gene\' at the protein level, indicating the presence of \'protein\' entity label in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains multiple protein names like \'SLAP-130\', \'SLP-76\', and \'T cell\', all of which correspond to the entity label \'protein\' and \'cell_type\' in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence mentions \'hepatitis B virus\' and \'HBxAg\' which are associated with \'DNA\' and \'protein\' entity labels respectively in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence refers to \'GM-CSF genes\' which are related to the entity label \'protein\' in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence talks about \'NF-kappa B\' which is associated with the entity label \'DNA\' in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence mentions \'p21(WAF1/CIP1)\' and \'p27(KIP1)\' which are specific proteins, aligning with the entity label \'protein\' in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence refers to \'protein\' which directly corresponds to the entity label \'protein\' in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains \'p50p50\' which is a specific protein name, matching the entity label \'protein\' in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence mentions various proteins like \'IFN A\', \'IFNA\', \'interleukin-2\', \'interleukin-2 receptor\', \'phytohemagglutinin\', and \'phorbol myristate acetate\' all of which align with the entity label \'protein\' in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence includes \'p50\' and \'p65\' proteins along with \'DNA\' and \'protein\' which correspond to the entity labels in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence mentions \'GM-kappa B\', \'GC-box\', \'GC-motif\', and \'GM-kappa B motif\' which are all related to the entity label \'DNA\' in the target sentence."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence refers to \'cDNA\', \'Jurkat\', and \'DRE 1\' which correspond to the entity labels \'DNA\' and \'cell_line\' in the target sentence."}\n]', 'response3': "[{'DNA': 'DNA'}]", 'prediction': {'DNA': 'DNA'}}
{'idx': 163, 'sentence': 'This phenomenon can be mimicked by administering MP in divided doses.', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides clear and direct examples of named entities with their corresponding entity labels, aiding in the extraction process."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1751, 'sentence': 'This effect is thought to be largely mediated through inactivation of the phosphatase calcineurin , which in turn inhibits translocation of an NFAT component to the nucleus.', 'label': {'NFAT': 'protein', 'calcineurin': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence 1": 5},\n    {"Sentence 2": 5},\n    {"Sentence 3": 5},\n    {"Sentence 4": 5},\n    {"Sentence 5": 5},\n    {"Sentence 6": 5},\n    {"Sentence 7": 5},\n    {"Sentence 8": 5},\n    {"Sentence 9": 5},\n    {"Sentence 10": 5},\n    {"Sentence 11": 5},\n    {"Sentence 12": 5},\n    {"Sentence 13": 5},\n    {"Sentence 14": 5},\n    {"Sentence 15": 5},\n    {"Sentence 16": 1},\n    {"Sentence 17": 1},\n    {"Sentence 18": 1},\n    {"Sentence 19": 1},\n    {"Sentence 20": 1}\n]', 'response3': '[{"calcineurin": "protein"}, {"NFAT": "protein"}]', 'prediction': {'calcineurin': 'protein', 'NFAT': 'protein'}}
{'idx': 1774, 'sentence': 'Further studies are needed to elucidate if this sex difference in PBMC receptors for 1.25 Dihydroxyvitamin D3 is of any pathophysiological relevance .', 'label': {'PBMC': 'cell_type', 'PBMC receptors': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains specific protein names such as CD14, IL-4, AP-1, retinoic acid receptor alpha, Oct-2A, HMG I/Y, HLA-DRA, NF-kappa B, VDR, RXR, GRIP-1, DRIP205, CD40, Rel/nuclear factor kappaB, interleukin-2, CD25, PU.1, CSF-1 receptor, TPCK, Sp1-binding site, Sp1, VitD3, CD14, anti-CD28, PMA which are directly related to the entity labels in the target sentence."}\n]', 'response3': '[{"PBMC receptors": "cell_type"}, {"1.25 Dihydroxyvitamin D3": "protein"}]', 'prediction': {'PBMC receptors': 'cell_type', '1.25 Dihydroxyvitamin D3': 'protein'}}
{'idx': 206, 'sentence': 'It is concluded that (i) patients with CLL rarely express ER and (ii) immunocytochemical staining of cytospin preparations is a valid technique for the measurement of ER .', 'label': {'ER': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor )": 5},\n    {"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 4},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL .": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 5},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .": 4},\n    {"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 5},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 5},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms .": 5}\n]', 'response3': '[{"ER": "protein"}, {"ER": "protein"}]', 'prediction': {'ER': 'protein'}}
{'idx': 928, 'sentence': 'A mouse ets-1 cDNA clone was obtained by screening a mouse thymus cDNA expression library with a double-stranded oligonucleotide probe representing 20 bp of the Moloney murine sarcoma virus ( MSV ) long terminal repeat ( LTR ).', 'label': {'ets-1': 'protein', 'long terminal repeat': 'DNA', 'double-stranded oligonucleotide probe': 'DNA', 'mouse thymus cDNA expression library': 'DNA', 'mouse ets-1 cDNA clone': 'DNA', 'LTR': 'DNA'}, 'response1': "['DNA', 'RNA']", 'response2': '[\n    {"SIVsmmPBj14": 5},\n    {"SIVmacMER": 5},\n    {"SIVmac239": 5},\n    {"CEMx174": 5},\n    {"GM-CSF": 5},\n    {"PML/RARalpha": 5},\n    {"Th2-type lymphocytes": 5},\n    {"protein": 5},\n    {"Sp1": 5},\n    {"Ets": 5},\n    {"c-kit": 5},\n    {"IL-4R alpha chain": 5},\n    {"TCF-1": 5},\n    {"MIP-1 alpha": 5},\n    {"GOS19": 5},\n    {"LD78": 5},\n    {"AT464": 5},\n    {"CD14": 5},\n    {"IFN A": 5},\n    {"IFNA": 5},\n    {"interleukin-2": 5},\n    {"interleukin-2 receptor": 5},\n    {"phytohemagglutinin": 5},\n    {"phorbol myristate acetate": 5},\n    {"SLAP-130": 5},\n    {"SLP-76": 5},\n    {"T cell": 5},\n    {"Egr-1": 5},\n    {"E2A": 5},\n    {"CD95 ligand": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1301, 'sentence': 'It was found that the most significant variable predicting NK activity at follow-up was tumor ER concentration , with higher NK activity associated with ER -status .', 'label': {'ER': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines.": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n    {"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"The expression of NDP kinase was intense in KA and SCC compared with BCC.": 5},\n    {"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 4},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 5},\n    {"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"ER": "protein"}, {"NK activity": "cell_type"}, {"tumor ER concentration": "cell_line"}, {"ER -status": "cell_type"}]', 'prediction': {'ER': 'protein', 'NK activity': 'cell_type', 'tumor ER concentration': 'cell_line', 'ER -status': 'cell_type'}}
{'idx': 1708, 'sentence': 'The Ca(2+) -dependent phosphatase calcineurin , a target of FK506 and CsA , synergizes with PKC -induced activation of nuclear factor (NF)-kappa B in T cell lines .', 'label': {'nuclear factor (NF)-kappa B': 'protein', 'T cell lines': 'cell_line', 'Ca(2+) -dependent phosphatase': 'protein', 'PKC': 'protein', 'calcineurin': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides specific named entities and their corresponding entity labels that directly match the entity types in the target sentence, making it highly helpful for extracting named entities."},\n    {"Example 2": 5},\n    {"Reason 2": "The example provides specific named entities and their corresponding entity labels that directly match the entity types in the target sentence, making it highly helpful for extracting named entities."},\n    {"Example 3": 5},\n    {"Reason 3": "The example provides specific named entities and their corresponding entity labels that directly match the entity types in the target sentence, making it highly helpful for extracting named entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The example provides specific named entities and their corresponding entity labels that directly match the entity types in the target sentence, making it highly helpful for extracting named entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides specific named entities and their corresponding entity labels that directly match the entity types in the target sentence, making it highly helpful for extracting named entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The example provides specific named entities and their corresponding entity labels that directly match the entity types in the target sentence, making it highly helpful for extracting named entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The example provides specific named entities and their corresponding entity labels that directly match the entity types in the target sentence, making it highly helpful for extracting named entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides specific named entities and their corresponding entity labels that directly match the entity types in the target sentence, making it highly helpful for extracting named entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides specific named entities and their corresponding entity labels that directly match the entity types in the target sentence, making it highly helpful for extracting named entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides specific named entities and their corresponding entity labels that directly match the entity types in the target sentence, making it highly helpful for extracting named entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The example provides specific named entities and their corresponding entity labels that directly match the entity types in the target sentence, making it highly helpful for extracting named entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The example provides specific named entities and their corresponding entity labels that directly match the entity types in the target sentence, making it highly helpful for extracting named entities."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides specific named entities and their corresponding entity labels that directly match the entity types in the target sentence, making it highly helpful for extracting named entities."},\n    {"Example 14": 5},\n    {"Reason 14": "The example provides specific named entities and their corresponding entity labels that directly match the entity types in the target sentence, making it highly helpful for extracting named entities."},\n    {"Example 15": 1},\n    {"Reason 15": "The example does not contain any named entities or entity labels that match the entity types in the target sentence, hence it is not helpful for extracting named entities."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain any named entities or entity labels that match the entity types in the target sentence, hence it is not helpful for extracting named entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain any named entities or entity labels that match the entity types in the target sentence, hence it is not helpful for extracting named entities."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any named entities or entity labels that match the entity types in the target sentence, hence it is not helpful for extracting named entities."},\n    {"Example 19": 1},\n    {"Reason 19": "The example does not contain any named entities or entity labels that match the entity types in the target sentence, hence it is not helpful for extracting named entities."}\n]', 'response3': '[{"calcineurin": "protein"}, {"FK506": "protein"}, {"CsA": "protein"}, {"PKC": "protein"}, {"NF-kappa B": "protein"}, {"T cell lines": "cell_line"}]', 'prediction': {'calcineurin': 'protein', 'FK506': 'protein', 'CsA': 'protein', 'PKC': 'protein', 'NF-kappa B': 'protein', 'T cell lines': 'cell_line'}}
{'idx': 747, 'sentence': 'Protein kinase inhibitor H-7 blocks accumulation of unspliced mRNA of human T-cell leukemia virus type I ( HTLV-I ).', 'label': {'unspliced mRNA': 'RNA'}, 'response1': "['protein', 'RNA']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .": 5},\n    {"Control of NF-kappa B activity by the I kappa B beta inhibitor .": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 4},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 4},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Tat-binding protein 7 is a subunit of the 26S protease .": 5},\n    {"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 4},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n    {"Binding of YY1 and Oct1 to a novel element that downregulates expression of IL-5 in human T cells .": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 333, 'sentence': 'These protoenhancers alone are weakly or not responsive to R .', 'label': {'protoenhancers': 'DNA', 'R': 'protein'}, 'response1': "['RNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 4},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 4},\n    {"Example 6": 4},\n    {"Example 7": 4},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 4},\n    {"Example 11": 5},\n    {"Example 12": 4},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 5},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 758, 'sentence': 'Cell proliferation of CEM-C7 cells cultured in both serum-free media has been sustained for 3 mo.', 'label': {'CEM-C7': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2.": 5},\n    {"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 4},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 4},\n    {"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 4},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 3},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 5},\n    {"Thus, we were able to derive a hematopoietic cell line, called 47.10, that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.": 5},\n    {"Notably, the lack of pRB in these U937-derived clones renders these p53-null cells highly resistant to apoptosis induced by serum withdrawal, calphostin C, and ceramide.": 5},\n    {"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.": 5},\n    {"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.": 5},\n    {"We isolated a novel subline, UT-7/GMT, from the human leukemia cell line UT-7/GM (N. Komatsu, et al., Blood, 89: 4021-4033, 1997).": 5},\n    {"The modified vectors were used to transduce human hematopoietic cell lines, cord blood-derived CD34(+) stem/progenitor cells, and murine bone marrow repopulating stem cells.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 727, 'sentence': 'The importance of the internal ATGs to Rex function is not known.', 'label': {'Rex': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence directly mentions the entity \'Runt domain\' which is a protein, making it highly relevant for named entity extraction."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence directly mentions the entity \'TCF-1\' which is a protein, making it highly relevant for named entity extraction."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence directly mentions the entity \'tyrosine\' which is a protein, making it highly relevant for named entity extraction."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence mentions \'nonhuman primates\' which is likely a cell type, providing relevant context for named entity extraction."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence directly mentions the entities \'IL-7R\' and \'gamma(c)\' which are proteins, making it highly relevant for named entity extraction."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence directly mentions the entity \'SIVsmmPBj14\' which is a cell line, making it highly relevant for named entity extraction."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence directly mentions the entities \'Jun\' and \'ATF-2\' which are proteins, making it highly relevant for named entity extraction."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence directly mentions the entity \'GATA-1\' which is a protein, making it highly relevant for named entity extraction."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence mentions \'NF-kappaB\' which is likely a protein, and \'rheumatoid arthritis\' which is a cell type, providing relevant context for named entity extraction."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence directly mentions the entities \'IL-2\', \'c-Jun\', and \'c-Fos\' which are proteins, making it highly relevant for named entity extraction."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence directly mentions the entity \'RXR\' which is a protein, making it highly relevant for named entity extraction."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence directly mentions the entity \'Protein\' which is a protein, making it highly relevant for named entity extraction."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence directly mentions the entities \'UAS3\', \'UAS2\', and \'YY1\' which are DNA and protein entities, making it highly relevant for named entity extraction."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence directly mentions the entities \'IL-2\', \'Aiolos\', and \'Ras\' which are proteins, making it highly relevant for named entity extraction."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence directly mentions the entity \'IL-4\' which is a protein, making it highly relevant for named entity extraction."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence directly mentions the entity \'SCM-1\' which is a cell line, making it highly relevant for named entity extraction."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific entities related to the entity labels in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific entities related to the entity labels in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific entities related to the entity labels in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any specific entities related to the entity labels in the target sentence."}\n]', 'response3': '[{}]', 'prediction': {}}
{'idx': 429, 'sentence': 'As shown by mobility-shift , methylation interference , and mutational analyses , the mammalian protein BSAP recognizes all four sea urchin binding sites in a manner indistinguishable from TSAP ; however, the two proteins differ in molecular weight.', 'label': {'TSAP': 'protein', 'mammalian protein': 'protein', 'sea urchin binding sites': 'DNA', 'BSAP': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.": 5},\n    {"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n    {"Tat-binding protein 7 is a subunit of the 26S protease.": 5},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 5},\n    {"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 5},\n    {"A gst-EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2-PU.1 interaction.": 5},\n    {"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.": 5},\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 5},\n    {"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1372, 'sentence': 'The TCL1 oncogene on human chromosome 14q32.1 is involved in chromosome translocations [ t(14;14)(q11;q32.1) and t(7;14)(q35;q32.1) ] and inversions [ inv14(q11;q32.1) ] with TCR alpha/beta loci in T-cell leukemias , such as T-prolymphocytic ( T-PLL ).', 'label': {'14q32.1': 'DNA', 'TCR alpha/beta loci': 'DNA', 't(14;14)(q11;q32.1)': 'DNA', 'TCL1 oncogene': 'DNA', 'human chromosome': 'DNA', 't(7;14)(q35;q32.1)': 'DNA', 'inv14(q11;q32.1)': 'DNA'}, 'response1': "['DNA', 'cell_type']", 'response2': '[\n{"Therefore, we investigated whether IVS1-10T-->C deleteriously affected BRCA1 splicing or expression, and thereby inactivated the other BRCA1 allele.": 5},\n{"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.": 5},\n{"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.": 5},\n{"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n{"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n{"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n{"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway, and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.": 5},\n{"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n{"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 5},\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n{"Here we examined the regulatory mechanism of the SCM-1 genes.": 5},\n{"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.": 5},\n{"By the time of diagnosis of T-PLL, the clone contains many more genetic changes in the form of additional translocations.": 5},\n{"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n{"SCL is expressed in erythroid, megakaryocyte and mast cell populations (the same cell lineages as GATA-1, a zinc-finger transcription factor).": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"TCL1": "protein"}, {"TCR alpha/beta": "protein"}, {"T-cell": "cell_type"}, {"T-prolymphocytic (T-PLL)": "cell_type"}]', 'prediction': {'TCL1': 'protein', 'TCR alpha/beta': 'protein', 'T-cell': 'cell_type', 'T-prolymphocytic (T-PLL)': 'cell_type'}}
{'idx': 546, 'sentence': 'Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin .', 'label': {'T lymphocytes': 'cell_type', 'immunophilin': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein entity (calcineurin) and its corresponding label, which directly aids in understanding how to extract protein entities from the target sentence."}\n]\n[\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides a clear example of a protein entity (NF-kappa B) and its corresponding label, which directly aids in understanding how to extract protein entities from the target sentence."}\n]\n[\n    {"Example 3": 5},\n    {"Reason 3": "The sentence provides multiple examples of protein entities (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) and their corresponding labels, which directly aid in understanding how to extract protein entities from the target sentence."}\n]\n[\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides multiple examples of protein entities (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) and their corresponding labels, which directly aid in understanding how to extract protein entities from the target sentence."}\n]\n[\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides examples of cell type (T cell) and protein entities (IL-2, IL-2 receptor, CD28) and their corresponding labels, which directly aid in understanding how to extract these entities from the target sentence."}\n]\n[\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides examples of RNA (IL-5 mRNA), cell type (TCR), and protein entities (IL-2R, dexamethasone) and their corresponding labels, which directly aid in understanding how to extract these entities from the target sentence."}\n]\n[\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides examples of protein entities (NF-kappa B, I kappa B alpha) and their corresponding labels, which directly aid in understanding how to extract these entities from the target sentence."}\n]\n[\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides an example of a protein entity (IL-2) and its corresponding label, which directly aids in understanding how to extract protein entities from the target sentence."}\n]\n[\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides examples of protein entities (CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, granulocyte-macrophage colony-stimulating factor) and their corresponding labels, which directly aid in understanding how to extract these entities from the target sentence."}\n]\n[\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides examples of protein entities (NF-ATc) and cell type (T lymphocytes) and their corresponding labels, which directly aid in understanding how to extract these entities from the target sentence."}\n]\n[\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides examples of protein entities (IkappaBbeta, NF-kappaB) and their corresponding labels, which directly aid in understanding how to extract these entities from the target sentence."}\n]\n[\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides examples of protein entities (IL-2 receptor alpha subunit, p21ras) and cell type (B cell) and their corresponding labels, which directly aid in understanding how to extract these entities from the target sentence."}\n]\n[\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides examples of protein entities (Syk, Zap) and cell type (T cell) and their corresponding labels, which directly aid in understanding how to extract these entities from the target sentence."}\n]\n[\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides examples of protein entities (IL-2, NF-kappa B, AP-1) and their corresponding labels, which directly aid in understanding how to extract these entities from the target sentence."}\n]\n[\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides examples of protein entities (IL-2, Aiolos, Ras) and their corresponding labels, which directly aid in understanding how to extract these entities from the target sentence."}\n]\n[\n    {"Example 16": 5},\n    {"Reason 16": "The sentence provides examples of protein entities (IkappaBalpha, NF-kappaB) and their corresponding labels, which directly aid in understanding how to extract these entities from the target sentence."}\n]\n[\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any named entities related to the provided entity labels, making it not helpful for extracting named entities from the target sentence."}\n]\n[\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any named entities related to the provided entity labels, making it not helpful for extracting named entities from the target sentence."}\n]\n[\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any named entities related to the provided entity labels, making it not helpful for extracting named entities from the target sentence."}\n]', 'response3': '[{"T lymphocytes": "cell_type"}, {"immunophilin": "protein"}, {"FK506": "protein"}, {"rapamycin": "protein"}]', 'prediction': {'T lymphocytes': 'cell_type', 'immunophilin': 'protein', 'FK506': 'protein', 'rapamycin': 'protein'}}
{'idx': 1437, 'sentence': 'In summary, we developed an assay for the quantitative determination of hTR beta 1 mRNA levels in small human tissue samples , containing as little as 50 ng of total RNA.', 'label': {'hTR beta 1': 'protein', 'hTR beta 1 mRNA': 'RNA'}, 'response1': "['RNA']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"IFN A": "The mention of IFN A is directly associated with the protein entity label."},\n    {"IFNA": "The mention of IFNA is directly associated with the protein entity label."},\n    {"interleukin-2": "The mention of interleukin-2 is directly associated with the protein entity label."},\n    {"interleukin-2 receptor": "The mention of interleukin-2 receptor is directly associated with the protein entity label."},\n    {"phytohemagglutinin": "The mention of phytohemagglutinin is directly associated with the protein entity label."},\n    {"phorbol myristate acetate": "The mention of phorbol myristate acetate is directly associated with the protein entity label."}\n]\n[\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 4},\n    {"GATA-1": "The mention of GATA-1 is directly associated with the protein entity label."}\n]\n[\n    {"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 3},\n    {"cDNAs": "The mention of cDNAs is directly associated with the DNA entity label."}\n]\n[\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"TCRzeta": "The mention of TCRzeta is directly associated with the protein entity label."},\n    {"p56(lck)": "The mention of p56(lck) is directly associated with the protein entity label."}\n]\n[\n    {"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.": 4},\n    {"nonhuman primates": "The mention of nonhuman primates is directly associated with the cell_type entity label."}\n]\n[\n    {"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n    {"TCF-1": "The mention of TCF-1 is directly associated with the protein entity label."}\n]\n[\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"NF-ATc": "The mention of NF-ATc is directly associated with the protein entity label."},\n    {"T lymphocytes": "The mention of T lymphocytes is directly associated with the cell_type entity label."},\n    {"embryonic cardiac cells": "The mention of embryonic cardiac cells is directly associated with the cell_type entity label."}\n]\n[\n    {"To evaluate the PML/RARalpha role in myelopoiesis, transgenic mice expressing PML/RARalpha were engineered.": 5},\n    {"PML/RARalpha": "The mention of PML/RARalpha is directly associated with the protein entity label."}\n]\n[\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 5},\n    {"retinoic acid receptor alpha": "The mention of retinoic acid receptor alpha is directly associated with the protein entity label."}\n]\n[\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"E2A": "The mention of E2A is directly associated with the protein entity label."}\n]\n[\n    {"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.": 5},\n    {"Ter 119": "The mention of Ter 119 is directly associated with the cell_line entity label."},\n    {"beta-globin": "The mention of beta-globin is directly associated with the protein entity label."},\n    {"glycoprotein IIb": "The mention of glycoprotein IIb is directly associated with the protein entity label."},\n    {"platelet factor 4": "The mention of platelet factor 4 is directly associated with the protein entity label."}\n]\n[\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"B and T cell activation": "The mention of B and T cell activation is directly associated with the cell_type entity label."},\n    {"Ramos": "The mention of Ramos is directly associated with the cell_line entity label."},\n    {"Jurkat": "The mention of Jurkat is directly associated with the cell_line entity label."},\n    {"cDNA microarray technology": "The mention of cDNA microarray technology is directly associated with the DNA entity label."}\n]\n[\n    {"Thus, we were able to derive a hematopoietic cell line, called 47.10, that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.": 5},\n    {"hematopoietic cell line": "The mention of hematopoietic cell line is directly associated with the cell_line entity label."},\n    {"47.10": "The mention of 47.10 is directly associated with the cell_line entity label."},\n    {"cell line": "The mention of cell line is directly associated with the cell_line entity label."},\n    {"nontransgenic mice": "The mention of nontransgenic mice is directly associated with the cell_line entity label."}\n]\n[\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"HIV-1 LTR": "The mention of HIV-1 LTR is directly associated with the DNA entity label."},\n    {"NFAT-1": "The mention of NFAT-1 is directly associated with the protein entity label."},\n    {"NF kappa B": "The mention of NF kappa B is directly associated with the protein entity label."}\n]\n[\n    {"Expression of tal-1 and GATA-binding proteins during human hematopoiesis.": 4},\n    {"tal-1": "The mention of tal-1 is directly associated with the protein entity label."},\n    {"GATA-binding proteins": "The mention of GATA-binding proteins is directly associated with the protein entity label."},\n    {"hematopoiesis": "The mention of hematopoiesis is directly associated with the cell_type entity label."}\n]\n[\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n    {"EBV": "The mention of EBV is directly associated with the DNA entity label."},\n    {"EBNA2": "The mention of EBNA2 is directly associated with the protein entity label."},\n    {"estrogen receptor": "The mention of estrogen receptor is directly associated with the protein entity label."}\n]\n[\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1}\n]\n[\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1}\n]\n[\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1}\n]\n[\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1}\n]\n[\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]\n', 'response3': '[{"hTR beta 1 mRNA": "RNA"}]', 'prediction': {'hTR beta 1 mRNA': 'RNA'}}
{'idx': 1399, 'sentence': 'To investigate the role of NF-M in hematopoietic cell lineage commitment, we constructed a conditional form of the protein by fusing it to the hormone binding domain of the human estrogen receptor .', 'label': {'hematopoietic cell lineage': 'cell_line', 'human estrogen receptor': 'protein', 'NF-M': 'protein', 'hormone binding domain': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 5},\n    {"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events.": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 5},\n    {"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n    {"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"NF-M": "protein"}, {"hematopoietic cell lineage commitment": "cell_type"}, {"human estrogen receptor": "protein"}]', 'prediction': {'NF-M': 'protein', 'hematopoietic cell lineage commitment': 'cell_type', 'human estrogen receptor': 'protein'}}
{'idx': 1327, 'sentence': 'Our results demonstrate that NF-IL6 is involved in transcriptional activation of the human IL-4 promoter in T cells .', 'label': {'human IL-4': 'protein', 'human IL-4 promoter': 'DNA', 'NF-IL6': 'protein', 'T cells': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of proteins and cell types mentioned in the target sentence, which can aid in identifying named entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of proteins, cell types, and transcription factors that are relevant to the target sentence, aiding in entity extraction."},\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions proteins and cell types that are directly related to the target sentence, making it highly relevant for entity extraction."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins, cell types, and transcription factors mentioned in the target sentence, facilitating entity extraction."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of proteins and transcription factors relevant to the target sentence, aiding in named entity extraction."},\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions proteins and cell types that are directly related to the target sentence, making it highly relevant for entity extraction."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins, cell types, and signaling pathways mentioned in the target sentence, aiding in entity extraction."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of proteins and transcription factors relevant to the target sentence, facilitating entity extraction."},\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions proteins and cell types that are directly related to the target sentence, making it highly relevant for entity extraction."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins and cell types mentioned in the target sentence, aiding in identifying named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of proteins and signaling pathways relevant to the target sentence, aiding in named entity extraction."},\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions proteins and cell types that are directly related to the target sentence, making it highly relevant for entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of proteins or cell types mentioned in the target sentence, hence not helpful for entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of proteins or cell types mentioned in the target sentence, hence not helpful for entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of proteins or cell types mentioned in the target sentence, hence not helpful for entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of proteins or cell types mentioned in the target sentence, hence not helpful for entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of proteins or cell types mentioned in the target sentence, hence not helpful for entity extraction."}\n]', 'response3': '[{"NF-IL6": "protein"}, {"IL-4": "protein"}, {"T cells": "cell_type"}]', 'prediction': {'NF-IL6': 'protein', 'IL-4': 'protein', 'T cells': 'cell_type'}}
{'idx': 146, 'sentence': 'Unlike other class II promoters , the HLA-DR alpha (DRA) promoter also contains one element identical to the "octamer" motif of immunoglobulin variable region promoters that is responsible for B cell-specific transcription .', 'label': {'"octamer" motif': 'DNA', 'HLA-DR alpha (DRA) promoter': 'DNA', 'class II promoters': 'DNA', 'immunoglobulin variable region promoters': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 4},\n    {"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.": 5},\n    {"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 4},\n    {"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"HLA-DR alpha (DRA)": "protein"}, {"octamer": "protein"}, {"immunoglobulin variable region": "protein"}, {"B cell-specific": "cell_type"}]', 'prediction': {'HLA-DR alpha (DRA)': 'protein', 'octamer': 'protein', 'immunoglobulin variable region': 'protein', 'B cell-specific': 'cell_type'}}
{'idx': 1247, 'sentence': 'The Janus family tyrosine kinase Jak3 is the only signaling molecule known to be associated with gamma c , so it was hypothesized that defects in Jak3 might cause an XSCID -like phenotype .', 'label': {'Janus family tyrosine kinase': 'protein', 'Jak3': 'protein', 'gamma c': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 3},\n    {"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway, and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.": 5},\n    {"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n    {"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/thrombopoiesis or possibly a mature platelet function such as aggregation.": 5},\n    {"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.": 5},\n    {"SCL is expressed in erythroid, megakaryocyte and mast cell populations (the same cell lineages as GATA-1, a zinc-finger transcription factor).": 5},\n    {"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine (IL-2 and IFN-gamma) production is normal.": 5},\n    {"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"Jak3": "protein"}, {"gamma c": "protein"}, {"XSCID": "cell_type"}]', 'prediction': {'Jak3': 'protein', 'gamma c': 'protein', 'XSCID': 'cell_type'}}
{'idx': 1300, 'sentence': 'As considerable evidence has accumulated that social support in both animal and human populations may have survival value, we sought to test the reliability of this regression model , using coping and perceived support factor values obtained at 3 months after surgery to account for concurrent follow-up NK activity in this serially assessed group of patients .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 5},\n    {"Because relatively little is known about these events in nonhuman primates , our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates .": 4},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .": 4},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes .": 4},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements .": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .": 5},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .": 4},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .": 4},\n    {"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .": 5},\n    {"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 350, 'sentence': 'Induction of 24,25-(OH)2D3 synthesis by 1,25(OH)2D3 was observed in the fifth cell line , designated Ro-VDR , although the sensitivity to hormone treatment was lower than in the control cell line from a normal donor .', 'label': {'control cell line': 'cell_line', 'cell line': 'cell_line', 'Ro-VDR': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[\n    {"Example 1": 3},\n    {"Reason 1": "The sentence provides examples of named entities and their corresponding labels, which can help in understanding the types of entities present in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence provides examples of named entities and their corresponding labels, which can help in understanding the types of entities present in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence provides multiple examples of named entities and their corresponding labels, covering a wide range of entity types present in the target sentence."},\n    {"Example 4": 2},\n    {"Reason 4": "The sentence provides an example of a named entity and its corresponding label, which may not cover all entity types present in the target sentence."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence provides examples of named entities and their corresponding labels, which can help in understanding the types of entities present in the target sentence."},\n    {"Example 6": 3},\n    {"Reason 6": "The sentence provides examples of named entities and their corresponding labels, which can help in understanding the types of entities present in the target sentence."},\n    {"Example 7": 3},\n    {"Reason 7": "The sentence provides examples of named entities and their corresponding labels, which can help in understanding the types of entities present in the target sentence."},\n    {"Example 8": 2},\n    {"Reason 8": "The sentence provides an example of a named entity and its corresponding label, which may not cover all entity types present in the target sentence."},\n    {"Example 9": 3},\n    {"Reason 9": "The sentence provides examples of named entities and their corresponding labels, which can help in understanding the types of entities present in the target sentence."},\n    {"Example 10": 3},\n    {"Reason 10": "The sentence provides examples of named entities and their corresponding labels, which can help in understanding the types of entities present in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides multiple examples of named entities and their corresponding labels, covering a wide range of entity types present in the target sentence."},\n    {"Example 12": 3},\n    {"Reason 12": "The sentence provides examples of named entities and their corresponding labels, which can help in understanding the types of entities present in the target sentence."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not provide examples of named entities and their corresponding labels, making it less helpful in understanding the types of entities present in the target sentence."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not provide examples of named entities and their corresponding labels, making it less helpful in understanding the types of entities present in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not provide examples of named entities and their corresponding labels, making it less helpful in understanding the types of entities present in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not provide examples of named entities and their corresponding labels, making it less helpful in understanding the types of entities present in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not provide examples of named entities and their corresponding labels, making it less helpful in understanding the types of entities present in the target sentence."}\n]', 'response3': '[{"24,25-(OH)2D3": "protein"}, {"1,25(OH)2D3": "protein"}, {"Ro-VDR": "cell_line"}, {"cell line": "cell_line"}]', 'prediction': {'24,25-(OH)2D3': 'protein', '1,25(OH)2D3': 'protein', 'Ro-VDR': 'cell_line', 'cell line': 'cell_line'}}
{'idx': 1093, 'sentence': 'The genomic actions of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) are mediated by the intracellular vitamin D receptor ( VDR ).', 'label': {'VDR': 'protein', 'vitamin D receptor': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements.": 4},\n    {"An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage.": 4},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.": 4},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n    {"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.": 4},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 4},\n    {"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex.": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"Protein kinase B ( c-Akt ), phosphatidylinositol 3-kinase , and STAT5 are activated by erythropoietin ( EPO ) in HCD57 erythroid cells but are constitutively active in an EPO -independent, apoptosis -resistant subclone ( HCD57-SREI cells ).": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"1,25-dihydroxyvitamin D3": "protein"}, {"VDR": "protein"}]', 'prediction': {'1,25-dihydroxyvitamin D3': 'protein', 'VDR': 'protein'}}
{'idx': 1493, 'sentence': 'Chronic HIV-1 infection of myeloid cells leads to constitutive NF-kappa B DNA-binding activity and provides an intranuclear environment capable of perpetuating HIV-1 replication .', 'label': {'myeloid cells': 'cell_type', 'NF-kappa B': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n    {"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B.": 5},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.": 5},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 5},\n    {"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"NF-kappa B": "DNA"}]', 'prediction': {'NF-kappa B': 'DNA'}}
{'idx': 334, 'sentence': "One of the protoenhancers contains the overlapping palindromes 5'-TTGTCCcgtGGACAAaTGTCC-3' .", 'label': {'protoenhancers': 'DNA', 'overlapping palindromes': 'DNA'}, 'response1': "['DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear and direct mention of the entity \'DNA\' in the context of \'proto-enhancer\', making it highly relevant for entity extraction."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 946, 'sentence': 'Compared to the control group , fewer depressed subjects down-regulated Bmax after DEX .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides clear examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 777, 'sentence': 'We have identified two human pre-B-cell lines that contain extremely low levels of OTF-2 yet still express high levels of steady-state immunoglobulin heavy-chain mRNA in vivo and efficiently transcribe an immunoglobulin gene in vitro.', 'label': {'OTF-2': 'protein', 'immunoglobulin gene': 'DNA', 'steady-state immunoglobulin heavy-chain mRNA': 'RNA', 'human pre-B-cell lines': 'cell_line', 'immunoglobulin heavy-chain': 'protein'}, 'response1': "['cell_line', 'RNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear and direct mention of the entity type with specific examples."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence directly mentions the entity type with specific examples and provides additional context for better understanding."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence mentions the entity type with specific examples and provides information on the action or function of the entity."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence directly mentions the entity type with specific examples and provides context for better understanding."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides a clear and direct mention of the entity type with specific examples."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence directly mentions the entity type with specific examples and provides additional context for better understanding."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence mentions the entity type with specific examples and provides information on the action or function of the entity."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence directly mentions the entity type with specific examples and provides context for better understanding."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides a clear and direct mention of the entity type with specific examples."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence directly mentions the entity type with specific examples and provides additional context for better understanding."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence mentions the entity type with specific examples and provides information on the action or function of the entity."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence directly mentions the entity type with specific examples and provides context for better understanding."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not mention any entity type relevant to the given label set."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not mention any entity type relevant to the given label set."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not mention any entity type relevant to the given label set."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not mention any entity type relevant to the given label set."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not mention any entity type relevant to the given label set."}\n]', 'response3': "[{'OTF-2': 'protein'}, {'immunoglobulin heavy-chain mRNA': 'RNA'}, {'immunoglobulin gene': 'DNA'}, {'pre-B-cell lines': 'cell_line'}]", 'prediction': {'OTF-2': 'protein', 'immunoglobulin heavy-chain mRNA': 'RNA', 'immunoglobulin gene': 'DNA', 'pre-B-cell lines': 'cell_line'}}
{'idx': 552, 'sentence': 'Similarly, an excess of FK506 is needed to revert rapamycin -mediated inhibition of IL-2 -induced proliferation .', 'label': {'IL-2': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1}\n]', 'response3': '[{"FK506": "protein"}, {"rapamycin": "protein"}, {"IL-2": "protein"}]', 'prediction': {'FK506': 'protein', 'rapamycin': 'protein', 'IL-2': 'protein'}}
{'idx': 1310, 'sentence': 'The abundant chromosomal protein HMG-1 belongs to this subgroup.', 'label': {'HMG-1': 'protein', 'chromosomal protein': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 5},\n    {"This protein has now been purified and its encoding gene cloned.": 5},\n    {"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.": 1},\n    {"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 1},\n    {"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 5},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n    {"Tat-binding protein 7 is a subunit of the 26S protease.": 5},\n    {"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n    {"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.": 5},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1409, 'sentence': 'We investigated the ability of PRL and IL-2 to activate Stat proteins in different T cell lines .', 'label': {'IL-2': 'protein', 'T cell lines': 'cell_line', 'PRL': 'protein', 'Stat proteins': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names that match the entity label \'protein\', making it highly relevant for named entity extraction."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence contains cell types and proteins that match the entity labels \'cell_type\' and \'protein\', providing relevant information for named entity extraction."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains specific protein names and cell types that match the entity labels \'protein\' and \'cell_type\', making it highly relevant for named entity extraction."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence contains cell types and proteins that match the entity labels \'cell_type\' and \'protein\', providing relevant information for named entity extraction."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence contains protein names and a cell type that match the entity labels \'protein\' and \'cell_type\', providing relevant information for named entity extraction."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains specific protein names that match the entity label \'protein\', making it highly relevant for named entity extraction."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains specific protein names that match the entity label \'protein\', making it highly relevant for named entity extraction."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains specific protein names and cell types that match the entity labels \'protein\' and \'cell_type\', making it highly relevant for named entity extraction."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains specific protein names that match the entity label \'protein\', making it highly relevant for named entity extraction."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains specific protein names that match the entity label \'protein\', making it highly relevant for named entity extraction."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains specific protein names that match the entity label \'protein\', making it highly relevant for named entity extraction."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains specific protein names that match the entity label \'protein\', making it highly relevant for named entity extraction."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains specific protein names and cell types that match the entity labels \'protein\' and \'cell_type\', making it highly relevant for named entity extraction."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains specific protein names that match the entity label \'protein\', making it highly relevant for named entity extraction."},\n    {"Example 15": 4},\n    {"Reason 15": "The sentence contains cell types and proteins that match the entity labels \'cell_type\' and \'protein\', providing relevant information for named entity extraction."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entity types from the given label set, hence not helpful for named entity extraction."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entity types from the given label set, hence not helpful for named entity extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entity types from the given label set, hence not helpful for named entity extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entity types from the given label set, hence not helpful for named entity extraction."}\n]', 'response3': "[{'PRL': 'protein'}, {'IL-2': 'protein'}, {'Stat proteins': 'protein'}, {'T cell lines': 'cell_line'}]", 'prediction': {'PRL': 'protein', 'IL-2': 'protein', 'Stat proteins': 'protein', 'T cell lines': 'cell_line'}}
{'idx': 1140, 'sentence': 'The conserved cis-acting sequence , GGAAAA , and transcription factors binding to this sequence are involved in the response to increased intracellular Ca2+ concentrations .', 'label': {'transcription factors': 'protein', 'conserved cis-acting sequence': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a transcription factor (AP-1) binding to DNA, which directly relates to the entity types mentioned in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides examples of two proteins (Jun and ATF-2) that are involved in transcription, which directly relates to the entity types mentioned in the target sentence."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence provides an example of a cell type (Th2-type lymphocytes) expressed by human cytokines, which indirectly relates to the entity types mentioned in the target sentence."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence provides an example of a protein involved in transcription, which directly relates to the entity types mentioned in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides a clear example of a protein (Egr-1) that is a zinc finger transcription factor, which directly relates to the entity types mentioned in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides examples of proteins (IL-2, c-Jun, c-Fos) involved in transcription and binding to specific sites, which directly relates to the entity types mentioned in the target sentence."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence provides an example of a protein (GM-CSF) that is highly conserved in genes, which indirectly relates to the entity types mentioned in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides a clear example of a protein (GATA-1) that is a lineage-specific transcription factor, which directly relates to the entity types mentioned in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides a clear example of a protein (TCF-1) that can transactivate through its cognate motif, which directly relates to the entity types mentioned in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides a clear example of proteins (Stat proteins) that form dimers, translocate to the nucleus, and induce transcription, which directly relates to the entity types mentioned in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides clear examples of proteins (EKLF, CBP, p300, P/CAF) that interact and are involved in transcription, which directly relates to the entity types mentioned in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides examples of proteins (SCL, GATA-1) expressed in specific cell lineages, which directly relates to the entity types mentioned in the target sentence."},\n    {"Example 13": 4},\n    {"Reason 13": "The sentence provides an example of a protein (G-CSF) that mediates effects by binding to receptors, which indirectly relates to the entity types mentioned in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides clear examples of proteins (VDR, RXR, GRIP-1, DRIP205) involved in interactions and coactivator complexes, which directly relates to the entity types mentioned in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides clear examples of proteins (ZEB, c-Myb, Ets) involved in transcriptional regulation and gene expression in specific cell types, which directly relates to the entity types mentioned in the target sentence."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence provides examples of proteins (tal-1, GATA-binding proteins) expressed during hematopoiesis, which directly relates to the entity types mentioned in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entity types mentioned in the target sentence, therefore not helpful for extracting named entities."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entity types mentioned in the target sentence, therefore not helpful for extracting named entities."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entity types mentioned in the target sentence, therefore not helpful for extracting named entities."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entity types mentioned in the target sentence, therefore not helpful for extracting named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 449, 'sentence': 'We find that the factor that binds to the E3 enhancer motif , CATGTGGC , is a ubiquitous transcription factor .', 'label': {'ubiquitous transcription factor': 'protein', 'E3 enhancer motif': 'DNA'}, 'response1': "['DNA']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with their corresponding entity labels, which can aid in understanding the relationship between the entities and their types."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of named entities with their corresponding entity labels, which can help in identifying the specific types of proteins mentioned."},\n    {"Sentence": 3},\n    {"Reason": "The sentence includes a specific example of a named entity with its corresponding entity label, which can assist in recognizing DNA-related elements."},\n    {"Sentence": 4},\n    {"Reason": "The sentence presents an example of a named entity with its corresponding entity label, aiding in identifying a specific protein."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with their corresponding entity labels, which can help in understanding the types of proteins and cell types mentioned."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of named entities with their corresponding entity labels, which can aid in identifying specific proteins."},\n    {"Sentence": 4},\n    {"Reason": "The sentence includes an example of a named entity with its corresponding entity label, which can assist in recognizing a specific protein."},\n    {"Sentence": 4},\n    {"Reason": "The sentence presents an example of a named entity with its corresponding entity label, aiding in identifying a specific protein."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of named entities with their corresponding entity labels, which can help in identifying specific proteins."},\n    {"Sentence": 3},\n    {"Reason": "The sentence includes a specific example of a named entity with its corresponding entity label, which can assist in recognizing DNA-related elements."},\n    {"Sentence": 4},\n    {"Reason": "The sentence presents an example of a named entity with its corresponding entity label, aiding in identifying a specific protein."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with their corresponding entity labels, which can aid in understanding the types of proteins mentioned."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the provided entity labels, hence not helpful in this context."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the provided entity labels, hence not helpful in this context."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the provided entity labels, hence not helpful in this context."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the provided entity labels, hence not helpful in this context."}\n]', 'response3': '[{"E3 enhancer motif": "DNA"}]', 'prediction': {'E3 enhancer motif': 'DNA'}}
{'idx': 1402, 'sentence': 'At the same time, we observed a down-regulation of progenitor-specific surface markers and the up-regulation of differentiation markers restricted to the eosinophil and myeloid lineages .', 'label': {'eosinophil': 'cell_type', 'myeloid lineages': 'cell_type', 'differentiation markers': 'protein', 'progenitor-specific surface markers': 'protein'}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein (GATA-1) in the context of differentiating erythroid cells, which directly relates to the entity types mentioned in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence clearly mentions a protein (Egr-1) in the context of macrophage differentiation, which directly relates to the entity types mentioned in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence provides a clear example of a protein (NF-E2) in the context of erythroid-specific gene expression and a cell-specific transcription factor, which directly relates to the entity types mentioned in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence clearly mentions a protein (retinoic acid receptor alpha) in the context of myeloid cell differentiation, which directly relates to the entity types mentioned in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides a clear example of a protein (CD14) in the context of monocytic differentiation, which directly relates to the entity types mentioned in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides clear examples of cell types (Th1 and Th2) in the context of distinct cytokine expression patterns, which directly relates to the entity types mentioned in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides a clear example of a protein (E2A) in the context of protein expression at the cellular level, which directly relates to the entity types mentioned in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides clear examples of a cell line (B cell) and a cell-specific element (UAS1) in the context of promoter activity, which directly relates to the entity types mentioned in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides a clear example of a protein (WT1) in the context of exclusive paternal expression, which directly relates to the entity types mentioned in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides clear examples of proteins (CD14 and CD23) in the context of mRNA and protein expression, which directly relates to the entity types mentioned in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides clear examples of proteins (myeloperoxidase, lysozyme, PU.1) in the context of granulocyte-associated lysosomal proteins and transcription factor, which directly relates to the entity types mentioned in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides clear examples of a protein (WT1) and a cell line (myeloid cell lines) in the context of differentiation induction, which directly relates to the entity types mentioned in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides clear examples of a protein (MNDA) and a cell line (Philadelphia chromosome-positive chronic myeloid leukemia) in the context of granulocyte-macrophage lineage and cell line establishment, which directly relates to the entity types mentioned in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides clear examples of cell types (granulocytes and T cells) in the context of methylation deviation, which directly relates to the entity types mentioned in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides a clear example of a protein (GATA-1) in the context of erythroid cells, which directly relates to the entity types mentioned in the target sentence."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence provides clear examples of proteins (Sp1 and Ets) in the context of CTL-specific expression and transcription factors, which directly relates to the entity types mentioned in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities related to the entity types mentioned in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities related to the entity types mentioned in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities related to the entity types mentioned in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities related to the entity types mentioned in the target sentence."}\n]', 'response3': "[{'eosinophil': 'cell_type'}, {'myeloid': 'cell_type'}]", 'prediction': {'eosinophil': 'cell_type', 'myeloid': 'cell_type'}}
{'idx': 664, 'sentence': 'Interferon-gamma and the sexual dimorphism of autoimmunity .', 'label': {'Interferon-gamma': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Th1": 5},\n    {"Th2": 5},\n    {"AP-1": 5},\n    {"IFN-gamma": 5},\n    {"IL4": 5},\n    {"IL13": 5},\n    {"STAT6": 5},\n    {"STAT3": 5},\n    {"STAT5": 5},\n    {"B cells": 5},\n    {"Sp1": 5},\n    {"Ets": 5},\n    {"IL-7R": 5},\n    {"gamma(c)": 5},\n    {"IL-2": 5},\n    {"IFN-gamma": 5},\n    {"jak kinases": 5},\n    {"STAT1(alpha)": 5},\n    {"IL-2": 5},\n    {"SP1": 5},\n    {"caspases": 5},\n    {"B-cell": 5},\n    {"IFN A": 5},\n    {"IFNA": 5},\n    {"interleukin-2": 5},\n    {"interleukin-2 receptor": 5},\n    {"phytohemagglutinin": 5},\n    {"phorbol myristate acetate": 5},\n    {"IkappaBbeta": 5},\n    {"NF-kappaB": 5},\n    {"NF-kappaB": 5},\n    {"rheumatoid arthritis": 5},\n    {"immunoglobulin kappa 3\' enhancer": 5},\n    {"Th2-type lymphocytes": 5},\n    {"GATA-1": 5},\n    {"CD40": 5},\n    {"IFN-gamma": 5},\n    {"tumor necrosis factor-alpha": 5},\n    {"interleukin (IL)-1beta": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1726, 'sentence': 'It is tempting to speculate that enhanced NF-kappa B expression caused by free radical production/oxidative stress may modulate liver injury , perhaps through an effect on cytotoxic cytokine synthesis .', 'label': {'NF-kappa B': 'protein', 'cytotoxic cytokine': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence 1": 5},\n    {"Sentence 2": 5},\n    {"Sentence 3": 5},\n    {"Sentence 4": 5},\n    {"Sentence 5": 5},\n    {"Sentence 6": 5},\n    {"Sentence 7": 5},\n    {"Sentence 8": 5},\n    {"Sentence 9": 1},\n    {"Sentence 10": 1},\n    {"Sentence 11": 1},\n    {"Sentence 12": 1},\n    {"Sentence 13": 5},\n    {"Sentence 14": 5},\n    {"Sentence 15": 5},\n    {"Sentence 16": 1},\n    {"Sentence 17": 1},\n    {"Sentence 18": 1},\n    {"Sentence 19": 1}\n]', 'response3': '[{"NF-kappa B": "protein"}]', 'prediction': {'NF-kappa B': 'protein'}}
{'idx': 1573, 'sentence': 'Immunofluorescence colocalization of both estrogen and progesterone receptors with eosinophil cationic protein showed that approximately 70% of positive cells were eosinophils .', 'label': {'estrogen': 'protein', 'eosinophil cationic protein': 'protein', 'positive cells': 'cell_type', 'progesterone receptors': 'protein', 'eosinophils': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example contains specific terms related to the entity labels in the target sentence, making it highly relevant for extracting named entities."},\n    {"Example 2": 4},\n    {"Reason 2": "The example includes terms related to multiple entity labels in the target sentence, providing valuable context for entity extraction."},\n    {"Example 3": 4},\n    {"Reason 3": "The example mentions a specific term related to one of the entity labels in the target sentence, aiding in entity extraction."},\n    {"Example 4": 5},\n    {"Reason 4": "The example directly mentions a specific entity label from the target sentence, making it highly relevant for entity extraction."},\n    {"Example 5": 5},\n    {"Reason 5": "The example contains multiple terms directly related to the entity labels in the target sentence, providing significant assistance in entity extraction."},\n    {"Example 6": 5},\n    {"Reason 6": "The example includes specific terms related to multiple entity labels in the target sentence, making it highly relevant for extracting named entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The example mentions specific terms related to the entity labels in the target sentence, aiding in entity extraction."},\n    {"Example 8": 5},\n    {"Reason 8": "The example directly mentions specific entity labels from the target sentence, making it highly relevant for entity extraction."},\n    {"Example 9": 5},\n    {"Reason 9": "The example contains specific terms related to the entity labels in the target sentence, providing valuable context for entity extraction."},\n    {"Example 10": 5},\n    {"Reason 10": "The example includes specific terms related to multiple entity labels in the target sentence, making it highly relevant for extracting named entities."},\n    {"Example 11": 4},\n    {"Reason 11": "The example mentions a specific term related to one of the entity labels in the target sentence, aiding in entity extraction."},\n    {"Example 12": 4},\n    {"Reason 12": "The example includes terms related to multiple entity labels in the target sentence, providing valuable context for entity extraction."},\n    {"Example 13": 3},\n    {"Reason 13": "The example mentions a specific term related to one of the entity labels in the target sentence, but the relevance is slightly lower compared to other examples."},\n    {"Example 14": 4},\n    {"Reason 14": "The example includes terms related to multiple entity labels in the target sentence, providing valuable context for entity extraction."},\n    {"Example 15": 1},\n    {"Reason 15": "The example does not contain terms directly related to the entity labels in the target sentence, hence providing minimal assistance in entity extraction."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain terms directly related to the entity labels in the target sentence, hence providing minimal assistance in entity extraction."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain terms directly related to the entity labels in the target sentence, hence providing minimal assistance in entity extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain terms directly related to the entity labels in the target sentence, hence providing minimal assistance in entity extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The example does not contain terms directly related to the entity labels in the target sentence, hence providing minimal assistance in entity extraction."}\n]', 'response3': '[{"estrogen": "protein"}, {"progesterone": "protein"}, {"eosinophil cationic protein": "protein"}, {"eosinophils": "cell_type"}]', 'prediction': {'estrogen': 'protein', 'progesterone': 'protein', 'eosinophil cationic protein': 'protein', 'eosinophils': 'cell_type'}}
{'idx': 1589, 'sentence': 'Inhibition of NF-AT -dependent transcription by NF-kappa B : implications for differential gene expression in T helper cell subsets .', 'label': {'NF-kappa B': 'protein', 'T helper cell subsets': 'cell_type', 'NF-AT': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains specific examples of entities mentioned in the target sentence, such as NF-kappa B and I kappa B alpha, which are both proteins. This provides direct examples of the entity types present in the target sentence, making it highly helpful for extracting named entities."}\n]', 'response3': '[{"NF-AT": "protein"}, {"NF-kappa B": "protein"}, {"T helper cell": "cell_type"}]', 'prediction': {'NF-AT': 'protein', 'NF-kappa B': 'protein', 'T helper cell': 'cell_type'}}
{'idx': 114, 'sentence': 'These results indicate that in monocytic cell lineage , HIV-1 could mimic some differentiation/activation stimuli allowing nuclear NF-KB expression .', 'label': {'NF-KB': 'protein', 'monocytic cell lineage': 'cell_line'}, 'response1': "['cell_line', 'cell_type']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with their corresponding entity labels, providing clear and direct assistance in identifying entities in the target sentence."}\n]', 'response3': '[{"monocytic cell lineage": "cell_type"}, {"HIV-1": "cell_type"}, {"NF-KB": "protein"}]', 'prediction': {'monocytic cell lineage': 'cell_type', 'HIV-1': 'cell_type', 'NF-KB': 'protein'}}
{'idx': 469, 'sentence': 'Cardiac and adrenergic diseases were excluded.', 'label': {}, 'response1': 'None.', 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific entities with clear labels that can be easily identified."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence contains specific entities with clear labels, but one entity may have multiple possible labels."},\n    {"Example 3": 3},\n    {"Reason 3": "The sentence contains entities with clear labels, but one entity may have multiple possible labels and another entity is less common."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence contains specific entities with clear labels, but one entity may have multiple possible labels."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains multiple entities with clear labels that can be easily identified."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence contains specific entities with clear labels, but one entity may have multiple possible labels."},\n    {"Example 7": 3},\n    {"Reason 7": "The sentence contains entities with clear labels, but one entity is less common."},\n    {"Example 8": 4},\n    {"Reason 8": "The sentence contains specific entities with clear labels, but one entity may have multiple possible labels."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence contains specific entities with clear labels, but one entity may have multiple possible labels."},\n    {"Example 10": 3},\n    {"Reason 10": "The sentence contains entities with clear labels, but one entity is less common."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains multiple entities with clear labels that can be easily identified."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains multiple entities with clear labels that can be easily identified."},\n    {"Example 13": 4},\n    {"Reason 13": "The sentence contains specific entities with clear labels, but one entity may have multiple possible labels."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains multiple entities with clear labels that can be easily identified."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any entities with clear labels."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entities with clear labels."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities with clear labels."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities with clear labels."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities with clear labels."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1683, 'sentence': 'These results strongly suggest that HU induces both transcriptional and post-transcription regulation of c-jun during erythroid differentiation .', 'label': {'c-jun': 'DNA'}, 'response1': "['RNA', 'protein']", 'response2': '[\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 3},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 4},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 3},\n    {"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 5},\n    {"SCL is expressed in erythroid, megakaryocyte and mast cell populations (the same cell lineages as GATA-1, a zinc-finger transcription factor).": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 4},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n    {"Our results demonstrate that the altered CCAAT box (CCAAC) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 4},\n    {"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts.": 5},\n    {"Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent, apoptosis-resistant subclone (HCD57-SREI cells).": 5},\n    {"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.": 4},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb/Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.": 5},\n    {"Expression of tal-1 and GATA-binding proteins during human hematopoiesis.": 4},\n    {"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.": 4},\n    {"Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB-induced trans-activation of the H4 promoter.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1648, 'sentence': 'Point mutations of either the PU.1 site or the C/EBP site that abolish the binding of the respective factors result in a significant decrease of GM-CSF receptor alpha promoter activity in myelomonocytic cells only.', 'label': {'PU.1 site': 'DNA', 'GM-CSF receptor alpha': 'protein', 'GM-CSF receptor alpha promoter': 'DNA', 'myelomonocytic cells': 'cell_type', 'C/EBP': 'protein', 'PU.1': 'protein', 'GM-CSF': 'protein', 'C/EBP site': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines .": 4},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .": 4},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors .": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .": 5},\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .": 5},\n    {"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 4},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .": 5},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"PU.1": "protein"}, {"C/EBP": "protein"}, {"GM-CSF receptor alpha": "protein"}, {"myelomonocytic cells": "cell_type"}]', 'prediction': {'PU.1': 'protein', 'C/EBP': 'protein', 'GM-CSF receptor alpha': 'protein', 'myelomonocytic cells': 'cell_type'}}
{'idx': 646, 'sentence': 'Surgically confirmed nodal involvement was observed in 42%.', 'label': {}, 'response1': 'None.', 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 5},\n    {"Example 17": 5},\n    {"Example 18": 5},\n    {"Example 19": 5},\n    {"Example 20": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 821, 'sentence': '(vi) The EBV type 2 EBNA-2 transactivated LMP1 as well as the EBV type 1 EBNA-2 .', 'label': {'LMP1': 'protein', 'EBNA-2': 'protein', 'EBV type 1 EBNA-2': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.": 4},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 3},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.": 3},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B.": 4},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 4},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 3},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 2},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 3},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 4},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 4},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"EBV type 2 EBNA-2": "protein"}, {"LMP1": "protein"}, {"EBV type 1 EBNA-2": "protein"}]', 'prediction': {'EBV type 2 EBNA-2': 'protein', 'LMP1': 'protein', 'EBV type 1 EBNA-2': 'protein'}}
{'idx': 548, 'sentence': 'On the other hand, interleukin 2 ( IL-2 )-induced signals are blocked by rapamycin but not by FK506 .', 'label': {'IL-2': 'protein', 'interleukin 2': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .": 4},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .": 4},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .": 5},\n    {"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway , and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells .": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 4},\n    {"Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.": 5},\n    {"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin .": 4},\n    {"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .": 5},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 135, 'sentence': 'Tumor necrosis factor alpha ( TNF-alpha ) mRNA production was analyzed by polymerase chain reaction amplification in monocytic U937 cells and in a chronically HIV infected U937 cell line ( U9-IIIB ).', 'label': {'U9-IIIB': 'cell_line', 'monocytic U937 cells': 'cell_line', 'Tumor necrosis factor alpha ( TNF-alpha ) mRNA': 'RNA', 'chronically HIV infected U937 cell line': 'cell_line', 'Tumor necrosis factor alpha': 'protein', 'TNF-alpha': 'protein'}, 'response1': "['RNA', 'cell_type', 'cell_line']", 'response2': '[\n    {"Sentence 1": 5},\n    {"Sentence 2": 5},\n    {"Sentence 3": 5},\n    {"Sentence 4": 5},\n    {"Sentence 5": 5},\n    {"Sentence 6": 5},\n    {"Sentence 7": 5},\n    {"Sentence 8": 1},\n    {"Sentence 9": 1},\n    {"Sentence 10": 5},\n    {"Sentence 11": 5},\n    {"Sentence 12": 5},\n    {"Sentence 13": 5},\n    {"Sentence 14": 5},\n    {"Sentence 15": 5},\n    {"Sentence 16": 1},\n    {"Sentence 17": 1},\n    {"Sentence 18": 1},\n    {"Sentence 19": 1},\n    {"Sentence 20": 1}\n]', 'response3': '[{"TNF-alpha": "protein"}, {"U937 cells": "cell_type"}, {"U9-IIIB": "cell_line"}, {"HIV": "cell_type"}]', 'prediction': {'TNF-alpha': 'protein', 'U937 cells': 'cell_type', 'U9-IIIB': 'cell_line', 'HIV': 'cell_type'}}
{'idx': 432, 'sentence': 'Moreover, BSAP is clearly a B-cell-specific transcription factor , as a wild-type but not a mutant TSAP -binding site of the sea urchin functions only in transfected B cells as an upstream promoter element .', 'label': {'transfected B cells': 'cell_line', 'TSAP': 'protein', 'mutant TSAP -binding site': 'DNA', 'upstream promoter element': 'DNA', 'BSAP': 'protein', 'B-cell-specific transcription factor': 'protein', 'wild-type': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n{"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 4},\n{"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n{"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n{"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.": 5},\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 4},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 4},\n{"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 3},\n{"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n{"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 4},\n{"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n{"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 4},\n{"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n{"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.": 5},\n{"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"BSAP": "protein"}, {"TSAP": "protein"}, {"sea urchin": "cell_line"}, {"B cells": "cell_type"}]', 'prediction': {'BSAP': 'protein', 'TSAP': 'protein', 'sea urchin': 'cell_line', 'B cells': 'cell_type'}}
{'idx': 1161, 'sentence': 'Deoxycholate treatment of the cytoplasmic extract prepared from cells stimulated by TNF-alpha in the presence of Cu2+ resulted in the release of NF kappa B from I kappa B alpha , indicating that Cu2+ interferes with the dissociation of the NF kappa B -I kappa B complex .', 'label': {'I kappa B alpha': 'protein', 'NF kappa B': 'protein', 'NF kappa B -I kappa B complex': 'protein', 'TNF-alpha': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.": 5},\n    {"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .": 5},\n    {"When the same MTHC lines are exposed to TNF-alpha in combination with IFN-gamma , the cells instead become DC .": 5},\n    {"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .": 5},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .": 5},\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .": 5},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .": 5},\n    {"Control of NF-kappa B activity by the I kappa B beta inhibitor .": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"NF kappa B": "protein"}, {"I kappa B alpha": "protein"}, {"Cu2+": "cell_line"}]', 'prediction': {'NF kappa B': 'protein', 'I kappa B alpha': 'protein', 'Cu2+': 'cell_line'}}
{'idx': 1794, 'sentence': 'Activation of the signal transducer and transcription ( STAT ) signaling pathway in a primary T cell response .', 'label': {'STAT': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 4},\n    {"Example 3": 5},\n    {"Example 4": 4},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 3},\n    {"Example 10": 3},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 3},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1470, 'sentence': 'Hence, induction of cell surface expression of this leukocyte adhesion molecule by tumor necrosis factor (TNF)-alpha was reduced by 40% in the presence of CsA , and this was reflected by a 29% decrease in neutrophil adhesion .', 'label': {'neutrophil': 'cell_type', 'tumor necrosis factor (TNF)-alpha': 'protein', 'leukocyte adhesion molecule': 'protein'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n{"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 5},\n{"PMA induced the expression of both CD14 and CD23 mRNA and protein.": 5},\n{"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n{"CD40 expression could be enhanced in CD40-positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5},\n{"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.": 5},\n{"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 5},\n{"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n{"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n{"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n{"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n{"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 5},\n{"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 5},\n{"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n{"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.": 5},\n{"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"TNF-alpha": "protein"}, {"CsA": "protein"}]', 'prediction': {'TNF-alpha': 'protein', 'CsA': 'protein'}}
{'idx': 644, 'sentence': 'Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers : a role for hematopoietic growth factor release by tumor cells ?', 'label': {'tumor cells': 'cell_type', 'hematopoietic growth factor': 'protein'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example contains specific terms that match the entity labels in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The example contains specific terms that match the entity labels in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The example contains specific terms that match the entity labels in the target sentence."},\n    {"Example 4": 4},\n    {"Reason 4": "The example contains relevant terms that match some entity labels in the target sentence."},\n    {"Example 5": 4},\n    {"Reason 5": "The example contains relevant terms that match some entity labels in the target sentence."},\n    {"Example 6": 4},\n    {"Reason 6": "The example contains relevant terms that match some entity labels in the target sentence."},\n    {"Example 7": 4},\n    {"Reason 7": "The example contains relevant terms that match some entity labels in the target sentence."},\n    {"Example 8": 3},\n    {"Reason 8": "The example contains terms that are related but not directly matching the entity labels in the target sentence."},\n    {"Example 9": 3},\n    {"Reason 9": "The example contains terms that are related but not directly matching the entity labels in the target sentence."},\n    {"Example 10": 3},\n    {"Reason 10": "The example contains terms that are related but not directly matching the entity labels in the target sentence."},\n    {"Example 11": 3},\n    {"Reason 11": "The example contains terms that are related but not directly matching the entity labels in the target sentence."},\n    {"Example 12": 2},\n    {"Reason 12": "The example contains terms that are not directly related to the entity labels in the target sentence."},\n    {"Example 13": 2},\n    {"Reason 13": "The example contains terms that are not directly related to the entity labels in the target sentence."},\n    {"Example 14": 1},\n    {"Reason 14": "The example does not contain terms related to the entity labels in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The example does not contain terms related to the entity labels in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain terms related to the entity labels in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain terms related to the entity labels in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain terms related to the entity labels in the target sentence."}\n]', 'response3': "[{'lymphocyte': 'cell_type'}, {'hematopoietic growth factor': 'protein'}, {'tumor cells': 'cell_line'}]", 'prediction': {'lymphocyte': 'cell_type', 'hematopoietic growth factor': 'protein', 'tumor cells': 'cell_line'}}
{'idx': 435, 'sentence': 'Antibodies are produced exclusively in B lymphocytes .', 'label': {'Antibodies': 'protein', 'lymphocytes': 'cell_type', 'B lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"IgH": 5, "Eosinophils": 4, "IL-13": 5, "IL-4": 5, "EBV": 4, "CD2": 4, "IL4": 5, "IL13": 5, "STAT6": 5, "STAT3": 5, "STAT5": 5, "Th1": 4, "Th2": 4, "Th2-type lymphocytes": 5, "CD70": 5, "NF-ATc": 5, "IL-2 receptor alpha subunit": 5, "p21ras": 5, "HLA-molecules": 5, "E2A": 5, "benzene": 4, "benzoquinone": 4, "ICAM-1": 5, "CD71": 5, "LMP1": 5, "IkappaB": 5, "CD40": 5, "Rel/nuclear factor kappaB": 5, "NF-kappaB": 5, "B lymphocytes": 5},\n{"reasons":  "The examples provided contain specific entities that match the entity types present in the target sentence, making them highly relevant for aiding in the extraction of named entities. The entities are directly related to the entity labels in the target sentence, providing clear and informative references for identification."}\n]', 'response3': "[{'B lymphocytes': 'cell_type'}]", 'prediction': {'B lymphocytes': 'cell_type'}}
{'idx': 1342, 'sentence': 'While Bik does not show overt homology to the BH1 and BH2 conserved domains characteristic of the Bcl-2 family , it does share a 9 amino acid domain ( BH3 ) with Bax and Bak which may be a critical determinant for the death-promoting activity of these proteins.', 'label': {'amino acid domain': 'protein', 'BH1': 'protein', 'BH3': 'protein', 'Bak': 'protein', 'BH2': 'protein', 'Bax': 'protein', 'Bik': 'protein', 'Bcl-2 family': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n{"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 5},\n{"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n{"These two related genes share the evolutionarily conserved region encoding the Runt domain.": 5},\n{"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.": 5},\n{"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n{"Tat-binding protein 7 is a subunit of the 26S protease.": 5},\n{"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n{"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n{"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.": 5},\n{"Activation of NF-kappaB by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.": 5},\n{"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n{"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"Bik": "protein"}, {"BH1": "protein"}, {"BH2": "protein"}, {"Bcl-2": "protein"}, {"BH3": "protein"}, {"Bax": "protein"}, {"Bak": "protein"}]', 'prediction': {'Bik': 'protein', 'BH1': 'protein', 'BH2': 'protein', 'Bcl-2': 'protein', 'BH3': 'protein', 'Bax': 'protein', 'Bak': 'protein'}}
{'idx': 1022, 'sentence': 'NK cell NFAT is present in the cytosol of nonstimulated cells , migrates to the nucleus upon stimulation, and can associate with AP-1 .', 'label': {'NK cell NFAT': 'protein', 'AP-1': 'protein', 'nonstimulated cells': 'cell_type'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Sentence 1": 5},\n    {"Sentence 2": 5},\n    {"Sentence 3": 5},\n    {"Sentence 4": 5},\n    {"Sentence 5": 5},\n    {"Sentence 6": 5},\n    {"Sentence 7": 5},\n    {"Sentence 8": 4},\n    {"Sentence 9": 1},\n    {"Sentence 10": 1},\n    {"Sentence 11": 5},\n    {"Sentence 12": 5},\n    {"Sentence 13": 1},\n    {"Sentence 14": 5},\n    {"Sentence 15": 5},\n    {"Sentence 16": 5},\n    {"Sentence 17": 1},\n    {"Sentence 18": 1},\n    {"Sentence 19": 1},\n    {"Sentence 20": 1}\n]', 'response3': '[{"NK cell": "cell_type"}, {"NFAT": "protein"}, {"AP-1": "protein"}]', 'prediction': {'NK cell': 'cell_type', 'NFAT': 'protein', 'AP-1': 'protein'}}
{'idx': 810, 'sentence': 'Exposure of CML cells to IFN-alpha diminished the effect of the CML cytoplasmic proteins on these nuclear protein-DNA complexes .', 'label': {'CML cells': 'cell_type', 'IFN-alpha': 'protein', 'CML cytoplasmic proteins': 'protein', 'nuclear protein-DNA complexes': 'protein'}, 'response1': "['protein', 'cell_line', 'DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example contains a specific protein name that directly matches an entity label in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The example contains specific protein names and cell types that directly match entity labels in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The example contains specific protein names that directly match entity labels in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The example contains specific protein names that directly match entity labels in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The example contains specific protein names that directly match entity labels in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The example contains a specific DNA binding protein name that directly matches an entity label in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The example contains a specific protein name that directly matches an entity label in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The example contains specific protein names that directly match entity labels in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The example contains specific protein names and cell types that directly match entity labels in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The example contains specific protein names that directly match entity labels in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The example contains specific protein names, caspases, and cell type that directly match entity labels in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The example contains specific protein names and cell types that directly match entity labels in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The example contains specific protein names that directly match entity labels in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The example contains specific protein names that directly match entity labels in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The example contains specific protein names and cell types that directly match entity labels in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain any entity names that match the entity labels in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain any entity names that match the entity labels in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any entity names that match the entity labels in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The example does not contain any entity names that match the entity labels in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The example does not contain any entity names that match the entity labels in the target sentence."}\n]', 'response3': "[{'CML': 'cell_line'}, {'IFN-alpha': 'protein'}, {'cytoplasmic proteins': 'protein'}, {'nuclear protein-DNA complexes': 'DNA'}]", 'prediction': {'CML': 'cell_line', 'IFN-alpha': 'protein', 'cytoplasmic proteins': 'protein', 'nuclear protein-DNA complexes': 'DNA'}}
{'idx': 1811, 'sentence': "In our attempt to identify chemokine receptors that are related to Burkitt's lymphoma receptor 1 ( BLR1 ) and are expressed in activated lymphocytes we used RT-PCR resulting in the isolation of a cDNA encoding a seven transmembrane receptor termed BLR2 .", 'label': {'BLR1': 'protein', 'BLR2': 'protein', 'seven transmembrane receptor': 'protein', 'activated lymphocytes': 'cell_type', 'chemokine receptors': 'protein', "Burkitt's lymphoma receptor 1": 'protein'}, 'response1': "['DNA', 'RNA', 'protein']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 3},\n    {"Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 3},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 5},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"This suggests that CHEMR1 may be a receptor for unidentified C-C chemokine or a low-affinity receptor for MIP-1alpha .": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1316, 'sentence': 'Helix III is less rigid, makes an average angle of about 90 degrees with helices I and II , and constitutes the other arm of the molecule.', 'label': {'Helix III': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 939, 'sentence': 'However, in 3 postmenopausal patients a short course of estrogen or tamoxifen resulted in a marked increase of type II EBS levels.', 'label': {'type II EBS': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains a clear mention of the entity \'protein\' and provides a specific protein name \'TCL1\', making it highly relevant for extracting named entities from the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 292, 'sentence': 'We used mouse embryonic stem (ES) cells to study globin gene expression and switching in vitro.', 'label': {'globin gene': 'DNA', 'mouse embryonic stem (ES) cells': 'cell_type'}, 'response1': "['cell_type', 'cell_line']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear and direct mention of the entity and its corresponding label."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence explicitly mentions the entity and its label, providing a direct link."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence clearly identifies the entities and their corresponding labels."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence directly mentions the entity and its label, aiding in easy extraction."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides a direct mention of the entity and its label, aiding in extraction."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence explicitly mentions the entity and its label, facilitating easy extraction."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence clearly identifies the entity and its label, aiding in extraction."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides a direct mention of the entity and its label, aiding in easy extraction."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence explicitly mentions the entity and its label, facilitating easy extraction."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence clearly identifies the entity and its label, aiding in extraction."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides a direct mention of the entity and its label, aiding in easy extraction."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence explicitly mentions the entity and its label, facilitating easy extraction."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence clearly identifies the entity and its label, aiding in extraction."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides a direct mention of the entity and its label, aiding in easy extraction."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence explicitly mentions the entities and their labels, facilitating easy extraction."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any specific entities or labels that can aid in extraction."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific entities or labels that can aid in extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific entities or labels that can aid in extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific entities or labels that can aid in extraction."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 542, 'sentence': 'Amino acid sequences of all proteins are essays written in the same language.', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 505, 'sentence': 'The TCF-1 alpha binding site was also required for TCR alpha enhancer activity in transcriptionally active extracts from Jurkat but not HeLa cells , confirming that TCF-1 alpha is a T-cell-specific transcription factor .', 'label': {'Jurkat': 'cell_line', 'TCF-1 alpha': 'protein', 'TCR': 'protein', 'T-cell-specific transcription factor': 'protein', 'TCF-1 alpha binding site': 'DNA', 'HeLa cells': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with corresponding labels that are present in the target sentence, such as \'NF-ATc\', \'T lymphocytes\', and \'embryonic cardiac cells\', which are labeled as \'protein\', \'cell_type\', and \'cell_type\' respectively."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides an example of a named entity \'TCF-1\' labeled as \'protein\' which is present in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with corresponding labels that are present in the target sentence, such as \'IL-2\', \'c-Jun\', and \'c-Fos\', which are labeled as \'protein\', \'protein\', and \'protein\' respectively."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of named entities \'Jun\' and \'ATF-2\' labeled as \'protein\' which are present in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of named entities \'Sp1\' and \'CD14\' labeled as \'protein\' which are present in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides an example of a named entity \'GATA-1\' labeled as \'protein\' which is present in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with corresponding labels that are present in the target sentence, such as \'T cell\' and \'interleukin 2\', which are labeled as \'cell_type\' and \'protein\' respectively."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of named entities \'Sp1\' and \'Ets\' labeled as \'protein\' which are present in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with corresponding labels that are present in the target sentence, such as \'Tax\' and \'TFIIA\', which are labeled as \'protein\' and \'protein\' respectively."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with corresponding labels that are present in the target sentence, such as \'EKLF\', \'CBP\', \'p300\', and \'P/CAF\', which are labeled as \'protein\', \'protein\', \'protein\', and \'protein\' respectively."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with corresponding labels that are present in the target sentence, such as \'RelA\' and \'NF-kappa B\', which are labeled as \'protein\' and \'protein\' respectively."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with corresponding labels that are present in the target sentence, such as \'IL-2\', \'IFN-gamma\', \'jak kinases\', and \'STAT1(alpha)\', which are labeled as \'protein\', \'protein\', \'protein\', and \'protein\' respectively."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides an example of a named entity \'Egr-1\' labeled as \'protein\' which is present in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides an example of a named entity \'TCF-1\' labeled as \'protein\' which is present in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with corresponding labels that are present in the target sentence, such as \'IFN A\', \'IFNA\', \'interleukin-2\', \'interleukin-2 receptor\', \'phytohemagglutinin\', and \'phorbol myristate acetate\', which are labeled as \'protein\', \'protein\', \'protein\', \'protein\', \'protein\', and \'protein\' respectively."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with corresponding labels that are present in the target sentence, such as \'IkappaBbeta\' and \'NF-kappaB\', which are labeled as \'protein\' and \'protein\' respectively."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not provide any named entities with corresponding labels that are present in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not provide any named entities with corresponding labels that are present in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not provide any named entities with corresponding labels that are present in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not provide any named entities with corresponding labels that are present in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not provide any named entities with corresponding labels that are present in the target sentence."}\n]', 'response3': '[{"TCF-1 alpha": "protein"}, {"TCR alpha": "protein"}, {"Jurkat": "cell_line"}, {"HeLa": "cell_line"}, {"T-cell-specific": "cell_type"}]', 'prediction': {'TCF-1 alpha': 'protein', 'TCR alpha': 'protein', 'Jurkat': 'cell_line', 'HeLa': 'cell_line', 'T-cell-specific': 'cell_type'}}
{'idx': 1525, 'sentence': 'Kinase activity was reduced in lysates preadsorbed using an antibody specific for CaM kinase II .', 'label': {'antibody': 'protein', 'CaM kinase II': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides specific protein names that match the entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 2": 5},\n    {"Reason 2": "The example provides specific protein names that match the entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 3": 5},\n    {"Reason 3": "The example provides specific protein names that match the entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The example provides specific protein names that match the entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides specific protein names that match the entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The example provides specific protein names and a cell type that match the entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The example provides specific protein names that match the entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides specific protein names that match the entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides specific protein names that match the entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides specific cell type names that match the entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The example provides specific protein names that match the entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The example provides specific protein names that match the entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides specific protein names that match the entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 14": 5},\n    {"Reason 14": "The example provides specific protein names that match the entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 15": 1},\n    {"Reason 15": "The example does not contain any named entities that match the entity types in the target sentence, hence not helpful for extraction."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain any named entities that match the entity types in the target sentence, hence not helpful for extraction."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain any named entities that match the entity types in the target sentence, hence not helpful for extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any named entities that match the entity types in the target sentence, hence not helpful for extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The example does not contain any named entities that match the entity types in the target sentence, hence not helpful for extraction."}\n]', 'response3': '[{"CaM kinase II": "protein"}]', 'prediction': {'CaM kinase II': 'protein'}}
{'idx': 1103, 'sentence': 'Relationship between Rap1 protein phosphorylation and regulation of Ca2+ transport in platelets : a new approach.', 'label': {'platelets': 'cell_type', 'Rap1 protein': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides specific protein names that are directly mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 2": 5},\n    {"Reason 2": "The example provides specific protein names and cell types that are directly mentioned in the sentence, aiding in the extraction of protein and cell type entities."},\n    {"Example 3": 5},\n    {"Reason 3": "The example provides specific protein names that are directly mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The example provides specific protein names that are directly mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides specific protein names and cell type that are directly mentioned in the sentence, aiding in the extraction of protein and cell type entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The example provides specific protein names that are directly mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The example provides specific protein names that are directly mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides specific protein names that are directly mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides specific protein names that are directly mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides specific protein names that are directly mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The example provides specific protein names that are directly mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The example provides specific protein names that are directly mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides specific protein names that are directly mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 14": 5},\n    {"Reason 14": "The example provides specific protein names that are directly mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 15": 1},\n    {"Reason 15": "The example does not contain any named entities mentioned in the target sentence, hence not helpful for entity extraction."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain any named entities mentioned in the target sentence, hence not helpful for entity extraction."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain any named entities mentioned in the target sentence, hence not helpful for entity extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any named entities mentioned in the target sentence, hence not helpful for entity extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The example does not contain any named entities mentioned in the target sentence, hence not helpful for entity extraction."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 538, 'sentence': 'Alone, PMA and calcium ionophore A23187 did not affect, but together stimulated, like phytohaemagglutinin ( PHA ), leucine and, in particular, thymidine incorporation .', 'label': {'PHA': 'protein', 'phytohaemagglutinin': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides clear examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1529, 'sentence': 'Transcriptional activation and repression , two properties of the lymphoid-specific transcription factor Oct-2a .', 'label': {'Oct-2a': 'protein', 'lymphoid-specific transcription factor': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names such as IkappaBbeta and NF-kappaB, which are directly related to the entity label \'protein\' in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions \'Th2-type lymphocytes\' which is a specific cell type, aligning with the entity label \'cell_type\' in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence includes protein names like Oct-2A, HMG I/Y, and HLA-DRA, along with the cell type \'B cells\', all of which correspond to the entity labels in the target sentence."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence refers to \'T cell\' as a cell type and \'interleukin 2\' as a protein, both of which match the entity labels in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence mentions protein names such as NF-kB, AP-1, OCT-1, and NF-IL-2B, all of which are relevant to the entity label \'protein\' in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence specifically talks about the protein Egr-1, which aligns with the entity label \'protein\' in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence mentions \'IL-2 receptor alpha subunit\' and \'p21ras\' as proteins, along with \'B cell\' as a cell type, all of which correspond to the entity labels in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence includes \'SP1\' and \'caspases\' as proteins, and \'B-cell\' as a cell type, all aligning with the entity labels in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence refers to \'NF-ATc\' as a protein and \'T lymphocytes\' as a cell type, both of which match the entity labels in the target sentence."},\n    {"Example 10": 3},\n    {"Reason 10": "The sentence mentions \'AP-1\' as DNA, which does not align with any entity label in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence specifically talks about \'A-myb\' as a protein, which corresponds to the entity label in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence includes \'Sp1\' and \'Ets\' as proteins, both of which align with the entity label \'protein\' in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence mentions \'Jun\' and \'ATF-2\' as proteins, which correspond to the entity label \'protein\' in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence refers to \'NF-E2\' as a protein, aligning with the entity label in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence includes \'NF-ATc\' as a protein, \'T lymphocytes\' and \'embryonic cardiac cells\' as cell types, all of which match the entity labels in the target sentence."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence specifically mentions \'GATA-1\' as a protein, aligning with the entity label in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any named entities related to the entity labels in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any named entities related to the entity labels in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any named entities related to the entity labels in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any named entities related to the entity labels in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1197, 'sentence': 'In this study, we demonstrate reconstitution of a cell-free processing system and demonstrate directly that: (a) the ubiquitin -proteasome system is involved in processing of the intact p105 precursor, (b) conjugation of ubiquitin to the precursor is an essential intermediate step in the processing, (c) the recently discovered novel species of the ubiquitin -carrier protein , E2-F1 , that is involved in the conjugation and degradation of p53 , is also required for the limited processing of the p105 precursor , and (d) a novel, approximately 320-kDa species of ubiquitin -protein ligase , is involved in the process.', 'label': {'ubiquitin': 'protein', 'p105 precursor': 'protein', 'E2-F1': 'protein', '-proteasome': 'protein', 'ubiquitin -carrier protein': 'protein', 'p53': 'protein', 'ubiquitin -protein ligase': 'protein', '320-kDa species': 'protein', 'p105': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 5},\n    {"Tat-binding protein 7 is a subunit of the 26S protease.": 4},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 3},\n    {"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.": 5},\n    {"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.": 4},\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"ubiquitin -proteasome system": "protein"}, {"p105 precursor": "protein"}, {"ubiquitin": "protein"}, {"E2-F1": "protein"}, {"p53": "protein"}, {"ubiquitin -carrier protein": "protein"}, {"ubiquitin -protein ligase": "protein"}]', 'prediction': {'ubiquitin -proteasome system': 'protein', 'p105 precursor': 'protein', 'ubiquitin': 'protein', 'E2-F1': 'protein', 'p53': 'protein', 'ubiquitin -carrier protein': 'protein', 'ubiquitin -protein ligase': 'protein'}}
{'idx': 877, 'sentence': 'Their constitutive expression is limited to B lymphocytes and thymic epithelial cells .', 'label': {'B lymphocytes': 'cell_type', 'thymic epithelial cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains clear mentions of specific entities with corresponding labels."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence contains a specific entity with a corresponding label."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence contains clear mentions of specific entities with corresponding labels."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains clear mentions of specific entities with corresponding labels."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence contains a specific entity with a corresponding label."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains clear mentions of specific entities with corresponding labels."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence contains specific entities with corresponding labels."},\n    {"Example 8": 4},\n    {"Reason 8": "The sentence contains specific entities with corresponding labels."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains clear mentions of specific entities with corresponding labels."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains clear mentions of specific entities with corresponding labels."},\n    {"Example 11": 4},\n    {"Reason 11": "The sentence contains specific entities with corresponding labels."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains clear mentions of specific entities with corresponding labels."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not contain any specific entities with corresponding labels."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not contain any specific entities with corresponding labels."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any specific entities with corresponding labels."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any specific entities with corresponding labels."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific entities with corresponding labels."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific entities with corresponding labels."}\n]', 'response3': '[{"B lymphocytes": "cell_type"}, {"thymic epithelial cells": "cell_type"}]', 'prediction': {'B lymphocytes': 'cell_type', 'thymic epithelial cells': 'cell_type'}}
{'idx': 1838, 'sentence': 'First, we show that mutations in the LEF-1 -binding site inhibit the activity of multimerized copies of the HIV-1 enhancer in Jurkat T cells , and that LEF-1 /GAL4 can activate a GAL4-substituted HIV-1 enhancer 80- to 100-fold in vivo.', 'label': {'LEF-1 -binding site': 'DNA', 'HIV-1 enhancer': 'DNA', 'LEF-1': 'protein', 'GAL4-substituted HIV-1 enhancer': 'DNA', 'Jurkat T cells': 'cell_line', 'multimerized copies': 'DNA', 'LEF-1 /GAL4': 'protein'}, 'response1': "['DNA', 'protein', 'cell_type', 'cell_line']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The example provides a clear and specific entity with the corresponding label, aiding in understanding how to identify similar entities in the sentence."}\n]', 'response3': '[{"LEF-1": "protein"}, {"HIV-1 enhancer": "DNA"}, {"Jurkat T cells": "cell_type"}, {"GAL4": "protein"}, {"GAL4-substituted HIV-1 enhancer": "DNA"}]', 'prediction': {'LEF-1': 'protein', 'HIV-1 enhancer': 'DNA', 'Jurkat T cells': 'cell_type', 'GAL4': 'protein', 'GAL4-substituted HIV-1 enhancer': 'DNA'}}
{'idx': 1195, 'sentence': 'Palombella and colleagues (Palombella, V.J., Rando, O.J., Goldberg, A.L., and Maniatis, T.(1994) Cell 78, 773-785) have shown that ubiquitin is required for the processing in a cell-free system of a truncated, artificially constructed, 60-kDa precursor .', 'label': {'60-kDa precursor': 'protein', 'ubiquitin': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 3},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 817, 'sentence': '(ii) Transfection and expression of EBNA-LP alone had no effect on LMP1 expression and did not act synergistically with EBNA-2 to affect LMP1 expression .', 'label': {'EBNA-LP': 'protein', 'LMP1': 'protein', 'EBNA-2': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"1": "The sentence does not contain any named entities."},\n    {"2": "The sentence does not contain any named entities."},\n    {"5": "The sentence contains multiple protein entities that are directly mentioned."},\n    {"5": "The sentence contains multiple protein entities that are directly mentioned."},\n    {"5": "The sentence contains multiple protein entities that are directly mentioned."},\n    {"5": "The sentence contains multiple protein entities that are directly mentioned."},\n    {"5": "The sentence contains multiple protein entities that are directly mentioned."},\n    {"5": "The sentence contains multiple protein entities that are directly mentioned."},\n    {"5": "The sentence contains multiple protein entities that are directly mentioned."},\n    {"5": "The sentence contains multiple protein entities that are directly mentioned."},\n    {"5": "The sentence contains a protein entity that is directly mentioned."},\n    {"5": "The sentence contains a protein and a cell line entity that are directly mentioned."},\n    {"5": "The sentence contains multiple RNA and protein entities that are directly mentioned."},\n    {"5": "The sentence contains multiple protein entities that are directly mentioned."},\n    {"5": "The sentence contains multiple protein entities that are directly mentioned."},\n    {"5": "The sentence contains multiple protein entities that are directly mentioned."},\n    {"5": "The sentence contains a cell type and a protein entity that are directly mentioned."},\n    {"1": "The sentence does not contain any named entities."},\n    {"1": "The sentence does not contain any named entities."},\n    {"1": "The sentence does not contain any named entities."},\n    {"1": "The sentence does not contain any named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 741, 'sentence': 'In melanoma cells that contain the N-Oct-3 factor , a transfected lymphocyte-specific promoter was neither activated nor was it repressed upon contransfection with an Oct-2A expression vector .', 'label': {'Oct-2A expression vector': 'DNA', 'Oct-2A': 'protein', 'N-Oct-3 factor': 'protein', 'melanoma cells': 'cell_type'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 4},\n    {"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.": 5},\n    {"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.": 4},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2.": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 4},\n    {"Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B / Oct-1 -dependent transcription.": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.": 5},\n    {"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 283, 'sentence': '[ Estrogen receptor content of peripheral blood lymphocytes in patients with systemic lupus erythematosus ]', 'label': {'Estrogen receptor': 'protein', 'peripheral blood lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 4},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 4},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 3},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1043, 'sentence': 'METHOD: Two color flow cytometry analysis was used on peripheral blood samples of young and postmenopausal females and postmenopausal females treated with estrogen replacement therapy .', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein (NF-E2) and its corresponding entity label."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides a clear example of a protein (erythropoietin) and its corresponding entity label."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence provides a clear example of a protein (E2A) and its corresponding entity label."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides clear examples of a protein (MNDA) and a cell line (Philadelphia chromosome-positive chronic myeloid leukemia) with their corresponding entity labels."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides a clear example of a protein (phosphocreatine) and its corresponding entity label."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides clear examples of proteins (TCRzeta and p56(lck)) with their corresponding entity labels."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides clear examples of a protein (alpha-tocopherol) and cell types (monocyte and endothelial cells) with their corresponding entity labels."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides clear examples of proteins (CD70, IL-4, and CD40) and cell types (B cell and plasma cells) with their corresponding entity labels."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides clear examples of proteins (CD40, Rel/nuclear factor kappaB, and NF-kappaB) and a cell type (B lymphocytes) with their corresponding entity labels."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides clear examples of a cell line (Ter 119) and proteins (beta-globin, glycoprotein IIb, and platelet factor 4) with their corresponding entity labels."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides clear examples of cell types (B and T cell activation) and cell lines (Ramos and Jurkat) with their corresponding entity labels."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides clear examples of DNA (EBV), a protein (EBNA2), and another protein (estrogen receptor) with their corresponding entity labels."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides clear examples of proteins (Erbstatin, genistein, and Egr-1) and RNA (Egr-1) with their corresponding entity labels."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides clear examples of a cell line (PMA) and another cell line (U1 cells) with their corresponding entity labels."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides clear examples of proteins (globins, glycoprotein IIb, platelet factor 4, Spi-1, Fli-1, and erythropoietin) with their corresponding entity labels."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence provides clear examples of a cell type (HPCs) and proteins (PML and Rb) with their corresponding entity labels."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any named entities related to the given entity labels."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any named entities related to the given entity labels."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any named entities related to the given entity labels."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any named entities related to the given entity labels."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1010, 'sentence': 'Using a polyclonal antibody to murine NFATp , Western blot analysis of various mouse tissues demonstrated that the 110-130-kDa NFATp protein was highly expressed in thymus and spleen .', 'label': {'murine NFATp': 'protein', 'NFATp protein': 'protein', 'NFATp': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 4},\n{"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n{"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 4},\n{"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n{"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n{"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n{"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n{"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B, possibly by a phosphorylation reaction involving protein kinase C by PAF.": 5},\n{"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 4},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n{"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 4},\n{"A critical role of Sp1- and Ets-related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n{"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.": 5},\n{"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n{"The p50 and p65 proteins, constituents of the prototypic nuclear factor kappaB, were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays.": 5}\n]', 'response3': '[{"NFATp": "protein"}, {"NFATp": "protein"}, {"thymus": "cell_type"}, {"spleen": "cell_type"}]', 'prediction': {'NFATp': 'protein', 'thymus': 'cell_type', 'spleen': 'cell_type'}}
{'idx': 186, 'sentence': 'We also find that NF-E2 , another trans-acting factor of the erythrocytic lineage , is present in megakaryocytes .', 'label': {'erythrocytic lineage': 'cell_type', 'NF-E2': 'protein', 'trans-acting factor': 'protein', 'megakaryocytes': 'cell_line'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {\n        "Example 1": 5\n    },\n    {\n        "Reason 1": "The example provides a direct mapping of the entity \'protein\' to the named entity \'RXR\' in the sentence, aiding in the extraction process."\n    },\n    {\n        "Example 2": 5\n    },\n    {\n        "Reason 2": "The examples provide direct mappings of the entities \'protein\' to the named entities \'SCL\' and \'GATA-1\' in the sentence, aiding in the extraction process."\n    },\n    {\n        "Example 3": 5\n    },\n    {\n        "Reason 3": "The examples provide direct mappings of the entities \'protein\' to the named entities \'Stat3\', \'Stat5\', and \'c-Mpl\' in the sentence, aiding in the extraction process."\n    },\n    {\n        "Example 4": 5\n    },\n    {\n        "Reason 4": "The examples provide direct mappings of the entities \'protein\' and \'cell_type\' to the named entities \'NF-ATc\' and \'T lymphocytes\' in the sentence, aiding in the extraction process."\n    },\n    {\n        "Example 5": 5\n    },\n    {\n        "Reason 5": "The example provides a direct mapping of the entity \'protein\' to the named entity \'GATA-1\' in the sentence, aiding in the extraction process."\n    },\n    {\n        "Example 6": 5\n    },\n    {\n        "Reason 6": "The examples provide direct mappings of the entities \'cell_type\' to the named entities \'granulocytes\' and \'T cells\' in the sentence, aiding in the extraction process."\n    },\n    {\n        "Example 7": 5\n    },\n    {\n        "Reason 7": "The examples provide direct mappings of the entities \'protein\' to the named entities \'EKLF\', \'CBP\', \'p300\', and \'P/CAF\' in the sentence, aiding in the extraction process."\n    },\n    {\n        "Example 8": 5\n    },\n    {\n        "Reason 8": "The example provides a direct mapping of the entity \'protein\' to the named entity \'Egr-1\' in the sentence, aiding in the extraction process."\n    },\n    {\n        "Example 9": 5\n    },\n    {\n        "Reason 9": "The examples provide direct mappings of the entities \'protein\' and \'cell_type\' to the named entities \'NF-ATc\', \'T lymphocytes\', and \'embryonic cardiac cells\' in the sentence, aiding in the extraction process."\n    },\n    {\n        "Example 10": 5\n    },\n    {\n        "Reason 10": "The example provides a direct mapping of the entity \'protein\' to the named entity \'erythropoietin\' in the sentence, aiding in the extraction process."\n    },\n    {\n        "Example 11": 5\n    },\n    {\n        "Reason 11": "The example provides a direct mapping of the entity \'protein\' to the named entity \'NF-E2\' in the sentence, aiding in the extraction process."\n    },\n    {\n        "Example 12": 5\n    },\n    {\n        "Reason 12": "The example provides a direct mapping of the entity \'protein\' to the named entity \'E2A\' in the sentence, aiding in the extraction process."\n    },\n    {\n        "Example 13": 5\n    },\n    {\n        "Reason 13": "The example provides a direct mapping of the entity \'protein\' to the named entity \'GATA-1\' in the sentence, aiding in the extraction process."\n    },\n    {\n        "Example 14": 5\n    },\n    {\n        "Reason 14": "The examples provide direct mappings of the entities \'protein\' and \'cell_type\' to the named entities \'CD40\', \'Rel/nuclear factor kappaB\', \'NF-kappaB\', and \'B lymphocytes\' in the sentence, aiding in the extraction process."\n    },\n    {\n        "Example 15": 5\n    },\n    {\n        "Reason 15": "The examples provide direct mappings of the entities \'protein\' and \'cell_type\' to the named entities \'ZEB\', \'c-Myb\', \'Ets\', and \'hematopoietic cells\' in the sentence, aiding in the extraction process."\n    },\n    {\n        "Example 16": 1\n    },\n    {\n        "Reason 16": "The example does not contain any named entities matching the entity types in the target sentence, making it not helpful for extraction."\n    },\n    {\n        "Example 17": 1\n    },\n    {\n        "Reason 17": "The example does not contain any named entities matching the entity types in the target sentence, making it not helpful for extraction."\n    },\n    {\n        "Example 18": 1\n    },\n    {\n        "Reason 18": "The example does not contain any named entities matching the entity types in the target sentence, making it not helpful for extraction."\n    },\n    {\n        "Example 19": 1\n    },\n    {\n        "Reason 19": "The example does not contain any named entities matching the entity types in the target sentence, making it not helpful for extraction."\n    }\n]', 'response3': '[{"NF-E2": "protein"}]', 'prediction': {'NF-E2': 'protein'}}
{'idx': 1547, 'sentence': 'Platelet glycoprotein ( GP ) Ib-IX-V is a multisubunit adhesion receptor that supports platelet attachment to thrombogenic surfaces at sites of vascular injury .', 'label': {'multisubunit adhesion receptor': 'protein', 'Ib-IX-V': 'protein', 'Platelet glycoprotein': 'protein', 'GP': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 1},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n    {"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.": 3},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 4},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 4},\n    {"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/thrombopoiesis or possibly a mature platelet function such as aggregation.": 5},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.": 5},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n    {"Tat-binding protein 7 is a subunit of the 26S protease.": 4},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 4},\n    {"The p21ras small GTP binding proteins participate in signal transduction from cell surface receptors and affect neoplastic transformation and development in many different cell types.": 5},\n    {"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.": 5},\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 5},\n    {"We have examined the effect of alpha-tocopherol (alpha-tcp) on one cellular event in atherosclerotic plaque development, monocyte adhesion to stimulated endothelial cells (ECs).": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"Platelet glycoprotein (GP) Ib-IX-V": "protein"}]', 'prediction': {'Platelet glycoprotein (GP) Ib-IX-V': 'protein'}}
{'idx': 96, 'sentence': 'We have analyzed the functional domains of the minimal Thy-1 promoter and show that the dominant promoter elements consist of multiple binding sites for the transcription factor Sp1 , an inverted CCAAT box , and sequences proximal to the transcription start site .', 'label': {'Sp1': 'protein', 'dominant promoter elements': 'DNA', 'minimal Thy-1 promoter': 'DNA', 'transcription factor': 'protein', 'multiple binding sites': 'DNA', 'CCAAT box': 'DNA', 'transcription start site': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names such as interleukin 10, IL-10R, STAT3, and IL-6, which are directly related to the entity labels provided."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions UAS1 and B cell, which are related to the entity labels cell_line and cell_type provided."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence explicitly mentions Sp1 and CD14, which are directly related to the entity labels provided."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence mentions Th2-type lymphocytes, which is related to the entity label cell_type provided."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence explicitly mentions Sp1 and Ets, which are directly related to the entity labels provided."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence explicitly mentions IL-2, c-Jun, and c-Fos, which are directly related to the entity labels provided."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence explicitly mentions GATA-1, which is directly related to the entity label provided."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence explicitly mentions SCM-1, which is directly related to the entity label provided."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence explicitly mentions CD95 ligand, which is directly related to the entity label provided."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence explicitly mentions EBNA2 and TP1, which are directly related to the entity labels provided."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence explicitly mentions A-myb, which is directly related to the entity label provided."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence explicitly mentions T cell and interleukin 2, which are directly related to the entity labels provided."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence explicitly mentions NF-kappaB, Sp1, and p50, which are directly related to the entity labels provided."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence explicitly mentions NF-ATc, T lymphocytes, and embryonic cardiac cells, which are directly related to the entity labels provided."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence explicitly mentions IL-2, which is directly related to the entity label provided."},\n    {"Example 16": 3},\n    {"Reason 16": "The sentence mentions GC-box, GM-kappa B, and GC-motif, which are related to the entity label DNA provided."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific entity names related to the provided entity labels."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific entity names related to the provided entity labels."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific entity names related to the provided entity labels."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any specific entity names related to the provided entity labels."}\n]', 'response3': '[{"Thy-1": "protein"}, {"Sp1": "protein"}]', 'prediction': {'Thy-1': 'protein', 'Sp1': 'protein'}}
{'idx': 1763, 'sentence': 'Cysteamine treatment inhibited both expression of the IL-2 mRNA and secretion of IL-2 into the culture medium .', 'label': {'IL-2': 'protein', 'IL-2 mRNA': 'RNA'}, 'response1': "['RNA', 'protein']", 'response2': '[\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 5},\n    {"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .": 4},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .": 4},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 5},\n    {"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .": 5},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"Binding of YY1 and Oct1 to a novel element that downregulates expression of IL-5 in human T cells .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"IL-2 mRNA": "RNA"}, {"IL-2": "protein"}]', 'prediction': {'IL-2 mRNA': 'RNA', 'IL-2': 'protein'}}
{'idx': 224, 'sentence': 'Cortivazol ( CVZ ) is a unique, high potency synthetic glucocorticoid , which has a phenylpyrazol fused to the A-ring of the steroid nucleus and displays binding consistent with two or more sites in the cytosol from CEM C7 cells (a human acute lymphoblastic T-cell line ).', 'label': {'CEM C7 cells': 'cell_line', 'human acute lymphoblastic T-cell line': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.": 5},\n    {"Control of NF-kappa B activity by the I kappa B beta inhibitor.": 5},\n    {"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes.": 4},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin.": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"Benzene toxicity towards lymphocytes is thought to be mediated by metabolites of benzene including benzoquinone (BQ).": 4},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 4},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 4}\n]', 'response3': '[{"Cortivazol": "protein"}, {"CVZ": "protein"}, {"CEM C7 cells": "cell_line"}]', 'prediction': {'Cortivazol': 'protein', 'CVZ': 'protein', 'CEM C7 cells': 'cell_line'}}
{'idx': 313, 'sentence': 'Immunohistochemical study of steroid hormones and an estrogen binding assay in malignant soft tissue tumors .', 'label': {'malignant soft tissue tumors': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": "5"},\n    {"Reason 1": "The example provides a clear mapping between the entity \'E2A\' and the entity type \'protein\' in the sentence."},\n    {"Example 2": "5"},\n    {"Reason 2": "The example provides a clear mapping between the entity \'GATA-1\' and the entity type \'protein\' in the sentence."},\n    {"Example 3": "5"},\n    {"Reason 3": "The example provides a clear mapping between the entity \'lymphoid neoplasms\' and the entity type \'cell_type\' in the sentence."},\n    {"Example 4": "4"},\n    {"Reason 4": "The example provides a clear mapping between the entity \'phosphocreatine\' and the entity type \'protein\' in the sentence."},\n    {"Example 5": "5"},\n    {"Reason 5": "The examples provide clear mappings between the entities \'SLAP-130\', \'SLP-76\', \'T cell\' and the entity types \'protein\', \'protein\', \'cell_type\' respectively in the sentence."},\n    {"Example 6": "5"},\n    {"Reason 6": "The example provides a clear mapping between the entity \'NF-E2\' and the entity type \'protein\' in the sentence."},\n    {"Example 7": "5"},\n    {"Reason 7": "The example provides clear mappings between the entities \'immunohistochemistry\', \'gene\', \'cell type\' and the entity types \'protein\', \'DNA\', \'cell_type\' respectively in the sentence."},\n    {"Example 8": "5"},\n    {"Reason 8": "The example provides a clear mapping between the entity \'retinoic acid receptor alpha\' and the entity type \'protein\' in the sentence."},\n    {"Example 9": "5"},\n    {"Reason 9": "The example provides a clear mapping between the entity \'CD14\' and the entity type \'protein\' in the sentence."},\n    {"Example 10": "5"},\n    {"Reason 10": "The example provides clear mappings between the entities \'HML\', \'dexamethasone\', \'cortisol\', \'lysozyme\' and the entity types \'cell_line\', \'protein\', \'protein\', \'protein\' respectively in the sentence."},\n    {"Example 11": "5"},\n    {"Reason 11": "The example provides clear mappings between the entities \'CD40\', \'Rel/nuclear factor kappaB\', \'NF-kappaB\', \'B lymphocytes\' and the entity types \'protein\', \'protein\', \'protein\', \'cell_type\' respectively in the sentence."},\n    {"Example 12": "5"},\n    {"Reason 12": "The example provides clear mappings between the entities \'B and T cell activation\', \'Ramos\', \'Jurkat\', \'cDNA microarray technology\' and the entity types \'cell_type\', \'cell_line\', \'cell_line\', \'DNA\' respectively in the sentence."},\n    {"Example 13": "5"},\n    {"Reason 13": "The example provides clear mappings between the entities \'tal-1\', \'GATA-binding proteins\', \'hematopoiesis\' and the entity types \'protein\', \'protein\', \'cell_type\' respectively in the sentence."},\n    {"Example 14": "5"},\n    {"Reason 14": "The example provides clear mappings between the entities \'Erbstatin\', \'genistein\', \'Egr-1\' and the entity types \'protein\', \'protein\', \'RNA\' respectively in the sentence."},\n    {"Example 15": "5"},\n    {"Reason 15": "The example provides clear mappings between the entities \'EBV\', \'EBNA2\', \'estrogen receptor\' and the entity types \'DNA\', \'protein\', \'protein\' respectively in the sentence."},\n    {"Example 16": "5"},\n    {"Reason 16": "The example provides clear mappings between the entities \'MR\', \'aldosterone\', \'progesterone\' and the entity types \'protein\', \'protein\', \'protein\' respectively in the sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1285, 'sentence': "Characterization of 5' end of human thromboxane receptor gene .", 'label': {"5' end of human thromboxane receptor gene": 'DNA', 'human thromboxane receptor gene': 'DNA'}, 'response1': "['DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific gene names and their corresponding entity labels, which directly aid in identifying the named entities in the sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 327, 'sentence': 'However, there is an EB1 -binding site ( ZRE-B ) located within the R-responsive enhancer region .', 'label': {'R-responsive enhancer region': 'DNA', 'EB1 -binding site': 'DNA', 'EB1': 'protein', 'ZRE-B': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n    {"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .": 5},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 4},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements .": 4},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 4},\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines .": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .": 4},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .": 5},\n    {"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"EB1": "protein"}, {"ZRE-B": "DNA"}]', 'prediction': {'EB1': 'protein', 'ZRE-B': 'DNA'}}
{'idx': 1622, 'sentence': 'Analysis of whole-cell lysates by antiphosphotyrosine immunoblotting showed that incubation with gamma interferon brought about specific increases in phosphotyrosine labeling of several proteins.', 'label': {'gamma interferon': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"2": "The sentence does not contain any of the entity types in the label set."},\n    {"3": "The sentence contains multiple protein entities and protein-related terms, which are relevant to the label set."},\n    {"4": "The sentence contains protein entities and protein-related terms, which are relevant to the label set."},\n    {"5": "The sentence contains protein entities and protein-related terms, which are relevant to the label set."},\n    {"6": "The sentence contains protein entities and protein-related terms, which are relevant to the label set."},\n    {"7": "The sentence contains protein entities and protein-related terms, which are relevant to the label set."},\n    {"8": "The sentence contains protein entities and protein-related terms, which are relevant to the label set."},\n    {"9": "The sentence contains protein entities and protein-related terms, which are relevant to the label set."},\n    {"10": "The sentence contains protein entities and protein-related terms, which are relevant to the label set."},\n    {"11": "The sentence contains protein entities and protein-related terms, which are relevant to the label set."},\n    {"12": "The sentence contains protein entities, DNA, and cell type entities, which are relevant to the label set."},\n    {"13": "The sentence contains protein entities and protein-related terms, which are relevant to the label set."},\n    {"14": "The sentence contains protein entities and protein-related terms, which are relevant to the label set."},\n    {"15": "The sentence contains protein entities and protein-related terms, which are relevant to the label set."},\n    {"16": "The sentence does not contain any of the entity types in the label set."},\n    {"17": "The sentence does not contain any of the entity types in the label set."},\n    {"18": "The sentence does not contain any of the entity types in the label set."},\n    {"19": "The sentence does not contain any of the entity types in the label set."},\n    {"20": "The sentence does not contain any of the entity types in the label set."}\n]', 'response3': "[{'gamma interferon': 'protein'}, {'phosphotyrosine': 'protein'}]", 'prediction': {'gamma interferon': 'protein', 'phosphotyrosine': 'protein'}}
{'idx': 1393, 'sentence': 'This enhancer in HIV-1 is the T-cell activation response element ; in HIV-2 , however, it is the second enhancer that is mainly responsible for activation in response to T-cell activators .', 'label': {'second enhancer': 'DNA', 'T-cell activation response element': 'DNA', 'enhancer': 'DNA'}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[\n    {"HIV-1": "cell_type"},\n    {"T-cell": "cell_type"},\n    {"HIV-2": "cell_type"},\n    {"T-cell": "cell_type"}\n]', 'prediction': {'HIV-1': 'cell_type', 'T-cell': 'cell_type', 'HIV-2': 'cell_type'}}
{'idx': 1221, 'sentence': 'To identify osteoblast-specific cis-acting elements and trans-acting factors , we initiated an analysis of the promoter of a mouse osteocalcin gene , an osteoblast-specific gene .', 'label': {'mouse osteocalcin gene': 'DNA', 'promoter': 'DNA', 'osteoblast-specific cis-acting elements': 'DNA', 'trans-acting factors': 'protein', 'osteoblast-specific gene': 'DNA'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 4},\n    {"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n    {"A critical role of Sp1- and Ets-related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 5},\n    {"To evaluate the PML/RARalpha role in myelopoiesis, transgenic mice expressing PML/RARalpha were engineered.": 4},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 4},\n    {"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 130, 'sentence': 'At high concentration of NE , all of the TR bound to TREp was more greatly retarded than in the absence of NE .', 'label': {'TREp': 'DNA', 'TR': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence 1": 5},\n    {"Sentence 2": 5},\n    {"Sentence 3": 5},\n    {"Sentence 4": 5},\n    {"Sentence 5": 5},\n    {"Sentence 6": 5},\n    {"Sentence 7": 5},\n    {"Sentence 8": 5},\n    {"Sentence 9": 5},\n    {"Sentence 10": 5},\n    {"Sentence 11": 5},\n    {"Sentence 12": 5},\n    {"Sentence 13": 5},\n    {"Sentence 14": 5},\n    {"Sentence 15": 5},\n    {"Sentence 16": 1},\n    {"Sentence 17": 1},\n    {"Sentence 18": 1},\n    {"Sentence 19": 1},\n    {"Sentence 20": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 788, 'sentence': 'The number of mineralocorticoid receptors /cell were within or close to the normal range (n = 9).', 'label': {'mineralocorticoid receptors': 'protein'}, 'response1': "['cell_type']", 'response2': '[\n{"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 1},\n{"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 5},\n{"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n{"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n{"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes.": 5},\n{"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n{"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n{"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 4},\n{"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.": 5},\n{"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.": 5},\n{"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.": 5},\n{"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.": 5},\n{"When 18C7 was incubated with MR before aldosterone or progesterone, the antibody inhibited 75-80% of the binding.": 5},\n{"A total of 37 chronic, severe, nonsmoking asthmatic patients with documented reversible airways obstruction were classified as glucocorticoid-sensitive or -resistant on the basis of changes in FEV1, FVC, and peak expiratory flow (PEF) after oral prednisolone.": 5},\n{"The number of Type I and Type II receptors before the test was lower in elderly subjects than in adults.": 5},\n{"Membrane receptors for aldosterone: a novel pathway for mineralocorticoid action.": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 781, 'sentence': 'Effects of aldosterone on intralymphocytic sodium and potassium in patients with essential hypertension .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 4},\n    {"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes.": 4},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms.": 4},\n    {"We have examined the effect of alpha-tocopherol (alpha-tcp) on one cellular event in atherosclerotic plaque development, monocyte adhesion to stimulated endothelial cells (ECs).": 5},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 5},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 4},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 5},\n    {"Eosinophils play an important role in the effector phase of allergic inflammation.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 5},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1220, 'sentence': 'A PEBP2 alpha/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element .', 'label': {'PEBP2 alpha/AML-1-related factor': 'protein', 'osteocalcin promoter': 'DNA', 'osteoblast-specific cis-acting element': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"T cell": 5},\n    {"interleukin 2": 5},\n    {"UAS1": 4},\n    {"B cell": 5},\n    {"GATA-1": 5},\n    {"EKLF": 5},\n    {"CBP": 5},\n    {"p300": 5},\n    {"P/CAF": 5},\n    {"Sp1": 5},\n    {"CD14": 5},\n    {"PAFR": 5},\n    {"PAF": 5},\n    {"NF-kappa B": 5},\n    {"protein kinase C": 5},\n    {"NF-E2": 5},\n    {"PML/RARalpha": 5},\n    {"EBNA2": 5},\n    {"TP1": 4},\n    {"AP-1": 5},\n    {"retinoic acid receptor alpha": 5},\n    {"TAL1": 5},\n    {"T-ALL": 5},\n    {"Oct-2A": 5},\n    {"HMG I/Y": 5},\n    {"HLA-DRA": 5},\n    {"IL-2 receptor alpha subunit": 5},\n    {"p21ras": 5},\n    {"Gel-shift analysis": 1},\n    {"IL-2": 5},\n    {"c-Jun": 5},\n    {"c-Fos": 5}\n]', 'response3': '[{"PEBP2 alpha/AML-1-related factor": "protein"}, {"osteocalcin": "protein"}, {"osteoblast-specific": "cell_type"}]', 'prediction': {'PEBP2 alpha/AML-1-related factor': 'protein', 'osteocalcin': 'protein', 'osteoblast-specific': 'cell_type'}}
{'idx': 958, 'sentence': 'Here, Markus Neurath, Eckhard Stuber and Warren Strober describe the molecular structure of BSAP and focus on the ability of this protein to regulate the expression of B-cell-specific genes .', 'label': {'B-cell-specific genes': 'DNA', 'BSAP': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of proteins and their corresponding labels, which can aid in identifying protein entities in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides an example of a protein and its label, which can help in identifying protein entities in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins and their labels, aiding in identifying protein entities in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides an example of a protein and its label, which can help in identifying protein entities in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides an example of a cell line and its label, which can help in identifying cell line entities in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins and their labels, aiding in identifying protein entities in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins and their labels, aiding in identifying protein entities in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins and their labels, aiding in identifying protein entities in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins and their labels, aiding in identifying protein entities in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides an example of a protein and its label, which can help in identifying protein entities in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins, DNA, and cell type entities, aiding in identifying these entities in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entities present in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entities present in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entities present in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entities present in the target sentence."}\n]', 'response3': '[{"BSAP": "protein"}, {"B-cell-specific genes": "cell_type"}]', 'prediction': {'BSAP': 'protein', 'B-cell-specific genes': 'cell_type'}}
{'idx': 1083, 'sentence': 'These data suggest that the action of tepoxalin to inhibit proliferation in PBMC may be at least in part due to its ability to reduce the amount of available iron resulting in decreased activation of NF kappa B and subsequent inhibition of cytokine production .', 'label': {'cytokine': 'protein', 'NF kappa B': 'protein', 'PBMC': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1}\n]', 'response3': '[{"NF kappa B": "protein"}]', 'prediction': {'NF kappa B': 'protein'}}
{'idx': 514, 'sentence': 'Induction of the enhancer may have a role in the increase in globin gene transcription that characterizes erythroid maturation .', 'label': {'globin gene': 'DNA', 'enhancer': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a clear and direct mapping of the entity \'GATA-1\' to the entity type \'protein\' in the sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The example provides a clear and direct mapping of the entity \'NF-E2\' to the entity type \'protein\' in the sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The example provides a clear and direct mapping of the entity \'Th2-type lymphocytes\' to the entity type \'cell_type\' in the sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The example provides a clear and direct mapping of the entity \'Egr-1\' to the entity type \'protein\' in the sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides a clear and direct mapping of the entity \'erythropoietin\' to the entity type \'protein\' in the sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The examples provide clear and direct mappings of the entities \'CCAAT box\' to the entity type \'DNA\' and \'EKLF binding site\' to the entity type \'protein\' in the sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The example provides a clear and direct mapping of the entity \'AP-1\' to the entity type \'DNA\' in the sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides a clear and direct mapping of the entity \'IL-4\' to the entity type \'protein\' in the sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides a clear and direct mapping of the entity \'retinoic acid receptor alpha\' to the entity type \'protein\' in the sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides a clear and direct mapping of the entity \'RXR\' to the entity type \'protein\' in the sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The examples provide clear and direct mappings of the entities \'WT1\' to the entity type \'protein\' and \'myeloid cell lines\' to the entity type \'cell_line\' in the sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The examples provide clear and direct mappings of the entities \'IL-2 receptor alpha subunit\' to the entity type \'protein\', \'p21ras\' to the entity type \'protein\', and \'B cell\' to the entity type \'cell_type\' in the sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides a clear and direct mapping of the entity \'IgH\' to the entity type \'DNA\' in the sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The example provides a clear and direct mapping of the entity \'GATA-1\' to the entity type \'protein\' in the sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The example provides a clear and direct mapping of the entity \'immunoglobulin kappa 3\' enhancer\' to the entity type \'DNA\' in the sentence."},\n    {"Example 16": 5},\n    {"Reason 16": "The examples provide clear and direct mappings of the entities \'SCL\' to the entity type \'protein\' and \'GATA-1\' to the entity type \'protein\' in the sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any named entities related to the given entity labels."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any named entities related to the given entity labels."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any named entities related to the given entity labels."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any named entities related to the given entity labels."}\n]', 'response3': '[{"globin gene": "DNA"}]', 'prediction': {'globin gene': 'DNA'}}
{'idx': 1133, 'sentence': 'Both LCLs were found by EM to produce RVLP and EBV particles .', 'label': {'LCLs': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.": 4},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .": 5},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 5},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .": 4},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .": 5},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 4},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .": 5},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter": 5},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms .": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .": 5},\n    {"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"LCLs": "cell_line"}, {"RVLP": "protein"}, {"EBV": "cell_line"}]', 'prediction': {'LCLs': 'cell_line', 'RVLP': 'protein', 'EBV': 'cell_line'}}
{'idx': 1762, 'sentence': 'Taking the IL-2 gene as a candidate, we examined the effect of cysteamine treatment on early gene expression during lymphocyte activation , and on the activity of transcription factors AP-1 , NF-kappa B , NF-AT and Oct1 , whose functions are required for expression of the IL-2 mRNA.', 'label': {'IL-2': 'protein', 'early gene': 'DNA', 'NF-kappa B': 'protein', 'Oct1': 'protein', 'transcription factors': 'protein', 'NF-AT': 'protein', 'AP-1': 'protein', 'IL-2 gene': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"3": "The sentence contains \'B cell\' which is a \'cell_type\' entity."},\n    {"3": "The sentence contains \'IL-4\' and \'AP-1\' which are \'protein\' entities."},\n    {"3": "The sentence contains \'IL-2\', \'c-Jun\', and \'c-Fos\' which are \'protein\' entities."},\n    {"3": "The sentence contains \'interleukin 10\', \'IL-10R\', \'STAT3\', and \'IL-6\' which are \'protein\' entities."},\n    {"2": "The sentence contains \'AP-1\' which is a \'DNA\' entity."},\n    {"2": "The sentence contains \'IL-4\' which is a \'protein\' entity."},\n    {"3": "The sentence contains \'Th2-type lymphocytes\' which is a \'cell_type\' entity."},\n    {"3": "The sentence contains \'interleukin-2\', \'alpha chain\', \'CD25\', and \'IL-2 receptor\' which are \'protein\' entities."},\n    {"3": "The sentence contains \'B and T cell activation\', \'Ramos\', \'Jurkat\', and \'cDNA microarray technology\' which are \'cell_type\' and \'DNA\' entities."},\n    {"3": "The sentence contains \'CD40\', \'Rel/nuclear factor kappaB\', \'NF-kappaB\', and \'B lymphocytes\' which are \'protein\' and \'cell_type\' entities."},\n    {"4": "The sentence contains \'IL-2\', \'NFAT\', \'NFAT delta418\', \'calcineurin\', \'Tpl-2\', and \'cyclosporin A\' which are \'DNA\' and \'protein\' entities."},\n    {"3": "The sentence contains \'Erbstatin\', \'genistein\', and \'Egr-1\' which are \'protein\' and \'RNA\' entities."},\n    {"4": "The sentence contains \'AP-1\', \'c-jun\', \'IL-2\', \'NF-AT\', and \'T cell\' which are \'protein\' and \'cell_type\' entities."},\n    {"3": "The sentence contains \'LITAF\' and \'TNF-alpha\' which are \'protein\' entities."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."}\n]', 'response3': '[{"IL-2": "DNA"}, {"AP-1": "protein"}, {"NF-kappa B": "protein"}, {"NF-AT": "protein"}, {"Oct1": "protein"}]', 'prediction': {'IL-2': 'DNA', 'AP-1': 'protein', 'NF-kappa B': 'protein', 'NF-AT': 'protein', 'Oct1': 'protein'}}
{'idx': 23, 'sentence': 'Furthermore, a mutant E6 motif lost both in vitro binding activity and in vivo enhancer activity .', 'label': {'mutant E6 motif': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"E6 motif": "protein"}]', 'prediction': {'E6 motif': 'protein'}}
{'idx': 1476, 'sentence': 'Protein phosphorylation has an important role in the regulation of these two factors: (1) it induces the transactivating capacity of the AP-1 protein c-Jun ; and (2) it is involved in the release of the cytoplasmic inhibitor , I kappa B , from NF-kappa B , allowing translocation of the latter into the nucleus .', 'label': {'AP-1 protein': 'protein', 'c-Jun': 'protein', 'I kappa B': 'protein', 'NF-kappa B': 'protein', 'cytoplasmic inhibitor': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of protein names and their corresponding entity labels, making it very helpful for extracting named entities from the target sentence."}\n]', 'response3': '[{"AP-1": "protein"}, {"c-Jun": "protein"}, {"I kappa B": "protein"}, {"NF-kappa B": "protein"}]', 'prediction': {'AP-1': 'protein', 'c-Jun': 'protein', 'I kappa B': 'protein', 'NF-kappa B': 'protein'}}
{'idx': 234, 'sentence': 'A similar infection with a recombinant retrovirus containing the beta-galactosidase gene with an adenovirus E2 promoter , results in beta-galactosidase activity in a limited number of cultured and primary cells .', 'label': {'cultured': 'cell_line', 'primary cells': 'cell_type', 'adenovirus E2 promoter': 'DNA', 'beta-galactosidase gene': 'DNA', 'beta-galactosidase': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 4},\n    {"In addition, assay of PBMC by the adenovirus-specific PCR may help detect early invasive disease and warrants further evaluation.": 4},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 3},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"This protein has now been purified and its encoding gene cloned.": 5},\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 4},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 4},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 5},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 4},\n    {"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n    {"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"beta-galactosidase gene": "protein"}, {"adenovirus E2 promoter": "DNA"}]', 'prediction': {'beta-galactosidase gene': 'protein', 'adenovirus E2 promoter': 'DNA'}}
{'idx': 1396, 'sentence': 'NF-M ( chicken C/EBP beta ) induces eosinophilic differentiation and apoptosis in a hematopoietic progenitor cell line .', 'label': {'hematopoietic progenitor cell line': 'cell_line', 'NF-M': 'protein', 'chicken C/EBP beta': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 4},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 4},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n    {"Control of NF-kappa B activity by the I kappa B beta inhibitor.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 4},\n    {"Recently, activation of NF-kappa B has been linked to ARDS and has been shown to be a critical proximal step in the initiation of neutrophilic inflammation in animal models.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 4},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 5},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 5},\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"NF-M": "protein"}, {"C/EBP beta": "protein"}, {"hematopoietic progenitor cell line": "cell_line"}]', 'prediction': {'NF-M': 'protein', 'C/EBP beta': 'protein', 'hematopoietic progenitor cell line': 'cell_line'}}
{'idx': 1812, 'sentence': 'The protein shows significant sequence similarities to the family of G-protein coupled chemokine receptors and turned out to be identical to the recently described receptor EBI1 .', 'label': {'G-protein coupled chemokine receptors': 'protein', 'chemokine receptors': 'protein', 'G-protein': 'protein', 'receptor EBI1': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names that match the entity label \'protein\', making it highly relevant for named entity extraction."}\n]', 'response3': '[{"G-protein coupled chemokine receptors": "protein"}, {"EBI1": "protein"}]', 'prediction': {'G-protein coupled chemokine receptors': 'protein', 'EBI1': 'protein'}}
{'idx': 1099, 'sentence': 'Interestingly, microtubule disruption also decreased monocyte 1,25(OH)2D3 synthesis , not by decreasing the Vmax of monocyte mitochondrial 1 alpha-hydroxylase but through an increase in the Km for 25(OH)2D3 .', 'label': {'monocyte mitochondrial 1 alpha-hydroxylase': 'protein', 'monocyte': 'cell_type', 'microtubule': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 4},\n    {"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 3},\n    {"Changes in PKC isoforms in human alveolar macrophages compared with blood monocytes.": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 5},\n    {"We have examined the effect of alpha-tocopherol (alpha-tcp) on one cellular event in atherosclerotic plaque development, monocyte adhesion to stimulated endothelial cells (ECs).": 4},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 4},\n    {"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.": 4},\n    {"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.": 4},\n    {"When the same MTHC lines are exposed to TNF-alpha in combination with IFN-gamma, the cells instead become DC.": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 4},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 4},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n    {"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]": 4},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 4},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"monocyte": "cell_type"}, {"1,25(OH)2D3": "protein"}, {"Vmax": "protein"}, {"monocyte mitochondrial 1 alpha-hydroxylase": "protein"}, {"Km": "protein"}, {"25(OH)2D3": "protein"}]', 'prediction': {'monocyte': 'cell_type', '1,25(OH)2D3': 'protein', 'Vmax': 'protein', 'monocyte mitochondrial 1 alpha-hydroxylase': 'protein', 'Km': 'protein', '25(OH)2D3': 'protein'}}
{'idx': 1537, 'sentence': 'Furthermore, we identified a repression domain at the N-terminus of Oct-2a .', 'label': {'Oct-2a': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 1},\n{"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n{"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.": 5},\n{"Here we examined the regulatory mechanism of the SCM-1 genes.": 5},\n{"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n{"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.": 5},\n{"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements.": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n{"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 5},\n{"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n{"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system.": 5},\n{"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n{"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n{"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"Oct-2a": "protein"}]', 'prediction': {'Oct-2a': 'protein'}}
{'idx': 1574, 'sentence': 'CONCLUSIONS: Sexual hormones , through their receptors , may influence the activity of eosinophils in patients with VKC .', 'label': {'receptors': 'protein', 'eosinophils': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Eosinophils play an important role in the effector phase of allergic inflammation.": 5},\n    {"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.": 5},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 4},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 5},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms.": 5},\n    {"In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine (IFN-gamma) in combination with allergy-driven overproduction of T helper 2-type cytokines.": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 4},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5},\n    {"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.": 5},\n    {"To study the regulatory mechanism of gp91phox gene expression in eosinophils, we transiently transfected eosinophil-committed HL-60-C15 cells with gp91phox promoter constructs, and identified a negative element from bp -267 to -246 of the gp91phox gene, the deletion of which caused an 83% increase in promoter activity.": 5},\n    {"This phenomenon is mediated, in part, through inducible expression of the CXC chemokine, interleukin-8 (IL-8).": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"Sexual hormones": "protein"}, {"receptors": "protein"}, {"eosinophils": "cell_type"}]', 'prediction': {'Sexual hormones': 'protein', 'receptors': 'protein', 'eosinophils': 'cell_type'}}
{'idx': 1312, 'sentence': 'A solution structure for the non-sequence-specific C-terminal HMG box of HMG-1 has recently been proposed.', 'label': {'HMG-1': 'protein', 'C-terminal HMG box': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 1},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 601, 'sentence': 'To determine whether enhancer elements in addition to the highly conserved octamer (OCTA)-nucleotide motif are important for lymphoid-specific expression of the immunoglobulin heavy-chain (IgH) gene , we have investigated the effect of mutating the binding site for a putative additional lymphoid-specific transcription factor , designated NF-microB , in the murine IgH enhancer .', 'label': {'murine IgH enhancer': 'DNA', 'putative additional lymphoid-specific transcription factor': 'protein', 'octamer (OCTA)-nucleotide motif': 'DNA', 'NF-microB': 'protein', 'enhancer elements': 'DNA', 'immunoglobulin heavy-chain (IgH) gene': 'DNA', 'binding site': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence provides a clear example of a protein entity (NF-E2) and its corresponding label, which directly matches one of the entity types in the target sentence."},\n{"Example 2": 5},\n{"Reason 2": "The sentence contains multiple examples of protein entities (Oct-2A, HMG I/Y, HLA-DRA) and a cell type entity (B cells) with their corresponding labels, which directly match the entity types in the target sentence."},\n{"Example 3": 5},\n{"Reason 3": "The sentence provides a clear example of a protein entity (IL-2) and its corresponding label, which directly matches one of the entity types in the target sentence."},\n{"Example 4": 5},\n{"Reason 4": "The sentence contains examples of protein entities (NF-ATc) and cell type entities (T lymphocytes, embryonic cardiac cells) with their corresponding labels, which directly match the entity types in the target sentence."},\n{"Example 5": 5},\n{"Reason 5": "The sentence provides a clear example of a protein entity (Egr-1) and its corresponding label, which directly matches one of the entity types in the target sentence."},\n{"Example 6": 5},\n{"Reason 6": "The sentence provides a clear example of a protein entity (IL-4) and its corresponding label, which directly matches one of the entity types in the target sentence."},\n{"Example 7": 5},\n{"Reason 7": "The sentence contains examples of a cell type entity (T cell) and a protein entity (interleukin 2) with their corresponding labels, which directly match the entity types in the target sentence."},\n{"Example 8": 5},\n{"Reason 8": "The sentence contains examples of protein entities (IL-2, c-Jun, c-Fos) with their corresponding labels, which directly match the entity types in the target sentence."},\n{"Example 9": 5},\n{"Reason 9": "The sentence provides a clear example of a cell type entity (Th2-type lymphocytes) and its corresponding label, which directly matches one of the entity types in the target sentence."},\n{"Example 10": 5},\n{"Reason 10": "The sentence provides a clear example of a DNA entity (IgH) and its corresponding label, which directly matches one of the entity types in the target sentence."},\n{"Example 11": 5},\n{"Reason 11": "The sentence provides a clear example of a DNA entity (immunoglobulin kappa 3\' enhancer) and its corresponding label, which directly matches one of the entity types in the target sentence."},\n{"Example 12": 5},\n{"Reason 12": "The sentence contains examples of protein entities (c-kit, IL-4R alpha chain) with their corresponding labels, which directly match the entity types in the target sentence."},\n{"Example 13": 5},\n{"Reason 13": "The sentence provides a clear example of a protein entity (NF-kappa B) and its corresponding label, which directly matches one of the entity types in the target sentence."},\n{"Example 14": 5},\n{"Reason 14": "The sentence contains examples of protein entities (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) with their corresponding labels, which directly match the entity types in the target sentence."},\n{"Example 15": 5},\n{"Reason 15": "The sentence contains examples of protein entities (CD40, Rel/nuclear factor kappaB, NF-kappaB) and a cell type entity (B lymphocytes) with their corresponding labels, which directly match the entity types in the target sentence."},\n{"Example 16": 5},\n{"Reason 16": "The sentence contains examples of protein entities (p50, p65) and DNA entities with their corresponding labels, which directly match the entity types in the target sentence."},\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any examples of entities that match the entity types in the target sentence."},\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any examples of entities that match the entity types in the target sentence."},\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any examples of entities that match the entity types in the target sentence."},\n{"Example 20": 1},\n{"Reason 20": "The sentence does not contain any examples of entities that match the entity types in the target sentence."}\n]', 'response3': '[{"NF-microB": "protein"}, {"IgH": "DNA"}]', 'prediction': {'NF-microB': 'protein', 'IgH': 'DNA'}}
{'idx': 890, 'sentence': 'Treatment of 10 with warm HCl furnished 19-chloro-4,21-dihydroxypregna-4,9(11)-diene-3,20-dione (13).', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 4},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 4},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n    {"We found that they reduced the initial interleukin-1beta mRNA transcription rate through prevention of degradation of inhibitor-kappaB alpha.": 4},\n    {"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.": 5},\n    {"This hybrid clone, designated NR2, was characterized by several methods, including PCR, with eight pairs of oligonucleotides mapped to Chr 20: D20S5, D20S41, D20S42, D20S56, D20S57, D20S58, adenosine deaminase (ADA), and Prion protein (PRIP); Restriction Fragment Length Polymorphism (RFLP) analyses with four genomic anonymous probes (D20S5, cD3H12, D20S17, D20S18); and fluorescent in situ hybridization (FISH) with total human DNA and D20Z1, a sequence specific to the human Chr 20 centromere, as probes.": 5},\n    {"Treatment with soluble, bivalent mAb J393 killed 25-50% of the cell population, while concomitant engagement of either the CD3.TcR complex or the integrins CD18 and CD29 significantly potentiated this effect.": 5},\n    {"Combined treatment of HPCs with alpha-PML and alpha-Rb oligomers inhibited both PML and Rb protein expression and completely blocked erythroid colony development.": 5},\n    {"When 18C7 was incubated with MR before aldosterone or progesterone, the antibody inhibited 75-80% of the binding.": 5},\n    {"A 3-bp mutation at the distal Sp1-binding site not only eliminates Sp1 interaction, but also abolishes most of the VitD3 induction of CD14 expression.": 5},\n    {"CONCLUSION: Our results show that the tested agents (except indomethacin) are inhibitors of the T cell-mediated immune response, as expected, that aspirin is an effective suppressor of adhesion molecule expression, and that all three agents can induce Hsp60 in HUVECs.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 323, 'sentence': 'The Epstein-Barr virus ( EBV ) ORI1yt enhancer is not B-cell specific and does not respond synergistically to the EBV transcription factors R and Z .', 'label': {'Epstein-Barr virus ( EBV ) ORI1yt enhancer': 'DNA'}, 'response1': "['DNA', 'cell_type', 'protein']", 'response2': '[\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"5": "The sentence contains the entity \'RXR\' which is a protein, matching one of the entity types in the label set."},\n{"4": "The sentence contains the entities \'IL-2\' and \'IFN-gamma\' which are proteins, matching some of the entity types in the label set."},\n{"5": "The sentence contains the entities \'NF-kappaB\', \'Sp1\', and \'p50\' which are proteins, matching some of the entity types in the label set."},\n{"5": "The sentence contains the entities \'EBNA2\' and \'TP1\' which are proteins and a cell line respectively, matching some of the entity types in the label set."},\n{"4": "The sentence contains the entities \'T cell\' and \'interleukin 2\' which are a cell type and a protein respectively, matching some of the entity types in the label set."},\n{"4": "The sentence contains the entity \'IL-2\' which is a protein, matching one of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"5": "The sentence contains the entities \'NF-kB\', \'AP-1\', \'OCT-1\', and \'NF-IL-2B\' which are proteins, matching some of the entity types in the label set."},\n{"5": "The sentence contains the entities \'EBV\' and \'CD2\' which are a cell line and a protein respectively, matching some of the entity types in the label set."},\n{"4": "The sentence contains the entities \'CD4+\' and \'EBV\' which are a cell type and a protein respectively, matching some of the entity types in the label set."},\n{"5": "The sentence contains the entities \'EBNA-2\' and \'PU.1\' which are proteins, matching some of the entity types in the label set."},\n{"5": "The sentence contains the entities \'UAS1\' and \'B cell\' which are a cell line and a cell type respectively, matching some of the entity types in the label set."},\n{"5": "The sentence contains the entities \'EBV\' and \'B-cell\' which are a cell line and a cell type respectively, matching some of the entity types in the label set."},\n{"5": "The sentence contains the entity \'GATA-1\' which is a protein, matching one of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."}\n]', 'response3': "[{'Epstein-Barr virus': 'cell_line'}, {'EBV': 'cell_line'}, {'R': 'protein'}, {'Z': 'protein'}]", 'prediction': {'Epstein-Barr virus': 'cell_line', 'EBV': 'cell_line', 'R': 'protein', 'Z': 'protein'}}
{'idx': 929, 'sentence': 'The cDNA sequence has an 813-bp open reading frame ( ORF ) whose predicted amino acid sequence is 97.6% identical to the 272 carboxy-terminal amino acids of the human ets-1 protein .', 'label': {'ORF': 'DNA', '272 carboxy-terminal amino acids': 'protein', 'ets-1': 'protein', 'human ets-1 protein': 'protein', '813-bp open reading frame': 'DNA', 'cDNA sequence': 'DNA', 'amino acid sequence': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"Sentence": "The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.", "helpfulness score": 5, "reasons": "The sentence contains specific entities such as NF-ATc (protein), T lymphocytes (cell_type), and embryonic cardiac cells (cell_type), which are directly related to the entity labels in the target sentence."},\n{"Sentence": "Human cDNAs encoding subunits of these factors have been cloned and sequenced.", "helpfulness score": 4, "reasons": "The sentence mentions cDNAs, which is related to the entity label \'DNA\' in the target sentence."},\n{"Sentence": "A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.", "helpfulness score": 4, "reasons": "The sentence refers to Th2-type lymphocytes, which is related to the entity label \'cell_type\' in the target sentence."},\n{"Sentence": "Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.", "helpfulness score": 5, "reasons": "The sentence contains specific entities such as SLAP-130 (protein), SLP-76 (protein), and T cell (cell_type), which are directly related to the entity labels in the target sentence."},\n{"Sentence": "The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.", "helpfulness score": 4, "reasons": "The sentence mentions GM-CSF, which is related to the entity label \'protein\' in the target sentence."},\n{"Sentence": "By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.", "helpfulness score": 5, "reasons": "The sentence contains specific entities such as TCF-1 (protein), human TCF-1 protein, and mouse TCF-1 protein, which are directly related to the entity labels in the target sentence."},\n{"Sentence": "The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.", "helpfulness score": 5, "reasons": "The sentence contains specific entities such as interleukin 10 (protein), IL-10R (protein), STAT3 (protein), and IL-6 (protein), which are directly related to the entity labels in the target sentence."},\n{"Sentence": "This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.", "helpfulness score": 5, "reasons": "The sentence mentions SIVsmmPBj14, which is related to the entity label \'cell_line\' in the target sentence."},\n{"Sentence": "One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.", "helpfulness score": 5, "reasons": "The sentence contains specific entities such as cDNA (DNA) and Egr-1 (protein), which are directly related to the entity labels in the target sentence."},\n{"Sentence": "We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.", "helpfulness score": 5, "reasons": "The sentence mentions E2A, which is related to the entity label \'protein\' in the target sentence."},\n{"Sentence": "This protein has now been purified and its encoding gene cloned.", "helpfulness score": 5, "reasons": "The sentence mentions protein, which is related to the entity label \'protein\' in the target sentence."},\n{"Sentence": "Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.", "helpfulness score": 5, "reasons": "The sentence mentions Protein, which is related to the entity label \'protein\' in the target sentence."},\n{"Sentence": "Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.", "helpfulness score": 5, "reasons": "The sentence contains specific entities such as cDNA (DNA), Jurkat (cell_line), and DRE 1 (cell_type), which are directly related to the entity labels in the target sentence."},\n{"Sentence": "Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB-induced trans-activation of the H4 promoter.", "helpfulness score": 5, "reasons": "The sentence contains specific entities such as ATF1 (protein), CREB (protein), and H4 (protein), which are directly related to the entity labels in the target sentence."},\n{"Sentence": "Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.", "helpfulness score": 5, "reasons": "The sentence contains specific entities such as NF-kappaB (protein), Sp1 (protein), and SIVmac (cell_line), which are directly related to the entity labels in the target sentence."},\n{"Sentence": "Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.", "helpfulness score": 5, "reasons": "The sentence contains specific entities such as HIV-1 LTR (DNA), NFAT-1 (protein), and NF kappa B (protein), which are directly related to the entity labels in the target sentence."},\n{"Sentence": "We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.", "helpfulness score": 1, "reasons": "The sentence does not contain any entities related to the entity labels in the target sentence."},\n{"Sentence": "However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.", "helpfulness score": 1, "reasons": "The sentence does not contain any entities related to the entity labels in the target sentence."},\n{"Sentence": "In 2 complex translocations, none of the three genes was rearranged.", "helpfulness score": 1, "reasons": "The sentence does not contain any entities related to the entity labels in the target sentence."},\n{"Sentence": "Deletions or mutations in this element also reduced the serum response by 80-90%.", "helpfulness score": 1, "reasons": "The sentence does not contain any entities related to the entity labels in the target sentence."},\n{"Sentence": "In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.", "helpfulness score": 1, "reasons": "The sentence does not contain any entities related to the entity labels in the target sentence."}\n]', 'response3': '[{"cDNA": "DNA"}, {"ets-1 protein": "protein"}]', 'prediction': {'cDNA': 'DNA', 'ets-1 protein': 'protein'}}
{'idx': 6, 'sentence': 'Platelet-activating factor induces phospholipid turnover , calcium flux , arachidonic acid liberation , eicosanoid generation , and oncogene expression in a human B cell line .', 'label': {'Platelet-activating factor': 'protein', 'oncogene': 'DNA', 'human B cell line': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence contains a named entity with a clear entity label that matches one of the entity types in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence contains a named entity with a clear entity label that matches one of the entity types in the target sentence."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence contains a named entity with a clear entity label that matches one of the entity types in the target sentence."},\n    {"Example 8": 4},\n    {"Reason 8": "The sentence contains a named entity with a clear entity label that matches one of the entity types in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 10": 4},\n    {"Reason 10": "The sentence contains a named entity with a clear entity label that matches one of the entity types in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 12": 3},\n    {"Reason 12": "The sentence contains a named entity with a clear entity label that matches one of the entity types in the target sentence, but the relevance to the target sentence is not as direct."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not contain any named entities with entity labels matching the entity types in the target sentence."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not contain any named entities with entity labels matching the entity types in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any named entities with entity labels matching the entity types in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any named entities with entity labels matching the entity types in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any named entities with entity labels matching the entity types in the target sentence."}\n]', 'response3': '[{"phospholipid turnover": "protein"}, {"calcium flux": "protein"}, {"arachidonic acid liberation": "protein"}, {"eicosanoid generation": "protein"}, {"oncogene expression": "protein"}, {"human B cell line": "cell_line"}]', 'prediction': {'phospholipid turnover': 'protein', 'calcium flux': 'protein', 'arachidonic acid liberation': 'protein', 'eicosanoid generation': 'protein', 'oncogene expression': 'protein', 'human B cell line': 'cell_line'}}
{'idx': 1478, 'sentence': 'Furthermore, in activated T cells , the kinetics of the two phosphorylation events are essentially similar.', 'label': {'activated T cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n    {"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 4},\n    {"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n    {"The phosphorylated tyrosine residue itself is important for the protein-protein interaction .": 4},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .": 4},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .": 5},\n    {"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 1},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .": 5},\n    {"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .": 5},\n    {"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"T cells": "cell_type"}]', 'prediction': {'T cells': 'cell_type'}}
{'idx': 1793, 'sentence': 'The clinical benefits of salicylates in the treatment of several diseases, including atherosclerosis and rheumatoid arthritis , may be related to their ability to reduce monocyte gene expression .', 'label': {}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."}\n]', 'response3': '[{"salicylates": "protein"}, {"atherosclerosis": "cell_type"}, {"rheumatoid arthritis": "cell_type"}, {"monocyte": "cell_type"}]', 'prediction': {'salicylates': 'protein', 'atherosclerosis': 'cell_type', 'rheumatoid arthritis': 'cell_type', 'monocyte': 'cell_type'}}
{'idx': 1473, 'sentence': 'Costimulation requirement for AP-1 and NF-kappa B transcription factor activation in T cells .', 'label': {'NF-kappa B': 'protein', 'T cells': 'cell_type', 'AP-1': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 4},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 5},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"AP-1": "protein"}, {"NF-kappa B": "protein"}, {"T cells": "cell_type"}]', 'prediction': {'AP-1': 'protein', 'NF-kappa B': 'protein', 'T cells': 'cell_type'}}
{'idx': 539, 'sentence': 'PMA enhanced slightly the stimulatory effect of PHA .', 'label': {'PHA': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names (NF-kappa B, AP-1) that are directly mentioned and can be easily identified as protein entities."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains a specific protein name (NF-E2) that is directly mentioned and can be easily identified as a protein entity."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains specific protein names (AP-1, PMA) and cell types (monocytes, macrophages) that are directly mentioned and can be easily identified as protein and cell type entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains specific protein names (PAFR, PAF, NF-kappa B, protein kinase C) that are directly mentioned and can be easily identified as protein entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains specific protein names (IL-2, NF-kappa B, AP-1) that are directly mentioned and can be easily identified as protein entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains specific protein name (MNDA) and a cell line (Philadelphia chromosome-positive chronic myeloid leukemia) that are directly mentioned and can be easily identified as protein and cell line entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains specific protein names (Oct-2A, HMG I/Y, HLA-DRA) and a cell type (B cells) that are directly mentioned and can be easily identified as protein and cell type entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains a specific protein name (NF-kappa B) that is directly mentioned and can be easily identified as a protein entity."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains a specific protein name (P selectin) that is directly mentioned and can be easily identified as a protein entity."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains a specific protein name (phosphocreatine) that is directly mentioned and can be easily identified as a protein entity."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains specific protein names (NDP kinase, KA, SCC, BCC) that are directly mentioned and can be easily identified as protein and cell type entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains specific protein names (CD14, CD23) that are directly mentioned and can be easily identified as protein entities."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains specific protein names (IL-4, LPS, AP-1) that are directly mentioned and can be easily identified as protein entities."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains specific protein names (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) that are directly mentioned and can be easily identified as protein entities."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains specific protein names (Epo, alpha-globin, beta-globin, haemoglobin, haemin, delta-ALA) that are directly mentioned and can be easily identified as protein entities."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence contains specific protein names (PMA, IFN-gamma) and a cell type (T cell blasts) that are directly mentioned and can be easily identified as protein and cell type entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific entity names related to the given entity labels."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific entity names related to the given entity labels."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific entity names related to the given entity labels."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any specific entity names related to the given entity labels."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1025, 'sentence': 'NK cells do not express NFATc constitutively, but NFATc mRNA accumulation is induced in these cells within 2 h of stimulation with CD16 ligands .', 'label': {'NFATc': 'protein', 'NK cells': 'cell_type', 'NFATc mRNA': 'RNA'}, 'response1': "['RNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific entities with clear entity labels that match the entity label set."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains specific entities with clear entity labels that match the entity label set."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains specific entities with clear entity labels that match the entity label set."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains specific entities with clear entity labels that match the entity label set."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains specific entities with clear entity labels that match the entity label set."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains specific entities with clear entity labels that match the entity label set."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains specific entities with clear entity labels that match the entity label set."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains specific entities with clear entity labels that match the entity label set."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains specific entities with clear entity labels that match the entity label set."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains specific entities with clear entity labels that match the entity label set."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains specific entities with clear entity labels that match the entity label set."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains specific entities with clear entity labels that match the entity label set."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains specific entities with clear entity labels that match the entity label set."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains specific entities with clear entity labels that match the entity label set."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains specific entities with clear entity labels that match the entity label set."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entities that match the entity label set."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities that match the entity label set."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities that match the entity label set."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities that match the entity label set."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities that match the entity label set."}\n]', 'response3': '[{"NFATc": "protein"}, {"NFATc mRNA": "RNA"}, {"NK cells": "cell_type"}, {"CD16 ligands": "protein"}]', 'prediction': {'NFATc': 'protein', 'NFATc mRNA': 'RNA', 'NK cells': 'cell_type', 'CD16 ligands': 'protein'}}
{'idx': 1560, 'sentence': 'Moreover, in human T helper (Th) clones functionally characterized as being of the type 0, type 1 and type 2 (28%, < 1% und 93% CD30+, respectively), the extent of CD30 -mediated NF-kappa B activation correlated with the proportion of CD30+ cells .', 'label': {'human T helper (Th) clones': 'cell_line', 'CD30+ cells': 'cell_line', 'CD30': 'protein', 'NF-kappa B': 'protein'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n{"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n{"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 4},\n{"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.": 4},\n{"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation.": 4},\n{"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB.": 5},\n{"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 4},\n{"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.": 4},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n{"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5},\n{"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n{"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n{"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n{"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.": 5},\n{"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 4},\n{"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"Th": "cell_type"}, {"CD30": "protein"}, {"NF-kappa B": "protein"}]', 'prediction': {'Th': 'cell_type', 'CD30': 'protein', 'NF-kappa B': 'protein'}}
{'idx': 365, 'sentence': 'Run-on analysis demonstrated detectable levels of c-jun gene transcription in untreated HL-60 cells , and that exposure to TPA increases this rate 3.3-fold.', 'label': {'c-jun': 'DNA', 'HL-60 cells': 'cell_line', 'untreated HL-60 cells': 'cell_line'}, 'response1': "['DNA', 'cell_type', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 1},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 1},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1039, 'sentence': 'Peripheral blood mononuclear cells ( pbmc ) and bone marrow cells of 26 patients were examined for c-fos , c-myc , p53 and the hybrid bcr/abl mRNA levels .', 'label': {'Peripheral blood mononuclear cells': 'cell_type', 'pbmc': 'cell_type', 'bone marrow cells': 'cell_type'}, 'response1': "['RNA', 'protein']", 'response2': '[\n    {"PBMC": 5},\n    {"adenovirus DNA": 4},\n    {"CD70": 4},\n    {"B cell": 4},\n    {"plasma cells": 4},\n    {"IL-4": 4},\n    {"CD40": 4},\n    {"MNDA": 4},\n    {"Philadelphia chromosome-positive chronic myeloid leukemia": 4},\n    {"PMA": 3},\n    {"CD14": 4},\n    {"CD23": 4},\n    {"IL-2": 4},\n    {"c-Jun": 4},\n    {"c-Fos": 4},\n    {"PML/RARalpha": 5},\n    {"myeloperoxidase": 4},\n    {"lysozyme": 4},\n    {"PU.1": 4},\n    {"NF-kappaB": 4},\n    {"Tax": 3},\n    {"ATL": 3},\n    {"TCRzeta": 4},\n    {"p56(lck)": 4},\n    {"p21(WAF1/CIP1)": 4},\n    {"p27(KIP1)": 4},\n    {"IFN A": 4},\n    {"IFNA": 4},\n    {"interleukin-2": 4},\n    {"interleukin-2 receptor": 4},\n    {"phytohemagglutinin": 4},\n    {"phorbol myristate acetate": 4},\n    {"Ter 119": 4},\n    {"beta-globin": 4},\n    {"glycoprotein IIb": 4},\n    {"platelet factor 4": 4},\n    {"CD40": 4},\n    {"Rel/nuclear factor kappaB": 4},\n    {"NF-kappaB": 4},\n    {"B lymphocytes": 4},\n    {"B and T cell activation": 3},\n    {"Ramos": 4},\n    {"Jurkat": 4},\n    {"cDNA microarray technology": 4},\n    {"HeLa cells": 4},\n    {"Daudi": 4},\n    {"B cell-encoded genes": 4},\n    {"B cell-specific": 4},\n    {"PU.1": 4},\n    {"CSF-1 receptor": 4},\n    {"Mono A": 4},\n    {"Mono B": 4}\n]', 'response3': '[{"pbmc": "cell_type"}, {"bone marrow cells": "cell_type"}, {"c-fos": "protein"}, {"c-myc": "protein"}, {"p53": "protein"}, {"bcr/abl mRNA": "RNA"}]', 'prediction': {'pbmc': 'cell_type', 'bone marrow cells': 'cell_type', 'c-fos': 'protein', 'c-myc': 'protein', 'p53': 'protein', 'bcr/abl mRNA': 'RNA'}}
{'idx': 217, 'sentence': 'Quantitation of glucocorticoid receptors ( GCR ) and the study of their affinity for glucocorticosteroids ( GCS ) were made in peripheral blood lymphocytes of bronchial asthma ( BA ) patients in consideration of GCR treatment and serum levels of endogenous cortisol .', 'label': {'GCR': 'protein', 'glucocorticoid receptors': 'protein', 'peripheral blood lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 3},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 4},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.": 5},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.": 5},\n    {"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n    {"In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine (IFN-gamma) in combination with allergy-driven overproduction of T helper 2-type cytokines.": 4},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 4},\n    {"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1782, 'sentence': 'In addition, resting PBL constitutively expressed prominent levels of Id2 mRNA , but not Id3 mRNA .', 'label': {'Id3': 'protein', 'resting PBL': 'cell_type', 'Id3 mRNA': 'RNA', 'PBL': 'cell_type', 'Id2': 'protein', 'Id2 mRNA': 'RNA'}, 'response1': "['RNA', 'protein']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 5},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n    {"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.": 5},\n    {"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA/NF-kappaB1 binding complexes.": 5},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti-EBV antibody titres (P > 0.05).": 5},\n    {"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells, but not in primary T cells, consistent with the lack of the IL-12 receptor in resting T cells.": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"PMA induced the expression of both CD14 and CD23 mRNA and protein.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1280, 'sentence': "Sequence analysis of the 5'-flanking region of the CD69 gene revealed the presence of a potential TATA element 30 base pairs upstream of the major transcription initiation site and several putative binding sequences for inducible transcription factors ( NF-kappa B , Egr-1 , AP-1 ), which might mediate the inducible expression of this gene.", 'label': {'NF-kappa B': 'protein', 'TATA element': 'DNA', 'transcription factors': 'protein', 'CD69': 'protein', 'AP-1': 'protein', '30 base pairs upstream': 'DNA', 'CD69 gene': 'DNA', "5'-flanking region": 'DNA', 'transcription initiation site': 'DNA', 'Egr-1': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes": 4},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein": 5},\n{"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms": 4},\n{"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells": 5},\n{"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation": 5},\n{"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor": 5},\n{"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter": 4},\n{"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements": 5},\n{"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements": 5},\n{"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif": 4},\n{"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF": 5},\n{"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region": 5},\n{"These properties suggest that TAFII105 is a cell type-specific subunit of TFIID that may be responsible for mediating transcription by a subset of activators in B cells": 5},\n{"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B": 5},\n{"This sequence element was referred to as the BAT box and its deletion significantly reduced the activity of a CD20 promoter-CAT construct in B cells": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required": 1},\n{"In 2 complex translocations, none of the three genes was rearranged": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity": 1}\n]', 'response3': '[{"CD69 gene": "protein"}, {"TATA element": "DNA"}, {"NF-kappa B": "protein"}, {"Egr-1": "protein"}, {"AP-1": "protein"}]', 'prediction': {'CD69 gene': 'protein', 'TATA element': 'DNA', 'NF-kappa B': 'protein', 'Egr-1': 'protein', 'AP-1': 'protein'}}
{'idx': 611, 'sentence': 'Transactivation by some DNA viruses has been implicated in inducing HIV-1 replication and pathogenesis.', 'label': {}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains a clear mention of the entity \'TCL1\' and its association with the entity type \'protein\', making it highly helpful for extracting named entities."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions the entity \'NF-kappa B\' and its association with the entity type \'protein\', which is helpful for entity extraction, but the context is slightly more complex compared to Example 1."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence mentions the entities \'TIMP-1\' and \'DNA\' with their respective entity types, providing clear information for entity extraction."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence mentions the entity \'AP-1\' and its association with the entity type \'DNA\', which is helpful for entity extraction, but the context may require additional information."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence mentions the entities \'IkappaBbeta\' and \'NF-kappaB\' with their respective entity types, providing clear information for entity extraction."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence mentions the entity \'ZAP-70\' and its association with the entity type \'protein\', making it highly helpful for extracting named entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence mentions the entity \'SIVsmmPBj14\' and its association with the entity type \'cell_line\', providing clear information for entity extraction."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions the entities \'hepatitis B virus\' and \'HBxAg\' with their respective entity types, providing clear information for entity extraction."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence mentions multiple entities such as \'IFN A\', \'IFNA\', \'interleukin-2\', \'interleukin-2 receptor\', \'phytohemagglutinin\', and \'phorbol myristate acetate\' with their respective entity types, making it highly helpful for extracting named entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence mentions the entity \'TCF-1\' and its association with the entity type \'protein\', making it highly helpful for extracting named entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence mentions the entities \'HIV-1\', \'IFN\', \'PKR\', and \'IkappaBalpha\' with their respective entity types, providing clear information for entity extraction."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence mentions the entities \'EBV\', \'EBNA2\', and \'estrogen receptor\' with their respective entity types, providing clear information for entity extraction."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence mentions the entities \'NF-kappaB\', \'Sp1\', and \'SIVmac\' with their respective entity types, providing clear information for entity extraction."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence mentions the entities \'TR55\', \'TNF-alpha\', and \'HIV\' with their respective entity types, providing clear information for entity extraction."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence mentions the entities \'HIV-1 LTR\', \'NFAT-1\', and \'NF kappa B\' with their respective entity types, providing clear information for entity extraction."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any specific entities related to the given entity labels, making it less helpful for entity extraction."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific entities related to the given entity labels, making it less helpful for entity extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific entities related to the given entity labels, making it less helpful for entity extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific entities related to the given entity labels, making it less helpful for entity extraction."}\n]', 'response3': "[{'DNA viruses': 'DNA'}, {'HIV-1': 'cell_type'}]", 'prediction': {'DNA viruses': 'DNA', 'HIV-1': 'cell_type'}}
{'idx': 1723, 'sentence': 'In vitro treatment of a monocyte/macrophage cell line with CCl4 led to enhanced NF-kappa B binding and an increase in tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA levels .', 'label': {'tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA': 'RNA', 'NF-kappa B': 'protein', 'tumor necrosis factor-alpha': 'protein', 'TNF-alpha': 'protein'}, 'response1': "['cell_line', 'protein', 'RNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains multiple examples of proteins and cell types that are relevant to the entity labels in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence contains examples of proteins and cytokines that are relevant to the entity labels in the target sentence."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence contains examples of proteins that are relevant to the entity labels in the target sentence."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence contains examples of proteins and cell types that are relevant to the entity labels in the target sentence."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence contains examples of proteins that are relevant to the entity labels in the target sentence."},\n    {"Example 6": 3},\n    {"Reason 6": "The sentence contains an example of a protein that is relevant to the entity labels in the target sentence."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence contains examples of proteins and cytokines that are relevant to the entity labels in the target sentence."},\n    {"Example 8": 4},\n    {"Reason 8": "The sentence contains examples of proteins that are relevant to the entity labels in the target sentence."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence contains examples of proteins and cell types that are relevant to the entity labels in the target sentence."},\n    {"Example 10": 3},\n    {"Reason 10": "The sentence contains an example of DNA binding activity that is relevant to the entity labels in the target sentence."},\n    {"Example 11": 4},\n    {"Reason 11": "The sentence contains an example of protein inhibition that is relevant to the entity labels in the target sentence."},\n    {"Example 12": 4},\n    {"Reason 12": "The sentence contains examples of proteins and cell types that are relevant to the entity labels in the target sentence."},\n    {"Example 13": 4},\n    {"Reason 13": "The sentence contains examples of proteins and cytokines that are relevant to the entity labels in the target sentence."},\n    {"Example 14": 4},\n    {"Reason 14": "The sentence contains examples of proteins and cell types that are relevant to the entity labels in the target sentence."},\n    {"Example 15": 4},\n    {"Reason 15": "The sentence contains examples of proteins and cell types that are relevant to the entity labels in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any examples of entity labels relevant to the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any examples of entity labels relevant to the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any examples of entity labels relevant to the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any examples of entity labels relevant to the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any examples of entity labels relevant to the target sentence."}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"TNF-alpha": "protein"}, {"messenger RNA": "RNA"}]', 'prediction': {'NF-kappa B': 'protein', 'TNF-alpha': 'protein', 'messenger RNA': 'RNA'}}
{'idx': 1308, 'sentence': 'Two groups of HMG box proteins are distinguished.', 'label': {'HMG box proteins': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of HMG box proteins, which are directly relevant to the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains a cDNA example, which is relevant to the target sentence as it involves DNA."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains an IgH example, which is relevant to the target sentence as it involves DNA."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of CCAAT box and EKLF binding site, which are relevant to the target sentence as they involve DNA and protein, respectively."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of p21(WAF1/CIP1) and p27(KIP1), which are directly relevant to the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of NF-kappaB, Sp1, and p50, which are directly relevant to the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of NF-ATc, T lymphocytes, and embryonic cardiac cells, which are directly relevant to the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains an example of GATA-1, which is directly relevant to the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains an example of EKLF, which is directly relevant to the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains an example of Protein, which is directly relevant to the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of IL-2, c-Jun, and c-Fos, which are directly relevant to the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains an example of calcineurin, which is directly relevant to the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains an example of SCM-1, which is directly relevant to the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains an example of A-myb, which is directly relevant to the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains an example of IL-4, which is directly relevant to the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains an example of E2A, which is directly relevant to the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant examples to the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant examples to the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant examples to the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant examples to the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant examples to the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant examples to the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant examples to the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant examples to the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 765, 'sentence': 'Our results suggest that substances in serum influence steroid effects on these cells and that the molecular details of glucocorticoid hormone action may be pursued more precisely in a clearly defined culture medium.', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a cell type (nonhuman primates) and specifies that the study involves cells from nonhuman primates, making it highly relevant for identifying cell types."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence explicitly mentions \'cell adhesion molecules\' which is a clear indicator of cell type, making it highly relevant for identifying cell types."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence directly mentions \'G-CSF\' as a protein, providing a clear example of a protein entity, making it highly relevant for identifying proteins."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains multiple examples of entities such as \'CD70\' (protein), \'B cell\' (cell type), \'plasma cells\' (cell type), \'IL-4\' (protein), and \'CD40\' (protein), making it highly relevant for identifying various entity types."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence explicitly mentions \'E2A\' as a protein, providing a clear example of a protein entity, making it highly relevant for identifying proteins."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence directly mentions \'NF-E2\' as a protein, providing a clear example of a protein entity, making it highly relevant for identifying proteins."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains multiple examples of entities such as \'IL-5 mRNA\' (RNA), \'TCR\' (cell type), \'IL-2R\' (protein), and \'dexamethasone\' (protein), making it highly relevant for identifying various entity types."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides clear examples of cell types \'granulocytes\' and \'T cells\', making it highly relevant for identifying cell types."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence explicitly mentions \'IL-4\' as a protein, providing a clear example of a protein entity, making it highly relevant for identifying proteins."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains multiple examples of entities such as \'IL-2\' (protein), \'c-Jun\' (protein), and \'c-Fos\' (protein), making it highly relevant for identifying various protein entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence explicitly mentions \'phosphocreatine\' as a protein, providing a clear example of a protein entity, making it highly relevant for identifying proteins."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains multiple examples of entities such as \'HML\' (cell line), \'dexamethasone\' (protein), \'cortisol\' (protein), and \'lysozyme\' (protein), making it highly relevant for identifying various entity types."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence explicitly mentions \'IFN-gamma\' as a protein, providing a clear example of a protein entity, making it highly relevant for identifying proteins."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence explicitly mentions \'NF-kappa B\' as a protein, providing a clear example of a protein entity, making it highly relevant for identifying proteins."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains multiple examples of entities such as \'VDR\' (protein), \'RXR\' (protein), \'GRIP-1\' (protein), \'DRIP205\' (protein), and \'DRIP\' (protein), making it highly relevant for identifying various protein entities."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence contains multiple examples of entities such as \'CD40\' (protein), \'Rel/nuclear factor kappaB\' (protein), \'NF-kappaB\' (protein), and \'B lymphocytes\' (cell type), making it highly relevant for identifying various entity types."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1561, 'sentence': 'In all cell lines investigated, the NF-kappa B complexes induced following CD30 engagement were shown to contain p50 NF-kappa B1 , p65 RelA , and possibly other transcription factors .', 'label': {'CD30': 'protein', 'NF-kappa B complexes': 'protein', 'p65 RelA': 'protein', 'p50 NF-kappa B1': 'protein', 'NF-kappa B': 'protein', 'transcription factors': 'protein'}, 'response1': "['cell_line', 'protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of the entity types present in the target sentence, such as \'NF-kappaB\', \'Sp1\', and \'p50\', making it highly relevant for extracting named entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of the entity types present in the target sentence, such as \'NF-ATc\' and \'T lymphocytes\', which can aid in extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of the entity types present in the target sentence, such as \'CD28\', \'CD80\', \'CD86\', \'CBL\', \'VAV\', \'NFAT\', \'interleukin-2\', and \'granulocyte-macrophage colony-stimulating factor\', making it highly relevant for extracting named entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of the entity types present in the target sentence, such as \'PAFR\', \'PAF\', \'NF-kappa B\', and \'protein kinase C\', which can aid in extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of the entity types present in the target sentence, such as \'RelA\' and \'NF-kappa B\', making it highly relevant for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of the entity types present in the target sentence, such as \'NF-kappa B\' and \'I kappa B alpha\', making it highly relevant for extracting named entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of the entity types present in the target sentence, such as \'NF-kappaB\', \'Tax\', and \'ATL\', which can aid in extracting named entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of the entity types present in the target sentence, such as \'NF-kappa B\' and \'I kappa B alpha\', which can aid in extracting named entities."},\n    {"Sentence": 3},\n    {"Reason": "The sentence contains an example of the entity type present in the target sentence, \'NF-kappa B\', but lacks additional relevant entities for a higher score."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of the entity types present in the target sentence, such as \'CD40\' and \'NF-kappa B\', which can aid in extracting named entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of the entity types present in the target sentence, such as \'NF-kappa B\' and \'AP-1\', which can aid in extracting named entities."},\n    {"Sentence": 3},\n    {"Reason": "The sentence contains an example of the entity type present in the target sentence, \'NF-kappa B\', but lacks additional relevant entities for a higher score."},\n    {"Sentence": 3},\n    {"Reason": "The sentence contains an example of the entity type present in the target sentence, \'NF-kB\', but lacks additional relevant entities for a higher score."},\n    {"Sentence": 3},\n    {"Reason": "The sentence contains an example of the entity type present in the target sentence, \'IkappaBalpha\', but lacks additional relevant entities for a higher score."},\n    {"Sentence": 3},\n    {"Reason": "The sentence contains an example of the entity type present in the target sentence, \'NF-kappa B\', but lacks additional relevant entities for a higher score."},\n    {"Sentence": 3},\n    {"Reason": "The sentence contains examples of the entity types present in the target sentence, such as \'IkappaBbeta\' and \'NF-kappaB\', but lacks additional relevant entities for a higher score."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of the entity types present in the target sentence, resulting in a low helpfulness score."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of the entity types present in the target sentence, resulting in a low helpfulness score."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of the entity types present in the target sentence, resulting in a low helpfulness score."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of the entity types present in the target sentence, resulting in a low helpfulness score."}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"p50 NF-kappa B1": "protein"}, {"p65 RelA": "protein"}]', 'prediction': {'NF-kappa B': 'protein', 'p50 NF-kappa B1': 'protein', 'p65 RelA': 'protein'}}
{'idx': 330, 'sentence': 'ZRE-B is therefore not part of the R- inducible enhancer .', 'label': {'ZRE-B': 'DNA', 'R- inducible enhancer': 'DNA'}, 'response1': 'None.', 'response2': '[\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 3},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 4},\n    {"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 2},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 3},\n    {"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 4},\n    {"Our results demonstrate that the altered CCAAT box (CCAAC) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 3},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n    {"RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA/NF-kappaB1 binding complexes.": 4},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 3},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 4},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.": 4},\n    {"Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B/Oct-1-dependent transcription.": 4},\n    {"We have found that the recruitment of EKLF to 5\'HS3 depends on the presence of 5\'HS2 in cis, but the recruitment to 5\'HS2 does not depend on 5\'HS3.": 4},\n    {"The protein from E. coli specifically converted dUTP to dUMP and did not react with other dNTPs or NTPs.": 3},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1104, 'sentence': 'Although the interrelationship between the two messengers Ca2+ and cyclic AMP in platelet function is well documented, its mechanism of action still remains to be established.', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 4},\n    {"Example 7": 4},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1594, 'sentence': 'Human IL4 promoter -mediated transcription is downregulated in Jurkat cells stimulated with the NF-kappa B -activating cytokine tumor necrosis factor alpha and suppressed in RelA -overexpressing cells .', 'label': {'Jurkat cells': 'cell_line', 'NF-kappa B -activating cytokine': 'protein', 'Human IL4 promoter': 'DNA', 'tumor necrosis factor alpha': 'protein', 'RelA -overexpressing cells': 'cell_line', 'NF-kappa B': 'protein', 'RelA': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.": 5},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.": 5},\n    {"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5},\n    {"Binding of YY1 and Oct1 to a novel element that downregulates expression of IL-5 in human T cells.": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).": 5},\n    {"Interestingly, CTLA4Ig did not significantly inhibit the activation of either NF of activated T cells (NFAT) or AP-1 reporters.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"IL4": "protein"}, {"Jurkat cells": "cell_line"}, {"NF-kappa B": "protein"}, {"tumor necrosis factor alpha": "protein"}, {"RelA": "protein"}]', 'prediction': {'IL4': 'protein', 'Jurkat cells': 'cell_line', 'NF-kappa B': 'protein', 'tumor necrosis factor alpha': 'protein', 'RelA': 'protein'}}
{'idx': 1086, 'sentence': 'Analysis of the expression of human I kappa B alpha protein in stable transfectants of mouse 70Z/3 cells shows that, as for the endogenous murine protein, exogenous I kappa B alpha is degraded in response to inducers of NF-kappa B activity , such as phorbol myristate acetate or lipopolysaccharide .', 'label': {'NF-kappa B': 'protein', 'I kappa B alpha': 'protein', 'human I kappa B alpha protein': 'protein', 'mouse 70Z/3 cells': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"2": "The sentence does not contain any of the entity types in the target sentence."},\n    {"5": "The sentence contains \'NF-kappa B\' and \'I kappa B alpha\' which are both proteins mentioned in the target sentence."},\n    {"5": "The sentence contains \'IkappaBalpha\' and \'NF-kappaB\' which are both proteins mentioned in the target sentence."},\n    {"5": "The sentence contains \'IkappaBbeta\' and \'NF-kappaB\' which are both proteins mentioned in the target sentence."},\n    {"5": "The sentence contains \'RelA\' and \'NF-kappa B\' which are both proteins mentioned in the target sentence."},\n    {"5": "The sentence contains \'NF-kappa B\' and \'I kappa B beta\' which are both proteins mentioned in the target sentence."},\n    {"5": "The sentence contains \'CD40\' and \'NF-kappa B\' which are both proteins mentioned in the target sentence."},\n    {"5": "The sentence contains \'NF-kappa B\' which is a protein mentioned in the target sentence."},\n    {"5": "The sentence contains \'IL-2\', \'c-Jun\', and \'c-Fos\' which are all proteins mentioned in the target sentence."},\n    {"5": "The sentence contains \'IFN A\', \'IFNA\', \'interleukin-2\', \'interleukin-2 receptor\', \'phytohemagglutinin\', and \'phorbol myristate acetate\' which are all proteins mentioned in the target sentence."},\n    {"5": "The sentence contains \'E2A\' which is a protein mentioned in the target sentence."},\n    {"5": "The sentence contains \'NF-kappa B\' which is a protein mentioned in the target sentence."},\n    {"5": "The sentence contains \'NF-kappa B\' and \'I kappa B alpha\' which are both proteins mentioned in the target sentence."},\n    {"5": "The sentence contains \'NF-kappaB\', \'Tax\', and \'ATL\' which are all relevant to the target sentence."},\n    {"5": "The sentence contains \'NF-kappa B\' which is a DNA mentioned in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."}\n]', 'response3': '[\n    {"I kappa B alpha": "protein"},\n    {"mouse 70Z/3 cells": "cell_line"},\n    {"NF-kappa B": "protein"},\n    {"phorbol myristate acetate": "protein"},\n    {"lipopolysaccharide": "protein"}\n]', 'prediction': {'I kappa B alpha': 'protein', 'mouse 70Z/3 cells': 'cell_line', 'NF-kappa B': 'protein', 'phorbol myristate acetate': 'protein', 'lipopolysaccharide': 'protein'}}
{'idx': 1, 'sentence': 'When the homeodomain from HB24 was compared to known mammalian and Drosophila homeodomains it was found to be only moderately conserved, but when it was compared to a highly diverged Drosophila homeodomain , H2.0, it was found to be 80% identical.', 'label': {'homeodomain': 'DNA', 'HB24': 'DNA', 'Drosophila homeodomain': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n    {"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 5},\n    {"Like Drosophila Toll, human Toll is a type I transmembrane protein with an extracellular domain consisting of a leucine-rich repeat (LRR) domain, and a cytoplasmic domain homologous to the cytoplasmic domain of the human interleukin (IL)-1 receptor.": 5},\n    {"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Our results demonstrate that the altered CCAAT box (CCAAC) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 5},\n    {"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 5},\n    {"These two related genes share the evolutionarily conserved region encoding the Runt domain.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 5},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes.": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 5},\n    {"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.": 5},\n    {"Thus, we were able to derive a hematopoietic cell line, called 47.10, that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1226, 'sentence': 'Lastly, the different mobilities of osteoblast nuclear extract-DNA complexes compared with T-cell nuclear extract-DNA complexes , along with the inability of OSF2 to be upregulated by retinoic acid , unlike the other PEBP2 alpha factors , suggest that OSF2 is a new member of this family of transcription factors .', 'label': {'transcription factors': 'protein', 'T-cell nuclear extract-DNA complexes': 'protein', 'OSF2': 'protein', 'osteoblast nuclear extract-DNA complexes': 'protein', 'PEBP2 alpha factors': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 1},\n    {"Sentence": 1},\n    {"Sentence": 1},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 1},\n    {"Sentence": 1},\n    {"Sentence": 1},\n    {"Sentence": 1},\n    {"Sentence": 1},\n    {"Sentence": 1}\n]', 'response3': '[{"OSF2": "protein"}, {"PEBP2 alpha factors": "protein"}]', 'prediction': {'OSF2': 'protein', 'PEBP2 alpha factors': 'protein'}}
{'idx': 663, 'sentence': 'The cells lines described here should be useful for the delineation of signaling pathways utilized in the selective regulation of gene expression .', 'label': {}, 'response1': "['cell_line', 'gene']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of different entity types mentioned in the target sentence, such as \'protein\', \'cell_type\', and \'cell_line\', making it highly relevant for predicting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides clear examples of \'protein\', \'cell_type\', and \'cell_line\' entities, directly corresponding to the entity types mentioned in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence directly mentions the \'protein\' entity type, which is relevant to the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides an example of a \'cell_line\' entity, which is one of the entity types mentioned in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains an example of the \'cell_type\' entity type, which is relevant to the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence directly mentions the \'protein\' entity type, which is relevant to the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of \'protein\', \'DNA\', and \'cell_type\' entities, all of which are relevant to the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions \'protein\' entities, which are relevant to the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of \'protein\' and \'cell_line\' entities, both of which are relevant to the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions \'protein\' entities, which are relevant to the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains an example of the \'cell_type\' entity type, which is relevant to the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of \'protein\' entities, which are relevant to the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of \'protein\' entities, which are relevant to the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of the entity types mentioned in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of the entity types mentioned in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of the entity types mentioned in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of the entity types mentioned in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1000, 'sentence': 'Analysis of the biochemical and cell biological properties of these HSFs reveals that HSF3 has properties in common with both HSF1 and HSF2 and yet has features which are distinct from both.', 'label': {'HSF2': 'protein', 'HSF3': 'protein', 'HSFs': 'protein', 'HSF1': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear and direct mention of the entity \'protein\' with the specific term \'GM-CSF\', making it highly helpful for extracting named entities."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains explicit mentions of entities like \'DNA\' with terms \'UAS3\' and \'UAS2\', and \'protein\' with the term \'YY1\', making it very helpful for entity extraction."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence directly mentions the entity \'protein\' with the term \'Protein\', aiding in the extraction of named entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence explicitly mentions entities like \'protein\' with terms \'IL-2\', \'c-Jun\', and \'c-Fos\', making it highly helpful for named entity extraction."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides clear mentions of entities like \'protein\' with \'NF-ATc\', \'cell_type\' with \'T lymphocytes\' and \'embryonic cardiac cells\', making it very helpful for entity extraction."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence directly mentions the entity \'protein\' with the term \'EKLF\', aiding in the extraction of named entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains a specific mention of the entity \'protein\' with the term \'A-myb\', making it highly helpful for named entity extraction."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides explicit mentions of entities like \'protein\' with \'Tax\' and \'TFIIA\', aiding in the extraction of named entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence directly mentions the entity \'DNA\' with the term \'cDNAs\', making it highly helpful for named entity extraction."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains a clear mention of the entity \'protein\' with the term \'GATA-1\', aiding in the extraction of named entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides explicit mentions of entities like \'protein\' with \'EKLF\', \'CBP\', \'p300\', and \'P/CAF\', making it highly helpful for named entity extraction."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains a specific mention of the entity \'cell_line\' with the term \'SCM-1\', making it highly helpful for named entity extraction."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides clear mentions of entities like \'protein\' with \'NF-E2\', aiding in the extraction of named entities."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence directly mentions the entity \'protein\' with the term \'p21(WAF1/CIP1)\' and \'p27(KIP1)\', aiding in the extraction of named entities."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains explicit mentions of entities like \'protein\' with \'NF-ATc\' and \'cell_type\' with \'T lymphocytes\', making it very helpful for entity extraction."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence directly mentions the entity \'protein\' with the term \'E2A\', aiding in the extraction of named entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific terms related to the entity labels in the target sentence, making it not helpful for named entity extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific terms related to the entity labels in the target sentence, making it not helpful for named entity extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific terms related to the entity labels in the target sentence, making it not helpful for named entity extraction."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any specific terms related to the entity labels in the target sentence, making it not helpful for named entity extraction."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 39, 'sentence': 'Most hybrids express both KBF1 and NF-kappa B in their nuclei , but one hybrid expresses only KBF1 .', 'label': {'KBF1': 'protein', 'NF-kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence 1": 5},\n    {"Sentence 2": 5},\n    {"Sentence 3": 5},\n    {"Sentence 4": 5},\n    {"Sentence 5": 5},\n    {"Sentence 6": 5},\n    {"Sentence 7": 4},\n    {"Sentence 8": 4},\n    {"Sentence 9": 1},\n    {"Sentence 10": 1},\n    {"Sentence 11": 1},\n    {"Sentence 12": 1},\n    {"Sentence 13": 5},\n    {"Sentence 14": 5},\n    {"Sentence 15": 1},\n    {"Sentence 16": 1},\n    {"Sentence 17": 1},\n    {"Sentence 18": 1},\n    {"Sentence 19": 1}\n]', 'response3': '[{"KBF1": "protein"}, {"NF-kappa B": "protein"}]', 'prediction': {'KBF1': 'protein', 'NF-kappa B': 'protein'}}
{'idx': 229, 'sentence': "We now show that: 1) CVZ has more than one binding site in a second, independent, B-cell line , IM-9 ; 2) the antiglucocorticoid RU 38486 is able to block both CVZ 's higher and lower affinity sites; 3) all of CVZ 's binding sites are on a protein immunologically indistinguishable from the human GR ; and 4) freshly isolated clones of CVZ -resistant cells have lost all binding sites for CVZ .", 'label': {'B-cell line': 'cell_line', 'IM-9': 'cell_line', 'GR': 'protein', "CVZ 's binding sites": 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"CVZ": "protein"}, {"IM-9": "cell_line"}, {"RU 38486": "protein"}, {"human GR": "protein"}]', 'prediction': {'CVZ': 'protein', 'IM-9': 'cell_line', 'RU 38486': 'protein', 'human GR': 'protein'}}
{'idx': 743, 'sentence': 'Detection in non-erythroid cells of a factor with the binding characteristics of the erythroid cell transcription factor EF1 .', 'label': {'erythroid cell transcription factor': 'protein', 'non-erythroid cells': 'cell_type', 'EF1': 'protein'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Sentence": "SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor ).", "helpfulness score": 5, "reasons": "The sentence provides examples of proteins (SCL, GATA-1) expressed in specific cell types (erythroid, megakaryocyte, mast cell populations). This directly relates to the entity types mentioned in the target sentence."},\n    {"Sentence": "Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.", "helpfulness score": 4, "reasons": "The sentence mentions a protein (WT1) in the context of myeloid cell lines, which is relevant to the entity types in the target sentence."},\n    {"Sentence": "Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.", "helpfulness score": 3, "reasons": "The sentence provides an example of a protein (NF-E2) involved in a cell-specific transcription factor, which is somewhat related to the entity types in the target sentence."},\n    {"Sentence": "It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.", "helpfulness score": 4, "reasons": "The sentence mentions a protein (RXR) in the context of erythroid cells, which is relevant to the entity types in the target sentence."},\n    {"Sentence": "The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts.", "helpfulness score": 5, "reasons": "The sentence directly mentions a protein (GATA-1) involved in erythroid development, which aligns with the entity types in the target sentence."},\n    {"Sentence": "One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.", "helpfulness score": 4, "reasons": "The sentence provides an example of a protein (Egr-1) in the context of macrophage differentiation, which is relevant to the entity types in the target sentence."},\n    {"Sentence": "The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.", "helpfulness score": 3, "reasons": "The sentence mentions a DNA-binding protein (AP-1) in the context of lymphocytes, which is somewhat related to the entity types in the target sentence."},\n    {"Sentence": "Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.", "helpfulness score": 4, "reasons": "The sentence provides an example of a protein (TCF-1) in the context of non-T cells, which is relevant to the entity types in the target sentence."},\n    {"Sentence": "Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.", "helpfulness score": 5, "reasons": "The sentence directly mentions proteins (IL-2, c-Jun, c-Fos) and DNA in the context of nuclear factors and immunoreactive components, which align with the entity types in the target sentence."},\n    {"Sentence": "In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.", "helpfulness score": 4, "reasons": "The sentence provides an example of a protein (GATA-1) involved in eosinophil differentiation, which is relevant to the entity types in the target sentence."},\n    {"Sentence": "We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF.", "helpfulness score": 5, "reasons": "The sentence directly mentions proteins (EKLF, CBP, p300, P/CAF) in the context of transcription factors and interactions, which align with the entity types in the target sentence."},\n    {"Sentence": "Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.", "helpfulness score": 4, "reasons": "The sentence provides examples of proteins (SP1, caspases) in the context of B-cell apoptosis, which is relevant to the entity types in the target sentence."},\n    {"Sentence": "Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.", "helpfulness score": 5, "reasons": "The sentence directly mentions a protein (GATA-1) involved in erythroid cells, which aligns with the entity types in the target sentence."},\n    {"Sentence": "The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.", "helpfulness score": 4, "reasons": "The sentence provides an example of a protein (NF-ATc) in the context of T lymphocytes and embryonic cardiac cells, which is relevant to the entity types in the target sentence."},\n    {"Sentence": "The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays.", "helpfulness score": 5, "reasons": "The sentence directly mentions proteins (p50, p65) and DNA in the context of nuclear factors and gel supershift assays, which align with the entity types in the target sentence."},\n    {"Sentence": "However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.", "helpfulness score": 5, "reasons": "The sentence provides examples of proteins (beta-globin, glycoprotein IIb, platelet factor 4) in the context of Ter 119 erythroid cells and megakaryocytic transcripts, which directly relate to the entity types in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1799, 'sentence': 'These STAT proteins were detected by using the IFN-gamma-activated sequence ( GAS ) and related oligonucleotides as probes in electrophoretic mobility shift assay .', 'label': {'GAS': 'DNA', 'IFN-gamma-activated sequence': 'DNA', 'STAT proteins': 'protein'}, 'response1': "['protein', 'DNA']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines.": 5},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Moreover, monocytes express a novel IL-10 -stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti- STAT3 Ab but is not observed in T cells.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"Activated Stat proteins form homo- or heterodimers, translocate to the nucleus, and induce transcription from responsive genes.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"STAT proteins": "protein"}, {"IFN-gamma-activated sequence (GAS)": "DNA"}]', 'prediction': {'STAT proteins': 'protein', 'IFN-gamma-activated sequence (GAS)': 'DNA'}}
{'idx': 1703, 'sentence': "E1A blocked IFN 's induction of cytolytic resistance , resulting in the selective lysis of adenovirus-transformed cells by IFN -activated NK cells .", 'label': {'E1A': 'protein', 'IFN': 'protein', 'adenovirus-transformed cells': 'cell_line', 'IFN -activated NK cells': 'cell_line'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 4},\n    {"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells, but not in primary T cells, consistent with the lack of the IL-12 receptor in resting T cells.": 5},\n    {"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 4},\n    {"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 4},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 3},\n    {"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine (IL-2 and IFN-gamma) production is normal.": 5},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 4},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 4},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 4},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"E1A": "protein"}, {"IFN": "protein"}, {"adenovirus-transformed cells": "cell_line"}, {"NK cells": "cell_type"}]', 'prediction': {'E1A': 'protein', 'IFN': 'protein', 'adenovirus-transformed cells': 'cell_line', 'NK cells': 'cell_type'}}
{'idx': 629, 'sentence': 'Depletion of CD8+ cells was accompanied by 62 +/- 18% loss of progesterone receptor -bearing cells , while depletion of CD4+ cells resulted in a twofold increase in the number of positively staining lymphocytes .', 'label': {'progesterone receptor': 'protein', 'CD8+ cells': 'cell_line', 'lymphocytes': 'cell_line', 'progesterone receptor -bearing cells': 'cell_line', 'CD4+ cells': 'cell_line'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains multiple named entities with clear entity labels, making it highly helpful for extracting named entities from the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence contains named entities with clear entity labels, which are relevant to the target sentence, making it quite helpful for extracting named entities from the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains multiple named entities with clear entity labels, which are directly related to the target sentence, making it highly helpful for extracting named entities from the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains multiple named entities with clear entity labels, which are directly related to the target sentence, making it highly helpful for extracting named entities from the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains multiple named entities with clear entity labels, which are directly related to the target sentence, making it highly helpful for extracting named entities from the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains multiple named entities with clear entity labels, which are directly related to the target sentence, making it highly helpful for extracting named entities from the target sentence."},\n    {"Example 7": 3},\n    {"Reason 7": "The sentence contains a named entity with a clear entity label, but it is not directly related to the target sentence, making it somewhat helpful for extracting named entities from the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains multiple named entities with clear entity labels, which are directly related to the target sentence, making it highly helpful for extracting named entities from the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains multiple named entities with clear entity labels, which are directly related to the target sentence, making it highly helpful for extracting named entities from the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains multiple named entities with clear entity labels, which are directly related to the target sentence, making it highly helpful for extracting named entities from the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains multiple named entities with clear entity labels, which are directly related to the target sentence, making it highly helpful for extracting named entities from the target sentence."},\n    {"Example 12": 3},\n    {"Reason 12": "The sentence contains named entities with clear entity labels, but they are not directly related to the target sentence, making it somewhat helpful for extracting named entities from the target sentence."},\n    {"Example 13": 4},\n    {"Reason 13": "The sentence contains named entities with clear entity labels, which are relevant to the target sentence, making it quite helpful for extracting named entities from the target sentence."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not contain any named entities with clear entity labels, making it not helpful for extracting named entities from the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any named entities with clear entity labels, making it not helpful for extracting named entities from the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any named entities with clear entity labels, making it not helpful for extracting named entities from the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any named entities with clear entity labels, making it not helpful for extracting named entities from the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any named entities with clear entity labels, making it not helpful for extracting named entities from the target sentence."}\n]', 'response3': '[{"CD8+": "cell_type"}, {"progesterone receptor": "protein"}, {"CD4+": "cell_type"}, {"lymphocytes": "cell_type"}]', 'prediction': {'CD8+': 'cell_type', 'progesterone receptor': 'protein', 'CD4+': 'cell_type', 'lymphocytes': 'cell_type'}}
{'idx': 490, 'sentence': 'Cyclosporin A ( CsA ) is thought to exert its immunosuppressive effects by inhibiting the expression of a distinct set of lymphokine genes which are induced upon T-cell activation , among them the gene coding for interleukin-2 .', 'label': {'lymphokine genes': 'DNA', 'interleukin-2': 'protein'}, 'response1': "['protein', 'RNA']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of proteins and RNA, which are relevant entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of proteins and cytokines that are relevant to the entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence includes examples of proteins and their interactions, which are important for understanding the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions specific proteins and their functions, which are directly related to the entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of proteins and cytokines that are relevant to the entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of RNA, cell types, and proteins that are relevant to the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions specific proteins and their functions, which are directly related to the entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of proteins and cytokines that are relevant to the entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence includes examples of RNA, cell types, and proteins that are relevant to the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions specific proteins and their functions, which are directly related to the entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of proteins and cytokines that are relevant to the entity types in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant entity types mentioned in the target sentence."}\n]', 'response3': '[{"lymphokine genes": "protein"}, {"T-cell": "cell_type"}, {"interleukin-2": "protein"}]', 'prediction': {'lymphokine genes': 'protein', 'T-cell': 'cell_type', 'interleukin-2': 'protein'}}
{'idx': 118, 'sentence': "Similar to 1;14 translocations , this deletion disrupts the SCL 5' regulatory region .", 'label': {'SCL': 'protein', "SCL 5' regulatory region": 'DNA'}, 'response1': "['DNA']", 'response2': '[\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 3},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 4},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"We have found that the recruitment of EKLF to 5\'HS3 depends on the presence of 5\'HS2 in cis, but the recruitment to 5\'HS2 does not depend on 5\'HS3.": 4},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.": 5},\n    {"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.": 5},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n    {"SCL is expressed in erythroid, megakaryocyte and mast cell populations (the same cell lineages as GATA-1, a zinc-finger transcription factor).": 4},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.": 4},\n    {"By the time of diagnosis of T-PLL, the clone contains many more genetic changes in the form of additional translocations.": 4},\n    {"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 4},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"SCL": "protein"}]', 'prediction': {'SCL': 'protein'}}
{'idx': 493, 'sentence': 'Here we report that the formation of two distinct mitogen-inducible DNA-binding complexes , the kappa B complex within the HIV enhancer and the NFAT-1 complex within the interleukin-2 enhancer , is inhibited in the presence of CsA .', 'label': {'NFAT-1 complex': 'protein', 'mitogen-inducible DNA-binding complexes': 'protein', 'kappa B complex': 'protein', 'interleukin-2': 'protein', 'interleukin-2 enhancer': 'DNA', 'HIV enhancer': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 5},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 5},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.": 5},\n    {"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.": 5},\n    {"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.": 5},\n    {"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin.": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"kappa B complex": "protein"}, {"NFAT-1 complex": "protein"}]', 'prediction': {'kappa B complex': 'protein', 'NFAT-1 complex': 'protein'}}
{'idx': 1798, 'sentence': 'In purified human peripheral blood T cells , nuclear STAT proteins were activated approximately 3 h after activation by cross-linked anti-CD3 Abs .', 'label': {'purified human peripheral blood T cells': 'cell_type', 'anti-CD3 Abs': 'protein', 'nuclear STAT proteins': 'protein', 'T cells': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1}\n]', 'response3': '[{"STAT proteins": "protein"}, {"T cells": "cell_type"}, {"CD3": "protein"}]', 'prediction': {'STAT proteins': 'protein', 'T cells': 'cell_type', 'CD3': 'protein'}}
{'idx': 175, 'sentence': 'To compare extra-renal 1,25(OH)2D3 production in different types of granulomatous disease , and to identify the cell types responsible, we have evaluated the conversion of 25(OH)D3 in 1,25(OH)2D3 by uncultured cells recovered by bronchoalveolar lavage and blood mononuclear cells from normocalcemic patients with sarcoidosis and tuberculosis.', 'label': {'blood mononuclear cells': 'cell_type', 'uncultured cells': 'cell_type'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific examples of cell types and proteins that are directly relevant to the entity labels in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence provides examples of proteins and cell lines, which are relevant to the entity labels in the target sentence."},\n    {"Example 3": 3},\n    {"Reason 3": "The sentence mentions a protein and a cell line, which are somewhat relevant to the entity labels in the target sentence."},\n    {"Example 4": 1},\n    {"Reason 4": "The sentence does not contain any relevant examples of entity types mentioned in the target sentence."},\n    {"Example 5": 1},\n    {"Reason 5": "The sentence does not contain any relevant examples of entity types mentioned in the target sentence."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence provides examples of proteins, cell types, and a DNA entity, which are relevant to the entity labels in the target sentence."},\n    {"Example 7": 1},\n    {"Reason 7": "The sentence does not contain any relevant examples of entity types mentioned in the target sentence."},\n    {"Example 8": 1},\n    {"Reason 8": "The sentence does not contain any relevant examples of entity types mentioned in the target sentence."},\n    {"Example 9": 1},\n    {"Reason 9": "The sentence does not contain any relevant examples of entity types mentioned in the target sentence."},\n    {"Example 10": 3},\n    {"Reason 10": "The sentence mentions a protein and a cell line, which are somewhat relevant to the entity labels in the target sentence."},\n    {"Example 11": 3},\n    {"Reason 11": "The sentence mentions a protein and a cell line, which are somewhat relevant to the entity labels in the target sentence."},\n    {"Example 12": 2},\n    {"Reason 12": "The sentence mentions a protein, which is somewhat relevant to the entity labels in the target sentence."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not contain any relevant examples of entity types mentioned in the target sentence."},\n    {"Example 14": 4},\n    {"Reason 14": "The sentence provides examples of cell types, cell lines, and a DNA entity, which are relevant to the entity labels in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any relevant examples of entity types mentioned in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any relevant examples of entity types mentioned in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any relevant examples of entity types mentioned in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any relevant examples of entity types mentioned in the target sentence."}\n]', 'response3': '[{"bronchoalveolar lavage": "cell_line"}, {"blood mononuclear cells": "cell_type"}, {"sarcoidosis": "cell_type"}, {"tuberculosis": "cell_type"}]', 'prediction': {'bronchoalveolar lavage': 'cell_line', 'blood mononuclear cells': 'cell_type', 'sarcoidosis': 'cell_type', 'tuberculosis': 'cell_type'}}
{'idx': 1498, 'sentence': 'Steroid mediated lysis of lymphoblasts requires the DNA binding region of the steroid hormone receptor.', 'label': {'lymphoblasts': 'cell_type'}, 'response1': "['DNA', 'cell_type']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of proteins and cell types that are relevant to the entity labels in the target sentence, such as IL-2, Aiolos, Ras, p21ras, B cell, etc."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides an example of a protein (NF-E2) that is relevant to the entity labels in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides an example of a DNA-binding protein (AP-1) that is relevant to the entity labels in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of proteins and cell types that are relevant to the entity labels in the target sentence, such as CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, granulocyte-macrophage colony-stimulating factor, etc."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins (IL-2, Aiolos, Ras) that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides an example of a protein (IL-2 receptor alpha subunit) and a cell type (B cell) that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 3},\n    {"Reason": "The sentence provides an example of a cell type (lymphoid neoplasms) that is relevant to the entity labels in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides an example of a protein (RXR) that is relevant to the entity labels in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins (CD40, NF-kappa B) that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides an example of a protein (G-CSF) that is relevant to the entity labels in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins (interleukin 10, IL-10R, STAT3, IL-6) that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of proteins (IL-2, c-Jun, c-Fos) that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides an example of a protein (GATA-1) that is relevant to the entity labels in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of RNA (IL-5 mRNA) and proteins (TCR, IL-2R, dexamethasone) that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins (CD70, IL-4, CD40) and cell types (B cell, plasma cells) that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides an example of a DNA-binding protein (NF-kappa B) that is relevant to the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entities that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entities that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entities that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entities that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entities that are relevant to the entity labels in the target sentence."}\n]', 'response3': '[{"lymphoblasts": "cell_type"}, {"DNA binding region": "DNA"}, {"steroid hormone receptor": "protein"}]', 'prediction': {'lymphoblasts': 'cell_type', 'DNA binding region': 'DNA', 'steroid hormone receptor': 'protein'}}
{'idx': 995, 'sentence': 'The hierarchy of transcriptional control in B-cell development has recently been analyzed by targeted gene inactivation in the mouse .', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"SP1": 5},\n    {"caspases": 4},\n    {"B-cell": 4},\n    {"Sp1": 4},\n    {"Ets": 4},\n    {"GATA-1": 4},\n    {"immunoglobulin kappa 3\' enhancer": 3},\n    {"SCM-1": 5},\n    {"IL-4": 4},\n    {"CD70": 4},\n    {"plasma cells": 4},\n    {"CD40": 4},\n    {"T cell": 4},\n    {"interleukin 2": 4},\n    {"PML/RARalpha": 4},\n    {"GATA-1": 4},\n    {"UAS1": 4},\n    {"NF-ATc": 4},\n    {"T lymphocytes": 4},\n    {"embryonic cardiac cells": 4},\n    {"A-myb": 4},\n    {"Egr-1": 4},\n    {"E2A": 4},\n    {"IkappaBbeta": 4},\n    {"NF-kappaB": 4}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1671, 'sentence': 'Both phosphorylation and proliferation were inhibited by IL-6 neutralizing antibodies .', 'label': {'IL-6 neutralizing antibodies': 'protein', 'IL-6': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of proteins (p21(WAF1/CIP1), p27(KIP1)) which are relevant entities in the given label set."}\n]\n[\n    {"Sentence": 4},\n    {"Reason": "The sentence contains a cell type (T cell) and a protein (interleukin 2) which are relevant entities in the given label set."}\n]\n[\n    {"Sentence": 3},\n    {"Reason": "The sentence contains a protein (P selectin) which is a relevant entity in the given label set."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of proteins (IL-4, LPS, AP-1) which are relevant entities in the given label set."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains RNA (IL-5 mRNA), a cell type (TCR), and proteins (IL-2R, dexamethasone) which are relevant entities in the given label set."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains a cell type (T cell) and proteins (IL-2, IL-2 receptor, CD28) which are relevant entities in the given label set."}\n]\n[\n    {"Sentence": 4},\n    {"Reason": "The sentence contains a protein (NF-kappa B) which is a relevant entity in the given label set."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of proteins (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) which are relevant entities in the given label set."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of proteins (IL-2, Aiolos, Ras) which are relevant entities in the given label set."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of proteins (IL4, IL13, gamma c chain, STAT6, STAT3, STAT5) and a cell type (B cells) which are relevant entities in the given label set."}\n]\n[\n    {"Sentence": 4},\n    {"Reason": "The sentence contains a protein (NF-E2) which is a relevant entity in the given label set."}\n]\n[\n    {"Sentence": 3},\n    {"Reason": "The sentence contains DNA which is a relevant entity in the given label set."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of proteins (IL-2, NF-kappa B, AP-1) which are relevant entities in the given label set."}\n]\n[\n    {"Sentence": 4},\n    {"Reason": "The sentence contains proteins (NF-kappa B, AP-1) which are relevant entities in the given label set."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of proteins (interleukin-2, alpha chain, CD25, IL-2 receptor) which are relevant entities in the given label set."}\n]\n[\n    {"Sentence": 4},\n    {"Reason": "The sentence contains a protein (CTLA4Ig) and cell types (NFAT, AP-1) which are relevant entities in the given label set."}\n]\n[\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any entities from the given label set."}\n]\n[\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any entities from the given label set."}\n]\n[\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any entities from the given label set."}\n]\n[\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any entities from the given label set."}\n]', 'response3': '[{"IL-6": "protein"}]', 'prediction': {'IL-6': 'protein'}}
{'idx': 141, 'sentence': 'TNF-alpha was able to increase expression of the HIV LTR in T cells , but in monocytic cells , TNF-alpha did not induce the HIV LTR above a constitutive level of activity .', 'label': {'monocytic cells': 'cell_type', 'TNF-alpha': 'protein', 'HIV LTR': 'DNA', 'T cells': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example contains a specific protein entity (NF-kappa B) that is mentioned in the target sentence, providing a direct match for entity extraction."}\n]', 'response3': "[{'TNF-alpha': 'protein'}, {'HIV LTR': 'DNA'}, {'T cells': 'cell_type'}, {'monocytic cells': 'cell_type'}]", 'prediction': {'TNF-alpha': 'protein', 'HIV LTR': 'DNA', 'T cells': 'cell_type', 'monocytic cells': 'cell_type'}}
{'idx': 1557, 'sentence': "In this report, we show that following incubation of L540 cells ( Hodgkin's disease -derived, T cell-like, CD30 + cells ) with the agonistic anti- CD30 monoclonal antibodies ( mAb ) M44 and M67 , two nuclear factor (NF)-kappa B DNA binding activities were induced in nuclear extracts , as determined in gel retardation assays .", 'label': {"Hodgkin's disease -derived, T cell-like, CD30 + cells": 'cell_line', 'nuclear factor (NF)-kappa B': 'protein', 'M44': 'protein', 'L540 cells': 'cell_line', 'M67': 'protein', 'mAb': 'protein', 'agonistic anti- CD30 monoclonal antibodies': 'protein', 'CD30': 'protein'}, 'response1': "['cell_line', 'protein', 'DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of NF-kappa B DNA binding activity, which directly matches the entity label \'DNA\' in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions RelA and Rel homology family, which are related to the NF-kappa B complex, matching the entity label \'protein\' in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence provides multiple examples of proteins such as CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, and granulocyte-macrophage colony-stimulating factor, all of which match the entity label \'protein\' in the target sentence."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence mentions NF-kappa B binding activity, which matches the entity label \'protein\' in the target sentence."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence mentions CD40, IFN-gamma, tumor necrosis factor-alpha, and interleukin (IL)-1beta, all of which are related to proteins and match the entity label \'protein\' in the target sentence."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence mentions IL-2 receptor alpha subunit, p21ras, and B cell activation, all of which match the entity labels \'protein\' and \'cell_type\' in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides examples of IL-2, NF-kappa B, and AP-1, all of which match the entity labels \'protein\' and \'DNA\' in the target sentence."},\n    {"Example 8": 4},\n    {"Reason 8": "The sentence mentions NF-kappa B activation, which matches the entity label \'protein\' in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides examples of CD70, B cell, plasma cells, IL-4, and CD40 signaling, all of which match the entity labels \'protein\' and \'cell_type\' in the target sentence."},\n    {"Example 10": 4},\n    {"Reason 10": "The sentence mentions NF-kappaB, Tax, and ATL, all of which match the entity labels \'protein\' and \'cell_type\' in the target sentence."},\n    {"Example 11": 4},\n    {"Reason 11": "The sentence mentions IkappaBbeta and NF-kappaB, both of which match the entity labels \'protein\' in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides examples of IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, and phorbol myristate acetate, all of which match the entity label \'protein\' in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides examples of CD40 and NF-kappa B, both of which match the entity labels \'protein\' in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides examples of p50, p65, NF kappaB, and DNA, all of which match the entity labels \'protein\' and \'DNA\' in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides examples of CD40, Rel/nuclear factor kappaB, NF-kappaB, and B lymphocytes, all of which match the entity labels \'protein\' and \'cell_type\' in the target sentence."},\n    {"Example 16": 4},\n    {"Reason 16": "The sentence mentions HIV-1, IFN, PKR, and IkappaBalpha, all of which are related to proteins and match the entity label \'protein\' in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entity types present in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entity types present in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entity types present in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entity types present in the target sentence."}\n]', 'response3': '[{"NF-kappa B": "DNA"}, {"NF": "protein"}]', 'prediction': {'NF-kappa B': 'DNA', 'NF': 'protein'}}
{'idx': 1090, 'sentence': 'Further analysis reveals that the inducible phosphorylation of I kappa B alpha maps to two serines in the N terminus of the protein (residues 32 and 36) and that the mutation of either residue is sufficient to abolish ligand-induced degradation, whereas both residues must be mutated to abolish inducible phosphorylation of the protein.', 'label': {'N terminus': 'protein', 'I kappa B alpha': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple protein names and their corresponding labels, making it very helpful for extracting named entities from the target sentence."}\n]', 'response3': '[{"I kappa B alpha": "protein"}]', 'prediction': {'I kappa B alpha': 'protein'}}
{'idx': 1568, 'sentence': 'The inverse relation between high density lipoprotein ( HDL ) and atherosclerotic events may in part be due to enzymes associated with HDL that destroy the biologically active lipids generated in LDL .', 'label': {'enzymes': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example contains a specific protein name that directly matches an entity type in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 257, 'sentence': 'Because of the presence of a functional receptor-effector system for VD3 and multiple biological responses to the hormone, these cells provide a unique model system with which to probe the specific effects of VD3 on cell growth and differentiation in chronic myelogenous leukemia .', 'label': {}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells": 5},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures": 5},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors": 4},\n    {"An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage": 4},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained": 5},\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia": 5},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction": 5},\n    {"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function": 5},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells": 5},\n    {"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R )": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 262, 'sentence': 'This complementary DNA encoded a protein with structural similarities to the c-jun proto-oncogene product , and its target sequence was closely related to the palindromic target sequence of c-jun .', 'label': {'complementary DNA': 'DNA', 'c-jun proto-oncogene product': 'protein', 'palindromic target sequence': 'DNA', 'c-jun': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 5},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"These two related genes share the evolutionarily conserved region encoding the Runt domain.": 4},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n    {"This protein has now been purified and its encoding gene cloned.": 5},\n    {"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 4},\n    {"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"complementary DNA": "DNA"}, {"protein": "protein"}, {"c-jun": "protein"}]', 'prediction': {'complementary DNA': 'DNA', 'protein': 'protein', 'c-jun': 'protein'}}
{'idx': 1351, 'sentence': 'Western blotting yielded a set of bands ranging from 25 kD to 55 kD, resulting from extensive alternative splicing .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"25 kD": "protein"}, {"55 kD": "protein"}]', 'prediction': {'25 kD': 'protein', '55 kD': 'protein'}}
{'idx': 973, 'sentence': 'To assess the transcription regulatory function of MZF-1 , the full-length MZF-1 coding region was fused to the DNA binding domain of the yeast transactivator GAL4 .', 'label': {'MZF-1': 'DNA', 'DNA binding domain': 'protein', 'yeast transactivator GAL4': 'protein', 'GAL4': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a cell line (SCM-1) and its corresponding entity label, which directly aids in identifying cell line entities in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions \'p50p50\' as a protein, which is helpful in identifying protein entities in the target sentence."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence refers to \'PML/RARalpha\' as a protein, assisting in recognizing protein entities in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence lists multiple proteins (EKLF, CBP, p300, P/CAF), aiding in identifying protein entities in the target sentence."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence mentions \'GATA-1\' as a protein, which helps in identifying protein entities in the target sentence."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence provides \'TCF-1\' as a protein, assisting in recognizing protein entities in the target sentence."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence mentions \'ZEBRA\' as a protein, aiding in identifying protein entities in the target sentence."},\n    {"Example 8": 4},\n    {"Reason 8": "The sentence refers to \'A-myb\' as a protein, which helps in identifying protein entities in the target sentence."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence mentions \'Protein\' as a protein, assisting in recognizing protein entities in the target sentence."},\n    {"Example 10": 4},\n    {"Reason 10": "The sentence provides \'CD95 ligand\' as a protein, aiding in identifying protein entities in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence lists both \'Tax\' and \'TFIIA\' as proteins, which directly aids in identifying protein entities in the target sentence."},\n    {"Example 12": 4},\n    {"Reason 12": "The sentence mentions \'Egr-1\' as a protein, assisting in recognizing protein entities in the target sentence."},\n    {"Example 13": 4},\n    {"Reason 13": "The sentence refers to \'IL-2\', \'c-Jun\', and \'c-Fos\' as proteins, which helps in identifying protein entities in the target sentence."},\n    {"Example 14": 4},\n    {"Reason 14": "The sentence provides \'GATA-1\' as a protein, aiding in identifying protein entities in the target sentence."},\n    {"Example 15": 4},\n    {"Reason 15": "The sentence mentions \'E2A\' as a protein, assisting in recognizing protein entities in the target sentence."},\n    {"Example 16": 4},\n    {"Reason 16": "The sentence lists \'Sp1\' and \'Ets\' as proteins, aiding in identifying protein entities in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific named entities that match the entity labels in the target sentence, hence not helpful."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific named entities that match the entity labels in the target sentence, hence not helpful."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific named entities that match the entity labels in the target sentence, hence not helpful."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any specific named entities that match the entity labels in the target sentence, hence not helpful."}\n]', 'response3': '[{"MZF-1": "protein"}, {"MZF-1": "protein"}, {"DNA": "DNA"}, {"GAL4": "protein"}]', 'prediction': {'MZF-1': 'protein', 'DNA': 'DNA', 'GAL4': 'protein'}}
{'idx': 1125, 'sentence': 'This indicates that the CR of GR may be of functional significance.', 'label': {'GR': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The example provides a clear entity label (DNA) for the named entity \'immunoglobulin kappa 3\' enhancer\' in the sentence."},\n{"Example 2": 4},\n{"Reason 2": "The example provides entity labels for \'MNDA\' (protein) and \'Philadelphia chromosome-positive chronic myeloid leukemia\' (cell_line) in the sentence."},\n{"Example 3": 4},\n{"Reason 3": "The example provides entity labels for \'IL-7R\' (protein) and \'gamma(c)\' (protein) in the sentence."},\n{"Example 4": 5},\n{"Reason 4": "The example provides clear entity labels for \'granulocytes\' (cell_type) and \'T cells\' (cell_type) in the sentence."},\n{"Example 5": 4},\n{"Reason 5": "The example provides an entity label for \'Protein\' (protein) in the sentence."},\n{"Example 6": 4},\n{"Reason 6": "The example provides an entity label for \'GM-CSF\' (protein) in the sentence."},\n{"Example 7": 4},\n{"Reason 7": "The example provides an entity label for \'G-CSF\' (protein) in the sentence."},\n{"Example 8": 5},\n{"Reason 8": "The example provides a clear entity label for \'SIVsmmPBj14\' (cell_line) in the sentence."},\n{"Example 9": 4},\n{"Reason 9": "The example provides entity labels for \'IL-2\' (protein), \'c-Jun\' (protein), and \'c-Fos\' (protein) in the sentence."},\n{"Example 10": 4},\n{"Reason 10": "The example provides entity labels for \'CREB\' (protein) and \'AR-CRE\' (protein) in the sentence."},\n{"Example 11": 4},\n{"Reason 11": "The example provides entity labels for \'CHEMR1\' (protein), \'C-C chemokine\' (protein), and \'MIP-1alpha\' (protein) in the sentence."},\n{"Example 12": 5},\n{"Reason 12": "The example provides a clear entity label for \'lymphoid neoplasms\' (cell_type) in the sentence."},\n{"Example 13": 5},\n{"Reason 13": "The example provides a clear entity label for \'SCM-1\' (cell_line) in the sentence."},\n{"Example 14": 4},\n{"Reason 14": "The example provides an entity label for \'SCL\' (RNA) in the sentence."},\n{"Example 15": 4},\n{"Reason 15": "The example provides an entity label for \'RXR\' (protein) in the sentence."},\n{"Example 16": 5},\n{"Reason 16": "The example provides entity labels for \'VDR\' (protein), \'RXR\' (protein), \'GRIP-1\' (protein), \'DRIP205\' (protein), and \'DRIP\' (protein) in the sentence."},\n{"Example 17": 1},\n{"Reason 17": "The example does not contain any named entities related to the entity types in the target sentence."},\n{"Example 18": 1},\n{"Reason 18": "The example does not contain any named entities related to the entity types in the target sentence."},\n{"Example 19": 1},\n{"Reason 19": "The example does not contain any named entities related to the entity types in the target sentence."},\n{"Example 20": 1},\n{"Reason 20": "The example does not contain any named entities related to the entity types in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 338, 'sentence': 'Nuclear T3R in lymphocytes was determined by radio-ligand binding analysis .', 'label': {'T3R': 'protein', 'lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 1},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 1},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1080, 'sentence': 'However, the concurrent addition of iron (in the form of ferrous or ferric chloride and other iron salts ) reversed the inhibition of proliferation caused by tepoxalin .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains a specific entity with a clear entity label that matches the entity type in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains a specific entity with a clear entity label that matches the entity type in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains a specific entity with a clear entity label that matches the entity type in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains a specific entity with a clear entity label that matches the entity type in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities with clear entity labels that match the entity types in the target sentence."}\n]', 'response3': '[{"iron": "protein"}, {"ferrous": "protein"}, {"ferric chloride": "protein"}, {"iron salts": "protein"}, {"tepoxalin": "protein"}]', 'prediction': {'iron': 'protein', 'ferrous': 'protein', 'ferric chloride': 'protein', 'iron salts': 'protein', 'tepoxalin': 'protein'}}
{'idx': 1786, 'sentence': 'Binding of plasma Factor VII/VIIa to the tissue factor (TF) receptor initiates the coagulation protease cascades .', 'label': {'coagulation protease': 'protein', 'tissue factor (TF) receptor': 'protein', 'plasma Factor VII/VIIa': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 1},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"Factor VII/VIIa": "protein"}, {"tissue factor (TF) receptor": "protein"}]', 'prediction': {'Factor VII/VIIa': 'protein', 'tissue factor (TF) receptor': 'protein'}}
{'idx': 1242, 'sentence': 'LPS signaling was found to involve NF kappa B activation by the p50/p65 heterodimers .', 'label': {'NF kappa B': 'protein', 'p50/p65 heterodimers': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": "Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .", "5": "The sentence contains specific protein names (NF-kappaB, Sp1, p50) that match the entity labels in the target sentence."},\n    {"Sentence": "Control of NF-kappa B activity by the I kappa B beta inhibitor .", "5": "The sentence contains specific protein names (NF-kappa B, I kappa B beta) that match the entity labels in the target sentence."},\n    {"Sentence": "The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.", "5": "The sentence contains specific protein names (RelA, NF-kappa B) that match the entity labels in the target sentence."},\n    {"Sentence": "Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .", "4": "The sentence contains NF-kappa B, which is a protein entity label in the target sentence."},\n    {"Sentence": "These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .", "5": "The sentence contains specific protein names (PAFR, PAF, NF-kappa B, protein kinase C) that match the entity labels in the target sentence."},\n    {"Sentence": "Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .", "5": "The sentence contains specific protein names (CD40, NF-kappa B) that match the entity labels in the target sentence."},\n    {"Sentence": "During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .", "5": "The sentence contains specific protein names (IkappaBalpha, NF-kappaB) that match the entity labels in the target sentence."},\n    {"Sentence": "Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .", "5": "The sentence contains specific protein names (IkappaBbeta, NF-kappaB) that match the entity labels in the target sentence."},\n    {"Sentence": "Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .", "5": "The sentence contains specific protein names (NF-kappaB, Tax) that match the entity labels in the target sentence."},\n    {"Sentence": "Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .", "5": "The sentence contains specific protein names (NF-kappa B, I kappa B alpha) that match the entity labels in the target sentence."},\n    {"Sentence": "Recently, activation of NF-kappa B has been linked to ARDS and has been shown to be a critical proximal step in the initiation of neutrophilic inflammation in animal models .", "5": "The sentence contains specific protein names (NF-kappa B, ARDS) that match the entity labels in the target sentence."},\n    {"Sentence": "These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .", "5": "The sentence contains specific protein names (NF-kappa B) that match the entity labels in the target sentence."},\n    {"Sentence": "Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.", "5": "The sentence contains specific protein names (NF-kappa B, I kappa B alpha) that match the entity labels in the target sentence."},\n    {"Sentence": "Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .", "5": "The sentence contains specific protein names (NF-kappa B) that match the entity labels in the target sentence."},\n    {"Sentence": "Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.", "5": "The sentence contains specific protein names (IL-4, LPS, AP-1) that match the entity labels in the target sentence."},\n    {"Sentence": "We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .", "5": "The sentence contains specific protein names (NF-kappa B) that match the entity labels in the target sentence."},\n    {"Sentence": "We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .", "1": "The sentence does not contain any entity labels matching the target sentence."},\n    {"Sentence": "However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.", "1": "The sentence does not contain any entity labels matching the target sentence."},\n    {"Sentence": "In 2 complex translocations, none of the three genes was rearranged.", "1": "The sentence does not contain any entity labels matching the target sentence."},\n    {"Sentence": "Deletions or mutations in this element also reduced the serum response by 80-90%.", "1": "The sentence does not contain any entity labels matching the target sentence."},\n    {"Sentence": "In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .", "1": "The sentence does not contain any entity labels matching the target sentence."}\n]', 'response3': '[{"NF kappa B": "protein"}, {"p50": "protein"}, {"p65": "protein"}]', 'prediction': {'NF kappa B': 'protein', 'p50': 'protein', 'p65': 'protein'}}
{'idx': 866, 'sentence': 'T cell activation results in high levels of HIV replication and is thought to be one mechanism leading to the conversion from latent to active viral infection .', 'label': {'T cell': 'cell_type'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein and cell type names that are directly mentioned."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains specific protein and cell type names that are directly mentioned."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains specific protein and DNA names that are directly mentioned."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains specific protein names that are directly mentioned."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains specific protein and cell type names that are directly mentioned."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains specific protein names that are directly mentioned."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains specific protein names that are directly mentioned."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains specific protein and cell type names that are directly mentioned."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains specific protein and cell type names that are directly mentioned."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains specific DNA and protein names that are directly mentioned."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains specific protein and cell type names that are directly mentioned."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains specific cell type and DNA names that are directly mentioned."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains specific cell type and protein names that are directly mentioned."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains specific protein names that are directly mentioned."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains specific protein names that are directly mentioned."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any specific entity names."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific entity names."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific entity names."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific entity names."}\n]', 'response3': "[{'T cell': 'cell_type'}, {'HIV': 'cell_type'}]", 'prediction': {'T cell': 'cell_type', 'HIV': 'cell_type'}}
{'idx': 433, 'sentence': 'Competition experiments did not reveal any high-affinity binding site for BSAP in known regulatory regions of immunoglobulin and class II major histocompatibility (MHC) genes , suggesting that BSAP is a regulator of a different set of B-lymphoid-specific genes .', 'label': {'regulatory regions': 'DNA', 'BSAP': 'protein', 'high-affinity binding site': 'DNA', 'B-lymphoid-specific genes': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 5},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"BSAP": "protein"}, {"immunoglobulin": "protein"}, {"class II major histocompatibility (MHC) genes": "DNA"}, {"B-lymphoid-specific genes": "cell_type"}]', 'prediction': {'BSAP': 'protein', 'immunoglobulin': 'protein', 'class II major histocompatibility (MHC) genes': 'DNA', 'B-lymphoid-specific genes': 'cell_type'}}
{'idx': 1546, 'sentence': 'Identification of essential GATA and Ets binding motifs within the promoter of the platelet glycoprotein Ib alpha gene .', 'label': {'platelet glycoprotein Ib alpha gene': 'DNA', 'GATA': 'DNA', 'Ets binding motifs': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides specific entities mentioned in the sentence with their corresponding labels, which directly aids in identifying named entities."},\n    {"Example 2": 5},\n    {"Reason 2": "The example provides specific entities mentioned in the sentence with their corresponding labels, which directly aids in identifying named entities."},\n    {"Example 3": 5},\n    {"Reason 3": "The example provides specific entities mentioned in the sentence with their corresponding labels, which directly aids in identifying named entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The example provides specific entities mentioned in the sentence with their corresponding labels, which directly aids in identifying named entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides specific entities mentioned in the sentence with their corresponding labels, which directly aids in identifying named entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The example provides specific entities mentioned in the sentence with their corresponding labels, which directly aids in identifying named entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The example provides specific entities mentioned in the sentence with their corresponding labels, which directly aids in identifying named entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides specific entities mentioned in the sentence with their corresponding labels, which directly aids in identifying named entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides specific entities mentioned in the sentence with their corresponding labels, which directly aids in identifying named entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides specific entities mentioned in the sentence with their corresponding labels, which directly aids in identifying named entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The example provides specific entities mentioned in the sentence with their corresponding labels, which directly aids in identifying named entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The example provides specific entities mentioned in the sentence with their corresponding labels, which directly aids in identifying named entities."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides specific entities mentioned in the sentence with their corresponding labels, which directly aids in identifying named entities."},\n    {"Example 14": 5},\n    {"Reason 14": "The example provides specific entities mentioned in the sentence with their corresponding labels, which directly aids in identifying named entities."},\n    {"Example 15": 1},\n    {"Reason 15": "The example does not contain any entities relevant to the entity labels provided."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain any entities relevant to the entity labels provided."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain any entities relevant to the entity labels provided."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any entities relevant to the entity labels provided."},\n    {"Example 19": 1},\n    {"Reason 19": "The example does not contain any entities relevant to the entity labels provided."}\n]', 'response3': '[{"GATA": "protein"}, {"Ets": "protein"}]', 'prediction': {'GATA': 'protein', 'Ets': 'protein'}}
{'idx': 1412, 'sentence': 'We found that these parameters were indistinguishable for one of the PRL- and IL-2- induced factors .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a clear entity and label that directly matches the entity types in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The example provides multiple entities with their corresponding labels that directly match the entity types in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The example provides multiple entities with their corresponding labels that directly match the entity types in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The example provides multiple entities with their corresponding labels that directly match the entity types in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides multiple entities with their corresponding labels that directly match the entity types in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The example provides multiple entities with their corresponding labels that directly match the entity types in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The example provides multiple entities with their corresponding labels that directly match the entity types in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides a clear entity and label that directly matches the entity types in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides multiple entities with their corresponding labels that directly match the entity types in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides a clear entity and label that directly matches the entity types in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The example provides a clear entity and label that directly matches the entity types in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The example provides multiple entities with their corresponding labels that directly match the entity types in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides multiple entities with their corresponding labels that directly match the entity types in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The example provides a clear entity and label that directly matches the entity types in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The example provides multiple entities with their corresponding labels that directly match the entity types in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain any entities or labels that match the entity types in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain any entities or labels that match the entity types in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any entities or labels that match the entity types in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The example does not contain any entities or labels that match the entity types in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The example does not contain any entities or labels that match the entity types in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 411, 'sentence': 'There was a significant positive correlation between VDR concentration and serum phosphate (P less than 0.05).', 'label': {'VDR': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 3},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 3},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 4},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 4},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 3},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 3},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti-EBV antibody titres (P > 0.05).": 4},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 3},\n    {"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.": 5},\n    {"Both haemin and delta-ALA caused a de novo increase in alpha-globin expression as well as enhancing Epo-induced beta-globin expression, leading to a marked increase in haemoglobin production.": 5},\n    {"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 4},\n    {"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.": 4},\n    {"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.": 4},\n    {"The affinity of the BAT box binding proteins for the BAT box was approximately 25-fold less than for the octamer sequence and the BAT box binding proteins dissociated from the BAT box 10-fold more rapidly than from the octamer sequence.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"VDR": "protein"}, {"serum phosphate": "protein"}]', 'prediction': {'VDR': 'protein', 'serum phosphate': 'protein'}}
{'idx': 1460, 'sentence': 'In contrast, in a number of multiple myeloma cell lines , representing differentiated, plasma cell-like B cells , PU.1 DNA binding activity , mRNA expression , and Pu box -dependent transactivation were absent or detectable at a very low level.', 'label': {'multiple myeloma cell lines': 'cell_line', 'PU.1': 'protein', 'Pu box': 'DNA', 'differentiated, plasma cell-like B cells': 'cell_type'}, 'response1': "['cell_line', 'DNA', 'protein', 'RNA']", 'response2': '[\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 4},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 3},\n    {"Sentence": 3},\n    {"Sentence": 4},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 3},\n    {"Sentence": 1},\n    {"Sentence": 1},\n    {"Sentence": 1},\n    {"Sentence": 1}\n]', 'response3': '[{"PU.1": "protein"}, {"DNA": "DNA"}, {"mRNA": "RNA"}]', 'prediction': {'PU.1': 'protein', 'DNA': 'DNA', 'mRNA': 'RNA'}}
{'idx': 638, 'sentence': 'Thus the VLA-5 fibronectin receptor on CD4 cells can play a complementary role in CD3 - TCR -mediated signal transduction through its interaction with fibronectin .', 'label': {'CD3': 'protein', 'TCR': 'protein', 'VLA-5 fibronectin receptor': 'protein', 'fibronectin': 'protein', 'CD4 cells': 'cell_line'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence provides examples of specific proteins that match the entity types in the target sentence, although the relevance is slightly lower compared to Example 1."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence mentions specific proteins and a cell type that match the entity types in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence provides examples of specific proteins that match the entity types in the target sentence, although the relevance is slightly lower compared to Example 4."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence mentions specific proteins and a cell type that match the entity types in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence mentions specific proteins and a cell type that match the entity types in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions specific proteins and a cell type that match the entity types in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence mentions specific proteins and a cell type that match the entity types in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence mentions specific proteins and a cell type that match the entity types in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence mentions specific proteins that match the entity types in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence mentions specific proteins that match the entity types in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence mentions specific proteins and a cell type that match the entity types in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence mentions a specific protein that matches the entity types in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any entity names or labels that match the entity types in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entity names or labels that match the entity types in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entity names or labels that match the entity types in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entity names or labels that match the entity types in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entity names or labels that match the entity types in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1375, 'sentence': 'We have analyzed the expression of TCL1 mRNA and protein in peripheral blood lymphocytes ( PBLs ) from four AT cases and from healthy controls .', 'label': {'PBLs': 'cell_type', 'peripheral blood lymphocytes': 'cell_type', 'TCL1 mRNA': 'RNA', 'protein': 'protein'}, 'response1': "['RNA', 'protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence directly mentions the entity \'TCL1\' and specifies that it is expressed, indicating it is a protein."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence mentions entities like \'IL-2\', \'c-Jun\', and \'c-Fos\' in the context of binding to nuclear factors, indicating they are proteins."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence directly mentions the entity \'SCM-1\' in the context of genes, indicating it is a cell line."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence directly mentions the entity \'AP-1\' in the context of DNA binding activity, indicating it is DNA."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence mentions entities like \'NF-kappaB\', \'Tax\', and \'ATL\' in the context of activation and leukemic cells, indicating they are proteins or cell types."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence mentions entities like \'TAL1\' and \'T-ALL\' in the context of promoting development, indicating they are proteins or cell types."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence mentions entities like \'SCL\' and \'GATA-1\' in the context of cell lineages and transcription factors, indicating they are proteins."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions entities like \'SLAP-130\', \'SLP-76\', and \'T cell\' in the context of molecular cloning and antigen receptor-stimulated proteins, indicating they are proteins or cell types."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence directly mentions the entity \'E2A\' in the context of protein level and cellular extracts, indicating it is a protein."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence mentions entities like \'MNDA\' and \'Philadelphia chromosome-positive chronic myeloid leukemia\' in the context of specificity and cell lines, indicating they are proteins or cell lines."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence mentions entities like \'TCRzeta\' and \'p56(lck)\' in the context of detected levels in T cells, indicating they are proteins."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence mentions entities like \'granulocytes\' and \'T cells\' in the context of methylation deviation, indicating they are cell types."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence directly mentions the entity \'WT1\' in the context of paternal expression, indicating it is a protein."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence mentions entities like \'CD70\', \'B cell\', \'plasma cells\', \'IL-4\', and \'CD40\' in the context of differentiation and signaling, indicating they are proteins or cell types."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence mentions entities like \'B and T cell activation\', \'Ramos\', \'Jurkat\', and \'cDNA microarray technology\' in the context of gene expression and technology, indicating they are cell types, cell lines, or DNA."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence mentions entities like \'CD40\', \'Rel/nuclear factor kappaB\', \'NF-kappaB\', and \'B lymphocytes\' in the context of stimulation, activity, and nuclear appearance, indicating they are proteins or cell types."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific entities related to the given entity labels."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific entities related to the given entity labels."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific entities related to the given entity labels."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any specific entities related to the given entity labels."}\n]', 'response3': '[{"TCL1": "protein"}]', 'prediction': {'TCL1': 'protein'}}
{'idx': 764, 'sentence': 'The increased sensitivity of CEM-C7 cells and its subclones to dexamethasone in serum-free medium returned to previous levels when these cells were recultured in serum-containing medium .', 'label': {'CEM-C7': 'cell_line', 'CEM-C7 cells': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .": 4},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 4},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .": 4},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release .": 5},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 4},\n    {"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .": 4},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .": 4},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice .": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 897, 'sentence': 'The system is based on the use of an oligomerized NFAT-1 binding motif that directs transcription of SV40 T-antigen in transgenic mice .', 'label': {'transcription of SV40 T-antigen': 'protein', 'NFAT-1': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"NFAT-1": "protein"}, {"SV40 T-antigen": "protein"}]', 'prediction': {'NFAT-1': 'protein', 'SV40 T-antigen': 'protein'}}
{'idx': 1842, 'sentence': 'Individually or collectively, none of the three enhancer-binding proteins ( LEF-1 , Ets-1 , and TFE-3 ) could activate transcription in the absence of Sp1 .', 'label': {'Ets-1': 'protein', 'TFE-3': 'protein', 'LEF-1': 'protein', 'enhancer-binding proteins': 'protein', 'Sp1': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of proteins that are relevant to the entity labels in the target sentence, such as Sp1, NF-kappaB, p50, and PU.1."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of proteins and a cell type that are relevant to the entity labels in the target sentence, such as PU.1, M-CSF receptor, and macrophage."},\n    {"Sentence": 3},\n    {"Reason": "The sentence includes examples of a cell type and a protein that are relevant to the entity labels in the target sentence, such as T cell and interleukin 2."},\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions a specific protein, GATA-1, which is relevant to the entity labels in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of proteins that are relevant to the entity labels in the target sentence, such as Jun and ATF-2."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of proteins that are relevant to the entity labels in the target sentence, such as NF-kB, AP-1, OCT-1, and NF-IL-2B."},\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions a specific protein, Egr-1, which is relevant to the entity labels in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of proteins that are relevant to the entity labels in the target sentence, such as EKLF, CBP, p300, and P/CAF."},\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions a specific protein, A-myb, which is relevant to the entity labels in the target sentence."},\n    {"Sentence": 3},\n    {"Reason": "The sentence includes an example of a DNA-binding protein, AP-1, which is relevant to the entity labels in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of proteins that are relevant to the entity labels in the target sentence, such as EBNA2 and TP1."},\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions specific proteins, Sp1 and Ets, which are relevant to the entity labels in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins and a cell type that are relevant to the entity labels in the target sentence, such as SP1, caspases, and B-cell."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of proteins that are relevant to the entity labels in the target sentence, such as Sp1 and CD14."},\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions a specific protein, NF-E2, which is relevant to the entity labels in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence includes examples of a protein and cell types that are relevant to the entity labels in the target sentence, such as NF-ATc, T lymphocytes, and embryonic cardiac cells."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entities that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entities that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entities that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entities that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entities that are relevant to the entity labels in the target sentence."}\n]', 'response3': '[{"LEF-1": "protein"}, {"Ets-1": "protein"}, {"TFE-3": "protein"}, {"Sp1": "protein"}]', 'prediction': {'LEF-1': 'protein', 'Ets-1': 'protein', 'TFE-3': 'protein', 'Sp1': 'protein'}}
{'idx': 1059, 'sentence': 'Transcription factors belonging to the NF-kappa B family are controlled by inhibitory I kappa B proteins , mainly I kappa B alpha and I kappa B beta .', 'label': {'NF-kappa B family': 'protein', 'Transcription factors': 'protein', 'I kappa B beta': 'protein', 'inhibitory I kappa B proteins': 'protein', 'I kappa B alpha': 'protein', 'NF-kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence 1": 5},\n    {"Sentence 2": 5},\n    {"Sentence 3": 5},\n    {"Sentence 4": 5},\n    {"Sentence 5": 5},\n    {"Sentence 6": 5},\n    {"Sentence 7": 5},\n    {"Sentence 8": 5},\n    {"Sentence 9": 5},\n    {"Sentence 10": 5},\n    {"Sentence 11": 5},\n    {"Sentence 12": 5},\n    {"Sentence 13": 5},\n    {"Sentence 14": 5},\n    {"Sentence 15": 5},\n    {"Sentence 16": 1},\n    {"Sentence 17": 1},\n    {"Sentence 18": 1},\n    {"Sentence 19": 1},\n    {"Sentence 20": 1}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"I kappa B alpha": "protein"}, {"I kappa B beta": "protein"}]', 'prediction': {'NF-kappa B': 'protein', 'I kappa B alpha': 'protein', 'I kappa B beta': 'protein'}}
{'idx': 924, 'sentence': 'We conclude that p56 exists in cytosol in a higher order complex containing hsp70 and hsp90 , both of which in turn have been found to be associated with untransformed steroid receptors .', 'label': {'hsp70': 'protein', 'untransformed steroid receptors': 'protein', 'hsp90': 'protein', 'p56': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence 1": 5},\n    {"Sentence 2": 1},\n    {"Sentence 3": 1},\n    {"Sentence 4": 1},\n    {"Sentence 5": 1},\n    {"Sentence 6": 5},\n    {"Sentence 7": 5},\n    {"Sentence 8": 5},\n    {"Sentence 9": 1},\n    {"Sentence 10": 5},\n    {"Sentence 11": 5},\n    {"Sentence 12": 5},\n    {"Sentence 13": 5},\n    {"Sentence 14": 5},\n    {"Sentence 15": 5},\n    {"Sentence 16": 1},\n    {"Sentence 17": 1},\n    {"Sentence 18": 1},\n    {"Sentence 19": 1},\n    {"Sentence 20": 1}\n]', 'response3': '[{"p56": "protein"}, {"hsp70": "protein"}, {"hsp90": "protein"}, {"steroid receptors": "protein"}]', 'prediction': {'p56': 'protein', 'hsp70': 'protein', 'hsp90': 'protein', 'steroid receptors': 'protein'}}
{'idx': 247, 'sentence': 'Antigen B27 seems to be a cause of lower levels of glucocorticoid receptors in blood lymphocytes .', 'label': {'Antigen B27': 'protein', 'glucocorticoid receptors': 'protein', 'blood lymphocytes': 'cell_type', 'lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.": 4},\n    {"Benzene toxicity towards lymphocytes is thought to be mediated by metabolites of benzene including benzoquinone ( BQ ).": 4},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.": 4},\n    {"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes.": 3},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 3},\n    {"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.": 4},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.": 5},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms.": 4},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 4},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"Antigen B27": "protein"}, {"glucocorticoid receptors": "protein"}, {"blood lymphocytes": "cell_type"}]', 'prediction': {'Antigen B27': 'protein', 'glucocorticoid receptors': 'protein', 'blood lymphocytes': 'cell_type'}}
{'idx': 507, 'sentence': 'Thus, the transcriptional activity of TCF-1 alpha appears to depend on the TCF-2 alpha and T alpha 1 ( CREB ) transcription factors and the context of its binding site within the TCR alpha enhancer .', 'label': {'TCF-2 alpha': 'protein', 'TCR alpha enhancer': 'DNA', 'CREB': 'protein', 'transcription factors': 'protein', 'T alpha 1': 'protein', 'TCR': 'protein', 'TCF-1 alpha': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"TCF-1 alpha": "protein"}, {"TCF-2 alpha": "protein"}, {"T alpha 1": "protein"}, {"CREB": "protein"}, {"TCR alpha enhancer": "DNA"}]', 'prediction': {'TCF-1 alpha': 'protein', 'TCF-2 alpha': 'protein', 'T alpha 1': 'protein', 'CREB': 'protein', 'TCR alpha enhancer': 'DNA'}}
{'idx': 460, 'sentence': "To characterize these regulatory elements further, mutations in these regions were inserted into both the 5' and 3' HIV LTRs and infectious proviral constructs were assembled.", 'label': {'HIV LTRs': 'DNA', 'regulatory elements': 'DNA'}, 'response1': "['DNA']", 'response2': '[\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 5},\n{"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 5},\n{"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 5},\n{"Here we examined the regulatory mechanism of the SCM-1 genes.": 5},\n{"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 5},\n{"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 5},\n{"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 5},\n{"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements.": 5},\n{"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 5},\n{"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n{"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5},\n{"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n{"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 131, 'sentence': 'Truncation of TR alpha 1 at amino acid 210 prevented additional complex formation in the presence of NE without affecting DNA binding , suggesting that the carboxyl-terminus of the TRs is essential for interaction with nuclear proteins .', 'label': {'TRs': 'protein', 'carboxyl-terminus': 'protein', 'TR alpha 1': 'protein', 'nuclear proteins': 'protein', 'amino acid 210': 'protein'}, 'response1': "['protein', 'DNA']", 'response2': '[\n    {"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes.": 5},\n    {"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system.": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 5},\n    {"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n    {"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events.": 5},\n    {"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 5},\n    {"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex.": 5},\n    {"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays.": 5},\n    {"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"TR alpha 1": "protein"}, {"NE": "cell_line"}, {"DNA": "DNA"}, {"TRs": "protein"}]', 'prediction': {'TR alpha 1': 'protein', 'NE': 'cell_line', 'DNA': 'DNA', 'TRs': 'protein'}}
{'idx': 692, 'sentence': 'The human T-cell leukemia virus type I ( HTLV-I ) promoter contains three copies of imperfect repeats of a 21-base pair sequence designated here as TRE ( Tax -response element ) that is responsive to the virally encoded transactivator protein Tax .', 'label': {'virally encoded transactivator protein': 'protein', 'Tax -response element': 'DNA', 'TRE': 'DNA', 'human T-cell leukemia virus type I ( HTLV-I ) promoter': 'DNA', 'Tax': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n{"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.": 5},\n{"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 4},\n{"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n{"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n{"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n{"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 5},\n{"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n{"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n{"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 4},\n{"Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB- induced trans-activation of the H4 promoter.": 5},\n{"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n{"Expression of tal-1 and GATA-binding proteins during human hematopoiesis.": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': "[{'HTLV-I': 'cell_type'}, {'TRE': 'DNA'}, {'Tax': 'protein'}]", 'prediction': {'HTLV-I': 'cell_type', 'TRE': 'DNA', 'Tax': 'protein'}}
{'idx': 43, 'sentence': 'T-helper-cell determinants in protein antigens are preferentially located in cysteine-rich antigen segments resistant to proteolytic cleavage by cathepsin B , L , and D .', 'label': {'cysteine-rich antigen segments': 'protein', 'T-helper-cell determinants': 'protein', 'protein antigens': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.": 4},\n    {"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Tat-binding protein 7 is a subunit of the 26S protease.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.": 5},\n    {"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"cathepsin B": "protein"}, {"cathepsin L": "protein"}, {"cathepsin D": "protein"}]', 'prediction': {'cathepsin B': 'protein', 'cathepsin L': 'protein', 'cathepsin D': 'protein'}}
{'idx': 1204, 'sentence': 'Hirsutism , graded by the modified Ferriman-Gallwey score , and hormonal parameters were evaluated basally and at 4-month intervals during treatment.', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a clear and direct mention of the entity label \'cell_line\' in the sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The example mentions the entity label \'protein\' in a context that indicates a specific protein being referred to."},\n    {"Example 3": 5},\n    {"Reason 3": "The example contains multiple mentions of entity labels \'cell_line\' and \'protein\' in a clear and relevant context."},\n    {"Example 4": 4},\n    {"Reason 4": "The example mentions the entity label \'protein\' in a context that indicates a specific protein being referred to."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides a clear and direct mention of the entity label \'cell_type\' in the sentence."},\n    {"Example 6": 4},\n    {"Reason 6": "The example mentions the entity label \'protein\' in a context that indicates a specific protein being referred to."},\n    {"Example 7": 5},\n    {"Reason 7": "The example provides clear mentions of the entity labels \'cell_type\' and \'cell_type\' in the sentence."},\n    {"Example 8": 4},\n    {"Reason 8": "The example mentions the entity label \'DNA\' in a context that indicates a specific DNA element being referred to."},\n    {"Example 9": 4},\n    {"Reason 9": "The example mentions the entity label \'protein\' in a context that indicates a specific protein being referred to."},\n    {"Example 10": 4},\n    {"Reason 10": "The example mentions the entity labels \'protein\' and \'RNA\' in a context that indicates specific proteins and RNA being referred to."},\n    {"Example 11": 4},\n    {"Reason 11": "The example mentions the entity labels \'protein\' and \'protein\' in a context that indicates specific proteins being referred to."},\n    {"Example 12": 4},\n    {"Reason 12": "The example mentions the entity labels \'protein\' and \'protein\' in a context that indicates specific proteins being referred to."},\n    {"Example 13": 4},\n    {"Reason 13": "The example mentions the entity labels \'protein\' and \'protein\' in a context that indicates specific proteins being referred to."},\n    {"Example 14": 4},\n    {"Reason 14": "The example mentions the entity labels \'cell_type\' and \'cell_type\' in a context that indicates specific cell types being referred to."},\n    {"Example 15": 1},\n    {"Reason 15": "The example does not contain any mention of the entity labels present in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain any mention of the entity labels present in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain any mention of the entity labels present in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any mention of the entity labels present in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The example does not contain any mention of the entity labels present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1134, 'sentence': 'Reverse transcriptase (RT) assays were positive in purified viral material from both LCLs .', 'label': {'LCLs': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 5},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 5},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 5},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"In addition, assay of PBMC by the adenovirus -specific PCR may help detect early invasive disease and warrants further evaluation.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 471, 'sentence': 'The lymphocyte nuclear T3 receptor was found with an affinity close to that of normal volunteers (Ka: 1.42 x 10(10) M-1 vs 1.95 +/- 0.35 x 10(10) M-1) and a binding capacity markedly increased (9.9 vs 3.7 +/- 0.4 fmol T3 /100 micrograms DNA).', 'label': {'lymphocyte nuclear T3 receptor': 'protein'}, 'response1': "['protein', 'DNA']", 'response2': '[\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 3},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.": 4},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 4},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"T3 receptor": "protein"}, {"DNA": "DNA"}]', 'prediction': {'T3 receptor': 'protein', 'DNA': 'DNA'}}
{'idx': 1205, 'sentence': 'Gonadotropin-releasing hormone and ACTH stimulation tests were performed before and after 3 to 4 months of therapy .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides multiple examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence provides an example of a named entity with its corresponding entity label, which is helpful for extracting named entities from the target sentence."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence provides multiple examples of named entities with their corresponding entity labels, making it helpful for extracting named entities from the target sentence."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence provides an example of a named entity with its corresponding entity label, which is helpful for extracting named entities from the target sentence."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence provides an example of a named entity with its corresponding entity label, which is helpful for extracting named entities from the target sentence."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence provides multiple examples of named entities with their corresponding entity labels, making it helpful for extracting named entities from the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides multiple examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."},\n    {"Example 8": 4},\n    {"Reason 8": "The sentence provides an example of a named entity with its corresponding entity label, which is helpful for extracting named entities from the target sentence."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence provides an example of a named entity with its corresponding entity label, which is helpful for extracting named entities from the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides multiple examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides multiple examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."},\n    {"Example 12": 4},\n    {"Reason 12": "The sentence provides an example of a named entity with its corresponding entity label, which is helpful for extracting named entities from the target sentence."},\n    {"Example 13": 4},\n    {"Reason 13": "The sentence provides multiple examples of named entities with their corresponding entity labels, making it helpful for extracting named entities from the target sentence."},\n    {"Example 14": 4},\n    {"Reason 14": "The sentence provides an example of a named entity with its corresponding entity label, which is helpful for extracting named entities from the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, hence not helpful for extracting named entities."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, hence not helpful for extracting named entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, hence not helpful for extracting named entities."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, hence not helpful for extracting named entities."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, hence not helpful for extracting named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 14, 'sentence': 'Moreover, platelet-activating factor was capable of inducing transcription of the nuclear proto-oncogenes c-fos and c-jun .', 'label': {'c-fos': 'DNA', 'nuclear proto-oncogenes': 'DNA', 'c-jun': 'DNA', 'platelet-activating factor': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.": 5},\n    {"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .": 5},\n    {"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .": 5},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .": 5},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n    {"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"c-fos": "protein"}, {"c-jun": "protein"}]', 'prediction': {'c-fos': 'protein', 'c-jun': 'protein'}}
{'idx': 145, 'sentence': 'Two consensus sequences, called X and Y boxes , capable of binding nuclear proteins and regulating expression in B cells have been defined within the immediate upstream region of major histocompatibility complex (MHC) class II promoters .', 'label': {'nuclear proteins': 'protein', 'major histocompatibility complex (MHC) class II promoters': 'DNA', 'B cells': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 4},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 3},\n    {"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 4},\n    {"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 4},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n    {"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements.": 4},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 4},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.": 5},\n    {"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"X boxes": "protein"}, {"Y boxes": "protein"}, {"B cells": "cell_type"}, {"major histocompatibility complex (MHC) class II promoters": "DNA"}]', 'prediction': {'X boxes': 'protein', 'Y boxes': 'protein', 'B cells': 'cell_type', 'major histocompatibility complex (MHC) class II promoters': 'DNA'}}
{'idx': 1449, 'sentence': 'DNA binding specificity of complex 3 overlaps with that of upstream stimulatory factor but is clearly distinct.', 'label': {'upstream stimulatory factor': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"A-myb": 5},\n    {"Protein": 5},\n    {"NF-kappa B": 5, "AP-1": 5},\n    {"UAS3": 5, "UAS2": 5, "YY1": 5},\n    {"UAS1": 5, "B cell": 5},\n    {"DNA": 5},\n    {"NF-ATc": 5, "T lymphocytes": 5, "embryonic cardiac cells": 5},\n    {"PU.1": 5, "M-CSF receptor": 5, "macrophage": 5},\n    {"T cell": 5, "interleukin 2": 5},\n    {"EKLF": 5, "CBP": 5, "p300": 5, "P/CAF": 5},\n    {"RelA": 5, "NF-kappaB1": 5},\n    {"immunoglobulin kappa 3\' enhancer": 5},\n    {"NF-kappa B": 5},\n    {"NF-kappaB": 5, "Sp1": 5, "p50": 5},\n    {"Jun": 5, "ATF-2": 5},\n    {"p50p50": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1292, 'sentence': "Promoter function of the 5' flanking region of the thromboxane receptor gene was evaluated by transfection of thromboxane receptor gene promoter/ chloramphenicol acetyltransferase ( CAT ) chimera plasmids into platelet-like K562 cells .", 'label': {'thromboxane receptor': 'protein', 'thromboxane receptor gene': 'DNA', 'CAT': 'protein', 'chloramphenicol acetyltransferase': 'protein', "5' flanking region": 'DNA', 'thromboxane receptor gene promoter/ chloramphenicol acetyltransferase ( CAT ) chimera plasmids': 'DNA', 'K562 cells': 'cell_line'}, 'response1': "['DNA', 'protein', 'cell_line']", 'response2': '[\n    {"1": "The sentence does not contain any named entities."},\n    {"1": "The sentence does not contain any named entities."},\n    {"1": "The sentence does not contain any named entities."},\n    {"5": "The sentence contains multiple protein entities (Stat3, Stat5, c-Mpl) which are directly relevant to the entity labels in the target sentence."},\n    {"5": "The sentence contains the protein entity \'TCF-1\' which is directly relevant to the entity labels in the target sentence."},\n    {"5": "The sentence contains multiple protein entities (PAFR, PAF, NF-kappa B, protein kinase C) which are directly relevant to the entity labels in the target sentence."},\n    {"5": "The sentence contains multiple protein entities (Sp1, CD14) which are directly relevant to the entity labels in the target sentence."},\n    {"5": "The sentence contains the protein entity \'E2A\' which is directly relevant to the entity labels in the target sentence."},\n    {"5": "The sentence contains multiple protein entities (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) which are directly relevant to the entity labels in the target sentence."},\n    {"5": "The sentence contains the protein entity \'CD95 ligand\' which is directly relevant to the entity labels in the target sentence."},\n    {"5": "The sentence contains the cell line entity \'SCM-1\' which is directly relevant to the entity labels in the target sentence."},\n    {"5": "The sentence contains multiple cell line entities (Ramos, Jurkat) and the DNA entity \'cDNA microarray technology\' which are directly relevant to the entity labels in the target sentence."},\n    {"5": "The sentence contains multiple protein entities (Ter 119, beta-globin, glycoprotein IIb, platelet factor 4) and the cell line entity \'Ter 119\' which are directly relevant to the entity labels in the target sentence."},\n    {"5": "The sentence contains multiple protein entities (ATF1, CREB, H4) which are directly relevant to the entity labels in the target sentence."},\n    {"5": "The sentence contains the DNA entity \'BAT box\', the protein entity \'CD20\', and the cell type entity \'B cells\' which are directly relevant to the entity labels in the target sentence."},\n    {"5": "The sentence contains multiple DNA entities (IL-2, NFAT), protein entities (NFAT delta418, calcineurin, Tpl-2, cyclosporin A) which are directly relevant to the entity labels in the target sentence."},\n    {"1": "The sentence does not contain any named entities."},\n    {"1": "The sentence does not contain any named entities."},\n    {"1": "The sentence does not contain any named entities."},\n    {"1": "The sentence does not contain any named entities."}\n]', 'response3': '[{"thromboxane receptor gene": "protein"}, {"thromboxane receptor gene promoter": "protein"}, {"chloramphenicol acetyltransferase": "protein"}, {"K562 cells": "cell_line"}]', 'prediction': {'thromboxane receptor gene': 'protein', 'thromboxane receptor gene promoter': 'protein', 'chloramphenicol acetyltransferase': 'protein', 'K562 cells': 'cell_line'}}
{'idx': 120, 'sentence': 'Two other T cell lines , CEM and RPMI 8402 , have essentially identical deletions.', 'label': {'RPMI 8402': 'cell_line', 'T cell lines': 'cell_line', 'CEM': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 1},\n    {"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 3},\n    {"These two related genes share the evolutionarily conserved region encoding the Runt domain.": 1},\n    {"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 4},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 1},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 4},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 5},\n    {"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.": 4},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 1},\n    {"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 1},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 4},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"CEM": "cell_line"}, {"RPMI 8402": "cell_line"}]', 'prediction': {'CEM': 'cell_line', 'RPMI 8402': 'cell_line'}}
{'idx': 468, 'sentence': 'A 52-year-old male presented himself with tachycardia crises which appeared first during childhood, increased in frequency without goiter or exophthalmos .', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 5},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 5},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms.": 4},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 4},\n    {"By the time of diagnosis of T-PLL, the clone contains many more genetic changes in the form of additional translocations.": 4},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 4},\n    {"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"Expression of tal-1 and GATA-binding proteins during human hematopoiesis.": 5},\n    {"Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1/c6.1B, in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients.": 5},\n    {"Initiation of proliferation but not of differentiation was followed by a 20- to 25-fold increase in the nuclear level of the DNA polymerase-associated processivity factor PCNA and of the proliferation-specific transcription factor E2F1.": 5},\n    {"A total of 37 chronic, severe, nonsmoking asthmatic patients with documented reversible airways obstruction were classified as glucocorticoid-sensitive or -resistant on the basis of changes in FEV1, FVC, and peak expiratory flow (PEF) after oral prednisolone.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 138, 'sentence': 'The effects of TNF-alpha on gene expression were examined by transient expression assays using reporter chloramphenicol acetyltransferase plasmids linked to regulatory elements from the HIV long terminal repeat ( LTR ) and the beta interferon promoter .', 'label': {'beta interferon promoter': 'DNA', 'regulatory elements': 'DNA', 'HIV long terminal repeat': 'DNA', 'TNF-alpha': 'protein', 'LTR': 'DNA', 'reporter chloramphenicol acetyltransferase plasmids': 'DNA'}, 'response1': "['protein', 'DNA']", 'response2': '[\n    {"IkappaBbeta": 5},\n    {"NF-kappaB": 5},\n    {"NF-kappa B": 5},\n    {"I kappa B alpha": 5},\n    {"Egr-1": 5},\n    {"IFN A": 5},\n    {"IFNA": 5},\n    {"interleukin-2": 5},\n    {"interleukin-2 receptor": 5},\n    {"phytohemagglutinin": 5},\n    {"phorbol myristate acetate": 5},\n    {"HIV-1 LTR": 5},\n    {"NFAT-1": 5},\n    {"NF kappa B": 5},\n    {"CTLA4Ig": 5},\n    {"NFAT": 5},\n    {"AP-1": 5},\n    {"TR55": 5},\n    {"TNF-alpha": 5},\n    {"HIV": 5},\n    {"IkappaB -alpha": 5},\n    {"IkappaB -epsilon": 5},\n    {"IKK-alpha": 5},\n    {"IKK-beta": 5},\n    {"NIK": 5},\n    {"LITAF": 5},\n    {"TNF-alpha": 5},\n    {"interleukin-1beta": 5},\n    {"inhibitor-kappaB alpha": 5},\n    {"nuclear factor-kappa B": 5},\n    {"NF-kappa B": 5},\n    {"alpha 4 beta 1": 5},\n    {"TCR/CD3": 5},\n    {"DNA": 5},\n    {"reverse transcriptase": 5},\n    {"mRNA": 5},\n    {"c-jun": 5},\n    {"c-fos": 5},\n    {"NF kappa B": 5},\n    {"p50 subunit": 5},\n    {"polymerase chain reaction": 5},\n    {"T-antigen": 5},\n    {"DNA": 5},\n    {"TATA-binding protein": 5},\n    {"CREB": 5},\n    {"cAMP-response-element-binding protein": 5},\n    {"HLF": 5},\n    {"E2A-HLF": 5},\n    {"T cell": 5},\n    {"DNA": 5},\n    {"myeloid differentiation": 1},\n    {"protein synthesis": 1},\n    {"cycloheximide": 1},\n    {"chromatin fragmentation": 1},\n    {"complex translocations": 1},\n    {"genes": 1},\n    {"deletions": 1},\n    {"mutations": 1},\n    {"serum response": 1},\n    {"biophysical properties": 1},\n    {"pulmonary surfactant": 1},\n    {"immunomodulatory activity": 1}\n]', 'response3': '[{"TNF-alpha": "protein"}, {"chloramphenicol acetyltransferase": "protein"}, {"HIV long terminal repeat (LTR)": "DNA"}, {"beta interferon promoter": "DNA"}]', 'prediction': {'TNF-alpha': 'protein', 'chloramphenicol acetyltransferase': 'protein', 'HIV long terminal repeat (LTR)': 'DNA', 'beta interferon promoter': 'DNA'}}
{'idx': 64, 'sentence': 'Uninduced or Sendai virus induced HeLa extracts were used to examine transcription in vitro using a series of IFN beta promoter deletions .', 'label': {'IFN beta promoter deletions': 'DNA'}, 'response1': "['cell_line', 'protein']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 3},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 4},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 4},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 4},\n    {"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 4},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner.": 5},\n    {"We found that they reduced the initial interleukin-1beta mRNA transcription rate through prevention of degradation of inhibitor-kappaB alpha.": 4},\n    {"NF-E1 is encoded by the same gene as the YY-1 protein , which binds to the adeno-associated virus P5 promoter.": 4},\n    {"We conclude, rather, that alpha 4 beta 1 in freshly isolated T cells delivers a distinct signal that synergizes early with signals initiated by TCR/CD3 ligation to induce DNA binding of multiple transcription factors required for cytokine gene induction.": 5},\n    {"Extracts prepared from XP-B and XP-D lymphoblastoid cells exhibited similar transcription activity from the adenovirus major late promoter when compared to that in extracts from normal cells.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"HeLa": "cell_line"}, {"Sendai virus": "cell_type"}, {"IFN beta": "protein"}]', 'prediction': {'HeLa': 'cell_line', 'Sendai virus': 'cell_type', 'IFN beta': 'protein'}}
{'idx': 1760, 'sentence': 'This inhibitory effect was limited to the first 2 h after mitogenic activation , localizing the time-frame of action of cysteamine to within the commitment period .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names and their corresponding labels, which directly match the entity labels in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence contains a specific protein name that matches one of the entity labels in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains multiple specific protein names, RNA, and cell type names that match the entity labels in the target sentence."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence contains specific protein and DNA names that match the entity labels in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains specific cell type and protein names that match the entity labels in the target sentence."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence contains a specific protein name that matches one of the entity labels in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains specific protein names that match the entity labels in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains specific protein and DNA names that match the entity labels in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains a specific protein name that matches one of the entity labels in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains specific protein names and cell type names that match the entity labels in the target sentence."},\n    {"Example 11": 4},\n    {"Reason 11": "The sentence contains a specific RNA name that matches one of the entity labels in the target sentence."},\n    {"Example 12": 4},\n    {"Reason 12": "The sentence contains specific DNA and cell line names that match the entity labels in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains specific protein names that match the entity labels in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains specific protein and cell type names that match the entity labels in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any specific entity names that match the entity labels in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any specific entity names that match the entity labels in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific entity names that match the entity labels in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific entity names that match the entity labels in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific entity names that match the entity labels in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 676, 'sentence': 'The interleukin 2 ( IL-2 ) gene promoter is recognized by several cell-type-specific and ubiquitous transcriptional regulators that integrate information transmitted by various signaling systems leading to IL-2 production and T-cell activation .', 'label': {'IL-2': 'protein', 'interleukin 2': 'protein', 'interleukin 2 ( IL-2 ) gene promoter': 'DNA', 'T-cell': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence directly mentions the entity \'IL-2\' and its association with the entity type \'protein\', making it highly relevant for named entity extraction."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence mentions multiple entities such as \'IL-13\', \'IL-4\', \'B cell\', and \'monocyte\' along with their association with the entity type \'protein\' and \'cell_type\', providing valuable information for named entity extraction."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence provides information about various entities like \'IL4\', \'IL13\', \'STAT6\', \'STAT3\', \'STAT5\', and \'B cells\' along with their association with the entity type \'protein\' and \'cell_type\', aiding in named entity extraction."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence mentions entities like \'IL-2\', \'Aiolos\', and \'Ras\' along with their association with the entity type \'protein\', which is crucial for named entity extraction."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides information about entities \'NF-ATc\' and \'T lymphocytes\' along with their association with the entity type \'protein\' and \'cell_type\', aiding in named entity extraction."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence directly mentions the entity \'IL-2\' and its association with the entity type \'protein\', making it highly relevant for named entity extraction."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence mentions multiple entities like \'IFN A\', \'IFNA\', \'interleukin-2\', \'interleukin-2 receptor\', \'phytohemagglutinin\', and \'phorbol myristate acetate\' along with their association with the entity type \'protein\', providing valuable information for named entity extraction."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions entities like \'interleukin 10\', \'IL-10R\', \'STAT3\', and \'IL-6\' along with their association with the entity type \'protein\', aiding in named entity extraction."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence mentions entities \'T cell\' and \'interleukin 2\' along with their association with the entity type \'cell_type\' and \'protein\', which is crucial for named entity extraction."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides information about entities \'IL-13\', \'IL-4R\', \'JAK2\', and \'IL-13R\' along with their association with the entity type \'protein\', aiding in named entity extraction."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence mentions entities like \'IL-2\', \'c-Jun\', and \'c-Fos\' along with their association with the entity type \'protein\', providing valuable information for named entity extraction."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides information about entities \'IL-2 receptor alpha subunit\', \'p21ras\', and \'B cell\' along with their association with the entity type \'protein\' and \'cell_type\', aiding in named entity extraction."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence mentions the entity \'Th2-type lymphocytes\' along with its association with the entity type \'cell_type\', making it highly relevant for named entity extraction."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence mentions the entity \'IL-4\' along with its association with the entity type \'protein\', making it highly relevant for named entity extraction."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides information about entities \'IL-2\', \'IFN-gamma\', \'jak kinases\', and \'STAT1(alpha)\' along with their association with the entity type \'protein\', aiding in named entity extraction."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entities related to the given entity labels, hence not helpful for named entity extraction."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities related to the given entity labels, hence not helpful for named entity extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities related to the given entity labels, hence not helpful for named entity extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities related to the given entity labels, hence not helpful for named entity extraction."}\n]', 'response3': "[{'interleukin 2': 'protein'}, {'T-cell': 'cell_type'}]", 'prediction': {'interleukin 2': 'protein', 'T-cell': 'cell_type'}}
{'idx': 1052, 'sentence': 'Thus, after 4 hr of exposure to SEA and SEB , the expression of IL-2R beta was down-regulated, IL-2R gamma was slightly up-regulated, while IL-2R alpha remained largely unaffected.', 'label': {'IL-2R alpha': 'protein', 'SEA': 'protein', 'IL-2R gamma': 'protein', 'SEB': 'protein', 'IL-2R beta': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 4},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Our results demonstrate that the altered CCAAT box (CCAAC) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 4},\n    {"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.": 5},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb/Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"IL-2R beta": "protein"}, {"IL-2R gamma": "protein"}, {"IL-2R alpha": "protein"}]', 'prediction': {'IL-2R beta': 'protein', 'IL-2R gamma': 'protein', 'IL-2R alpha': 'protein'}}
{'idx': 487, 'sentence': 'Therefore, in normal human monocytes M-CSF induces immediate early response genes without inducing cell proliferation.', 'label': {'human monocytes': 'cell_type', 'normal human monocytes': 'cell_type', 'M-CSF': 'protein', 'immediate early response genes': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of proteins and cell types that are relevant to the entity labels in the target sentence, making it highly helpful for extracting named entities."}\n]', 'response3': '[{"M-CSF": "protein"}, {"monocytes": "cell_type"}]', 'prediction': {'M-CSF': 'protein', 'monocytes': 'cell_type'}}
{'idx': 570, 'sentence': 'Modulation of these events at the time of adherence offers a mechanism by which differential priming of the cells may be accomplished.', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"Sentence": "The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.", "helpfulness score": 4, "reasons": "The sentence contains a clear reference to \'cell adhesion molecules\' which is a cell_type entity."},\n    {"Sentence": "We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.", "helpfulness score": 5, "reasons": "The sentence contains references to \'AP-1\', \'PMA\', \'monocytes\', and \'macrophages\' which are protein and cell_type entities."},\n    {"Sentence": "Yet, for many pathogens, the molecules that induce IL-12 production by macrophages and the mechanisms by which they do so remain undefined.", "helpfulness score": 4, "reasons": "The sentence contains a reference to \'IL-12\' which is a protein entity and \'macrophages\' which is a cell_type entity."},\n    {"Sentence": "Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.", "helpfulness score": 3, "reasons": "The sentence contains a reference to \'CD14\' which is a protein entity."},\n    {"Sentence": "Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.", "helpfulness score": 4, "reasons": "The sentence contains references to \'Th1\' and \'Th2\' which are cell_type entities."},\n    {"Sentence": "Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.", "helpfulness score": 5, "reasons": "The sentence contains references to \'IL-2\', \'AP-1\', \'c-Jun\', and \'c-Fos\' which are protein entities."},\n    {"Sentence": "Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.", "helpfulness score": 5, "reasons": "The sentence contains references to \'CD70\', \'B cell\', \'plasma cells\', \'IL-4\', and \'CD40\' which are protein and cell_type entities."},\n    {"Sentence": "Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.", "helpfulness score": 5, "reasons": "The sentence contains references to \'IL-4\', \'LPS\', and \'AP-1\' which are protein entities."},\n    {"Sentence": "Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.", "helpfulness score": 4, "reasons": "The sentence contains a reference to \'NF-kappa B\' which is a protein entity."},\n    {"Sentence": "We also found that the deviation of methylation in granulocytes and T cells was well correlated.", "helpfulness score": 4, "reasons": "The sentence contains references to \'granulocytes\' and \'T cells\' which are cell_type entities."},\n    {"Sentence": "Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.", "helpfulness score": 5, "reasons": "The sentence contains references to \'NF-kappa B\' and \'I kappa B alpha\' which are protein entities."},\n    {"Sentence": "We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.", "helpfulness score": 5, "reasons": "The sentence contains a reference to \'NF-kappa B\' which is a protein entity."},\n    {"Sentence": "Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.", "helpfulness score": 4, "reasons": "The sentence contains a reference to \'nonhuman primates\' which is a cell_type entity."},\n    {"Sentence": "Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.", "helpfulness score": 4, "reasons": "The sentence contains a reference to \'NF-kappa B\' which is a protein entity."},\n    {"Sentence": "We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.", "helpfulness score": 5, "reasons": "The sentence contains references to \'HIV-1\', \'IFN\', \'PKR\', and \'IkappaBalpha\' which are protein and cell_type entities."},\n    {"Sentence": "To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.", "helpfulness score": 5, "reasons": "The sentence contains references to \'B and T cell activation\', \'Ramos\', \'Jurkat\', and \'cDNA microarray technology\' which are cell_type, cell_line, and DNA entities."},\n    {"Sentence": "We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.", "helpfulness score": 1, "reasons": "The sentence does not contain any named entities relevant to the given entity labels."},\n    {"Sentence": "However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.", "helpfulness score": 1, "reasons": "The sentence does not contain any named entities relevant to the given entity labels."},\n    {"Sentence": "In 2 complex translocations, none of the three genes was rearranged.", "helpfulness score": 1, "reasons": "The sentence does not contain any named entities relevant to the given entity labels."},\n    {"Sentence": "Deletions or mutations in this element also reduced the serum response by 80-90%.", "helpfulness score": 1, "reasons": "The sentence does not contain any named entities relevant to the given entity labels."},\n    {"Sentence": "In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.", "helpfulness score": 1, "reasons": "The sentence does not contain any named entities relevant to the given entity labels."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1370, 'sentence': 'Although anti- CD28 MoAb costimulation enhances all of the above signals, NF kappa B and IL-2 levels remain lower than in adults , suggesting the need for further activation requirements in the neonate .', 'label': {'CD28': 'protein', 'anti- CD28 MoAb': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"NF kappa B": "protein"}, {"IL-2": "protein"}]', 'prediction': {'NF kappa B': 'protein', 'IL-2': 'protein'}}
{'idx': 994, 'sentence': 'The role of BSAP ( Pax-5 ) in B-cell development .', 'label': {'BSAP': 'protein', 'Pax-5': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Th1": 5, "Th2": 5, "Reasons": "Both \'Th1\' and \'Th2\' are cell types mentioned in the sentence, and providing examples of these specific cell types is highly relevant for extracting named entities."},\n    {"SLAP-130": 5, "SLP-76": 5, "T cell": 5, "Reasons": "All three examples (\'SLAP-130\', \'SLP-76\', \'T cell\') are proteins or cell types mentioned in the sentence, and providing examples of these specific entities is highly relevant for extracting named entities."},\n    {"Sp1": 5, "Ets": 5, "Reasons": "Both \'Sp1\' and \'Ets\' are proteins mentioned in the sentence, and providing examples of these specific proteins is highly relevant for extracting named entities."},\n    {"UAS3": 5, "UAS2": 5, "YY1": 5, "Reasons": "All three examples (\'UAS3\', \'UAS2\', \'YY1\') are DNA or protein mentioned in the sentence, and providing examples of these specific entities is highly relevant for extracting named entities."},\n    {"CD70": 5, "B cell": 5, "plasma cells": 5, "IL-4": 5, "CD40": 5, "Reasons": "All examples (\'CD70\', \'B cell\', \'plasma cells\', \'IL-4\', \'CD40\') are proteins or cell types mentioned in the sentence, and providing examples of these specific entities is highly relevant for extracting named entities."},\n    {"GATA-1": 5, "Reasons": "\'GATA-1\' is a protein mentioned in the sentence, and providing an example of this specific protein is highly relevant for extracting named entities."},\n    {"IL-13": 5, "IL-4": 5, "B cell": 5, "monocyte": 5, "Reasons": "All examples (\'IL-13\', \'IL-4\', \'B cell\', \'monocyte\') are proteins or cell types mentioned in the sentence, and providing examples of these specific entities is highly relevant for extracting named entities."},\n    {"IL-2": 5, "c-Jun": 5, "c-Fos": 5, "Reasons": "All examples (\'IL-2\', \'c-Jun\', \'c-Fos\') are proteins mentioned in the sentence, and providing examples of these specific proteins is highly relevant for extracting named entities."},\n    {"Th2-type lymphocytes": 5, "Reasons": "\'Th2-type lymphocytes\' is a cell type mentioned in the sentence, and providing an example of this specific cell type is highly relevant for extracting named entities."},\n    {"IL4": 5, "IL13": 5, "STAT6": 5, "STAT3": 5, "STAT5": 5, "B cells": 5, "Reasons": "All examples (\'IL4\', \'IL13\', \'STAT6\', \'STAT3\', \'STAT5\', \'B cells\') are proteins or cell types mentioned in the sentence, and providing examples of these specific entities is highly relevant for extracting named entities."},\n    {"lymphoid neoplasms": 5, "Reasons": "\'lymphoid neoplasms\' is a cell type mentioned in the sentence, and providing an example of this specific cell type is highly relevant for extracting named entities."},\n    {"PML/RARalpha": 5, "Reasons": "\'PML/RARalpha\' is a protein mentioned in the sentence, and providing an example of this specific protein is highly relevant for extracting named entities."},\n    {"GM-CSF": 5, "Reasons": "\'GM-CSF\' is a protein mentioned in the sentence, and providing an example of this specific protein is highly relevant for extracting named entities."},\n    {"UAS1": 5, "B cell": 5, "Reasons": "Both \'UAS1\' and \'B cell\' are DNA or cell types mentioned in the sentence, and providing examples of these specific entities is highly relevant for extracting named entities."},\n    {"T cell": 5, "interleukin 2": 5, "Reasons": "Both \'T cell\' and \'interleukin 2\' are cell types or proteins mentioned in the sentence, and providing examples of these specific entities is highly relevant for extracting named entities."},\n    {"GATA-1": 5, "Reasons": "\'GATA-1\' is a protein mentioned in the sentence, and providing an example of this specific protein is highly relevant for extracting named entities."},\n    {"Reasons": "No specific entities mentioned in the sentence, so providing examples would not aid in extracting named entities."},\n    {"Reasons": "No specific entities mentioned in the sentence, so providing examples would not aid in extracting named entities."},\n    {"Reasons": "No specific entities mentioned in the sentence, so providing examples would not aid in extracting named entities."},\n    {"Reasons": "No specific entities mentioned in the sentence, so providing examples would not aid in extracting named entities."}\n]', 'response3': '[{"BSAP": "protein"}, {"Pax-5": "protein"}, {"B-cell": "cell_type"}]', 'prediction': {'BSAP': 'protein', 'Pax-5': 'protein', 'B-cell': 'cell_type'}}
{'idx': 438, 'sentence': 'This sequence motif is a binding site for nuclear proteins , the so-called octamer transcription factors ( Oct or OTF factors ).', 'label': {'OTF factors': 'protein', 'nuclear proteins': 'protein', 'sequence motif': 'DNA', 'octamer transcription factors': 'protein', 'Oct': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .": 5},\n    {"Activated Stat proteins form homo- or heterodimers, translocate to the nucleus , and induce transcription from responsive genes.": 5},\n    {"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50 .": 5},\n    {"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .": 5},\n    {"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 5},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .": 5},\n    {"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2 .": 5},\n    {"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 270, 'sentence': 'There was evidence for an autosomal recessive form of inheritance in four families, while the other four families appeared to have an autosomal dominant mode of transmission .', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 1},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 1},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1481, 'sentence': 'We, therefore, propose the activation scheme presented in FIGURE 3 for T-cell costimulation .', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1807, 'sentence': 'We show that the expression of four cell genes , cdc-2 , cyclin E , CD23 , and cyclin D2 , are up-regulated approximately 100-fold as a result of EBV -mediated immortalization .', 'label': {'cell genes': 'DNA', 'cyclin E': 'DNA', 'cyclin D2': 'DNA', 'CD23': 'DNA', 'cdc-2': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 5},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .": 4},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .": 5},\n    {"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB .": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n    {"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .": 5},\n    {"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"cdc-2": "protein"}, {"cyclin E": "protein"}, {"CD23": "protein"}, {"cyclin D2": "protein"}, {"EBV": "cell_line"}]', 'prediction': {'cdc-2': 'protein', 'cyclin E': 'protein', 'CD23': 'protein', 'cyclin D2': 'protein', 'EBV': 'cell_line'}}
{'idx': 1169, 'sentence': 'However, B4-2 has an unusually high proline content (13%), contains a putative nuclear targeting sequence , and has several SPXX motifs which are frequently found in gene regulatory proteins .', 'label': {'SPXX motifs': 'protein', 'nuclear targeting sequence': 'protein', 'gene regulatory proteins': 'protein', 'B4-2': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 5},\n    {"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 5},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .": 5},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50 .": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .": 5},\n    {"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n    {"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .": 5},\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines .": 5},\n    {"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .": 5},\n    {"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif .": 5}\n]', 'response3': '[{"B4-2": "protein"}]', 'prediction': {'B4-2': 'protein'}}
{'idx': 1180, 'sentence': 'We therefore propose that IL-2 receptor signal transduction does not depend on equimolar heterodimerization of JAK1 and JAK3 following IL-2 -induced heterodimerization of IL-2R beta and IL-2R gamma .', 'label': {'IL-2R': 'protein', 'IL-2': 'protein', 'IL-2R gamma': 'protein', 'JAK3': 'protein', 'IL-2 receptor': 'protein', 'JAK1': 'protein', 'IL-2R beta': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any relevant entity types that match the entity labels in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any relevant entity types that match the entity labels in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any relevant entity types that match the entity labels in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any relevant entity types that match the entity labels in the target sentence."}\n]', 'response3': "[{'IL-2': 'protein'}, {'JAK1': 'protein'}, {'JAK3': 'protein'}, {'IL-2R beta': 'protein'}, {'IL-2R gamma': 'protein'}]", 'prediction': {'IL-2': 'protein', 'JAK1': 'protein', 'JAK3': 'protein', 'IL-2R beta': 'protein', 'IL-2R gamma': 'protein'}}
{'idx': 968, 'sentence': 'These observations demonstrate directly that there is de novo synthesis of NF-kappa B during human lymphocyte activation and suggest that this process is hormonally regulated.', 'label': {'NF-kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence 1": 5},\n    {"Sentence 2": 5},\n    {"Sentence 3": 5},\n    {"Sentence 4": 5},\n    {"Sentence 5": 5},\n    {"Sentence 6": 5},\n    {"Sentence 7": 5},\n    {"Sentence 8": 1},\n    {"Sentence 9": 1},\n    {"Sentence 10": 1},\n    {"Sentence 11": 5},\n    {"Sentence 12": 5},\n    {"Sentence 13": 5},\n    {"Sentence 14": 5},\n    {"Sentence 15": 1},\n    {"Sentence 16": 1},\n    {"Sentence 17": 1},\n    {"Sentence 18": 1},\n    {"Sentence 19": 1},\n    {"Sentence 20": 1}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"lymphocyte": "cell_type"}]', 'prediction': {'NF-kappa B': 'protein', 'lymphocyte': 'cell_type'}}
{'idx': 497, 'sentence': 'The differentiation of T cells into functionally diverse subpopulations is controlled in part, by transcriptional activation and silencing ; however, little is known in detail about the proteins that influence this developmental process .', 'label': {'T cells': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 4},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 4},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.": 4},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 4},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n    {"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 4},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1606, 'sentence': 'Triggering of complement receptors CR1 ( CD35 ) and CR3 ( CD11b/CD18 ) induces nuclear translocation of NF-kappa B ( p50/p65 ) in human monocytes and enhances viral replication in HIV-infected monocytic cells .', 'label': {'CD11b/CD18': 'protein', 'CD35': 'protein', 'p50/p65': 'protein', 'CR1': 'protein', 'HIV-infected monocytic cells': 'cell_type', 'complement receptors': 'protein', 'human monocytes': 'cell_type', 'NF-kappa B': 'protein', 'CR3': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 4},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"CD40 expression could be enhanced in CD40-positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5},\n    {"Murine macrophage inflammatory protein 1 alpha (MIP-1 alpha) and its human equivalent (GOS19, LD78, or AT464) are members of the -C-C family of low-molecular-weight chemokines.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"CR1": "protein"}, {"CD35": "protein"}, {"CR3": "protein"}, {"CD11b/CD18": "protein"}, {"NF-kappa B": "protein"}, {"p50/p65": "protein"}, {"monocytes": "cell_type"}, {"HIV-infected monocytic cells": "cell_type"}]', 'prediction': {'CR1': 'protein', 'CD35': 'protein', 'CR3': 'protein', 'CD11b/CD18': 'protein', 'NF-kappa B': 'protein', 'p50/p65': 'protein', 'monocytes': 'cell_type', 'HIV-infected monocytic cells': 'cell_type'}}
{'idx': 1653, 'sentence': 'Expression of PU.1 in nonmyeloid cells can activate the GM-CSF receptor alpha promoter .', 'label': {'nonmyeloid cells': 'cell_type', 'GM-CSF': 'protein', 'PU.1': 'protein', 'GM-CSF receptor alpha promoter': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.": 5},\n    {"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"PMA induced the expression of both CD14 and CD23 mRNA and protein.": 5},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n    {"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.": 5},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"PU.1": "protein"}, {"GM-CSF receptor alpha": "protein"}]', 'prediction': {'PU.1': 'protein', 'GM-CSF receptor alpha': 'protein'}}
{'idx': 833, 'sentence': 'Mapping of B-cell epitopes of the human hepatitis B virus X protein .', 'label': {'human hepatitis B virus X protein': 'protein', 'B-cell epitopes': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any named entities from the given entity label set."}\n]', 'response3': '[{"B-cell": "cell_type"}, {"hepatitis B virus X protein": "protein"}]', 'prediction': {'B-cell': 'cell_type', 'hepatitis B virus X protein': 'protein'}}
{'idx': 389, 'sentence': 'The predicted periplasmic domain of the PhoQ protein contained a markedly anionic domain that could interact with cationic proteins and that could be responsible for resistance to defensin .', 'label': {'periplasmic domain': 'protein', 'PhoQ protein': 'protein', 'cationic proteins': 'protein', 'defensin': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter": 5},\n    {"Tat-binding protein 7 is a subunit of the 26S protease": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50": 4},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor": 5},\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO": 5},\n    {"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein": 5},\n    {"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells": 5},\n    {"The phosphorylated tyrosine residue itself is important for the protein-protein interaction": 4},\n    {"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system": 5},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 193, 'sentence': 'The calcium ionophore-induced c-myc suppression , however, strictly requires de novo protein synthesis .', 'label': {'c-myc': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"1": []},\n    {"2": []},\n    {"3": [{\'IL-5 mRNA\': \'RNA\'}, {\'TCR\': \'cell_type\'}, {\'IL-2R\': \'protein\'}, {\'dexamethasone\': \'protein\'}]},\n    {"4": [{\'RelA\': \'protein\'}, {\'NF-kappaB1\': \'protein\'}]},\n    {"5": [{\'SP1\': \'protein\'}, {\'caspases\': \'protein\'}, {\'B-cell\': \'cell_type\'}]},\n    {"6": [{\'NF-E2\': \'protein\'}]},\n    {"7": [{\'IL-2\': \'protein\'}, {\'NF-kappa B\': \'protein\'}, {\'AP-1\': \'protein\'}]},\n    {"8": [{\'IL-2\': \'protein\'}, {\'Aiolos\': \'protein\'}, {\'Ras\': \'protein\'}]},\n    {"9": [{\'SCL\': \'RNA\'}]},\n    {"10": [{\'IFN A\': \'protein\'}, {\'IFNA\': \'protein\'}, {\'interleukin-2\': \'protein\'}, {\'interleukin-2 receptor\': \'protein\'}, {\'phytohemagglutinin\': \'protein\'}, {\'phorbol myristate acetate\': \'protein\'}]},\n    {"11": [{\'NF-kappa B\': \'protein\'}]},\n    {"12": [{\'TIMP-1\': \'protein\'}, {\'DNA\': \'DNA\'}]},\n    {"13": [{\'EBV\': \'cell_line\'}, {\'CD2\': \'protein\'}]},\n    {"14": [{\'IL-2\': \'protein\'}, {\'c-Jun\': \'protein\'}, {\'c-Fos\': \'protein\'}]},\n    {"15": [{\'WT1\': \'protein\'}, {\'myeloid cell lines\': \'cell_line\'}]},\n    {"16": [{\'calcineurin\': \'protein\'}]},\n    {"17": []},\n    {"18": []},\n    {"19": []},\n    {"20": []}\n]', 'response3': '[{"c-myc": "protein"}]', 'prediction': {'c-myc': 'protein'}}
{'idx': 1349, 'sentence': 'Its expression was always restricted to the nucleus .', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides specific protein names that are mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 2": 4},\n    {"Reason 2": "The example provides protein names mentioned in the sentence, which are helpful for extracting protein entities."},\n    {"Example 3": 5},\n    {"Reason 3": "The example provides protein names mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The example provides protein names mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides protein names and other relevant terms mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 6": 4},\n    {"Reason 6": "The example provides a cell type and a protein name mentioned in the sentence, aiding in the extraction of cell type and protein entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The example provides a protein name mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides protein names mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides protein names mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides a cell line name mentioned in the sentence, aiding in the extraction of cell line entities."},\n    {"Example 11": 4},\n    {"Reason 11": "The example provides RNA, cell type, and protein names mentioned in the sentence, aiding in the extraction of RNA, cell type, and protein entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The example provides a protein name mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides DNA and protein names mentioned in the sentence, aiding in the extraction of DNA and protein entities."},\n    {"Example 14": 5},\n    {"Reason 14": "The example provides a protein name mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 15": 5},\n    {"Reason 15": "The example provides protein and cell type names mentioned in the sentence, aiding in the extraction of protein and cell type entities."},\n    {"Example 16": 4},\n    {"Reason 16": "The example provides an RNA name mentioned in the sentence, aiding in the extraction of RNA entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not provide specific entities mentioned in the sentence, hence not helpful for entity extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not provide specific entities mentioned in the sentence, hence not helpful for entity extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The example does not provide specific entities mentioned in the sentence, hence not helpful for entity extraction."},\n    {"Example 20": 1},\n    {"Reason 20": "The example does not provide specific entities mentioned in the sentence, hence not helpful for entity extraction."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 882, 'sentence': 'This cDNA clone was isolated by expression cDNA cloning , and encodes the human c-Jun protein , which together with c-Fos forms the heterodimeric activator protein-1 transcription complex .', 'label': {'c-Jun': 'protein', 'heterodimeric activator protein-1 transcription complex': 'protein', 'c-Fos': 'protein', 'cDNA': 'DNA', 'human c-Jun protein': 'protein', 'cDNA clone': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 4},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 3},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"cDNA clone": "DNA"}, {"c-Jun": "protein"}, {"c-Fos": "protein"}, {"activator protein-1": "protein"}]', 'prediction': {'cDNA clone': 'DNA', 'c-Jun': 'protein', 'c-Fos': 'protein', 'activator protein-1': 'protein'}}
{'idx': 725, 'sentence': 'Rex acts posttranscriptionally to facilitate accumulation of full-length gag/pol and singly spliced env mRNA in the cytoplasm of HTLV-infected cells .', 'label': {'Rex': 'protein', 'HTLV-infected cells': 'cell_type', 'gag/pol': 'protein', 'env mRNA': 'RNA'}, 'response1': "['RNA', 'protein']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence contains specific gene/protein names that match the entity labels in the target sentence, providing direct examples for extraction."}\n]\n[\n{"Example 2": 4},\n{"Reason 2": "The sentence contains gene/protein names that match the entity labels in the target sentence, providing relevant examples for extraction."}\n]\n[\n{"Example 3": 4},\n{"Reason 3": "The sentence contains gene/protein names that match the entity labels in the target sentence, providing relevant examples for extraction."}\n]\n[\n{"Example 4": 5},\n{"Reason 4": "The sentence contains specific gene/protein names and a virus name that match the entity labels in the target sentence, providing direct examples for extraction."}\n]\n[\n{"Example 5": 5},\n{"Reason 5": "The sentence contains a specific cell line name that matches the entity label in the target sentence, providing a direct example for extraction."}\n]\n[\n{"Example 6": 5},\n{"Reason 6": "The sentence contains multiple gene/protein names that match the entity labels in the target sentence, providing direct examples for extraction."}\n]\n[\n{"Example 7": 5},\n{"Reason 7": "The sentence contains a specific protein name and DNA mention that match the entity labels in the target sentence, providing direct examples for extraction."}\n]\n[\n{"Example 8": 5},\n{"Reason 8": "The sentence contains a specific protein name that matches the entity label in the target sentence, providing a direct example for extraction."}\n]\n[\n{"Example 9": 5},\n{"Reason 9": "The sentence contains specific cell type, protein, and virus names that match the entity labels in the target sentence, providing direct examples for extraction."}\n]\n[\n{"Example 10": 5},\n{"Reason 10": "The sentence contains specific DNA and protein names that match the entity labels in the target sentence, providing direct examples for extraction."}\n]\n[\n{"Example 11": 5},\n{"Reason 11": "The sentence contains specific DNA, cell line, and cell type names that match the entity labels in the target sentence, providing direct examples for extraction."}\n]\n[\n{"Example 12": 5},\n{"Reason 12": "The sentence contains specific protein and cell type names that match the entity labels in the target sentence, providing direct examples for extraction."}\n]\n[\n{"Example 13": 5},\n{"Reason 13": "The sentence contains specific protein names that match the entity labels in the target sentence, providing direct examples for extraction."}\n]\n[\n{"Example 14": 5},\n{"Reason 14": "The sentence contains specific cell type and DNA names that match the entity labels in the target sentence, providing direct examples for extraction."}\n]\n[\n{"Example 15": 5},\n{"Reason 15": "The sentence contains specific protein and cell type names that match the entity labels in the target sentence, providing direct examples for extraction."}\n]\n[\n{"Example 16": 5},\n{"Reason 16": "The sentence contains specific cell line names that match the entity labels in the target sentence, providing direct examples for extraction."}\n]\n[\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any specific gene/protein names or entities that match the entity labels in the target sentence, making it less helpful for extraction."}\n]\n[\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any specific gene/protein names or entities that match the entity labels in the target sentence, making it less helpful for extraction."}\n]\n[\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any specific gene/protein names or entities that match the entity labels in the target sentence, making it less helpful for extraction."}\n]\n[\n{"Example 20": 1},\n{"Reason 20": "The sentence does not contain any specific gene/protein names or entities that match the entity labels in the target sentence, making it less helpful for extraction."}\n]', 'response3': "[{'gag/pol': 'protein'}, {'env mRNA': 'RNA'}, {'HTLV-infected cells': 'cell_type'}]", 'prediction': {'gag/pol': 'protein', 'env mRNA': 'RNA', 'HTLV-infected cells': 'cell_type'}}
{'idx': 867, 'sentence': 'In HIV-1 , the sequences that respond to these signaling events are found in the long terminal repeat ( LTR ) and comprise the transcriptional enhancer , which contains two conserved binding sites for the nuclear factor kappa B ( NF kappa B ).', 'label': {'conserved binding sites': 'DNA', 'nuclear factor kappa B': 'protein', 'long terminal repeat': 'DNA', 'LTR': 'DNA', 'NF kappa B': 'protein', 'transcriptional enhancer': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 4},\n    {"Example 4": 5},\n    {"Example 5": 4},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 3},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 4},\n    {"Example 14": 5},\n    {"Example 15": 4},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"HIV-1": "cell_type"}, {"long terminal repeat (LTR)": "DNA"}, {"nuclear factor kappa B (NF kappa B)": "protein"}]', 'prediction': {'HIV-1': 'cell_type', 'long terminal repeat (LTR)': 'DNA', 'nuclear factor kappa B (NF kappa B)': 'protein'}}
{'idx': 841, 'sentence': 'Such tests may become useful diagnostic tools .', 'label': {}, 'response1': 'None.', 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence contains specific protein names such as myeloperoxidase, lysozyme, and PU.1, which are directly related to the \'protein\' entity label."},\n{"Example 2": 4},\n{"Reason 2": "The sentence mentions PBMC (peripheral blood mononuclear cells) and adenovirus, which are associated with the \'cell_type\' and \'DNA\' entity labels respectively."},\n{"Example 3": 4},\n{"Reason 3": "The sentence refers to PBMC and adenovirus DNA, which are linked to the \'cell_type\' and \'DNA\' entity labels."},\n{"Example 4": 5},\n{"Reason 4": "The sentence mentions IFN-gamma, a protein, which is directly related to the \'protein\' entity label."},\n{"Example 5": 5},\n{"Reason 5": "The sentence talks about lymphoid neoplasms, which are associated with the \'cell_type\' entity label."},\n{"Example 6": 5},\n{"Reason 6": "The sentence mentions STAT1, a protein, which is directly related to the \'protein\' entity label."},\n{"Example 7": 5},\n{"Reason 7": "The sentence refers to Ras, a protein, which is associated with the \'protein\' entity label."},\n{"Example 8": 5},\n{"Reason 8": "The sentence contains terms like immunohistochemistry, gene, and cell type, which are linked to the \'protein\', \'DNA\', and \'cell_type\' entity labels respectively."},\n{"Example 9": 5},\n{"Reason 9": "The sentence mentions NF-kappa B, a protein, which is directly related to the \'protein\' entity label."},\n{"Example 10": 5},\n{"Reason 10": "The sentence talks about SCM-1, a cell line, which is associated with the \'cell_line\' entity label."},\n{"Example 11": 5},\n{"Reason 11": "The sentence refers to SIVsmmPBj14, a cell line, which is directly related to the \'cell_line\' entity label."},\n{"Example 12": 4},\n{"Reason 12": "The sentence mentions nonhuman primates, which are associated with the \'cell_type\' entity label."},\n{"Example 13": 5},\n{"Reason 13": "The sentence contains T-PLL, a cell type, which is directly related to the \'cell_type\' entity label."},\n{"Example 14": 5},\n{"Reason 14": "The sentence mentions E2A, a protein, which is associated with the \'protein\' entity label."},\n{"Example 15": 4},\n{"Reason 15": "The sentence refers to AP-1, which is linked to the \'DNA\' entity label."},\n{"Example 16": 5},\n{"Reason 16": "The sentence contains terms related to B and T cell activation, Ramos, Jurkat cells, and cDNA microarray technology, which are associated with the \'cell_type\', \'cell_line\', and \'DNA\' entity labels respectively."},\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any specific entity names or terms related to the entity labels in the target sentence."},\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any specific entity names or terms related to the entity labels in the target sentence."},\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any specific entity names or terms related to the entity labels in the target sentence."},\n{"Example 20": 1},\n{"Reason 20": "The sentence does not contain any specific entity names or terms related to the entity labels in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 956, 'sentence': 'BSAP : a key regulator of B-cell development and differentiation .', 'label': {'BSAP': 'protein', 'B-cell': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"NF-E2": 5},\n{"EBV": 4, "B-cell": 4},\n{"CD70": 5, "B cell": 4, "plasma cells": 4, "IL-4": 5, "CD40": 5},\n{"Th2-type lymphocytes": 5},\n{"GATA-1": 5},\n{"Syk": 5, "Zap": 5, "T cell": 4},\n{"Th1": 5, "Th2": 5},\n{"T cell": 5, "interleukin 2": 5},\n{"IL-2": 5},\n{"AP-1": 4},\n{"IL-2": 5, "c-Jun": 5, "c-Fos": 5},\n{"UAS3": 5, "UAS2": 5, "YY1": 5},\n{"SCL": 5, "GATA-1": 5},\n{"IL-2": 5, "NF-kappa B": 5, "AP-1": 5},\n{"IL4": 5, "IL13": 5, "STAT6": 5, "STAT3": 5, "STAT5": 5, "B cells": 5},\n{"STAT1": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1769, 'sentence': 'We have tried to find out whether these receptors could show any difference in sex or age distribution.', 'label': {}, 'response1': 'None.', 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific entities with clear labels that are directly mentioned in the text."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions a specific entity related to a cell type, which can aid in identifying cell types."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence mentions a specific protein entity, which can help in identifying proteins."},\n    {"Example 4": 3},\n    {"Reason 4": "The sentence mentions a specific DNA entity, which can be helpful in identifying DNA entities."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence mentions a specific protein entity, which can help in identifying proteins."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence mentions a specific protein entity, which can help in identifying proteins."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence mentions a specific cell type entity, which can aid in identifying cell types."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains specific entities with clear labels that are directly mentioned in the text."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains specific entities with clear labels that are directly mentioned in the text."},\n    {"Example 10": 4},\n    {"Reason 10": "The sentence mentions specific cell types, which can aid in identifying cell types."},\n    {"Example 11": 3},\n    {"Reason 11": "The sentence mentions a specific DNA entity, which can be helpful in identifying DNA entities."},\n    {"Example 12": 4},\n    {"Reason 12": "The sentence mentions a specific protein entity, which can help in identifying proteins."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains specific entities with clear labels that are directly mentioned in the text."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains specific entities with clear labels that are directly mentioned in the text."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not mention any specific entities that can be used to identify named entities."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not mention any specific entities that can be used to identify named entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not mention any specific entities that can be used to identify named entities."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not mention any specific entities that can be used to identify named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 110, 'sentence': 'Electrophoretic mobility shift assays and Southwestern blotting experiments were used to detect the binding of cellular transactivation factor NF-KB to the double repeat-KB enhancer sequence located in the long terminal repeat .', 'label': {'long terminal repeat': 'DNA', 'NF-KB': 'protein', 'double repeat-KB enhancer sequence': 'DNA', 'cellular transactivation factor': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of proteins (IL-4, LPS, AP-1) which are relevant entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of proteins (NF-kappaB, Sp1, p50) which are relevant entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins (NF-kappaB, Tax) and cell type (ATL) which are relevant entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains an example of a protein (NF-kappa B) which is a relevant entity type in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins (NF-kappa B, I kappa B alpha) which are relevant entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins (EKLF, CBP, p300, P/CAF) which are relevant entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins (CD40, NF-kappa B) which are relevant entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins (NF-kappa B, I kappa B alpha) which are relevant entity types in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains an example of a cell type (T cell) and a protein (interleukin 2) which are relevant entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains an example of a protein (NF-kappa B) which is a relevant entity type in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins (EBNA2, TP1) which are relevant entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins (PAFR, PAF, NF-kappa B, protein kinase C) which are relevant entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins (RelA, NF-kappa B) which are relevant entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins (IL-2, c-Jun, c-Fos) which are relevant entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins (NF-kappaB, rheumatoid arthritis) which are relevant entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins (TRAF6, RANKL, NF-kappaB) which are relevant entity types in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant entity types present in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant entity types present in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant entity types present in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant entity types present in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant entity types present in the target sentence."}\n]', 'response3': "[{'NF-KB': 'protein'}]", 'prediction': {'NF-KB': 'protein'}}
{'idx': 1379, 'sentence': 'Deregulation of TCL1 is the first event in the initiation of malignancy in these types of leukemias and represents a potential tool for clinical evaluation .', 'label': {'TCL1': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"IkappaBbeta": 5},\n    {"NF-kappaB": 5},\n    {"AP-1": 5},\n    {"WT1": 4},\n    {"myeloid cell lines": 4},\n    {"myeloperoxidase": 5},\n    {"lysozyme": 5},\n    {"PU.1": 5},\n    {"IL-2 receptor alpha subunit": 5},\n    {"p21ras": 5},\n    {"B cell": 5},\n    {"MNDA": 5},\n    {"Philadelphia chromosome-positive chronic myeloid leukemia": 5},\n    {"SCM-1": 5},\n    {"IL-13": 5},\n    {"IL-4R": 5},\n    {"JAK2": 5},\n    {"IL-13R": 5},\n    {"STAT1": 5},\n    {"SCL": 5},\n    {"GATA-1": 5},\n    {"PML/RARalpha": 5},\n    {"TCRzeta": 5},\n    {"p56(lck)": 5},\n    {"lymphoid neoplasms": 5},\n    {"CD28": 5},\n    {"CD80": 5},\n    {"CD86": 5},\n    {"CBL": 5},\n    {"VAV": 5},\n    {"NFAT": 5},\n    {"interleukin-2": 5},\n    {"granulocyte-macrophage colony-stimulating factor": 5},\n    {"GATA-1": 5},\n    {"NF-kappaB": 5},\n    {"Tax": 4},\n    {"ATL": 4}\n]', 'response3': '[{"TCL1": "protein"}]', 'prediction': {'TCL1': 'protein'}}
{'idx': 1338, 'sentence': 'The survival-promoting activity of the Bcl-2 family of proteins appears to be modulated by interactions between various cellular proteins .', 'label': {'Bcl-2 family': 'protein', 'cellular proteins': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "Both NF-kappa B and I kappa B alpha are mentioned in the sentence, providing clear examples of protein entities."},\n    {"Example 2": 4},\n    {"Reason 2": "TIMP-1 and DNA are mentioned in the sentence, providing examples of protein and DNA entities respectively."},\n    {"Example 3": 5},\n    {"Reason 3": "Both NF-kappa B and I kappa B alpha are mentioned in the sentence, providing clear examples of protein entities."},\n    {"Example 4": 4},\n    {"Reason 4": "NF-kappa B is mentioned in the sentence, providing a clear example of a protein entity."},\n    {"Example 5": 5},\n    {"Reason 5": "SP1, caspases, and B-cell are mentioned in the sentence, providing examples of protein and cell_type entities."},\n    {"Example 6": 3},\n    {"Reason 6": "The mention of cell adhesion molecules provides an example of a cell_type entity, but the sentence is less specific in terms of named entities."},\n    {"Example 7": 4},\n    {"Reason 7": "NF-kappa B is mentioned in the sentence, providing a clear example of a protein entity."},\n    {"Example 8": 5},\n    {"Reason 8": "Both p21(WAF1/CIP1) and p27(KIP1) are mentioned in the sentence, providing clear examples of protein entities."},\n    {"Example 9": 5},\n    {"Reason 9": "IL-2, c-Jun, and c-Fos are mentioned in the sentence, providing examples of protein entities."},\n    {"Example 10": 5},\n    {"Reason 10": "CD70, B cell, plasma cells, IL-4, and CD40 are mentioned in the sentence, providing examples of protein and cell_type entities."},\n    {"Example 11": 5},\n    {"Reason 11": "IkappaBbeta and NF-kappaB are mentioned in the sentence, providing clear examples of protein entities."},\n    {"Example 12": 5},\n    {"Reason 12": "CD40 and NF-kappa B are mentioned in the sentence, providing clear examples of protein entities."},\n    {"Example 13": 4},\n    {"Reason 13": "IL-4 is mentioned in the sentence, providing an example of a protein entity."},\n    {"Example 14": 5},\n    {"Reason 14": "Bak, Bad, and Bcl-2 are mentioned in the sentence, providing examples of protein entities. PDBu and DMSO are mentioned as cell_line entities."},\n    {"Example 15": 5},\n    {"Reason 15": "IL-2 receptor alpha subunit, p21ras, and B cell are mentioned in the sentence, providing examples of protein and cell_type entities."},\n    {"Example 16": 4},\n    {"Reason 16": "The mention of tyrosine provides an example of a protein entity."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not mention any specific named entities related to the entity labels."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not mention any specific named entities related to the entity labels."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not mention any specific named entities related to the entity labels."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not mention any specific named entities related to the entity labels."}\n]', 'response3': '[{"Bcl-2": "protein"}]', 'prediction': {'Bcl-2': 'protein'}}
{'idx': 1323, 'sentence': 'PRE-I forms multiple DNA-protein complexes with nuclear extracts from Jurkat cells .', 'label': {'PRE-I': 'DNA', 'Jurkat cells': 'cell_line', 'multiple DNA-protein complexes': 'protein'}, 'response1': "['DNA', 'protein', 'cell_line']", 'response2': '[\n    {"1": "The example does not contain any of the entity types present in the target sentence."},\n    {"2": "The example contains some protein entities, but they are not directly related to the entities in the target sentence."},\n    {"3": "The example contains a protein entity, but it is not directly related to the entities in the target sentence."},\n    {"4": "The example contains a protein entity that is directly related to the entities in the target sentence."},\n    {"5": "The example contains a protein entity that is directly related to the entities in the target sentence."}\n]', 'response3': '[{"PRE-I": "protein"}, {"DNA": "DNA"}, {"Jurkat cells": "cell_line"}]', 'prediction': {'PRE-I': 'protein', 'DNA': 'DNA', 'Jurkat cells': 'cell_line'}}
{'idx': 1309, 'sentence': 'Proteins in the first group contain multiple HMG boxes , are non-sequence-specific , and recognize structural features as found in cruciform DNA and cross-over DNA .', 'label': {'cruciform DNA': 'DNA', 'HMG boxes': 'protein', 'cross-over DNA': 'DNA'}, 'response1': "['protein', 'DNA']", 'response2': '[\n    {"p50p50": 5},\n    {"p21(WAF1/CIP1)": 5},\n    {"p27(KIP1)": 5},\n    {"GATA-1": 5},\n    {"NF-ATc": 5},\n    {"T lymphocytes": 5},\n    {"Protein": 5},\n    {"GM-CSF": 5},\n    {"cDNAs": 5},\n    {"IgH": 5},\n    {"IL-2": 5},\n    {"c-Jun": 5},\n    {"c-Fos": 5},\n    {"Stat proteins": 5},\n    {"immunohistochemistry": 5},\n    {"gene": 5},\n    {"cell type": 5},\n    {"Th2-type lymphocytes": 5},\n    {"GM-kappa B": 5},\n    {"GC-box": 5},\n    {"GC-motif": 5},\n    {"GM-kappa B motif": 5},\n    {"p50": 5},\n    {"p65": 5},\n    {"HIV-1 LTR": 5},\n    {"NFAT-1": 5},\n    {"NF kappa B": 5},\n    {"NF-kappaB": 5},\n    {"Sp1": 5},\n    {"SIVmac": 5}\n]', 'response3': '[{"HMG boxes": "protein"}, {"DNA": "DNA"}]', 'prediction': {'HMG boxes': 'protein', 'DNA': 'DNA'}}
{'idx': 228, 'sentence': 'We have carried out experiments to define the nature of the higher affinity CVZ binding site .', 'label': {'higher affinity CVZ binding site': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 5},\n{"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .": 5},\n{"The effects of G-CSF are mediated by binding to specific, high affinity receptors .": 5},\n{"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements .": 5},\n{"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 5},\n{"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 5},\n{"Here we examined the regulatory mechanism of the SCM-1 genes .": 5},\n{"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules .": 5},\n{"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 5},\n{"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .": 5},\n{"Therefore, we investigated whether IVS1-10T-->C deleteriously affected BRCA1 splicing or expression, and thereby inactivated the other BRCA1 allele .": 5},\n{"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .": 5},\n{"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .": 5},\n{"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .": 5},\n{"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .": 5},\n{"This protein has now been purified and its encoding gene cloned.": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 51, 'sentence': 'Such segments accord well with empirically known T-cell determinants and our algorithm produces a lower number of false positive predictions than the principle based on discrete Fourier transformations previously described.', 'label': {'T-cell determinants': 'protein'}, 'response1': "['cell_type']", 'response2': '[\n{"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n{"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n{"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 4},\n{"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.": 5},\n{"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 4},\n{"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n{"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n{"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 4},\n{"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 5},\n{"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.": 5},\n{"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n{"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 4},\n{"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1518, 'sentence': 'Anti-immunoglobulin M activates nuclear calcium/calmodulin-dependent protein kinase II in human B lymphocytes .', 'label': {'nuclear calcium/calmodulin-dependent protein kinase II': 'protein', 'human B lymphocytes': 'cell_type', 'Anti-immunoglobulin M': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities (proteins and cell types) that are directly relevant to the entity labels in the target sentence, aiding in understanding the context and relationships between entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of proteins and their interactions, which can help in understanding the functions and roles of proteins in the context of the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence directly mentions proteins and their activation, which is relevant to the entity labels in the target sentence, providing insights into protein functions."},\n    {"Sentence": 5},\n    {"Reason": "The sentence discusses the activation of proteins and receptors, which are key entities in the target sentence, aiding in understanding the signaling pathways and interactions."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of proteins and cell types involved in T cell signaling, which are relevant to the entity labels in the target sentence, aiding in understanding immune responses."},\n    {"Sentence": 5},\n    {"Reason": "The sentence directly mentions proteins and their activation, which is relevant to the entity labels in the target sentence, providing insights into protein functions."},\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions the activation of NF-kappaB, which is a key protein entity in the target sentence, aiding in understanding the regulatory mechanisms."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of proteins and their interactions, which can help in understanding the signaling pathways and protein functions in the context of the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence discusses the activation of NF-kappaB and its implications in leukemic cells, which is relevant to the entity labels in the target sentence, providing insights into immune responses."},\n    {"Sentence": 3},\n    {"Reason": "The sentence mentions the involvement of T lymphocytes in an immunomodulatory response, which is relevant to the cell type entity in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of proteins and their interactions, which can help in understanding the differentiation and signaling pathways in B cells."},\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions the activation of STAT proteins in B cells, which are key entities in the target sentence, aiding in understanding the signaling pathways and immune responses."},\n    {"Sentence": 5},\n    {"Reason": "The sentence discusses the activation of NF-kappaB and its inhibitor, which are relevant to the entity labels in the target sentence, providing insights into regulatory mechanisms."},\n    {"Sentence": 3},\n    {"Reason": "The sentence mentions the involvement of P selectin in cytokine production, which is relevant to the protein entity in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of named entities relevant to the entity labels in the target sentence, hence not helpful for entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of named entities relevant to the entity labels in the target sentence, hence not helpful for entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of named entities relevant to the entity labels in the target sentence, hence not helpful for entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of named entities relevant to the entity labels in the target sentence, hence not helpful for entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of named entities relevant to the entity labels in the target sentence, hence not helpful for entity extraction."}\n]', 'response3': '[{"Anti-immunoglobulin M": "protein"}, {"nuclear calcium/calmodulin-dependent protein kinase II": "protein"}, {"human B lymphocytes": "cell_type"}]', 'prediction': {'Anti-immunoglobulin M': 'protein', 'nuclear calcium/calmodulin-dependent protein kinase II': 'protein', 'human B lymphocytes': 'cell_type'}}
{'idx': 563, 'sentence': 'The 6-h increase in PDGF(B) mRNA was adherence dependent, and in addition, was abrogated when the cytoskeletal integrity was compromised by cytochalasin D .', 'label': {'PDGF(B)': 'protein', 'PDGF(B) mRNA': 'RNA'}, 'response1': "['RNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence directly mentions the entity \'DNA\' and provides clear context for its presence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence directly mentions the entity \'RNA\' and provides clear context for its presence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence mentions multiple entities such as \'PAFR\', \'PAF\', \'NF-kappa B\', and \'protein kinase C\' with clear context for their presence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence mentions \'TIMP-1\' and \'DNA\' with clear context for their presence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence mentions \'IL-2\', \'c-Jun\', and \'c-Fos\' as entities with clear context for their presence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence mentions \'MNDA\' and \'myeloid cell lines\' as entities with clear context for their presence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence mentions \'NF-kappa B\' and \'DNA\' with clear context for their presence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions \'CD14\' as an entity with clear context for its presence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence mentions \'Bak\', \'Bad\', \'Bcl-2\', \'PDBu\', and \'DMSO\' as entities with clear context for their presence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence mentions \'P selectin\' as an entity with clear context for its presence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence mentions \'CD14\' and \'CD23\' as entities with clear context for their presence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence mentions \'p21(WAF1/CIP1)\' and \'p27(KIP1)\' as entities with clear context for their presence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence mentions \'cell adhesion molecules\' as an entity with clear context for its presence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence mentions \'CD70\', \'B cell\', \'plasma cells\', \'IL-4\', and \'CD40\' as entities with clear context for their presence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence mentions multiple entities such as \'Protein kinase B\', \'phosphatidylinositol 3-kinase\', \'STAT5\', \'erythropoietin\', \'HCD57\', \'EPO\', \'HCD57-SREI\', and \'c-Akt\' with clear context for their presence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not mention any entities present in the entity label set."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not mention any entities present in the entity label set."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not mention any entities present in the entity label set."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not mention any entities present in the entity label set."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not mention any entities present in the entity label set."}\n]', 'response3': "[{'PDGF(B)': 'RNA'}, {'cytochalasin D': 'protein'}]", 'prediction': {'PDGF(B)': 'RNA', 'cytochalasin D': 'protein'}}
{'idx': 501, 'sentence': 'Southwestern and gel renaturation experiments with the use of purified protein fractions revealed that TCF-1 alpha activity is derived from a family of 57- to 53-kD proteins that are abundantly expressed in mature and immature T-cell lines ( Jurkat , CCRF-CEM ) and not in mature B cells ( JY , Namalwa ) or nonlymphoid (HeLa) cell lines .', 'label': {'CCRF-CEM': 'cell_line', 'TCF-1 alpha': 'protein', 'nonlymphoid (HeLa) cell lines': 'cell_line', 'mature B cells': 'cell_line', 'JY': 'cell_line', 'Namalwa': 'cell_line', '57- to 53-kD proteins': 'protein', 'Jurkat': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n    {"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 5},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"TCF-1 alpha": "protein"}, {"57- to 53-kD proteins": "protein"}, {"Jurkat": "cell_line"}, {"CCRF-CEM": "cell_line"}, {"JY": "cell_line"}, {"Namalwa": "cell_line"}, {"HeLa": "cell_line"}]', 'prediction': {'TCF-1 alpha': 'protein', '57- to 53-kD proteins': 'protein', 'Jurkat': 'cell_line', 'CCRF-CEM': 'cell_line', 'JY': 'cell_line', 'Namalwa': 'cell_line', 'HeLa': 'cell_line'}}
{'idx': 457, 'sentence': 'TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes .', 'label': {'T lymphocytes': 'cell_type', 'TAR': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 5},\n    {"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .": 5},\n    {"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .": 5},\n    {"Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 285, 'sentence': 'ER content in lymphocytes of each sample was expressed by both fmol/mg of lymphocyte cytosolic protein and fmol/micrograms of lymphocyte DNA .', 'label': {'ER': 'protein', 'lymphocyte DNA': 'DNA', 'lymphocytes': 'cell_type', 'lymphocyte cytosolic protein': 'protein'}, 'response1': "['protein', 'DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names that match the entity label \'protein\', making it highly relevant for named entity extraction."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions a specific protein name \'WT1\' which aligns with the entity label \'protein\', providing relevant information for named entity extraction."},\n    {"Example 3": 3},\n    {"Reason 3": "The sentence refers to \'Th2-type lymphocytes\' which corresponds to the entity label \'cell_type\', offering some relevance for named entity extraction."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence includes \'NF-ATc\' and \'T lymphocytes\' which match the entity labels \'protein\' and \'cell_type\' respectively, aiding in named entity extraction."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains multiple protein and cell type references that align with the entity labels provided, making it highly beneficial for named entity extraction."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence mentions various proteins and stimuli that match the entity labels, offering valuable information for named entity extraction."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence refers to specific cell types \'granulocytes\' and \'T cells\' which correspond to the entity label \'cell_type\', providing relevant details for named entity extraction."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence includes a specific protein name \'Egr-1\' which aligns with the entity label \'protein\', aiding in named entity extraction."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence mentions \'CD4+\' and \'EBV\' which match the entity labels \'cell_type\' and \'protein\' respectively, providing relevant information for named entity extraction."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains specific protein names \'IL-2\', \'c-Jun\', and \'c-Fos\' that align with the entity label \'protein\', making it highly relevant for named entity extraction."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence includes specific cell type \'PBMC\' and entity \'adenovirus DNA\' which correspond to the entity labels provided, aiding in named entity extraction."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence mentions specific protein names \'myeloperoxidase\', \'lysozyme\', and \'PU.1\' which align with the entity label \'protein\', making it highly beneficial for named entity extraction."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains a specific protein name \'E2A\' which matches the entity label \'protein\', providing valuable information for named entity extraction."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence includes a specific protein name \'RXR\' which aligns with the entity label \'protein\', aiding in named entity extraction."},\n    {"Example 15": 4},\n    {"Reason 15": "The sentence mentions \'EBV\' and \'CD2\' which match the entity labels \'cell_line\' and \'protein\' respectively, providing relevant details for named entity extraction."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence contains specific cell line \'Ter 119\' and protein names \'beta-globin\', \'glycoprotein IIb\', and \'platelet factor 4\' which align with the entity labels provided, making it highly beneficial for named entity extraction."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific entities that match the provided entity labels, hence not helpful for named entity extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not mention any specific entities relevant to the provided entity labels, hence not helpful for named entity extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not include any specific entities that align with the provided entity labels, hence not helpful for named entity extraction."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence lacks specific entities related to the provided entity labels, hence not helpful for named entity extraction."}\n]', 'response3': "[{'lymphocyte cytosolic protein': 'protein'}, {'lymphocyte DNA': 'DNA'}]", 'prediction': {'lymphocyte cytosolic protein': 'protein', 'lymphocyte DNA': 'DNA'}}
{'idx': 1508, 'sentence': 'Functional characterization of the murine homolog of the B cell-specific coactivator BOB.1/OBF.1 .', 'label': {'BOB.1/OBF.1': 'protein', 'B cell-specific coactivator': 'protein', 'murine homolog': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear and direct mention of the entity along with its corresponding label, aiding in the extraction process."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence explicitly mentions the entity and its label, making it highly helpful for named entity extraction."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence directly identifies the entity and its label, facilitating the extraction of named entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains a specific mention of the entity and its label, which is crucial for named entity extraction."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides a clear reference to the entity and its label, aiding in the extraction of named entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence explicitly mentions multiple entities and their labels, making it highly beneficial for named entity extraction."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence directly identifies the entity and its label, aiding in the extraction process."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides a clear mention of the entity and its label, aiding in named entity extraction."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence explicitly mentions the entity and its label, making it highly helpful for named entity extraction."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence directly identifies the entity and its label, facilitating the extraction of named entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains a specific mention of the entity and its label, which is crucial for named entity extraction."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides a clear reference to the entity and its label, aiding in the extraction of named entities."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence explicitly mentions multiple entities and their labels, making it highly beneficial for named entity extraction."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence directly identifies the entity and its label, aiding in the extraction process."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides a clear mention of the entity and its label, aiding in named entity extraction."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any specific entities or labels that can aid in named entity extraction."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence lacks specific entities or labels that can assist in named entity extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not provide any specific entities or labels that can aid in named entity extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence lacks specific entities or labels that can assist in named entity extraction."}\n]', 'response3': '[{"BOB.1/OBF.1": "protein"}]', 'prediction': {'BOB.1/OBF.1': 'protein'}}
{'idx': 209, 'sentence': 'Type-II estrogen -binding sites ( type-II EBS ) have been demonstrated in the human lymphoblastoid cell line IM-9 using a whole-cell assay with (6,7-3H) estradiol ( 3H-E2 ) as tracer.', 'label': {'lymphoblastoid cell line': 'cell_line', 'IM-9': 'cell_line', 'type-II EBS': 'protein', 'Type-II estrogen -binding sites': 'protein', 'human lymphoblastoid cell line': 'cell_line'}, 'response1': "['cell_line', 'protein']", 'response2': '[\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 4},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .": 3},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 4},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 3},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .": 4},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .": 4},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .": 5},\n    {"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus , and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development .": 5},\n    {"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.": 5},\n    {"Expression of tal-1 and GATA-binding proteins during human hematopoiesis .": 4},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5}\n]', 'response3': '[{"IM-9": "cell_line"}, {"estradiol": "protein"}]', 'prediction': {'IM-9': 'cell_line', 'estradiol': 'protein'}}
{'idx': 1385, 'sentence': "Mutational analyses of the HIV-1 LTR showed that one C/EBP site is required for normal LTR transcription both before and after cellular activation and that the two 3' C/EBP sites are functionally equivalent.", 'label': {'LTR': 'DNA', 'HIV-1 LTR': 'DNA', 'C/EBP sites': 'DNA', 'C/EBP site': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n{"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.": 5},\n{"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n{"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 5},\n{"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 4},\n{"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n{"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n{"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.": 5},\n{"The balance between repression by ZEB and transcriptional activation by c-Myb/Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.": 5},\n{"Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB-induced trans-activation of the H4 promoter.": 5},\n{"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5},\n{"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 5},\n{"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n{"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"C/EBP": "protein"}, {"HIV-1 LTR": "DNA"}]', 'prediction': {'C/EBP': 'protein', 'HIV-1 LTR': 'DNA'}}
{'idx': 1516, 'sentence': 'Fusion of subdomains of BOB.1/OBF.1 with the GAL4 DNA binding domain reveals that both NH2- and COOH- terminal domains of BOB.1/OBF.1 contribute to full transactivation function, the COOH-terminal domain is more efficient in this transactivation assay .', 'label': {'BOB.1/OBF.1': 'protein', 'GAL4 DNA binding domain': 'protein', 'COOH-terminal domain': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events.": 5},\n    {"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.": 4},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n    {"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 5},\n    {"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system.": 5},\n    {"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF.": 5},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 4},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 5},\n    {"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif.": 5},\n    {"Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB- induced trans-activation of the H4 promoter.": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1827, 'sentence': 'A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR-1 .', 'label': {'human interleukin 2 gene promoter': 'DNA', 'EGR-1': 'protein', 'Sp1': 'protein', 'regulatory element': 'DNA', 'binding site': 'DNA', 'zinc finger proteins': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific gene names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides specific gene names, cytokines, and cell types that match the entity types in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence mentions a specific cell type that matches one of the entity types in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains specific gene names and protein factors that correspond to the entity types in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence mentions a specific gene name that corresponds to one of the entity types in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides a specific gene name that matches the entity type in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains specific gene names, cytokines, and cell types that correspond to the entity types in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions a specific protein factor that matches the entity type in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides specific gene names and protein factors that correspond to the entity types in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence mentions specific gene names and protein factors that match the entity types in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains specific gene names and protein factors that correspond to the entity types in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides a specific protein factor that matches the entity type in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence mentions a specific cytokine that corresponds to the entity type in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains specific gene names, cytokines, and protein factors that match the entity types in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides specific protein factors and stimuli that correspond to the entity types in the target sentence."}\n]', 'response3': '[{"interleukin 2": "protein"}, {"Sp1": "protein"}, {"EGR-1": "protein"}]', 'prediction': {'interleukin 2': 'protein', 'Sp1': 'protein', 'EGR-1': 'protein'}}
{'idx': 1116, 'sentence': 'The tumour suppressor p53 has been shown to regulate this type of apoptosis in thymocytes , but an as yet unknown, p53 -independent pathway (s) appears to mediate the same event in mitogen-activated mature T lymphocytes .', 'label': {'thymocytes': 'cell_type', 'p53': 'protein', 'mitogen-activated mature T lymphocytes': 'cell_line', 'tumour suppressor p53': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 5},\n{"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .": 5},\n{"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .": 4},\n{"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n{"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .": 4},\n{"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .": 5},\n{"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n{"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .": 4},\n{"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 4},\n{"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .": 5},\n{"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .": 5},\n{"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 5},\n{"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .": 5},\n{"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n{"The process of apoptosis is used to eliminate unwanted cells from a wide variety of organisms.": 4},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"p53": "protein"}, {"apoptosis": "cell_type"}, {"thymocytes": "cell_type"}, {"p53": "protein"}, {"mitogen-activated mature T lymphocytes": "cell_type"}]', 'prediction': {'p53': 'protein', 'apoptosis': 'cell_type', 'thymocytes': 'cell_type', 'mitogen-activated mature T lymphocytes': 'cell_type'}}
{'idx': 178, 'sentence': 'T lymphocytes appeared to be an important source of 1,25(OH)2D3 production , since purified T lymphocytes from all patients with tuberculosis produced 1,25(OH)2D3 , and 1,25(OH)2D3 production by these cells correlated closely with that produced by unseparated lavage cells .', 'label': {'T lymphocytes': 'cell_type', 'lavage cells': 'cell_type'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein entity (TCL1) and its corresponding entity label."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides clear examples of cell type entities (granulocytes and T cells) and their corresponding entity labels."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence provides a clear example of a protein entity (CD14) and its corresponding entity label."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides multiple examples of protein entities (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) and their corresponding entity labels."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides a clear example of a protein entity (ZAP-70) and its corresponding entity label."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides clear examples of cell type (T lymphocytes) and protein (HLA-molecules) entities and their corresponding entity labels."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides clear examples of protein (NF-ATc) and cell type (T lymphocytes) entities and their corresponding entity labels."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides clear examples of protein entities (Oct-2A, HMG I/Y, HLA-DRA) and cell type entity (B cells) and their corresponding entity labels."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides clear examples of cell line (EBV) and protein (CD2) entities and their corresponding entity labels."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides a clear example of a cell type entity (Th2-type lymphocytes) and its corresponding entity label."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides clear examples of protein (CD70, IL-4, CD40) and cell type (B cell, plasma cells) entities and their corresponding entity labels."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides clear examples of protein entities (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) and their corresponding entity labels."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides clear examples of protein (IL-2 receptor alpha subunit, p21ras) and cell type (B cell) entities and their corresponding entity labels."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides clear examples of cell type (B and T cell activation) and cell line (Ramos, Jurkat) entities, and DNA entity (cDNA microarray technology) and their corresponding entity labels."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides clear examples of DNA (2-deoxyguanosine), cell type (lymphoid progenitor cells, thymus stromal cells, B cell, fetal liver cells, T cell), and cell line (tg epsilon26) entities and their corresponding entity labels."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entities related to the given entity labels."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities related to the given entity labels."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities related to the given entity labels."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities related to the given entity labels."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities related to the given entity labels."}\n]', 'response3': "[{'T lymphocytes': 'cell_type'}, {'1,25(OH)2D3': 'protein'}, {'tuberculosis': 'cell_type'}, {'unseparated lavage cells': 'cell_line'}]", 'prediction': {'T lymphocytes': 'cell_type', '1,25(OH)2D3': 'protein', 'tuberculosis': 'cell_type', 'unseparated lavage cells': 'cell_line'}}
{'idx': 1209, 'sentence': 'A reduction of serum androgens was found, whereas no change was observed in either basal or GnRH-stimulated gonadotropins or in the cortisol and 17 alpha-hydroxyprogesterone response to ACTH .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .": 4},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .": 4},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release .": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 5},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .": 5},\n    {"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 4},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .": 4},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"Interestingly, CTLA4Ig did not significantly inhibit the activation of either NF of activated T cells ( NFAT ) or AP-1 reporters .": 4},\n    {"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.": 5},\n    {"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator .": 5},\n    {"When 18C7 was incubated with MR before aldosterone or progesterone , the antibody inhibited 75-80% of the binding.": 5},\n    {"In apparent contradiction, expression of a dominant negative form of Ras , RasN17 , also inhibited IL-2 -induced activation of the promoter containing the minimal beta-casein STAT5 element as well as the promoters of CIS and OSM .": 5},\n    {"The number of Type I and Type II receptors before the test was lower in elderly subjects than in adults .": 4},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 864, 'sentence': 'Differences in transcriptional enhancers of HIV-1 and HIV-2 .', 'label': {'transcriptional enhancers': 'DNA'}, 'response1': "['DNA', 'RNA']", 'response2': '[\n    {"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.": 5},\n    {"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 4},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 3},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 3},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 4},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 4},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 4},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 4},\n    {"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 4},\n    {"NF-E1 is encoded by the same gene as the YY-1 protein, which binds to the adeno-associated virus P5 promoter.": 4},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 65, 'sentence': 'Deletions upstream of the PRDII element increased transcription in the uninduced extract, indicating predominantly negative regulation of the promoter .', 'label': {'promoter': 'DNA', 'PRDII element': 'DNA'}, 'response1': "['DNA', 'RNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 61, 'sentence': 'From HeLa cells , two major proteins of 52 and 45 kilodaltons (kD) copurified with DNA binding activity , whereas from T-cells , four proteins--a major protein of 52 kD and three minor proteins of 82 , 67 , and 43-47 kD --were purified.', 'label': {'82': 'protein', '43-47 kD': 'protein', 'major protein': 'protein', 'T-cells': 'cell_type', 'minor proteins': 'protein', '67': 'protein', 'HeLa cells': 'cell_line', '52 kD': 'protein'}, 'response1': "['protein', 'cell_line', 'DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names that match the entity label \'protein\' in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence contains a specific protein name that matches the entity label \'protein\' in the target sentence."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence contains specific protein names that match the entity label \'protein\' in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains specific protein names that match the entity label \'protein\' in the target sentence."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence contains a specific protein name that matches the entity label \'protein\' in the target sentence."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence contains a specific protein name that matches the entity label \'protein\' in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains specific protein names that match the entity label \'protein\' in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains a specific protein name that matches the entity label \'protein\' in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains specific protein names that match the entity label \'protein\' in the target sentence."},\n    {"Example 10": 4},\n    {"Reason 10": "The sentence contains a specific protein name that matches the entity label \'protein\' in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains specific protein names that match the entity label \'protein\' in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains specific protein names that match the entity label \'protein\' in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains specific protein names that match the entity label \'protein\' in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains specific protein names that match the entity label \'protein\' in the target sentence."},\n    {"Example 15": 4},\n    {"Reason 15": "The sentence contains a specific protein name that matches the entity label \'protein\' in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entity types present in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entity types present in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entity types present in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entity types present in the target sentence."}\n]', 'response3': "[{'HeLa cells': 'cell_line'}, {'T-cells': 'cell_line'}, {'DNA': 'DNA'}, {'protein': 'protein'}, {'52 kD': 'protein'}, {'45 kilodaltons (kD)': 'protein'}, {'82': 'protein'}, {'67': 'protein'}, {'43-47 kD': 'protein'}]", 'prediction': {'HeLa cells': 'cell_line', 'T-cells': 'cell_line', 'DNA': 'DNA', 'protein': 'protein', '52 kD': 'protein', '45 kilodaltons (kD)': 'protein', '82': 'protein', '67': 'protein', '43-47 kD': 'protein'}}
{'idx': 191, 'sentence': 'A block to RNA elongation is largely responsible for decreased c-myc transcription .', 'label': {'c-myc': 'DNA'}, 'response1': "['RNA']", 'response2': '[\n    {"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .": 5},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n    {"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 5},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 5},\n    {"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .": 5},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 447, 'sentence': 'Each binding site contributes to the overall activity of the enhancer , however no single element seems absolutely required for activity.', 'label': {'enhancer': 'DNA', 'binding site': 'DNA'}, 'response1': "['DNA']", 'response2': '[\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 4},\n    {"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 3},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 3},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 3},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 4},\n    {"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.": 4},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 4},\n    {"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 4},\n    {"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 4},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n    {"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 4},\n    {"We have found that the recruitment of EKLF to 5\'HS3 depends on the presence of 5\'HS2 in cis, but the recruitment to 5\'HS2 does not depend on 5\'HS3.": 4},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 4},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 4},\n    {"Our results demonstrate that the altered CCAAT box (CCAAC) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 4},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 476, 'sentence': 'A group of coordinately induced protooncogenes , cytoskeletal , and extracellular matrix genes have been termed immediate early response genes , and their induction has been associated with growth factor -stimulated cell proliferation .', 'label': {'protooncogenes': 'DNA', 'immediate early response genes': 'DNA', 'growth factor': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .": 5},\n    {"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .": 4},\n    {"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 5},\n    {"The p21ras small GTP binding proteins participate in signal transduction from cell surface receptors and affect neoplastic transformation and development in many different cell types.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 5},\n    {"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .": 5},\n    {"Activated Stat proteins form homo- or heterodimers, translocate to the nucleus , and induce transcription from responsive genes.": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1034, 'sentence': 'p94 and p95 share homology with Stat1 at the phosphorylation site and in the Src homology 2 (SH2) domain , but otherwise are immunologically distinct from Stat1 .', 'label': {'Stat1': 'protein', 'phosphorylation site': 'protein', 'Src homology 2 (SH2) domain': 'protein', 'p94': 'protein', 'p95': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"p94": "protein"}, {"p95": "protein"}, {"Stat1": "protein"}]', 'prediction': {'p94': 'protein', 'p95': 'protein', 'Stat1': 'protein'}}
{'idx': 1232, 'sentence': 'IBR is a 503-amino-acid-long acidic protein which is 99.0% identical to the recently reported human NRF-1/alpha-Pal factor and highly related to the invertebrate transcription factors P3A2 and erected wing gene product ( EWG ).', 'label': {'IBR': 'protein', 'transcription factors': 'protein', 'erected wing gene product': 'protein', 'human NRF-1/alpha-Pal factor': 'protein', 'EWG': 'protein', 'P3A2': 'protein', '503-amino-acid-long acidic protein': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein (Egr-1) being mentioned in relation to a zinc finger transcription factor, aiding in the extraction of protein entities."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any specific entities related to the entity labels provided in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any specific entities related to the entity labels provided in the target sentence."},\n    {"Example 4": 1},\n    {"Reason 4": "The sentence does not contain any specific entities related to the entity labels provided in the target sentence."},\n    {"Example 5": 1},\n    {"Reason 5": "The sentence does not contain any specific entities related to the entity labels provided in the target sentence."},\n    {"Example 6": 1},\n    {"Reason 6": "The sentence does not contain any specific entities related to the entity labels provided in the target sentence."},\n    {"Example 7": 1},\n    {"Reason 7": "The sentence does not contain any specific entities related to the entity labels provided in the target sentence."},\n    {"Example 8": 1},\n    {"Reason 8": "The sentence does not contain any specific entities related to the entity labels provided in the target sentence."},\n    {"Example 9": 1},\n    {"Reason 9": "The sentence does not contain any specific entities related to the entity labels provided in the target sentence."},\n    {"Example 10": 1},\n    {"Reason 10": "The sentence does not contain any specific entities related to the entity labels provided in the target sentence."},\n    {"Example 11": 1},\n    {"Reason 11": "The sentence does not contain any specific entities related to the entity labels provided in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides a clear example of a protein (EBNA-2) and a transcription factor (PU.1) being mentioned in relation to a direct interaction, aiding in the extraction of protein entities."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not contain any specific entities related to the entity labels provided in the target sentence."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not contain any specific entities related to the entity labels provided in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any specific entities related to the entity labels provided in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any specific entities related to the entity labels provided in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific entities related to the entity labels provided in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific entities related to the entity labels provided in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific entities related to the entity labels provided in the target sentence."}\n]', 'response3': '[{"IBR": "protein"}, {"NRF-1/alpha-Pal": "protein"}, {"P3A2": "protein"}, {"erected wing gene product (EWG)": "protein"}]', 'prediction': {'IBR': 'protein', 'NRF-1/alpha-Pal': 'protein', 'P3A2': 'protein', 'erected wing gene product (EWG)': 'protein'}}
{'idx': 54, 'sentence': 'Virus stocks obtained from these experiments exhibited a continuum of replicative capacities in different human T-cell types depending on which element (s) was present in the LTR .', 'label': {'LTR': 'DNA', 'human T-cell types': 'cell_type', 'T-cell types': 'cell_type', 'element': 'DNA'}, 'response1': "['cell_type']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence directly mentions the entity types and provides clear examples of the entities, making it highly helpful for extracting named entities from the target sentence."}\n]', 'response3': "[{'Virus stocks': 'protein'}, {'human T-cell types': 'cell_type'}, {'LTR': 'DNA'}]", 'prediction': {'Virus stocks': 'protein', 'human T-cell types': 'cell_type', 'LTR': 'DNA'}}
{'idx': 1149, 'sentence': 'The expression and activity of NF-kappa B and Sp1 were, therefore, analyzed in isolated T cells and DCs from humans and mice .', 'label': {'Sp1': 'protein', 'DCs': 'cell_type', 'NF-kappa B': 'protein', 'T cells': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 4},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"Sp1": "protein"}, {"T cells": "cell_type"}, {"DCs": "cell_type"}, {"humans": "cell_type"}, {"mice": "cell_type"}]', 'prediction': {'NF-kappa B': 'protein', 'Sp1': 'protein', 'T cells': 'cell_type', 'DCs': 'cell_type', 'humans': 'cell_type', 'mice': 'cell_type'}}
{'idx': 407, 'sentence': 'Since most of the actions of vitamin D are mediated by its receptors ( VDR ), abnormalities of VDR have been postulated in XLH .', 'label': {'VDR': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names that match the entity label \'protein\', making it highly relevant for named entity extraction."}\n]', 'response3': '[{"VDR": "protein"}]', 'prediction': {'VDR': 'protein'}}
{'idx': 1466, 'sentence': 'As we observed that activated endothelial cells also expressed NFAT , we tested the antiinflammatory properties of CsA in endothelial cells .', 'label': {'endothelial cells': 'cell_type', 'NFAT': 'protein', 'activated endothelial cells': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a clear mapping between the entity \'NF-kappa B\' and its corresponding label \'DNA\', aiding in the extraction of named entities from the target sentence."},\n\n    {"Example 2": 4},\n    {"Reason 2": "The example provides mappings for \'NF-kappa B\' and \'I kappa B alpha\' to their corresponding labels \'protein\', which helps in identifying protein entities in the target sentence."},\n\n    {"Example 3": 5},\n    {"Reason 3": "The example provides mappings for \'AP-1\', \'PMA\', \'monocytes\', and \'macrophages\' to their corresponding labels \'protein\' and \'cell_type\', aiding in the extraction of named entities from the target sentence."},\n\n    {"Example 4": 5},\n    {"Reason 4": "The example provides mappings for \'granulocytes\' and \'T cells\' to their corresponding labels \'cell_type\', helping in identifying cell type entities in the target sentence."},\n\n    {"Example 5": 4},\n    {"Reason 5": "The example provides a mapping for \'NF-kappa B\' to its corresponding label \'protein\', aiding in the extraction of protein entities from the target sentence."},\n\n    {"Example 6": 4},\n    {"Reason 6": "The example provides mappings for \'NF-kappaB\', \'Tax\', and \'ATL\' to their corresponding labels \'protein\' and \'cell_type\', helping in identifying protein and cell type entities in the target sentence."},\n\n    {"Example 7": 5},\n    {"Reason 7": "The example provides mappings for \'alpha-tocopherol\', \'monocyte\', and \'endothelial cells\' to their corresponding labels \'protein\' and \'cell_type\', aiding in the extraction of named entities from the target sentence."},\n\n    {"Example 8": 4},\n    {"Reason 8": "The example provides a mapping for \'NF-kappa B\' to its corresponding label \'protein\', aiding in the extraction of protein entities from the target sentence."},\n\n    {"Example 9": 4},\n    {"Reason 9": "The example provides a mapping for \'P selectin\' to its corresponding label \'protein\', helping in identifying protein entities in the target sentence."},\n\n    {"Example 10": 5},\n    {"Reason 10": "The example provides mappings for \'NF-kappa B\' and \'ARDS\' to their corresponding labels \'protein\' and \'cell_type\', aiding in the extraction of named entities from the target sentence."},\n\n    {"Example 11": 4},\n    {"Reason 11": "The example provides a mapping for \'NF-kappa B\' to its corresponding label \'protein\', aiding in the extraction of protein entities from the target sentence."},\n\n    {"Example 12": 4},\n    {"Reason 12": "The example provides a mapping for \'MNDA\' to its corresponding label \'protein\' and \'Philadelphia chromosome-positive chronic myeloid leukemia\' to its corresponding label \'cell_line\', aiding in the extraction of named entities from the target sentence."},\n\n    {"Example 13": 5},\n    {"Reason 13": "The example provides a mapping for \'E2A\' to its corresponding label \'protein\', aiding in the extraction of protein entities from the target sentence."},\n\n    {"Example 14": 5},\n    {"Reason 14": "The example provides mappings for \'NF-kappa B\' and \'AP-1\' to their corresponding labels \'protein\', aiding in the extraction of protein entities from the target sentence."},\n\n    {"Example 15": 5},\n    {"Reason 15": "The example provides mappings for \'IFN A\', \'IFNA\', \'interleukin-2\', \'interleukin-2 receptor\', \'phytohemagglutinin\', and \'phorbol myristate acetate\' to their corresponding label \'protein\', aiding in the extraction of named entities from the target sentence."},\n\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain any entities that match the entity labels in the target sentence, hence not helpful in extracting named entities."},\n\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain any entities that match the entity labels in the target sentence, hence not helpful in extracting named entities."},\n\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any entities that match the entity labels in the target sentence, hence not helpful in extracting named entities."},\n\n    {"Example 19": 1},\n    {"Reason 19": "The example does not contain any entities that match the entity labels in the target sentence, hence not helpful in extracting named entities."}\n]', 'response3': "[{'NFAT': 'protein'}, {'CsA': 'protein'}, {'endothelial cells': 'cell_type'}]", 'prediction': {'NFAT': 'protein', 'CsA': 'protein', 'endothelial cells': 'cell_type'}}
{'idx': 1330, 'sentence': 'Stimulation of cells leads to a rapid phosphorylation of I kappa B alpha , which is presumed to be important for the subsequent degradation .', 'label': {'I kappa B alpha': 'protein', 'I kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence 1": 5},\n    {"Sentence 2": 5},\n    {"Sentence 3": 5},\n    {"Sentence 4": 5},\n    {"Sentence 5": 5},\n    {"Sentence 6": 5},\n    {"Sentence 7": 5},\n    {"Sentence 8": 4},\n    {"Sentence 9": 1},\n    {"Sentence 10": 1},\n    {"Sentence 11": 1},\n    {"Sentence 12": 1},\n    {"Sentence 13": 5},\n    {"Sentence 14": 5},\n    {"Sentence 15": 5},\n    {"Sentence 16": 1},\n    {"Sentence 17": 1},\n    {"Sentence 18": 1},\n    {"Sentence 19": 1}\n]', 'response3': '[{"I kappa B alpha": "protein"}]', 'prediction': {'I kappa B alpha': 'protein'}}
{'idx': 1436, 'sentence': 'Similar levels of hTR beta 1 mRNA levels were detected in thyroid gland from euthyroid patients .', 'label': {'hTR beta 1 mRNA': 'RNA', 'hTR beta 1': 'protein'}, 'response1': "['RNA']", 'response2': '[\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects.": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.": 5},\n    {"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus , and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"hTR beta 1 mRNA": "RNA"}]', 'prediction': {'hTR beta 1 mRNA': 'RNA'}}
{'idx': 859, 'sentence': 'We show that at least one inducible , C1 , and one constitutive, C2 , protein can bind to the HIV enhancer in Jurkat cells .', 'label': {'inducible': 'protein', 'Jurkat cells': 'cell_line', 'C1': 'protein', 'HIV enhancer': 'DNA', 'C2': 'protein', 'constitutive, C2 , protein': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n{"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n{"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n{"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 4},\n{"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n{"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 4},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n{"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n{"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n{"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n{"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 5},\n{"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n{"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5},\n{"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 5},\n{"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells (Daudi) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner.": 5}\n]', 'response3': '[{"C1": "protein"}, {"C2": "protein"}, {"HIV enhancer": "DNA"}, {"Jurkat cells": "cell_line"}]', 'prediction': {'C1': 'protein', 'C2': 'protein', 'HIV enhancer': 'DNA', 'Jurkat cells': 'cell_line'}}
{'idx': 451, 'sentence': 'However, despite its ability to activate transcription of a transfected reporter gene , the factor is apparently unable to bind to the endogenous Ig heavy chain enhancer in non- lymphoid cells : In previous experiments by others, the characteristic in vivo footprint of this factor, designated NF-muE3 , was detected in B cells but not in non-B cells .', 'label': {'NF-muE3': 'protein', 'B cells': 'cell_type', 'lymphoid cells': 'cell_type', 'transfected reporter gene': 'DNA', 'Ig heavy chain enhancer': 'DNA', 'non- lymphoid cells': 'cell_type', 'non-B cells': 'cell_type', 'endogenous Ig heavy chain enhancer': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"p50p50": 5},\n    {"Egr-1": 5},\n    {"IFN A": 4},\n    {"IFNA": 4},\n    {"interleukin-2": 4},\n    {"interleukin-2 receptor": 4},\n    {"phytohemagglutinin": 4},\n    {"phorbol myristate acetate": 4},\n    {"TCF-1": 5},\n    {"IL-2 receptor alpha subunit": 5},\n    {"p21ras": 5},\n    {"B cell": 5},\n    {"NF-ATc": 5},\n    {"T lymphocytes": 5},\n    {"embryonic cardiac cells": 5},\n    {"IL-2": 5},\n    {"NF-kappaB": 5},\n    {"Sp1": 5},\n    {"p50": 5},\n    {"c-kit": 5},\n    {"IL-4R alpha chain": 5},\n    {"c-Jun": 5},\n    {"c-Fos": 5},\n    {"immunoglobulin kappa 3\' enhancer": 5},\n    {"IL-2": 5},\n    {"IFN-gamma": 5},\n    {"jak kinases": 5},\n    {"STAT1(alpha)": 5},\n    {"rheumatoid arthritis": 5},\n    {"CD40": 5},\n    {"Rel/nuclear factor kappaB": 5},\n    {"B lymphocytes": 5},\n    {"SIVmac": 5},\n    {"NFAT": 5},\n    {"AP-1": 5}\n]', 'response3': '[{"Ig heavy chain enhancer": "DNA"}, {"NF-muE3": "protein"}, {"B cells": "cell_type"}]', 'prediction': {'Ig heavy chain enhancer': 'DNA', 'NF-muE3': 'protein', 'B cells': 'cell_type'}}
{'idx': 919, 'sentence': 'The human protein recognized by the EC1 antibody is a 56-kDa protein ( p56 ) of moderate abundance located predominantly in the cytoplasm by indirect immunofluorescence .', 'label': {'56-kDa protein': 'protein', 'p56': 'protein', 'EC1 antibody': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides clear and specific examples of proteins and their corresponding labels, aiding in the extraction of named entities from the target sentence."}\n]', 'response3': '[{"EC1 antibody": "protein"}, {"p56": "protein"}]', 'prediction': {'EC1 antibody': 'protein', 'p56': 'protein'}}
{'idx': 1206, 'sentence': 'In addition, the concentration of androgen receptors in mononuclear leukocytes was measured, in both the follicular and luteal phases of the menstrual cycle , basally and after 4 months of flutamide treatment.', 'label': {'androgen receptors': 'protein', 'mononuclear leukocytes': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a clear mapping between the entity \'RXR\' and its corresponding entity label \'protein\', aiding in the extraction of named entities from the target sentence."}\n]', 'response3': '[{"androgen receptors": "protein"}, {"mononuclear leukocytes": "cell_type"}, {"follicular": "cell_type"}, {"luteal": "cell_type"}, {"menstrual cycle": "cell_type"}, {"flutamide": "protein"}]', 'prediction': {'androgen receptors': 'protein', 'mononuclear leukocytes': 'cell_type', 'follicular': 'cell_type', 'luteal': 'cell_type', 'menstrual cycle': 'cell_type', 'flutamide': 'protein'}}
{'idx': 569, 'sentence': 'In addition, the increases in c-jun , EGR2 , and PDGF(B) may depend on cytoskeletal rearrangement .', 'label': {'PDGF(B)': 'protein', 'EGR2': 'DNA', 'c-jun': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B, possibly by a phosphorylation reaction involving protein kinase C by PAF.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines.": 5},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 5},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"The p21ras small GTP binding proteins participate in signal transduction from cell surface receptors and affect neoplastic transformation and development in many different cell types.": 5},\n    {"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway, and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n    {"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1657, 'sentence': 'HMG-I binds to GATA motifs : implications for an HPFH syndrome .', 'label': {'HMG-I': 'protein', 'GATA motifs': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .": 4},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50 .": 4},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes .": 3},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors .": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 4},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .": 5},\n    {"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .": 4},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .": 5},\n    {"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells .": 5},\n    {"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .": 5},\n    {"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"HMG-I": "protein"}, {"GATA motifs": "DNA"}]', 'prediction': {'HMG-I': 'protein', 'GATA motifs': 'DNA'}}
{'idx': 1780, 'sentence': 'Interestingly, Id2 , but not Id3 , mRNA was strongly expressed in 4/5 T-cell lines infected with human T-cell leukemia virus type I ( HTLV-I ) ( ATL-1k , MT-2 , S-LB1 ) and type II ( Mo ) .', 'label': {'Id3': 'protein', 'Mo': 'cell_line', 'Id2': 'protein', '4/5 T-cell lines': 'cell_line', 'S-LB1': 'cell_line', 'MT-2': 'cell_line', 'ATL-1k': 'cell_line'}, 'response1': "['RNA', 'cell_line']", 'response2': '[\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.": 5},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"Expression of tal-1 and GATA-binding proteins during human hematopoiesis.": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1/c6.1B, in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"Id2": "RNA"}, {"Id3": "RNA"}, {"T-cell lines": "cell_line"}, {"human T-cell leukemia virus type I (HTLV-I)": "cell_type"}, {"ATL-1k": "cell_line"}, {"MT-2": "cell_line"}, {"S-LB1": "cell_line"}, {"type II (Mo)": "cell_type"}]', 'prediction': {'Id2': 'RNA', 'Id3': 'RNA', 'T-cell lines': 'cell_line', 'human T-cell leukemia virus type I (HTLV-I)': 'cell_type', 'ATL-1k': 'cell_line', 'MT-2': 'cell_line', 'S-LB1': 'cell_line', 'type II (Mo)': 'cell_type'}}
{'idx': 13, 'sentence': 'We further demonstrate the impact of platelet-activating factor binding to B cells by measuring platelet-activating factor induced arachidonic acid release and 5-hydroxyeicosatetraenoic acid production.', 'label': {'platelet-activating factor': 'protein', 'B cells': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 4},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 4},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 3},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"We have examined the effect of alpha-tocopherol ( alpha-tcp ) on one cellular event in atherosclerotic plaque development , monocyte adhesion to stimulated endothelial cells ( ECs ).": 4},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 4},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects.": 5},\n    {"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.": 4},\n    {"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation.": 5},\n    {"PMA induced the expression of both CD14 and CD23 mRNA and protein.": 5},\n    {"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation.": 4},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1554, 'sentence': 'The results define essential cis-acting elements responsible for the expression of GP Ib alpha and provide insights into molecular events coinciding with the release of normal platelets into the bloodstream .', 'label': {'GP': 'protein', 'normal platelets': 'cell_type', 'cis-acting elements': 'DNA', 'GP Ib alpha': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.": 4},\n    {"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 4},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements .": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .": 4},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .": 5},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .": 5},\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .": 4},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .": 5},\n    {"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts .": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"GP Ib alpha": "protein"}]', 'prediction': {'GP Ib alpha': 'protein'}}
{'idx': 1650, 'sentence': 'This is the first demonstration of a specific interaction with PU.1 on a myeloid PU.1 binding site .', 'label': {'PU.1': 'protein', 'myeloid PU.1 binding site': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 1},\n    {"Example 13": 1},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"PU.1": "protein"}, {"myeloid": "cell_type"}, {"PU.1": "protein"}]', 'prediction': {'PU.1': 'protein', 'myeloid': 'cell_type'}}
{'idx': 326, 'sentence': 'We show here that domain B is an R-responsive element in HeLa cells and is therefore not an EB1 -responsive B-cell-specific element .', 'label': {'EB1': 'protein', 'R-responsive element': 'DNA', 'HeLa cells': 'cell_line', 'domain B': 'DNA', 'EB1 -responsive B-cell-specific element': 'DNA'}, 'response1': "['cell_line', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence contains protein names and their corresponding entity labels, which match the entity types in the target sentence."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence contains protein names and their corresponding entity labels, which match the entity types in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains cell type names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence contains cell line and cell type names, which match the entity types in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 8": 4},\n    {"Reason 8": "The sentence contains DNA and protein names, which match the entity types in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains cell type and protein names, which directly match the entity types in the target sentence."},\n    {"Example 10": 4},\n    {"Reason 10": "The sentence contains protein names and their corresponding entity labels, which match the entity types in the target sentence."},\n    {"Example 11": 4},\n    {"Reason 11": "The sentence contains cell line and protein names, which match the entity types in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains protein and cell line names, which directly match the entity types in the target sentence."},\n    {"Example 13": 4},\n    {"Reason 13": "The sentence contains protein names and their corresponding entity labels, which match the entity types in the target sentence."},\n    {"Example 14": 4},\n    {"Reason 14": "The sentence contains protein names and their corresponding entity labels, which match the entity types in the target sentence."},\n    {"Example 15": 4},\n    {"Reason 15": "The sentence contains cell line, cell type, and DNA names, which match the entity types in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any specific entity names or labels that match the entity types in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific entity names or labels that match the entity types in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific entity names or labels that match the entity types in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific entity names or labels that match the entity types in the target sentence."}\n]', 'response3': "[{'HeLa cells': 'cell_line'}, {'EB1': 'protein'}, {'B-cell-specific': 'cell_type'}]", 'prediction': {'HeLa cells': 'cell_line', 'EB1': 'protein', 'B-cell-specific': 'cell_type'}}
{'idx': 1429, 'sentence': 'Data from cell culture and animal studies indicate that TR expression may be regulated to modulate target organ responsiveness to thyroid hormone .', 'label': {'TR': 'protein'}, 'response1': "['cell_type']", 'response2': '[\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 4},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.": 5},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 5},\n    {"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 4},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 4},\n    {"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL-mediated NF-kappaB activation, but failed to affect constitutive signaling induced by receptor overexpression, revealing a selective role for TRAF6 in ligand-induced activation events.": 5},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb/Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"TR": "protein"}]', 'prediction': {'TR': 'protein'}}
{'idx': 865, 'sentence': 'Response to T cell activation signals .', 'label': {'T cell': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n{"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n{"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n{"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.": 4},\n{"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n{"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 4},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n{"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n{"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.": 5},\n{"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.": 5},\n{"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n{"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n{"Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency.": 5},\n{"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n{"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.": 4},\n{"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n{"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 696, 'sentence': 'First, from different cell lines three or all four of the nuclear proteins were specifically cross-linked by UV irradiation to the radioactively labeled TRE -DNA fragment .', 'label': {'TRE -DNA fragment': 'DNA', 'nuclear proteins': 'protein', 'TRE': 'DNA'}, 'response1': "['protein', 'cell_line', 'DNA']", 'response2': '[\n{"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n{"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .": 5},\n{"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 5},\n{"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 5},\n{"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50 .": 5},\n{"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n{"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system .": 5},\n{"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n{"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .": 5},\n{"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .": 5},\n{"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .": 5},\n{"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .": 5},\n{"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 318, 'sentence': 'Furthermore, the existence of estrogen receptor (estrogen binding activity) was examined histochemically in 39 cases and it was detected in 8.', 'label': {'estrogen receptor': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein (RXR) and its corresponding entity label."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides a clear example of a protein (retinoic acid receptor alpha) and its corresponding entity label."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence provides a clear example of a protein (NF-E2) and its corresponding entity label."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides clear examples of proteins (IL-2, c-Jun, c-Fos) and their corresponding entity labels."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides a clear example of a protein (E2A) and its corresponding entity label."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides clear examples of proteins (NF-kB, AP-1, OCT-1, NF-IL-2B) and their corresponding entity labels."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides clear examples of proteins (TCRzeta, p56(lck)) and their corresponding entity labels."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides clear examples of a cell line (Ter 119) and proteins (beta-globin, glycoprotein IIb, platelet factor 4) with their corresponding entity labels."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides clear examples of proteins (Erbstatin, genistein, Egr-1) and RNA (Egr-1) with their corresponding entity labels."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides clear examples of DNA (EBV) and proteins (EBNA2, estrogen receptor) with their corresponding entity labels."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides clear examples of cell lines (PMA-stimulated U1 cells) with their corresponding entity labels."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides clear examples of DNA (nuclear factor-kappa B, NF-kappa B) with their corresponding entity labels."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides clear examples of proteins (CD3.TcR, CD18, CD29) with their corresponding entity labels."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides clear examples of DNA (DNA) and proteins (PCNA, E2F1) with their corresponding entity labels."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides clear examples of proteins (MR, aldosterone, progesterone) with their corresponding entity labels."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence provides clear examples of proteins (E2F, E2F-4, DP-1, p130) and a cell type (AML) with their corresponding entity labels."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any named entities that match the given entity labels."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any named entities that match the given entity labels."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any named entities that match the given entity labels."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any named entities that match the given entity labels."}\n]', 'response3': '[{"estrogen receptor": "protein"}]', 'prediction': {'estrogen receptor': 'protein'}}
{'idx': 440, 'sentence': 'All three proteins show the same sequence specificity and binding affinity .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"These two related genes share the evolutionarily conserved region encoding the Runt domain.": 5},\n    {"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.": 4},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.": 5},\n    {"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.": 5},\n    {"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 5},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n    {"Tat-binding protein 7 is a subunit of the 26S protease.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n    {"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 5},\n    {"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1563, 'sentence': 'Pathogenesis of atherosclerosis .', 'label': {}, 'response1': 'None.', 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides clear examples of entities and their corresponding labels, making it very helpful for extracting named entities from the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 689, 'sentence': 'High-risk patients can be recognized morphologically.', 'label': {}, 'response1': 'None.', 'response2': '[\n    {"PBMC": 5},\n    {"adenovirus": 5},\n    {"WT1": 5},\n    {"CD70": 5},\n    {"B cell": 5},\n    {"plasma cells": 5},\n    {"IL-4": 5},\n    {"CD40": 5},\n    {"TCL1": 5},\n    {"myeloperoxidase": 5},\n    {"lysozyme": 5},\n    {"PU.1": 5},\n    {"Ras": 5},\n    {"T-PLL": 5},\n    {"T lymphocytes": 5},\n    {"HLA-molecules": 5},\n    {"MNDA": 5},\n    {"Philadelphia chromosome-positive chronic myeloid leukemia": 5},\n    {"granulocytes": 5},\n    {"T cells": 5},\n    {"TCRzeta": 5},\n    {"p56(lck)": 5},\n    {"PML/RARalpha": 5},\n    {"SIVmacMER": 5},\n    {"SIVmac239": 5},\n    {"CEMx174": 5},\n    {"lymphoid neoplasms": 5},\n    {"SIVsmmPBj14": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 189, 'sentence': 'Transcriptional down-regulation of c-myc expression by protein synthesis -dependent and -independent pathways in a human T lymphoblastic tumor cell line .', 'label': {'human T lymphoblastic tumor cell line': 'cell_line', 'c-myc': 'DNA'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple entities relevant to the entity labels in the target sentence, such as \'NF-ATc\' (protein) and \'T lymphocytes\' (cell_type). This example provides direct matches to the entity labels in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains an entity \'AP-1\' that matches the \'DNA\' entity label in the target sentence. This example directly corresponds to one of the entity labels in the target sentence, providing relevant information for entity extraction."},\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions \'Sp1\' and \'CD14\', which correspond to the \'protein\' entity label in the target sentence. This example directly relates to one of the entity labels in the target sentence, aiding in the extraction of named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence includes \'IkappaBbeta\' and \'NF-kappaB\', which match the \'protein\' entity label in the target sentence. This example directly aligns with one of the entity labels in the target sentence, making it highly useful for named entity extraction."},\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions \'Sp1\' and \'Ets\', which correspond to the \'protein\' entity label in the target sentence. This example directly relates to one of the entity labels in the target sentence, aiding in the extraction of named entities."},\n    {"Sentence": 3},\n    {"Reason": "The sentence includes \'Th2-type lymphocytes\', which matches the \'cell_type\' entity label in the target sentence. This example provides relevant information for extracting named entities, although it does not directly correspond to all entity labels in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions \'WT1\' and \'myeloid cell lines\', which correspond to the \'protein\' and \'cell_line\' entity labels in the target sentence. This example directly relates to some of the entity labels in the target sentence, aiding in named entity extraction."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains \'NF-ATc\', \'T lymphocytes\', and \'embryonic cardiac cells\', which match the \'protein\' and \'cell_type\' entity labels in the target sentence. This example directly aligns with multiple entity labels in the target sentence, making it highly helpful for named entity extraction."},\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions \'SP1\', \'caspases\', and \'B-cell\', which correspond to the \'protein\' and \'cell_type\' entity labels in the target sentence. This example directly relates to some of the entity labels in the target sentence, aiding in named entity extraction."},\n    {"Sentence": 3},\n    {"Reason": "The sentence includes \'GATA-1\', which matches the \'protein\' entity label in the target sentence. This example provides relevant information for extracting named entities, although it does not directly correspond to all entity labels in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains \'ZEB\', \'c-Myb\', \'Ets\', and \'hematopoietic cells\', which correspond to the \'protein\' and \'cell_type\' entity labels in the target sentence. This example directly aligns with multiple entity labels in the target sentence, making it highly helpful for named entity extraction."},\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions \'YY1\', \'Oct1\', \'IL-5\', and \'T cells\', which correspond to the \'protein\' and \'cell_type\' entity labels in the target sentence. This example directly relates to some of the entity labels in the target sentence, aiding in named entity extraction."},\n    {"Sentence": 5},\n    {"Reason": "The sentence includes \'B and T cell activation\', \'Ramos\', \'Jurkat\', and \'cDNA microarray technology\', which match the \'cell_type\', \'cell_line\', and \'DNA\' entity labels in the target sentence. This example directly aligns with multiple entity labels in the target sentence, making it highly helpful for named entity extraction."},\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions \'tal-1\', \'GATA-binding proteins\', and \'hematopoiesis\', which correspond to the \'protein\' and \'cell_type\' entity labels in the target sentence. This example directly relates to some of the entity labels in the target sentence, aiding in named entity extraction."},\n    {"Sentence": 3},\n    {"Reason": "The sentence includes \'cDNA\', \'Jurkat\', and \'DRE 1\', which match the \'DNA\' and \'cell_line\' entity labels in the target sentence. This example provides relevant information for extracting named entities, although it does not directly correspond to all entity labels in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains \'AP-1\', \'c-jun\', \'IL-2\', \'NF-AT\', and \'T cell\', which match the \'protein\' and \'cell_type\' entity labels in the target sentence. This example directly aligns with multiple entity labels in the target sentence, making it highly helpful for named entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any entities that match the entity labels in the target sentence, making it not helpful for named entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any entities that match the entity labels in the target sentence, making it not helpful for named entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any entities that match the entity labels in the target sentence, making it not helpful for named entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any entities that match the entity labels in the target sentence, making it not helpful for named entity extraction."}\n]', 'response3': '[{"c-myc": "protein"}, {"T lymphoblastic tumor cell line": "cell_line"}]', 'prediction': {'c-myc': 'protein', 'T lymphoblastic tumor cell line': 'cell_line'}}
{'idx': 778, 'sentence': 'Addition of a highly enriched preparation of OTF-1 made from one of these pre-B cells or from HeLa cells specifically stimulated in vitro transcription of an immunoglobulin gene .', 'label': {'OTF-1': 'protein', 'pre-B cells': 'cell_line', 'immunoglobulin gene': 'DNA', 'HeLa cells': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .": 4},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 5},\n    {"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 4},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 4},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .": 4},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"T cell blasts treated with PMA are now responsive to IFN-gamma .": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n    {"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .": 5},\n    {"Fibroblast growth factor-1 ( FGF-1 ) enhances IL-2 production and nuclear translocation of NF-kappaB in FGF receptor -bearing Jurkat T cells .": 5}\n]', 'response3': '[{"OTF-1": "protein"}, {"pre-B cells": "cell_type"}, {"HeLa cells": "cell_line"}, {"immunoglobulin gene": "protein"}]', 'prediction': {'OTF-1': 'protein', 'pre-B cells': 'cell_type', 'HeLa cells': 'cell_line', 'immunoglobulin gene': 'protein'}}
{'idx': 198, 'sentence': "Tamoxifen , an oestrogen antagonist , has been given in some patients with CLL and Hodgkin's disease , with dramatic response in single cases.", 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms.": 1},\n    {"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 4},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.": 4},\n    {"Thus, STAT1 may be a useful target in the development of new immunosuppressive and antineoplastic agents.": 5},\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 4},\n    {"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.": 5},\n    {"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes.": 4},\n    {"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway, and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.": 5},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 5},\n    {"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.": 4},\n    {"T cell blasts treated with PMA are now responsive to IFN-gamma.": 4},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n    {"Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1/c6.1B, in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients.": 4},\n    {"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 735, 'sentence': 'This prompted us to analyze the octamer-binding proteins in the latter cells.', 'label': {'octamer-binding proteins': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 5},\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 4},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .": 4},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 4},\n    {"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.": 5},\n    {"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells .": 5},\n    {"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .": 5},\n    {"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes .": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1735, 'sentence': 'We therefore examined vitamin D3 -mediated repression of activated IL-2 expression by cotransfecting Jurkat cells with IL-2 promoter/reporter constructs and a VDR overexpression vector and by DNA binding .', 'label': {'VDR': 'protein', 'IL-2 promoter/reporter constructs': 'DNA', 'Jurkat cells': 'cell_line', 'VDR overexpression vector': 'DNA', 'IL-2': 'protein'}, 'response1': "['DNA', 'protein', 'cell_line']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 4},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 4},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .": 4},\n    {"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex .": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .": 5},\n    {"While the activation of the IL-2 promoter and an NFAT -driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418 , it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2 -mediated NFAT activation is under the control of a combination of calcineurin- dependent and independent pathways .": 5},\n    {"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"IL-2": "protein"}, {"Jurkat": "cell_line"}, {"IL-2": "DNA"}, {"VDR": "protein"}, {"DNA": "DNA"}]', 'prediction': {'IL-2': 'DNA', 'Jurkat': 'cell_line', 'VDR': 'protein', 'DNA': 'DNA'}}
{'idx': 704, 'sentence': 'Activity of the immunoglobulin heavy and kappa light chain gene enhancers depends on a complex interplay of ubiquitous and developmentally regulated proteins .', 'label': {'ubiquitous and developmentally regulated proteins': 'protein', 'ubiquitous': 'protein', 'developmentally regulated proteins': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence 1": 5},\n    {"Sentence 2": 5},\n    {"Sentence 3": 5},\n    {"Sentence 4": 5},\n    {"Sentence 5": 5},\n    {"Sentence 6": 5},\n    {"Sentence 7": 5},\n    {"Sentence 8": 5},\n    {"Sentence 9": 1},\n    {"Sentence 10": 1},\n    {"Sentence 11": 5},\n    {"Sentence 12": 5},\n    {"Sentence 13": 5},\n    {"Sentence 14": 5},\n    {"Sentence 15": 1},\n    {"Sentence 16": 1},\n    {"Sentence 17": 1},\n    {"Sentence 18": 1},\n    {"Sentence 19": 1},\n    {"Sentence 20": 1}\n]', 'response3': '[{"immunoglobulin heavy and kappa light chain gene enhancers": "DNA"}]', 'prediction': {'immunoglobulin heavy and kappa light chain gene enhancers': 'DNA'}}
{'idx': 1236, 'sentence': 'Binding site selection revealed that the alternating RCGCRYGCGY consensus constitutes high-affinity IBR/F binding sites and that the direct-repeat palindrome TGCGCATGCGCA is the optimal site .', 'label': {'direct-repeat palindrome': 'DNA', 'IBR/F': 'protein', 'IBR/F binding sites': 'DNA', 'optimal site': 'DNA', 'alternating RCGCRYGCGY consensus': 'protein'}, 'response1': "['DNA']", 'response2': '[\n{"T cell": 5, "kB-like proto-enhancer element": 4, "interleukin 2": 4},\n{"immunoglobulin kappa 3\' enhancer": 5},\n{"CREB": 4, "AR-CRE": 4},\n{"SIVsmmPBj14": 5},\n{"EBNA2": 4, "TP1": 4},\n{"BRCA1": 5},\n{"p50p50": 5},\n{"GM-CSF": 4},\n{"retinoic acid receptor alpha": 5},\n{"IL-2": 4, "c-Jun": 4, "c-Fos": 4},\n{"Protein": 4},\n{"Th2-type lymphocytes": 5},\n{"IgH": 5},\n{"VDR": 4, "RXR": 4, "GRIP-1": 4, "DRIP205": 4, "DRIP": 4},\n{"GM-kappa B": 4, "GC-box": 4, "GC-motif": 4, "GM-kappa B motif": 4},\n{"NF-kappaB": 4, "Sp1": 4, "SIVmac": 4}\n]', 'response3': '[{"RCGCRYGCGY": "DNA"}, {"IBR/F": "protein"}, {"TGCGCATGCGCA": "DNA"}]', 'prediction': {'RCGCRYGCGY': 'DNA', 'IBR/F': 'protein', 'TGCGCATGCGCA': 'DNA'}}
{'idx': 541, 'sentence': 'To be or not to be a responder in T-cell responses : ubiquitous oligopeptides in all proteins.', 'label': {}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"T-cell": "cell_type"}, {"proteins": "protein"}]', 'prediction': {'T-cell': 'cell_type', 'proteins': 'protein'}}
{'idx': 1652, 'sentence': 'Furthermore, we demonstrate that the PU-SF complex binds to PU.1 sites found on a number of myeloid promoters , and its formation requires an intact PU.1 site adjacent to a single-stranded region.', 'label': {'PU.1': 'protein', 'PU-SF complex': 'protein', 'myeloid promoters': 'DNA', 'PU.1 site': 'DNA', 'PU-SF': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 3},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 4},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 3},\n    {"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.": 4},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 4},\n    {"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 3},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 4},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 4},\n    {"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 4},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes.": 3},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"PU-SF complex": "protein"}, {"PU.1": "protein"}]', 'prediction': {'PU-SF complex': 'protein', 'PU.1': 'protein'}}
{'idx': 88, 'sentence': 'TNF alpha did not activate cAMP production and its signal was not modulated by cAMP activators .', 'label': {'TNF alpha': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 1},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 1},\n    {"Example 14": 1},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1494, 'sentence': 'Increased intracellular stores of latent NF-kappa B may also result in rapid inducibility of NF-kappa B -dependent cytokine gene expression .', 'label': {'latent NF-kappa B': 'protein', 'cytokine': 'protein', 'NF-kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 4},\n    {"Example 6": 4},\n    {"Example 7": 4},\n    {"Example 8": 4},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 1},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 3},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"NF-kappa B": "protein"}]', 'prediction': {'NF-kappa B': 'protein'}}
{'idx': 940, 'sentence': 'Tamoxifen was also found to compete with 17 beta-estradiol for type II EBS in PBMC , although to a lesser extent than diethylstilbestrol .', 'label': {'PBMC': 'cell_type', 'type II EBS': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The example provides a specific protein entity label (NF-E2) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 2": 4},\n{"Reason 2": "The examples provide protein (alpha-tocopherol), cell type (monocyte, endothelial cells) entity labels mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 3": 4},\n{"Reason 3": "The examples provide protein entities (NF-kappa B, AP-1) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 4": 4},\n{"Reason 4": "The examples provide protein entities (IL-2, NF-kappa B, AP-1) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 5": 5},\n{"Reason 5": "The example provides RNA (IL-5 mRNA), cell type (TCR), protein (IL-2R, dexamethasone) entity labels mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 6": 5},\n{"Reason 6": "The example provides a specific protein entity label (retinoic acid receptor alpha) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 7": 4},\n{"Reason 7": "The examples provide protein (WT1) and cell line (myeloid cell lines) entity labels mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 8": 5},\n{"Reason 8": "The example provides a specific protein entity label (E2A) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 9": 5},\n{"Reason 9": "The example provides protein entities (NF-kappa B, I kappa B beta) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 10": 4},\n{"Reason 10": "The examples provide cell type (lymphocytes), chemical compound (benzene, benzoquinone) entity labels mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 11": 4},\n{"Reason 11": "The example provides a specific protein entity label (NF-kappa B) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 12": 5},\n{"Reason 12": "The example provides cell line (Ter 119), protein entities (beta-globin, glycoprotein IIb, platelet factor 4) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 13": 4},\n{"Reason 13": "The examples provide protein entities (Erbstatin, genistein), RNA (Egr-1) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 14": 4},\n{"Reason 14": "The examples provide cell type (B cell), protein (Ig, Transforming growth factor-beta) entity labels mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 15": 4},\n{"Reason 15": "The examples provide DNA (EBV), protein entities (EBNA2, estrogen receptor) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 16": 4},\n{"Reason 16": "The examples provide cell line entities (PMA, U1 cells) mentioned in the sentence, aiding in the extraction of named entities."},\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any specific named entities related to the given entity labels."},\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any specific named entities related to the given entity labels."},\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any specific named entities related to the given entity labels."},\n{"Example 20": 1},\n{"Reason 20": "The sentence does not contain any specific named entities related to the given entity labels."}\n]', 'response3': "[{'17 beta-estradiol': 'protein'}, {'diethylstilbestrol': 'protein'}]", 'prediction': {'17 beta-estradiol': 'protein', 'diethylstilbestrol': 'protein'}}
{'idx': 1098, 'sentence': 'Thus, intact microtubules are essential for 1,25(OH)2D3 -dependent modulation of gene transcription .', 'label': {'microtubules': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.": 5},\n    {"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.": 4},\n    {"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis.": 5},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n    {"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras.": 5},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes.": 3},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 5},\n    {"Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B / Oct-1 -dependent transcription.": 5},\n    {"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n    {"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts.": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 255, 'sentence': 'c-myc RNA , which is constitutively expressed in RWLeu-4 cells , increased after 0.5 h of treatment with 50 nM VD3 and then rapidly decreased to barely detectable levels after 4 h of treatment.', 'label': {'c-myc RNA': 'RNA', 'RWLeu-4 cells': 'cell_line'}, 'response1': "['RNA', 'cell_line']", 'response2': '[\n    {"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.": 5},\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 5},\n    {"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 5},\n    {"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA -stimulated U1 cells , respectively.": 5},\n    {"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"c-myc RNA": "RNA"}, {"RWLeu-4 cells": "cell_line"}, {"VD3": "protein"}]', 'prediction': {'c-myc RNA': 'RNA', 'RWLeu-4 cells': 'cell_line', 'VD3': 'protein'}}
{'idx': 775, 'sentence': 'Some of these proteins (referred to as OTF-2 ) are lymphoid specific, whereas at least one other, and possibly more (referred to as OTF-1 ), is found ubiquitously in all cell types.', 'label': {'OTF-1': 'protein', 'OTF-2': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"NF-ATc": 5},\n    {"T lymphocytes": 5},\n    {"IL-4": 4},\n    {"Protein": 4},\n    {"WT1": 4},\n    {"IFN A": 5},\n    {"IFNA": 5},\n    {"interleukin-2": 5},\n    {"interleukin-2 receptor": 5},\n    {"phytohemagglutinin": 5},\n    {"phorbol myristate acetate": 5},\n    {"GATA-1": 5},\n    {"Syk": 5},\n    {"Zap": 5},\n    {"T cell": 5},\n    {"RXR": 5},\n    {"E2A": 5},\n    {"Th2-type lymphocytes": 5},\n    {"TCF-1": 5},\n    {"immunohistochemistry": 4},\n    {"gene": 3},\n    {"myeloperoxidase": 5},\n    {"lysozyme": 5},\n    {"PU.1": 5},\n    {"Th1": 5},\n    {"Th2": 5},\n    {"Egr-1": 5},\n    {"CD70": 5},\n    {"B cell": 5},\n    {"plasma cells": 5},\n    {"IL-4": 5},\n    {"CD40": 5}\n]', 'response3': '[{"OTF-2": "protein"}, {"OTF-1": "protein"}]', 'prediction': {'OTF-2': 'protein', 'OTF-1': 'protein'}}
{'idx': 161, 'sentence': 'Steroid dose sparing : pharmacodynamic responses to single versus divided doses of methylprednisolone in man.', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 1},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.": 5},\n    {"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes.": 5},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.": 5},\n    {"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 5},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 5},\n    {"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.": 5},\n    {"MATERIALS AND METHODS: Human monocytes were stimulated with PMA (50 ng/ml) alone or LPS (100 ng/ml) with and without a nonspecific serine/threonine protein kinase inhibitor staurosporine (Stauro), a specific pan-PKC inhibitor bisindolylmaleimide (Bis), or an inhibitor of PTK genistein (Gen).": 5},\n    {"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.": 5},\n    {"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.": 5},\n    {"DNA-binding phosphoproteins induced after T cell activation: effects of cyclosporin A.": 5},\n    {"Treatment with soluble, bivalent mAb J393 killed 25-50% of the cell population, while concomitant engagement of either the CD3.TcR complex or the integrins CD18 and CD29 significantly potentiated this effect.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1130, 'sentence': 'B-lymphoblastoid cell lines from multiple sclerosis patients and a healthy control producing a putative new human retrovirus and Epstein-Barr virus .', 'label': {'B-lymphoblastoid cell lines': 'cell_line'}, 'response1': "['cell_line', 'virus']", 'response2': '[\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 1},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .": 4},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .": 4},\n    {"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.": 3},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 3},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .": 5},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 4},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .": 4},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n    {"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .": 5},\n    {"Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice .": 5},\n    {"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"B-lymphoblastoid cell lines": "cell_line"}, {"multiple sclerosis patients": "cell_type"}, {"healthy control": "cell_type"}, {"putative new human retrovirus": "virus"}, {"Epstein-Barr virus": "virus"}]', 'prediction': {'B-lymphoblastoid cell lines': 'cell_line', 'multiple sclerosis patients': 'cell_type', 'healthy control': 'cell_type', 'putative new human retrovirus': 'virus', 'Epstein-Barr virus': 'virus'}}
{'idx': 600, 'sentence': 'Involvement of a second lymphoid-specific enhancer element in the regulation of immunoglobulin heavy-chain gene expression .', 'label': {'immunoglobulin heavy-chain gene': 'DNA', 'lymphoid-specific enhancer element': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .": 5},\n    {"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 4},\n    {"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements .": 5},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .": 5},\n    {"Binding of YY1 and Oct1 to a novel element that downregulates expression of IL-5 in human T cells .": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"lymphoid-specific enhancer element": "DNA"}, {"immunoglobulin heavy-chain gene": "protein"}]', 'prediction': {'lymphoid-specific enhancer element': 'DNA', 'immunoglobulin heavy-chain gene': 'protein'}}
{'idx': 1698, 'sentence': 'Oncogenicity of human papillomavirus- or adenovirus- transformed cells correlates with resistance to lysis by natural killer cells .', 'label': {'natural killer cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 4},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 4},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 4},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5},\n    {"Notably, the lack of pRB in these U937-derived clones renders these p53-null cells highly resistant to apoptosis induced by serum withdrawal, calphostin C, and ceramide.": 5},\n    {"Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype.": 5},\n    {"To our knowledge, this represents the first demonstration that phagocytic stimuli can induce NF-kappa B activation in human neutrophils.": 5},\n    {"These results demonstrate the existence of a triple autoregulatory loop in monocytes and macrophages involving HIV, p105 and p50, and MAD3, with the end result of persistent NF-kappa B activation and viral persistence.": 5},\n    {"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': "[{'human papillomavirus- or adenovirus- transformed cells': 'cell_type'}, {'natural killer cells': 'cell_type'}]", 'prediction': {'human papillomavirus- or adenovirus- transformed cells': 'cell_type', 'natural killer cells': 'cell_type'}}
{'idx': 1287, 'sentence': 'Platelet thromboxane receptors are acutely and reversibly upregulated after acute myocardial infarction .', 'label': {'Platelet thromboxane receptors': 'protein', 'Platelet': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides clear and specific examples of protein names that are directly mentioned in the text, making it highly helpful for extracting named entities."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions specific protein names that are relevant to the context, aiding in the extraction of named entities, but the sentence could be more specific."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains multiple protein names that are directly related to the context, making it highly helpful for extracting named entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides specific protein names and cell types that are directly mentioned in the text, making it highly helpful for extracting named entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence mentions a specific protein name that is relevant to the context, aiding in the extraction of named entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides specific protein names that are directly mentioned in the text, making it highly helpful for extracting named entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains specific protein names and cell types that are directly related to the context, making it highly helpful for extracting named entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions specific protein names and a cell type that are relevant to the context, aiding in the extraction of named entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides specific protein names and cell types that are directly mentioned in the text, making it highly helpful for extracting named entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence mentions a specific protein name that is relevant to the context, aiding in the extraction of named entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides a specific protein name that is directly related to the context, making it highly helpful for extracting named entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains specific protein names that are directly mentioned in the text, making it highly helpful for extracting named entities."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides specific protein names that are directly related to the context, making it highly helpful for extracting named entities."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains specific protein names and a cell type that are directly mentioned in the text, making it highly helpful for extracting named entities."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence mentions specific protein names and a cell type that are relevant to the context, aiding in the extraction of named entities."}\n]', 'response3': "[{'Platelet thromboxane receptors': 'protein'}]", 'prediction': {'Platelet thromboxane receptors': 'protein'}}
{'idx': 1266, 'sentence': 'Human herpesvirus 6 , a predominantly T lymphotropic virus , has been recently shown to infect some EBV -positive B cell lines , and to induce in them the activation of the EBV lytic cycle .', 'label': {'EBV -positive B cell lines': 'cell_line'}, 'response1': "['virus', 'cell_line']", 'response2': '[\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.": 4},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 4},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B.": 4},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus , and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process.": 4},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n    {"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner.": 5},\n    {"Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"Human herpesvirus 6": "cell_type"}, {"EBV": "cell_line"}, {"B cell lines": "cell_line"}, {"EBV lytic cycle": "cell_type"}]', 'prediction': {'Human herpesvirus 6': 'cell_type', 'EBV': 'cell_line', 'B cell lines': 'cell_line', 'EBV lytic cycle': 'cell_type'}}
{'idx': 1813, 'sentence': 'Northern blot analysis revealed that BLR2 mRNA could be highly stimulated in mitogen- and anti-CD3- treated peripheral blood lymphocytes .', 'label': {'BLR2 mRNA': 'RNA', 'BLR2': 'protein'}, 'response1': "['RNA', 'cell_type']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities (proteins, cytokines, receptors) that are relevant to the entity labels in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities (proteins, cytokines, receptors) that are relevant to the entity labels in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities (proteins, cytokines, receptors, cell types) that are relevant to the entity labels in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities (proteins) that are relevant to the entity labels in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities (proteins, cytokines, receptors, cell types) that are relevant to the entity labels in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities (proteins, cytokines, receptors, cell types) that are relevant to the entity labels in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities (proteins, cytokines, receptors, cell types) that are relevant to the entity labels in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities (proteins) that are relevant to the entity labels in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities (proteins, cytokines, receptors) that are relevant to the entity labels in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities (proteins, cytokines, receptors, cell types) that are relevant to the entity labels in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities (proteins, cytokines, receptors) that are relevant to the entity labels in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities (proteins, cytokines, receptors, cell types) that are relevant to the entity labels in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, hence it is not helpful for extracting named entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, hence it is not helpful for extracting named entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, hence it is not helpful for extracting named entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, hence it is not helpful for extracting named entities."}\n]', 'response3': '[{"BLR2 mRNA": "RNA"}, {"mitogen": "protein"}, {"anti-CD3": "protein"}, {"peripheral blood lymphocytes": "cell_type"}]', 'prediction': {'BLR2 mRNA': 'RNA', 'mitogen': 'protein', 'anti-CD3': 'protein', 'peripheral blood lymphocytes': 'cell_type'}}
{'idx': 1764, 'sentence': 'The inhibitory effect of cysteamine may be mediated at least in part by an effect on transcription factor function , as the DNA binding activities of AP-1 and NF-kappa B extracted from mitogen-stimulated cells were significantly inhibited by cysteamine treatment .', 'label': {'AP-1': 'protein', 'NF-kappa B': 'protein', 'transcription factor': 'protein', 'mitogen-stimulated cells': 'cell_type'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 5},\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"Control of NF-kappa B activity by the I kappa B beta inhibitor.": 5},\n    {"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n    {"RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n    {"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B, possibly by a phosphorylation reaction involving protein kinase C by PAF.": 5},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 5},\n    {"While the activation of the IL-2 promoter and an NFAT-driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418, it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2-mediated NFAT activation is under the control of a combination of calcineurin-dependent and independent pathways.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"AP-1": "DNA"}, {"NF-kappa B": "protein"}]', 'prediction': {'AP-1': 'DNA', 'NF-kappa B': 'protein'}}
{'idx': 740, 'sentence': 'On the basis of these assays, all N-Oct-factors were found to be distinct from the ubiquitous Oct-1 and the lymphoid-specific Oct-2A proteins.', 'label': {'ubiquitous Oct-1': 'protein', 'Oct-1': 'protein', 'Oct-2A': 'protein', 'lymphoid-specific Oct-2A': 'protein', 'N-Oct-factors': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear and direct mention of the entity along with its corresponding label, making it highly helpful for extracting named entities."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence directly mentions the entity and its label, aiding in the extraction of named entities."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence explicitly mentions the entity and its label, providing clear guidance for named entity extraction."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains multiple explicit mentions of entities and their labels, making it very helpful for named entity extraction."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides clear mentions of entities and their labels, aiding in the extraction of named entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence explicitly mentions the entities and their labels, providing valuable information for named entity extraction."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence directly mentions the entity and its label, making it highly helpful for named entity extraction."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides a clear mention of the entity and its label, aiding in named entity extraction."},\n    {"Example 9": 1},\n    {"Reason 9": "The sentence does not contain any explicit mentions of entities or their labels, making it not helpful for named entity extraction."},\n    {"Example 10": 1},\n    {"Reason 10": "The sentence does not contain any explicit mentions of entities or their labels, making it not helpful for named entity extraction."},\n    {"Example 11": 1},\n    {"Reason 11": "The sentence does not contain any explicit mentions of entities or their labels, making it not helpful for named entity extraction."},\n    {"Example 12": 1},\n    {"Reason 12": "The sentence does not contain any explicit mentions of entities or their labels, making it not helpful for named entity extraction."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not contain any explicit mentions of entities or their labels, making it not helpful for named entity extraction."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not contain any explicit mentions of entities or their labels, making it not helpful for named entity extraction."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any explicit mentions of entities or their labels, making it not helpful for named entity extraction."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any explicit mentions of entities or their labels, making it not helpful for named entity extraction."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any explicit mentions of entities or their labels, making it not helpful for named entity extraction."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1182, 'sentence': 'Moreover, STAT5 was found to be the predominant STAT transcription factor used by IL-2 in human T cells , and specifically required a COOH-terminal region of IL-2R beta ( Ser386-Val525 ), while STAT5 recruitment was not correlated to activation of IL-2R gamma or JAK3 .', 'label': {'IL-2': 'protein', 'T cells': 'cell_type', 'COOH-terminal region': 'protein', 'human T cells': 'cell_type', 'Ser386-Val525': 'protein', 'JAK3': 'protein', 'STAT transcription factor': 'protein', 'STAT5': 'protein', 'IL-2R beta': 'protein', 'IL-2R gamma': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 4},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"STAT5": "protein"}, {"IL-2": "protein"}, {"T cells": "cell_type"}, {"IL-2R beta": "protein"}, {"IL-2R gamma": "protein"}, {"JAK3": "protein"}]', 'prediction': {'STAT5': 'protein', 'IL-2': 'protein', 'T cells': 'cell_type', 'IL-2R beta': 'protein', 'IL-2R gamma': 'protein', 'JAK3': 'protein'}}
{'idx': 393, 'sentence': 'We also tested for the ability of defensins NP-1 , NP-5 , and HNP-1 to activate pag expression and found that these peptides have no effect.', 'label': {'HNP-1': 'protein', 'pag': 'DNA', 'NP-1': 'protein', 'defensins': 'protein', 'NP-5': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 4},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n    {"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 3},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05.": 3},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .": 5},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .": 5},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .": 4},\n    {"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.": 5},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1442, 'sentence': 'T cell expression of interleukin 3 ( IL-3 ) is directed by positive and negative cis-acting DNA elements clustered within 300 base pairs of the transcriptional start site .', 'label': {'interleukin 3': 'protein', 'transcriptional start site': 'DNA', 'IL-3': 'protein'}, 'response1': "['DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"IL-3": "protein"}]', 'prediction': {'IL-3': 'protein'}}
{'idx': 142, 'sentence': 'This level of NF-kappa B -independent activity appears to be sufficient for virus multiplication , since TNF-alpha treatment had no effect on the kinetics of de novo HIV type 1 ( HIV-1 ) infection and viral RNA production in U937 cells .', 'label': {'U937 cells': 'cell_line', 'NF-kappa B': 'protein', 'viral RNA': 'RNA', 'TNF-alpha': 'protein'}, 'response1': "['RNA', 'protein', 'cell_line']", 'response2': '[\n    {"TIMP-1": 5},\n    {"DNA": 4},\n    {"NF-kB": 4},\n    {"AP-1": 4},\n    {"OCT-1": 4},\n    {"NF-IL-2B": 4},\n    {"RelA": 4},\n    {"NF-kappa B": 5},\n    {"Tax": 4},\n    {"ATL": 4},\n    {"IkappaBbeta": 4},\n    {"IL-2": 4},\n    {"I kappa B alpha": 4},\n    {"IFN A": 4},\n    {"IFNA": 4},\n    {"interleukin-2": 4},\n    {"interleukin-2 receptor": 4},\n    {"phytohemagglutinin": 4},\n    {"phorbol myristate acetate": 4},\n    {"HIV-1": 4},\n    {"PKR": 4},\n    {"TR55": 4},\n    {"SIVmac": 4},\n    {"Sp1": 4}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"TNF-alpha": "protein"}, {"HIV type 1": "cell_type"}, {"HIV-1": "cell_type"}, {"RNA": "RNA"}, {"U937 cells": "cell_line"}]', 'prediction': {'NF-kappa B': 'protein', 'TNF-alpha': 'protein', 'HIV type 1': 'cell_type', 'HIV-1': 'cell_type', 'RNA': 'RNA', 'U937 cells': 'cell_line'}}
{'idx': 93, 'sentence': 'The Thy-1 gene promoter resembles a "housekeeping" promoter in that it is located within a methylation-free island , lacks a canonical TATA box , and displays heterogeneity in the 5\'-end termini of the mRNA .', 'label': {'canonical TATA box': 'DNA', '"housekeeping" promoter': 'DNA', 'methylation-free island': 'DNA', "5'-end termini": 'RNA', 'Thy-1 gene promoter': 'DNA', 'mRNA': 'RNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 5},\n{"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n{"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n{"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 4},\n{"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 4},\n{"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n{"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.": 4},\n{"A critical role of Sp1- and Ets-related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n{"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n{"While the activation of the IL-2 promoter and an NFAT-driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418, it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2-mediated NFAT activation is under the control of a combination of calcineurin-dependent and independent pathways.": 5},\n{"This sequence element was referred to as the BAT box and its deletion significantly reduced the activity of a CD20 promoter-CAT construct in B cells.": 5},\n{"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"Thy-1 gene": "protein"}]', 'prediction': {'Thy-1 gene': 'protein'}}
{'idx': 1354, 'sentence': 'In addition, these results indicate that nuclear TCF-1 expression can serve as a pan-T-lineage marker in the diagnosis of lymphoid malignancies .', 'label': {'TCF-1': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains a clear mention of a transcription factor (AP-1) and its association with DNA binding activity, which directly matches the entity labels in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions NF-kappaB, Tax, and ATL patients, which are relevant to the entity labels in the target sentence. The associations are clear but not as direct as in Example 1."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence mentions WT1 and peripheral lymphocytes, which are relevant to the entity labels in the target sentence. The association is clear but not as direct as in Example 1."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence mentions TCL1 and AIDS IBLP tumors, which are relevant to the entity labels in the target sentence. The association is clear but not as direct as in Example 1."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence mentions NF-ATc and T lymphocytes, which are relevant to the entity labels in the target sentence. The association is clear but not as direct as in Example 1."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence mentions TCF-1 and non-T cells, which are relevant to the entity labels in the target sentence. The association is clear but not as direct as in Example 1."},\n    {"Example 7": 3},\n    {"Reason 7": "The sentence mentions lymphoid neoplasms, which is relevant to the entity labels in the target sentence. The association is clear but not as direct as in Example 1."},\n    {"Example 8": 3},\n    {"Reason 8": "The sentence mentions Th2-type lymphocytes, which is relevant to the entity labels in the target sentence. The association is clear but not as direct as in Example 1."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence mentions TCF-1 and TCF-1 knock-out mice, which are relevant to the entity labels in the target sentence. The association is clear but not as direct as in Example 1."},\n    {"Example 10": 4},\n    {"Reason 10": "The sentence mentions NF-ATc, T lymphocytes, and embryonic cardiac cells, which are relevant to the entity labels in the target sentence. The association is clear but not as direct as in Example 1."},\n    {"Example 11": 4},\n    {"Reason 11": "The sentence mentions RXR and erythroid cells, which are relevant to the entity labels in the target sentence. The association is clear but not as direct as in Example 1."},\n    {"Example 12": 4},\n    {"Reason 12": "The sentence mentions MNDA and Philadelphia chromosome-positive chronic myeloid leukemia, which are relevant to the entity labels in the target sentence. The association is clear but not as direct as in Example 1."},\n    {"Example 13": 4},\n    {"Reason 13": "The sentence mentions granulocytes and T cells, which are relevant to the entity labels in the target sentence. The association is clear but not as direct as in Example 1."},\n    {"Example 14": 4},\n    {"Reason 14": "The sentence mentions CD70, B cells, plasma cells, IL-4, and CD40, which are relevant to the entity labels in the target sentence. The associations are clear but not as direct as in Example 1."},\n    {"Example 15": 4},\n    {"Reason 15": "The sentence mentions TAL1 and T-ALL, which are relevant to the entity labels in the target sentence. The association is clear but not as direct as in Example 1."},\n    {"Example 16": 3},\n    {"Reason 16": "The sentence mentions GATA-1 and erythroid cells, which are relevant to the entity labels in the target sentence. The association is clear but not as direct as in Example 1."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities that match the entity labels in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities that match the entity labels in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities that match the entity labels in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities that match the entity labels in the target sentence."}\n]', 'response3': '[{"TCF-1": "protein"}, {"lymphoid malignancies": "cell_type"}]', 'prediction': {'TCF-1': 'protein', 'lymphoid malignancies': 'cell_type'}}
{'idx': 466, 'sentence': '(ABSTRACT TRUNCATED AT 250 WORDS)', 'label': {}, 'response1': 'None.', 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a clear and specific entity with its corresponding label, aiding in understanding how named entities are identified in the sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The example includes multiple entities with their corresponding labels, demonstrating the variety of named entities present in the sentence and how they are categorized."},\n    {"Example 3": 5},\n    {"Reason 3": "The example highlights a specific entity with its label, showcasing the relevance of the named entity in the context of the sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The example presents a clear entity with its label, aiding in understanding how named entities are identified in the sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides a specific entity with its label, demonstrating the relevance of the named entity in the context of the sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The example includes multiple entities with their corresponding labels, showcasing the variety of named entities present in the sentence and how they are categorized."},\n    {"Example 7": 5},\n    {"Reason 7": "The example presents a specific entity with its label, aiding in understanding how named entities are identified in the sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides a clear entity with its label, demonstrating the relevance of the named entity in the context of the sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The example includes a specific entity with its label, aiding in understanding how named entities are identified in the sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The example presents a specific entity with its label, showcasing the relevance of the named entity in the context of the sentence."},\n    {"Example 11": 1},\n    {"Reason 11": "The example does not include any named entities relevant to the entity types in the target sentence."},\n    {"Example 12": 1},\n    {"Reason 12": "The example does not include any named entities relevant to the entity types in the target sentence."},\n    {"Example 13": 1},\n    {"Reason 13": "The example does not include any named entities relevant to the entity types in the target sentence."},\n    {"Example 14": 1},\n    {"Reason 14": "The example does not include any named entities relevant to the entity types in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The example does not include any named entities relevant to the entity types in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1583, 'sentence': 'Associations between HLA class II antigens and autoantibodies to the ribonucleoproteins Ro(SSA) and La(SSB) have been reported in these patients.', 'label': {'ribonucleoproteins': 'protein', 'Ro(SSA)': 'protein', 'autoantibodies': 'protein', 'HLA class II antigens': 'protein', 'La(SSB)': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names that are directly mentioned."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains specific protein names that are directly mentioned."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains specific protein names that are directly mentioned."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains a specific cell type name that is directly mentioned."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains a specific protein name that is directly mentioned."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains specific protein names that are directly mentioned."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains a specific DNA name that is directly mentioned."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains specific protein names that are directly mentioned."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains specific protein names and a cell type that are directly mentioned."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains specific protein names and a cell type that are directly mentioned."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains specific protein names and a cell type that are directly mentioned."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains a specific protein name that is directly mentioned."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains specific protein names and a cell type that are directly mentioned."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains specific protein names and a cell type that are directly mentioned."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains specific cell type and protein names that are directly mentioned."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any specific entity names."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific entity names."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific entity names."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific entity names."}\n]', 'response3': '[{"HLA class II antigens": "protein"}, {"ribonucleoproteins Ro(SSA)": "protein"}, {"La(SSB)": "protein"}]', 'prediction': {'HLA class II antigens': 'protein', 'ribonucleoproteins Ro(SSA)': 'protein', 'La(SSB)': 'protein'}}
{'idx': 592, 'sentence': 'The DNA isolated contained an open reading frame encoding 108 amino acid residues .', 'label': {}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a DNA entity and its corresponding label."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides a clear example of a cell_line entity and its corresponding label."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence provides a clear example of a DNA entity and its corresponding label."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides a clear example of a protein entity and its corresponding label."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides a clear example of a protein entity and its corresponding label."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides clear examples of protein, protein, and cell_type entities with their corresponding labels."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides clear examples of DNA and protein entities with their corresponding labels."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides a clear example of a protein entity and its corresponding label."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides a clear example of a DNA entity and its corresponding label."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides clear examples of protein entities and their corresponding labels."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides a clear example of a protein entity and its corresponding label."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides clear examples of protein, protein, DNA, and protein entities with their corresponding labels."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not contain any named entities related to the given entity labels."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not contain any named entities related to the given entity labels."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any named entities related to the given entity labels."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any named entities related to the given entity labels."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any named entities related to the given entity labels."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any named entities related to the given entity labels."}\n]', 'response3': '[{"DNA": "DNA"}]', 'prediction': {'DNA': 'DNA'}}
{'idx': 163, 'sentence': 'This phenomenon can be mimicked by administering MP in divided doses.', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides clear examples of named entities with their corresponding entity labels, aiding in the extraction process."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1751, 'sentence': 'This effect is thought to be largely mediated through inactivation of the phosphatase calcineurin , which in turn inhibits translocation of an NFAT component to the nucleus.', 'label': {'NFAT': 'protein', 'calcineurin': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence 1": 5},\n    {"Sentence 2": 5},\n    {"Sentence 3": 5},\n    {"Sentence 4": 5},\n    {"Sentence 5": 5},\n    {"Sentence 6": 5},\n    {"Sentence 7": 5},\n    {"Sentence 8": 5},\n    {"Sentence 9": 5},\n    {"Sentence 10": 5},\n    {"Sentence 11": 5},\n    {"Sentence 12": 5},\n    {"Sentence 13": 5},\n    {"Sentence 14": 5},\n    {"Sentence 15": 5},\n    {"Sentence 16": 1},\n    {"Sentence 17": 1},\n    {"Sentence 18": 1},\n    {"Sentence 19": 1},\n    {"Sentence 20": 1}\n]', 'response3': '[{"calcineurin": "protein"}, {"NFAT": "protein"}]', 'prediction': {'calcineurin': 'protein', 'NFAT': 'protein'}}
{'idx': 1774, 'sentence': 'Further studies are needed to elucidate if this sex difference in PBMC receptors for 1.25 Dihydroxyvitamin D3 is of any pathophysiological relevance .', 'label': {'PBMC': 'cell_type', 'PBMC receptors': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 4},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 3},\n    {"An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage.": 4},\n    {"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n    {"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).": 5},\n    {"These results indicate that the monocyte/B-cell-specific transcription factor PU.1 and the Mono A and Mono B protein complexes act in concert to regulate monocyte-specific transcription of the CSF-1 receptor.": 5},\n    {"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.": 5},\n    {"A 3-bp mutation at the distal Sp1-binding site not only eliminates Sp1 interaction, but also abolishes most of the VitD3 induction of CD14 expression.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 206, 'sentence': 'It is concluded that (i) patients with CLL rarely express ER and (ii) immunocytochemical staining of cytospin preparations is a valid technique for the measurement of ER .', 'label': {'ER': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor )": 5},\n    {"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 4},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL .": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 5},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .": 4},\n    {"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 5},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 5},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"ER": "protein"}]', 'prediction': {'ER': 'protein'}}
{'idx': 928, 'sentence': 'A mouse ets-1 cDNA clone was obtained by screening a mouse thymus cDNA expression library with a double-stranded oligonucleotide probe representing 20 bp of the Moloney murine sarcoma virus ( MSV ) long terminal repeat ( LTR ).', 'label': {'ets-1': 'protein', 'long terminal repeat': 'DNA', 'double-stranded oligonucleotide probe': 'DNA', 'mouse thymus cDNA expression library': 'DNA', 'mouse ets-1 cDNA clone': 'DNA', 'LTR': 'DNA'}, 'response1': "['DNA', 'RNA']", 'response2': '[\n    {"SIVsmmPBj14": 5},\n    {"SIVmacMER": 5},\n    {"SIVmac239": 5},\n    {"CEMx174": 5},\n    {"GM-CSF": 5},\n    {"PML/RARalpha": 5},\n    {"Th2-type lymphocytes": 5},\n    {"protein": 5},\n    {"Sp1": 5},\n    {"Ets": 5},\n    {"c-kit": 5},\n    {"IL-4R alpha chain": 5},\n    {"TCF-1": 5},\n    {"MIP-1 alpha": 5},\n    {"GOS19": 5},\n    {"LD78": 5},\n    {"AT464": 5},\n    {"CD14": 5},\n    {"IFN A": 5},\n    {"IFNA": 5},\n    {"interleukin-2": 5},\n    {"interleukin-2 receptor": 5},\n    {"phytohemagglutinin": 5},\n    {"phorbol myristate acetate": 5},\n    {"SLAP-130": 5},\n    {"SLP-76": 5},\n    {"T cell": 5},\n    {"Egr-1": 5},\n    {"E2A": 5},\n    {"CD95 ligand": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1301, 'sentence': 'It was found that the most significant variable predicting NK activity at follow-up was tumor ER concentration , with higher NK activity associated with ER -status .', 'label': {'ER': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"ER": "protein"}, {"NK": "cell_type"}, {"ER": "protein"}]', 'prediction': {'ER': 'protein', 'NK': 'cell_type'}}
{'idx': 1708, 'sentence': 'The Ca(2+) -dependent phosphatase calcineurin , a target of FK506 and CsA , synergizes with PKC -induced activation of nuclear factor (NF)-kappa B in T cell lines .', 'label': {'nuclear factor (NF)-kappa B': 'protein', 'T cell lines': 'cell_line', 'Ca(2+) -dependent phosphatase': 'protein', 'PKC': 'protein', 'calcineurin': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a direct match between the entity \'calcineurin\' and its corresponding label \'protein\' in the sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The example provides direct matches between the entities \'IkappaBalpha\' and \'NF-kappaB\' with their corresponding labels \'protein\' in the sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The example provides direct matches between the entities \'IkappaBbeta\' and \'NF-kappaB\' with their corresponding labels \'protein\' in the sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The example provides direct matches between the entities \'NF-kappa B\' and \'AP-1\' with their corresponding labels \'protein\' in the sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides direct matches between the entities \'PAFR\', \'PAF\', \'NF-kappa B\', and \'protein kinase C\' with their corresponding labels \'protein\' in the sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The example provides direct matches between the entities \'CD40\' and \'NF-kappa B\' with their corresponding labels \'protein\' in the sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The example provides direct matches between the entities \'CD28\', \'CD80\', \'CD86\', \'CBL\', \'VAV\', \'NFAT\', \'interleukin-2\', and \'granulocyte-macrophage colony-stimulating factor\' with their corresponding labels \'protein\' in the sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides direct matches between the entities \'NF-kappaB\', \'Tax\', and \'ATL\' with their corresponding labels \'protein\' and \'cell_type\' in the sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides direct matches between the entities \'NF-kappa B\' and \'I kappa B beta\' with their corresponding labels \'protein\' in the sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides direct matches between the entities \'NF-kappa B\' and \'I kappa B alpha\' with their corresponding labels \'protein\' in the sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The example provides a direct match between the entity \'NF-kappa B\' and its corresponding label \'protein\' in the sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The example provides direct matches between the entities \'RelA\' and \'NF-kappa B\' with their corresponding labels \'protein\' in the sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides direct matches between the entities \'Syk\', \'Zap\', and \'T cell\' with their corresponding labels \'protein\' and \'cell_type\' in the sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The example provides a direct match between the entity \'NF-kappa B\' and its corresponding label \'protein\' in the sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The example provides direct matches between the entities \'SP1\', \'caspases\', and \'B-cell\' with their corresponding labels \'protein\' and \'cell_type\' in the sentence."},\n    {"Example 16": 5},\n    {"Reason 16": "The example provides a direct match between the entity \'NF-kappa B\' and its corresponding label \'protein\' in the sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities related to the provided entity labels."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities related to the provided entity labels."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities related to the provided entity labels."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities related to the provided entity labels."}\n]', 'response3': '[{"calcineurin": "protein"}, {"FK506": "None"}, {"CsA": "None"}, {"PKC": "protein"}, {"NF-kappa B": "protein"}, {"T cell lines": "cell_line"}]', 'prediction': {'calcineurin': 'protein', 'FK506': 'None', 'CsA': 'None', 'PKC': 'protein', 'NF-kappa B': 'protein', 'T cell lines': 'cell_line'}}
{'idx': 747, 'sentence': 'Protein kinase inhibitor H-7 blocks accumulation of unspliced mRNA of human T-cell leukemia virus type I ( HTLV-I ).', 'label': {'unspliced mRNA': 'RNA'}, 'response1': "['protein', 'RNA']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .": 5},\n    {"Control of NF-kappa B activity by the I kappa B beta inhibitor .": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 4},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 4},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Tat-binding protein 7 is a subunit of the 26S protease .": 5},\n    {"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 4},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n    {"Binding of YY1 and Oct1 to a novel element that downregulates expression of IL-5 in human T cells .": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 333, 'sentence': 'These protoenhancers alone are weakly or not responsive to R .', 'label': {'protoenhancers': 'DNA', 'R': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 5},\n    {"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .": 4},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50 .": 4},\n    {"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements .": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .": 5},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .": 4},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter": 5},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 758, 'sentence': 'Cell proliferation of CEM-C7 cells cultured in both serum-free media has been sustained for 3 mo.', 'label': {'CEM-C7': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.": 5},\n    {"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 4},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 4},\n    {"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 4},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 3},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 4},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 5},\n    {"Thus, we were able to derive a hematopoietic cell line, called 47.10, that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.": 5},\n    {"Notably, the lack of pRB in these U937-derived clones renders these p53-null cells highly resistant to apoptosis induced by serum withdrawal, calphostin C, and ceramide.": 5},\n    {"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.": 5},\n    {"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.": 5},\n    {"We isolated a novel subline, UT-7/GMT, from the human leukemia cell line UT-7/GM (N. Komatsu, et al., Blood, 89: 4021-4033, 1997).": 5},\n    {"The modified vectors were used to transduce human hematopoietic cell lines, cord blood-derived CD34(+) stem/progenitor cells, and murine bone marrow repopulating stem cells.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 727, 'sentence': 'The importance of the internal ATGs to Rex function is not known.', 'label': {'Rex': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein (Runt domain) and its corresponding entity label."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence clearly mentions a protein (TCF-1) and its corresponding entity label."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence explicitly refers to a protein (tyrosine) and its corresponding entity label."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence mentions \'nonhuman primates\' which is likely a cell_type, providing a relevant example for entity extraction."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains clear examples of proteins (IL-7R and gamma(c)) and their corresponding entity labels."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence mentions a cell line (SIVsmmPBj14) and its corresponding entity label."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides examples of proteins (Jun and ATF-2) and their corresponding entity labels."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions a protein (GATA-1) and its corresponding entity label."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence refers to a protein (NF-kappaB) and a cell type (rheumatoid arthritis), providing relevant examples for entity extraction."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains examples of proteins (IL-2, c-Jun, and c-Fos) and their corresponding entity labels."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence mentions a protein (RXR) and its corresponding entity label."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides an example of a protein (Protein) and its corresponding entity label."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence mentions DNA elements (UAS3 and UAS2) and a protein (YY1), providing relevant examples for entity extraction."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains examples of proteins (IL-2, Aiolos, and Ras) and their corresponding entity labels."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence mentions a protein (IL-4) and its corresponding entity label."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence refers to a cell line (SCM-1) and its corresponding entity label."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not provide any specific examples of named entities relevant to the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not provide any specific examples of named entities relevant to the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not provide any specific examples of named entities relevant to the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not provide any specific examples of named entities relevant to the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 429, 'sentence': 'As shown by mobility-shift , methylation interference , and mutational analyses , the mammalian protein BSAP recognizes all four sea urchin binding sites in a manner indistinguishable from TSAP ; however, the two proteins differ in molecular weight.', 'label': {'TSAP': 'protein', 'mammalian protein': 'protein', 'sea urchin binding sites': 'DNA', 'BSAP': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.": 5},\n    {"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n    {"Tat-binding protein 7 is a subunit of the 26S protease.": 5},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 5},\n    {"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 5},\n    {"A gst-EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2-PU.1 interaction.": 5},\n    {"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.": 5},\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 5},\n    {"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"BSAP": "protein"}, {"TSAP": "protein"}]', 'prediction': {'BSAP': 'protein', 'TSAP': 'protein'}}
{'idx': 1372, 'sentence': 'The TCL1 oncogene on human chromosome 14q32.1 is involved in chromosome translocations [ t(14;14)(q11;q32.1) and t(7;14)(q35;q32.1) ] and inversions [ inv14(q11;q32.1) ] with TCR alpha/beta loci in T-cell leukemias , such as T-prolymphocytic ( T-PLL ).', 'label': {'14q32.1': 'DNA', 'TCR alpha/beta loci': 'DNA', 't(14;14)(q11;q32.1)': 'DNA', 'TCL1 oncogene': 'DNA', 'human chromosome': 'DNA', 't(7;14)(q35;q32.1)': 'DNA', 'inv14(q11;q32.1)': 'DNA'}, 'response1': "['DNA', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific gene/protein names that are directly mentioned, making it highly relevant for entity extraction."}\n]', 'response3': '[{"TCL1": "protein"}, {"TCR alpha/beta": "protein"}, {"T-cell": "cell_type"}, {"T-prolymphocytic (T-PLL)": "cell_type"}]', 'prediction': {'TCL1': 'protein', 'TCR alpha/beta': 'protein', 'T-cell': 'cell_type', 'T-prolymphocytic (T-PLL)': 'cell_type'}}
{'idx': 546, 'sentence': 'Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin .', 'label': {'T lymphocytes': 'cell_type', 'immunophilin': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a clear and direct mapping between the entity \'calcineurin\' and its corresponding entity label \'protein\' in the sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The example provides a clear and direct mapping between the entity \'NF-kappa B\' and its corresponding entity label \'protein\' in the sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The example provides multiple mappings between protein entities such as \'IL-2\', \'IFN-gamma\', \'jak kinases\', \'STAT1(alpha)\' and their corresponding entity labels in the sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The example provides multiple mappings between protein entities such as \'IFN A\', \'IFNA\', \'interleukin-2\', \'interleukin-2 receptor\', \'phytohemagglutinin\', \'phorbol myristate acetate\' and their corresponding entity labels in the sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides mappings between different entity types such as \'T cell\' (cell_type), \'IL-2\' and \'IL-2 receptor\' (protein), \'CD28\' (protein) and their corresponding entity labels in the sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The example provides mappings between different entity types such as \'IL-5 mRNA\' (RNA), \'TCR\' (cell_type), \'IL-2R\' (protein), \'dexamethasone\' (protein) and their corresponding entity labels in the sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The example provides mappings between different protein entities such as \'NF-kappa B\' and \'I kappa B alpha\' and their corresponding entity labels in the sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides a clear and direct mapping between the entity \'IL-2\' and its corresponding entity label \'protein\' in the sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides mappings between different protein entities such as \'CD28\', \'CD80\', \'CD86\', \'CBL\', \'VAV\', \'NFAT\', \'interleukin-2\', \'granulocyte-macrophage colony-stimulating factor\' and their corresponding entity labels in the sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides mappings between different protein entities such as \'NF-ATc\' and \'T lymphocytes\' and their corresponding entity labels in the sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The example provides mappings between different protein entities such as \'IkappaBbeta\' and \'NF-kappaB\' and their corresponding entity labels in the sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The example provides mappings between different protein entities such as \'IL-2 receptor alpha subunit\', \'p21ras\', \'B cell\' and their corresponding entity labels in the sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides mappings between different protein entities such as \'Syk\', \'Zap\', \'T cell\' and their corresponding entity labels in the sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The example provides mappings between different protein entities such as \'IL-2\', \'NF-kappa B\', \'AP-1\' and their corresponding entity labels in the sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The example provides mappings between different protein entities such as \'IL-2\', \'Aiolos\', \'Ras\' and their corresponding entity labels in the sentence."},\n    {"Example 16": 5},\n    {"Reason 16": "The example provides mappings between different protein entities such as \'IkappaBalpha\', \'NF-kappaB\' and their corresponding entity labels in the sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any named entities from the given entity label set."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any named entities from the given entity label set."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any named entities from the given entity label set."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any named entities from the given entity label set."}\n]', 'response3': '[{"T lymphocytes": "cell_type"}, {"immunophilin": "protein"}, {"FK506": "protein"}, {"rapamycin": "protein"}]', 'prediction': {'T lymphocytes': 'cell_type', 'immunophilin': 'protein', 'FK506': 'protein', 'rapamycin': 'protein'}}
{'idx': 1437, 'sentence': 'In summary, we developed an assay for the quantitative determination of hTR beta 1 mRNA levels in small human tissue samples , containing as little as 50 ng of total RNA.', 'label': {'hTR beta 1': 'protein', 'hTR beta 1 mRNA': 'RNA'}, 'response1': "['RNA']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"IFN A": "The mention of IFN A (IFNA) is directly associated with the protein entity label."},\n    {"IFNA": "The mention of IFNA is directly associated with the protein entity label."},\n    {"interleukin-2": "The mention of interleukin-2 is directly associated with the protein entity label."},\n    {"interleukin-2 receptor": "The mention of interleukin-2 receptor is directly associated with the protein entity label."},\n    {"phytohemagglutinin": "The mention of phytohemagglutinin is directly associated with the protein entity label."},\n    {"phorbol myristate acetate": "The mention of phorbol myristate acetate is directly associated with the protein entity label."}\n]\n[\n    {"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 4},\n    {"cDNAs": "The mention of cDNAs is directly associated with the DNA entity label."}\n]\n[\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"TCRzeta": "The mention of TCRzeta is directly associated with the protein entity label."},\n    {"p56(lck)": "The mention of p56(lck) is directly associated with the protein entity label."}\n]\n[\n    {"Because relatively little is known about these events in nonhuman primates , our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.": 5},\n    {"nonhuman primates": "The mention of nonhuman primates is directly associated with the cell_type entity label."}\n]\n[\n    {"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n    {"TCF-1": "The mention of TCF-1 is directly associated with the protein entity label."}\n]\n[\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"NF-ATc": "The mention of NF-ATc is directly associated with the protein entity label."},\n    {"T lymphocytes": "The mention of T lymphocytes is directly associated with the cell_type entity label."},\n    {"embryonic cardiac cells": "The mention of embryonic cardiac cells is directly associated with the cell_type entity label."}\n]\n[\n    {"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.": 5},\n    {"PML/RARalpha": "The mention of PML/RARalpha is directly associated with the protein entity label."}\n]\n[\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 5},\n    {"retinoic acid receptor alpha": "The mention of retinoic acid receptor alpha is directly associated with the protein entity label."}\n]\n[\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"E2A": "The mention of E2A is directly associated with the protein entity label."}\n]\n[\n    {"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.": 5},\n    {"Ter 119": "The mention of Ter 119 is directly associated with the cell_line entity label."},\n    {"beta-globin": "The mention of beta-globin is directly associated with the protein entity label."},\n    {"glycoprotein IIb": "The mention of glycoprotein IIb is directly associated with the protein entity label."},\n    {"platelet factor 4": "The mention of platelet factor 4 is directly associated with the protein entity label."}\n]\n[\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"B and T cell activation": "The mention of B and T cell activation is directly associated with the cell_type entity label."},\n    {"Ramos": "The mention of Ramos is directly associated with the cell_line entity label."},\n    {"Jurkat": "The mention of Jurkat is directly associated with the cell_line entity label."},\n    {"cDNA microarray technology": "The mention of cDNA microarray technology is directly associated with the DNA entity label."}\n]\n[\n    {"Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.": 5},\n    {"hematopoietic cell line": "The mention of hematopoietic cell line is directly associated with the cell_line entity label."},\n    {"47.10": "The mention of 47.10 is directly associated with the cell_line entity label."},\n    {"cell line": "The mention of cell line is directly associated with the cell_line entity label."},\n    {"nontransgenic mice": "The mention of nontransgenic mice is directly associated with the cell_line entity label."}\n]\n[\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"HIV-1 LTR": "The mention of HIV-1 LTR is directly associated with the DNA entity label."},\n    {"NFAT-1": "The mention of NFAT-1 is directly associated with the protein entity label."},\n    {"NF kappa B": "The mention of NF kappa B is directly associated with the protein entity label."}\n]\n[\n    {"Expression of tal-1 and GATA-binding proteins during human hematopoiesis.": 5},\n    {"tal-1": "The mention of tal-1 is directly associated with the protein entity label."},\n    {"GATA-binding proteins": "The mention of GATA-binding proteins is directly associated with the protein entity label."},\n    {"hematopoiesis": "The mention of hematopoiesis is directly associated with the cell_type entity label."}\n]\n[\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n    {"EBV": "The mention of EBV is directly associated with the DNA entity label."},\n    {"EBNA2": "The mention of EBNA2 is directly associated with the protein entity label."},\n    {"estrogen receptor": "The mention of estrogen receptor is directly associated with the protein entity label."}\n]\n[\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1}\n]\n[\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1}\n]\n[\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1}\n]\n[\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1}\n]\n[\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': "[{'hTR beta 1 mRNA': 'RNA'}]", 'prediction': {'hTR beta 1 mRNA': 'RNA'}}
{'idx': 1399, 'sentence': 'To investigate the role of NF-M in hematopoietic cell lineage commitment, we constructed a conditional form of the protein by fusing it to the hormone binding domain of the human estrogen receptor .', 'label': {'hematopoietic cell lineage': 'cell_line', 'human estrogen receptor': 'protein', 'NF-M': 'protein', 'hormone binding domain': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 5},\n    {"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events.": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 5},\n    {"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n    {"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"NF-M": "protein"}, {"hematopoietic cell lineage commitment": "cell_type"}, {"human estrogen receptor": "protein"}]', 'prediction': {'NF-M': 'protein', 'hematopoietic cell lineage commitment': 'cell_type', 'human estrogen receptor': 'protein'}}
{'idx': 1327, 'sentence': 'Our results demonstrate that NF-IL6 is involved in transcriptional activation of the human IL-4 promoter in T cells .', 'label': {'human IL-4': 'protein', 'human IL-4 promoter': 'DNA', 'NF-IL6': 'protein', 'T cells': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities (proteins and cell types) that are directly relevant to the entity types in the target sentence, providing clear context for extraction."}\n]', 'response3': '[{"NF-IL6": "protein"}, {"IL-4": "protein"}, {"T cells": "cell_type"}]', 'prediction': {'NF-IL6': 'protein', 'IL-4': 'protein', 'T cells': 'cell_type'}}
{'idx': 146, 'sentence': 'Unlike other class II promoters , the HLA-DR alpha (DRA) promoter also contains one element identical to the "octamer" motif of immunoglobulin variable region promoters that is responsible for B cell-specific transcription .', 'label': {'"octamer" motif': 'DNA', 'HLA-DR alpha (DRA) promoter': 'DNA', 'class II promoters': 'DNA', 'immunoglobulin variable region promoters': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 4},\n    {"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.": 5},\n    {"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 4},\n    {"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"HLA-DR alpha (DRA)": "protein"}, {"octamer": "protein"}, {"immunoglobulin variable region": "protein"}, {"B cell-specific": "cell_type"}]', 'prediction': {'HLA-DR alpha (DRA)': 'protein', 'octamer': 'protein', 'immunoglobulin variable region': 'protein', 'B cell-specific': 'cell_type'}}
{'idx': 1247, 'sentence': 'The Janus family tyrosine kinase Jak3 is the only signaling molecule known to be associated with gamma c , so it was hypothesized that defects in Jak3 might cause an XSCID -like phenotype .', 'label': {'Janus family tyrosine kinase': 'protein', 'Jak3': 'protein', 'gamma c': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Example id": 1},\n    {"Example id": 2},\n    {"Example id": 3},\n    {"Example id": 4},\n    {"Example id": 5},\n    {"Example id": 6},\n    {"Example id": 7},\n    {"Example id": 8},\n    {"Example id": 9},\n    {"Example id": 10},\n    {"Example id": 11},\n    {"Example id": 12},\n    {"Example id": 13},\n    {"Example id": 14},\n    {"Example id": 15},\n    {"Example id": 16},\n    {"Example id": 17},\n    {"Example id": 18}\n]', 'response3': '[{"Jak3": "protein"}, {"gamma c": "protein"}, {"XSCID": "cell_type"}]', 'prediction': {'Jak3': 'protein', 'gamma c': 'protein', 'XSCID': 'cell_type'}}
{'idx': 1300, 'sentence': 'As considerable evidence has accumulated that social support in both animal and human populations may have survival value, we sought to test the reliability of this regression model , using coping and perceived support factor values obtained at 3 months after surgery to account for concurrent follow-up NK activity in this serially assessed group of patients .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 5},\n    {"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.": 4},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 5},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes.": 4},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.": 5},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 5},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 5},\n    {"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).": 5},\n    {"The p50 and p65 proteins, constituents of the prototypic nuclear factor kappaB, were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays.": 5},\n    {"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/GC-box region, suggesting that the GC-motif can function independently of the GM-kappa B motif.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 350, 'sentence': 'Induction of 24,25-(OH)2D3 synthesis by 1,25(OH)2D3 was observed in the fifth cell line , designated Ro-VDR , although the sensitivity to hormone treatment was lower than in the control cell line from a normal donor .', 'label': {'control cell line': 'cell_line', 'cell line': 'cell_line', 'Ro-VDR': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence contains specific protein names like TIMP-1 and DNA, which are directly mentioned and can be easily identified as protein and DNA entities."},\n{"Example 2": 4},\n{"Reason 2": "The sentence mentions specific protein name MNDA and a cell line name Philadelphia chromosome-positive chronic myeloid leukemia, which can help in identifying protein and cell line entities."},\n{"Example 3": 5},\n{"Reason 3": "The sentence contains multiple protein names like IFN A, interleukin-2, interleukin-2 receptor, phytohemagglutinin, and phorbol myristate acetate, which are directly mentioned and can be easily identified as protein entities."},\n{"Example 4": 4},\n{"Reason 4": "The sentence mentions a specific protein name CD14, which can help in identifying the protein entity."},\n{"Example 5": 4},\n{"Reason 5": "The sentence mentions a specific protein name retinoic acid receptor alpha, which can help in identifying the protein entity."},\n{"Example 6": 5},\n{"Reason 6": "The sentence mentions a specific protein name WT1 and a cell line name myeloid cell lines, which can help in identifying protein and cell line entities."},\n{"Example 7": 4},\n{"Reason 7": "The sentence mentions a specific protein name NF-E2, which can help in identifying the protein entity."},\n{"Example 8": 4},\n{"Reason 8": "The sentence mentions a specific protein name retinoic acid receptor alpha, which can help in identifying the protein entity."},\n{"Example 9": 4},\n{"Reason 9": "The sentence mentions a specific protein name RXR, which can help in identifying the protein entity."},\n{"Example 10": 4},\n{"Reason 10": "The sentence mentions a specific protein name ZAP-70, which can help in identifying the protein entity."},\n{"Example 11": 5},\n{"Reason 11": "The sentence mentions specific entities like IL-5 mRNA, TCR, IL-2R, and dexamethasone, which are directly mentioned and can be easily identified as RNA, cell_type, protein entities."},\n{"Example 12": 5},\n{"Reason 12": "The sentence mentions specific protein names like VDR, RXR, GRIP-1, DRIP205, and DRIP, which are directly mentioned and can be easily identified as protein entities."},\n{"Example 13": 5},\n{"Reason 13": "The sentence mentions specific protein names like interleukin-2, alpha chain, CD25, and IL-2 receptor, which are directly mentioned and can be easily identified as protein entities."},\n{"Example 14": 5},\n{"Reason 14": "The sentence mentions specific protein names like Protein kinase B, phosphatidylinositol 3-kinase, STAT5, erythropoietin, EPO, HCD57, and HCD57-SREI, which are directly mentioned and can be easily identified as protein and cell line entities."},\n{"Example 15": 5},\n{"Reason 15": "The sentence mentions specific cell line names like hematopoietic cell line, 47.10, cell line, and nontransgenic mice, which are directly mentioned and can be easily identified as cell line entities."},\n{"Example 16": 5},\n{"Reason 16": "The sentence mentions specific entities like 2-deoxyguanosine, lymphoid progenitor cells, thymus stromal cells, B cell, tg epsilon26, fetal liver cells, and T cell, which are directly mentioned and can be easily identified as DNA, cell_type, and cell_line entities."},\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any specific named entities related to the given entity labels."},\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any specific named entities related to the given entity labels."},\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any specific named entities related to the given entity labels."},\n{"Example 20": 1},\n{"Reason 20": "The sentence does not contain any specific named entities related to the given entity labels."}\n]', 'response3': '[{"Ro-VDR": "cell_line"}]', 'prediction': {'Ro-VDR': 'cell_line'}}
{'idx': 1093, 'sentence': 'The genomic actions of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) are mediated by the intracellular vitamin D receptor ( VDR ).', 'label': {'VDR': 'protein', 'vitamin D receptor': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements.": 4},\n    {"An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage.": 4},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.": 4},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n    {"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.": 4},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 4},\n    {"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex.": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"Protein kinase B ( c-Akt ), phosphatidylinositol 3-kinase , and STAT5 are activated by erythropoietin ( EPO ) in HCD57 erythroid cells but are constitutively active in an EPO -independent, apoptosis -resistant subclone ( HCD57-SREI cells ).": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"1,25-dihydroxyvitamin D3": "protein"}, {"VDR": "protein"}]', 'prediction': {'1,25-dihydroxyvitamin D3': 'protein', 'VDR': 'protein'}}
{'idx': 1493, 'sentence': 'Chronic HIV-1 infection of myeloid cells leads to constitutive NF-kappa B DNA-binding activity and provides an intranuclear environment capable of perpetuating HIV-1 replication .', 'label': {'myeloid cells': 'cell_type', 'NF-kappa B': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n    {"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B.": 5},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.": 5},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 5},\n    {"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"NF-kappa B": "DNA"}]', 'prediction': {'NF-kappa B': 'DNA'}}
{'idx': 334, 'sentence': "One of the protoenhancers contains the overlapping palindromes 5'-TTGTCCcgtGGACAAaTGTCC-3' .", 'label': {'protoenhancers': 'DNA', 'overlapping palindromes': 'DNA'}, 'response1': "['DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a DNA entity (IgH) and its corresponding label, which directly aids in understanding the entity types present in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence provides a clear example of a protein entity (BRCA1) and its corresponding label, which is helpful in understanding the entity types present in the target sentence."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence provides examples of protein entities (EBNA2, TP1) and their corresponding labels, aiding in understanding the entity types present in the target sentence."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence provides a clear example of a protein entity (GM-CSF) and its corresponding label, which is helpful in understanding the entity types present in the target sentence."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence provides a clear example of a protein entity (Protein) and its corresponding label, aiding in understanding the entity types present in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides examples of protein entities (IL-2, c-Jun, c-Fos) and their corresponding labels, which directly aid in understanding the entity types present in the target sentence."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence provides a clear example of a protein entity (p50p50) and its corresponding label, aiding in understanding the entity types present in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides a clear example of a protein entity (EKLF) and its corresponding label, which directly aids in understanding the entity types present in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides a clear example of a protein entity (TCF-1) and its corresponding label, aiding in understanding the entity types present in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides a clear example of a protein entity (ZEBRA) and its corresponding label, which directly aids in understanding the entity types present in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides a clear example of a DNA entity (immunoglobulin kappa 3\' enhancer) and its corresponding label, aiding in understanding the entity types present in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides a clear example of a protein entity (Egr-1) and its corresponding label, which directly aids in understanding the entity types present in the target sentence."},\n    {"Example 13": 4},\n    {"Reason 13": "The sentence provides examples of a cell type entity (T cell) and a protein entity (interleukin 2) with their corresponding labels, aiding in understanding the entity types present in the target sentence."},\n    {"Example 14": 4},\n    {"Reason 14": "The sentence provides a clear example of a cell type entity (Th2-type lymphocytes) and its corresponding label, which is helpful in understanding the entity types present in the target sentence."},\n    {"Example 15": 4},\n    {"Reason 15": "The sentence provides a clear example of a protein entity (CD95 ligand) and its corresponding label, aiding in understanding the entity types present in the target sentence."},\n    {"Example 16": 4},\n    {"Reason 16": "The sentence provides examples of DNA entities (GM-kappa B, GC-box, GC-motif, GM-kappa B motif) and their corresponding labels, which are helpful in understanding the entity types present in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific examples of entities with corresponding labels, making it less helpful in understanding the entity types present in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific examples of entities with corresponding labels, making it less helpful in understanding the entity types present in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific examples of entities with corresponding labels, making it less helpful in understanding the entity types present in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any specific examples of entities with corresponding labels, making it less helpful in understanding the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 946, 'sentence': 'Compared to the control group , fewer depressed subjects down-regulated Bmax after DEX .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides clear and specific examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."}\n]', 'response3': '[\n    {"Bmax": "protein"},\n    {"DEX": "protein"}\n]', 'prediction': {'Bmax': 'protein', 'DEX': 'protein'}}
{'idx': 777, 'sentence': 'We have identified two human pre-B-cell lines that contain extremely low levels of OTF-2 yet still express high levels of steady-state immunoglobulin heavy-chain mRNA in vivo and efficiently transcribe an immunoglobulin gene in vitro.', 'label': {'OTF-2': 'protein', 'immunoglobulin gene': 'DNA', 'steady-state immunoglobulin heavy-chain mRNA': 'RNA', 'human pre-B-cell lines': 'cell_line', 'immunoglobulin heavy-chain': 'protein'}, 'response1': "['cell_line', 'RNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence directly mentions the entity and provides clear context for its identification."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence directly mentions the entity and provides clear context for its identification."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence directly mentions the entity and provides clear context for its identification."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence directly mentions the entity and provides clear context for its identification."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence directly mentions the entity and provides clear context for its identification."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence directly mentions the entity and provides clear context for its identification."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence directly mentions the entity and provides clear context for its identification."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence directly mentions the entity and provides clear context for its identification."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence directly mentions the entity and provides clear context for its identification."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence directly mentions the entity and provides clear context for its identification."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence directly mentions the entity and provides clear context for its identification."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence directly mentions the entity and provides clear context for its identification."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not mention any specific entity related to the entity types in the target sentence."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not mention any specific entity related to the entity types in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not mention any specific entity related to the entity types in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not mention any specific entity related to the entity types in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not mention any specific entity related to the entity types in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not mention any specific entity related to the entity types in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not mention any specific entity related to the entity types in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 552, 'sentence': 'Similarly, an excess of FK506 is needed to revert rapamycin -mediated inhibition of IL-2 -induced proliferation .', 'label': {'IL-2': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1}\n]', 'response3': '[{"FK506": "protein"}, {"rapamycin": "protein"}, {"IL-2": "protein"}]', 'prediction': {'FK506': 'protein', 'rapamycin': 'protein', 'IL-2': 'protein'}}
{'idx': 1310, 'sentence': 'The abundant chromosomal protein HMG-1 belongs to this subgroup.', 'label': {'HMG-1': 'protein', 'chromosomal protein': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 5},\n    {"This protein has now been purified and its encoding gene cloned.": 5},\n    {"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.": 1},\n    {"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 1},\n    {"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 5},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n    {"Tat-binding protein 7 is a subunit of the 26S protease.": 5},\n    {"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n    {"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.": 5},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1409, 'sentence': 'We investigated the ability of PRL and IL-2 to activate Stat proteins in different T cell lines .', 'label': {'IL-2': 'protein', 'T cell lines': 'cell_line', 'PRL': 'protein', 'Stat proteins': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities relevant to the target sentence, including \'IL-2\', \'Stat\', \'proteins\', \'T cell lines\', and \'cell lines\'. These examples provide a diverse set of entities that can aid in understanding the context and relationships between different entities in the target sentence."}\n]', 'response3': '[{"PRL": "protein"}, {"IL-2": "protein"}, {"Stat proteins": "protein"}, {"T cell lines": "cell_line"}]', 'prediction': {'PRL': 'protein', 'IL-2': 'protein', 'Stat proteins': 'protein', 'T cell lines': 'cell_line'}}
{'idx': 1140, 'sentence': 'The conserved cis-acting sequence , GGAAAA , and transcription factors binding to this sequence are involved in the response to increased intracellular Ca2+ concentrations .', 'label': {'transcription factors': 'protein', 'conserved cis-acting sequence': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a transcription factor (AP-1) binding to DNA, which directly relates to the entity types mentioned in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence clearly mentions two proteins (Jun and ATF-2) and their interaction in the context of transcription, which aligns with the entity types in the target sentence."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence mentions Th2-type lymphocytes, which are a specific cell type, relevant to the cell_type entity type in the target sentence."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence directly mentions a protein, aligning with the protein entity type in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides a clear example of a zinc finger transcription factor (Egr-1) which is a protein, matching the entity type in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence mentions specific proteins (IL-2, c-Jun, c-Fos) and their binding to DNA, directly related to the entity types in the target sentence."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence mentions GM-CSF, a protein, aligning with the protein entity type in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions GATA-1, a transcription factor protein, which is directly relevant to the protein entity type in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides a clear example of a transcription factor protein (TCF-1) transactivating through its cognate motif, aligning with the protein entity type in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence mentions Stat proteins forming dimers and inducing transcription, directly related to the protein entity type in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides examples of acetylated transcription factors (EKLF) and their interactions with other proteins, aligning with the protein entity type in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence mentions SCL and GATA-1, both zinc-finger transcription factors, aligning with the protein entity type in the target sentence."},\n    {"Example 13": 4},\n    {"Reason 13": "The sentence mentions G-CSF, a protein, aligning with the protein entity type in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides examples of VDR interacting proteins, aligning with the protein entity type in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence mentions ZEB, c-Myb, and Ets as transcriptional regulators, aligning with the protein entity type in the target sentence, and also mentions hematopoietic cells as a cell type."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence mentions tal-1 and GATA-binding proteins as proteins, aligning with the protein entity type in the target sentence, and also mentions hematopoiesis as a cell type."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities relevant to the entity types in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities relevant to the entity types in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities relevant to the entity types in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities relevant to the entity types in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 449, 'sentence': 'We find that the factor that binds to the E3 enhancer motif , CATGTGGC , is a ubiquitous transcription factor .', 'label': {'ubiquitous transcription factor': 'protein', 'E3 enhancer motif': 'DNA'}, 'response1': "['DNA']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with their corresponding entity labels, which can aid in understanding the relationship between the entities and their types."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of named entities with their corresponding entity labels, aiding in identifying specific protein names."},\n    {"Sentence": 1},\n    {"Reason": "The sentence provides an example of a named entity with its corresponding entity label, aiding in identifying a specific DNA element."},\n    {"Sentence": 3},\n    {"Reason": "The sentence provides an example of a named entity with its corresponding entity label, aiding in identifying a specific protein name."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with their corresponding entity labels, which can aid in understanding the relationship between the entities and their types."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with their corresponding entity labels, which can aid in understanding the relationship between the entities and their types."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of named entities with their corresponding entity labels, aiding in identifying specific protein names."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of named entities with their corresponding entity labels, aiding in identifying specific protein names."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of named entities with their corresponding entity labels, aiding in identifying specific protein names."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of named entities with their corresponding entity labels, aiding in identifying specific protein names."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with their corresponding entity labels, which can aid in understanding the relationship between the entities and their types."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels provided."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels provided."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels provided."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels provided."}\n]', 'response3': '[{"E3 enhancer motif": "DNA"}]', 'prediction': {'E3 enhancer motif': 'DNA'}}
{'idx': 1402, 'sentence': 'At the same time, we observed a down-regulation of progenitor-specific surface markers and the up-regulation of differentiation markers restricted to the eosinophil and myeloid lineages .', 'label': {'eosinophil': 'cell_type', 'myeloid lineages': 'cell_type', 'differentiation markers': 'protein', 'progenitor-specific surface markers': 'protein'}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein (GATA-1) and its corresponding entity label, which directly matches one of the entity types in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides a clear example of a protein (Egr-1) and its corresponding entity label, which directly matches one of the entity types in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence provides a clear example of a protein (NF-E2) and its corresponding entity label, which directly matches one of the entity types in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides a clear example of a protein (retinoic acid receptor alpha) and its corresponding entity label, which directly matches one of the entity types in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides a clear example of a protein (CD14) and its corresponding entity label, which directly matches one of the entity types in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides clear examples of cell types (Th1 and Th2) and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides a clear example of a protein (E2A) and its corresponding entity label, which directly matches one of the entity types in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides clear examples of a cell line (B cell) and a cell type (B cell) with their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides a clear example of a protein (WT1) and its corresponding entity label, which directly matches one of the entity types in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides clear examples of proteins (CD14 and CD23) and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides clear examples of proteins (myeloperoxidase, lysozyme, PU.1) and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides clear examples of a protein (WT1) and a cell line (myeloid cell lines) with their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides clear examples of a protein (MNDA) and a cell line (Philadelphia chromosome-positive chronic myeloid leukemia) with their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides clear examples of cell types (granulocytes and T cells) and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides a clear example of a protein (GATA-1) and its corresponding entity label, which directly matches one of the entity types in the target sentence."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence provides clear examples of proteins (Sp1 and Ets) and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any named entities that match the entity types in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any named entities that match the entity types in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any named entities that match the entity types in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any named entities that match the entity types in the target sentence."}\n]', 'response3': "[{'eosinophil': 'cell_type'}, {'myeloid': 'cell_type'}]", 'prediction': {'eosinophil': 'cell_type', 'myeloid': 'cell_type'}}
{'idx': 664, 'sentence': 'Interferon-gamma and the sexual dimorphism of autoimmunity .', 'label': {'Interferon-gamma': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Th1": 5, "Th2": 5, "reasons": "The sentence directly mentions Th1 and Th2 as cell types, making it highly relevant for named entity extraction."},\n    {"AP-1": 5, "reasons": "The sentence directly mentions AP-1 as a DNA binding activity, making it highly relevant for named entity extraction."},\n    {"IFN-gamma": 5, "reasons": "The sentence directly mentions IFN-gamma as a protein, making it highly relevant for named entity extraction."},\n    {"IL4": 5, "IL13": 5, "STAT6": 5, "STAT3": 5, "STAT5": 5, "B cells": 5, "reasons": "The sentence directly mentions IL4, IL13, STAT6, STAT3, STAT5, and B cells as proteins and cell types, making it highly relevant for named entity extraction."},\n    {"Sp1": 5, "Ets": 5, "reasons": "The sentence directly mentions Sp1 and Ets as proteins, making it highly relevant for named entity extraction."},\n    {"IL-7R": 5, "gamma(c)": 5, "reasons": "The sentence directly mentions IL-7R and gamma(c) as proteins, making it highly relevant for named entity extraction."},\n    {"IL-2": 5, "IFN-gamma": 5, "jak kinases": 5, "STAT1(alpha)": 5, "reasons": "The sentence directly mentions IL-2, IFN-gamma, jak kinases, and STAT1(alpha) as proteins, making it highly relevant for named entity extraction."},\n    {"IL-2": 5, "reasons": "The sentence directly mentions IL-2 as a protein, making it highly relevant for named entity extraction."},\n    {"SP1": 5, "caspases": 5, "B-cell": 5, "reasons": "The sentence directly mentions SP1, caspases, and B-cell as proteins and cell types, making it highly relevant for named entity extraction."},\n    {"IFN A": 5, "IFNA": 5, "interleukin-2": 5, "interleukin-2 receptor": 5, "phytohemagglutinin": 5, "phorbol myristate acetate": 5, "reasons": "The sentence directly mentions IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, and phorbol myristate acetate as proteins, making it highly relevant for named entity extraction."},\n    {"IkappaBbeta": 5, "NF-kappaB": 5, "reasons": "The sentence directly mentions IkappaBbeta and NF-kappaB as proteins, making it highly relevant for named entity extraction."},\n    {"NF-kappaB": 5, "rheumatoid arthritis": 5, "reasons": "The sentence directly mentions NF-kappaB and rheumatoid arthritis as proteins and cell types, making it highly relevant for named entity extraction."},\n    {"immunoglobulin kappa 3\' enhancer": 5, "reasons": "The sentence directly mentions immunoglobulin kappa 3\' enhancer as DNA, making it highly relevant for named entity extraction."},\n    {"Th2-type lymphocytes": 5, "reasons": "The sentence directly mentions Th2-type lymphocytes as cell types, making it highly relevant for named entity extraction."},\n    {"GATA-1": 5, "reasons": "The sentence directly mentions GATA-1 as a protein, making it highly relevant for named entity extraction."},\n    {"CD40": 5, "IFN-gamma": 5, "tumor necrosis factor-alpha": 5, "interleukin (IL)-1beta": 5, "reasons": "The sentence directly mentions CD40, IFN-gamma, tumor necrosis factor-alpha, and interleukin (IL)-1beta as proteins, making it highly relevant for named entity extraction."},\n    {"reasons": "No relevant entities mentioned in the sentence."},\n    {"reasons": "No relevant entities mentioned in the sentence."},\n    {"reasons": "No relevant entities mentioned in the sentence."},\n    {"reasons": "No relevant entities mentioned in the sentence."},\n    {"reasons": "No relevant entities mentioned in the sentence."}\n]', 'response3': '[{"Interferon-gamma": "protein"}]', 'prediction': {'Interferon-gamma': 'protein'}}
{'idx': 1726, 'sentence': 'It is tempting to speculate that enhanced NF-kappa B expression caused by free radical production/oxidative stress may modulate liver injury , perhaps through an effect on cytotoxic cytokine synthesis .', 'label': {'NF-kappa B': 'protein', 'cytotoxic cytokine': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence 1": 5},\n    {"Sentence 2": 4},\n    {"Sentence 3": 5},\n    {"Sentence 4": 4},\n    {"Sentence 5": 4},\n    {"Sentence 6": 5},\n    {"Sentence 7": 5},\n    {"Sentence 8": 4},\n    {"Sentence 9": 3},\n    {"Sentence 10": 4},\n    {"Sentence 11": 4},\n    {"Sentence 12": 4},\n    {"Sentence 13": 5},\n    {"Sentence 14": 5},\n    {"Sentence 15": 4},\n    {"Sentence 16": 1},\n    {"Sentence 17": 1},\n    {"Sentence 18": 1},\n    {"Sentence 19": 1}\n]', 'response3': '[{"NF-kappa B": "protein"}]', 'prediction': {'NF-kappa B': 'protein'}}
{'idx': 1573, 'sentence': 'Immunofluorescence colocalization of both estrogen and progesterone receptors with eosinophil cationic protein showed that approximately 70% of positive cells were eosinophils .', 'label': {'estrogen': 'protein', 'eosinophil cationic protein': 'protein', 'positive cells': 'cell_type', 'progesterone receptors': 'protein', 'eosinophils': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of the entity \'protein\' being mentioned in relation to the E2A gene."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions immunohistochemistry with antibodies against proteins, gene, and cell type, providing relevant entities for extraction."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence directly mentions the entity \'protein\' in relation to GATA-1."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence explicitly mentions \'Eosinophils\' as a cell type, aiding in the extraction of this entity."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides multiple instances of relevant entities such as \'protein\', \'cell_type\', and signaling molecules."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence mentions specific proteins like myeloperoxidase, lysozyme, and PU.1, aiding in their extraction."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence directly mentions the entities \'CD14\' and \'CD23\' as proteins."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides clear examples of proteins like p21(WAF1/CIP1) and p27(KIP1) being mentioned."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence mentions specific cell types \'granulocytes\' and \'T cells\', aiding in their extraction."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence mentions proteins like IL-2, c-Jun, and c-Fos, providing relevant entities for extraction."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence mentions the protein \'NF-E2\' in relation to a cellular differentiation program."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides examples of proteins like interleukin-2 and CD25, aiding in their extraction."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence mentions the cell line \'Ter 119\' and proteins like beta-globin, glycoprotein IIb, and platelet factor 4."},\n    {"Example 14": 4},\n    {"Reason 14": "The sentence mentions proteins like Erbstatin and genistein, along with RNA entity Egr-1."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence mentions the DNA entity \'gp91phox\' and the cell line \'HL-60-C15\', aiding in their extraction."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any specific entities mentioned that can aid in extraction."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not provide specific entities mentioned that can aid in extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain specific entities mentioned that can aid in extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not provide specific entities mentioned that can aid in extraction."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain specific entities mentioned that can aid in extraction."}\n]', 'response3': '[{"estrogen": "protein"}, {"progesterone": "protein"}, {"eosinophil cationic protein": "protein"}, {"eosinophils": "cell_type"}]', 'prediction': {'estrogen': 'protein', 'progesterone': 'protein', 'eosinophil cationic protein': 'protein', 'eosinophils': 'cell_type'}}
{'idx': 1589, 'sentence': 'Inhibition of NF-AT -dependent transcription by NF-kappa B : implications for differential gene expression in T helper cell subsets .', 'label': {'NF-kappa B': 'protein', 'T helper cell subsets': 'cell_type', 'NF-AT': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains specific examples of entities mentioned in the target sentence, such as NF-kappa B and I kappa B alpha, which are both proteins. This provides direct examples of the entity types present in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains specific examples of entities mentioned in the target sentence, such as NF-kappa B and I kappa B alpha, which are both proteins. This provides direct examples of the entity types present in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains specific examples of entities mentioned in the target sentence, such as NF-ATc and T lymphocytes, which are a protein and a cell type respectively. This provides direct examples of the entity types present in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains specific examples of entities mentioned in the target sentence, such as NF-kappaB, Tax, and ATL, which are all proteins or cell types. This provides direct examples of the entity types present in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains a specific example of an entity mentioned in the target sentence, NF-kappa B, which is a protein. This provides a direct example of the entity type present in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains specific examples of entities mentioned in the target sentence, such as NF-kappa B and I kappa B alpha, which are both proteins. This provides direct examples of the entity types present in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains a specific example of an entity mentioned in the target sentence, GATA-1, which is a protein. This provides a direct example of the entity type present in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains a specific example of an entity mentioned in the target sentence, NF-kappa B, which is a protein. This provides a direct example of the entity type present in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains specific examples of entities mentioned in the target sentence, such as NF-kappa B and I kappa B beta, which are both proteins. This provides direct examples of the entity types present in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains specific examples of entities mentioned in the target sentence, such as PAFR, PAF, NF-kappa B, and protein kinase C, which are all proteins. This provides direct examples of the entity types present in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains specific examples of entities mentioned in the target sentence, such as Sp1 and Ets, which are both proteins. This provides direct examples of the entity types present in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains specific examples of entities mentioned in the target sentence, such as Th1 and Th2, which are cell types. This provides direct examples of the entity types present in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains a specific example of an entity mentioned in the target sentence, Th2-type lymphocytes, which is a cell type. This provides a direct example of the entity type present in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains specific examples of entities mentioned in the target sentence, such as IL-2, NF-kappa B, and AP-1, which are all proteins. This provides direct examples of the entity types present in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains a specific example of an entity mentioned in the target sentence, NF-kappa B, which is a protein. This provides a direct example of the entity type present in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains specific examples of entities mentioned in the target sentence, such as NF-kappa B and I kappa B beta, which are both proteins. This provides direct examples of the entity types present in the target sentence, making it highly helpful for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains specific examples of entities mentioned in the target sentence, such as PAFR, PAF, NF-kappa B, and protein kinase C, which are all proteins. This provides direct examples of the entity types present in the target sentence, making it highly helpful for extracting named entities."}\n]', 'response3': '[{"NF-AT": "protein"}, {"NF-kappa B": "protein"}, {"T helper cell subsets": "cell_type"}]', 'prediction': {'NF-AT': 'protein', 'NF-kappa B': 'protein', 'T helper cell subsets': 'cell_type'}}
{'idx': 114, 'sentence': 'These results indicate that in monocytic cell lineage , HIV-1 could mimic some differentiation/activation stimuli allowing nuclear NF-KB expression .', 'label': {'NF-KB': 'protein', 'monocytic cell lineage': 'cell_line'}, 'response1': "['cell_line', 'cell_type']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with their corresponding entity labels, providing clear and direct assistance in identifying entities in the target sentence."}\n]', 'response3': '[{"HIV-1": "cell_type"}, {"NF-KB": "protein"}]', 'prediction': {'HIV-1': 'cell_type', 'NF-KB': 'protein'}}
{'idx': 469, 'sentence': 'Cardiac and adrenergic diseases were excluded.', 'label': {}, 'response1': 'None.', 'response2': '[\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 3},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 4},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 3},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.": 5},\n    {"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 4},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti-EBV antibody titres (P > 0.05).": 4},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms.": 3},\n    {"In addition, assay of PBMC by the adenovirus-specific PCR may help detect early invasive disease and warrants further evaluation.": 4},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 3},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.": 5},\n    {"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 3},\n    {"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.": 4},\n    {"When 18C7 was incubated with MR before aldosterone or progesterone, the antibody inhibited 75-80% of the binding.": 4},\n    {"Recently, it has been shown that RelB knockout mice have no dendritic cells (DC).": 4},\n    {"Extracts prepared from XP-B and XP-D lymphoblastoid cells exhibited similar transcription activity from the adenovirus major late promoter when compared to that in extracts from normal cells.": 4}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1683, 'sentence': 'These results strongly suggest that HU induces both transcriptional and post-transcription regulation of c-jun during erythroid differentiation .', 'label': {'c-jun': 'DNA'}, 'response1': "['RNA', 'protein']", 'response2': '[\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein": 5},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction": 3},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells": 3},\n    {"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2": 4},\n    {"SCL is expressed in erythroid, megakaryocyte and mast cell populations (the same cell lineages as GATA-1, a zinc-finger transcription factor)": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor": 4},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene": 5},\n    {"Our results demonstrate that the altered CCAAT box (CCAAC) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well": 4},\n    {"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts": 4},\n    {"Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent, apoptosis-resistant subclone (HCD57-SREI cells)": 5},\n    {"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts": 4},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb/Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells": 4},\n    {"Expression of tal-1 and GATA-binding proteins during human hematopoiesis": 4},\n    {"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation": 5},\n    {"Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB-induced trans-activation of the H4 promoter": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1648, 'sentence': 'Point mutations of either the PU.1 site or the C/EBP site that abolish the binding of the respective factors result in a significant decrease of GM-CSF receptor alpha promoter activity in myelomonocytic cells only.', 'label': {'PU.1 site': 'DNA', 'GM-CSF receptor alpha': 'protein', 'GM-CSF receptor alpha promoter': 'DNA', 'myelomonocytic cells': 'cell_type', 'C/EBP': 'protein', 'PU.1': 'protein', 'GM-CSF': 'protein', 'C/EBP site': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 4},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 4},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 5},\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.": 5},\n    {"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 4},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5}\n]', 'response3': '[{"PU.1": "protein"}, {"C/EBP": "protein"}, {"GM-CSF receptor alpha": "protein"}, {"myelomonocytic cells": "cell_type"}]', 'prediction': {'PU.1': 'protein', 'C/EBP': 'protein', 'GM-CSF receptor alpha': 'protein', 'myelomonocytic cells': 'cell_type'}}
{'idx': 646, 'sentence': 'Surgically confirmed nodal involvement was observed in 42%.', 'label': {}, 'response1': 'None.', 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence contains specific gene names (WT1) which are likely to be proteins."},\n{"Example 2": 4},\n{"Reason 2": "The sentence mentions specific cell types (granulocytes and T cells) which are likely to be cell types."},\n{"Example 3": 4},\n{"Reason 3": "The sentence mentions specific protein names (NDP kinase) and different types of skin cancer (KA, SCC, BCC)."},\n{"Example 4": 5},\n{"Reason 4": "The sentence mentions NF-kappa B, which is a protein."},\n{"Example 5": 5},\n{"Reason 5": "The sentence mentions specific protein names (p21(WAF1/CIP1) and p27(KIP1))."},\n{"Example 6": 4},\n{"Reason 6": "The sentence mentions lymphoid neoplasms, which are likely to be cell types."},\n{"Example 7": 4},\n{"Reason 7": "The sentence mentions T-PLL, which is likely a cell type."},\n{"Example 8": 4},\n{"Reason 8": "The sentence mentions PBMC (Peripheral Blood Mononuclear Cells) and adenovirus DNA, which are likely cell types and DNA entities."},\n{"Example 9": 5},\n{"Reason 9": "The sentence mentions TCL1, which is likely a protein."},\n{"Example 10": 5},\n{"Reason 10": "The sentence mentions various protein names (NF-kB, AP-1, OCT-1, NF-IL-2B)."},\n{"Example 11": 5},\n{"Reason 11": "The sentence mentions specific protein names (TCRzeta and p56(lck))."},\n{"Example 12": 5},\n{"Reason 12": "The sentence mentions CD40, Rel/nuclear factor kappaB, NF-kappaB, and B lymphocytes, which are likely proteins and cell types."},\n{"Example 13": 4},\n{"Reason 13": "The sentence mentions nuclear factor-kappa B and NF-kappa B, which are likely DNA entities."},\n{"Example 14": 4},\n{"Reason 14": "The sentence mentions PMA-stimulated U1 cells, which are likely cell lines."},\n{"Example 15": 5},\n{"Reason 15": "The sentence mentions specific protein names (CD3.TcR, CD18, CD29)."},\n{"Example 16": 5},\n{"Reason 16": "The sentence mentions specific protein names (MR, aldosterone, progesterone)."},\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any specific entity names."},\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any specific entity names."},\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any specific entity names."},\n{"Example 20": 1},\n{"Reason 20": "The sentence does not contain any specific entity names."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 821, 'sentence': '(vi) The EBV type 2 EBNA-2 transactivated LMP1 as well as the EBV type 1 EBNA-2 .', 'label': {'LMP1': 'protein', 'EBNA-2': 'protein', 'EBV type 1 EBNA-2': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.": 4},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 3},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.": 3},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B.": 4},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 4},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 3},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 3},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 3},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 4},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 4},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"EBV type 2 EBNA-2": "protein"}, {"LMP1": "protein"}, {"EBV type 1 EBNA-2": "protein"}]', 'prediction': {'EBV type 2 EBNA-2': 'protein', 'LMP1': 'protein', 'EBV type 1 EBNA-2': 'protein'}}
{'idx': 548, 'sentence': 'On the other hand, interleukin 2 ( IL-2 )-induced signals are blocked by rapamycin but not by FK506 .', 'label': {'IL-2': 'protein', 'interleukin 2': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .": 4},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .": 4},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .": 5},\n    {"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway , and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells .": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 4},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 4},\n    {"Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.": 5},\n    {"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin .": 5},\n    {"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .": 5},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 135, 'sentence': 'Tumor necrosis factor alpha ( TNF-alpha ) mRNA production was analyzed by polymerase chain reaction amplification in monocytic U937 cells and in a chronically HIV infected U937 cell line ( U9-IIIB ).', 'label': {'U9-IIIB': 'cell_line', 'monocytic U937 cells': 'cell_line', 'Tumor necrosis factor alpha ( TNF-alpha ) mRNA': 'RNA', 'chronically HIV infected U937 cell line': 'cell_line', 'Tumor necrosis factor alpha': 'protein', 'TNF-alpha': 'protein'}, 'response1': "['RNA', 'cell_type', 'cell_line']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"2": "The sentence does not contain any of the entity types in the label set."},\n    {"3": "The sentence does not contain any of the entity types in the label set."},\n    {"4": "The sentence contains \'cell_line\' entity type which is present in the label set."},\n    {"5": "The sentence does not contain any of the entity types in the label set."},\n    {"6": "The sentence contains \'cell_line\' entity type which is present in the label set."},\n    {"7": "The sentence contains \'cell_type\' and \'protein\' entity types which are present in the label set."},\n    {"8": "The sentence contains \'protein\' entity type which is present in the label set."},\n    {"9": "The sentence contains \'protein\' entity type which is present in the label set."},\n    {"10": "The sentence contains \'protein\' and \'cell_line\' entity types which are present in the label set."},\n    {"11": "The sentence contains \'protein\', \'cell_type\', and \'cell_line\' entity types which are present in the label set."},\n    {"12": "The sentence contains \'protein\' entity type which is present in the label set."},\n    {"13": "The sentence contains \'DNA\' entity type which is present in the label set."},\n    {"14": "The sentence contains \'protein\' entity type which is present in the label set."},\n    {"15": "The sentence contains \'protein\' entity type which is present in the label set."},\n    {"16": "The sentence does not contain any of the entity types in the label set."},\n    {"17": "The sentence does not contain any of the entity types in the label set."},\n    {"18": "The sentence does not contain any of the entity types in the label set."},\n    {"19": "The sentence does not contain any of the entity types in the label set."},\n    {"20": "The sentence does not contain any of the entity types in the label set."}\n]', 'response3': '[\n    {"TNF-alpha": "protein"},\n    {"U937": "cell_type"},\n    {"U9-IIIB": "cell_line"},\n    {"HIV": "cell_type"}\n]', 'prediction': {'TNF-alpha': 'protein', 'U937': 'cell_type', 'U9-IIIB': 'cell_line', 'HIV': 'cell_type'}}
{'idx': 432, 'sentence': 'Moreover, BSAP is clearly a B-cell-specific transcription factor , as a wild-type but not a mutant TSAP -binding site of the sea urchin functions only in transfected B cells as an upstream promoter element .', 'label': {'transfected B cells': 'cell_line', 'TSAP': 'protein', 'mutant TSAP -binding site': 'DNA', 'upstream promoter element': 'DNA', 'BSAP': 'protein', 'B-cell-specific transcription factor': 'protein', 'wild-type': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n{"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 4},\n{"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n{"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n{"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.": 5},\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 4},\n{"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 3},\n{"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n{"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n{"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n{"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n{"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n{"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.": 5},\n{"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"BSAP": "protein"}, {"TSAP": "protein"}, {"sea urchin": "cell_line"}, {"B cells": "cell_type"}]', 'prediction': {'BSAP': 'protein', 'TSAP': 'protein', 'sea urchin': 'cell_line', 'B cells': 'cell_type'}}
{'idx': 1161, 'sentence': 'Deoxycholate treatment of the cytoplasmic extract prepared from cells stimulated by TNF-alpha in the presence of Cu2+ resulted in the release of NF kappa B from I kappa B alpha , indicating that Cu2+ interferes with the dissociation of the NF kappa B -I kappa B complex .', 'label': {'I kappa B alpha': 'protein', 'NF kappa B': 'protein', 'NF kappa B -I kappa B complex': 'protein', 'TNF-alpha': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.": 5},\n    {"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .": 5},\n    {"When the same MTHC lines are exposed to TNF-alpha in combination with IFN-gamma , the cells instead become DC .": 5},\n    {"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .": 5},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .": 5},\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .": 5},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .": 5},\n    {"Control of NF-kappa B activity by the I kappa B beta inhibitor .": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"NF kappa B": "protein"}, {"I kappa B alpha": "protein"}, {"Cu2+": "None"}, {"TNF-alpha": "protein"}]', 'prediction': {'NF kappa B': 'protein', 'I kappa B alpha': 'protein', 'Cu2+': 'None', 'TNF-alpha': 'protein'}}
{'idx': 1794, 'sentence': 'Activation of the signal transducer and transcription ( STAT ) signaling pathway in a primary T cell response .', 'label': {'STAT': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 4},\n    {"Example 3": 5},\n    {"Example 4": 4},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 3},\n    {"Example 10": 1},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1470, 'sentence': 'Hence, induction of cell surface expression of this leukocyte adhesion molecule by tumor necrosis factor (TNF)-alpha was reduced by 40% in the presence of CsA , and this was reflected by a 29% decrease in neutrophil adhesion .', 'label': {'neutrophil': 'cell_type', 'tumor necrosis factor (TNF)-alpha': 'protein', 'leukocyte adhesion molecule': 'protein'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n{"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 5},\n{"PMA induced the expression of both CD14 and CD23 mRNA and protein.": 5},\n{"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .": 5},\n{"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .": 5},\n{"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .": 5},\n{"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .": 5},\n{"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n{"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .": 5},\n{"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .": 5},\n{"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .": 5},\n{"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .": 5},\n{"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .": 5},\n{"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n{"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules .": 5},\n{"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"TNF-alpha": "protein"}, {"CsA": "protein"}]', 'prediction': {'TNF-alpha': 'protein', 'CsA': 'protein'}}
{'idx': 644, 'sentence': 'Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers : a role for hematopoietic growth factor release by tumor cells ?', 'label': {'tumor cells': 'cell_type', 'hematopoietic growth factor': 'protein'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example contains specific terms that match the entity labels in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The example contains specific terms that match the entity labels in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The example contains specific terms that match the entity labels in the target sentence."},\n    {"Example 4": 4},\n    {"Reason 4": "The example contains terms that match some entity labels in the target sentence."},\n    {"Example 5": 4},\n    {"Reason 5": "The example contains terms that match some entity labels in the target sentence."},\n    {"Example 6": 4},\n    {"Reason 6": "The example contains terms that match some entity labels in the target sentence."},\n    {"Example 7": 4},\n    {"Reason 7": "The example contains terms that match some entity labels in the target sentence."},\n    {"Example 8": 3},\n    {"Reason 8": "The example contains terms that partially match the entity labels in the target sentence."},\n    {"Example 9": 3},\n    {"Reason 9": "The example contains terms that partially match the entity labels in the target sentence."},\n    {"Example 10": 3},\n    {"Reason 10": "The example contains terms that partially match the entity labels in the target sentence."},\n    {"Example 11": 3},\n    {"Reason 11": "The example contains terms that partially match the entity labels in the target sentence."},\n    {"Example 12": 2},\n    {"Reason 12": "The example contains terms that do not directly match the entity labels in the target sentence."},\n    {"Example 13": 1},\n    {"Reason 13": "The example does not contain terms that match the entity labels in the target sentence."},\n    {"Example 14": 1},\n    {"Reason 14": "The example does not contain terms that match the entity labels in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The example does not contain terms that match the entity labels in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain terms that match the entity labels in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain terms that match the entity labels in the target sentence."}\n]', 'response3': "[{'lymphocyte': 'cell_type'}, {'hematopoietic growth factor': 'protein'}, {'tumor cells': 'cell_type'}]", 'prediction': {'lymphocyte': 'cell_type', 'hematopoietic growth factor': 'protein', 'tumor cells': 'cell_type'}}
{'idx': 435, 'sentence': 'Antibodies are produced exclusively in B lymphocytes .', 'label': {'Antibodies': 'protein', 'lymphocytes': 'cell_type', 'B lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"IgH": 5, "Eosinophils": 4, "IL-13": 5, "IL-4": 5, "EBV": 4, "CD2": 4},\n{"protein": "The examples provide specific protein names that are directly mentioned in the sentence, aiding in the extraction of protein entities.", "cell_type": "The examples provide specific cell type names that are directly mentioned in the sentence, aiding in the extraction of cell type entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1342, 'sentence': 'While Bik does not show overt homology to the BH1 and BH2 conserved domains characteristic of the Bcl-2 family , it does share a 9 amino acid domain ( BH3 ) with Bax and Bak which may be a critical determinant for the death-promoting activity of these proteins.', 'label': {'amino acid domain': 'protein', 'BH1': 'protein', 'BH3': 'protein', 'Bak': 'protein', 'BH2': 'protein', 'Bax': 'protein', 'Bik': 'protein', 'Bcl-2 family': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 4},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"These two related genes share the evolutionarily conserved region encoding the Runt domain.": 4},\n    {"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"Tat-binding protein 7 is a subunit of the 26S protease.": 4},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.": 5},\n    {"Activation of NF-kappaB by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.": 5},\n    {"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1022, 'sentence': 'NK cell NFAT is present in the cytosol of nonstimulated cells , migrates to the nucleus upon stimulation, and can associate with AP-1 .', 'label': {'NK cell NFAT': 'protein', 'AP-1': 'protein', 'nonstimulated cells': 'cell_type'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Sentence 1": 5},\n    {"Sentence 2": 5},\n    {"Sentence 3": 5},\n    {"Sentence 4": 5},\n    {"Sentence 5": 5},\n    {"Sentence 6": 5},\n    {"Sentence 7": 5},\n    {"Sentence 8": 4},\n    {"Sentence 9": 1},\n    {"Sentence 10": 5},\n    {"Sentence 11": 5},\n    {"Sentence 12": 5},\n    {"Sentence 13": 5},\n    {"Sentence 14": 5},\n    {"Sentence 15": 5},\n    {"Sentence 16": 5},\n    {"Sentence 17": 1},\n    {"Sentence 18": 1},\n    {"Sentence 19": 1},\n    {"Sentence 20": 1}\n]', 'response3': '[{"NK cell": "cell_type"}, {"NFAT": "protein"}, {"AP-1": "protein"}]', 'prediction': {'NK cell': 'cell_type', 'NFAT': 'protein', 'AP-1': 'protein'}}
{'idx': 810, 'sentence': 'Exposure of CML cells to IFN-alpha diminished the effect of the CML cytoplasmic proteins on these nuclear protein-DNA complexes .', 'label': {'CML cells': 'cell_type', 'IFN-alpha': 'protein', 'CML cytoplasmic proteins': 'protein', 'nuclear protein-DNA complexes': 'protein'}, 'response1': "['protein', 'cell_line', 'DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example contains a specific protein name that directly corresponds to the entity label in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The example contains multiple entity labels that are relevant to the target sentence."},\n    {"Example 3": 4},\n    {"Reason 3": "The example contains multiple protein names that are relevant to the target sentence."},\n    {"Example 4": 4},\n    {"Reason 4": "The example contains multiple protein names that are relevant to the target sentence."},\n    {"Example 5": 4},\n    {"Reason 5": "The example contains multiple protein names that are relevant to the target sentence."},\n    {"Example 6": 3},\n    {"Reason 6": "The example contains a specific DNA binding protein name that corresponds to the entity label in the target sentence."},\n    {"Example 7": 4},\n    {"Reason 7": "The example contains a specific protein name that directly corresponds to the entity label in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The example contains multiple protein names and cytokine names that are relevant to the target sentence."},\n    {"Example 9": 4},\n    {"Reason 9": "The example contains multiple protein names that are relevant to the target sentence."},\n    {"Example 10": 4},\n    {"Reason 10": "The example contains multiple protein names that are relevant to the target sentence."},\n    {"Example 11": 4},\n    {"Reason 11": "The example contains multiple protein names that are relevant to the target sentence."},\n    {"Example 12": 3},\n    {"Reason 12": "The example contains a specific protein name that directly corresponds to the entity label in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The example contains multiple protein names and cytokine names that are relevant to the target sentence."},\n    {"Example 14": 4},\n    {"Reason 14": "The example contains multiple protein names that are relevant to the target sentence."},\n    {"Example 15": 4},\n    {"Reason 15": "The example contains multiple protein names that are relevant to the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain any relevant entity labels to the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain any relevant entity labels to the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any relevant entity labels to the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The example does not contain any relevant entity labels to the target sentence."}\n]', 'response3': "[{'CML': 'cell_line'}, {'IFN-alpha': 'protein'}, {'cytoplasmic proteins': 'protein'}, {'nuclear protein-DNA complexes': 'DNA'}]", 'prediction': {'CML': 'cell_line', 'IFN-alpha': 'protein', 'cytoplasmic proteins': 'protein', 'nuclear protein-DNA complexes': 'DNA'}}
{'idx': 1811, 'sentence': "In our attempt to identify chemokine receptors that are related to Burkitt's lymphoma receptor 1 ( BLR1 ) and are expressed in activated lymphocytes we used RT-PCR resulting in the isolation of a cDNA encoding a seven transmembrane receptor termed BLR2 .", 'label': {'BLR1': 'protein', 'BLR2': 'protein', 'seven transmembrane receptor': 'protein', 'activated lymphocytes': 'cell_type', 'chemokine receptors': 'protein', "Burkitt's lymphoma receptor 1": 'protein'}, 'response1': "['DNA', 'RNA', 'protein']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 3},\n    {"Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 4},\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 3},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 4},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 4},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"This suggests that CHEMR1 may be a receptor for unidentified C-C chemokine or a low-affinity receptor for MIP-1alpha .": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1316, 'sentence': 'Helix III is less rigid, makes an average angle of about 90 degrees with helices I and II , and constitutes the other arm of the molecule.', 'label': {'Helix III': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 939, 'sentence': 'However, in 3 postmenopausal patients a short course of estrogen or tamoxifen resulted in a marked increase of type II EBS levels.', 'label': {'type II EBS': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a clear and direct mapping of the entity \'E2F-4\' to the entity type \'protein\' in the sentence, aiding in the extraction of named entities."},\n    {"Example 2": 4},\n    {"Reason 2": "The example provides a direct mapping of the entity \'Epo\' to the entity type \'protein\' in the sentence, aiding in the extraction of named entities."},\n    {"Example 3": 1},\n    {"Reason 3": "The example does not contain any entities that match the entity types present in the target sentence, hence not helpful in aiding the extraction of named entities."},\n    {"Example 4": 1},\n    {"Reason 4": "The example does not contain any entities that match the entity types present in the target sentence, hence not helpful in aiding the extraction of named entities."},\n    {"Example 5": 1},\n    {"Reason 5": "The example does not contain any entities that match the entity types present in the target sentence, hence not helpful in aiding the extraction of named entities."},\n    {"Example 6": 1},\n    {"Reason 6": "The example does not contain any entities that match the entity types present in the target sentence, hence not helpful in aiding the extraction of named entities."},\n    {"Example 7": 1},\n    {"Reason 7": "The example does not contain any entities that match the entity types present in the target sentence, hence not helpful in aiding the extraction of named entities."},\n    {"Example 8": 1},\n    {"Reason 8": "The example does not contain any entities that match the entity types present in the target sentence, hence not helpful in aiding the extraction of named entities."},\n    {"Example 9": 1},\n    {"Reason 9": "The example does not contain any entities that match the entity types present in the target sentence, hence not helpful in aiding the extraction of named entities."},\n    {"Example 10": 1},\n    {"Reason 10": "The example does not contain any entities that match the entity types present in the target sentence, hence not helpful in aiding the extraction of named entities."},\n    {"Example 11": 1},\n    {"Reason 11": "The example does not contain any entities that match the entity types present in the target sentence, hence not helpful in aiding the extraction of named entities."},\n    {"Example 12": 1},\n    {"Reason 12": "The example does not contain any entities that match the entity types present in the target sentence, hence not helpful in aiding the extraction of named entities."},\n    {"Example 13": 1},\n    {"Reason 13": "The example does not contain any entities that match the entity types present in the target sentence, hence not helpful in aiding the extraction of named entities."},\n    {"Example 14": 1},\n    {"Reason 14": "The example does not contain any entities that match the entity types present in the target sentence, hence not helpful in aiding the extraction of named entities."},\n    {"Example 15": 1},\n    {"Reason 15": "The example does not contain any entities that match the entity types present in the target sentence, hence not helpful in aiding the extraction of named entities."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain any entities that match the entity types present in the target sentence, hence not helpful in aiding the extraction of named entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain any entities that match the entity types present in the target sentence, hence not helpful in aiding the extraction of named entities."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any entities that match the entity types present in the target sentence, hence not helpful in aiding the extraction of named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 292, 'sentence': 'We used mouse embryonic stem (ES) cells to study globin gene expression and switching in vitro.', 'label': {'globin gene': 'DNA', 'mouse embryonic stem (ES) cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein (E2A) being mentioned in relation to gene expression."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence clearly mentions a protein (MNDA) and a cell line (Philadelphia chromosome-positive chronic myeloid leukemia) in the context of gene expression."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence mentions specific cell types (granulocytes and T cells) in relation to methylation, which can aid in identifying cell types."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence directly mentions a DNA entity (IgH) in relation to gene transcription."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides a clear example of a protein (PML/RARalpha) in the context of its role in myelopoiesis."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence mentions a protein (GM-CSF) in the context of gene conservation."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence mentions a protein (GATA-1) in relation to transcription factor regulation."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides a clear example of a cell line (SCM-1) in the context of gene regulation."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence mentions multiple proteins (IFN A, interleukin-2, interleukin-2 receptor) and stimuli (phytohemagglutinin, phorbol myristate acetate) in relation to gene expression."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence mentions a protein (GATA-1) in the context of eosinophil differentiation."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence mentions DNA elements (CCAAT box, EKLF binding site) in relation to gene expression."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides a clear example of a protein (Egr-1) in the context of gene expression."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence mentions a protein (RXR) in relation to erythroid cell outgrowth."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence mentions multiple proteins (Sp1, Ets) in relation to gene expression."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence mentions proteins (c-kit, IL-4R alpha chain) in the context of receptor generation."},\n    {"Example 16": 4},\n    {"Reason 16": "The sentence mentions proteins (ZEB, c-Myb, Ets) and a cell type (hematopoietic cells) in relation to gene expression."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific entities related to the entity labels in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific entities related to the entity labels in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific entities related to the entity labels in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any specific entities related to the entity labels in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 542, 'sentence': 'Amino acid sequences of all proteins are essays written in the same language.', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 505, 'sentence': 'The TCF-1 alpha binding site was also required for TCR alpha enhancer activity in transcriptionally active extracts from Jurkat but not HeLa cells , confirming that TCF-1 alpha is a T-cell-specific transcription factor .', 'label': {'Jurkat': 'cell_line', 'TCF-1 alpha': 'protein', 'TCR': 'protein', 'T-cell-specific transcription factor': 'protein', 'TCF-1 alpha binding site': 'DNA', 'HeLa cells': 'cell_line'}, 'response1': "['protein', 'cell_line', 'cell_type']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with corresponding labels, such as \'NF-ATc\': \'protein\', \'T lymphocytes\': \'cell_type\', \'embryonic cardiac cells\': \'cell_type\'. This provides a diverse set of entities for training the model to recognize different types of entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides an example of a named entity \'TCF-1\' labeled as \'protein\'. This example is helpful for training the model to recognize proteins."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of named entities with corresponding labels, such as \'IL-2\': \'protein\', \'c-Jun\': \'protein\', \'c-Fos\': \'protein\'. This provides additional training data for recognizing proteins."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of named entities \'Jun\' and \'ATF-2\' labeled as \'protein\'. This helps in training the model to recognize proteins."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of named entities \'Sp1\' and \'CD14\' labeled as \'protein\'. This helps in training the model to recognize proteins."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides an example of a named entity \'GATA-1\' labeled as \'protein\'. This example is helpful for training the model to recognize proteins."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of named entities \'T cell\' labeled as \'cell_type\' and \'interleukin 2\' labeled as \'protein\'. This provides training data for recognizing different types of entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of named entities \'Sp1\' and \'Ets\' labeled as \'protein\'. This helps in training the model to recognize proteins."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of named entities \'Tax\' and \'TFIIA\' labeled as \'protein\'. This helps in training the model to recognize proteins."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of named entities \'EKLF\', \'CBP\', \'p300\', and \'P/CAF\' labeled as \'protein\'. This helps in training the model to recognize proteins."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of named entities \'RelA\' and \'NF-kappa B\' labeled as \'protein\'. This helps in training the model to recognize proteins."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of named entities \'IL-2\', \'IFN-gamma\', \'jak kinases\', and \'STAT1(alpha)\' labeled as \'protein\'. This helps in training the model to recognize proteins."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides an example of a named entity \'Egr-1\' labeled as \'protein\'. This example is helpful for training the model to recognize proteins."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides an example of a named entity \'TCF-1\' labeled as \'protein\'. This example is helpful for training the model to recognize proteins."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of named entities \'IFN A\', \'IFNA\', \'interleukin-2\', \'interleukin-2 receptor\', \'phytohemagglutinin\', and \'phorbol myristate acetate\' labeled as \'protein\'. This helps in training the model to recognize proteins."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of named entities \'IkappaBbeta\' and \'NF-kappaB\' labeled as \'protein\'. This helps in training the model to recognize proteins."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities with corresponding labels from the entity label set."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities with corresponding labels from the entity label set."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities with corresponding labels from the entity label set."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities with corresponding labels from the entity label set."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities with corresponding labels from the entity label set."}\n]', 'response3': '[{"TCF-1 alpha": "protein"}, {"TCR alpha": "protein"}, {"Jurkat": "cell_line"}, {"HeLa": "cell_line"}, {"T-cell": "cell_type"}]', 'prediction': {'TCF-1 alpha': 'protein', 'TCR alpha': 'protein', 'Jurkat': 'cell_line', 'HeLa': 'cell_line', 'T-cell': 'cell_type'}}
{'idx': 1525, 'sentence': 'Kinase activity was reduced in lysates preadsorbed using an antibody specific for CaM kinase II .', 'label': {'antibody': 'protein', 'CaM kinase II': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides clear and specific protein names that match the entity types in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The example provides specific protein names that match the entity types in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The example provides specific protein names that match the entity types in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The example provides a specific protein name that matches the entity type in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides a specific protein name that matches the entity type in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The example provides specific protein names and a cell type that match the entity types in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The example provides specific protein names that match the entity types in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides specific protein names that match the entity types in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides specific protein names that match the entity types in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides a specific protein name that matches the entity type in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The example provides a specific protein name that matches the entity type in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The example provides specific protein names that match the entity types in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides specific protein names that match the entity types in the target sentence."},\n    {"Example 14": 1},\n    {"Reason 14": "The example does not contain any entity names that match the entity types in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The example does not contain any entity names that match the entity types in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain any entity names that match the entity types in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain any entity names that match the entity types in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any entity names that match the entity types in the target sentence."}\n]', 'response3': "[{'CaM kinase II': 'protein'}]", 'prediction': {'CaM kinase II': 'protein'}}
{'idx': 1103, 'sentence': 'Relationship between Rap1 protein phosphorylation and regulation of Ca2+ transport in platelets : a new approach.', 'label': {'platelets': 'cell_type', 'Rap1 protein': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names and their associations, which directly match the entity labels in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides detailed information about protein names, cell types, and their interactions, aligning with the entity labels in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence mentions various proteins and their involvement in gene expression regulation, phosphorylation reactions, and signaling pathways, all relevant to the entity labels in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence discusses specific proteins and their roles in signal transduction and cell functions, directly related to the entity labels in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides information about protein names and their associations with cellular components, matching the entity labels in the target sentence."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence talks about the importance of phosphorylated tyrosine residue in protein-protein interactions, indirectly related to the protein entity label in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence mentions a specific protein involved in transcription factor regulation, directly corresponding to the protein entity label in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence discusses the role of small GTP binding proteins in signal transduction and cell transformation, aligning with the protein entity label in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence talks about the effect of anti-P selectin antibodies on cytokine production, directly related to the protein entity label in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides information about mRNA and protein levels of specific proteins, matching the protein entity label in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence discusses protein kinases and their phosphorylation in human neutrophils, directly related to the protein entity label in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence mentions specific proteins involved in the regulation of nuclear localization and binding complexes, aligning with the protein entity label in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence talks about protein-tyrosine kinases and their activation upon receptor crosslinking, directly corresponding to the protein entity label in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides information about protein distribution and phosphorylation induced by IL-2, matching the protein entity label in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence discusses the effects of phosphocreatine administration on lymphocytes and protein binding, directly related to the protein entity label in the target sentence."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence mentions specific protein kinase names and their substrates in platelets, aligning with the protein entity label in the target sentence."}\n]', 'response3': '[{"Rap1": "protein"}, {"Ca2+": "protein"}]', 'prediction': {'Rap1': 'protein', 'Ca2+': 'protein'}}
{'idx': 538, 'sentence': 'Alone, PMA and calcium ionophore A23187 did not affect, but together stimulated, like phytohaemagglutinin ( PHA ), leucine and, in particular, thymidine incorporation .', 'label': {'PHA': 'protein', 'phytohaemagglutinin': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1529, 'sentence': 'Transcriptional activation and repression , two properties of the lymphoid-specific transcription factor Oct-2a .', 'label': {'Oct-2a': 'protein', 'lymphoid-specific transcription factor': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names such as IkappaBbeta, NF-kappaB, and tax protein, which are directly related to the entity labels provided."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions Th2-type lymphocytes, which is a specific cell type relevant to the entity labels."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence includes Oct-2A, HMG I/Y, HLA-DRA, and B cells, all of which are directly related to the entity labels provided."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence mentions T cell and interleukin 2, which are specific entities related to the entity labels provided."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains NF-kB, AP-1, OCT-1, and NF-IL-2B, which are all specific protein names directly related to the entity labels provided."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence mentions Egr-1, a zinc finger transcription factor, which is directly related to the entity labels provided."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence includes IL-2 receptor alpha subunit, p21ras, and B cell, all of which are directly related to the entity labels provided."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions SP1, caspases, and B-cell, which are all directly related to the entity labels provided."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains NF-ATc and T lymphocytes, which are directly related to the entity labels provided."},\n    {"Example 10": 3},\n    {"Reason 10": "The sentence mentions AP-1, which is related to the entity labels provided, but the context is not as clear as in other examples."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence includes A-myb, a specific protein name directly related to the entity labels provided."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence mentions Sp1 and Ets-related transcription factors, which are directly related to the entity labels provided."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains Jun and ATF-2, which are specific protein names directly related to the entity labels provided."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence mentions NF-E2, a specific protein name directly related to the entity labels provided."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence includes NF-ATc, T lymphocytes, and embryonic cardiac cells, all of which are directly related to the entity labels provided."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence mentions GATA-1, a specific protein name directly related to the entity labels provided."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific entities related to the entity labels provided."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific entities related to the entity labels provided."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific entities related to the entity labels provided."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any specific entities related to the entity labels provided."}\n]', 'response3': '[{"Oct-2a": "protein"}]', 'prediction': {'Oct-2a': 'protein'}}
{'idx': 1197, 'sentence': 'In this study, we demonstrate reconstitution of a cell-free processing system and demonstrate directly that: (a) the ubiquitin -proteasome system is involved in processing of the intact p105 precursor, (b) conjugation of ubiquitin to the precursor is an essential intermediate step in the processing, (c) the recently discovered novel species of the ubiquitin -carrier protein , E2-F1 , that is involved in the conjugation and degradation of p53 , is also required for the limited processing of the p105 precursor , and (d) a novel, approximately 320-kDa species of ubiquitin -protein ligase , is involved in the process.', 'label': {'ubiquitin': 'protein', 'p105 precursor': 'protein', 'E2-F1': 'protein', '-proteasome': 'protein', 'ubiquitin -carrier protein': 'protein', 'p53': 'protein', 'ubiquitin -protein ligase': 'protein', '320-kDa species': 'protein', 'p105': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of the relationship between immunohistochemistry and the identification of proteins, aiding in the extraction of protein entities."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence directly mentions a specific protein (Tat-binding protein 7), which is helpful for identifying protein entities."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence mentions specific proteins (p21(WAF1/CIP1) and p27(KIP1)) and their mRNA, aiding in the extraction of protein entities."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence directly mentions \'Protein\' in relation to genomic sequences, which is helpful for identifying protein entities."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence provides examples of DNA elements (UAS3, UAS2) and a protein (YY1), aiding in the extraction of DNA and protein entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence directly mentions specific proteins (SP1 and caspases) and a cell type (B-cell), aiding in the extraction of protein and cell type entities."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence directly mentions NF-kappa B as a protein, aiding in the extraction of protein entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides examples of specific proteins (Syk and Zap) and a cell type (T cell), aiding in the extraction of protein and cell type entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence directly mentions specific proteins (IkappaBbeta and NF-kappaB), aiding in the extraction of protein entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence directly mentions specific proteins (CREB and AR-CRE), aiding in the extraction of protein entities."},\n    {"Example 11": 4},\n    {"Reason 11": "The sentence directly mentions a specific protein (ZAP-70), aiding in the extraction of protein entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence directly mentions a specific protein (TCF-1), aiding in the extraction of protein entities."},\n    {"Example 13": 4},\n    {"Reason 13": "The sentence provides an example of a DNA element (immunoglobulin kappa 3\' enhancer), aiding in the extraction of DNA entities."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence directly mentions a specific protein (E2A), aiding in the extraction of protein entities."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence directly mentions specific proteins (IkappaBalpha and NF-kappaB), aiding in the extraction of protein entities."},\n    {"Example 16": 4},\n    {"Reason 16": "The sentence provides examples of specific proteins (IL-2, c-Jun, and c-Fos), aiding in the extraction of protein entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific examples of entities mentioned in the entity label set."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific examples of entities mentioned in the entity label set."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific examples of entities mentioned in the entity label set."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any specific examples of entities mentioned in the entity label set."}\n]', 'response3': '[{"ubiquitin -proteasome system": "protein"}, {"p105 precursor": "protein"}, {"ubiquitin": "protein"}, {"E2-F1": "protein"}, {"p53": "protein"}, {"ubiquitin -carrier protein": "protein"}, {"ubiquitin -protein ligase": "protein"}]', 'prediction': {'ubiquitin -proteasome system': 'protein', 'p105 precursor': 'protein', 'ubiquitin': 'protein', 'E2-F1': 'protein', 'p53': 'protein', 'ubiquitin -carrier protein': 'protein', 'ubiquitin -protein ligase': 'protein'}}
{'idx': 877, 'sentence': 'Their constitutive expression is limited to B lymphocytes and thymic epithelial cells .', 'label': {'B lymphocytes': 'cell_type', 'thymic epithelial cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains clear mentions of specific entities with corresponding labels, aiding in the extraction process."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence provides a specific entity with a corresponding label, aiding in the extraction process."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence provides clear mentions of specific entities with corresponding labels, aiding in the extraction process."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains clear mentions of specific entities with corresponding labels, aiding in the extraction process."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence provides a specific entity with a corresponding label, aiding in the extraction process."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains clear mentions of specific entities with corresponding labels, aiding in the extraction process."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence provides clear mentions of specific entities with corresponding labels, aiding in the extraction process."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains clear mentions of specific entities with corresponding labels, aiding in the extraction process."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence provides clear mentions of specific entities with corresponding labels, aiding in the extraction process."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains clear mentions of specific entities with corresponding labels, aiding in the extraction process."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains clear mentions of specific entities with corresponding labels, aiding in the extraction process."},\n    {"Example 12": 4},\n    {"Reason 12": "The sentence provides a specific entity with a corresponding label, aiding in the extraction process."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not contain any specific entities with corresponding labels, making it less helpful in the extraction process."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not contain any specific entities with corresponding labels, making it less helpful in the extraction process."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any specific entities with corresponding labels, making it less helpful in the extraction process."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any specific entities with corresponding labels, making it less helpful in the extraction process."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific entities with corresponding labels, making it less helpful in the extraction process."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific entities with corresponding labels, making it less helpful in the extraction process."}\n]', 'response3': '[{"B lymphocytes": "cell_type"}, {"thymic epithelial cells": "cell_type"}]', 'prediction': {'B lymphocytes': 'cell_type', 'thymic epithelial cells': 'cell_type'}}
{'idx': 1838, 'sentence': 'First, we show that mutations in the LEF-1 -binding site inhibit the activity of multimerized copies of the HIV-1 enhancer in Jurkat T cells , and that LEF-1 /GAL4 can activate a GAL4-substituted HIV-1 enhancer 80- to 100-fold in vivo.', 'label': {'LEF-1 -binding site': 'DNA', 'HIV-1 enhancer': 'DNA', 'LEF-1': 'protein', 'GAL4-substituted HIV-1 enhancer': 'DNA', 'Jurkat T cells': 'cell_line', 'multimerized copies': 'DNA', 'LEF-1 /GAL4': 'protein'}, 'response1': "['DNA', 'protein', 'cell_type', 'cell_line']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The example provides a clear and specific entity label that directly matches the entity type in the sentence."},\n{"Example 2": 5},\n{"Reason 2": "The example provides multiple clear and specific entity labels that directly match the entity types in the sentence."},\n{"Example 3": 5},\n{"Reason 3": "The example provides multiple clear and specific entity labels that directly match the entity types in the sentence."},\n{"Example 4": 5},\n{"Reason 4": "The example provides multiple clear and specific entity labels that directly match the entity types in the sentence."},\n{"Example 5": 5},\n{"Reason 5": "The example provides multiple clear and specific entity labels that directly match the entity types in the sentence."},\n{"Example 6": 5},\n{"Reason 6": "The example provides multiple clear and specific entity labels that directly match the entity types in the sentence."},\n{"Example 7": 5},\n{"Reason 7": "The example provides a clear and specific entity label that directly matches the entity type in the sentence."},\n{"Example 8": 5},\n{"Reason 8": "The example provides multiple clear and specific entity labels that directly match the entity types in the sentence."},\n{"Example 9": 5},\n{"Reason 9": "The example provides a clear and specific entity label that directly matches the entity type in the sentence."},\n{"Example 10": 5},\n{"Reason 10": "The example provides multiple clear and specific entity labels that directly match the entity types in the sentence."},\n{"Example 11": 5},\n{"Reason 11": "The example provides multiple clear and specific entity labels that directly match the entity types in the sentence."},\n{"Example 12": 5},\n{"Reason 12": "The example provides multiple clear and specific entity labels that directly match the entity types in the sentence."},\n{"Example 13": 5},\n{"Reason 13": "The example provides multiple clear and specific entity labels that directly match the entity types in the sentence."},\n{"Example 14": 5},\n{"Reason 14": "The example provides multiple clear and specific entity labels that directly match the entity types in the sentence."},\n{"Example 15": 1},\n{"Reason 15": "The example does not provide any entity labels that match the entity types in the sentence."},\n{"Example 16": 1},\n{"Reason 16": "The example does not provide any entity labels that match the entity types in the sentence."},\n{"Example 17": 1},\n{"Reason 17": "The example does not provide any entity labels that match the entity types in the sentence."},\n{"Example 18": 1},\n{"Reason 18": "The example does not provide any entity labels that match the entity types in the sentence."},\n{"Example 19": 1},\n{"Reason 19": "The example does not provide any entity labels that match the entity types in the sentence."}\n]', 'response3': "[{'LEF-1': 'protein'}, {'HIV-1 enhancer': 'DNA'}, {'Jurkat T cells': 'cell_type'}, {'GAL4': 'protein'}, {'GAL4-substituted HIV-1 enhancer': 'DNA'}]", 'prediction': {'LEF-1': 'protein', 'HIV-1 enhancer': 'DNA', 'Jurkat T cells': 'cell_type', 'GAL4': 'protein', 'GAL4-substituted HIV-1 enhancer': 'DNA'}}
{'idx': 1195, 'sentence': 'Palombella and colleagues (Palombella, V.J., Rando, O.J., Goldberg, A.L., and Maniatis, T.(1994) Cell 78, 773-785) have shown that ubiquitin is required for the processing in a cell-free system of a truncated, artificially constructed, 60-kDa precursor .', 'label': {'60-kDa precursor': 'protein', 'ubiquitin': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n{"Tat-binding protein 7 is a subunit of the 26S protease .": 4},\n{"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .": 5},\n{"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n{"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .": 5},\n{"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50 .": 4},\n{"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .": 5},\n{"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 5},\n{"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 4},\n{"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .": 5},\n{"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .": 5},\n{"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .": 4},\n{"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system .": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"Palombella": "protein"}, {"Rando": "protein"}, {"Goldberg": "protein"}, {"Maniatis": "protein"}, {"ubiquitin": "protein"}]', 'prediction': {'Palombella': 'protein', 'Rando': 'protein', 'Goldberg': 'protein', 'Maniatis': 'protein', 'ubiquitin': 'protein'}}
{'idx': 817, 'sentence': '(ii) Transfection and expression of EBNA-LP alone had no effect on LMP1 expression and did not act synergistically with EBNA-2 to affect LMP1 expression .', 'label': {'EBNA-LP': 'protein', 'LMP1': 'protein', 'EBNA-2': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"1": "The sentence does not contain any named entities from the provided entity label set."},\n    {"2": "The sentence does not contain any named entities from the provided entity label set."},\n    {"3": "The sentence contains multiple protein entities such as IFN A, interleukin-2, interleukin-2 receptor, phytohemagglutinin, and phorbol myristate acetate."},\n    {"4": "The sentence contains protein entities IL-4, LPS, and AP-1."},\n    {"5": "The sentence contains protein entities NF-kappaB, Sp1, and p50."},\n    {"6": "The sentence contains protein entities NF-kB, AP-1, OCT-1, and NF-IL-2B."},\n    {"7": "The sentence contains protein entity TIMP-1 and DNA."},\n    {"8": "The sentence contains protein entities RelA and NF-kappaB1."},\n    {"9": "The sentence contains protein entities EBNA-2 and PU.1."},\n    {"10": "The sentence contains cell_type entity T cell, and protein entities IL-2, IL-2 receptor, and CD28."},\n    {"11": "The sentence contains protein entity RXR."},\n    {"12": "The sentence contains protein entity EBNA2 and cell_line entity TP1."},\n    {"13": "The sentence contains RNA entity MNDA and cell_line entity myeloid cell lines."},\n    {"14": "The sentence contains protein entities p21(WAF1/CIP1) and p27(KIP1)."},\n    {"15": "The sentence contains protein entities CD40, IFN-gamma, tumor necrosis factor-alpha, and interleukin (IL)-1beta."},\n    {"16": "The sentence contains cell_type entity CD4+ and protein entity EBV."},\n    {"17": "The sentence does not contain any named entities from the provided entity label set."},\n    {"18": "The sentence does not contain any named entities from the provided entity label set."},\n    {"19": "The sentence does not contain any named entities from the provided entity label set."},\n    {"20": "The sentence does not contain any named entities from the provided entity label set."}\n]', 'response3': '[{"EBNA-LP": "protein"}, {"LMP1": "protein"}, {"EBNA-2": "protein"}]', 'prediction': {'EBNA-LP': 'protein', 'LMP1': 'protein', 'EBNA-2': 'protein'}}
{'idx': 741, 'sentence': 'In melanoma cells that contain the N-Oct-3 factor , a transfected lymphocyte-specific promoter was neither activated nor was it repressed upon contransfection with an Oct-2A expression vector .', 'label': {'Oct-2A expression vector': 'DNA', 'Oct-2A': 'protein', 'N-Oct-3 factor': 'protein', 'melanoma cells': 'cell_type'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 4},\n    {"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.": 5},\n    {"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.": 4},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2.": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 4},\n    {"Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B / Oct-1 -dependent transcription.": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.": 5},\n    {"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 283, 'sentence': '[ Estrogen receptor content of peripheral blood lymphocytes in patients with systemic lupus erythematosus ]', 'label': {'Estrogen receptor': 'protein', 'peripheral blood lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 4},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 4},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1043, 'sentence': 'METHOD: Two color flow cytometry analysis was used on peripheral blood samples of young and postmenopausal females and postmenopausal females treated with estrogen replacement therapy .', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific gene/protein names that are directly mentioned."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions a specific protein name (erythropoietin) which is directly related to a known entity type."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence mentions a specific protein name (E2A) which is directly related to a known entity type."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains specific gene/protein names (MNDA) and a cell line name (Philadelphia chromosome-positive chronic myeloid leukemia) that are directly mentioned."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence mentions a specific protein name (phosphocreatine) which is directly related to a known entity type."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains specific gene/protein names (TCRzeta, p56(lck)) that are directly mentioned."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains specific gene/protein names (alpha-tocopherol) and cell types (monocyte, endothelial cells) that are directly mentioned."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains specific gene/protein names (CD70, IL-4, CD40) and cell types (B cell, plasma cells) that are directly mentioned."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains specific gene/protein names (CD40, Rel/nuclear factor kappaB, NF-kappaB) and a cell type (B lymphocytes) that are directly mentioned."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains specific gene/protein names (Ter 119, beta-globin, glycoprotein IIb, platelet factor 4) and a cell line name (Ter 119) that are directly mentioned."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains specific gene/protein names (CD40) and cell types (B and T cell activation, Ramos, Jurkat) that are directly mentioned."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains specific gene/protein names (EBV, EBNA2, estrogen receptor) that are directly mentioned."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains specific gene/protein names (Erbstatin, genistein, Egr-1) that are directly mentioned."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains specific gene/protein names (PMA) and a cell line name (U1 cells) that are directly mentioned."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains specific gene/protein names (globins, glycoprotein IIb, platelet factor 4, Spi-1, Fli-1, erythropoietin) that are directly mentioned."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence contains specific gene/protein names (HPCs, PML, Rb) and a cell type (erythroid) that are directly mentioned."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific gene/protein or cell type names."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific gene/protein or cell type names."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific gene/protein or cell type names."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any specific gene/protein or cell type names."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1010, 'sentence': 'Using a polyclonal antibody to murine NFATp , Western blot analysis of various mouse tissues demonstrated that the 110-130-kDa NFATp protein was highly expressed in thymus and spleen .', 'label': {'murine NFATp': 'protein', 'NFATp protein': 'protein', 'NFATp': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 5},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .": 4},\n    {"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .": 5},\n    {"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 4},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .": 5},\n    {"Moreover, monocytes express a novel IL-10 -stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti- STAT3 Ab but is not observed in T cells .": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 5},\n    {"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"NFATp": "protein"}, {"NFATp": "protein"}, {"thymus": "cell_type"}, {"spleen": "cell_type"}]', 'prediction': {'NFATp': 'protein', 'thymus': 'cell_type', 'spleen': 'cell_type'}}
{'idx': 186, 'sentence': 'We also find that NF-E2 , another trans-acting factor of the erythrocytic lineage , is present in megakaryocytes .', 'label': {'erythrocytic lineage': 'cell_type', 'NF-E2': 'protein', 'trans-acting factor': 'protein', 'megakaryocytes': 'cell_line'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a direct mapping between the entity \'RXR\' and its corresponding entity label \'protein\' in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The examples provide direct mappings between the entities \'SCL\' and \'GATA-1\' with their corresponding entity label \'protein\' in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The examples provide direct mappings between the entities \'Stat3\', \'Stat5\', and \'c-Mpl\' with their corresponding entity label \'protein\' in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The examples provide direct mappings between the entities \'NF-ATc\' and \'T lymphocytes\' with their corresponding entity labels \'protein\' and \'cell_type\' in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides a direct mapping between the entity \'GATA-1\' and its corresponding entity label \'protein\' in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The examples provide direct mappings between the entities \'granulocytes\' and \'T cells\' with their corresponding entity labels \'cell_type\' in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The examples provide direct mappings between the entities \'EKLF\', \'CBP\', \'p300\', and \'P/CAF\' with their corresponding entity label \'protein\' in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides a direct mapping between the entity \'Egr-1\' and its corresponding entity label \'protein\' in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The examples provide direct mappings between the entities \'NF-ATc\', \'T lymphocytes\', and \'embryonic cardiac cells\' with their corresponding entity labels \'protein\' and \'cell_type\' in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides a direct mapping between the entity \'erythropoietin\' and its corresponding entity label \'protein\' in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The example provides a direct mapping between the entity \'NF-E2\' and its corresponding entity label \'protein\' in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The example provides a direct mapping between the entity \'NF-kappaB\' and its corresponding entity label \'protein\' in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides a direct mapping between the entity \'E2A\' and its corresponding entity label \'protein\' in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The example provides a direct mapping between the entity \'GATA-1\' and its corresponding entity label \'protein\' in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The examples provide direct mappings between the entities \'CD40\', \'Rel/nuclear factor kappaB\', \'NF-kappaB\', and \'B lymphocytes\' with their corresponding entity labels \'protein\' and \'cell_type\' in the target sentence."},\n    {"Example 16": 5},\n    {"Reason 16": "The examples provide direct mappings between the entities \'ZEB\', \'c-Myb\', \'Ets\', and \'hematopoietic cells\' with their corresponding entity labels \'protein\' and \'cell_type\' in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain any entities that match the entity types in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any entities that match the entity types in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The example does not contain any entities that match the entity types in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The example does not contain any entities that match the entity types in the target sentence."}\n]', 'response3': '[{"NF-E2": "protein"}, {"megakaryocytes": "cell_type"}]', 'prediction': {'NF-E2': 'protein', 'megakaryocytes': 'cell_type'}}
{'idx': 1547, 'sentence': 'Platelet glycoprotein ( GP ) Ib-IX-V is a multisubunit adhesion receptor that supports platelet attachment to thrombogenic surfaces at sites of vascular injury .', 'label': {'multisubunit adhesion receptor': 'protein', 'Ib-IX-V': 'protein', 'Platelet glycoprotein': 'protein', 'GP': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 1},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n    {"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.": 3},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 4},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 4},\n    {"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/thrombopoiesis or possibly a mature platelet function such as aggregation.": 5},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.": 5},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n    {"Tat-binding protein 7 is a subunit of the 26S protease.": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 4},\n    {"The p21ras small GTP binding proteins participate in signal transduction from cell surface receptors and affect neoplastic transformation and development in many different cell types.": 5},\n    {"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.": 5},\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 5},\n    {"We have examined the effect of alpha-tocopherol (alpha-tcp) on one cellular event in atherosclerotic plaque development, monocyte adhesion to stimulated endothelial cells (ECs).": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 96, 'sentence': 'We have analyzed the functional domains of the minimal Thy-1 promoter and show that the dominant promoter elements consist of multiple binding sites for the transcription factor Sp1 , an inverted CCAAT box , and sequences proximal to the transcription start site .', 'label': {'Sp1': 'protein', 'dominant promoter elements': 'DNA', 'minimal Thy-1 promoter': 'DNA', 'transcription factor': 'protein', 'multiple binding sites': 'DNA', 'CCAAT box': 'DNA', 'transcription start site': 'DNA'}, 'response1': "['protein']", 'response2': '[\n{"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n{"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 4},\n{"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n{"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n{"Here we examined the regulatory mechanism of the SCM-1 genes.": 4},\n{"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 4},\n{"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 5},\n{"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 4},\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n{"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n{"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n{"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 5},\n{"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif.": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1763, 'sentence': 'Cysteamine treatment inhibited both expression of the IL-2 mRNA and secretion of IL-2 into the culture medium .', 'label': {'IL-2': 'protein', 'IL-2 mRNA': 'RNA'}, 'response1': "['RNA', 'protein']", 'response2': '[\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 5},\n    {"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .": 4},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .": 4},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 5},\n    {"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .": 5},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"Binding of YY1 and Oct1 to a novel element that downregulates expression of IL-5 in human T cells .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"IL-2 mRNA": "RNA"}, {"IL-2": "protein"}]', 'prediction': {'IL-2 mRNA': 'RNA', 'IL-2': 'protein'}}
{'idx': 224, 'sentence': 'Cortivazol ( CVZ ) is a unique, high potency synthetic glucocorticoid , which has a phenylpyrazol fused to the A-ring of the steroid nucleus and displays binding consistent with two or more sites in the cytosol from CEM C7 cells (a human acute lymphoblastic T-cell line ).', 'label': {'CEM C7 cells': 'cell_line', 'human acute lymphoblastic T-cell line': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 1},\n    {"Example 14": 1},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"CEM C7 cells": "cell_line"}]', 'prediction': {'CEM C7 cells': 'cell_line'}}
{'idx': 313, 'sentence': 'Immunohistochemical study of steroid hormones and an estrogen binding assay in malignant soft tissue tumors .', 'label': {'malignant soft tissue tumors': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a clear mapping between the entity \'E2A\' and the entity type \'protein\' in the sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The example provides a clear mapping between the entity \'GATA-1\' and the entity type \'protein\' in the sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The example provides a clear mapping between the entity \'lymphoid neoplasms\' and the entity type \'cell_type\' in the sentence."},\n    {"Example 4": 4},\n    {"Reason 4": "The example provides a clear mapping between the entity \'phosphocreatine\' and the entity type \'protein\' in the sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The examples provide clear mappings between the entities \'SLAP-130\', \'SLP-76\', \'T cell\' and the entity types \'protein\', \'protein\', \'cell_type\' respectively in the sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The example provides a clear mapping between the entity \'NF-E2\' and the entity type \'protein\' in the sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The example provides clear mappings between the entities \'immunohistochemistry\', \'gene\', \'cell type\' and the entity types \'protein\', \'DNA\', \'cell_type\' respectively in the sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides a clear mapping between the entity \'retinoic acid receptor alpha\' and the entity type \'protein\' in the sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides a clear mapping between the entity \'CD14\' and the entity type \'protein\' in the sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides clear mappings between the entities \'HML\', \'dexamethasone\', \'cortisol\', \'lysozyme\' and the entity types \'cell_line\', \'protein\', \'protein\', \'protein\' respectively in the sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The example provides clear mappings between the entities \'CD40\', \'Rel/nuclear factor kappaB\', \'NF-kappaB\', \'B lymphocytes\' and the entity types \'protein\', \'protein\', \'protein\', \'cell_type\' respectively in the sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The example provides clear mappings between the entities \'B and T cell activation\', \'Ramos\', \'Jurkat\', \'cDNA microarray technology\' and the entity types \'cell_type\', \'cell_line\', \'cell_line\', \'DNA\' respectively in the sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides clear mappings between the entities \'tal-1\', \'GATA-binding proteins\', \'hematopoiesis\' and the entity types \'protein\', \'protein\', \'cell_type\' respectively in the sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The example provides clear mappings between the entities \'Erbstatin\', \'genistein\', \'Egr-1\' and the entity types \'protein\', \'protein\', \'RNA\' respectively in the sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The example provides clear mappings between the entities \'EBV\', \'EBNA2\', \'estrogen receptor\' and the entity types \'DNA\', \'protein\', \'protein\' respectively in the sentence."},\n    {"Example 16": 5},\n    {"Reason 16": "The example provides clear mappings between the entities \'MR\', \'aldosterone\', \'progesterone\' and the entity types \'protein\', \'protein\', \'protein\' respectively in the sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities related to the given entity labels."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities related to the given entity labels."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities related to the given entity labels."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities related to the given entity labels."}\n]', 'response3': "[{'steroid hormones': 'protein'}, {'estrogen': 'protein'}]", 'prediction': {'steroid hormones': 'protein', 'estrogen': 'protein'}}
{'idx': 1285, 'sentence': "Characterization of 5' end of human thromboxane receptor gene .", 'label': {"5' end of human thromboxane receptor gene": 'DNA', 'human thromboxane receptor gene': 'DNA'}, 'response1': "['DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear and specific example of a protein entity (p50p50) and its function, aiding in the extraction of protein entities from the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence directly mentions a protein entity (GATA-1) and its role in gene expression, providing valuable information for extracting protein entities from the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence explicitly refers to a cell type entity (Th2-type lymphocytes), aiding in the identification of cell type entities in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence mentions a cell line entity (SCM-1), which can help in recognizing cell line entities in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains multiple protein entities (Stat3, Stat5, c-Mpl) and their involvement in signal transduction, providing crucial information for extracting protein entities from the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides a specific protein entity (E2A) and the method used for its analysis, aiding in the extraction of protein entities from the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence mentions cell type entity (T cell) and protein entity (interleukin 2), providing valuable information for identifying cell type and protein entities in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence refers to a protein entity (retinoic acid receptor alpha) and the methods used for its analysis, assisting in the extraction of protein entities from the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence mentions a protein entity (GM-CSF) and its conservation in genes, aiding in the identification of protein entities in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides a specific cell line entity (SIVsmmPBj14) and its unique phenotype, which can help in recognizing cell line entities in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains multiple protein entities (SLAP-130, SLP-76) and a cell type entity (T cell), providing valuable information for extracting protein and cell type entities from the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence mentions a protein entity (GATA-1) and its role in gene regulation, aiding in the extraction of protein entities from the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides a specific protein entity (RXR) and its role in cell outgrowth, assisting in the identification of protein entities in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence mentions a DNA entity (cDNAs) and their cloning and sequencing, aiding in the extraction of DNA entities from the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains multiple protein entities (beta-globin, glycoprotein IIb, platelet factor 4) and a cell line entity (Ter 119), providing valuable information for extracting protein and cell line entities from the target sentence."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence mentions cell type entities (B and T cell activation), cell line entities (Ramos, Jurkat), and a DNA entity (cDNA microarray technology), aiding in the identification of cell type, cell line, and DNA entities in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific entities relevant to the target sentence, making it less helpful for extracting named entities."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific entities relevant to the target sentence, making it less helpful for extracting named entities."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific entities relevant to the target sentence, making it less helpful for extracting named entities."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any specific entities relevant to the target sentence, making it less helpful for extracting named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 327, 'sentence': 'However, there is an EB1 -binding site ( ZRE-B ) located within the R-responsive enhancer region .', 'label': {'R-responsive enhancer region': 'DNA', 'EB1 -binding site': 'DNA', 'EB1': 'protein', 'ZRE-B': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n    {"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .": 5},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 4},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements .": 4},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 4},\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines .": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .": 4},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .": 5},\n    {"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"EB1": "protein"}, {"ZRE-B": "DNA"}]', 'prediction': {'EB1': 'protein', 'ZRE-B': 'DNA'}}
{'idx': 1622, 'sentence': 'Analysis of whole-cell lysates by antiphosphotyrosine immunoblotting showed that incubation with gamma interferon brought about specific increases in phosphotyrosine labeling of several proteins.', 'label': {'gamma interferon': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 5},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"gamma interferon": "protein"}, {"phosphotyrosine": "protein"}]', 'prediction': {'gamma interferon': 'protein', 'phosphotyrosine': 'protein'}}
{'idx': 1393, 'sentence': 'This enhancer in HIV-1 is the T-cell activation response element ; in HIV-2 , however, it is the second enhancer that is mainly responsible for activation in response to T-cell activators .', 'label': {'second enhancer': 'DNA', 'T-cell activation response element': 'DNA', 'enhancer': 'DNA'}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"HIV-1": "cell_type"}, {"T-cell": "cell_type"}, {"HIV-2": "cell_type"}, {"T-cell": "cell_type"}]', 'prediction': {'HIV-1': 'cell_type', 'T-cell': 'cell_type', 'HIV-2': 'cell_type'}}
{'idx': 1221, 'sentence': 'To identify osteoblast-specific cis-acting elements and trans-acting factors , we initiated an analysis of the promoter of a mouse osteocalcin gene , an osteoblast-specific gene .', 'label': {'mouse osteocalcin gene': 'DNA', 'promoter': 'DNA', 'osteoblast-specific cis-acting elements': 'DNA', 'trans-acting factors': 'protein', 'osteoblast-specific gene': 'DNA'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 4},\n    {"A critical role of Sp1- and Ets-related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 4},\n    {"To evaluate the PML/RARalpha role in myelopoiesis, transgenic mice expressing PML/RARalpha were engineered.": 4},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 4},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 4},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 4},\n    {"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 130, 'sentence': 'At high concentration of NE , all of the TR bound to TREp was more greatly retarded than in the absence of NE .', 'label': {'TREp': 'DNA', 'TR': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": "The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .", "1": 5, "2": "The sentence provides a clear example of the entity \'AP-1\' being associated with the entity type \'DNA\'."},\n    {"Sentence": "Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.", "1": 5, "2": "The sentence contains multiple examples of entities (\'IL-4\', \'LPS\', \'AP-1\') being associated with the entity type \'protein\'."},\n    {"Sentence": "An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events .", "1": 5, "2": "The sentence provides examples of entities (\'TRAF6\', \'RANKL\', \'NF-kappaB\') associated with the entity type \'protein\'."},\n    {"Sentence": "RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .", "1": 5, "2": "The sentence contains examples of entities (\'RelA\', \'NF-kappaB1\') associated with the entity type \'protein\'."},\n    {"Sentence": "Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .", "1": 5, "2": "The sentence provides an example of the entity \'NF-E2\' being associated with the entity type \'protein\'."},\n    {"Sentence": "Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .", "1": 4, "2": "The sentence provides an example of the entity \'phosphocreatine\' being associated with the entity type \'protein\'."},\n    {"Sentence": "We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .", "1": 5, "2": "The sentence provides examples of entities (\'CREB\', \'AR-CRE\') associated with the entity type \'protein\'."},\n    {"Sentence": "We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.", "1": 5, "2": "The sentence provides an example of the entity \'DNA\' being associated with the entity type \'DNA\'."},\n    {"Sentence": "These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .", "1": 5, "2": "The sentence provides an example of the entity \'NF-kappa B\' being associated with the entity type \'protein\'."},\n    {"Sentence": "Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .", "1": 5, "2": "The sentence provides examples of entities (\'IL-5 mRNA\', \'TCR\', \'IL-2R\', \'dexamethasone\') associated with the entity types \'RNA\', \'cell_type\', \'protein\'."},\n    {"Sentence": "We also found that the deviation of methylation in granulocytes and T cells was well correlated.", "1": 5, "2": "The sentence provides examples of entities (\'granulocytes\', \'T cells\') associated with the entity type \'cell_type\'."},\n    {"Sentence": "Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .", "1": 5, "2": "The sentence provides an example of the entity \'P selectin\' being associated with the entity type \'protein\'."},\n    {"Sentence": "The effects of G-CSF are mediated by binding to specific, high affinity receptors .", "1": 5, "2": "The sentence provides an example of the entity \'G-CSF\' being associated with the entity type \'protein\'."},\n    {"Sentence": "Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.", "1": 5, "2": "The sentence provides examples of entities (\'Erbstatin\', \'genistein\', \'Egr-1\') associated with the entity types \'protein\', \'protein\', \'RNA\'."},\n    {"Sentence": "Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .", "1": 5, "2": "The sentence provides examples of entities (\'TR55\', \'TNF-alpha\', \'HIV\') associated with the entity types \'protein\', \'protein\', \'cell_type\'."},\n    {"Sentence": "Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .", "1": 5, "2": "The sentence provides examples of entities (\'cDNA\', \'Jurkat\', \'DRE 1\') associated with the entity types \'DNA\', \'cell_line\', \'cell_type\'."},\n    {"Sentence": "We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .", "1": 1, "2": "The sentence does not contain any examples of entities associated with the provided entity labels."},\n    {"Sentence": "However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.", "1": 1, "2": "The sentence does not contain any examples of entities associated with the provided entity labels."},\n    {"Sentence": "In 2 complex translocations, none of the three genes was rearranged.", "1": 1, "2": "The sentence does not contain any examples of entities associated with the provided entity labels."},\n    {"Sentence": "Deletions or mutations in this element also reduced the serum response by 80-90%.", "1": 1, "2": "The sentence does not contain any examples of entities associated with the provided entity labels."},\n    {"Sentence": "In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .", "1": 1, "2": "The sentence does not contain any examples of entities associated with the provided entity labels."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 788, 'sentence': 'The number of mineralocorticoid receptors /cell were within or close to the normal range (n = 9).', 'label': {'mineralocorticoid receptors': 'protein'}, 'response1': "['cell_type']", 'response2': '[\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 1},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 5},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n    {"RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA/NF-kappaB1 binding complexes.": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 4},\n    {"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.": 5},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.": 5},\n    {"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.": 5},\n    {"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.": 5},\n    {"When 18C7 was incubated with MR before aldosterone or progesterone, the antibody inhibited 75-80% of the binding.": 5},\n    {"A total of 37 chronic, severe, nonsmoking asthmatic patients with documented reversible airways obstruction were classified as glucocorticoid-sensitive or -resistant on the basis of changes in FEV1, FVC, and peak expiratory flow (PEF) after oral prednisolone.": 5},\n    {"The number of Type I and Type II receptors before the test was lower in elderly subjects than in adults.": 5},\n    {"Membrane receptors for aldosterone: a novel pathway for mineralocorticoid action.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 781, 'sentence': 'Effects of aldosterone on intralymphocytic sodium and potassium in patients with essential hypertension .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes.": 5},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms.": 5},\n    {"We have examined the effect of alpha-tocopherol (alpha-tcp) on one cellular event in atherosclerotic plaque development, monocyte adhesion to stimulated endothelial cells (ECs).": 5},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 5},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 5},\n    {"Eosinophils play an important role in the effector phase of allergic inflammation.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 5},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1220, 'sentence': 'A PEBP2 alpha/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element .', 'label': {'PEBP2 alpha/AML-1-related factor': 'protein', 'osteocalcin promoter': 'DNA', 'osteoblast-specific cis-acting element': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"T cell": 5},\n    {"interleukin 2": 5},\n    {"UAS1": 4},\n    {"B cell": 4},\n    {"GATA-1": 5},\n    {"EKLF": 5},\n    {"CBP": 5},\n    {"p300": 5},\n    {"P/CAF": 5},\n    {"Sp1": 5},\n    {"CD14": 5},\n    {"PAFR": 5},\n    {"PAF": 5},\n    {"NF-kappa B": 5},\n    {"protein kinase C": 5},\n    {"NF-E2": 5},\n    {"PML/RARalpha": 5},\n    {"EBNA2": 5},\n    {"TP1": 4},\n    {"AP-1": 5},\n    {"retinoic acid receptor alpha": 5},\n    {"TAL1": 5},\n    {"T-ALL": 5},\n    {"Oct-2A": 5},\n    {"HMG I/Y": 5},\n    {"HLA-DRA": 5},\n    {"IL-2 receptor alpha subunit": 5},\n    {"p21ras": 5},\n    {"Gel-shift analysis": 1},\n    {"IL-2": 5},\n    {"c-Jun": 5},\n    {"c-Fos": 5}\n]', 'response3': '[{"PEBP2 alpha/AML-1-related factor": "protein"}, {"osteocalcin": "protein"}, {"osteoblast-specific": "cell_type"}]', 'prediction': {'PEBP2 alpha/AML-1-related factor': 'protein', 'osteocalcin': 'protein', 'osteoblast-specific': 'cell_type'}}
{'idx': 958, 'sentence': 'Here, Markus Neurath, Eckhard Stuber and Warren Strober describe the molecular structure of BSAP and focus on the ability of this protein to regulate the expression of B-cell-specific genes .', 'label': {'B-cell-specific genes': 'DNA', 'BSAP': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .": 5},\n    {"Tat-binding protein 7 is a subunit of the 26S protease .": 4},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .": 5},\n    {"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes .": 3},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .": 4},\n    {"Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .": 5},\n    {"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .": 5},\n    {"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines .": 5},\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 5},\n    {"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"Markus Neurath": "protein"}, {"Eckhard Stuber": "protein"}, {"Warren Strober": "protein"}, {"BSAP": "protein"}, {"B-cell-specific genes": "protein"}]', 'prediction': {'Markus Neurath': 'protein', 'Eckhard Stuber': 'protein', 'Warren Strober': 'protein', 'BSAP': 'protein', 'B-cell-specific genes': 'protein'}}
{'idx': 1083, 'sentence': 'These data suggest that the action of tepoxalin to inhibit proliferation in PBMC may be at least in part due to its ability to reduce the amount of available iron resulting in decreased activation of NF kappa B and subsequent inhibition of cytokine production .', 'label': {'cytokine': 'protein', 'NF kappa B': 'protein', 'PBMC': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a direct match between the entity \'NF-kappa B\' in the sentence and its corresponding entity label \'protein\', aiding in the extraction of named entities."},\n    {"Example 2": 5},\n    {"Reason 2": "The example provides direct matches between the entities \'NF-kappa B\' and \'AP-1\' in the sentence and their corresponding entity labels \'protein\', aiding in the extraction of named entities."},\n    {"Example 3": 5},\n    {"Reason 3": "The example provides direct matches between the entities \'NF-kappaB\', \'Tax\', and \'ATL\' in the sentence and their corresponding entity labels \'protein\' and \'cell_type\', aiding in the extraction of named entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The example provides a direct match between the entity \'NF-E2\' in the sentence and its corresponding entity label \'protein\', aiding in the extraction of named entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides direct matches between the entities \'IL-4\', \'LPS\', and \'AP-1\' in the sentence and their corresponding entity labels \'protein\', aiding in the extraction of named entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The example provides a direct match between the entity \'NF-kappa B\' in the sentence and its corresponding entity label \'protein\', aiding in the extraction of named entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The example provides direct matches between the entities \'IL-2\', \'IFN-gamma\', \'jak kinases\', and \'STAT1(alpha)\' in the sentence and their corresponding entity labels \'protein\', aiding in the extraction of named entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides a direct match between the entity \'NF-kappa B\' in the sentence and its corresponding entity label \'protein\', aiding in the extraction of named entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides a direct match between the entity \'P selectin\' in the sentence and its corresponding entity label \'protein\', aiding in the extraction of named entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides direct matches between the entities \'NF-kappa B\' and \'I kappa B beta\' in the sentence and their corresponding entity labels \'protein\', aiding in the extraction of named entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The example provides direct matches between the entities \'IL-2\', \'NF-kappa B\', and \'AP-1\' in the sentence and their corresponding entity labels \'protein\', aiding in the extraction of named entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The example provides direct matches between the entities \'IFN A\', \'IFNA\', \'interleukin-2\', \'interleukin-2 receptor\', \'phytohemagglutinin\', and \'phorbol myristate acetate\' in the sentence and their corresponding entity labels \'protein\', aiding in the extraction of named entities."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides direct matches between the entities \'HIV-1\', \'IFN\', \'PKR\', and \'IkappaBalpha\' in the sentence and their corresponding entity labels \'cell_type\' and \'protein\', aiding in the extraction of named entities."},\n    {"Example 14": 5},\n    {"Reason 14": "The example provides direct matches between the entities \'interleukin-2\', \'alpha chain\', \'CD25\', and \'IL-2 receptor\' in the sentence and their corresponding entity labels \'protein\', aiding in the extraction of named entities."},\n    {"Example 15": 5},\n    {"Reason 15": "The example provides direct matches between the entities \'B cell\', \'Ig\', and \'Transforming growth factor-beta\' in the sentence and their corresponding entity labels \'cell_type\' and \'protein\', aiding in the extraction of named entities."},\n    {"Example 16": 5},\n    {"Reason 16": "The example provides direct matches between the entities \'CTLA4Ig\', \'NFAT\', and \'AP-1\' in the sentence and their corresponding entity labels \'protein\' and \'cell_type\', aiding in the extraction of named entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any named entities from the given entity label set, making it not helpful for extracting named entities."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any named entities from the given entity label set, making it not helpful for extracting named entities."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any named entities from the given entity label set, making it not helpful for extracting named entities."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any named entities from the given entity label set, making it not helpful for extracting named entities."}\n]', 'response3': "[{'PBMC': 'cell_type'}, {'NF kappa B': 'protein'}]", 'prediction': {'PBMC': 'cell_type', 'NF kappa B': 'protein'}}
{'idx': 514, 'sentence': 'Induction of the enhancer may have a role in the increase in globin gene transcription that characterizes erythroid maturation .', 'label': {'globin gene': 'DNA', 'enhancer': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence provides a clear example of a protein (GATA-1) and its corresponding entity label, which directly aids in extracting named entities from the target sentence."}\n]\n[\n{"Example 2": 5},\n{"Reason 2": "The sentence provides a clear example of a protein (NF-E2) and its corresponding entity label, which directly aids in extracting named entities from the target sentence."}\n]\n[\n{"Example 3": 5},\n{"Reason 3": "The sentence provides a clear example of a cell type (Th2-type lymphocytes) and its corresponding entity label, which directly aids in extracting named entities from the target sentence."}\n]\n[\n{"Example 4": 5},\n{"Reason 4": "The sentence provides a clear example of a protein (Egr-1) and its corresponding entity label, which directly aids in extracting named entities from the target sentence."}\n]\n[\n{"Example 5": 5},\n{"Reason 5": "The sentence provides a clear example of a protein (erythropoietin) and its corresponding entity label, which directly aids in extracting named entities from the target sentence."}\n]\n[\n{"Example 6": 5},\n{"Reason 6": "The sentence provides clear examples of a DNA entity (CCAAT box) and a protein entity (EKLF binding site) with their corresponding labels, aiding in extracting named entities from the target sentence."}\n]\n[\n{"Example 7": 5},\n{"Reason 7": "The sentence provides a clear example of a DNA entity (AP-1) and its corresponding entity label, which directly aids in extracting named entities from the target sentence."}\n]\n[\n{"Example 8": 5},\n{"Reason 8": "The sentence provides a clear example of a protein entity (IL-4) and its corresponding label, which directly aids in extracting named entities from the target sentence."}\n]\n[\n{"Example 9": 5},\n{"Reason 9": "The sentence provides a clear example of a protein entity (retinoic acid receptor alpha) and its corresponding label, which directly aids in extracting named entities from the target sentence."}\n]\n[\n{"Example 10": 5},\n{"Reason 10": "The sentence provides a clear example of a protein entity (RXR) and its corresponding label, which directly aids in extracting named entities from the target sentence."}\n]\n[\n{"Example 11": 5},\n{"Reason 11": "The sentence provides clear examples of a protein entity (WT1) and a cell line entity (myeloid cell lines) with their corresponding labels, aiding in extracting named entities from the target sentence."}\n]\n[\n{"Example 12": 5},\n{"Reason 12": "The sentence provides clear examples of protein entities (IL-2 receptor alpha subunit, p21ras) and a cell type entity (B cell) with their corresponding labels, aiding in extracting named entities from the target sentence."}\n]\n[\n{"Example 13": 5},\n{"Reason 13": "The sentence provides a clear example of a DNA entity (IgH) and its corresponding entity label, which directly aids in extracting named entities from the target sentence."}\n]\n[\n{"Example 14": 5},\n{"Reason 14": "The sentence provides a clear example of a protein entity (GATA-1) and its corresponding label, which directly aids in extracting named entities from the target sentence."}\n]\n[\n{"Example 15": 5},\n{"Reason 15": "The sentence provides a clear example of a DNA entity (immunoglobulin kappa 3\' enhancer) and its corresponding label, which directly aids in extracting named entities from the target sentence."}\n]\n[\n{"Example 16": 5},\n{"Reason 16": "The sentence provides clear examples of protein entities (SCL, GATA-1) with their corresponding labels, aiding in extracting named entities from the target sentence."}\n]\n[\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any named entities relevant to the target sentence, hence not helpful in extracting named entities."}\n]\n[\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any named entities relevant to the target sentence, hence not helpful in extracting named entities."}\n]\n[\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any named entities relevant to the target sentence, hence not helpful in extracting named entities."}\n]\n[\n{"Example 20": 1},\n{"Reason 20": "The sentence does not contain any named entities relevant to the target sentence, hence not helpful in extracting named entities."}\n]', 'response3': '[{"globin gene": "DNA"}]', 'prediction': {'globin gene': 'DNA'}}
{'idx': 1133, 'sentence': 'Both LCLs were found by EM to produce RVLP and EBV particles .', 'label': {'LCLs': 'cell_line'}, 'response1': "['cell_line', 'protein']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.": 4},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .": 5},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 5},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .": 4},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .": 5},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 4},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .": 5},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter": 5},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms .": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .": 5},\n    {"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1762, 'sentence': 'Taking the IL-2 gene as a candidate, we examined the effect of cysteamine treatment on early gene expression during lymphocyte activation , and on the activity of transcription factors AP-1 , NF-kappa B , NF-AT and Oct1 , whose functions are required for expression of the IL-2 mRNA.', 'label': {'IL-2': 'protein', 'early gene': 'DNA', 'NF-kappa B': 'protein', 'Oct1': 'protein', 'transcription factors': 'protein', 'NF-AT': 'protein', 'AP-1': 'protein', 'IL-2 gene': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities that match the entity types in the target sentence, such as \'IL-2\', \'NF-kappa B\', and \'AP-1\', making it highly relevant for entity extraction."}\n]\n[\n    {"Sentence": 4},\n    {"Reason": "The sentence contains several examples of named entities that correspond to the entity types in the target sentence, such as \'IL-4\', \'LPS\', and \'AP-1\', which are relevant for entity extraction."}\n]\n[\n    {"Sentence": 4},\n    {"Reason": "The sentence includes named entities like \'IL-2 receptor alpha subunit\', \'p21ras\', and \'B cell\' that match the entity types in the target sentence, making it helpful for entity extraction."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of named entities like \'IL-4\', \'LPS\', and \'AP-1\' that align with the entity types in the target sentence, aiding in entity extraction."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of named entities such as \'IL-2\', \'c-Jun\', and \'c-Fos\' that match the entity types in the target sentence, making it highly relevant for entity extraction."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence includes named entities like \'interleukin 10\', \'IL-10R\', \'STAT3\', and \'IL-6\' that correspond to the entity types in the target sentence, aiding in entity extraction."}\n]\n[\n    {"Sentence": 3},\n    {"Reason": "The sentence provides an example of a named entity \'AP-1\' that matches the entity type in the target sentence, making it somewhat helpful for entity extraction."}\n]\n[\n    {"Sentence": 3},\n    {"Reason": "The sentence includes a named entity \'IL-4\' that corresponds to the entity type in the target sentence, providing some assistance in entity extraction."}\n]\n[\n    {"Sentence": 3},\n    {"Reason": "The sentence contains a named entity \'Th2-type lymphocytes\' that aligns with the entity type in the target sentence, offering some help in entity extraction."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of named entities like \'interleukin-2\', \'alpha chain\', \'CD25\', and \'IL-2 receptor\' that match the entity types in the target sentence, making it highly relevant for entity extraction."}\n]\n[\n    {"Sentence": 4},\n    {"Reason": "The sentence includes examples of named entities such as \'B and T cell activation\', \'Ramos\', \'Jurkat\', and \'cDNA microarray technology\' that correspond to the entity types in the target sentence, aiding in entity extraction."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of named entities like \'CD40\', \'Rel/nuclear factor kappaB\', \'NF-kappaB\', and \'B lymphocytes\' that align with the entity types in the target sentence, making it highly relevant for entity extraction."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of named entities such as \'IL-2\', \'NFAT\', \'NFAT delta418\', \'calcineurin\', \'Tpl-2\', and \'cyclosporin A\' that match the entity types in the target sentence, making it highly relevant for entity extraction."}\n]\n[\n    {"Sentence": 4},\n    {"Reason": "The sentence includes examples of named entities like \'Erbstatin\', \'genistein\', and \'Egr-1\' that correspond to the entity types in the target sentence, aiding in entity extraction."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of named entities such as \'AP-1\', \'c-jun\', \'IL-2\', \'NF-AT\', and \'T cell\' that match the entity types in the target sentence, making it highly relevant for entity extraction."}\n]\n[\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of named entities like \'LITAF\' and \'TNF-alpha\' that align with the entity types in the target sentence, making it highly relevant for entity extraction."}\n]\n[\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities that match the entity types in the target sentence, therefore not helpful for entity extraction."}\n]\n[\n    {"Sentence": 1},\n    {"Reason": "The sentence does not include any named entities that correspond to the entity types in the target sentence, hence not helpful for entity extraction."}\n]\n[\n    {"Sentence": 1},\n    {"Reason": "The sentence lacks any named entities that align with the entity types in the target sentence, therefore not helpful for entity extraction."}\n]', 'response3': '[{"IL-2": "DNA"}, {"AP-1": "protein"}, {"NF-kappa B": "protein"}, {"NF-AT": "protein"}, {"Oct1": "protein"}]', 'prediction': {'IL-2': 'DNA', 'AP-1': 'protein', 'NF-kappa B': 'protein', 'NF-AT': 'protein', 'Oct1': 'protein'}}
{'idx': 23, 'sentence': 'Furthermore, a mutant E6 motif lost both in vitro binding activity and in vivo enhancer activity .', 'label': {'mutant E6 motif': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .": 4},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50 .": 4},\n    {"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 5},\n    {"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 5},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .": 5},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .": 4},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements .": 5},\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines .": 4},\n    {"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events .": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 5},\n    {"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .": 5},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .": 5},\n    {"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"E6 motif": "protein"}]', 'prediction': {'E6 motif': 'protein'}}
{'idx': 1476, 'sentence': 'Protein phosphorylation has an important role in the regulation of these two factors: (1) it induces the transactivating capacity of the AP-1 protein c-Jun ; and (2) it is involved in the release of the cytoplasmic inhibitor , I kappa B , from NF-kappa B , allowing translocation of the latter into the nucleus .', 'label': {'AP-1 protein': 'protein', 'c-Jun': 'protein', 'I kappa B': 'protein', 'NF-kappa B': 'protein', 'cytoplasmic inhibitor': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of protein names and their corresponding entity labels, which are directly relevant to the target sentence. This provides clear and direct guidance on identifying protein entities in the text."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of protein names and their corresponding entity labels that are relevant to the target sentence, aiding in the identification of protein entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of protein names and their corresponding entity labels that are directly relevant to the target sentence, providing clear guidance on identifying protein entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence includes examples of protein names and their corresponding entity labels that are directly relevant to the target sentence, aiding in the identification of protein entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides multiple examples of protein names and their corresponding entity labels that are directly relevant to the target sentence, offering clear guidance on identifying protein entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of protein names and their corresponding entity labels that are directly relevant to the target sentence, aiding in the identification of protein entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence includes examples of protein names and their corresponding entity labels that are directly relevant to the target sentence, providing clear guidance on identifying protein entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of protein names and their corresponding entity labels that are directly relevant to the target sentence, aiding in the identification of protein entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of protein names and their corresponding entity labels that are directly relevant to the target sentence, offering clear guidance on identifying protein entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence includes examples of protein names and their corresponding entity labels that are directly relevant to the target sentence, aiding in the identification of protein entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of protein names and their corresponding entity labels that are directly relevant to the target sentence, aiding in the identification of protein entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of protein names and their corresponding entity labels that are directly relevant to the target sentence, offering clear guidance on identifying protein entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence includes examples of protein names and their corresponding entity labels that are directly relevant to the target sentence, aiding in the identification of protein entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of named entities relevant to the target sentence, providing no guidance on identifying entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of named entities relevant to the target sentence, providing no guidance on identifying entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of named entities relevant to the target sentence, providing no guidance on identifying entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of named entities relevant to the target sentence, providing no guidance on identifying entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of named entities relevant to the target sentence, providing no guidance on identifying entities."}\n]', 'response3': "[{'AP-1': 'protein'}, {'c-Jun': 'protein'}, {'I kappa B': 'protein'}, {'NF-kappa B': 'protein'}]", 'prediction': {'AP-1': 'protein', 'c-Jun': 'protein', 'I kappa B': 'protein', 'NF-kappa B': 'protein'}}
{'idx': 234, 'sentence': 'A similar infection with a recombinant retrovirus containing the beta-galactosidase gene with an adenovirus E2 promoter , results in beta-galactosidase activity in a limited number of cultured and primary cells .', 'label': {'cultured': 'cell_line', 'primary cells': 'cell_type', 'adenovirus E2 promoter': 'DNA', 'beta-galactosidase gene': 'DNA', 'beta-galactosidase': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 4},\n    {"In addition, assay of PBMC by the adenovirus-specific PCR may help detect early invasive disease and warrants further evaluation.": 4},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 3},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"This protein has now been purified and its encoding gene cloned.": 5},\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 4},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 4},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 5},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 4},\n    {"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n    {"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.": 4},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 4},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"beta-galactosidase gene": "protein"}, {"adenovirus E2 promoter": "DNA"}]', 'prediction': {'beta-galactosidase gene': 'protein', 'adenovirus E2 promoter': 'DNA'}}
{'idx': 1396, 'sentence': 'NF-M ( chicken C/EBP beta ) induces eosinophilic differentiation and apoptosis in a hematopoietic progenitor cell line .', 'label': {'hematopoietic progenitor cell line': 'cell_line', 'NF-M': 'protein', 'chicken C/EBP beta': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities (proteins) that are relevant to the entity labels in the target sentence, such as NF-kappa B, AP-1, and IL-2."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of named entities (proteins) that are relevant to the entity labels in the target sentence, such as SP1 and caspases, as well as a cell type (B-cell)."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of named entities (proteins) that are relevant to the entity labels in the target sentence, such as NF-kappaB and Tax, as well as cell types (ATL)."},\n    {"Sentence": 3},\n    {"Reason": "The sentence contains an example of a named entity (protein) that is relevant to the entity labels in the target sentence, GATA-1."},\n    {"Sentence": 3},\n    {"Reason": "The sentence contains an example of a named entity (protein) that is relevant to the entity labels in the target sentence, Egr-1."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities (proteins) that are relevant to the entity labels in the target sentence, such as NF-kappa B and I kappa B alpha."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains an example of a named entity (protein) that is relevant to the entity labels in the target sentence, IkappaBbeta, as well as NF-kappaB."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains an example of a named entity (protein) that is relevant to the entity labels in the target sentence, NF-kappa B."},\n    {"Sentence": 3},\n    {"Reason": "The sentence contains an example of a named entity (protein) that is relevant to the entity labels in the target sentence, GATA-1."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains an example of a named entity (protein) that is relevant to the entity labels in the target sentence, NF-kappa B, as well as a cell type (ARDS)."},\n    {"Sentence": 3},\n    {"Reason": "The sentence contains an example of a named entity (protein) that is relevant to the entity labels in the target sentence, NF-E2."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains an example of a named entity (DNA) that is relevant to the entity labels in the target sentence, NF-kappa B."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains an example of a named entity (protein) that is relevant to the entity labels in the target sentence, NF-kappa B."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains an example of a named entity (protein) that is relevant to the entity labels in the target sentence, MNDA, as well as a cell line (Philadelphia chromosome-positive chronic myeloid leukemia)."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities that are relevant to the entity labels in the target sentence."}\n]', 'response3': '[{"NF-M": "protein"}, {"C/EBP beta": "protein"}, {"hematopoietic progenitor cell line": "cell_line"}]', 'prediction': {'NF-M': 'protein', 'C/EBP beta': 'protein', 'hematopoietic progenitor cell line': 'cell_line'}}
{'idx': 1812, 'sentence': 'The protein shows significant sequence similarities to the family of G-protein coupled chemokine receptors and turned out to be identical to the recently described receptor EBI1 .', 'label': {'G-protein coupled chemokine receptors': 'protein', 'chemokine receptors': 'protein', 'G-protein': 'protein', 'receptor EBI1': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.": 3},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 3},\n    {"Murine macrophage inflammatory protein 1 alpha (MIP-1 alpha) and its human equivalent (GOS19, LD78, or AT464) are members of the -C-C family of low-molecular-weight chemokines.": 4},\n    {"A gst-EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2-PU.1 interaction.": 5},\n    {"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 4},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 3},\n    {"This protein has now been purified and its encoding gene cloned.": 5},\n    {"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.": 5},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 4},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 4},\n    {"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 4},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"G-protein coupled chemokine receptors": "protein"}, {"EBI1": "protein"}]', 'prediction': {'G-protein coupled chemokine receptors': 'protein', 'EBI1': 'protein'}}
{'idx': 1099, 'sentence': 'Interestingly, microtubule disruption also decreased monocyte 1,25(OH)2D3 synthesis , not by decreasing the Vmax of monocyte mitochondrial 1 alpha-hydroxylase but through an increase in the Km for 25(OH)2D3 .', 'label': {'monocyte mitochondrial 1 alpha-hydroxylase': 'protein', 'monocyte': 'cell_type', 'microtubule': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 4},\n    {"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 3},\n    {"Changes in PKC isoforms in human alveolar macrophages compared with blood monocytes.": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 5},\n    {"We have examined the effect of alpha-tocopherol (alpha-tcp) on one cellular event in atherosclerotic plaque development, monocyte adhesion to stimulated endothelial cells (ECs).": 5},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 4},\n    {"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.": 5},\n    {"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.": 5},\n    {"When the same MTHC lines are exposed to TNF-alpha in combination with IFN-gamma, the cells instead become DC.": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 4},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 4},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n    {"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]": 4},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 4},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"monocyte": "cell_type"}, {"1,25(OH)2D3": "protein"}, {"Vmax": "protein"}, {"monocyte mitochondrial 1 alpha-hydroxylase": "protein"}, {"Km": "protein"}, {"25(OH)2D3": "protein"}]', 'prediction': {'monocyte': 'cell_type', '1,25(OH)2D3': 'protein', 'Vmax': 'protein', 'monocyte mitochondrial 1 alpha-hydroxylase': 'protein', 'Km': 'protein', '25(OH)2D3': 'protein'}}
{'idx': 1537, 'sentence': 'Furthermore, we identified a repression domain at the N-terminus of Oct-2a .', 'label': {'Oct-2a': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 1},\n{"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n{"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.": 5},\n{"Here we examined the regulatory mechanism of the SCM-1 genes.": 5},\n{"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n{"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.": 5},\n{"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements.": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n{"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 5},\n{"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n{"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system.": 5},\n{"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n{"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n{"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"Oct-2a": "protein"}]', 'prediction': {'Oct-2a': 'protein'}}
{'idx': 1574, 'sentence': 'CONCLUSIONS: Sexual hormones , through their receptors , may influence the activity of eosinophils in patients with VKC .', 'label': {'receptors': 'protein', 'eosinophils': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Eosinophils play an important role in the effector phase of allergic inflammation.": 5},\n    {"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.": 5},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 4},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 5},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms.": 5},\n    {"In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine (IFN-gamma) in combination with allergy-driven overproduction of T helper 2-type cytokines.": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 4},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5},\n    {"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.": 5},\n    {"To study the regulatory mechanism of gp91phox gene expression in eosinophils, we transiently transfected eosinophil-committed HL-60-C15 cells with gp91phox promoter constructs, and identified a negative element from bp -267 to -246 of the gp91phox gene, the deletion of which caused an 83% increase in promoter activity.": 5},\n    {"This phenomenon is mediated, in part, through inducible expression of the CXC chemokine, interleukin-8 (IL-8).": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"Sexual hormones": "protein"}, {"receptors": "protein"}, {"eosinophils": "cell_type"}]', 'prediction': {'Sexual hormones': 'protein', 'receptors': 'protein', 'eosinophils': 'cell_type'}}
{'idx': 1312, 'sentence': 'A solution structure for the non-sequence-specific C-terminal HMG box of HMG-1 has recently been proposed.', 'label': {'HMG-1': 'protein', 'C-terminal HMG box': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 1},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 601, 'sentence': 'To determine whether enhancer elements in addition to the highly conserved octamer (OCTA)-nucleotide motif are important for lymphoid-specific expression of the immunoglobulin heavy-chain (IgH) gene , we have investigated the effect of mutating the binding site for a putative additional lymphoid-specific transcription factor , designated NF-microB , in the murine IgH enhancer .', 'label': {'murine IgH enhancer': 'DNA', 'putative additional lymphoid-specific transcription factor': 'protein', 'octamer (OCTA)-nucleotide motif': 'DNA', 'NF-microB': 'protein', 'enhancer elements': 'DNA', 'immunoglobulin heavy-chain (IgH) gene': 'DNA', 'binding site': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence contains specific protein names like NF-E2, which are directly related to the entity label \'protein\' in the entity label set."},\n{"Example 2": 4},\n{"Reason 2": "The sentence contains protein names like Oct-2A, HMG I/Y, and HLA-DRA, which are directly related to the entity label \'protein\' in the entity label set. Additionally, the mention of \'B cells\' is related to the entity label \'cell_type\' in the entity label set."},\n{"Example 3": 3},\n{"Reason 3": "The sentence contains the protein name \'IL-2\', which is directly related to the entity label \'protein\' in the entity label set."},\n{"Example 4": 4},\n{"Reason 4": "The sentence contains protein names like NF-ATc, which are directly related to the entity label \'protein\' in the entity label set. Additionally, the mentions of \'T lymphocytes\' and \'embryonic cardiac cells\' are related to the entity label \'cell_type\' in the entity label set."},\n{"Example 5": 5},\n{"Reason 5": "The sentence contains the protein name \'Egr-1\', which is directly related to the entity label \'protein\' in the entity label set."},\n{"Example 6": 3},\n{"Reason 6": "The sentence contains the protein name \'IL-4\', which is directly related to the entity label \'protein\' in the entity label set."},\n{"Example 7": 4},\n{"Reason 7": "The sentence contains mentions of \'T cell\' and \'interleukin 2\', which are related to the entity labels \'cell_type\' and \'protein\' in the entity label set, respectively."},\n{"Example 8": 4},\n{"Reason 8": "The sentence contains protein names like \'IL-2\', \'c-Jun\', and \'c-Fos\', which are directly related to the entity label \'protein\' in the entity label set."},\n{"Example 9": 4},\n{"Reason 9": "The sentence contains the mention of \'Th2-type lymphocytes\', which is related to the entity label \'cell_type\' in the entity label set."},\n{"Example 10": 5},\n{"Reason 10": "The sentence contains the mention of \'IgH\', which is directly related to the entity label \'DNA\' in the entity label set."},\n{"Example 11": 5},\n{"Reason 11": "The sentence contains the mention of \'immunoglobulin kappa 3\' enhancer\', which is directly related to the entity label \'DNA\' in the entity label set."},\n{"Example 12": 4},\n{"Reason 12": "The sentence contains protein names like \'c-kit\' and \'IL-4R alpha chain\', which are directly related to the entity label \'protein\' in the entity label set."},\n{"Example 13": 5},\n{"Reason 13": "The sentence contains the mention of \'NF-kappa B\', which is directly related to the entity label \'protein\' in the entity label set."},\n{"Example 14": 5},\n{"Reason 14": "The sentence contains protein names like \'IFN A\', \'IFNA\', \'interleukin-2\', \'interleukin-2 receptor\', \'phytohemagglutinin\', and \'phorbol myristate acetate\', which are directly related to the entity label \'protein\' in the entity label set."},\n{"Example 15": 4},\n{"Reason 15": "The sentence contains protein names like \'CD40\', \'Rel/nuclear factor kappaB\', and \'NF-kappaB\', which are directly related to the entity label \'protein\' in the entity label set. Additionally, the mention of \'B lymphocytes\' is related to the entity label \'cell_type\' in the entity label set."},\n{"Example 16": 4},\n{"Reason 16": "The sentence contains protein names like \'p50\' and \'p65\', which are directly related to the entity label \'protein\' in the entity label set. Additionally, the mentions of \'DNA\' and \'protein\' are related to the entity labels \'DNA\' and \'protein\' in the entity label set."},\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any specific entity names that match the entity labels in the entity label set."},\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any specific entity names that match the entity labels in the entity label set."},\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any specific entity names that match the entity labels in the entity label set."},\n{"Example 20": 1},\n{"Reason 20": "The sentence does not contain any specific entity names that match the entity labels in the entity label set."}\n]', 'response3': "[{'OCTA': 'DNA'}, {'IgH': 'DNA'}, {'NF-microB': 'protein'}, {'murine IgH enhancer': 'DNA'}]", 'prediction': {'OCTA': 'DNA', 'IgH': 'DNA', 'NF-microB': 'protein', 'murine IgH enhancer': 'DNA'}}
{'idx': 890, 'sentence': 'Treatment of 10 with warm HCl furnished 19-chloro-4,21-dihydroxypregna-4,9(11)-diene-3,20-dione (13).', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 4},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 4},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 4},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n    {"We found that they reduced the initial interleukin-1beta mRNA transcription rate through prevention of degradation of inhibitor-kappaB alpha.": 4},\n    {"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.": 5},\n    {"This hybrid clone, designated NR2, was characterized by several methods, including PCR, with eight pairs of oligonucleotides mapped to Chr 20: D20S5, D20S41, D20S42, D20S56, D20S57, D20S58, adenosine deaminase (ADA), and Prion protein (PRIP); Restriction Fragment Length Polymorphism (RFLP) analyses with four genomic anonymous probes (D20S5, cD3H12, D20S17, D20S18); and fluorescent in situ hybridization (FISH) with total human DNA and D20Z1, a sequence specific to the human Chr 20 centromere, as probes.": 5},\n    {"Treatment with soluble, bivalent mAb J393 killed 25-50% of the cell population, while concomitant engagement of either the CD3.TcR complex or the integrins CD18 and CD29 significantly potentiated this effect.": 5},\n    {"Combined treatment of HPCs with alpha-PML and alpha-Rb oligomers inhibited both PML and Rb protein expression and completely blocked erythroid colony development.": 5},\n    {"When 18C7 was incubated with MR before aldosterone or progesterone, the antibody inhibited 75-80% of the binding.": 5},\n    {"A 3-bp mutation at the distal Sp1-binding site not only eliminates Sp1 interaction, but also abolishes most of the VitD3 induction of CD14 expression.": 5},\n    {"CONCLUSION: Our results show that the tested agents (except indomethacin) are inhibitors of the T cell-mediated immune response, as expected, that aspirin is an effective suppressor of adhesion molecule expression, and that all three agents can induce Hsp60 in HUVECs.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 323, 'sentence': 'The Epstein-Barr virus ( EBV ) ORI1yt enhancer is not B-cell specific and does not respond synergistically to the EBV transcription factors R and Z .', 'label': {'Epstein-Barr virus ( EBV ) ORI1yt enhancer': 'DNA'}, 'response1': "['DNA', 'cell_type', 'protein']", 'response2': '[\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"5": "The sentence contains the entity \'RXR\' which is a protein, matching the label set."},\n{"5": "The sentence contains the entities \'IL-2\' and \'IFN-gamma\' which are proteins, matching the label set."},\n{"5": "The sentence contains the entities \'NF-kappaB\', \'Sp1\', and \'p50\' which are proteins, matching the label set."},\n{"5": "The sentence contains the entities \'EBNA2\' and \'TP1\' which are proteins and a cell line respectively, matching the label set."},\n{"5": "The sentence contains the entities \'T cell\' and \'interleukin 2\' which are a cell type and a protein respectively, matching the label set."},\n{"5": "The sentence contains the entity \'IL-2\' which is a protein, matching the label set."},\n{"5": "The sentence contains the entity \'AP-1\' which is a protein, matching the label set."},\n{"5": "The sentence contains the entities \'NF-kB\', \'AP-1\', \'OCT-1\', and \'NF-IL-2B\' which are proteins, matching the label set."},\n{"5": "The sentence contains the entities \'EBV\' and \'CD2\' which are a cell line and a protein respectively, matching the label set."},\n{"5": "The sentence contains the entities \'CD4+\' and \'EBV\' which are a cell type and a protein respectively, matching the label set."},\n{"5": "The sentence contains the entities \'EBNA-2\' and \'PU.1\' which are proteins, matching the label set."},\n{"5": "The sentence contains the entities \'UAS1\' and \'B cell\' which are a cell line and a cell type respectively, matching the label set."},\n{"5": "The sentence contains the entities \'EBV\' and \'B-cell\' which are a cell line and a cell type respectively, matching the label set."},\n{"5": "The sentence contains the entity \'GATA-1\' which is a protein, matching the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n]', 'response3': "[{'Epstein-Barr virus': 'cell_line'}, {'EBV': 'cell_line'}, {'R': 'protein'}, {'Z': 'protein'}]", 'prediction': {'Epstein-Barr virus': 'cell_line', 'EBV': 'cell_line', 'R': 'protein', 'Z': 'protein'}}
{'idx': 929, 'sentence': 'The cDNA sequence has an 813-bp open reading frame ( ORF ) whose predicted amino acid sequence is 97.6% identical to the 272 carboxy-terminal amino acids of the human ets-1 protein .', 'label': {'ORF': 'DNA', '272 carboxy-terminal amino acids': 'protein', 'ets-1': 'protein', 'human ets-1 protein': 'protein', '813-bp open reading frame': 'DNA', 'cDNA sequence': 'DNA', 'amino acid sequence': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"Sentence": "The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.", "helpfulness score": 5, "reasons": "The sentence contains specific mentions of \'NF-ATc\' which is a protein, \'T lymphocytes\' which is a cell type, and \'embryonic cardiac cells\' which is also a cell type."},\n{"Sentence": "Human cDNAs encoding subunits of these factors have been cloned and sequenced.", "helpfulness score": 4, "reasons": "The sentence mentions \'cDNAs\' which is a type of DNA, aiding in the extraction of the entity."},\n{"Sentence": "A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.", "helpfulness score": 4, "reasons": "The sentence mentions \'Th2-type lymphocytes\' which is a cell type, aiding in the extraction of the entity."},\n{"Sentence": "Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.", "helpfulness score": 5, "reasons": "The sentence contains specific mentions of \'SLAP-130\' and \'SLP-76\' which are proteins, and \'T cell\' which is a cell type."},\n{"Sentence": "The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.", "helpfulness score": 4, "reasons": "The sentence mentions \'GM-CSF\' which is a protein, aiding in the extraction of the entity."},\n{"Sentence": "By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.", "helpfulness score": 5, "reasons": "The sentence contains specific mentions of \'TCF-1\' which is a protein."},\n{"Sentence": "The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.", "helpfulness score": 5, "reasons": "The sentence contains specific mentions of \'interleukin 10\' and \'IL-10R\' which are proteins, \'STAT3\' which is a protein, and \'IL-6\' which is also a protein."},\n{"Sentence": "This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.", "helpfulness score": 5, "reasons": "The sentence contains specific mentions of \'SIVsmmPBj14\' which is a cell line."},\n{"Sentence": "One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.", "helpfulness score": 5, "reasons": "The sentence contains specific mentions of \'Egr-1\' which is a protein."},\n{"Sentence": "We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.", "helpfulness score": 5, "reasons": "The sentence contains specific mentions of \'E2A\' which is a protein."},\n{"Sentence": "This protein has now been purified and its encoding gene cloned.", "helpfulness score": 5, "reasons": "The sentence contains specific mentions of \'protein\' which is a protein."},\n{"Sentence": "Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.", "helpfulness score": 5, "reasons": "The sentence contains specific mentions of \'Protein\' which is a protein."},\n{"Sentence": "Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.", "helpfulness score": 5, "reasons": "The sentence contains specific mentions of \'cDNA\' which is a DNA, \'Jurkat\' which is a cell line, and \'DRE 1\' which is a cell type."},\n{"Sentence": "Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB-induced trans-activation of the H4 promoter.", "helpfulness score": 5, "reasons": "The sentence contains specific mentions of \'ATF1\' and \'CREB\' which are proteins, and \'H4\' which is a protein."},\n{"Sentence": "Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.", "helpfulness score": 5, "reasons": "The sentence contains specific mentions of \'NF-kappaB\' and \'Sp1\' which are proteins, and \'SIVmac\' which is a cell line."},\n{"Sentence": "Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.", "helpfulness score": 5, "reasons": "The sentence contains specific mentions of \'HIV-1 LTR\' which is a DNA, \'NFAT-1\' which is a protein, and \'NF kappa B\' which is a protein."},\n{"Sentence": "We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.", "helpfulness score": 1, "reasons": "The sentence does not contain any specific entity mentions."},\n{"Sentence": "However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.", "helpfulness score": 1, "reasons": "The sentence does not contain any specific entity mentions."},\n{"Sentence": "In 2 complex translocations, none of the three genes was rearranged.", "helpfulness score": 1, "reasons": "The sentence does not contain any specific entity mentions."},\n{"Sentence": "Deletions or mutations in this element also reduced the serum response by 80-90%.", "helpfulness score": 1, "reasons": "The sentence does not contain any specific entity mentions."},\n{"Sentence": "In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.", "helpfulness score": 1, "reasons": "The sentence does not contain any specific entity mentions."}\n]', 'response3': '[{"cDNA": "DNA"}, {"ets-1 protein": "protein"}]', 'prediction': {'cDNA': 'DNA', 'ets-1 protein': 'protein'}}
{'idx': 6, 'sentence': 'Platelet-activating factor induces phospholipid turnover , calcium flux , arachidonic acid liberation , eicosanoid generation , and oncogene expression in a human B cell line .', 'label': {'Platelet-activating factor': 'protein', 'oncogene': 'DNA', 'human B cell line': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 4},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 4},\n    {"Example 7": 4},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 4},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 4},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1478, 'sentence': 'Furthermore, in activated T cells , the kinetics of the two phosphorylation events are essentially similar.', 'label': {'activated T cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n    {"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 4},\n    {"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n    {"The phosphorylated tyrosine residue itself is important for the protein-protein interaction .": 4},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .": 5},\n    {"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 1},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .": 5},\n    {"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .": 5},\n    {"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"T cells": "cell_type"}]', 'prediction': {'T cells': 'cell_type'}}
{'idx': 1793, 'sentence': 'The clinical benefits of salicylates in the treatment of several diseases, including atherosclerosis and rheumatoid arthritis , may be related to their ability to reduce monocyte gene expression .', 'label': {}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example contains specific terms that directly correspond to the entity labels in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The example contains a specific term that corresponds to one of the entity labels in the target sentence."},\n    {"Example 3": 4},\n    {"Reason 3": "The example contains a specific term that corresponds to one of the entity labels in the target sentence."},\n    {"Example 4": 4},\n    {"Reason 4": "The example contains a specific term that corresponds to one of the entity labels in the target sentence."},\n    {"Example 5": 4},\n    {"Reason 5": "The example contains a specific term that corresponds to one of the entity labels in the target sentence."},\n    {"Example 6": 4},\n    {"Reason 6": "The example contains specific terms that directly correspond to the entity labels in the target sentence."},\n    {"Example 7": 4},\n    {"Reason 7": "The example contains specific terms that directly correspond to the entity labels in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The example contains a specific term that directly corresponds to one of the entity labels in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The example contains specific terms that directly correspond to the entity labels in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The example contains specific terms that directly correspond to the entity labels in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The example contains a specific term that directly corresponds to one of the entity labels in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The example contains specific terms that directly correspond to the entity labels in the target sentence."},\n    {"Example 13": 1},\n    {"Reason 13": "The example does not contain any terms that correspond to the entity labels in the target sentence."},\n    {"Example 14": 1},\n    {"Reason 14": "The example does not contain any terms that correspond to the entity labels in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The example does not contain any terms that correspond to the entity labels in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain any terms that correspond to the entity labels in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain any terms that correspond to the entity labels in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any terms that correspond to the entity labels in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The example does not contain any terms that correspond to the entity labels in the target sentence."}\n]', 'response3': '[{"atherosclerosis": "cell_type"}, {"rheumatoid arthritis": "cell_type"}, {"monocyte": "cell_type"}]', 'prediction': {'atherosclerosis': 'cell_type', 'rheumatoid arthritis': 'cell_type', 'monocyte': 'cell_type'}}
{'idx': 1473, 'sentence': 'Costimulation requirement for AP-1 and NF-kappa B transcription factor activation in T cells .', 'label': {'NF-kappa B': 'protein', 'T cells': 'cell_type', 'AP-1': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example contains specific protein names that are directly related to the entity types in the target sentence, making it highly relevant for named entity extraction."}\n]', 'response3': '[{"AP-1": "protein"}, {"NF-kappa B": "protein"}, {"T cells": "cell_type"}]', 'prediction': {'AP-1': 'protein', 'NF-kappa B': 'protein', 'T cells': 'cell_type'}}
{'idx': 539, 'sentence': 'PMA enhanced slightly the stimulatory effect of PHA .', 'label': {'PHA': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence contains a specific protein name that matches one of the entity types in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains specific protein names, a cell type, and a protein kinase name that directly match the entity types in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains specific protein names and a protein kinase name that directly match the entity types in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains specific protein names that directly match the entity types in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains a specific protein name and a cell line name that directly match the entity types in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains specific protein names, a cell type, and a protein kinase name that directly match the entity types in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains a specific protein name that matches one of the entity types in the target sentence."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence contains a specific protein name that matches one of the entity types in the target sentence."},\n    {"Example 10": 4},\n    {"Reason 10": "The sentence contains specific protein names and cell type names that match the entity types in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains specific protein names that directly match the entity types in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains specific protein names and a protein kinase name that directly match the entity types in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains specific protein names, a protein kinase name, and cell type names that directly match the entity types in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains specific protein names that directly match the entity types in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains specific protein names that directly match the entity types in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any specific entities that match the entity types in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific entities that match the entity types in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific entities that match the entity types in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific entities that match the entity types in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any specific entities that match the entity types in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1025, 'sentence': 'NK cells do not express NFATc constitutively, but NFATc mRNA accumulation is induced in these cells within 2 h of stimulation with CD16 ligands .', 'label': {'NFATc': 'protein', 'NK cells': 'cell_type', 'NFATc mRNA': 'RNA'}, 'response1': "['RNA', 'cell_type']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with their corresponding labels, which can help in understanding the relationship between the entities and their labels."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of named entities with their corresponding labels, aiding in the identification of specific entities and their types."},\n    {"Sentence": 5},\n    {"Reason": "The sentence includes various examples of named entities and their labels, helping in recognizing the entities and their roles in the context."},\n    {"Sentence": 5},\n    {"Reason": "The sentence presents multiple instances of named entities along with their labels, facilitating the extraction of entities and their types."},\n    {"Sentence": 5},\n    {"Reason": "The sentence offers clear examples of named entities and their labels, assisting in the identification of specific entities and their roles."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of named entities and their labels, aiding in understanding the entities and their functions."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of named entities and their labels, helping in recognizing the entities and their roles."},\n    {"Sentence": 5},\n    {"Reason": "The sentence includes instances of named entities with their labels, aiding in the identification of specific entities and their types."},\n    {"Sentence": 5},\n    {"Reason": "The sentence presents examples of named entities along with their labels, facilitating the extraction of entities and their types."},\n    {"Sentence": 5},\n    {"Reason": "The sentence offers clear examples of named entities and their labels, assisting in the identification of specific entities and their roles."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of named entities and their labels, aiding in understanding the entities and their functions."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the provided entity labels."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not include any named entities relevant to the provided entity labels."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the provided entity labels."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not include any named entities relevant to the provided entity labels."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the provided entity labels."}\n]', 'response3': '[{"NFATc": "protein"}, {"NFATc mRNA": "RNA"}, {"NK cells": "cell_type"}, {"CD16 ligands": "protein"}]', 'prediction': {'NFATc': 'protein', 'NFATc mRNA': 'RNA', 'NK cells': 'cell_type', 'CD16 ligands': 'protein'}}
{'idx': 1560, 'sentence': 'Moreover, in human T helper (Th) clones functionally characterized as being of the type 0, type 1 and type 2 (28%, < 1% und 93% CD30+, respectively), the extent of CD30 -mediated NF-kappa B activation correlated with the proportion of CD30+ cells .', 'label': {'human T helper (Th) clones': 'cell_line', 'CD30+ cells': 'cell_line', 'CD30': 'protein', 'NF-kappa B': 'protein'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n{"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n{"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 4},\n{"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.": 4},\n{"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation.": 4},\n{"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB.": 5},\n{"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 4},\n{"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.": 4},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n{"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5},\n{"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n{"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n{"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n{"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.": 5},\n{"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 4},\n{"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"Th": "cell_type"}, {"CD30": "protein"}, {"NF-kappa B": "protein"}]', 'prediction': {'Th': 'cell_type', 'CD30': 'protein', 'NF-kappa B': 'protein'}}
{'idx': 365, 'sentence': 'Run-on analysis demonstrated detectable levels of c-jun gene transcription in untreated HL-60 cells , and that exposure to TPA increases this rate 3.3-fold.', 'label': {'c-jun': 'DNA', 'HL-60 cells': 'cell_line', 'untreated HL-60 cells': 'cell_line'}, 'response1': "['DNA', 'cell_type', 'protein']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence contains specific gene names and proteins that are directly related to the entity labels in the entity label set."},\n{"Example 2": 4},\n{"Reason 2": "The sentence contains a specific protein name that is directly related to the entity labels in the entity label set."},\n{"Example 3": 5},\n{"Reason 3": "The sentence contains specific gene names and proteins that are directly related to the entity labels in the entity label set."},\n{"Example 4": 4},\n{"Reason 4": "The sentence contains a specific protein name that is directly related to the entity labels in the entity label set."},\n{"Example 5": 5},\n{"Reason 5": "The sentence contains specific gene names and proteins that are directly related to the entity labels in the entity label set."},\n{"Example 6": 3},\n{"Reason 6": "The sentence contains a specific DNA binding activity related to the entity labels in the entity label set, but the entity label \'DNA\' is not explicitly mentioned."},\n{"Example 7": 5},\n{"Reason 7": "The sentence contains specific gene names, proteins, and cell types that are directly related to the entity labels in the entity label set."},\n{"Example 8": 5},\n{"Reason 8": "The sentence contains specific gene names, proteins, and cell types that are directly related to the entity labels in the entity label set."},\n{"Example 9": 5},\n{"Reason 9": "The sentence contains specific gene names and proteins that are directly related to the entity labels in the entity label set."},\n{"Example 10": 5},\n{"Reason 10": "The sentence contains a specific protein name that is directly related to the entity labels in the entity label set."},\n{"Example 11": 5},\n{"Reason 11": "The sentence contains specific gene names and proteins that are directly related to the entity labels in the entity label set."},\n{"Example 12": 5},\n{"Reason 12": "The sentence contains specific gene names and proteins that are directly related to the entity labels in the entity label set."},\n{"Example 13": 5},\n{"Reason 13": "The sentence contains specific gene names, proteins, and cell types that are directly related to the entity labels in the entity label set."},\n{"Example 14": 3},\n{"Reason 14": "The sentence contains a specific DNA binding activity related to the entity labels in the entity label set, but the entity label \'DNA\' is not explicitly mentioned."},\n{"Example 15": 4},\n{"Reason 15": "The sentence contains a specific protein name that is directly related to the entity labels in the entity label set."},\n{"Example 16": 1},\n{"Reason 16": "The sentence does not contain any specific gene names, proteins, or cell types that are directly related to the entity labels in the entity label set."},\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any specific gene names, proteins, or cell types that are directly related to the entity labels in the entity label set."},\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any specific gene names, proteins, or cell types that are directly related to the entity labels in the entity label set."},\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any specific gene names, proteins, or cell types that are directly related to the entity labels in the entity label set."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1039, 'sentence': 'Peripheral blood mononuclear cells ( pbmc ) and bone marrow cells of 26 patients were examined for c-fos , c-myc , p53 and the hybrid bcr/abl mRNA levels .', 'label': {'Peripheral blood mononuclear cells': 'cell_type', 'pbmc': 'cell_type', 'bone marrow cells': 'cell_type'}, 'response1': "['RNA', 'protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 1},\n    {"Sentence": 1},\n    {"Sentence": 1},\n    {"Sentence": 1},\n    {"Sentence": 1},\n    {"Sentence": 1}\n]', 'response3': '[{"pbmc": "cell_type"}, {"bone marrow cells": "cell_type"}, {"c-fos": "protein"}, {"c-myc": "protein"}, {"p53": "protein"}, {"bcr/abl mRNA": "RNA"}]', 'prediction': {'pbmc': 'cell_type', 'bone marrow cells': 'cell_type', 'c-fos': 'protein', 'c-myc': 'protein', 'p53': 'protein', 'bcr/abl mRNA': 'RNA'}}
{'idx': 217, 'sentence': 'Quantitation of glucocorticoid receptors ( GCR ) and the study of their affinity for glucocorticosteroids ( GCS ) were made in peripheral blood lymphocytes of bronchial asthma ( BA ) patients in consideration of GCR treatment and serum levels of endogenous cortisol .', 'label': {'GCR': 'protein', 'glucocorticoid receptors': 'protein', 'peripheral blood lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 3},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 4},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.": 5},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.": 5},\n    {"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n    {"In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine (IFN-gamma) in combination with allergy-driven overproduction of T helper 2-type cytokines.": 4},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 4},\n    {"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"GCR": "protein"}, {"GCS": "protein"}, {"bronchial asthma": "cell_type"}, {"cortisol": "protein"}]', 'prediction': {'GCR': 'protein', 'GCS': 'protein', 'bronchial asthma': 'cell_type', 'cortisol': 'protein'}}
{'idx': 1782, 'sentence': 'In addition, resting PBL constitutively expressed prominent levels of Id2 mRNA , but not Id3 mRNA .', 'label': {'Id3': 'protein', 'resting PBL': 'cell_type', 'Id3 mRNA': 'RNA', 'PBL': 'cell_type', 'Id2': 'protein', 'Id2 mRNA': 'RNA'}, 'response1': "['RNA']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 4},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n    {"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.": 5},\n    {"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA/NF-kappaB1 binding complexes.": 5},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti-EBV antibody titres (P > 0.05).": 4},\n    {"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells, but not in primary T cells, consistent with the lack of the IL-12 receptor in resting T cells.": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"PMA induced the expression of both CD14 and CD23 mRNA and protein.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"Id2 mRNA": "RNA"}, {"Id3 mRNA": "RNA"}]', 'prediction': {'Id2 mRNA': 'RNA', 'Id3 mRNA': 'RNA'}}
{'idx': 1280, 'sentence': "Sequence analysis of the 5'-flanking region of the CD69 gene revealed the presence of a potential TATA element 30 base pairs upstream of the major transcription initiation site and several putative binding sequences for inducible transcription factors ( NF-kappa B , Egr-1 , AP-1 ), which might mediate the inducible expression of this gene.", 'label': {'NF-kappa B': 'protein', 'TATA element': 'DNA', 'transcription factors': 'protein', 'CD69': 'protein', 'AP-1': 'protein', '30 base pairs upstream': 'DNA', 'CD69 gene': 'DNA', "5'-flanking region": 'DNA', 'transcription initiation site': 'DNA', 'Egr-1': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms": 5},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor": 5},\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter": 4},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements": 5},\n    {"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif": 5},\n    {"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF": 5},\n    {"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region": 5},\n    {"These properties suggest that TAFII105 is a cell type-specific subunit of TFIID that may be responsible for mediating transcription by a subset of activators in B cells": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B": 5},\n    {"This sequence element was referred to as the BAT box and its deletion significantly reduced the activity of a CD20 promoter-CAT construct in B cells": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity": 1}\n]', 'response3': '[{"CD69 gene": "protein"}, {"TATA element": "DNA"}, {"NF-kappa B": "protein"}, {"Egr-1": "protein"}, {"AP-1": "protein"}]', 'prediction': {'CD69 gene': 'protein', 'TATA element': 'DNA', 'NF-kappa B': 'protein', 'Egr-1': 'protein', 'AP-1': 'protein'}}
{'idx': 611, 'sentence': 'Transactivation by some DNA viruses has been implicated in inducing HIV-1 replication and pathogenesis.', 'label': {}, 'response1': "['DNA', 'RNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific gene/protein names that match the entity labels in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence contains a specific protein name that matches one of the entity labels in the target sentence."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence contains specific gene/protein names that match the entity labels in the target sentence."},\n    {"Example 4": 3},\n    {"Reason 4": "The sentence contains a specific DNA name that matches one of the entity labels in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains specific gene/protein names that match the entity labels in the target sentence."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence contains a specific protein name that matches one of the entity labels in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains a specific cell line name that matches one of the entity labels in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains specific gene/protein names that match the entity labels in the target sentence."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence contains a specific protein name that matches one of the entity labels in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains specific cell type and protein names that match the entity labels in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains specific gene/protein names that match the entity labels in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains specific DNA, protein, and cell line names that match the entity labels in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains specific cell type and DNA names that match the entity labels in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains specific DNA and protein names that match the entity labels in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any specific named entities that match the entity labels in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any specific named entities that match the entity labels in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific named entities that match the entity labels in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific named entities that match the entity labels in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1723, 'sentence': 'In vitro treatment of a monocyte/macrophage cell line with CCl4 led to enhanced NF-kappa B binding and an increase in tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA levels .', 'label': {'tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA': 'RNA', 'NF-kappa B': 'protein', 'tumor necrosis factor-alpha': 'protein', 'TNF-alpha': 'protein'}, 'response1': "['cell_line', 'protein', 'RNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains multiple examples of proteins and cell types that are relevant to the entity labels in the target sentence, making it highly helpful for extracting named entities."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence includes examples of proteins and cytokines that are relevant to the entity labels in the target sentence, providing valuable information for extracting named entities."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence mentions specific proteins and their human equivalents, which are relevant to the entity labels in the target sentence, aiding in the extraction of named entities."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence provides examples of proteins and cell types that are relevant to the entity labels in the target sentence, contributing to the extraction of named entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains examples of proteins that are directly related to the entity labels in the target sentence, making it highly helpful for extracting named entities."},\n    {"Example 6": 3},\n    {"Reason 6": "The sentence mentions a specific protein relevant to the entity labels in the target sentence, but the context is not as directly related, hence providing moderate help in extracting named entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence includes examples of proteins, cytokines, and stimuli that are directly relevant to the entity labels in the target sentence, making it highly helpful for extracting named entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides examples of proteins and cell types that are directly related to the entity labels in the target sentence, making it highly helpful for extracting named entities."},\n    {"Example 9": 3},\n    {"Reason 9": "The sentence mentions a specific protein relevant to the entity labels in the target sentence, but the context is not as directly related, hence providing moderate help in extracting named entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains examples of proteins, cytokines, and cell types that are directly relevant to the entity labels in the target sentence, making it highly helpful for extracting named entities."},\n    {"Example 11": 4},\n    {"Reason 11": "The sentence mentions a specific DNA-binding activity relevant to the entity labels in the target sentence, providing valuable information for extracting named entities."},\n    {"Example 12": 4},\n    {"Reason 12": "The sentence includes examples of proteins that are relevant to the entity labels in the target sentence, contributing to the extraction of named entities."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides examples of proteins, transcription factors, and cell types that are directly related to the entity labels in the target sentence, making it highly helpful for extracting named entities."},\n    {"Example 14": 4},\n    {"Reason 14": "The sentence mentions examples of proteins and stimuli that are relevant to the entity labels in the target sentence, providing valuable information for extracting named entities."},\n    {"Example 15": 4},\n    {"Reason 15": "The sentence includes examples of proteins and transcription factors that are relevant to the entity labels in the target sentence, contributing to the extraction of named entities."},\n    {"Example 16": 3},\n    {"Reason 16": "The sentence mentions a specific protein with immunomodulatory activity, which is relevant to the entity labels in the target sentence, but the context is not as directly related, hence providing moderate help in extracting named entities."}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"TNF-alpha": "protein"}, {"messenger RNA": "RNA"}, {"monocyte/macrophage cell line": "cell_line"}]', 'prediction': {'NF-kappa B': 'protein', 'TNF-alpha': 'protein', 'messenger RNA': 'RNA', 'monocyte/macrophage cell line': 'cell_line'}}
{'idx': 1308, 'sentence': 'Two groups of HMG box proteins are distinguished.', 'label': {'HMG box proteins': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of HMG box proteins, which are directly relevant to the target sentence and can help in identifying proteins in the text."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides an example of a DNA sequence, which is relevant to the target sentence and can aid in identifying DNA entities in the text."},\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions IgH genes, which are related to DNA sequences and can assist in identifying DNA entities in the text."},\n    {"Sentence": 3},\n    {"Reason": "The sentence includes examples of altered DNA sequences (CCAAT box) and a protein (EKLF binding site), which are relevant to the target sentence and can help in identifying DNA and protein entities in the text."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of specific proteins (p21(WAF1/CIP1) and p27(KIP1)) that are directly relevant to the target sentence and can aid in identifying proteins in the text."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of transcription factors (NF-kappaB, Sp1, p50) that are directly relevant to the target sentence and can help in identifying proteins in the text."},\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions the transcription factor NF-ATc and specific cell types (T lymphocytes, embryonic cardiac cells), which are directly relevant to the target sentence and can aid in identifying proteins and cell types in the text."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides an example of a specific protein (GATA-1) that is directly relevant to the target sentence and can help in identifying proteins in the text."},\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions the recruitment of a specific protein (EKLF) to DNA sequences, which is relevant to the target sentence and can aid in identifying proteins in the text."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains a general mention of proteins involved in transcription, which is directly relevant to the target sentence and can help in identifying proteins in the text."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of specific proteins (IL-2, c-Jun, c-Fos) that are directly relevant to the target sentence and can aid in identifying proteins in the text."},\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions the protein calcineurin, which is directly relevant to the target sentence and can help in identifying proteins in the text."},\n    {"Sentence": 4},\n    {"Reason": "The sentence includes an example of a cell line (SCM-1), which is relevant to the target sentence and can aid in identifying cell line entities in the text."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides an example of a specific protein (A-myb) that is directly relevant to the target sentence and can help in identifying proteins in the text."},\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions the IL-4 gene and proteins involved in gene expression, which are directly relevant to the target sentence and can aid in identifying proteins in the text."},\n    {"Sentence": 4},\n    {"Reason": "The sentence includes an example of a specific protein (E2A) that is directly relevant to the target sentence and can help in identifying proteins in the text."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entities relevant to the target sentence, so it is not helpful in extracting named entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entities relevant to the target sentence, so it is not helpful in extracting named entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entities relevant to the target sentence, so it is not helpful in extracting named entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entities relevant to the target sentence, so it is not helpful in extracting named entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entities relevant to the target sentence, so it is not helpful in extracting named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 765, 'sentence': 'Our results suggest that substances in serum influence steroid effects on these cells and that the molecular details of glucocorticoid hormone action may be pursued more precisely in a clearly defined culture medium.', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear and direct mention of the entity \'CD40\' and its association with stimulation, aiding in the extraction of the protein entity."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions \'NF-kappa B activation\' and \'NF-kappa B\' directly, providing a clear indication of the protein entity."},\n    {"Example 3": 3},\n    {"Reason 3": "The sentence mentions \'phosphocreatine administration\' which can be associated with a protein entity, but the connection is not as direct as in other examples."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence directly mentions multiple protein entities like \'VDR\', \'RXR\', \'GRIP-1\', \'DRIP205\', and \'DRIP\', aiding in their extraction."},\n    {"Example 5": 2},\n    {"Reason 5": "The sentence mentions \'HML\' which can be associated with a cell line entity, but the context is not as clear and direct as in other examples."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence mentions \'IFN-gamma\' directly, aiding in the extraction of the protein entity."},\n    {"Example 7": 3},\n    {"Reason 7": "The sentence mentions \'granulocytes\' and \'T cells\' which can be associated with cell type entities, but the context is not as specific."},\n    {"Example 8": 1},\n    {"Reason 8": "The sentence does not provide any clear indication or mention of entities relevant to the given entity labels."},\n    {"Example 9": 1},\n    {"Reason 9": "The sentence does not provide any clear indication or mention of entities relevant to the given entity labels."},\n    {"Example 10": 1},\n    {"Reason 10": "The sentence does not provide any clear indication or mention of entities relevant to the given entity labels."},\n    {"Example 11": 1},\n    {"Reason 11": "The sentence does not provide any clear indication or mention of entities relevant to the given entity labels."},\n    {"Example 12": 1},\n    {"Reason 12": "The sentence does not provide any clear indication or mention of entities relevant to the given entity labels."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not provide any clear indication or mention of entities relevant to the given entity labels."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not provide any clear indication or mention of entities relevant to the given entity labels."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not provide any clear indication or mention of entities relevant to the given entity labels."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not provide any clear indication or mention of entities relevant to the given entity labels."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not provide any clear indication or mention of entities relevant to the given entity labels."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not provide any clear indication or mention of entities relevant to the given entity labels."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1561, 'sentence': 'In all cell lines investigated, the NF-kappa B complexes induced following CD30 engagement were shown to contain p50 NF-kappa B1 , p65 RelA , and possibly other transcription factors .', 'label': {'CD30': 'protein', 'NF-kappa B complexes': 'protein', 'p65 RelA': 'protein', 'p50 NF-kappa B1': 'protein', 'NF-kappa B': 'protein', 'transcription factors': 'protein'}, 'response1': "['cell_line', 'protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of the entity types present in the target sentence, such as \'NF-kappaB\', \'Sp1\', and \'p50\', making it highly relevant for extracting named entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of the entity types present in the target sentence, such as \'NF-ATc\' and \'T lymphocytes\', which can aid in extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of the entity types present in the target sentence, such as \'CD28\', \'CD80\', \'CD86\', \'CBL\', \'VAV\', \'NFAT\', \'interleukin-2\', and \'granulocyte-macrophage colony-stimulating factor\', making it highly relevant for extracting named entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of the entity types present in the target sentence, such as \'PAFR\', \'PAF\', \'NF-kappa B\', and \'protein kinase C\', which can aid in extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of the entity types present in the target sentence, such as \'RelA\' and \'NF-kappa B\', making it highly relevant for extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of the entity types present in the target sentence, such as \'NF-kappa B\' and \'I kappa B alpha\', making it highly relevant for extracting named entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of the entity types present in the target sentence, such as \'NF-kappaB\', \'Tax\', and \'ATL\', which can aid in extracting named entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of the entity types present in the target sentence, such as \'NF-kappa B\' and \'I kappa B alpha\', which can aid in extracting named entities."},\n    {"Sentence": 3},\n    {"Reason": "The sentence contains an example of the entity type present in the target sentence, \'NF-kappa B\', but lacks additional relevant entities for a higher score."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of the entity types present in the target sentence, such as \'CD40\' and \'NF-kappa B\', which can aid in extracting named entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of the entity types present in the target sentence, such as \'NF-kappa B\' and \'AP-1\', which can aid in extracting named entities."},\n    {"Sentence": 3},\n    {"Reason": "The sentence contains an example of the entity type present in the target sentence, \'NF-kappa B\', but lacks additional relevant entities for a higher score."},\n    {"Sentence": 3},\n    {"Reason": "The sentence contains an example of the entity type present in the target sentence, \'NF-kB\', but lacks additional relevant entities for a higher score."},\n    {"Sentence": 3},\n    {"Reason": "The sentence contains examples of the entity types present in the target sentence, such as \'IkappaBalpha\' and \'NF-kappaB\', but lacks additional relevant entities for a higher score."},\n    {"Sentence": 3},\n    {"Reason": "The sentence contains an example of the entity type present in the target sentence, \'NF-kappa B\', but lacks additional relevant entities for a higher score."},\n    {"Sentence": 3},\n    {"Reason": "The sentence contains an example of the entity type present in the target sentence, \'NF-kappaB\', but lacks additional relevant entities for a higher score."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of the entity types present in the target sentence, resulting in a low helpfulness score."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of the entity types present in the target sentence, resulting in a low helpfulness score."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of the entity types present in the target sentence, resulting in a low helpfulness score."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of the entity types present in the target sentence, resulting in a low helpfulness score."}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"p50 NF-kappa B1": "protein"}, {"p65 RelA": "protein"}]', 'prediction': {'NF-kappa B': 'protein', 'p50 NF-kappa B1': 'protein', 'p65 RelA': 'protein'}}
{'idx': 330, 'sentence': 'ZRE-B is therefore not part of the R- inducible enhancer .', 'label': {'ZRE-B': 'DNA', 'R- inducible enhancer': 'DNA'}, 'response1': 'None.', 'response2': '[\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 3},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 4},\n    {"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 3},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 4},\n    {"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 3},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 4},\n    {"Our results demonstrate that the altered CCAAT box (CCAAC) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 4},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n    {"RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA/NF-kappaB1 binding complexes.": 4},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 4},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 4},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.": 4},\n    {"Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B/Oct-1-dependent transcription.": 4},\n    {"We have found that the recruitment of EKLF to 5\'HS3 depends on the presence of 5\'HS2 in cis, but the recruitment to 5\'HS2 does not depend on 5\'HS3.": 4},\n    {"The protein from E. coli specifically converted dUTP to dUMP and did not react with other dNTPs or NTPs.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1104, 'sentence': 'Although the interrelationship between the two messengers Ca2+ and cyclic AMP in platelet function is well documented, its mechanism of action still remains to be established.', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 4},\n    {"Example 7": 4},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1594, 'sentence': 'Human IL4 promoter -mediated transcription is downregulated in Jurkat cells stimulated with the NF-kappa B -activating cytokine tumor necrosis factor alpha and suppressed in RelA -overexpressing cells .', 'label': {'Jurkat cells': 'cell_line', 'NF-kappa B -activating cytokine': 'protein', 'Human IL4 promoter': 'DNA', 'tumor necrosis factor alpha': 'protein', 'RelA -overexpressing cells': 'cell_line', 'NF-kappa B': 'protein', 'RelA': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.": 5},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.": 5},\n    {"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5},\n    {"Binding of YY1 and Oct1 to a novel element that downregulates expression of IL-5 in human T cells.": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).": 5},\n    {"Interestingly, CTLA4Ig did not significantly inhibit the activation of either NF of activated T cells (NFAT) or AP-1 reporters.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"IL4": "protein"}, {"Jurkat cells": "cell_line"}, {"NF-kappa B": "protein"}, {"tumor necrosis factor alpha": "protein"}, {"RelA": "protein"}]', 'prediction': {'IL4': 'protein', 'Jurkat cells': 'cell_line', 'NF-kappa B': 'protein', 'tumor necrosis factor alpha': 'protein', 'RelA': 'protein'}}
{'idx': 1086, 'sentence': 'Analysis of the expression of human I kappa B alpha protein in stable transfectants of mouse 70Z/3 cells shows that, as for the endogenous murine protein, exogenous I kappa B alpha is degraded in response to inducers of NF-kappa B activity , such as phorbol myristate acetate or lipopolysaccharide .', 'label': {'NF-kappa B': 'protein', 'I kappa B alpha': 'protein', 'human I kappa B alpha protein': 'protein', 'mouse 70Z/3 cells': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"2": "The sentence does not contain any of the entity types in the target sentence."},\n    {"5": "The sentence contains \'NF-kappa B\' and \'I kappa B alpha\' which are both proteins mentioned in the target sentence."},\n    {"5": "The sentence contains \'IkappaBalpha\' and \'NF-kappaB\' which are both proteins mentioned in the target sentence."},\n    {"5": "The sentence contains \'IkappaBbeta\' and \'NF-kappaB\' which are both proteins mentioned in the target sentence."},\n    {"5": "The sentence contains \'RelA\' and \'NF-kappa B\' which are both proteins mentioned in the target sentence."},\n    {"5": "The sentence contains \'NF-kappa B\' and \'I kappa B beta\' which are both proteins mentioned in the target sentence."},\n    {"5": "The sentence contains \'CD40\' and \'NF-kappa B\' which are both proteins mentioned in the target sentence."},\n    {"5": "The sentence contains \'NF-kappa B\' which is a protein mentioned in the target sentence."},\n    {"5": "The sentence contains \'IL-2\', \'c-Jun\', and \'c-Fos\' which are proteins mentioned in the target sentence."},\n    {"5": "The sentence contains \'IFN A\', \'IFNA\', \'interleukin-2\', \'interleukin-2 receptor\', \'phytohemagglutinin\', and \'phorbol myristate acetate\' which are proteins mentioned in the target sentence."},\n    {"5": "The sentence contains \'E2A\' which is a protein mentioned in the target sentence."},\n    {"5": "The sentence contains \'NF-kappa B\' which is a protein mentioned in the target sentence."},\n    {"5": "The sentence contains \'NF-kappa B\' and \'I kappa B alpha\' which are both proteins mentioned in the target sentence."},\n    {"5": "The sentence contains \'NF-kappaB\', \'Tax\', and \'ATL\' which are relevant to the cell_type and protein entity types in the target sentence."},\n    {"5": "The sentence contains \'NF-kappa B\' which is a DNA mentioned in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."}\n]', 'response3': "[{'I kappa B alpha': 'protein'}, {'NF-kappa B': 'protein'}, {'phorbol myristate acetate': 'protein'}, {'lipopolysaccharide': 'protein'}]", 'prediction': {'I kappa B alpha': 'protein', 'NF-kappa B': 'protein', 'phorbol myristate acetate': 'protein', 'lipopolysaccharide': 'protein'}}
{'idx': 1, 'sentence': 'When the homeodomain from HB24 was compared to known mammalian and Drosophila homeodomains it was found to be only moderately conserved, but when it was compared to a highly diverged Drosophila homeodomain , H2.0, it was found to be 80% identical.', 'label': {'homeodomain': 'DNA', 'HB24': 'DNA', 'Drosophila homeodomain': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n    {"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 5},\n    {"Like Drosophila Toll, human Toll is a type I transmembrane protein with an extracellular domain consisting of a leucine-rich repeat (LRR) domain, and a cytoplasmic domain homologous to the cytoplasmic domain of the human interleukin (IL)-1 receptor.": 5},\n    {"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Our results demonstrate that the altered CCAAT box (CCAAC) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 5},\n    {"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 5},\n    {"These two related genes share the evolutionarily conserved region encoding the Runt domain.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 5},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes.": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 5},\n    {"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.": 5},\n    {"Thus, we were able to derive a hematopoietic cell line, called 47.10, that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1226, 'sentence': 'Lastly, the different mobilities of osteoblast nuclear extract-DNA complexes compared with T-cell nuclear extract-DNA complexes , along with the inability of OSF2 to be upregulated by retinoic acid , unlike the other PEBP2 alpha factors , suggest that OSF2 is a new member of this family of transcription factors .', 'label': {'transcription factors': 'protein', 'T-cell nuclear extract-DNA complexes': 'protein', 'OSF2': 'protein', 'osteoblast nuclear extract-DNA complexes': 'protein', 'PEBP2 alpha factors': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 1},\n    {"Sentence": 1},\n    {"Sentence": 1},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 1},\n    {"Sentence": 1},\n    {"Sentence": 1},\n    {"Sentence": 1},\n    {"Sentence": 1},\n    {"Sentence": 1}\n]', 'response3': '[{"OSF2": "protein"}, {"PEBP2 alpha factors": "protein"}]', 'prediction': {'OSF2': 'protein', 'PEBP2 alpha factors': 'protein'}}
{'idx': 663, 'sentence': 'The cells lines described here should be useful for the delineation of signaling pathways utilized in the selective regulation of gene expression .', 'label': {}, 'response1': "['cell_line', 'gene']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of different entity types mentioned in the target sentence, such as \'protein\', \'cell_type\', and \'cell_line\', making it highly relevant for predicting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides clear examples of \'protein\', \'cell_type\', and \'cell_line\' entities, directly related to the target sentence, thus aiding in the extraction of named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence directly mentions the \'protein\' entity type, which is relevant to the target sentence, making it highly helpful for predicting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence explicitly mentions the \'cell_line\' entity type, which is directly related to the target sentence, thus aiding in the extraction of named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides a clear example of the \'cell_type\' entity type mentioned in the target sentence, making it highly relevant for predicting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains a specific example of the \'protein\' entity type, directly related to the target sentence, thus aiding in the extraction of named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions various entity types, such as \'protein\', \'DNA\', and \'cell_type\', which are relevant to the target sentence, making it highly helpful for predicting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of \'protein\' entities directly related to the target sentence, making it highly relevant for predicting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions \'protein\' and \'cell_line\' entities, which are directly related to the target sentence, thus aiding in the extraction of named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of \'protein\' entities, directly related to the target sentence, making it highly helpful for predicting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions \'cell_type\' entities, which are relevant to the target sentence, making it highly helpful for predicting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of \'protein\' entities directly related to the target sentence, making it highly relevant for predicting named entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entity types mentioned in the target sentence, thus not aiding in the extraction of named entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entity types mentioned in the target sentence, thus not aiding in the extraction of named entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entity types mentioned in the target sentence, thus not aiding in the extraction of named entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entity types mentioned in the target sentence, thus not aiding in the extraction of named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1000, 'sentence': 'Analysis of the biochemical and cell biological properties of these HSFs reveals that HSF3 has properties in common with both HSF1 and HSF2 and yet has features which are distinct from both.', 'label': {'HSF2': 'protein', 'HSF3': 'protein', 'HSFs': 'protein', 'HSF1': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear and direct mention of the entity \'protein\' with the specific term \'GM-CSF\', making it highly helpful for extracting named entities."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains explicit mentions of entities such as \'DNA\' (UAS3, UAS2) and \'protein\' (YY1), making it very helpful for extracting named entities."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence directly mentions the entity \'protein\', making it highly helpful for extracting named entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence explicitly mentions entities like \'protein\' (IL-2, c-Jun, c-Fos), making it very helpful for extracting named entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides clear mentions of entities such as \'protein\' (NF-ATc), \'cell_type\' (T lymphocytes, embryonic cardiac cells), making it highly helpful for extracting named entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains a direct mention of the entity \'protein\' (EKLF), making it highly helpful for extracting named entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence explicitly mentions the entity \'protein\' (A-myb), making it highly helpful for extracting named entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides clear mentions of entities like \'protein\' (Tax, TFIIA), making it very helpful for extracting named entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence directly mentions the entity \'DNA\' (cDNAs), making it highly helpful for extracting named entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains a clear mention of the entity \'protein\' (GATA-1), making it highly helpful for extracting named entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides explicit mentions of entities like \'protein\' (EKLF, CBP, p300, P/CAF), making it highly helpful for extracting named entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains a direct mention of the entity \'cell_line\' (SCM-1), making it highly helpful for extracting named entities."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence explicitly mentions the entity \'protein\' (NF-E2), making it highly helpful for extracting named entities."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides clear mentions of entities like \'protein\' (p21(WAF1/CIP1), p27(KIP1)), making it very helpful for extracting named entities."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains explicit mentions of entities such as \'protein\' (NF-ATc) and \'cell_type\' (T lymphocytes), making it very helpful for extracting named entities."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence directly mentions the entity \'protein\' (E2A), making it highly helpful for extracting named entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any explicit mentions of the entity types present in the target sentence, making it not helpful for extracting named entities."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any explicit mentions of the entity types present in the target sentence, making it not helpful for extracting named entities."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any explicit mentions of the entity types present in the target sentence, making it not helpful for extracting named entities."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any explicit mentions of the entity types present in the target sentence, making it not helpful for extracting named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 39, 'sentence': 'Most hybrids express both KBF1 and NF-kappa B in their nuclei , but one hybrid expresses only KBF1 .', 'label': {'KBF1': 'protein', 'NF-kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence 1": 5},\n    {"Sentence 2": 5},\n    {"Sentence 3": 5},\n    {"Sentence 4": 5},\n    {"Sentence 5": 5},\n    {"Sentence 6": 5},\n    {"Sentence 7": 4},\n    {"Sentence 8": 4},\n    {"Sentence 9": 1},\n    {"Sentence 10": 1},\n    {"Sentence 11": 1},\n    {"Sentence 12": 1},\n    {"Sentence 13": 5},\n    {"Sentence 14": 5},\n    {"Sentence 15": 1},\n    {"Sentence 16": 1},\n    {"Sentence 17": 1},\n    {"Sentence 18": 1},\n    {"Sentence 19": 1}\n]', 'response3': '[{"KBF1": "protein"}, {"NF-kappa B": "protein"}]', 'prediction': {'KBF1': 'protein', 'NF-kappa B': 'protein'}}
{'idx': 229, 'sentence': "We now show that: 1) CVZ has more than one binding site in a second, independent, B-cell line , IM-9 ; 2) the antiglucocorticoid RU 38486 is able to block both CVZ 's higher and lower affinity sites; 3) all of CVZ 's binding sites are on a protein immunologically indistinguishable from the human GR ; and 4) freshly isolated clones of CVZ -resistant cells have lost all binding sites for CVZ .", 'label': {'B-cell line': 'cell_line', 'IM-9': 'cell_line', 'GR': 'protein', "CVZ 's binding sites": 'protein'}, 'response1': "['cell_line', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"CVZ": "protein"}, {"IM-9": "cell_line"}, {"RU 38486": "protein"}, {"human GR": "protein"}]', 'prediction': {'CVZ': 'protein', 'IM-9': 'cell_line', 'RU 38486': 'protein', 'human GR': 'protein'}}
{'idx': 743, 'sentence': 'Detection in non-erythroid cells of a factor with the binding characteristics of the erythroid cell transcription factor EF1 .', 'label': {'erythroid cell transcription factor': 'protein', 'non-erythroid cells': 'cell_type', 'EF1': 'protein'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Sentence": "SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor ).", "helpfulness score": 5, "reasons": "The sentence provides examples of proteins (SCL, GATA-1) expressed in specific cell lineages (erythroid, megakaryocyte, mast cell). This directly relates to the entity types mentioned in the target sentence."},\n    {"Sentence": "Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.", "helpfulness score": 4, "reasons": "The sentence mentions a protein (WT1) and its association with myeloid cell lines, which is relevant to the entity types in the target sentence."},\n    {"Sentence": "Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.", "helpfulness score": 3, "reasons": "The sentence provides an example of a protein (NF-E2) and its role in binding to an enhancer element in erythroid-specific gene expression, somewhat related to the entity types in the target sentence."},\n    {"Sentence": "It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.", "helpfulness score": 4, "reasons": "The sentence mentions a protein (RXR) and its role in supporting outgrowth of erythroid cells, which is relevant to the entity types in the target sentence."},\n    {"Sentence": "The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts.", "helpfulness score": 5, "reasons": "The sentence directly mentions a protein (GATA-1) involved in erythroid development and gene regulation, aligning with the entity types in the target sentence."},\n    {"Sentence": "One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.", "helpfulness score": 4, "reasons": "The sentence provides an example of a protein (Egr-1) and its association with macrophage differentiation, somewhat related to the entity types in the target sentence."},\n    {"Sentence": "The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.", "helpfulness score": 3, "reasons": "The sentence mentions a DNA-binding protein (AP-1) and its activity in lymphocytes, which is somewhat related to the entity types in the target sentence."},\n    {"Sentence": "Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.", "helpfulness score": 4, "reasons": "The sentence provides an example of a protein (TCF-1) and its transactivation ability in non-T cells, which is relevant to the entity types in the target sentence."},\n    {"Sentence": "Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.", "helpfulness score": 5, "reasons": "The sentence directly mentions proteins (IL-2, c-Jun, c-Fos) and their interactions with nuclear factors in PBL, aligning with the entity types in the target sentence."},\n    {"Sentence": "In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.", "helpfulness score": 4, "reasons": "The sentence provides an example of a protein (GATA-1) and its association with eosinophil differentiation, somewhat related to the entity types in the target sentence."},\n    {"Sentence": "We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF.", "helpfulness score": 5, "reasons": "The sentence directly mentions proteins (EKLF, CBP, p300, P/CAF) and their interactions, aligning with the entity types in the target sentence."},\n    {"Sentence": "Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.", "helpfulness score": 4, "reasons": "The sentence provides examples of proteins (SP1, caspases) involved in B-cell apoptosis, which is relevant to the entity types in the target sentence."},\n    {"Sentence": "Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.", "helpfulness score": 5, "reasons": "The sentence directly mentions a protein (GATA-1) and its role as a regulator in erythroid cells, aligning with the entity types in the target sentence."},\n    {"Sentence": "The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.", "helpfulness score": 5, "reasons": "The sentence directly mentions a protein (NF-ATc) and its role in gene expression in T lymphocytes and embryonic cardiac cells, aligning with the entity types in the target sentence."},\n    {"Sentence": "The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays.", "helpfulness score": 5, "reasons": "The sentence directly mentions proteins (p50, p65) and their association with DNA-protein complexes, aligning with the entity types in the target sentence."},\n    {"Sentence": "However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.", "helpfulness score": 5, "reasons": "The sentence directly mentions proteins (beta-globin, glycoprotein IIb, platelet factor 4) and their expression in Ter 119 erythroid cells and megakaryocytic transcripts, aligning with the entity types in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1799, 'sentence': 'These STAT proteins were detected by using the IFN-gamma-activated sequence ( GAS ) and related oligonucleotides as probes in electrophoretic mobility shift assay .', 'label': {'GAS': 'DNA', 'IFN-gamma-activated sequence': 'DNA', 'STAT proteins': 'protein'}, 'response1': "['protein', 'DNA']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines.": 5},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Moreover, monocytes express a novel IL-10 -stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti- STAT3 Ab but is not observed in T cells.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"Activated Stat proteins form homo- or heterodimers, translocate to the nucleus, and induce transcription from responsive genes.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1703, 'sentence': "E1A blocked IFN 's induction of cytolytic resistance , resulting in the selective lysis of adenovirus-transformed cells by IFN -activated NK cells .", 'label': {'E1A': 'protein', 'IFN': 'protein', 'adenovirus-transformed cells': 'cell_line', 'IFN -activated NK cells': 'cell_line'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 4},\n    {"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells, but not in primary T cells, consistent with the lack of the IL-12 receptor in resting T cells.": 5},\n    {"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 4},\n    {"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 4},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 4},\n    {"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine (IL-2 and IFN-gamma) production is normal.": 5},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 4},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 4},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 4},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"E1A": "protein"}, {"IFN": "protein"}, {"adenovirus-transformed cells": "cell_line"}, {"NK cells": "cell_type"}]', 'prediction': {'E1A': 'protein', 'IFN': 'protein', 'adenovirus-transformed cells': 'cell_line', 'NK cells': 'cell_type'}}
{'idx': 629, 'sentence': 'Depletion of CD8+ cells was accompanied by 62 +/- 18% loss of progesterone receptor -bearing cells , while depletion of CD4+ cells resulted in a twofold increase in the number of positively staining lymphocytes .', 'label': {'progesterone receptor': 'protein', 'CD8+ cells': 'cell_line', 'lymphocytes': 'cell_line', 'progesterone receptor -bearing cells': 'cell_line', 'CD4+ cells': 'cell_line'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"1": "The sentence contains terms like \'CD70\', \'B cell\', \'plasma cells\', \'IL-4\', and \'CD40\' which are directly related to the entity labels provided."},\n    {"2": "The sentence directly mentions \'CD4+\' and \'EBV\' which are relevant to the entity labels."},\n    {"3": "The sentence includes terms like \'T cell\', \'IL-2\', \'IL-2 receptor\', and \'CD28\' which are associated with the provided entity labels."},\n    {"4": "The sentence mentions \'granulocytes\' and \'T cells\' which are relevant to the entity labels."},\n    {"5": "The sentence contains \'FasL\', \'IL-2\', and \'IFN-gamma\' which are directly related to the entity labels provided."},\n    {"1": "The sentence includes terms like \'myeloperoxidase\', \'lysozyme\', and \'PU.1\' which are directly related to the entity labels provided."},\n    {"1": "The sentence mentions \'AP-1\' which is directly related to the entity labels provided."},\n    {"1": "The sentence contains \'TCRzeta\' and \'p56(lck)\' which are directly related to the entity labels provided."},\n    {"1": "The sentence mentions \'EBV\' and \'CD2\' which are directly related to the entity labels provided."},\n    {"1": "The sentence includes \'CD40\', \'IFN-gamma\', \'tumor necrosis factor-alpha\', and \'interleukin (IL)-1beta\' which are directly related to the entity labels provided."},\n    {"1": "The sentence contains terms like \'IFN A\', \'IFNA\', \'interleukin-2\', \'interleukin-2 receptor\', \'phytohemagglutinin\', and \'phorbol myristate acetate\' which are directly related to the entity labels provided."},\n    {"1": "The sentence includes \'CD40\', \'Rel/nuclear factor kappaB\', \'NF-kappaB\', and \'B lymphocytes\' which are directly related to the entity labels provided."},\n    {"1": "The sentence mentions \'interleukin-2\', \'alpha chain\', \'CD25\', and \'IL-2 receptor\' which are directly related to the entity labels provided."},\n    {"1": "The sentence contains terms like \'2-deoxyguanosine\', \'lymphoid progenitor cells\', \'thymus stromal cells\', \'B cell\', \'tg epsilon26\', \'fetal liver cells\', and \'T cell\' which are directly related to the entity labels provided."},\n    {"1": "The sentence includes \'PMA\' and \'U1 cells\' which are directly related to the entity labels provided."},\n    {"1": "The sentence mentions \'CD4+\', \'CD8+\', \'TPCK\', \'anti-CD28\', and \'PMA\' which are directly related to the entity labels provided."},\n    {"1": "The sentence does not contain any terms related to the entity labels provided."},\n    {"1": "The sentence does not contain any terms related to the entity labels provided."},\n    {"1": "The sentence does not contain any terms related to the entity labels provided."},\n    {"1": "The sentence does not contain any terms related to the entity labels provided."},\n    {"1": "The sentence does not contain any terms related to the entity labels provided."}\n]', 'response3': '[{"CD8+": "cell_type"}, {"progesterone receptor": "protein"}, {"CD4+": "cell_type"}, {"lymphocytes": "cell_type"}]', 'prediction': {'CD8+': 'cell_type', 'progesterone receptor': 'protein', 'CD4+': 'cell_type', 'lymphocytes': 'cell_type'}}
{'idx': 490, 'sentence': 'Cyclosporin A ( CsA ) is thought to exert its immunosuppressive effects by inhibiting the expression of a distinct set of lymphokine genes which are induced upon T-cell activation , among them the gene coding for interleukin-2 .', 'label': {'lymphokine genes': 'DNA', 'interleukin-2': 'protein'}, 'response1': "['protein', 'RNA']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of proteins and RNA, which are relevant entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of proteins and RNA that are relevant to the target sentence, aiding in the extraction of named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence includes examples of proteins that are mentioned in the target sentence, making it highly relevant for entity extraction."},\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions proteins and a cell type, which are relevant entity types in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of proteins that are relevant to the target sentence, aiding in the extraction of named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of proteins and relevant terms like \'NFAT\' and \'transcriptional activation\' that are important for entity extraction."},\n    {"Sentence": 5},\n    {"Reason": "The sentence specifically mentions the protein \'calcineurin\' which is relevant to the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions a cell type \'Th2-type lymphocytes\' which is relevant to the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides an example of the protein \'STAT1\' which is mentioned in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions proteins and cell types that are relevant to the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of RNA and proteins that are relevant to the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant entity types mentioned in the target sentence."}\n]', 'response3': '[{"CsA": "protein"}, {"lymphokine genes": "protein"}, {"T-cell": "cell_type"}, {"interleukin-2": "protein"}]', 'prediction': {'CsA': 'protein', 'lymphokine genes': 'protein', 'T-cell': 'cell_type', 'interleukin-2': 'protein'}}
{'idx': 118, 'sentence': "Similar to 1;14 translocations , this deletion disrupts the SCL 5' regulatory region .", 'label': {'SCL': 'protein', "SCL 5' regulatory region": 'DNA'}, 'response1': "['DNA']", 'response2': '[\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 3},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 4},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"We have found that the recruitment of EKLF to 5\'HS3 depends on the presence of 5\'HS2 in cis, but the recruitment to 5\'HS2 does not depend on 5\'HS3.": 4},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.": 5},\n    {"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.": 5},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n    {"SCL is expressed in erythroid, megakaryocyte and mast cell populations (the same cell lineages as GATA-1, a zinc-finger transcription factor).": 4},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.": 4},\n    {"By the time of diagnosis of T-PLL, the clone contains many more genetic changes in the form of additional translocations.": 4},\n    {"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 4},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"SCL": "RNA"}]', 'prediction': {'SCL': 'RNA'}}
{'idx': 493, 'sentence': 'Here we report that the formation of two distinct mitogen-inducible DNA-binding complexes , the kappa B complex within the HIV enhancer and the NFAT-1 complex within the interleukin-2 enhancer , is inhibited in the presence of CsA .', 'label': {'NFAT-1 complex': 'protein', 'mitogen-inducible DNA-binding complexes': 'protein', 'kappa B complex': 'protein', 'interleukin-2': 'protein', 'interleukin-2 enhancer': 'DNA', 'HIV enhancer': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 5},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 5},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.": 5},\n    {"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.": 5},\n    {"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.": 5},\n    {"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin.": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"kappa B complex": "protein"}, {"NFAT-1 complex": "protein"}, {"HIV enhancer": "cell_line"}, {"interleukin-2 enhancer": "protein"}, {"CsA": "None"}]', 'prediction': {'kappa B complex': 'protein', 'NFAT-1 complex': 'protein', 'HIV enhancer': 'cell_line', 'interleukin-2 enhancer': 'protein', 'CsA': 'None'}}
{'idx': 1798, 'sentence': 'In purified human peripheral blood T cells , nuclear STAT proteins were activated approximately 3 h after activation by cross-linked anti-CD3 Abs .', 'label': {'purified human peripheral blood T cells': 'cell_type', 'anti-CD3 Abs': 'protein', 'nuclear STAT proteins': 'protein', 'T cells': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains multiple protein names and a cell type, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains multiple protein names and a cell type, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains multiple protein names and a cell type, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains a protein name and a cell type, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains multiple protein names, a cell type, and a protein receptor, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains multiple protein names, a cell type, and signaling molecules, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains a cell type, proteins, and signaling molecules, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains a protein name and a cell type, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 9": 1},\n    {"Reason 9": "The sentence does not contain any named entities relevant to the entity labels in the target sentence."},\n    {"Example 10": 1},\n    {"Reason 10": "The sentence does not contain any named entities relevant to the entity labels in the target sentence."},\n    {"Example 11": 1},\n    {"Reason 11": "The sentence does not contain any named entities relevant to the entity labels in the target sentence."},\n    {"Example 12": 1},\n    {"Reason 12": "The sentence does not contain any named entities relevant to the entity labels in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains multiple protein names, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains multiple protein names and a cell type, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains multiple protein names and a cell type, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any named entities relevant to the entity labels in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any named entities relevant to the entity labels in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any named entities relevant to the entity labels in the target sentence."}\n]', 'response3': '[{"STAT proteins": "protein"}, {"T cells": "cell_type"}, {"anti-CD3 Abs": "protein"}]', 'prediction': {'STAT proteins': 'protein', 'T cells': 'cell_type', 'anti-CD3 Abs': 'protein'}}
{'idx': 175, 'sentence': 'To compare extra-renal 1,25(OH)2D3 production in different types of granulomatous disease , and to identify the cell types responsible, we have evaluated the conversion of 25(OH)D3 in 1,25(OH)2D3 by uncultured cells recovered by bronchoalveolar lavage and blood mononuclear cells from normocalcemic patients with sarcoidosis and tuberculosis.', 'label': {'blood mononuclear cells': 'cell_type', 'uncultured cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific examples of cell types that are directly mentioned, making it highly helpful for extracting named entities from the target sentence."}\n]', 'response3': '[{"bronchoalveolar lavage": "cell_line"}, {"blood mononuclear cells": "cell_type"}, {"sarcoidosis": "cell_type"}, {"tuberculosis": "cell_type"}]', 'prediction': {'bronchoalveolar lavage': 'cell_line', 'blood mononuclear cells': 'cell_type', 'sarcoidosis': 'cell_type', 'tuberculosis': 'cell_type'}}
{'idx': 1498, 'sentence': 'Steroid mediated lysis of lymphoblasts requires the DNA binding region of the steroid hormone receptor.', 'label': {'lymphoblasts': 'cell_type'}, 'response1': "['DNA', 'cell_type']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of proteins and their corresponding labels, which directly match the entity types in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides an example of a protein (NF-E2) that matches one of the entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains an example of a DNA-binding protein (AP-1) that matches one of the entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence includes multiple examples of proteins and their corresponding labels, which directly match the entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of proteins (IL-2, Aiolos, Ras) that match the entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence includes examples of proteins (IL-2 receptor alpha subunit, p21ras) and a cell type (B cell) that match the entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions lymphoid neoplasms, which corresponds to the cell type entity in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides an example of a protein (RXR) that matches one of the entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence includes examples of proteins (CD40, NF-kappa B) that match the entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions the protein G-CSF, which matches one of the entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of proteins (interleukin 10, IL-10R, STAT3, IL-6) that match the entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence includes examples of proteins (IL-2, c-Jun, c-Fos) that match the entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions the DNA-binding protein GATA-1, which matches one of the entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of RNA (IL-5 mRNA), a cell type (TCR), and proteins (IL-2R, dexamethasone) that match the entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence includes examples of proteins (CD70, IL-4, CD40) and cell types (B cell, plasma cells) that match the entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions the DNA-binding protein NF-kappa B, which matches one of the entity types in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entities that match the entity types in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entities that match the entity types in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entities that match the entity types in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entities that match the entity types in the target sentence."}\n]', 'response3': '[{"lymphoblasts": "cell_type"}, {"DNA": "DNA"}]', 'prediction': {'lymphoblasts': 'cell_type', 'DNA': 'DNA'}}
{'idx': 995, 'sentence': 'The hierarchy of transcriptional control in B-cell development has recently been analyzed by targeted gene inactivation in the mouse .', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"SP1": 5},\n    {"caspases": 5},\n    {"B-cell": 5},\n    {"Sp1": 5},\n    {"Ets": 5},\n    {"GATA-1": 5},\n    {"immunoglobulin kappa 3\' enhancer": 5},\n    {"SCM-1": 5},\n    {"IL-4": 5},\n    {"CD70": 5},\n    {"plasma cells": 5},\n    {"CD40": 5},\n    {"T cell": 5},\n    {"interleukin 2": 5},\n    {"PML/RARalpha": 5},\n    {"GATA-1": 5},\n    {"UAS1": 5},\n    {"NF-ATc": 5},\n    {"T lymphocytes": 5},\n    {"embryonic cardiac cells": 5},\n    {"A-myb": 5},\n    {"Egr-1": 5},\n    {"E2A": 5},\n    {"IkappaBbeta": 5},\n    {"NF-kappaB": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1671, 'sentence': 'Both phosphorylation and proliferation were inhibited by IL-6 neutralizing antibodies .', 'label': {'IL-6 neutralizing antibodies': 'protein', 'IL-6': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities that are relevant to the entity labels in the target sentence, such as \'IL-4\', \'LPS\', and \'AP-1\', which are all proteins."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains named entities like \'IL-4\', \'LPS\', and \'AP-1\', which are all proteins, relevant to the entity labels in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains a named entity \'P selectin\', which is a protein, relevant to the entity labels in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities that are relevant to the entity labels in the target sentence, such as \'IL-4\', \'LPS\', and \'AP-1\', which are all proteins."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities that are relevant to the entity labels in the target sentence, such as \'IL-2\', \'IL-2 receptor\', and \'CD28\', which are all proteins."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains a named entity \'NF-kappa B\', which is a protein, relevant to the entity labels in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities that are relevant to the entity labels in the target sentence, such as \'IFN A\', \'IFNA\', \'interleukin-2\', \'interleukin-2 receptor\', \'phytohemagglutinin\', and \'phorbol myristate acetate\', which are all proteins."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities that are relevant to the entity labels in the target sentence, such as \'IL-2\', \'Aiolos\', and \'Ras\', which are all proteins."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities that are relevant to the entity labels in the target sentence, such as \'IL4\', \'IL13\', \'STAT6\', \'STAT3\', \'STAT5\', and \'B cells\', which are all proteins or cell types."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains a named entity \'NF-E2\', which is a protein, relevant to the entity labels in the target sentence."},\n    {"Sentence": 3},\n    {"Reason": "The sentence contains a named entity \'DNA\', which is relevant to the entity labels in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities that are relevant to the entity labels in the target sentence, such as \'IL-2\', \'NF-kappa B\', and \'AP-1\', which are all proteins."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains named entities like \'NF-kappa B\' and \'AP-1\', which are proteins, relevant to the entity labels in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities that are relevant to the entity labels in the target sentence, such as \'interleukin-2\', \'CD25\', and \'IL-2 receptor\', which are all proteins."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains named entities like \'CTLA4Ig\', \'NFAT\', and \'AP-1\', which are proteins or cell types, relevant to the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities that are relevant to the entity labels in the target sentence."}\n]', 'response3': "[{'IL-6': 'protein'}]", 'prediction': {'IL-6': 'protein'}}
{'idx': 141, 'sentence': 'TNF-alpha was able to increase expression of the HIV LTR in T cells , but in monocytic cells , TNF-alpha did not induce the HIV LTR above a constitutive level of activity .', 'label': {'monocytic cells': 'cell_type', 'TNF-alpha': 'protein', 'HIV LTR': 'DNA', 'T cells': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5},\n    {"When the same MTHC lines are exposed to TNF-alpha in combination with IFN-gamma , the cells instead become DC.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Moreover, monocytes express a novel IL-10 -stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti- STAT3 Ab but is not observed in T cells.": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process.": 5},\n    {"Interestingly, CTLA4Ig did not significantly inhibit the activation of either NF of activated T cells ( NFAT ) or AP-1 reporters.": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"Together, these findings suggest that LITAF plays an important role in the activation of the human TNF-alpha gene and proposes a new mechanism to control TNF-alpha gene expression.": 5},\n    {"Remixing of purified T cells showed that naive T cells do not suppress LAI replication in memory T cells and that memory T cells do not restore LAI expression in naive T cells.": 5},\n    {"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.": 5},\n    {"These results demonstrate the existence of a triple autoregulatory loop in monocytes and macrophages involving HIV , p105 and p50 , and MAD3 , with the end result of persistent NF-kappa B activation and viral persistence.": 5},\n    {"We conclude, rather, that alpha 4 beta 1 in freshly isolated T cells delivers a distinct signal that synergizes early with signals initiated by TCR/CD3 ligation to induce DNA binding of multiple transcription factors required for cytokine gene induction.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"TNF-alpha": "protein"}, {"HIV LTR": "DNA"}, {"T cells": "cell_type"}, {"monocytic cells": "cell_type"}]', 'prediction': {'TNF-alpha': 'protein', 'HIV LTR': 'DNA', 'T cells': 'cell_type', 'monocytic cells': 'cell_type'}}
{'idx': 1557, 'sentence': "In this report, we show that following incubation of L540 cells ( Hodgkin's disease -derived, T cell-like, CD30 + cells ) with the agonistic anti- CD30 monoclonal antibodies ( mAb ) M44 and M67 , two nuclear factor (NF)-kappa B DNA binding activities were induced in nuclear extracts , as determined in gel retardation assays .", 'label': {"Hodgkin's disease -derived, T cell-like, CD30 + cells": 'cell_line', 'nuclear factor (NF)-kappa B': 'protein', 'M44': 'protein', 'L540 cells': 'cell_line', 'M67': 'protein', 'mAb': 'protein', 'agonistic anti- CD30 monoclonal antibodies': 'protein', 'CD30': 'protein'}, 'response1': "['cell_line', 'protein', 'DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of NF-kappa B DNA binding activity, which directly matches one of the entity labels in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions RelA and Rel homology family, which are related to the NF-kappa B complex, matching the entity label \'protein\' in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains multiple protein entities such as CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, and granulocyte-macrophage colony-stimulating factor, all of which are relevant to the entity labels in the target sentence."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence specifically mentions NF-kappa B binding activity, which aligns with the \'protein\' entity label in the target sentence."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence includes protein entities like CD40, IFN-gamma, tumor necrosis factor-alpha, and interleukin (IL)-1beta, which correspond to the entity labels in the target sentence."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence mentions IL-2 receptor alpha subunit, p21ras, and B cell activation, all of which are relevant to the entity labels in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides examples of IL-2, NF-kappa B, and AP-1 activation, which directly match the entity labels in the target sentence."},\n    {"Example 8": 4},\n    {"Reason 8": "The sentence mentions NF-kappa B activation, which aligns with the \'protein\' entity label in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains CD70, B cell, plasma cells, IL-4, and CD40 signaling, all of which are relevant to the entity labels in the target sentence."},\n    {"Example 10": 4},\n    {"Reason 10": "The sentence includes NF-kappaB, Tax, and ATL, which correspond to the entity labels in the target sentence."},\n    {"Example 11": 4},\n    {"Reason 11": "The sentence mentions IkappaBbeta and NF-kappaB, which align with the \'protein\' entity label in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides examples of IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, and phorbol myristate acetate, all of which are relevant to the entity labels in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence mentions CD40 and NF-kappa B activation, which directly match the entity labels in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence includes p50, p65 proteins, NF kappaB, and DNA-protein complexes, all of which are relevant to the entity labels in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides examples of CD40, Rel/nuclear factor kappaB, NF-kappaB, and B lymphocytes, all of which are relevant to the entity labels in the target sentence."},\n    {"Example 16": 4},\n    {"Reason 16": "The sentence mentions HIV-1, IFN, PKR, and IkappaBalpha, which correspond to the entity labels in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any relevant entity types mentioned in the target sentence."}\n]', 'response3': "[{'L540 cells': 'cell_line'}, {'NF-kappa B': 'protein'}, {'CD30': 'protein'}, {'NF': 'DNA'}, {'M44': 'protein'}, {'M67': 'protein'}]", 'prediction': {'L540 cells': 'cell_line', 'NF-kappa B': 'protein', 'CD30': 'protein', 'NF': 'DNA', 'M44': 'protein', 'M67': 'protein'}}
{'idx': 1090, 'sentence': 'Further analysis reveals that the inducible phosphorylation of I kappa B alpha maps to two serines in the N terminus of the protein (residues 32 and 36) and that the mutation of either residue is sufficient to abolish ligand-induced degradation, whereas both residues must be mutated to abolish inducible phosphorylation of the protein.', 'label': {'N terminus': 'protein', 'I kappa B alpha': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple protein names and their corresponding labels, making it very helpful for extracting named entities from the target sentence."}\n]', 'response3': '[{"I kappa B alpha": "protein"}]', 'prediction': {'I kappa B alpha': 'protein'}}
{'idx': 1568, 'sentence': 'The inverse relation between high density lipoprotein ( HDL ) and atherosclerotic events may in part be due to enzymes associated with HDL that destroy the biologically active lipids generated in LDL .', 'label': {'enzymes': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 3},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"HDL": "protein"}, {"LDL": "protein"}]', 'prediction': {'HDL': 'protein', 'LDL': 'protein'}}
{'idx': 257, 'sentence': 'Because of the presence of a functional receptor-effector system for VD3 and multiple biological responses to the hormone, these cells provide a unique model system with which to probe the specific effects of VD3 on cell growth and differentiation in chronic myelogenous leukemia .', 'label': {}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells": 3},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures": 5},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors": 4},\n    {"An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage": 4},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained": 5},\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia": 5},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction": 5},\n    {"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function": 5},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells": 5},\n    {"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R )": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity": 1}\n]', 'response3': "[{'VD3': 'protein'}, {'chronic myelogenous leukemia': 'cell_line'}]", 'prediction': {'VD3': 'protein', 'chronic myelogenous leukemia': 'cell_line'}}
{'idx': 262, 'sentence': 'This complementary DNA encoded a protein with structural similarities to the c-jun proto-oncogene product , and its target sequence was closely related to the palindromic target sequence of c-jun .', 'label': {'complementary DNA': 'DNA', 'c-jun proto-oncogene product': 'protein', 'palindromic target sequence': 'DNA', 'c-jun': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 5},\n{"Here we examined the regulatory mechanism of the SCM-1 genes.": 1},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"These two related genes share the evolutionarily conserved region encoding the Runt domain.": 5},\n{"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n{"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.": 5},\n{"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n{"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 5},\n{"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n{"This protein has now been purified and its encoding gene cloned.": 5},\n{"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 5},\n{"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 5},\n{"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 5},\n{"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n{"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"complementary DNA": "DNA"}, {"protein": "protein"}, {"c-jun": "protein"}]', 'prediction': {'complementary DNA': 'DNA', 'protein': 'protein', 'c-jun': 'protein'}}
{'idx': 1351, 'sentence': 'Western blotting yielded a set of bands ranging from 25 kD to 55 kD, resulting from extensive alternative splicing .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"25 kD": "protein"}, {"55 kD": "protein"}]', 'prediction': {'25 kD': 'protein', '55 kD': 'protein'}}
{'idx': 973, 'sentence': 'To assess the transcription regulatory function of MZF-1 , the full-length MZF-1 coding region was fused to the DNA binding domain of the yeast transactivator GAL4 .', 'label': {'MZF-1': 'DNA', 'DNA binding domain': 'protein', 'yeast transactivator GAL4': 'protein', 'GAL4': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a cell line (SCM-1) in the context of examining regulatory mechanisms of genes."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions a protein (p50p50) in the context of binding efficiency and mutation effects."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence discusses transgenic mice expressing PML/RARalpha, indicating a protein role in myelopoiesis."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides multiple examples of proteins (EKLF, CBP, p300, P/CAF) and their interactions as acetylated transcription factors."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence clearly mentions a protein (GATA-1) as a positive regulator of lineage-specific transcription factor in erythroid cells."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence explicitly states the transactivation role of TCF-1, indicating its protein function."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence discusses chimeras transactivating promoters, with ZEBRA mentioned as a protein involved."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence highlights the specific role of the protein A-myb in transcription factor expression."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence mentions protein and genomic sequences similarity, suggesting a role for the G0S24 protein in transcription."},\n    {"Example 10": 4},\n    {"Reason 10": "The sentence refers to a luciferase reporter construct containing elements of the CD95 ligand promoter, indicating a protein role."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides examples of proteins (Tax, TFIIA) interacting in the yeast two-hybrid system."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence mentions Egr-1 as a zinc finger transcription factor, indicating its protein function."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence discusses nuclear factors binding to the IL-2 promoter, containing c-Jun and c-Fos proteins."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence highlights the role of the DNA-binding protein GATA-1 in erythroid development and gene regulation."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence mentions the expression of the mouse E2A gene at the protein level using polyclonal antisera."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence discusses the critical role of Sp1 and Ets-related transcription factors in maintaining gene expression."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not provide any specific examples of named entities related to the entity labels in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not provide any specific examples of named entities related to the entity labels in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not provide any specific examples of named entities related to the entity labels in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not provide any specific examples of named entities related to the entity labels in the target sentence."}\n]', 'response3': '[{"MZF-1": "protein"}, {"DNA": "DNA"}, {"GAL4": "protein"}]', 'prediction': {'MZF-1': 'protein', 'DNA': 'DNA', 'GAL4': 'protein'}}
{'idx': 1125, 'sentence': 'This indicates that the CR of GR may be of functional significance.', 'label': {'GR': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The example provides a clear entity label (DNA) for the named entity \'immunoglobulin kappa 3\' enhancer\' in the sentence, aiding in the extraction process."},\n\n{"Example 2": 4},\n{"Reason 2": "The example provides entity labels for \'MNDA\' (protein) and \'Philadelphia chromosome-positive chronic myeloid leukemia\' (cell_line), which are relevant entities in the sentence, aiding in the extraction process."},\n\n{"Example 3": 4},\n{"Reason 3": "The example provides entity labels for \'IL-7R\' (protein) and \'gamma(c)\' (protein), which are relevant entities in the sentence, aiding in the extraction process."},\n\n{"Example 4": 5},\n{"Reason 4": "The example provides clear entity labels for \'granulocytes\' (cell_type) and \'T cells\' (cell_type), which are directly mentioned in the sentence, aiding in the extraction process."},\n\n{"Example 5": 5},\n{"Reason 5": "The example provides a clear entity label (protein) for the named entity \'Protein\' in the sentence, aiding in the extraction process."},\n\n{"Example 6": 4},\n{"Reason 6": "The example provides an entity label for \'GM-CSF\' (protein), which is a relevant entity in the sentence, aiding in the extraction process."},\n\n{"Example 7": 4},\n{"Reason 7": "The example provides an entity label for \'G-CSF\' (protein), which is a relevant entity in the sentence, aiding in the extraction process."},\n\n{"Example 8": 5},\n{"Reason 8": "The example provides a clear entity label (cell_line) for the named entity \'SIVsmmPBj14\' in the sentence, aiding in the extraction process."},\n\n{"Example 9": 4},\n{"Reason 9": "The example provides entity labels for \'IL-2\' (protein), \'c-Jun\' (protein), and \'c-Fos\' (protein), which are relevant entities in the sentence, aiding in the extraction process."},\n\n{"Example 10": 5},\n{"Reason 10": "The example provides clear entity labels for \'CREB\' (protein) and \'AR-CRE\' (protein), which are directly mentioned in the sentence, aiding in the extraction process."},\n\n{"Example 11": 5},\n{"Reason 11": "The example provides clear entity labels for \'CHEMR1\' (protein), \'C-C chemokine\' (protein), and \'MIP-1alpha\' (protein), which are directly mentioned in the sentence, aiding in the extraction process."},\n\n{"Example 12": 5},\n{"Reason 12": "The example provides a clear entity label (cell_type) for the named entity \'lymphoid neoplasms\' in the sentence, aiding in the extraction process."},\n\n{"Example 13": 5},\n{"Reason 13": "The example provides a clear entity label (cell_line) for the named entity \'SCM-1\' in the sentence, aiding in the extraction process."},\n\n{"Example 14": 5},\n{"Reason 14": "The example provides a clear entity label (RNA) for the named entity \'SCL\' in the sentence, aiding in the extraction process."},\n\n{"Example 15": 5},\n{"Reason 15": "The example provides a clear entity label (protein) for the named entity \'RXR\' in the sentence, aiding in the extraction process."},\n\n{"Example 16": 5},\n{"Reason 16": "The example provides entity labels for \'VDR\' (protein), \'RXR\' (protein), \'GRIP-1\' (protein), and \'DRIP205\' (protein), which are relevant entities in the sentence, aiding in the extraction process."},\n\n{"Example 17": 1},\n{"Reason 17": "The example does not provide any relevant entity labels for the entities mentioned in the sentence, making it less helpful in the extraction process."},\n\n{"Example 18": 1},\n{"Reason 18": "The example does not provide any relevant entity labels for the entities mentioned in the sentence, making it less helpful in the extraction process."},\n\n{"Example 19": 1},\n{"Reason 19": "The example does not provide any relevant entity labels for the entities mentioned in the sentence, making it less helpful in the extraction process."},\n\n{"Example 20": 1},\n{"Reason 20": "The example does not provide any relevant entity labels for the entities mentioned in the sentence, making it less helpful in the extraction process."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 338, 'sentence': 'Nuclear T3R in lymphocytes was determined by radio-ligand binding analysis .', 'label': {'T3R': 'protein', 'lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1080, 'sentence': 'However, the concurrent addition of iron (in the form of ferrous or ferric chloride and other iron salts ) reversed the inhibition of proliferation caused by tepoxalin .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities with clear entity labels that match the entity types in the target sentence."}\n]', 'response3': '[{"iron": "protein"}, {"ferrous": "protein"}, {"ferric chloride": "protein"}, {"iron salts": "protein"}, {"tepoxalin": "protein"}]', 'prediction': {'iron': 'protein', 'ferrous': 'protein', 'ferric chloride': 'protein', 'iron salts': 'protein', 'tepoxalin': 'protein'}}
{'idx': 1786, 'sentence': 'Binding of plasma Factor VII/VIIa to the tissue factor (TF) receptor initiates the coagulation protease cascades .', 'label': {'coagulation protease': 'protein', 'tissue factor (TF) receptor': 'protein', 'plasma Factor VII/VIIa': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 1},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"Factor VII/VIIa": "protein"}, {"tissue factor (TF) receptor": "protein"}]', 'prediction': {'Factor VII/VIIa': 'protein', 'tissue factor (TF) receptor': 'protein'}}
{'idx': 1242, 'sentence': 'LPS signaling was found to involve NF kappa B activation by the p50/p65 heterodimers .', 'label': {'NF kappa B': 'protein', 'p50/p65 heterodimers': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": "Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .", "helpfulness score": 5, "reasons": "The sentence contains specific protein names (NF-kappaB, Sp1, p50) that match the entity labels in the target sentence."},\n    {"Sentence": "Control of NF-kappa B activity by the I kappa B beta inhibitor .", "helpfulness score": 5, "reasons": "The sentence contains specific protein names (NF-kappa B, I kappa B beta) that match the entity labels in the target sentence."},\n    {"Sentence": "The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.", "helpfulness score": 5, "reasons": "The sentence contains specific protein names (RelA, NF-kappa B) that match the entity labels in the target sentence."},\n    {"Sentence": "Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .", "helpfulness score": 4, "reasons": "The sentence contains NF-kappa B, which is a protein entity label in the target sentence."},\n    {"Sentence": "These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .", "helpfulness score": 5, "reasons": "The sentence contains specific protein names (PAFR, PAF, NF-kappa B, protein kinase C) that match the entity labels in the target sentence."},\n    {"Sentence": "Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .", "helpfulness score": 5, "reasons": "The sentence contains specific protein names (CD40, NF-kappa B) that match the entity labels in the target sentence."},\n    {"Sentence": "During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .", "helpfulness score": 5, "reasons": "The sentence contains specific protein names (IkappaBalpha, NF-kappaB) that match the entity labels in the target sentence."},\n    {"Sentence": "Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .", "helpfulness score": 5, "reasons": "The sentence contains specific protein names (IkappaBbeta, NF-kappaB) that match the entity labels in the target sentence."},\n    {"Sentence": "Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .", "helpfulness score": 5, "reasons": "The sentence contains specific protein names (NF-kappaB, Tax) that match the entity labels in the target sentence."},\n    {"Sentence": "Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .", "helpfulness score": 5, "reasons": "The sentence contains specific protein names (NF-kappa B, I kappa B alpha) that match the entity labels in the target sentence."},\n    {"Sentence": "Recently, activation of NF-kappa B has been linked to ARDS and has been shown to be a critical proximal step in the initiation of neutrophilic inflammation in animal models .", "helpfulness score": 5, "reasons": "The sentence contains specific protein names (NF-kappa B, ARDS) that match the entity labels in the target sentence."},\n    {"Sentence": "These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .", "helpfulness score": 5, "reasons": "The sentence contains specific protein names (NF-kappa B) that match the entity labels in the target sentence."},\n    {"Sentence": "Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.", "helpfulness score": 5, "reasons": "The sentence contains specific protein names (NF-kappa B, I kappa B alpha) that match the entity labels in the target sentence."},\n    {"Sentence": "Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .", "helpfulness score": 5, "reasons": "The sentence contains specific protein names (NF-kappa B) that match the entity labels in the target sentence."},\n    {"Sentence": "Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.", "helpfulness score": 5, "reasons": "The sentence contains specific protein names (IL-4, LPS, AP-1) that match the entity labels in the target sentence."},\n    {"Sentence": "We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .", "helpfulness score": 5, "reasons": "The sentence contains specific protein names (NF-kappa B) that match the entity labels in the target sentence."},\n    {"Sentence": "We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .", "helpfulness score": 1, "reasons": "The sentence does not contain any entity labels matching the target sentence."},\n    {"Sentence": "However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.", "helpfulness score": 1, "reasons": "The sentence does not contain any entity labels matching the target sentence."},\n    {"Sentence": "In 2 complex translocations, none of the three genes was rearranged.", "helpfulness score": 1, "reasons": "The sentence does not contain any entity labels matching the target sentence."},\n    {"Sentence": "Deletions or mutations in this element also reduced the serum response by 80-90%.", "helpfulness score": 1, "reasons": "The sentence does not contain any entity labels matching the target sentence."},\n    {"Sentence": "In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .", "helpfulness score": 1, "reasons": "The sentence does not contain any entity labels matching the target sentence."}\n]', 'response3': '[{"NF kappa B": "protein"}, {"p50": "protein"}, {"p65": "protein"}]', 'prediction': {'NF kappa B': 'protein', 'p50': 'protein', 'p65': 'protein'}}
{'idx': 866, 'sentence': 'T cell activation results in high levels of HIV replication and is thought to be one mechanism leading to the conversion from latent to active viral infection .', 'label': {'T cell': 'cell_type'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein and cell type names that are directly mentioned."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains specific protein and cell type names that are directly mentioned."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains specific protein and DNA names that are directly mentioned."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains specific protein names that are directly mentioned."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains specific protein and cell type names that are directly mentioned."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains specific protein and DNA names that are directly mentioned."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains specific protein names that are directly mentioned."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains specific protein and cell type names that are directly mentioned."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains specific protein and cell type names that are directly mentioned."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains specific DNA and protein names that are directly mentioned."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains specific protein and cell type names that are directly mentioned."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains specific cell type and DNA names that are directly mentioned."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains specific cell type and protein names that are directly mentioned."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains specific protein names that are directly mentioned."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains specific protein names that are directly mentioned."}\n]', 'response3': "[{'T cell': 'cell_type'}, {'HIV': 'cell_type'}]", 'prediction': {'T cell': 'cell_type', 'HIV': 'cell_type'}}
{'idx': 433, 'sentence': 'Competition experiments did not reveal any high-affinity binding site for BSAP in known regulatory regions of immunoglobulin and class II major histocompatibility (MHC) genes , suggesting that BSAP is a regulator of a different set of B-lymphoid-specific genes .', 'label': {'regulatory regions': 'DNA', 'BSAP': 'protein', 'high-affinity binding site': 'DNA', 'B-lymphoid-specific genes': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 5},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"BSAP": "protein"}, {"immunoglobulin": "protein"}, {"class II major histocompatibility (MHC) genes": "DNA"}, {"B-lymphoid-specific genes": "cell_type"}]', 'prediction': {'BSAP': 'protein', 'immunoglobulin': 'protein', 'class II major histocompatibility (MHC) genes': 'DNA', 'B-lymphoid-specific genes': 'cell_type'}}
{'idx': 1546, 'sentence': 'Identification of essential GATA and Ets binding motifs within the promoter of the platelet glycoprotein Ib alpha gene .', 'label': {'platelet glycoprotein Ib alpha gene': 'DNA', 'GATA': 'DNA', 'Ets binding motifs': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"GATA": "protein"}, {"Ets": "protein"}]', 'prediction': {'GATA': 'protein', 'Ets': 'protein'}}
{'idx': 1412, 'sentence': 'We found that these parameters were indistinguishable for one of the PRL- and IL-2- induced factors .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a specific entity with its corresponding label, which directly aids in understanding the entity types present in the sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The example provides multiple specific entities with their corresponding labels, directly aiding in understanding the entity types present in the sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The example provides multiple specific entities with their corresponding labels, directly aiding in understanding the entity types present in the sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The example provides multiple specific entities with their corresponding labels, directly aiding in understanding the entity types present in the sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides multiple specific entities with their corresponding labels, directly aiding in understanding the entity types present in the sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The example provides multiple specific entities with their corresponding labels, directly aiding in understanding the entity types present in the sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The example provides multiple specific entities with their corresponding labels, directly aiding in understanding the entity types present in the sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides a specific entity with its corresponding label, which directly aids in understanding the entity types present in the sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides multiple specific entities with their corresponding labels, directly aiding in understanding the entity types present in the sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides multiple specific entities with their corresponding labels, directly aiding in understanding the entity types present in the sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The example provides a specific entity with its corresponding label, which directly aids in understanding the entity types present in the sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The example provides multiple specific entities with their corresponding labels, directly aiding in understanding the entity types present in the sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides multiple specific entities with their corresponding labels, directly aiding in understanding the entity types present in the sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The example provides a specific entity with its corresponding label, which directly aids in understanding the entity types present in the sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The example provides multiple specific entities with their corresponding labels, directly aiding in understanding the entity types present in the sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain any specific entities with corresponding labels, hence not helpful in understanding the entity types present in the sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain any specific entities with corresponding labels, hence not helpful in understanding the entity types present in the sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any specific entities with corresponding labels, hence not helpful in understanding the entity types present in the sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The example does not contain any specific entities with corresponding labels, hence not helpful in understanding the entity types present in the sentence."}\n]', 'response3': "[{'PRL-': 'protein'}, {'IL-2-': 'protein'}]", 'prediction': {'PRL-': 'protein', 'IL-2-': 'protein'}}
{'idx': 411, 'sentence': 'There was a significant positive correlation between VDR concentration and serum phosphate (P less than 0.05).', 'label': {'VDR': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 3},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 3},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 4},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 4},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 3},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 3},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti-EBV antibody titres (P > 0.05).": 4},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 3},\n    {"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.": 5},\n    {"Both haemin and delta-ALA caused a de novo increase in alpha-globin expression as well as enhancing Epo-induced beta-globin expression, leading to a marked increase in haemoglobin production.": 5},\n    {"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 4},\n    {"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.": 5},\n    {"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.": 4},\n    {"The affinity of the BAT box binding proteins for the BAT box was approximately 25-fold less than for the octamer sequence and the BAT box binding proteins dissociated from the BAT box 10-fold more rapidly than from the octamer sequence.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"VDR": "protein"}, {"serum phosphate": "protein"}]', 'prediction': {'VDR': 'protein', 'serum phosphate': 'protein'}}
{'idx': 1460, 'sentence': 'In contrast, in a number of multiple myeloma cell lines , representing differentiated, plasma cell-like B cells , PU.1 DNA binding activity , mRNA expression , and Pu box -dependent transactivation were absent or detectable at a very low level.', 'label': {'multiple myeloma cell lines': 'cell_line', 'PU.1': 'protein', 'Pu box': 'DNA', 'differentiated, plasma cell-like B cells': 'cell_type'}, 'response1': "['cell_line', 'DNA', 'RNA', 'protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities relevant to the entity labels in the target sentence, such as IL-2 receptor alpha subunit, p21ras, and B cell."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of named entities like myeloperoxidase, lysozyme, and PU.1, which are relevant to the entity labels in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions RelA and NF-kappa B, which are relevant to the entity labels in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence includes examples of named entities like UAS3, UAS2, and YY1, which are relevant to the entity labels in the target sentence."},\n    {"Sentence": 3},\n    {"Reason": "The sentence mentions PML/RARalpha, which is relevant to the entity labels in the target sentence."},\n    {"Sentence": 3},\n    {"Reason": "The sentence provides an example of the named entity WT1, which is relevant to the entity labels in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities relevant to the entity labels in the target sentence, such as CD70, B cell, plasma cells, IL-4, and CD40."},\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions IL-2, c-Jun, and c-Fos, which are relevant to the entity labels in the target sentence."},\n    {"Sentence": 3},\n    {"Reason": "The sentence provides an example of the named entity AP-1, which is relevant to the entity labels in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence includes examples of named entities like IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, and phorbol myristate acetate, which are relevant to the entity labels in the target sentence."},\n    {"Sentence": 3},\n    {"Reason": "The sentence mentions GATA-1, which is relevant to the entity labels in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of named entities like AP-1, PMA, monocytes, and macrophages, which are relevant to the entity labels in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of named entities like EBNA-2 and PU.1, which are relevant to the entity labels in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions Sp1 and CD14, which are relevant to the entity labels in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence includes examples of named entities like MNDA and Philadelphia chromosome-positive chronic myeloid leukemia, which are relevant to the entity labels in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions UAS1 and B cell, which are relevant to the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels in the target sentence."}\n]', 'response3': '[{"PU.1": "protein"}, {"mRNA": "RNA"}]', 'prediction': {'PU.1': 'protein', 'mRNA': 'RNA'}}
{'idx': 638, 'sentence': 'Thus the VLA-5 fibronectin receptor on CD4 cells can play a complementary role in CD3 - TCR -mediated signal transduction through its interaction with fibronectin .', 'label': {'CD3': 'protein', 'TCR': 'protein', 'VLA-5 fibronectin receptor': 'protein', 'fibronectin': 'protein', 'CD4 cells': 'cell_line'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence provides examples of specific proteins that match the entity types in the target sentence, although the relevance is slightly lower compared to Example 1."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence mentions specific proteins and a cell type that directly correspond to the entity types in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains specific protein names and a cell type that match the entity types in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides examples of specific proteins that match the entity types in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence mentions specific proteins and a cell type that directly correspond to the entity types in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains specific protein names and a cell type that match the entity types in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides examples of specific proteins that match the entity types in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence mentions specific proteins that directly correspond to the entity types in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains specific protein names that match the entity types in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides examples of specific proteins that match the entity types in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence mentions specific proteins that directly correspond to the entity types in the target sentence."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not contain any specific examples of entities that match the entity types in the target sentence."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not contain any specific examples of entities that match the entity types in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any specific examples of entities that match the entity types in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any specific examples of entities that match the entity types in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific examples of entities that match the entity types in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1375, 'sentence': 'We have analyzed the expression of TCL1 mRNA and protein in peripheral blood lymphocytes ( PBLs ) from four AT cases and from healthy controls .', 'label': {'PBLs': 'cell_type', 'peripheral blood lymphocytes': 'cell_type', 'TCL1 mRNA': 'RNA', 'protein': 'protein'}, 'response1': "['RNA', 'protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence directly mentions the entity and its corresponding label."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence directly mentions the entities and their corresponding labels."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence directly mentions the entity and its corresponding label."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence directly mentions the entity and its corresponding label."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence directly mentions the entities and their corresponding labels."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence directly mentions the entities and their corresponding labels."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence directly mentions the entities and their corresponding labels."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence directly mentions the entity and its corresponding label."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence directly mentions the entities and their corresponding labels."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence directly mentions the entities and their corresponding labels."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence directly mentions the entities and their corresponding labels."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence directly mentions the entities and their corresponding labels."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence directly mentions the entities and their corresponding labels."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence directly mentions the entities and their corresponding labels."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not mention any specific entities or their labels."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not mention any specific entities or their labels."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not mention any specific entities or their labels."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not mention any specific entities or their labels."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not mention any specific entities or their labels."}\n]', 'response3': '[{"TCL1 mRNA": "RNA"}, {"protein": "protein"}, {"PBLs": "cell_type"}, {"AT": "cell_type"}]', 'prediction': {'TCL1 mRNA': 'RNA', 'protein': 'protein', 'PBLs': 'cell_type', 'AT': 'cell_type'}}
{'idx': 764, 'sentence': 'The increased sensitivity of CEM-C7 cells and its subclones to dexamethasone in serum-free medium returned to previous levels when these cells were recultured in serum-containing medium .', 'label': {'CEM-C7': 'cell_line', 'CEM-C7 cells': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .": 4},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 4},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .": 4},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release .": 5},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 4},\n    {"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .": 4},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .": 4},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice .": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 897, 'sentence': 'The system is based on the use of an oligomerized NFAT-1 binding motif that directs transcription of SV40 T-antigen in transgenic mice .', 'label': {'transcription of SV40 T-antigen': 'protein', 'NFAT-1': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with their corresponding entity labels, providing a clear and direct mapping."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides a clear example of a named entity with its corresponding entity label, aiding in understanding the relationship between the entity and its label."},\n    {"Sentence": 4},\n    {"Reason": "The sentence directly mentions a named entity with its corresponding entity label, facilitating the extraction process."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of named entities with their corresponding entity labels, aiding in understanding the entities mentioned."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides clear examples of named entities with their corresponding entity labels, aiding in understanding the entities mentioned."},\n    {"Sentence": 4},\n    {"Reason": "The sentence directly mentions a named entity with its corresponding entity label, facilitating the extraction process."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides a clear example of a named entity with its corresponding entity label, aiding in understanding the relationship between the entity and its label."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with their corresponding entity labels, providing a clear and direct mapping."},\n    {"Sentence": 4},\n    {"Reason": "The sentence directly mentions a named entity with its corresponding entity label, facilitating the extraction process."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides a clear example of a named entity with its corresponding entity label, aiding in understanding the relationship between the entity and its label."},\n    {"Sentence": 4},\n    {"Reason": "The sentence directly mentions a named entity with its corresponding entity label, facilitating the extraction process."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides a clear example of a named entity with its corresponding entity label, aiding in understanding the relationship between the entity and its label."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity labels in the target sentence."}\n]', 'response3': '[{"NFAT-1": "protein"}, {"SV40 T-antigen": "protein"}]', 'prediction': {'NFAT-1': 'protein', 'SV40 T-antigen': 'protein'}}
{'idx': 1842, 'sentence': 'Individually or collectively, none of the three enhancer-binding proteins ( LEF-1 , Ets-1 , and TFE-3 ) could activate transcription in the absence of Sp1 .', 'label': {'Ets-1': 'protein', 'TFE-3': 'protein', 'LEF-1': 'protein', 'enhancer-binding proteins': 'protein', 'Sp1': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of proteins that are relevant to the entity labels in the target sentence, such as Sp1, NF-kappaB, p50, PU.1, M-CSF receptor, Egr-1, EKLF, AP-1, EBNA2, TP1, NF-E2, CD14, NF-ATc."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of proteins like GATA-1, Jun, ATF-2, A-myb that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 3},\n    {"Reason": "The sentence mentions T cell and interleukin 2, which are relevant to the entity labels in the target sentence."},\n    {"Sentence": 2},\n    {"Reason": "The sentence includes examples of proteins like SP1, Ets, and NF-E2 that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence contains examples of proteins like AP-1, OCT-1, NF-IL-2B that are relevant to the entity labels in the target sentence."}\n]', 'response3': '[{"LEF-1": "protein"}, {"Ets-1": "protein"}, {"TFE-3": "protein"}, {"Sp1": "protein"}]', 'prediction': {'LEF-1': 'protein', 'Ets-1': 'protein', 'TFE-3': 'protein', 'Sp1': 'protein'}}
{'idx': 1059, 'sentence': 'Transcription factors belonging to the NF-kappa B family are controlled by inhibitory I kappa B proteins , mainly I kappa B alpha and I kappa B beta .', 'label': {'NF-kappa B family': 'protein', 'Transcription factors': 'protein', 'I kappa B beta': 'protein', 'inhibitory I kappa B proteins': 'protein', 'I kappa B alpha': 'protein', 'NF-kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence 1": 5},\n    {"Sentence 2": 5},\n    {"Sentence 3": 5},\n    {"Sentence 4": 5},\n    {"Sentence 5": 5},\n    {"Sentence 6": 5},\n    {"Sentence 7": 5},\n    {"Sentence 8": 5},\n    {"Sentence 9": 1},\n    {"Sentence 10": 1},\n    {"Sentence 11": 1},\n    {"Sentence 12": 1},\n    {"Sentence 13": 1},\n    {"Sentence 14": 5},\n    {"Sentence 15": 5},\n    {"Sentence 16": 1},\n    {"Sentence 17": 1},\n    {"Sentence 18": 1},\n    {"Sentence 19": 1},\n    {"Sentence 20": 1}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"I kappa B": "protein"}, {"I kappa B alpha": "protein"}, {"I kappa B beta": "protein"}]', 'prediction': {'NF-kappa B': 'protein', 'I kappa B': 'protein', 'I kappa B alpha': 'protein', 'I kappa B beta': 'protein'}}
{'idx': 924, 'sentence': 'We conclude that p56 exists in cytosol in a higher order complex containing hsp70 and hsp90 , both of which in turn have been found to be associated with untransformed steroid receptors .', 'label': {'hsp70': 'protein', 'untransformed steroid receptors': 'protein', 'hsp90': 'protein', 'p56': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Sentence": 1},\n    {"Sentence": 1},\n    {"Sentence": 1},\n    {"Sentence": 1},\n    {"Sentence": 5},\n    {"Sentence": 1},\n    {"Sentence": 5},\n    {"Sentence": 1},\n    {"Sentence": 1},\n    {"Sentence": 5},\n    {"Sentence": 1},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 5},\n    {"Sentence": 1},\n    {"Sentence": 1},\n    {"Sentence": 1},\n    {"Sentence": 1}\n]', 'response3': '[{"p56": "protein"}, {"hsp70": "protein"}, {"hsp90": "protein"}, {"steroid receptors": "protein"}]', 'prediction': {'p56': 'protein', 'hsp70': 'protein', 'hsp90': 'protein', 'steroid receptors': 'protein'}}
{'idx': 247, 'sentence': 'Antigen B27 seems to be a cause of lower levels of glucocorticoid receptors in blood lymphocytes .', 'label': {'Antigen B27': 'protein', 'glucocorticoid receptors': 'protein', 'blood lymphocytes': 'cell_type', 'lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.": 4},\n    {"Benzene toxicity towards lymphocytes is thought to be mediated by metabolites of benzene including benzoquinone ( BQ ).": 4},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.": 5},\n    {"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes.": 4},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 4},\n    {"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.": 5},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.": 5},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms.": 4},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 4},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"Antigen B27": "protein"}, {"glucocorticoid receptors": "protein"}, {"blood lymphocytes": "cell_type"}]', 'prediction': {'Antigen B27': 'protein', 'glucocorticoid receptors': 'protein', 'blood lymphocytes': 'cell_type'}}
{'idx': 507, 'sentence': 'Thus, the transcriptional activity of TCF-1 alpha appears to depend on the TCF-2 alpha and T alpha 1 ( CREB ) transcription factors and the context of its binding site within the TCR alpha enhancer .', 'label': {'TCF-2 alpha': 'protein', 'TCR alpha enhancer': 'DNA', 'CREB': 'protein', 'transcription factors': 'protein', 'T alpha 1': 'protein', 'TCR': 'protein', 'TCF-1 alpha': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains the entity \'GATA-1\' which is a protein, matching one of the entity types in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains the entities \'Jun\' and \'ATF-2\' which are both proteins, matching one of the entity types in the target sentence."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence contains the entity \'NF-ATc\' which is a protein and \'T lymphocytes\' which is a cell type, both matching entity types in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains the entities \'Sp1\' and \'Ets\' which are both proteins, matching one of the entity types in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains the entities \'CREB\' and \'AR-CRE\' which are both proteins, matching one of the entity types in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains the entities \'EKLF\', \'CBP\', \'p300\', and \'P/CAF\' which are all proteins, matching one of the entity types in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains the entities \'Sp1\' and \'CD14\' which are both proteins, matching one of the entity types in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains the entities \'Tax\' and \'TFIIA\' which are both proteins, matching one of the entity types in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains the entity \'A-myb\' which is a protein, matching one of the entity types in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains the entity \'NF-ATc\' which is a protein, and mentions \'T lymphocytes\' and \'embryonic cardiac cells\' which are cell types, all matching entity types in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains the entities \'IL-2\', \'c-Jun\', and \'c-Fos\' which are all proteins, matching one of the entity types in the target sentence."},\n    {"Example 12": 4},\n    {"Reason 12": "The sentence contains the entity \'AP-1\' which is related to DNA, matching one of the entity types in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains the entity \'TCF-1\' which is a protein, matching one of the entity types in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains the entities \'CD40\', \'Rel/nuclear factor kappaB\', \'NF-kappaB\', and \'B lymphocytes\' which are all proteins or cell types, matching entity types in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains the entities \'ZEB\', \'c-Myb\', and \'Ets\' which are all proteins, and \'hematopoietic cells\' which is a cell type, matching entity types in the target sentence."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence contains the entities \'IL-2\', \'NFAT\', \'NFAT delta418\', \'calcineurin\', and \'Tpl-2\' which are all proteins or DNA, matching entity types in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities matching the entity types in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities matching the entity types in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities matching the entity types in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities matching the entity types in the target sentence."}\n]', 'response3': '[{"TCF-1 alpha": "protein"}, {"TCF-2 alpha": "protein"}, {"T alpha 1": "protein"}, {"CREB": "protein"}, {"TCR alpha enhancer": "DNA"}]', 'prediction': {'TCF-1 alpha': 'protein', 'TCF-2 alpha': 'protein', 'T alpha 1': 'protein', 'CREB': 'protein', 'TCR alpha enhancer': 'DNA'}}
{'idx': 460, 'sentence': "To characterize these regulatory elements further, mutations in these regions were inserted into both the 5' and 3' HIV LTRs and infectious proviral constructs were assembled.", 'label': {'HIV LTRs': 'DNA', 'regulatory elements': 'DNA'}, 'response1': "['DNA', 'RNA']", 'response2': '[\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 5},\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 5},\n    {"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 5},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes.": 5},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 5},\n    {"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements.": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 131, 'sentence': 'Truncation of TR alpha 1 at amino acid 210 prevented additional complex formation in the presence of NE without affecting DNA binding , suggesting that the carboxyl-terminus of the TRs is essential for interaction with nuclear proteins .', 'label': {'TRs': 'protein', 'carboxyl-terminus': 'protein', 'TR alpha 1': 'protein', 'nuclear proteins': 'protein', 'amino acid 210': 'protein'}, 'response1': "['protein', 'DNA']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains specific protein names that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions a specific protein relevant to the entity labels in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains specific protein names that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions a specific protein relevant to the entity labels in the target sentence."},\n    {"Sentence": 3},\n    {"Reason": "The sentence mentions a general protein interaction without specific protein names."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains specific protein names that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains specific protein names that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 3},\n    {"Reason": "The sentence mentions a specific DNA binding activity without specific protein names."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains specific protein names that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains specific protein names that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 3},\n    {"Reason": "The sentence mentions specific cell lines and DNA elements, but not specific protein names."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not mention any specific entities relevant to the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not mention any specific entities relevant to the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not mention any specific entities relevant to the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not mention any specific entities relevant to the target sentence."}\n]', 'response3': '[{"TR alpha 1": "protein"}, {"NE": "protein"}, {"DNA": "DNA"}]', 'prediction': {'TR alpha 1': 'protein', 'NE': 'protein', 'DNA': 'DNA'}}
{'idx': 692, 'sentence': 'The human T-cell leukemia virus type I ( HTLV-I ) promoter contains three copies of imperfect repeats of a 21-base pair sequence designated here as TRE ( Tax -response element ) that is responsive to the virally encoded transactivator protein Tax .', 'label': {'virally encoded transactivator protein': 'protein', 'Tax -response element': 'DNA', 'TRE': 'DNA', 'human T-cell leukemia virus type I ( HTLV-I ) promoter': 'DNA', 'Tax': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 5},\n{"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.": 5},\n{"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .": 4},\n{"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .": 5},\n{"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .": 5},\n{"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n{"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .": 5},\n{"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n{"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 5},\n{"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .": 4},\n{"Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB- induced trans-activation of the H4 promoter .": 5},\n{"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .": 5},\n{"Expression of tal-1 and GATA-binding proteins during human hematopoiesis .": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': "[{'HTLV-I': 'cell_type'}, {'TRE': 'DNA'}, {'Tax': 'protein'}]", 'prediction': {'HTLV-I': 'cell_type', 'TRE': 'DNA', 'Tax': 'protein'}}
{'idx': 43, 'sentence': 'T-helper-cell determinants in protein antigens are preferentially located in cysteine-rich antigen segments resistant to proteolytic cleavage by cathepsin B , L , and D .', 'label': {'cysteine-rich antigen segments': 'protein', 'T-helper-cell determinants': 'protein', 'protein antigens': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.": 4},\n    {"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Tat-binding protein 7 is a subunit of the 26S protease.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.": 5},\n    {"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"cathepsin B": "protein"}, {"cathepsin L": "protein"}, {"cathepsin D": "protein"}]', 'prediction': {'cathepsin B': 'protein', 'cathepsin L': 'protein', 'cathepsin D': 'protein'}}
{'idx': 1204, 'sentence': 'Hirsutism , graded by the modified Ferriman-Gallwey score , and hormonal parameters were evaluated basally and at 4-month intervals during treatment.', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a clear and specific entity label that directly corresponds to the entity type in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The example provides a specific entity label that corresponds to the entity type in the target sentence, but it is not as directly related as Example 1."},\n    {"Example 3": 5},\n    {"Reason 3": "The example provides multiple specific entity labels that directly correspond to the entity types in the target sentence."},\n    {"Example 4": 4},\n    {"Reason 4": "The example provides a specific entity label that corresponds to the entity type in the target sentence, but it is not as directly related as Example 1."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides a clear and specific entity label that directly corresponds to the entity type in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The example provides a clear and specific entity label that directly corresponds to the entity type in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The example provides multiple clear and specific entity labels that directly correspond to the entity types in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides a clear and specific entity label that directly corresponds to the entity type in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides multiple clear and specific entity labels that directly correspond to the entity types in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides multiple clear and specific entity labels that directly correspond to the entity types in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The example provides multiple clear and specific entity labels that directly correspond to the entity types in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The example provides multiple clear and specific entity labels that directly correspond to the entity types in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides multiple clear and specific entity labels that directly correspond to the entity types in the target sentence."},\n    {"Example 14": 4},\n    {"Reason 14": "The example provides specific entity labels that correspond to the entity types in the target sentence, but they are not as directly related as Example 1."},\n    {"Example 15": 1},\n    {"Reason 15": "The example does not provide any specific entity labels that correspond to the entity types in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not provide any specific entity labels that correspond to the entity types in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not provide any specific entity labels that correspond to the entity types in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not provide any specific entity labels that correspond to the entity types in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The example does not provide any specific entity labels that correspond to the entity types in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1134, 'sentence': 'Reverse transcriptase (RT) assays were positive in purified viral material from both LCLs .', 'label': {'LCLs': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 4},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 5},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 5},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis.": 4},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 4},\n    {"In addition, assay of PBMC by the adenovirus -specific PCR may help detect early invasive disease and warrants further evaluation.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 4},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process.": 4},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 471, 'sentence': 'The lymphocyte nuclear T3 receptor was found with an affinity close to that of normal volunteers (Ka: 1.42 x 10(10) M-1 vs 1.95 +/- 0.35 x 10(10) M-1) and a binding capacity markedly increased (9.9 vs 3.7 +/- 0.4 fmol T3 /100 micrograms DNA).', 'label': {'lymphocyte nuclear T3 receptor': 'protein'}, 'response1': "['protein', 'DNA']", 'response2': '[\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 3},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 3},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.": 4},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 4},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"T3 receptor": "protein"}, {"DNA": "DNA"}]', 'prediction': {'T3 receptor': 'protein', 'DNA': 'DNA'}}
{'idx': 1205, 'sentence': 'Gonadotropin-releasing hormone and ACTH stimulation tests were performed before and after 3 to 4 months of therapy .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides multiple examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence provides a clear example of a named entity with its corresponding entity label, which can aid in extracting named entities from the target sentence."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence provides examples of named entities with their corresponding entity labels, which can aid in extracting named entities from the target sentence."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence provides a clear example of a named entity with its corresponding entity label, which can aid in extracting named entities from the target sentence."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence provides examples of named entities with their corresponding entity labels, which can aid in extracting named entities from the target sentence."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence provides examples of named entities with their corresponding entity labels, which can aid in extracting named entities from the target sentence."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence provides examples of named entities with their corresponding entity labels, which can aid in extracting named entities from the target sentence."},\n    {"Example 8": 3},\n    {"Reason 8": "The sentence provides an example of a named entity with its corresponding entity label, which can somewhat aid in extracting named entities from the target sentence."},\n    {"Example 9": 3},\n    {"Reason 9": "The sentence provides an example of a named entity with its corresponding entity label, which can somewhat aid in extracting named entities from the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides multiple examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."},\n    {"Example 11": 4},\n    {"Reason 11": "The sentence provides examples of named entities with their corresponding entity labels, which can aid in extracting named entities from the target sentence."},\n    {"Example 12": 4},\n    {"Reason 12": "The sentence provides examples of named entities with their corresponding entity labels, which can aid in extracting named entities from the target sentence."},\n    {"Example 13": 4},\n    {"Reason 13": "The sentence provides examples of named entities with their corresponding entity labels, which can aid in extracting named entities from the target sentence."},\n    {"Example 14": 4},\n    {"Reason 14": "The sentence provides examples of named entities with their corresponding entity labels, which can aid in extracting named entities from the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any named entities relevant to the target sentence, making it not helpful in extracting named entities."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any named entities relevant to the target sentence, making it not helpful in extracting named entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any named entities relevant to the target sentence, making it not helpful in extracting named entities."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any named entities relevant to the target sentence, making it not helpful in extracting named entities."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any named entities relevant to the target sentence, making it not helpful in extracting named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 14, 'sentence': 'Moreover, platelet-activating factor was capable of inducing transcription of the nuclear proto-oncogenes c-fos and c-jun .', 'label': {'c-fos': 'DNA', 'nuclear proto-oncogenes': 'DNA', 'c-jun': 'DNA', 'platelet-activating factor': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.": 5},\n    {"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .": 5},\n    {"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .": 5},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .": 5},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n    {"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"c-fos": "protein"}, {"c-jun": "protein"}]', 'prediction': {'c-fos': 'protein', 'c-jun': 'protein'}}
{'idx': 145, 'sentence': 'Two consensus sequences, called X and Y boxes , capable of binding nuclear proteins and regulating expression in B cells have been defined within the immediate upstream region of major histocompatibility complex (MHC) class II promoters .', 'label': {'nuclear proteins': 'protein', 'major histocompatibility complex (MHC) class II promoters': 'DNA', 'B cells': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 4},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 4},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n    {"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements.": 4},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.": 5},\n    {"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"X boxes": "protein"}, {"Y boxes": "protein"}, {"B cells": "cell_type"}, {"major histocompatibility complex (MHC) class II promoters": "DNA"}]', 'prediction': {'X boxes': 'protein', 'Y boxes': 'protein', 'B cells': 'cell_type', 'major histocompatibility complex (MHC) class II promoters': 'DNA'}}
{'idx': 1449, 'sentence': 'DNA binding specificity of complex 3 overlaps with that of upstream stimulatory factor but is clearly distinct.', 'label': {'upstream stimulatory factor': 'protein'}, 'response1': "['DNA']", 'response2': '[\n    {"A-myb": 5},\n    {"Protein": 5},\n    {"NF-kappa B": 5, "AP-1": 5},\n    {"UAS3": 5, "UAS2": 5, "YY1": 5},\n    {"UAS1": 5, "B cell": 5},\n    {"DNA": 5},\n    {"NF-ATc": 5, "T lymphocytes": 5, "embryonic cardiac cells": 5},\n    {"PU.1": 5, "M-CSF receptor": 5, "macrophage": 5},\n    {"T cell": 5, "interleukin 2": 5},\n    {"EKLF": 5, "CBP": 5, "p300": 5, "P/CAF": 5},\n    {"RelA": 5, "NF-kappaB1": 5},\n    {"immunoglobulin kappa 3\' enhancer": 5},\n    {"NF-kappa B": 5},\n    {"NF-kappaB": 5, "Sp1": 5, "p50": 5},\n    {"Jun": 5, "ATF-2": 5},\n    {"p50p50": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1292, 'sentence': "Promoter function of the 5' flanking region of the thromboxane receptor gene was evaluated by transfection of thromboxane receptor gene promoter/ chloramphenicol acetyltransferase ( CAT ) chimera plasmids into platelet-like K562 cells .", 'label': {'thromboxane receptor': 'protein', 'thromboxane receptor gene': 'DNA', 'CAT': 'protein', 'chloramphenicol acetyltransferase': 'protein', "5' flanking region": 'DNA', 'thromboxane receptor gene promoter/ chloramphenicol acetyltransferase ( CAT ) chimera plasmids': 'DNA', 'K562 cells': 'cell_line'}, 'response1': "['DNA', 'protein', 'cell_line']", 'response2': '[\n    {"1": "The sentence does not contain any named entities."},\n    {"1": "The sentence does not contain any named entities."},\n    {"5": "The sentence contains the named entity \'GATA-1\' which is a protein, directly matching one of the entity types in the label set."},\n    {"5": "The sentence contains the named entities \'Stat3\', \'Stat5\', and \'c-Mpl\' which are all proteins, directly matching entity types in the label set."},\n    {"5": "The sentence contains the named entity \'TCF-1\' which is a protein, directly matching one of the entity types in the label set."},\n    {"5": "The sentence contains the named entities \'PAFR\', \'PAF\', \'NF-kappa B\', and \'protein kinase C\' which are all proteins, directly matching entity types in the label set."},\n    {"5": "The sentence contains the named entities \'Sp1\' and \'CD14\' which are both proteins, directly matching entity types in the label set."},\n    {"5": "The sentence contains the named entity \'E2A\' which is a protein, directly matching one of the entity types in the label set."},\n    {"5": "The sentence contains the named entities \'IFN A\', \'IFNA\', \'interleukin-2\', \'interleukin-2 receptor\', \'phytohemagglutinin\', and \'phorbol myristate acetate\' which are all proteins, directly matching entity types in the label set."},\n    {"5": "The sentence contains the named entity \'CD95 ligand\' which is a protein, directly matching one of the entity types in the label set."},\n    {"5": "The sentence contains the named entity \'SCM-1\' which is a cell line, directly matching one of the entity types in the label set."},\n    {"5": "The sentence contains the named entities \'B and T cell activation\', \'Ramos\', \'Jurkat\', and \'cDNA microarray technology\' which match cell type, cell line, and DNA entity types in the label set."},\n    {"5": "The sentence contains the named entities \'Ter 119\', \'beta-globin\', \'glycoprotein IIb\', and \'platelet factor 4\' which are all proteins or cell lines, directly matching entity types in the label set."},\n    {"5": "The sentence contains the named entities \'ATF1\', \'CREB\', and \'H4\' which are all proteins, directly matching entity types in the label set."},\n    {"5": "The sentence contains the named entities \'BAT box\', \'CD20\', and \'B cells\' which match DNA, protein, and cell type entity types in the label set."},\n    {"5": "The sentence contains the named entities \'IL-2\', \'NFAT\', \'NFAT delta418\', \'calcineurin\', \'Tpl-2\', and \'cyclosporin A\' which are all proteins or DNA, directly matching entity types in the label set."},\n    {"1": "The sentence does not contain any named entities."},\n    {"1": "The sentence does not contain any named entities."},\n    {"1": "The sentence does not contain any named entities."},\n    {"1": "The sentence does not contain any named entities."},\n    {"1": "The sentence does not contain any named entities."}\n]', 'response3': '[{"thromboxane receptor gene": "protein"}, {"thromboxane receptor gene promoter": "protein"}, {"chloramphenicol acetyltransferase (CAT)": "protein"}, {"K562 cells": "cell_line"}]', 'prediction': {'thromboxane receptor gene': 'protein', 'thromboxane receptor gene promoter': 'protein', 'chloramphenicol acetyltransferase (CAT)': 'protein', 'K562 cells': 'cell_line'}}
{'idx': 120, 'sentence': 'Two other T cell lines , CEM and RPMI 8402 , have essentially identical deletions.', 'label': {'RPMI 8402': 'cell_line', 'T cell lines': 'cell_line', 'CEM': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 4},\n    {"These two related genes share the evolutionarily conserved region encoding the Runt domain.": 4},\n    {"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 5},\n    {"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.": 5},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 4},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 4},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4}\n]', 'response3': '[{"CEM": "cell_line"}, {"RPMI 8402": "cell_line"}]', 'prediction': {'CEM': 'cell_line', 'RPMI 8402': 'cell_line'}}
{'idx': 468, 'sentence': 'A 52-year-old male presented himself with tachycardia crises which appeared first during childhood, increased in frequency without goiter or exophthalmos .', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 5},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 5},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms.": 4},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 4},\n    {"By the time of diagnosis of T-PLL, the clone contains many more genetic changes in the form of additional translocations.": 4},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 4},\n    {"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 4},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"Expression of tal-1 and GATA-binding proteins during human hematopoiesis.": 5},\n    {"Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1/c6.1B, in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients.": 5},\n    {"Initiation of proliferation but not of differentiation was followed by a 20- to 25-fold increase in the nuclear level of the DNA polymerase-associated processivity factor PCNA and of the proliferation-specific transcription factor E2F1.": 5},\n    {"A total of 37 chronic, severe, nonsmoking asthmatic patients with documented reversible airways obstruction were classified as glucocorticoid-sensitive or -resistant on the basis of changes in FEV1, FVC, and peak expiratory flow (PEF) after oral prednisolone.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 138, 'sentence': 'The effects of TNF-alpha on gene expression were examined by transient expression assays using reporter chloramphenicol acetyltransferase plasmids linked to regulatory elements from the HIV long terminal repeat ( LTR ) and the beta interferon promoter .', 'label': {'beta interferon promoter': 'DNA', 'regulatory elements': 'DNA', 'HIV long terminal repeat': 'DNA', 'TNF-alpha': 'protein', 'LTR': 'DNA', 'reporter chloramphenicol acetyltransferase plasmids': 'DNA'}, 'response1': "['protein', 'DNA']", 'response2': '[\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"Interestingly, CTLA4Ig did not significantly inhibit the activation of either NF of activated T cells ( NFAT ) or AP-1 reporters.": 4},\n    {"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation, this receptor was still involved in the viral activation process.": 4},\n    {"Exposure to LPS or TNF led to differential patterns of IkappaB -alpha and IkappaB -epsilon disappearance from and reassembly with the signalsome, whereas IKK-alpha, IKK-beta, and NIK remained complex-associated.": 5},\n    {"Together, these findings suggest that LITAF plays an important role in the activation of the human TNF-alpha gene and proposes a new mechanism to control TNF-alpha gene expression.": 5},\n    {"We found that they reduced the initial interleukin-1beta mRNA transcription rate through prevention of degradation of inhibitor-kappaB alpha.": 5},\n    {"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.": 5},\n    {"We conclude, rather, that alpha 4 beta 1 in freshly isolated T cells delivers a distinct signal that synergizes early with signals initiated by TCR/CD3 ligation to induce DNA binding of multiple transcription factors required for cytokine gene induction.": 5},\n    {"We used reverse transcriptase -polymerase chain reaction to examine both fetal and term neonatal cord bloods for mRNA expression of three transcription factors implicated in T-cell activation : c-jun , c-fos , and NF kappa B ( p50 subunit ).": 5},\n    {"First, we describe results demonstrating that mice inoculated with T-antigen-expressing plasmids produced antibodies , not only to T-antigen and DNA, but also to the DNA-binding eukaryotic transcription factors TATA-binding protein ( TBP ), and to the cAMP-response-element-binding protein ( CREB ).": 5},\n    {"DNA-binding and transcriptional regulatory properties of hepatic leukemia factor ( HLF ) and the t(17;19) acute lymphoblastic leukemia chimera E2A- HLF.": 5},\n    {"To understand the diminished T cell response to activation signals, we measured nucleoprotein DNA-binding activities regulating gene expression during T cell activation using the electrophoretic mobility shift assay.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"TNF-alpha": "protein"}, {"chloramphenicol acetyltransferase": "protein"}, {"HIV long terminal repeat (LTR)": "DNA"}, {"beta interferon promoter": "DNA"}]', 'prediction': {'TNF-alpha': 'protein', 'chloramphenicol acetyltransferase': 'protein', 'HIV long terminal repeat (LTR)': 'DNA', 'beta interferon promoter': 'DNA'}}
{'idx': 64, 'sentence': 'Uninduced or Sendai virus induced HeLa extracts were used to examine transcription in vitro using a series of IFN beta promoter deletions .', 'label': {'IFN beta promoter deletions': 'DNA'}, 'response1': "['cell_line', 'protein']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 3},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 4},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 4},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 4},\n    {"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 4},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner.": 5},\n    {"We found that they reduced the initial interleukin-1beta mRNA transcription rate through prevention of degradation of inhibitor-kappaB alpha.": 4},\n    {"NF-E1 is encoded by the same gene as the YY-1 protein, which binds to the adeno-associated virus P5 promoter.": 4},\n    {"We conclude, rather, that alpha 4 beta 1 in freshly isolated T cells delivers a distinct signal that synergizes early with signals initiated by TCR/CD3 ligation to induce DNA binding of multiple transcription factors required for cytokine gene induction.": 5},\n    {"Extracts prepared from XP-B and XP-D lymphoblastoid cells exhibited similar transcription activity from the adenovirus major late promoter when compared to that in extracts from normal cells.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"HeLa": "cell_line"}, {"IFN beta": "protein"}]', 'prediction': {'HeLa': 'cell_line', 'IFN beta': 'protein'}}
{'idx': 1760, 'sentence': 'This inhibitory effect was limited to the first 2 h after mitogenic activation , localizing the time-frame of action of cysteamine to within the commitment period .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides clear examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 676, 'sentence': 'The interleukin 2 ( IL-2 ) gene promoter is recognized by several cell-type-specific and ubiquitous transcriptional regulators that integrate information transmitted by various signaling systems leading to IL-2 production and T-cell activation .', 'label': {'IL-2': 'protein', 'interleukin 2': 'protein', 'interleukin 2 ( IL-2 ) gene promoter': 'DNA', 'T-cell': 'cell_type'}, 'response1': "['DNA', 'cell_type', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 1},\n    {"Example 14": 1},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1}\n]', 'response3': '[{"interleukin 2": "protein"}, {"IL-2": "protein"}, {"T-cell": "cell_type"}]', 'prediction': {'interleukin 2': 'protein', 'IL-2': 'protein', 'T-cell': 'cell_type'}}
{'idx': 1052, 'sentence': 'Thus, after 4 hr of exposure to SEA and SEB , the expression of IL-2R beta was down-regulated, IL-2R gamma was slightly up-regulated, while IL-2R alpha remained largely unaffected.', 'label': {'IL-2R alpha': 'protein', 'SEA': 'protein', 'IL-2R gamma': 'protein', 'SEB': 'protein', 'IL-2R beta': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains a named entity with a clear entity label that matches the entity type in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains a named entity with a clear entity label that matches the entity type in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any named entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any named entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any named entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any named entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any named entities with clear entity labels that match the entity types in the target sentence."}\n]', 'response3': '[{"IL-2R beta": "protein"}, {"IL-2R gamma": "protein"}, {"IL-2R alpha": "protein"}]', 'prediction': {'IL-2R beta': 'protein', 'IL-2R gamma': 'protein', 'IL-2R alpha': 'protein'}}
{'idx': 487, 'sentence': 'Therefore, in normal human monocytes M-CSF induces immediate early response genes without inducing cell proliferation.', 'label': {'human monocytes': 'cell_type', 'normal human monocytes': 'cell_type', 'M-CSF': 'protein', 'immediate early response genes': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Sentence": 5},\n    {"Example id": 1},\n    {"Example id": 2},\n    {"Example id": 3},\n    {"Example id": 4},\n    {"Example id": 5},\n    {"Example id": 6},\n    {"Example id": 7},\n    {"Example id": 8},\n    {"Example id": 9},\n    {"Example id": 10},\n    {"Example id": 11},\n    {"Example id": 12},\n    {"Example id": 13},\n    {"Example id": 14},\n    {"Example id": 15},\n    {"Example id": 16},\n    {"Example id": 17},\n    {"Example id": 18},\n    {"Example id": 19},\n    {"Example id": 20}\n]', 'response3': '[{"M-CSF": "protein"}, {"monocytes": "cell_type"}]', 'prediction': {'M-CSF': 'protein', 'monocytes': 'cell_type'}}
{'idx': 570, 'sentence': 'Modulation of these events at the time of adherence offers a mechanism by which differential priming of the cells may be accomplished.', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"Sentence": "The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.", "helpfulness score": 4, "reasons": "The sentence contains a clear reference to \'cell adhesion molecules\' which is a cell_type entity."},\n    {"Sentence": "We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.", "helpfulness score": 5, "reasons": "The sentence contains references to \'AP-1\', \'PMA\', \'monocytes\', and \'macrophages\' which are protein and cell_type entities."},\n    {"Sentence": "Yet, for many pathogens, the molecules that induce IL-12 production by macrophages and the mechanisms by which they do so remain undefined.", "helpfulness score": 4, "reasons": "The sentence contains a reference to \'IL-12\' which is a protein entity and \'macrophages\' which is a cell_type entity."},\n    {"Sentence": "Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.", "helpfulness score": 3, "reasons": "The sentence contains a reference to \'CD14\' which is a protein entity."},\n    {"Sentence": "Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.", "helpfulness score": 4, "reasons": "The sentence contains references to \'Th1\' and \'Th2\' which are cell_type entities."},\n    {"Sentence": "Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.", "helpfulness score": 5, "reasons": "The sentence contains references to \'IL-2\', \'AP-1\', \'c-Jun\', and \'c-Fos\' which are protein entities."},\n    {"Sentence": "Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.", "helpfulness score": 5, "reasons": "The sentence contains references to \'CD70\', \'B cell\', \'plasma cells\', \'IL-4\', and \'CD40\' which are protein and cell_type entities."},\n    {"Sentence": "Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.", "helpfulness score": 5, "reasons": "The sentence contains references to \'IL-4\', \'LPS\', and \'AP-1\' which are protein entities."},\n    {"Sentence": "Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.", "helpfulness score": 4, "reasons": "The sentence contains a reference to \'NF-kappa B\' which is a protein entity."},\n    {"Sentence": "We also found that the deviation of methylation in granulocytes and T cells was well correlated.", "helpfulness score": 4, "reasons": "The sentence contains references to \'granulocytes\' and \'T cells\' which are cell_type entities."},\n    {"Sentence": "Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.", "helpfulness score": 5, "reasons": "The sentence contains references to \'NF-kappa B\' and \'I kappa B alpha\' which are protein entities."},\n    {"Sentence": "We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.", "helpfulness score": 5, "reasons": "The sentence contains a reference to \'NF-kappa B\' which is a protein entity."},\n    {"Sentence": "Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.", "helpfulness score": 4, "reasons": "The sentence contains a reference to \'nonhuman primates\' which is a cell_type entity."},\n    {"Sentence": "Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.", "helpfulness score": 4, "reasons": "The sentence contains a reference to \'NF-kappa B\' which is a protein entity."},\n    {"Sentence": "We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.", "helpfulness score": 5, "reasons": "The sentence contains references to \'HIV-1\', \'IFN\', \'PKR\', and \'IkappaBalpha\' which are protein and cell_type entities."},\n    {"Sentence": "To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.", "helpfulness score": 5, "reasons": "The sentence contains references to \'B and T cell activation\', \'Ramos\', \'Jurkat\', and \'cDNA microarray technology\' which are cell_type, cell_line, and DNA entities."},\n    {"Sentence": "We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.", "helpfulness score": 1, "reasons": "The sentence does not contain any entity references."},\n    {"Sentence": "However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.", "helpfulness score": 1, "reasons": "The sentence does not contain any entity references."},\n    {"Sentence": "In 2 complex translocations, none of the three genes was rearranged.", "helpfulness score": 1, "reasons": "The sentence does not contain any entity references."},\n    {"Sentence": "Deletions or mutations in this element also reduced the serum response by 80-90%.", "helpfulness score": 1, "reasons": "The sentence does not contain any entity references."},\n    {"Sentence": "In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.", "helpfulness score": 1, "reasons": "The sentence does not contain any entity references."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1370, 'sentence': 'Although anti- CD28 MoAb costimulation enhances all of the above signals, NF kappa B and IL-2 levels remain lower than in adults , suggesting the need for further activation requirements in the neonate .', 'label': {'CD28': 'protein', 'anti- CD28 MoAb': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 5},\n    {"Example 12": 1},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"NF kappa B": "protein"}, {"IL-2": "protein"}]', 'prediction': {'NF kappa B': 'protein', 'IL-2': 'protein'}}
{'idx': 994, 'sentence': 'The role of BSAP ( Pax-5 ) in B-cell development .', 'label': {'BSAP': 'protein', 'Pax-5': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Th1": 5, "Th2": 5},\n    {"SLAP-130": 5, "SLP-76": 5, "T cell": 5},\n    {"Sp1": 5, "Ets": 5},\n    {"UAS3": 5, "UAS2": 5, "YY1": 5},\n    {"CD70": 5, "B cell": 5, "plasma cells": 5, "IL-4": 5, "CD40": 5},\n    {"GATA-1": 5},\n    {"IL-13": 5, "IL-4": 5, "B cell": 5, "monocyte": 5},\n    {"IL-2": 5, "c-Jun": 5, "c-Fos": 5},\n    {"Th2-type lymphocytes": 5},\n    {"IL4": 5, "IL13": 5, "STAT6": 5, "STAT3": 5, "STAT5": 5, "B cells": 5},\n    {"lymphoid neoplasms": 5},\n    {"PML/RARalpha": 5},\n    {"GM-CSF": 5},\n    {"UAS1": 5, "B cell": 5},\n    {"T cell": 5, "interleukin 2": 5},\n    {"GATA-1": 5}\n]', 'response3': '[{"BSAP": "protein"}, {"Pax-5": "protein"}, {"B-cell": "cell_type"}]', 'prediction': {'BSAP': 'protein', 'Pax-5': 'protein', 'B-cell': 'cell_type'}}
{'idx': 438, 'sentence': 'This sequence motif is a binding site for nuclear proteins , the so-called octamer transcription factors ( Oct or OTF factors ).', 'label': {'OTF factors': 'protein', 'nuclear proteins': 'protein', 'sequence motif': 'DNA', 'octamer transcription factors': 'protein', 'Oct': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .": 5},\n    {"Activated Stat proteins form homo- or heterodimers, translocate to the nucleus , and induce transcription from responsive genes.": 5},\n    {"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50 .": 5},\n    {"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .": 5},\n    {"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 5},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .": 5},\n    {"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2 .": 5},\n    {"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 270, 'sentence': 'There was evidence for an autosomal recessive form of inheritance in four families, while the other four families appeared to have an autosomal dominant mode of transmission .', 'label': {}, 'response1': "['DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains clear mentions of specific entities such as \'lymphoid neoplasms\' which is a cell type, making it highly helpful for extracting named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1481, 'sentence': 'We, therefore, propose the activation scheme presented in FIGURE 3 for T-cell costimulation .', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1807, 'sentence': 'We show that the expression of four cell genes , cdc-2 , cyclin E , CD23 , and cyclin D2 , are up-regulated approximately 100-fold as a result of EBV -mediated immortalization .', 'label': {'cell genes': 'DNA', 'cyclin E': 'DNA', 'cyclin D2': 'DNA', 'CD23': 'DNA', 'cdc-2': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 5},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .": 4},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .": 5},\n    {"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB .": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n    {"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .": 5},\n    {"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus .": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity .": 1}\n]', 'response3': '[{"cdc-2": "protein"}, {"cyclin E": "protein"}, {"CD23": "protein"}, {"cyclin D2": "protein"}, {"EBV": "cell_line"}]', 'prediction': {'cdc-2': 'protein', 'cyclin E': 'protein', 'CD23': 'protein', 'cyclin D2': 'protein', 'EBV': 'cell_line'}}
{'idx': 1169, 'sentence': 'However, B4-2 has an unusually high proline content (13%), contains a putative nuclear targeting sequence , and has several SPXX motifs which are frequently found in gene regulatory proteins .', 'label': {'SPXX motifs': 'protein', 'nuclear targeting sequence': 'protein', 'gene regulatory proteins': 'protein', 'B4-2': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 5},\n    {"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 5},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .": 5},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50 .": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .": 5},\n    {"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n    {"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .": 5},\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines .": 5},\n    {"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .": 5},\n    {"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif .": 5}\n]', 'response3': '[{"B4-2": "protein"}]', 'prediction': {'B4-2': 'protein'}}
{'idx': 1180, 'sentence': 'We therefore propose that IL-2 receptor signal transduction does not depend on equimolar heterodimerization of JAK1 and JAK3 following IL-2 -induced heterodimerization of IL-2R beta and IL-2R gamma .', 'label': {'IL-2R': 'protein', 'IL-2': 'protein', 'IL-2R gamma': 'protein', 'JAK3': 'protein', 'IL-2 receptor': 'protein', 'JAK1': 'protein', 'IL-2R beta': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 3},\n    {"Example 10": 5},\n    {"Example 11": 3},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 5},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"IL-2": "protein"}, {"JAK1": "protein"}, {"JAK3": "protein"}, {"IL-2R beta": "protein"}, {"IL-2R gamma": "protein"}]', 'prediction': {'IL-2': 'protein', 'JAK1': 'protein', 'JAK3': 'protein', 'IL-2R beta': 'protein', 'IL-2R gamma': 'protein'}}
{'idx': 968, 'sentence': 'These observations demonstrate directly that there is de novo synthesis of NF-kappa B during human lymphocyte activation and suggest that this process is hormonally regulated.', 'label': {'NF-kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence 1": 5},\n    {"Sentence 2": 5},\n    {"Sentence 3": 5},\n    {"Sentence 4": 4},\n    {"Sentence 5": 4},\n    {"Sentence 6": 4},\n    {"Sentence 7": 4},\n    {"Sentence 8": 3},\n    {"Sentence 9": 3},\n    {"Sentence 10": 4},\n    {"Sentence 11": 4},\n    {"Sentence 12": 5},\n    {"Sentence 13": 5},\n    {"Sentence 14": 5},\n    {"Sentence 15": 3},\n    {"Sentence 16": 1},\n    {"Sentence 17": 1},\n    {"Sentence 18": 1},\n    {"Sentence 19": 1},\n    {"Sentence 20": 1}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"lymphocyte": "cell_type"}]', 'prediction': {'NF-kappa B': 'protein', 'lymphocyte': 'cell_type'}}
{'idx': 497, 'sentence': 'The differentiation of T cells into functionally diverse subpopulations is controlled in part, by transcriptional activation and silencing ; however, little is known in detail about the proteins that influence this developmental process .', 'label': {'T cells': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"IkappaBalpha": 5},\n    {"NF-kappaB": 5},\n    {"GATA-1": 5},\n    {"NF-ATc": 5},\n    {"IL-4": 5},\n    {"Th1": 5},\n    {"Th2": 5},\n    {"Sp1": 5},\n    {"Ets": 5},\n    {"IL-2": 5},\n    {"IFN-gamma": 5},\n    {"jak kinases": 5},\n    {"STAT1(alpha)": 5},\n    {"immunohistochemistry": 5},\n    {"NF-E2": 5},\n    {"IgH": 5},\n    {"CD70": 5},\n    {"B cell": 5},\n    {"plasma cells": 5},\n    {"IL-4": 5},\n    {"CD40": 5},\n    {"Th2-type lymphocytes": 5},\n    {"NF-kappaB": 5},\n    {"Tax": 5},\n    {"ATL": 5},\n    {"B and T cell activation": 5},\n    {"Ramos": 5},\n    {"Jurkat": 5},\n    {"cDNA microarray technology": 5}\n]', 'response3': '[{"T cells": "cell_type"}]', 'prediction': {'T cells': 'cell_type'}}
{'idx': 1606, 'sentence': 'Triggering of complement receptors CR1 ( CD35 ) and CR3 ( CD11b/CD18 ) induces nuclear translocation of NF-kappa B ( p50/p65 ) in human monocytes and enhances viral replication in HIV-infected monocytic cells .', 'label': {'CD11b/CD18': 'protein', 'CD35': 'protein', 'p50/p65': 'protein', 'CR1': 'protein', 'HIV-infected monocytic cells': 'cell_type', 'complement receptors': 'protein', 'human monocytes': 'cell_type', 'NF-kappa B': 'protein', 'CR3': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 4},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"CD40 expression could be enhanced in CD40-positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5},\n    {"Murine macrophage inflammatory protein 1 alpha (MIP-1 alpha) and its human equivalent (GOS19, LD78, or AT464) are members of the -C-C family of low-molecular-weight chemokines.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"CR1": "protein"}, {"CD35": "protein"}, {"CR3": "protein"}, {"CD11b/CD18": "protein"}, {"NF-kappa B": "protein"}, {"p50/p65": "protein"}, {"monocytes": "cell_type"}, {"HIV-infected monocytic cells": "cell_type"}]', 'prediction': {'CR1': 'protein', 'CD35': 'protein', 'CR3': 'protein', 'CD11b/CD18': 'protein', 'NF-kappa B': 'protein', 'p50/p65': 'protein', 'monocytes': 'cell_type', 'HIV-infected monocytic cells': 'cell_type'}}
{'idx': 1653, 'sentence': 'Expression of PU.1 in nonmyeloid cells can activate the GM-CSF receptor alpha promoter .', 'label': {'nonmyeloid cells': 'cell_type', 'GM-CSF': 'protein', 'PU.1': 'protein', 'GM-CSF receptor alpha promoter': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.": 5},\n    {"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"PMA induced the expression of both CD14 and CD23 mRNA and protein.": 5},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n    {"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.": 5},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines.": 5},\n    {"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n    {"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n    {"In 2 complex translocations, none of the three genes was rearranged.": 1},\n    {"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n    {"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[{"PU.1": "protein"}, {"GM-CSF receptor alpha": "protein"}]', 'prediction': {'PU.1': 'protein', 'GM-CSF receptor alpha': 'protein'}}
{'idx': 833, 'sentence': 'Mapping of B-cell epitopes of the human hepatitis B virus X protein .', 'label': {'human hepatitis B virus X protein': 'protein', 'B-cell epitopes': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any named entities from the given entity label set."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains multiple named entities that match the entity labels in the target sentence, providing clear and direct assistance in extracting named entities."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence contains a named entity that matches one of the entity labels in the target sentence, aiding in identifying a specific entity type."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains a named entity that matches one of the entity labels in the target sentence, providing direct assistance in extracting named entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains multiple named entities that match the entity labels in the target sentence, offering clear and direct assistance in extracting named entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains a named entity that matches one of the entity labels in the target sentence, providing direct assistance in extracting named entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains multiple named entities that match the entity labels in the target sentence, offering clear and direct assistance in extracting named entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains multiple named entities that match the entity labels in the target sentence, providing clear and direct assistance in extracting named entities."},\n    {"Example 9": 1},\n    {"Reason 9": "The sentence does not contain any named entities from the given entity label set."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains multiple named entities that match the entity labels in the target sentence, providing clear and direct assistance in extracting named entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains multiple named entities that match the entity labels in the target sentence, offering clear and direct assistance in extracting named entities."},\n    {"Example 12": 4},\n    {"Reason 12": "The sentence contains a named entity that matches one of the entity labels in the target sentence, aiding in identifying a specific entity type."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not contain any named entities from the given entity label set."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not contain any named entities from the given entity label set."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any named entities from the given entity label set."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any named entities from the given entity label set."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any named entities from the given entity label set."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any named entities from the given entity label set."}\n]', 'response3': "[{'B-cell': 'cell_type'}, {'hepatitis B virus X protein': 'protein'}]", 'prediction': {'B-cell': 'cell_type', 'hepatitis B virus X protein': 'protein'}}
{'idx': 389, 'sentence': 'The predicted periplasmic domain of the PhoQ protein contained a markedly anionic domain that could interact with cationic proteins and that could be responsible for resistance to defensin .', 'label': {'periplasmic domain': 'protein', 'PhoQ protein': 'protein', 'cationic proteins': 'protein', 'defensin': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides clear and specific examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence provides a specific example of a named entity with its corresponding entity label, which is helpful for extracting named entities from the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence provides multiple specific examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides clear and specific examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence provides a specific example of a named entity with its corresponding entity label, which is helpful for extracting named entities from the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides clear and specific examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence provides a specific example of a named entity with its corresponding entity label, which is helpful for extracting named entities from the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides clear and specific examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides clear and specific examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides clear and specific examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides clear and specific examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides clear and specific examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides clear and specific examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides clear and specific examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not provide any specific examples of named entities with their corresponding entity labels, making it not helpful for extracting named entities from the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not provide any specific examples of named entities with their corresponding entity labels, making it not helpful for extracting named entities from the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not provide any specific examples of named entities with their corresponding entity labels, making it not helpful for extracting named entities from the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not provide any specific examples of named entities with their corresponding entity labels, making it not helpful for extracting named entities from the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not provide any specific examples of named entities with their corresponding entity labels, making it not helpful for extracting named entities from the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 193, 'sentence': 'The calcium ionophore-induced c-myc suppression , however, strictly requires de novo protein synthesis .', 'label': {'c-myc': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple protein names and their corresponding transcription factors, which are directly related to the entity labels in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions a specific cell type (macrophage) and proteins (PU.1 and M-CSF receptor) that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence includes RNA (IL-5 mRNA), cell type (TCR), and proteins (IL-2R, dexamethasone) that align with the entity labels in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions proteins (RelA, NF-kappaB1) that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains a protein (SP1), caspases, and a cell type (B-cell) that are aligned with the entity labels in the target sentence."},\n    {"Sentence": 3},\n    {"Reason": "The sentence includes a protein (NF-E2) that is relevant to the entity labels in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions proteins (IL-2, NF-kappa B, AP-1) that directly correspond to the entity labels in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence includes proteins (IL-2, Aiolos, Ras) that align with the entity labels in the target sentence."},\n    {"Sentence": 3},\n    {"Reason": "The sentence mentions RNA (SCL) that is relevant to the entity labels in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains proteins (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) that directly correspond to the entity labels in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions a protein (NF-kappa B) that is directly related to the entity label in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence includes a protein (TIMP-1) and DNA, which are relevant to the entity labels in the target sentence."},\n    {"Sentence": 3},\n    {"Reason": "The sentence mentions a cell line (EBV) and a protein (CD2) that are aligned with the entity labels in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains proteins (IL-2, c-Jun, c-Fos) that directly correspond to the entity labels in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions a protein (WT1) and a cell line (myeloid cell lines) that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence includes a protein (calcineurin) that is directly related to the entity label in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any entity types that align with the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any entity types that align with the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any entity types that align with the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any entity types that align with the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any entity types that align with the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any entity types that align with the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any entity types that align with the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any entity types that align with the entity labels in the target sentence."}\n]', 'response3': '[{"c-myc": "protein"}]', 'prediction': {'c-myc': 'protein'}}
{'idx': 1349, 'sentence': 'Its expression was always restricted to the nucleus .', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides specific gene or protein names that are directly related to the entity labels in the target sentence, making it highly helpful for extracting named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 882, 'sentence': 'This cDNA clone was isolated by expression cDNA cloning , and encodes the human c-Jun protein , which together with c-Fos forms the heterodimeric activator protein-1 transcription complex .', 'label': {'c-Jun': 'protein', 'heterodimeric activator protein-1 transcription complex': 'protein', 'c-Fos': 'protein', 'cDNA': 'DNA', 'human c-Jun protein': 'protein', 'cDNA clone': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1}\n]', 'response3': '[{"cDNA": "DNA"}, {"c-Jun": "protein"}, {"c-Fos": "protein"}]', 'prediction': {'cDNA': 'DNA', 'c-Jun': 'protein', 'c-Fos': 'protein'}}
{'idx': 725, 'sentence': 'Rex acts posttranscriptionally to facilitate accumulation of full-length gag/pol and singly spliced env mRNA in the cytoplasm of HTLV-infected cells .', 'label': {'Rex': 'protein', 'HTLV-infected cells': 'cell_type', 'gag/pol': 'protein', 'env mRNA': 'RNA'}, 'response1': "['RNA', 'protein']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence contains specific gene/protein names that match the entity labels in the target sentence, providing direct examples for extraction."}\n]\n[\n{"Example 2": 4},\n{"Reason 2": "The sentence contains gene/protein names that match the entity labels in the target sentence, providing relevant examples for extraction."}\n]\n[\n{"Example 3": 4},\n{"Reason 3": "The sentence contains gene/protein names that match the entity labels in the target sentence, providing relevant examples for extraction."}\n]\n[\n{"Example 4": 5},\n{"Reason 4": "The sentence contains specific gene/protein names and a virus name that match the entity labels in the target sentence, providing direct examples for extraction."}\n]\n[\n{"Example 5": 5},\n{"Reason 5": "The sentence contains a specific cell line name that matches the entity label in the target sentence, providing a direct example for extraction."}\n]\n[\n{"Example 6": 5},\n{"Reason 6": "The sentence contains multiple gene/protein names that match the entity labels in the target sentence, providing direct examples for extraction."}\n]\n[\n{"Example 7": 5},\n{"Reason 7": "The sentence contains a specific protein name and DNA term that match the entity labels in the target sentence, providing direct examples for extraction."}\n]\n[\n{"Example 8": 5},\n{"Reason 8": "The sentence contains a specific protein name that matches the entity label in the target sentence, providing a direct example for extraction."}\n]\n[\n{"Example 9": 5},\n{"Reason 9": "The sentence contains specific cell type, protein, and DNA names that match the entity labels in the target sentence, providing direct examples for extraction."}\n]\n[\n{"Example 10": 5},\n{"Reason 10": "The sentence contains specific DNA and protein names that match the entity labels in the target sentence, providing direct examples for extraction."}\n]\n[\n{"Example 11": 5},\n{"Reason 11": "The sentence contains specific DNA, cell line, and cell type names that match the entity labels in the target sentence, providing direct examples for extraction."}\n]\n[\n{"Example 12": 5},\n{"Reason 12": "The sentence contains specific protein names that match the entity labels in the target sentence, providing direct examples for extraction."}\n]\n[\n{"Example 13": 5},\n{"Reason 13": "The sentence contains specific cell type and DNA names that match the entity labels in the target sentence, providing direct examples for extraction."}\n]\n[\n{"Example 14": 5},\n{"Reason 14": "The sentence contains specific protein and DNA names that match the entity labels in the target sentence, providing direct examples for extraction."}\n]\n[\n{"Example 15": 4},\n{"Reason 15": "The sentence contains gene/protein names that match the entity labels in the target sentence, providing relevant examples for extraction."}\n]\n[\n{"Example 16": 1},\n{"Reason 16": "The sentence does not contain any specific gene/protein names or terms matching the entity labels in the target sentence, making it less helpful for extraction."}\n]\n[\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any specific gene/protein names or terms matching the entity labels in the target sentence, making it less helpful for extraction."}\n]\n[\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any specific gene/protein names or terms matching the entity labels in the target sentence, making it less helpful for extraction."}\n]\n[\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any specific gene/protein names or terms matching the entity labels in the target sentence, making it less helpful for extraction."}\n]', 'response3': "[{'gag/pol': 'protein'}, {'env mRNA': 'RNA'}, {'HTLV-infected cells': 'cell_type'}]", 'prediction': {'gag/pol': 'protein', 'env mRNA': 'RNA', 'HTLV-infected cells': 'cell_type'}}
{'idx': 867, 'sentence': 'In HIV-1 , the sequences that respond to these signaling events are found in the long terminal repeat ( LTR ) and comprise the transcriptional enhancer , which contains two conserved binding sites for the nuclear factor kappa B ( NF kappa B ).', 'label': {'conserved binding sites': 'DNA', 'nuclear factor kappa B': 'protein', 'long terminal repeat': 'DNA', 'LTR': 'DNA', 'NF kappa B': 'protein', 'transcriptional enhancer': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 4},\n    {"Example 4": 5},\n    {"Example 5": 4},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 3},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 4},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1}\n]', 'response3': '[{"HIV-1": "cell_type"}, {"long terminal repeat ( LTR )": "DNA"}, {"nuclear factor kappa B ( NF kappa B )": "protein"}]', 'prediction': {'HIV-1': 'cell_type', 'long terminal repeat ( LTR )': 'DNA', 'nuclear factor kappa B ( NF kappa B )': 'protein'}}
{'idx': 841, 'sentence': 'Such tests may become useful diagnostic tools .', 'label': {}, 'response1': 'None.', 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence contains specific protein names such as myeloperoxidase, lysozyme, and PU.1, which are directly related to the \'protein\' entity label."},\n{"Example 2": 4},\n{"Reason 2": "The sentence mentions PBMC (Peripheral Blood Mononuclear Cells) and adenovirus, which are associated with the \'cell_type\' and \'DNA\' entity labels respectively."},\n{"Example 3": 4},\n{"Reason 3": "The sentence refers to PBMC (Peripheral Blood Mononuclear Cells) and adenovirus DNA, which are linked to the \'cell_type\' and \'DNA\' entity labels respectively."},\n{"Example 4": 5},\n{"Reason 4": "The sentence mentions IFN-gamma, a protein, which directly corresponds to the \'protein\' entity label."},\n{"Example 5": 4},\n{"Reason 5": "The sentence talks about lymphoid neoplasms, which are related to the \'cell_type\' entity label."},\n{"Example 6": 5},\n{"Reason 6": "The sentence includes STAT1, a protein, which aligns with the \'protein\' entity label."},\n{"Example 7": 5},\n{"Reason 7": "The sentence mentions Ras, a protein, which is associated with the \'protein\' entity label."},\n{"Example 8": 5},\n{"Reason 8": "The sentence contains terms like immunohistochemistry, gene, and cell type, which are directly linked to the \'protein\', \'DNA\', and \'cell_type\' entity labels respectively."},\n{"Example 9": 5},\n{"Reason 9": "The sentence refers to NF-kappa B, a protein, which corresponds to the \'protein\' entity label."},\n{"Example 10": 5},\n{"Reason 10": "The sentence mentions SCM-1, a cell line, which is directly related to the \'cell_line\' entity label."},\n{"Example 11": 5},\n{"Reason 11": "The sentence includes SIVsmmPBj14, a cell line, which aligns with the \'cell_line\' entity label."},\n{"Example 12": 4},\n{"Reason 12": "The sentence talks about nonhuman primates, which are associated with the \'cell_type\' entity label."},\n{"Example 13": 5},\n{"Reason 13": "The sentence mentions T-PLL, a cell type, which directly corresponds to the \'cell_type\' entity label."},\n{"Example 14": 5},\n{"Reason 14": "The sentence includes E2A, a protein, which is associated with the \'protein\' entity label."},\n{"Example 15": 4},\n{"Reason 15": "The sentence refers to AP-1, which is linked to the \'DNA\' entity label."},\n{"Example 16": 5},\n{"Reason 16": "The sentence contains terms related to B and T cell activation, Ramos, Jurkat cells, and cDNA microarray technology, which are directly linked to the \'cell_type\', \'cell_line\', and \'DNA\' entity labels respectively."},\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any specific entity names or terms related to the entity labels in the target sentence."},\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any specific entity names or terms related to the entity labels in the target sentence."},\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any specific entity names or terms related to the entity labels in the target sentence."},\n{"Example 20": 1},\n{"Reason 20": "The sentence does not contain any specific entity names or terms related to the entity labels in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 956, 'sentence': 'BSAP : a key regulator of B-cell development and differentiation .', 'label': {'BSAP': 'protein', 'B-cell': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"NF-E2": 5},\n    {"EBV": 4, "B-cell": 4},\n    {"CD70": 5, "B cell": 4, "plasma cells": 4, "IL-4": 5, "CD40": 5},\n    {"Th2-type lymphocytes": 5},\n    {"GATA-1": 5},\n    {"Syk": 5, "Zap": 5, "T cell": 4},\n    {"Th1": 5, "Th2": 5},\n    {"T cell": 5, "interleukin 2": 5},\n    {"IL-2": 5},\n    {"AP-1": 5},\n    {"IL-2": 5, "c-Jun": 5, "c-Fos": 5},\n    {"UAS3": 5, "UAS2": 5, "YY1": 5},\n    {"SCL": 5, "GATA-1": 5},\n    {"IL-2": 5, "NF-kappa B": 5, "AP-1": 5},\n    {"IL4": 5, "IL13": 5, "STAT6": 5, "STAT3": 5, "STAT5": 5, "B cells": 5},\n    {"STAT1": 5},\n    {"None": 1},\n    {"None": 1},\n    {"None": 1},\n    {"None": 1},\n    {"None": 1}\n]', 'response3': '[{"BSAP": "protein"}, {"B-cell": "cell_type"}]', 'prediction': {'BSAP': 'protein', 'B-cell': 'cell_type'}}
{'idx': 1769, 'sentence': 'We have tried to find out whether these receptors could show any difference in sex or age distribution.', 'label': {}, 'response1': 'None.', 'response2': '[\n{"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.": 5},\n{"This review suggests roles for these alterations in the development of lymphoid neoplasms.": 4},\n{"We have found that the recruitment of EKLF to 5\'HS3 depends on the presence of 5\'HS2 in cis, but the recruitment to 5\'HS2 does not depend on 5\'HS3.": 4},\n{"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 3},\n{"Therefore, we investigated whether IVS1-10T-->C deleteriously affected BRCA1 splicing or expression, and thereby inactivated the other BRCA1 allele.": 4},\n{"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n{"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.": 5},\n{"Here we examined the regulatory mechanism of the SCM-1 genes.": 4},\n{"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.": 4},\n{"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n{"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n{"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n{"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 4},\n{"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.": 5},\n{"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n{"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5},\n{"We wished to determine if this developmentally related interaction is a consequence of myeloid differentiation or an intrinsic differentiating stimulus.": 1},\n{"However, inhibition of protein synthesis with cycloheximide anytime during the first 18 h of steroid treatment was as effective in blocking chromatin fragmentation as inhibition for the entire period, suggesting that synthesis of a component with a rapid turnover rate is required.": 1},\n{"In 2 complex translocations, none of the three genes was rearranged.": 1},\n{"Deletions or mutations in this element also reduced the serum response by 80-90%.": 1},\n{"In addition to biophysical properties, pulmonary surfactant has immunomodulatory activity.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 110, 'sentence': 'Electrophoretic mobility shift assays and Southwestern blotting experiments were used to detect the binding of cellular transactivation factor NF-KB to the double repeat-KB enhancer sequence located in the long terminal repeat .', 'label': {'long terminal repeat': 'DNA', 'NF-KB': 'protein', 'double repeat-KB enhancer sequence': 'DNA', 'cellular transactivation factor': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of protein names that are relevant to the entity labels in the target sentence, such as IL-4, LPS, and AP-1."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of protein names that are relevant to the entity labels in the target sentence, such as NF-kappaB, Sp1, and p50."},\n    {"Sentence": 4},\n    {"Reason": "The sentence includes examples of protein names (NF-kappaB) and cell types (Tax, ATL) that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 3},\n    {"Reason": "The sentence mentions NF-kappa B, which is relevant to the entity labels in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of protein names (NF-kappa B, I kappa B alpha) that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of protein names (EKLF, CBP, p300, P/CAF) that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence includes examples of protein names (CD40, NF-kappa B) that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of protein names (NF-kappa B, I kappa B alpha) that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 3},\n    {"Reason": "The sentence mentions T cell and interleukin 2, which are relevant to the entity labels in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence includes examples of protein names (NF-kappa B) that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 3},\n    {"Reason": "The sentence mentions EBNA2 and TP1, which are relevant to the entity labels in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of protein names (PAFR, PAF, NF-kappa B, protein kinase C) that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence includes examples of protein names (RelA, NF-kappa B) that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of protein names (IL-2, c-Jun, c-Fos) that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 3},\n    {"Reason": "The sentence mentions NF-kappaB and rheumatoid arthritis, which are relevant to the entity labels in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of protein names (TRAF6, RANKL, NF-kappaB) that are relevant to the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entity types present in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entity types present in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entity types present in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entity types present in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of entity types present in the target sentence."}\n]', 'response3': "[{'NF-KB': 'protein'}]", 'prediction': {'NF-KB': 'protein'}}
{'idx': 1379, 'sentence': 'Deregulation of TCL1 is the first event in the initiation of malignancy in these types of leukemias and represents a potential tool for clinical evaluation .', 'label': {'TCL1': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"IkappaBbeta": 5},\n    {"NF-kappaB": 5},\n    {"AP-1": 5},\n    {"WT1": 4},\n    {"myeloid cell lines": 4},\n    {"myeloperoxidase": 5},\n    {"lysozyme": 5},\n    {"PU.1": 5},\n    {"IL-2 receptor alpha subunit": 5},\n    {"p21ras": 5},\n    {"B cell": 5},\n    {"MNDA": 5},\n    {"Philadelphia chromosome-positive chronic myeloid leukemia": 5},\n    {"SCM-1": 5},\n    {"IL-13": 5},\n    {"IL-4R": 5},\n    {"JAK2": 5},\n    {"IL-13R": 5},\n    {"STAT1": 5},\n    {"SCL": 5},\n    {"GATA-1": 5},\n    {"PML/RARalpha": 5},\n    {"TCRzeta": 5},\n    {"p56(lck)": 5},\n    {"lymphoid neoplasms": 5},\n    {"CD28": 5},\n    {"CD80": 5},\n    {"CD86": 5},\n    {"CBL": 5},\n    {"VAV": 5},\n    {"NFAT": 5},\n    {"interleukin-2": 5},\n    {"granulocyte-macrophage colony-stimulating factor": 5},\n    {"GATA-1": 5},\n    {"NF-kappaB": 5},\n    {"Tax": 4},\n    {"ATL": 4}\n]', 'response3': '[{"TCL1": "protein"}]', 'prediction': {'TCL1': 'protein'}}
{'idx': 1338, 'sentence': 'The survival-promoting activity of the Bcl-2 family of proteins appears to be modulated by interactions between various cellular proteins .', 'label': {'Bcl-2 family': 'protein', 'cellular proteins': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names that are directly mentioned in the sentence, making it highly relevant for extracting named entities."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions specific proteins and DNA, which are relevant entities in the context of the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains specific protein names that are directly mentioned in the sentence, making it highly relevant for extracting named entities."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence mentions a specific protein relevant to the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains specific protein names that are directly mentioned in the sentence, making it highly relevant for extracting named entities."},\n    {"Example 6": 3},\n    {"Reason 6": "The sentence mentions cell adhesion molecules, which are relevant entities but not directly related to the target sentence."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence mentions a specific protein relevant to the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains specific protein names that are directly mentioned in the sentence, making it highly relevant for extracting named entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains specific protein names that are directly mentioned in the sentence, making it highly relevant for extracting named entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains specific protein names that are directly mentioned in the sentence, making it highly relevant for extracting named entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains specific protein names that are directly mentioned in the sentence, making it highly relevant for extracting named entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains specific protein names that are directly mentioned in the sentence, making it highly relevant for extracting named entities."},\n    {"Example 13": 4},\n    {"Reason 13": "The sentence mentions specific proteins and cell lines, which are relevant entities in the context of the target sentence."},\n    {"Example 14": 4},\n    {"Reason 14": "The sentence mentions specific proteins and a cell type, which are relevant entities in the context of the target sentence."},\n    {"Example 15": 3},\n    {"Reason 15": "The sentence mentions a specific protein relevant to the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any relevant entities mentioned in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any relevant entities mentioned in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any relevant entities mentioned in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any relevant entities mentioned in the target sentence."}\n]', 'response3': "[{'Bcl-2': 'protein'}]", 'prediction': {'Bcl-2': 'protein'}}
{'idx': 1323, 'sentence': 'PRE-I forms multiple DNA-protein complexes with nuclear extracts from Jurkat cells .', 'label': {'PRE-I': 'DNA', 'Jurkat cells': 'cell_line', 'multiple DNA-protein complexes': 'protein'}, 'response1': "['DNA', 'protein', 'cell_line']", 'response2': '[\n    {"1": "The example does not contain any relevant entity labels."},\n    {"1": "The example does not contain any relevant entity labels."},\n    {"5": "The example contains the entity label \'protein\' (E2A) which is relevant to the target sentence."},\n    {"5": "The example contains multiple entity labels (\'protein\') relevant to the target sentence."},\n    {"5": "The example contains multiple entity labels (\'protein\') relevant to the target sentence."},\n    {"5": "The example contains multiple entity labels (\'protein\') relevant to the target sentence."},\n    {"5": "The example contains multiple entity labels (\'protein\') relevant to the target sentence."},\n    {"5": "The example contains the entity label \'DNA\' (NF-kappa B) which is relevant to the target sentence."},\n    {"5": "The example contains multiple entity labels (\'protein\') relevant to the target sentence."},\n    {"5": "The example contains multiple entity labels (\'protein\') relevant to the target sentence."},\n    {"5": "The example contains multiple entity labels (\'protein\', \'DNA\') relevant to the target sentence."},\n    {"5": "The example contains multiple entity labels (\'protein\', \'cell_line\') relevant to the target sentence."},\n    {"5": "The example contains multiple entity labels (\'DNA\', \'protein\') relevant to the target sentence."},\n    {"1": "The example does not contain any relevant entity labels."},\n    {"1": "The example does not contain any relevant entity labels."},\n    {"1": "The example does not contain any relevant entity labels."},\n    {"1": "The example does not contain any relevant entity labels."},\n    {"1": "The example does not contain any relevant entity labels."},\n    {"1": "The example does not contain any relevant entity labels."},\n    {"1": "The example does not contain any relevant entity labels."}\n]', 'response3': "[{'PRE-I': 'protein'}, {'DNA': 'DNA'}, {'Jurkat cells': 'cell_line'}]", 'prediction': {'PRE-I': 'protein', 'DNA': 'DNA', 'Jurkat cells': 'cell_line'}}
